Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.6775198655648668,1.8835841869582814,0.0,1.0,0.72,17/67,13.93%,ADRA1A;ARC;CRHR2;NLGN1;CACNG4;TSHZ3;SLC8A3;RGS14;NMU;GRIK2;SYT1;CACNG2;RIMS2;ZDHHC12;NLGN3;CLSTN2;MPP2
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),0.8725382910197627,1.8823652694903843,0.0,1.0,0.72,2/14,0.48%,ADRA1A;ADRA1B
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),0.8792665452850157,1.8601615016711524,0.0,1.0,0.77,2/13,3.83%,PNP;AK3
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.6566362485281122,1.852450353916199,0.0,1.0,0.8,29/101,13.60%,ARC;NGF;GRID2;CEL;NLGN1;GRM3;SNCAIP;LRRC4C;DLGAP4;CX3CR1;GRIK1;SLC8A3;GRM8;NRG3;NMU;GRIK2;SYT1;GRM4;GRM2;GRM7;AKAP9;NPAS4;NLGN4X;RIMS2;NLGN3;PXK;CDH2;CLSTN2;LRP8
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),0.815285692283058,1.8489283536556773,0.0,1.0,0.8,1/15,0.97%,AUP1
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),0.9051956712333995,1.8297898340997345,0.0,1.0,0.85,2/13,1.42%,CLEC2A;KLRD1
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.6408799408153758,1.8245432601470029,0.0,0.9619329188037367,0.85,13/60,10.01%,VWC2;NGF;NEUROD2;FGFR1;NLGN1;BRINP3;BIN1;DTX1;ZC4H2;HES1;ZEB1;BEND6;BRINP1
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.8732047137951019,1.7898292307413297,0.0,1.0,0.94,3/17,4.25%,ADRA1A;ADRA1B;DRD5
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.7949773152630786,1.7896905151289928,0.0,1.0,0.94,2/20,1.84%,CPA1;MAPKAPK2
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),0.7436891787876967,1.7875419770433068,0.02702702702702703,0.9511489174718563,0.94,5/31,7.21%,IRGM;SIRT1;PYHIN1;SNCA;KDM8
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),-0.8721114981324082,-1.7826137229603536,0.0,0.38803462195354127,0.37,2/22,3.68%,GPR62;SCTR
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),0.8736362028972904,1.782152007698123,0.0,0.9072286211383794,0.94,1/14,0.06%,CLEC2A
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),0.7449263287014202,1.779329767259983,0.030303030303030304,0.8555307723291828,0.95,10/30,13.11%,GLYATL1;SLC39A8;DDAH2;KYAT1;RIMKLB;GLUD1;ALDH18A1;AADAT;DDAH1;GLUD2
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.7778281643886014,1.7677313262716996,0.0,0.8594019522944732,0.98,15/33,15.02%,ARC;NGF;GRID2;CEL;NLGN1;LRRC4C;CX3CR1;GRIK1;NRG3;GRIK2;NLGN4X;NLGN3;PXK;LRP8;BCR
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.9021969027726788,-1.7603805023884798,0.0,0.27515182283978384,0.48,3/20,1.85%,CD44;TGFB1;LYVE1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),0.6830827588768302,1.7539538205131375,0.0,0.9036993116115822,0.98,7/48,9.21%,NGF;NYAP2;CNTNAP2;SRGAP2;SGK1;PLXNB1;TNIK
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),0.8430687084680077,1.7536033989279503,0.0,0.8454657044194278,0.98,4/16,4.26%,FGF10;SCRIB;ANGPT1;SEMA5A
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.6493255108498285,1.752425658100522,0.0,0.7992292987089903,0.98,18/42,19.46%,NLGN1;GRM3;CACNG4;TSHZ3;GRIK1;GRM8;SYT1;GRM4;CACNG2;GRM2;GRM7;NLGN3;CDH2;NRXN1;GRIK3;GRM5;CDK5;DGKZ
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.7236558436583644,1.7517600014872432,0.0,0.7566562816862946,0.98,12/34,15.52%,GABRE;GRID2;GABRA5;GABRG3;ARRB2;DRD4;GRIN1;GABRG1;NPAS4;NLGN3;MPP2;INSYN2A
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),0.8791785885305864,1.748632866243341,0.0,0.7439762696627306,0.99,1/15,0.05%,ADRA1A
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.721451047097494,1.7484575895269396,0.0,0.7079980663888252,0.99,5/28,10.27%,ADRA1A;SLC8A1;JPH1;MICU1;MCU
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.8878243874296583,1.7467032899028552,0.0,0.6816567241881636,0.99,3/14,4.25%,ADRA1A;ADRA1B;DRD5
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.8418056452210922,-1.745809587450842,0.0,0.26809664789517396,0.57,1/29,0.01%,CD44
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),0.7786096819754639,1.7378557559557102,0.024390243902439025,0.6944896857731013,0.99,3/22,6.60%,PNP;FHIT;REXO2
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.8061068193087652,1.7326759850793056,0.0,0.695175940403312,0.99,4/20,5.60%,ADRA1A;TRPM2;SLC8A1;JPH1
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.5992019281271708,1.732531119729963,0.0,0.6656073169885868,0.99,53/128,19.93%,SLC17A6;ROBO2;NOVA1;BCL2;GRM3;EPHA7;POU3F2;LRRTM3;LRRC4C;ELAVL3;CADM2;PCLO;PAK5;PROX1;SLC35F1;HIVEP2;EPHA3;ERC2;ADGRA1;FEZF2;CELF5;CELF4;NXPH1;ELAVL4;NPAS3;RAB3C;OLFM3;ASCL1;SNAP91;FUT9;RBFOX1;NF1;SOX5;SCRT1;ANK2;SRRM4;NRXN1;NOTCH1;GRIK3;STIM2;SYN1;PAX6;PPFIA2;EFR3B;LSAMP;FAT3;MMD2;ST8SIA3;ADGRB3;CREB1;CTNNA2;UNC79;PAK3
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.7120669262848177,1.7301040345315928,0.0,0.6491968801792034,0.99,6/26,13.17%,ARC;NCOA3;GREM1;TGFA;NLGN3;HDAC1
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.8050482117021138,1.7175141066995732,0.0,0.6963013979968572,1.0,3/21,2.68%,GRIN3A;APOE;NLGN1
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.7264546347154425,1.7124343935435733,0.0,0.6997157787262434,1.0,4/46,2.06%,CPA1;PPP1R14D;PRSS3;CEL
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.6171655548182033,1.710365139030538,0.0,0.6844246178633462,1.0,33/93,16.24%,PDLIM3;LAMA4;GPR161;AMOTL1;ADGRL2;PARVA;ALDH7A1;PDE10A;IL17RD;RASSF8;SLIT2;EDNRA;ZNF462;TENM3;PPFIBP1;GUCY1A2;DENND2A;CHST3;FLRT2;RBMS3;MPDZ;FARP1;RNF150;TYRO3;NAV1;MAGI1;WWTR1;ANK2;CDH11;ANTXR1;CSRP2;CALD1;DIXDC1
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.9085785780458149,-1.7095834324513735,0.0,0.43389325909350523,0.85,1/15,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.7723287858335661,1.7091920338475868,0.0,0.6696864827097763,1.0,5/24,5.48%,GCK;ZNF692;SIRT1;CRY1;SIRT7
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.7094614981729939,1.7060514516031908,0.0,0.6648150890046854,1.0,8/31,6.01%,CDH20;CDH19;CDH12;CDH7;NLGN1;CDH5;CDH13;CDH6
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.6442665089957762,1.7028000797631606,0.0,0.6592619480889585,1.0,26/66,20.34%,ACADS;GLYATL2;CEL;ACAD10;PEX13;SLC27A2;ABHD3;ECHS1;ABCD3;AIG1;NUDT19;ABCD2;ACADM;MECR;BDH2;ECI1;PLA2G15;ECHDC1;PCCA;LPIN2;SLC27A4;ACOX1;DECR1;HADHB;ECHDC2;ACADVL
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.8112982321197927,1.7020943699411393,0.0,0.6409175501244049,1.0,6/17,10.59%,ARC;APOE;SGK1;RGS14;LDLR;NPAS4
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.6777582028651361,1.6982032613764324,0.0,0.6463660798295848,1.0,11/44,7.01%,CDH20;CDH19;CDH12;CDH7;CDH5;CDH13;CSK;CADM2;CADM1;CDH6;ZNF703
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),0.7365587659494938,1.6905922740534771,0.03225806451612903,0.6665819974778713,1.0,8/22,16.04%,MRAP2;PID1;MYC;LEPR;SDHAF4;COX10;ACSM1;NR4A3
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.591669557260352,1.6897622241162682,0.0,0.6518611628611974,1.0,24/74,20.10%,SLITRK6;LLGL1;PARD3;DSCAML1;SPTBN4;SEMA5A;DCC;DHFR;GRM7;MTR;NTNG2;ARHGAP35;RAB10;RYK;NREP;PARD6B;EPHB2;SLITRK2;S100B;CDK5;CTNNA2;NRCAM;PAK3;MARK2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.8323178923394597,-1.683519066374209,0.0,0.5559477856352555,0.92,3/23,2.28%,CD44;SIRPG;ITGB2
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.9086892970634015,-1.6797783185662096,0.0,0.5115001834842134,0.94,3/16,1.85%,CD44;TGFB1;LYVE1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),0.8832204473410532,1.676297647369243,0.08108108108108109,0.7091559275844587,1.0,2/8,4.29%,MAPKAPK2;CX3CR1
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),-0.797379614761073,-1.675601126067732,0.0,0.4767282498286364,0.98,2/42,1.49%,CD44;TGFB1
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.9581562803153854,-1.6739082386636883,0.0,0.42860187788504783,0.98,2/10,0.09%,CD44;ENPP2
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.5977740606399011,1.672989864943505,0.0,0.7133616881038921,1.0,31/103,17.72%,ARC;KLHL20;APOE;PACSIN2;FGD4;BIN1;SYNE3;PCLO;RHOBTB3;PAK5;RHOBTB1;FGD5;MAST1;MAST2;FGD1;SIPA1;TNIK;WASF3;RND3;SH3KBP1;CSPG5;LRCH3;PDZD8;CFAP410;DST;SIPA1L3;ZMYM4;MARK1;MICAL1;ARHGAP10;MAST4
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.7828823979712038,-1.6714434164044563,0.0,0.4107679634417285,0.99,5/34,5.43%,CD44;SIRPG;NODAL;CXCL13;RNASE10
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.8068357369343406,-1.6708441254980646,0.0,0.37462978955878257,0.99,2/33,4.14%,CD44;RORC
prerank,GO_Biological_Process_2021__positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),0.9541654890380492,1.6672679928087435,0.0,0.7291733657323926,1.0,2/6,0.48%,ADRA1A;ADRA1B
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.8051947530776731,1.6671571760979251,0.0,0.7103818982621883,1.0,4/13,8.49%,FGFR1;HSPB1;SEMA5A;FGF18
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.8264759093695498,-1.6525138390904086,0.016129032258064516,0.4662829258846685,1.0,1/16,0.37%,NEK2
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),0.9243206213583872,1.6498402096646927,0.0,0.8079152587561107,1.0,2/9,1.38%,ARC;GRID2
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.6298736585845027,1.649775231483672,0.038461538461538464,0.7877173772872079,1.0,18/53,24.33%,TRDMT1;TFB1M;METTL1;PUS7L;CTU1;TRMT9B;PUS7;CDKAL1;TRMT61A;ANKRD16;NSUN4;DTWD1;THUMPD1;ADAR;THG1L;NSUN2;ADAT2;TRMT1
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),0.7970659082135768,1.647295533373534,0.04878048780487805,0.7850752969608971,1.0,5/17,4.33%,SLC5A8;APOE;MFSD2A;LCN12;PPARG
prerank,PanglaoDB_Augmented_2021__Neutrophils,-0.6725702090417333,-1.6458021223831478,0.014925373134328358,0.46858120257117025,1.0,32/70,17.79%,LILRB3;RASGRP4;ITGB2;HCK;MMP9;DOCK8;TAGAP;NR1I3;PTAFR;FCGR3A;CEACAM1;LY86;NFAM1;MYO1F;IGSF6;FPR1;SLC11A1;CEACAM8;SPI1;CLEC12A;ARG2;ITGAM;TLR2;NLRP3;CD300LF;ADGRE3;PSTPIP1;ELANE;HK3;CD24;TBXAS1;ALOX5AP
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),-0.8670299952949155,-1.645311784774718,0.0,0.4341646119759902,1.0,2/16,0.81%,GPR62;NMUR2
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.642765022452911,1.643964186206706,0.0,0.7901078309157746,1.0,9/44,9.07%,VWC2L;BAMBI;VWC2;GREM2;PPARG;DLX1;GREM1;FSTL3;CRIM1
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),0.8519511452745968,1.6434971604947815,0.021739130434782608,0.7731376582772341,1.0,3/9,8.97%,GCK;SIRT1;LEPR
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.7390514028942309,1.6434706913363362,0.0,0.7559094751769478,1.0,11/36,9.93%,GRIN3A;GRID2;GRM3;GRIK1;GRM8;PLCB1;GRIK2;GRM4;GRM2;GRM7;GRIN1
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.9060404322151802,1.6420100881023003,0.0,0.7478345456948033,1.0,1/8,0.86%,FOXO1
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.5563230491555909,1.6391232432497944,0.0,0.7515980058697553,1.0,32/131,19.93%,ARC;NGF;SLITRK6;NYAP2;LLGL1;ALCAM;NLGN1;PARD3;DSCAML1;SPTBN4;CNTNAP2;SRGAP2;DCC;SGK1;PLXNB1;TNIK;NTNG2;FARP1;MAP6;RAB10;RYK;PARD6B;EPHB2;DCDC2;SLITRK2;S100B;IMPACT;CPNE1;CDK5;CTNNA2;NRCAM;PAK3
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",0.853139231101257,1.633892315326424,0.023809523809523808,0.7683715672383249,1.0,2/13,2.68%,ADRA1A;NLGN1
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),0.7270071248196778,1.6321193943777732,0.0,0.7674614281188258,1.0,5/20,7.32%,ARC;CRHR2;TSHZ3;SLC8A3;RGS14
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.639852831193707,1.6297232746426262,0.0,0.7705939237438005,1.0,3/50,1.84%,CPA1;PTGS1;MAPKAPK2
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.8165812232423134,1.6296898025823983,0.0,0.7557859493435098,1.0,5/12,10.80%,IRS1;ZBTB7B;SIRT1;SNX5;GKAP1
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),0.7896633945701039,1.6283657915267162,0.0,0.751623747731417,1.0,7/14,10.67%,IRS1;MFSD2A;PLIN5;TWIST1;AKT2;ABCD2;IRS2
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),-0.8388965980242475,-1.6272557360994513,0.0,0.5397208832626528,1.0,2/16,0.57%,BUB1;IHO1
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),0.8432155768435462,1.6228798316469402,0.0,0.776074803541597,1.0,3/12,7.93%,ADRA1A;SLC8A1;EDNRA
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.7629813365557442,1.6228766717932457,0.0,0.7614318827200575,1.0,6/15,15.58%,NLGN1;CACNG4;TSHZ3;CACNG2;NLGN3;NRXN1
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),0.6717642147645777,1.6210603246126214,0.02702702702702703,0.7585147010879323,1.0,13/35,20.96%,FOXO1;ZDHHC16;ZDHHC18;ZDHHC12;KAT6A;ZDHHC14;ZDHHC3;ZDHHC13;EP300;ZDHHC9;KAT2B;ZDHHC5;ZDHHC23
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),0.8671426833444823,1.6192990210636744,0.02040816326530612,0.7546055913795477,1.0,6/9,10.67%,IRS1;PLIN5;TWIST1;AKT2;ABCD2;IRS2
prerank,PanglaoDB_Augmented_2021__Clara Cells,-0.6759210887492054,-1.6188990627533069,0.0,0.5733505504986264,1.0,28/70,18.44%,PLEKHS1;DUOX1;ST6GALNAC1;SFTPA1;VSIG2;AHR;FOXM1;CAPN8;SMIM22;TMC4;DUOXA1;SFTPD;CYP2B7P;SYT2;MUC5B;BPIFB1;MS4A8;ITGB6;STEAP4;TRIM29;CYP4F12;MUC4;CYP2E1;PROM2;ADH7;SCNN1A;CYP4B1;CAPN13
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.6693643955224715,-1.6186942707169611,0.0,0.540602780130729,1.0,6/74,5.82%,CD44;ENPP2;TGFB1;ITGB2;TEC;VTN
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.8209797137995379,1.6165519005557738,0.0,0.7474637274033913,1.0,2/13,2.61%,IL7R;IRS1
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.8209797137995379,1.6165519005557738,0.0,0.7474637274033913,1.0,2/13,2.61%,IL7R;IRS1
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.6626600524033607,1.6126880582309264,0.0,0.7603464663205506,1.0,13/38,18.32%,IRS1;ZBTB7B;PID1;SIRT1;SNX5;KANK1;VWA2;GKAP1;PTPRE;PIP4K2A;NCK1;SLC27A4;SIK2
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.7064402194123036,-1.6126302173583682,0.0,0.561093913241912,1.0,1/41,0.01%,CD44
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.7057370206694772,-1.6125641386151104,0.016129032258064516,0.5303139833365064,1.0,21/74,13.10%,CD44;TRIM62;HCK;IRF4;WNT5A;SP100;IRF1;TRIM5;PTAFR;CIITA;TRIM25;STAT1;OAS2;HLA-A;HLA-DPB1;GBP1;HLA-DRB1;AQP4;OAS1;TLR2;HLA-DPA1
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.742457170816259,-1.6116509151894751,0.015625,0.5090865710031627,1.0,16/51,10.21%,CD44;TRIM62;HCK;IRF4;SP100;IRF1;TRIM5;PTAFR;CIITA;TRIM25;STAT1;OAS2;HLA-A;HLA-DPB1;GBP1;HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),0.6710982085855796,1.6116059521550865,0.030303030303030304,0.7553918763456873,1.0,1/36,0.03%,IL7R
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.8193824494141332,-1.6065717751850894,0.0,0.5280798446040466,1.0,1/16,0.01%,CD44
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.9201579577251628,-1.6046406242291857,0.01639344262295082,0.5146918102448703,1.0,1/8,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.7637756017133319,1.6042387740617419,0.02564102564102564,0.781610273582129,1.0,9/18,18.08%,GPC4;IL1RAPL2;GPC6;SNCA;LRFN5;WNT3A;PTPRD;MDGA1;SLITRK2
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.7637756017133319,1.6042387740617419,0.02564102564102564,0.781610273582129,1.0,9/18,18.08%,GPC4;IL1RAPL2;GPC6;SNCA;LRFN5;WNT3A;PTPRD;MDGA1;SLITRK2
prerank,GO_Biological_Process_2021__leukocyte aggregation (GO:0070486),-0.9686396641198071,-1.6040706642677678,0.0,0.49610707451415564,1.0,1/5,0.01%,CD44
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),0.7877760715863852,1.6035469874234758,0.03225806451612903,0.7733868310011814,1.0,1/16,0.17%,PNP
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),0.8674726559504077,1.603303981756411,0.05128205128205128,0.7620694274528855,1.0,1/7,3.19%,SLC39A8
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),0.8173837305549443,1.6032725161160273,0.023255813953488372,0.7501620926489342,1.0,1/10,0.75%,MT1G
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),0.6275126323796749,1.5998386681366144,0.027777777777777776,0.7627773003608243,1.0,10/42,9.94%,TSKU;LIPC;CEL;APOB;APOE;SOAT1;AKR1C1;SOAT2;ABCA1;LDLR
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.821401204192929,-1.5995979075476503,0.0,0.5076658492751863,1.0,1/23,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),0.7716211353194317,1.5991400663218105,0.05263157894736842,0.7537363355146142,1.0,6/14,16.95%,CTDNEP1;MFSD2A;PLIN5;LDLR;NR1H3;GPLD1
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.7900586493008788,1.5966316193626455,0.05555555555555555,0.762766900175843,1.0,10/18,12.56%,CSGALNACT1;HS6ST2;HS3ST3B1;EXT1;NDST3;HS3ST5;HS2ST1;B3GAT3;UGDH;EXT2
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.6663262404442609,1.5949614990583585,0.0,0.7613187763797841,1.0,8/24,15.52%,GRID2;ARRB2;DRD4;GRIN1;NPAS4;NLGN3;MPP2;INSYN2A
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),0.9150915895408529,1.5941042094844236,0.0,0.7557553165281323,1.0,2/8,4.19%,VEGFC;IL16
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),0.7880565849280948,1.5939081414042195,0.025,0.7456058520862145,1.0,2/12,0.67%,ADRA1A;DGKD
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.8009218259541974,1.5931867204100527,0.05405405405405406,0.7410583450457006,1.0,5/12,9.44%,SCRIB;WNT4;ZNF703;LATS1;AKT2
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.8064405407904524,-1.5913930049155103,0.015625,0.5550070956426408,1.0,5/15,12.20%,CRLF1;STAT1;OAS2;IL27;OAS1
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),0.7620118687728896,1.5906838879439753,0.05128205128205128,0.747121603384529,1.0,2/19,2.60%,CTDNEP1;TOR1B
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.8805334584150204,-1.5904363696196584,0.0,0.5429662637371733,1.0,1/17,0.01%,CD44
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.6661783412458632,1.589492810625809,0.09090909090909091,0.7441256371088798,1.0,17/43,21.52%,HDAC3;HDAC10;PRDM5;SIRT1;SIRT7;MIER2;FLNA;HDAC1;HDAC4;HDAC11;BAZ2A;SIRT6;BRMS1L;HDAC5;TBL1X;RCOR2;HDAC7
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.7719858249250638,1.588560883021116,0.0967741935483871,0.7387623831329024,1.0,11/21,12.57%,HS6ST2;HS3ST3B1;EXT1;NDST3;HPSE;HS3ST5;HS2ST1;B3GAT3;UGDH;EXT2;HS3ST4
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),-0.8969194991897919,-1.5884557706316669,0.0,0.5394495303801679,1.0,1/13,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.6750947719518018,1.585929251431536,0.047619047619047616,0.7448150253218767,1.0,18/45,16.57%,GPC4;GRID2;ROBO2;LHFPL4;NLGN1;IL1RAPL2;GPC6;SNCA;LRFN5;SYNDIG1;WNT3A;NLGN3;CLSTN2;NRXN1;PTPRD;DLG5;MDGA1;EPHB2
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.6953314587763632,-1.5845529417471822,0.0,0.549781040128115,1.0,2/46,2.53%,CD44;MMP9
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),0.7978253487715881,1.581726352892771,0.02,0.7638194627567433,1.0,2/9,5.38%,WNT4;SNCA
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.6996538290813497,1.5812797424841225,0.058823529411764705,0.7576251117524742,1.0,3/15,8.70%,NXF5;IWS1;NXF1
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.6505193123043015,-1.5801826482130847,0.0136986301369863,0.5649179366362593,1.0,3/78,0.93%,CD44;TBX1;FGF20
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",0.8653236219457259,1.5794605485525726,0.046511627906976744,0.7620417761674191,1.0,5/7,12.56%,CSGALNACT1;EXT1;NDST3;HS2ST1;EXT2
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),0.6782130509717835,1.5788526180998745,0.046511627906976744,0.7577467264970685,1.0,5/20,12.41%,NGF;MAGI2;RAPGEF1;RAB35;RAP1A
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.9085160306832278,-1.5780002816914085,0.0,0.5649005593580707,1.0,1/13,0.01%,CD44
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),0.913597898959778,1.5763569150457946,0.0,0.7673356147699538,1.0,2/8,6.26%,GRID2;PROX1
prerank,GO_Biological_Process_2021__regulation of skeletal muscle satellite cell proliferation (GO:0014842),0.9098572784682761,1.5753022573965505,0.0,0.7641996005554792,1.0,2/6,2.81%,CFLAR;ANGPT1
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.7550142396888612,-1.5739541197197566,0.0,0.5829926229229265,1.0,3/21,1.75%,SLC28A2;JCHAIN;TULP1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),0.8694901641107131,1.5728400950589374,0.0,0.7688729925208035,1.0,1/12,0.68%,CTDNEP1
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.6523256528084392,-1.565212246469673,0.0,0.6431588514021745,1.0,57/85,27.80%,RPL37A;RPL38;RPL15;RPS4X;RPL3;RPL35A;RPS9;RPS27;RPS21;SRP14;RPL13A;RPL27A;RPS16;RPL36;RPS20;RPL7A;RPL9;RPL13;RPS8;RPS27A;RPL21;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;SRP19;RPL27;RPL35;RPS14;RPL11;RPS15;RPLP1;RPS12;RPL24;RPL18A;RPS13;RPL29;RPLP2;RPL28;RPL12;RPL18;RPS3;RPL22;RPSA;RPS28;RPS19;RPS24;RPS3A;RPL19;RPL8;RPS6;RPL10;SRP68
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",0.7081269417675109,1.5651823661896023,0.037037037037037035,0.8105411314313617,1.0,2/17,9.36%,AUP1;RHBDD1
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.6551558753896849,-1.565124766444914,0.0,0.6239420341639329,1.0,58/87,27.27%,RPL37A;RPL38;RPL15;RPS4X;RPL3;RPL35A;RPS9;RPS27;RPS21;RPL13A;RPL27A;RPS16;RPL36;RPS20;RPL7A;RPL9;RPL13;RPS8;RPS27A;RPL21;EIF4A2;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;RPL27;RPL35;TMA7;RPS14;RPL11;DRG1;RPS15;RPLP1;RPS12;RPL24;RPL18A;RPS13;RPL29;ZC3H15;RPL28;RPL12;RPL18;RPS3;RPL22;RPSA;RPS28;RPS19;RPS24;RPL26L1;RPS3A;RPL19;RPL8;RPS6;RPL10
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.8028709382873794,1.564435430903941,0.05714285714285714,0.8064635662691267,1.0,6/13,11.85%,FGD4;VSTM5;SRGAP2;FGD5;FGD1;PPP1R9B
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.6925906186695469,-1.5641237047710737,0.028169014084507043,0.6150829792618944,1.0,9/59,9.19%,CD44;TGFB1;CXCL13;IRF1;TNFRSF1B;STAT1;IL7;IL3RA;OSMR
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.5758059145331229,1.5627792942789098,0.0,0.808343365716978,1.0,39/127,19.40%,CDH20;SLC17A6;POU3F1;SPHKAP;SEZ6L;GRM3;KCNB2;LRRTM3;KCNC2;ELAVL3;NGB;CADM2;PAK5;KCND2;ADGRA1;NR4A2;FEZF2;CELF4;BRINP1;GABRG1;NXPH1;ELAVL4;RAB3C;OLFM3;SNAP91;RBFOX1;SCRT1;VSTM2B;SRRM4;NRXN1;KCND3;RIT2;SYN1;SATB2;MMD2;ST8SIA3;ADGRB3;GRM5;CTNNA2
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),0.8264279252366485,1.5622011409600152,0.0,0.8022795409461762,1.0,3/11,4.79%,MT1G;PPARG;IFI16
prerank,GO_Biological_Process_2021__megakaryocyte development (GO:0035855),0.9754025967051632,1.5617387566171037,0.0,0.796181578792351,1.0,1/5,1.53%,KIT
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),0.7877946181857369,1.5613707364565115,0.0196078431372549,0.7900506430299239,1.0,7/12,16.04%,IRS1;PLIN5;TWIST1;AKT2;ABCD2;IRS2;NR4A3
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.6460646484428182,-1.5606592184065073,0.0,0.6312306523971511,1.0,57/88,27.27%,RPL37A;RPL38;RPL15;RPS4X;RPL3;SEC62;RPL35A;RPS9;RPS27;RPS21;SRP14;RPL13A;RPL27A;RPS16;RPL36;RPS20;RPL7A;RPL9;RPL13;RPS8;RPS27A;RPL21;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;SRP19;RPL27;RPL35;RPS14;RPL11;RPS15;RPLP1;RPS12;RPL24;RPL18A;RPS13;RPL29;RPLP2;RPL28;RPL12;RPL18;RPS3;RPL22;RPSA;RPS28;RPS19;RPS24;RPS3A;RPL19;RPL8;RPS6;RPL10
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.8218577196398971,1.560531385896399,0.023255813953488372,0.7881287445290251,1.0,5/12,10.67%,GCK;IRS1;PPP1R3E;AKT2;IRS2
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.8852154265530561,1.5590150501484061,0.023809523809523808,0.7864173060155312,1.0,4/6,9.08%,ROBO2;ALCAM;SLIT2;PTPRM
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.7408470609340071,-1.5586106700956404,0.03076923076923077,0.6323452514640305,1.0,1/22,0.37%,NEK2
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.8242295368344791,1.5583616910109928,0.023255813953488372,0.7825866812689247,1.0,5/11,10.67%,GCK;IRS1;PPP1R3E;AKT2;IRS2
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.6508890572886549,1.5571881877927336,0.03225806451612903,0.7817932095990205,1.0,7/28,8.53%,GRID2;ZC4H2;MDGA2;TOX;PROX1;NR4A2;LRP6
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,-0.6846306919359372,-1.556743692314644,0.0,0.6277145929884811,1.0,24/62,13.42%,LILRB3;CLEC5A;ITGB2;HCK;KLHDC4;TNFRSF1B;PTAFR;TRIM25;C3AR1;MS4A4A;FCGR3A;LY86;VSIG4;NFAM1;MYO1F;IGSF6;FPR1;SLC11A1;SPI1;CLEC12A;ITGAM;TLR2;NLRP3;CD300LF
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.6925758588344904,1.5562867280232036,0.0,0.7790687241760433,1.0,12/26,18.08%,GRID2;NLGN1;VSTM5;SYNDIG1;SEMA4A;NLGN3;CLSTN2;NRXN1;PTPRD;DLG5;EPHB2;SLITRK2
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),0.7847159848446988,1.5558710919784091,0.02631578947368421,0.7728687252405559,1.0,6/11,16.95%,CTDNEP1;MFSD2A;PLIN5;LDLR;NR1H3;GPLD1
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),0.8296693601677115,1.5556014388999018,0.02564102564102564,0.7666403304735562,1.0,1/10,0.67%,DGKD
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),0.9685001823536165,1.5550877543720039,0.0,0.7632152275943979,1.0,1/6,0.13%,PKD1L1
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.7314402805080239,1.5543955787125052,0.02702702702702703,0.7586155823527782,1.0,5/23,10.67%,GCK;IRS1;PPP1R3E;AKT2;IRS2
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),0.7626630663335374,1.5540274694909118,0.046511627906976744,0.7528773501271397,1.0,6/15,16.95%,CTDNEP1;MFSD2A;PLIN5;LDLR;NR1H3;GPLD1
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.7501332783081975,1.5525099909607016,0.0,0.7544225901448249,1.0,7/14,18.08%,GPC4;LRRC4C;GPC6;LRFN5;PTPRF;PTPRD;SLITRK2
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.820011112992713,1.5520583304102802,0.0,0.7501998366535957,1.0,5/11,10.80%,IRS1;ZBTB7B;SIRT1;SNX5;GKAP1
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.8278314723891015,-1.5518143929933983,0.01639344262295082,0.6546058266174483,1.0,3/13,3.57%,WNT5A;DOCK8;CXCL13
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),-0.8165523509978787,-1.5487144607164158,0.017543859649122806,0.6644860822831216,1.0,2/11,5.18%,AMBP;GPER1
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.8839761605665015,-1.5483484628815662,0.015625,0.650342408355702,1.0,1/9,0.37%,NEK2
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.7639295283486681,-1.5471801725772054,0.01694915254237288,0.6418445405858803,1.0,1/22,0.01%,CD44
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),0.9428743985113787,1.5466658042628378,0.023255813953488372,0.7796939735239984,1.0,1/8,1.53%,KIT
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.6709449329540527,1.5447276344898784,0.022222222222222223,0.7872955325292256,1.0,5/18,13.93%,GRID2;ARRB2;GRIN1;NPAS4;MPP2
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.5437760669270694,1.5425460098789543,0.037037037037037035,0.7924042299048936,1.0,32/85,12.56%,VCAN;GPC4;CSGALNACT1;ANGPT1;SDC4;HS6ST2;CHST6;CHSY3;HS3ST3B1;EXT1;HS3ST1;GPC6;PRELP;CHSY1;CHST12;HS3ST5;ST3GAL3;B4GALT2;HS2ST1;UST;HS3ST2;B4GALT3;GPC5;CHPF2;CHST11;CSPG5;B3GAT3;CHST3;UGDH;SDC3;DSEL;EXT2
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.6992657814559365,1.5414808243952356,0.0,0.7929144363906103,1.0,8/17,17.89%,WNT4;PKD2;PRKCSH;PROX1;COBL;NF1;ARID5B;NIPBL
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.6300941800568688,-1.5401961598235394,0.031746031746031744,0.6963973902642934,1.0,17/84,11.60%,CD44;RASGRP4;GMFG;NR1I3;PKLR;SLFN14;LOX;GYPB;ICAM3;C19ORF38;CA1;CEACAM1;MYO1F;THBS1;FPR1;ALAS2;CLEC12A
prerank,GO_Biological_Process_2021__intestinal lipid absorption (GO:0098856),0.8412524700453703,1.5400432134376227,0.047619047619047616,0.7958592982927776,1.0,4/10,9.94%,CEL;AKR1C1;SOAT2;LDLR
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.6343963778083835,-1.5397909633006885,0.0,0.6840160089155065,1.0,63/97,27.80%,RPL37A;RPL38;RPL15;RPS4X;RPL3;SEC62;RPL35A;RPS9;RPS27;RPS21;SRP14;RPL13A;RPL27A;RPS16;RPL36;RPS20;RPL7A;RPL9;RPL13;RPS8;RPS27A;RPL21;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;SRP19;RPL27;RPL35;RPS14;RPL11;SGTB;RPS15;RPLP1;RPS12;RPL24;RPL18A;RPS13;RPL29;RPLP2;RPL28;RPL12;RPL18;RPS3;RPL22;RPSA;RPS28;SPCS2;RPS19;RPS24;CHMP4B;RPS3A;RPL19;SPCS1;RPL8;RPS6;RPL10;ZFAND2A;SRP68
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.8356161606557457,1.5396671463139204,0.1,0.7900603541803514,1.0,2/10,3.92%,PLD6;PID1
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),0.9200739193824792,1.5372297676986748,0.041666666666666664,0.7915057570143518,1.0,3/5,4.38%,DPY19L3;DPM3;DPY19L1
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),0.9200739193824792,1.5372297676986748,0.041666666666666664,0.7915057570143518,1.0,3/5,4.38%,DPY19L3;DPM3;DPY19L1
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.6732012830062705,-1.537034534981183,0.0,0.6918993660795278,1.0,4/59,4.00%,CD44;MICB;IRF4;IFNK
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.772345936716875,1.536791793964841,0.1282051282051282,0.7865989081582454,1.0,3/8,14.76%,HDAC10;SIRT1;HDAC4
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.6942958724241458,1.5360340605273535,0.1,0.7841145404786024,1.0,7/19,14.59%,CEP135;CEP120;CROCC;CCDC88A;ARHGAP35;SEPTIN9;MARK4
prerank,GO_Biological_Process_2021__membrane depolarization during AV node cell action potential (GO:0086045),-0.9536085265269829,-1.5354364456312837,0.0,0.6890019712951928,1.0,1/5,1.19%,SCN5A
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),0.794548708820659,1.5339013698393933,0.06976744186046512,0.7916039896591167,1.0,2/9,9.93%,GRIN3A;GRIN1
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.6154560651502832,1.5337392222615778,0.043478260869565216,0.7857492970441396,1.0,16/57,10.27%,FGF10;KIT;PARVA;CAPN10;AUTS2;FER;PHACTR1;PDLIM4;FLNA;EFS;RALA;RAP2A;CASS4;TNIK;FARP2;MCU
prerank,GO_Biological_Process_2021__pyrimidine nucleoside transport (GO:0015864),-0.966968121265136,-1.533416478642345,0.0,0.6607846831100536,1.0,3/5,2.79%,SLC28A2;SLC28A1;SLC28A3
prerank,GO_Biological_Process_2021__uridine transport (GO:0015862),-0.966968121265136,-1.533416478642345,0.0,0.6607846831100536,1.0,3/5,2.79%,SLC28A2;SLC28A1;SLC28A3
prerank,GO_Biological_Process_2021__nucleoside transport (GO:0015858),-0.966968121265136,-1.533416478642345,0.0,0.6607846831100536,1.0,3/5,2.79%,SLC28A2;SLC28A1;SLC28A3
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),0.7957753796849785,1.5328195656909602,0.04878048780487805,0.7837392259994251,1.0,4/17,8.20%,ERBB2;SIRT7;EIF2AK3;FLNA
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),-0.8456775733781563,-1.5321785666692793,0.017543859649122806,0.655249372980639,1.0,2/16,2.76%,SCN5A;CAV3
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.6990279959956873,-1.5317155987650368,0.0625,0.6463404148235423,1.0,5/28,11.29%,MICB;AIM2;STAT1;TRAF3IP2;USP17L2
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.6282958649579686,-1.531703418274115,0.014285714285714285,0.6335547100259636,1.0,9/86,10.40%,CD44;LYVE1;ECM2;ITGB2;VTN;PARVG;ACTN3;ITGBL1;CD63
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.5661758210943666,1.5315562811257528,0.0,0.7845455565445942,1.0,26/61,22.14%,VWC2L;BAMBI;VWC2;CDH5;CCN1;PPARG;DLX1;GREM1;UBE2O;FSTL3;CRIM1;ITGA3;TWSG1;SMAD2;BMPER;SMURF1;ELAPOR2;NOTCH1;SKI;RBPJ;ACVR2A;FSTL1;BMPR2;BMP4;SMAD5;SMAD7
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,-0.6977632704166643,-1.531253002047816,0.014925373134328358,0.6252821715614997,1.0,24/51,14.67%,LILRB3;ITGB2;HCK;CYTIP;TAGAP;TNFRSF1B;PTAFR;PARVG;FCGR3A;LY86;NFAM1;ADGRE1;MYO1F;IGSF6;PTPRC;FPR1;CEACAM8;SPI1;CLEC12A;ITGAM;CD300LF;ADGRE3;PSTPIP1;CD80
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),0.8587441212456034,1.5310792850785688,0.022727272727272728,0.7810055086321702,1.0,1/7,0.82%,IRGM
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.6419208437362977,1.530433016085192,0.04878048780487805,0.7810405930143143,1.0,6/24,11.50%,PNP;NT5C1A;NUDT4B;PRTFDC1;PDE9A;NUDT18
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),0.8823384388887701,1.5290462775461813,0.0,0.783526824974781,1.0,1/11,0.03%,IL7R
prerank,GO_Biological_Process_2021__meiotic DNA double-strand break formation (GO:0042138),-0.9747615978392337,-1.5271067702627008,0.0,0.6447344487843455,1.0,1/5,0.57%,IHO1
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),0.8244620847351612,1.5250324116391556,0.05,0.8038833264024311,1.0,4/9,11.22%,SLC38A5;SLC6A17;SLC6A20;SLC7A8
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),-0.7606174842757059,-1.524983983358054,0.017857142857142856,0.6492092114124942,1.0,2/18,3.57%,DOCK8;CXCL13
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),0.7806204581690842,1.5240969022661708,0.0,0.8037252757348551,1.0,2/10,8.97%,SIRT1;LEPR
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.5463344186967413,1.5231721556811633,0.0,0.8030666058495844,1.0,25/94,15.10%,EYA4;GPR161;ADGRL2;KIAA1549;MID1;IL17RD;GPC6;ZFHX4;KCNIP3;OSR1;RAI14;SLIT2;TENM3;AADAT;PRTG;CAP2;CHST3;MPDZ;DDAH1;RBFOX2;CDH2;FJX1;NR2F2;MAGI1;ANTXR1
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,-0.6526847891780927,-1.5230941253253318,0.015384615384615385,0.6536488934793154,1.0,29/63,16.71%,AHR;ITGB2;HCK;CYTIP;TAGAP;ALOX5;CLDN1;PTAFR;HLA-DMA;CIITA;MS4A4A;PARVG;FCGR3A;LY86;NFAM1;HLA-DPB1;MYO1F;IGSF6;HLA-DRB1;PTPRC;SPI1;ITGAM;TLR2;HLA-DPA1;CD300LF;CD80;HLA-F;HK3;NAPSB
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),0.6318046842074584,1.5207163340850194,0.09375,0.8146466328445163,1.0,3/19,6.48%,PNP;AMPD1;POLD3
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),0.9295913979131984,1.5199269989243624,0.03571428571428571,0.8141567431755584,1.0,2/7,2.68%,GRIN3A;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.891869982572983,-1.5196857352628852,0.014925373134328358,0.6558792993149791,1.0,1/10,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.891869982572983,-1.5196857352628852,0.014925373134328358,0.6558792993149791,1.0,1/10,0.01%,CD44
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.7089311103792214,1.5186214422894535,0.02857142857142857,0.8163752032656234,1.0,5/15,12.78%,KCNC2;PKD2;GRIN1;MAT2A;CPSF7
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.8619964761689936,1.515131865021812,0.0,0.8272278013669515,1.0,3/7,10.21%,FOXO1;KCNC2;MTR
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.8619964761689936,1.515131865021812,0.0,0.8272278013669515,1.0,3/7,10.21%,FOXO1;KCNC2;MTR
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.4940235850228582,1.5143416841877526,0.0,0.8273725466292728,1.0,22/157,12.22%,ARC;GPRIN3;NGF;NYAP2;TSKU;IFT88;GPRIN1;APOE;NLGN1;CNTNAP2;WHRN;SRGAP2;SAMD14;HMGB1;SGK1;PLXNB1;PTPRM;TNIK;GRM7;RAB35;PPP1R9B;ADGRV1
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),-0.8906404134617104,-1.5133693946578026,0.0,0.6998238445056849,1.0,4/10,9.22%,ENPP2;CYP1B1;PDXDC1;PPT1
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.577945462757316,1.5131897121111373,0.043478260869565216,0.8285849212322007,1.0,15/83,7.95%,ADRA1A;GPR3;LGR5;ADRA1B;ADGRG6;GPR161;ADGRL2;ADGRG3;DRD5;GPR26;GPR78;RXFP1;S1PR5;ABCA1;ADCY2
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),0.6715475682132448,1.5130415920760298,0.0,0.8231731516661812,1.0,5/24,8.83%,ARC;NLGN1;CACNG4;CNIH3;CACNG2
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),0.8365261865426811,1.5118334788176127,0.0,0.8258037112933945,1.0,2/8,5.35%,GCK;CRY1
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),0.8069512008410088,1.5114194765384354,0.0,0.8225870308245612,1.0,1/12,0.33%,NIPAL1
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.605152119566694,-1.5111064221341808,0.0,0.7062473401449093,1.0,28/99,13.64%,CD44;ITGB2;HCK;TAGAP;TNFRSF1B;PTAFR;C3AR1;PARVG;FCGR3A;PLAU;IFIT3;LY86;NFAM1;PSAP;ADGRE1;MYO1F;IGSF6;GBP1;PTPRC;FPR1;SPI1;CLEC12A;ITGAM;IFIT1;OAS1;TLR2;CD300LF;ADGRE3
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),0.5191136393308944,1.5108086307152735,0.037037037037037035,0.820341450934772,1.0,23/87,18.66%,NGF;TGFBR1;BCL2;MFSD2A;ERBB2;SYT3;SLC25A33;SYT17;GOLGA4;SYT1;RPS6KA3;ADNP2;RIMS2;MACF1;MAP3K13;CPNE6;KLHL22;SMURF1;DNPH1;CPNE9;BRAT1;LIMK1;ADAM10
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.7067120937943874,1.509823580147843,0.03225806451612903,0.820760537731847,1.0,3/15,10.38%,DHFR;ACER2;ACER3
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),0.862947637988512,1.509755667392272,0.06382978723404255,0.8148164374761886,1.0,3/7,13.11%,GLUD1;ALDH18A1;GLUD2
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),0.8563912281458159,1.5096151331009229,0.04878048780487805,0.8096370671585832,1.0,2/9,5.38%,SCRIB;SNCA
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),0.8748676991144587,1.508217936135081,0.027777777777777776,0.806611581973682,1.0,2/8,2.66%,CEL;APOE
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),0.8748676991144587,1.508217936135081,0.027777777777777776,0.806611581973682,1.0,2/8,2.66%,CEL;APOE
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.7325768172934899,1.5080731281819129,0.12121212121212122,0.8020463238744258,1.0,2/14,1.73%,SLC5A8;RNLS
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),0.7428436946789312,1.5057329495297986,0.08108108108108109,0.8108943842076602,1.0,4/10,19.46%,PNPLA3;GAL3ST1;PLA2G15;DGKZ
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),-0.8559096241976967,-1.5045733587345402,0.02127659574468085,0.7474898064195952,1.0,1/10,0.45%,TICRR
prerank,GO_Biological_Process_2021__intracellular pH elevation (GO:0051454),0.8765753563881921,1.5042961777752466,0.09302325581395349,0.8138584947603767,1.0,2/6,2.31%,SLC26A3;BCL2
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.6809726686104566,-1.5037745969703633,0.0,0.7434978529128002,1.0,21/49,13.64%,LILRB3;CLEC5A;HCK;SLC7A7;C3AR1;MS4A4A;FCGR3A;LY86;VSIG4;NFAM1;ADGRE1;MYO1F;IGSF6;FPR1;SLC11A1;SPI1;CLEC12A;ITGAM;TLR2;CD300LF;ADGRE3
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.868119612326298,-1.5035144248582821,0.0,0.7337381942394235,1.0,1/14,0.01%,CD44
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),0.715286422470601,1.5010888467126093,0.05714285714285714,0.8263780220619993,1.0,3/21,4.57%,PNP;FHIT;NT5C1A
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),-0.7325401040321526,-1.5009983004012466,0.045454545454545456,0.7436381977907308,1.0,3/21,2.91%,TBX1;DNAH11;MMP21
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.5971788112971353,-1.4997221808331458,0.012987012987012988,0.7435930417811006,1.0,7/99,5.82%,CD44;ENPP2;CRLF1;TGFB1;TEC;CLCF1;VTN
prerank,GO_Biological_Process_2021__heparin metabolic process (GO:0030202),0.8982110350550395,1.4990174176209163,0.0196078431372549,0.8360430876528485,1.0,2/5,2.81%,CSGALNACT1;ANGPT1
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),-0.8346007271219867,-1.4986439113275263,0.043478260869565216,0.7409036062925428,1.0,4/18,7.40%,C1QTNF1;ALOX12;BLK;CEACAM1
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),0.7298520173113406,1.4959530182060132,0.0425531914893617,0.853014505351744,1.0,4/18,10.32%,HTR2C;DLGAP4;SLC8A3;AKAP9
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),0.881038445147016,1.4954108493850038,0.023809523809523808,0.8518003625444485,1.0,2/5,9.91%,HMGB1;LPL
prerank,GO_Biological_Process_2021__positive regulation of receptor binding (GO:1900122),-0.9142835793731807,-1.4951552378622044,0.03636363636363636,0.7606564001819348,1.0,1/6,2.53%,MMP9
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.8148181056475925,1.494406232079895,0.06666666666666667,0.8526999719795643,1.0,2/11,6.85%,PHLDB2;OSR1
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),0.7442863662135815,1.494003844403536,0.13157894736842105,0.8491099531453735,1.0,2/8,7.57%,APOE;ABL1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),-0.8101429861549108,-1.4937918276541473,0.05454545454545454,0.7626002735582819,1.0,4/11,16.13%,ITGB2;ITGAM;HLA-F;F2RL1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.6278064791429193,-1.4931300229925046,0.014285714285714285,0.7563779347333206,1.0,5/64,5.61%,CD44;TGFB1;TERF2IP;IFNK;PINK1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.7207376564223116,1.4925341443855837,0.02631578947368421,0.8521872394961477,1.0,4/15,5.25%,ANGPT1;CDH5;SEMA5A;SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.803480931591342,1.492376953790358,0.045454545454545456,0.8476225046858039,1.0,4/11,7.74%,FGFR1;ITGA4;HMGB1;SP1
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.685476976217623,1.4920328825755762,0.06451612903225806,0.8451596719491986,1.0,6/21,7.63%,DPY19L3;DPM3;TMTC2;DPY19L1;FKTN;FKRP
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),0.7625283834895478,1.4919860457574345,0.0,0.8394874593857812,1.0,6/13,10.07%,EGLN3;JMJD4;P3H3;P3H2;PLOD3;P3H4
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),0.7707445986940304,1.4918339330369073,0.09090909090909091,0.835299985830575,1.0,3/9,7.17%,TOP2A;HMGB1;TOP1MT
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.5607549799704901,1.491602221990752,0.04,0.8323677849209716,1.0,24/72,20.13%,GCK;FOXO1;CPEB1;IRS1;RAB31;ZBTB7B;CAPN10;PPARG;SIRT1;SLC25A33;FER;AKT2;IRS2;TBC1D4;RAB10;INSR;LPIN2;GPLD1;SYAP1;MYO5A;PDE3B;KAT2B;HDAC5;MARS1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.8368403684382345,1.4896753646615826,0.058823529411764705,0.840499388016588,1.0,4/9,9.48%,POGLUT3;GALNT1;POGLUT2;GALNT13
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.7925020237112679,1.4895817967062488,0.023809523809523808,0.824621273457935,1.0,3/8,17.56%,HSPB1;RAB27B;DLG2
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.7925020237112679,1.4895817967062488,0.023809523809523808,0.824621273457935,1.0,3/8,17.56%,HSPB1;RAB27B;DLG2
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.7925020237112679,1.4895817967062488,0.023809523809523808,0.824621273457935,1.0,3/8,17.56%,HSPB1;RAB27B;DLG2
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.6252886549311245,-1.4894403176305426,0.014084507042253521,0.7781442953613795,1.0,6/78,7.22%,NLRP4;IRF1;UBE2L6;TRIM25;NFKB2;POLR1C
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),0.6382861833339865,1.488814146028274,0.08,0.8261098045929756,1.0,6/26,11.22%,SLC38A5;SLC3A2;SLC7A9;SLC6A17;SLC6A20;SLC7A8
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),0.9633707297492811,1.4884922704659715,0.0,0.8228673831570794,1.0,1/5,2.08%,ROBO2
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),0.8630334028153306,1.4884185141427064,0.0,0.818137133955599,1.0,2/8,6.21%,NGF;DCC
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.8042057368282703,1.4866118774607566,0.041666666666666664,0.82438603389145,1.0,4/8,12.41%,NGF;MAGI2;RAPGEF1;RAP1A
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),0.8610856054573909,1.486436494820748,0.05263157894736842,0.8096787962958542,1.0,1/6,5.79%,GBF1
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),0.8610856054573909,1.486436494820748,0.05263157894736842,0.8096787962958542,1.0,1/6,5.79%,GBF1
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),0.8610856054573909,1.486436494820748,0.05263157894736842,0.8096787962958542,1.0,1/6,5.79%,GBF1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),-0.8128598551759372,-1.485823198141183,0.03125,0.8007112317570966,1.0,4/14,4.08%,PKP2;TGFB1;MYH7;MYBPC3
prerank,GO_Biological_Process_2021__long-chain fatty acid catabolic process (GO:0042758),0.8719823881061024,1.4852062884549524,0.02127659574468085,0.8136032808523503,1.0,2/5,10.07%,GLYATL2;AIG1
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.7700342252885666,1.4851445714292693,0.1,0.8091946365251274,1.0,3/14,5.38%,SCRIB;TBC1D16;SNCA
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.8016349548611128,1.484713846763253,0.1,0.8066694426581899,1.0,3/11,3.42%,GABRE;GABRA5;GABRG3
prerank,GO_Biological_Process_2021__regulation of excitatory synapse assembly (GO:1904889),0.8434191751320544,1.483385096985167,0.08333333333333333,0.8103592326137156,1.0,3/6,10.79%,VSTM5;SEMA4A;ABI3
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),0.6995752501568598,1.4833234666337554,0.05714285714285714,0.8060492109285305,1.0,2/12,4.74%,PNP;AMPD1
prerank,GO_Biological_Process_2021__development of primary female sexual characteristics (GO:0046545),0.8630466266228299,1.4821699615944408,0.05263157894736842,0.8079912997911431,1.0,1/6,0.55%,LHFPL2
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.7632133018988323,1.482008016235596,0.0,0.8049076497061542,1.0,4/14,5.48%,PER2;HDAC3;SIRT1;SIRT7
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.5386457152951089,1.4819269683584002,0.0,0.8006169459391954,1.0,24/96,15.15%,TEAD2;ADAMTS1;AMOTL1;PARVA;MID1;COL12A1;B4GALT2;RAI14;TENM3;SNAI2;P3H4;RND3;CAP2;CHST3;AMH;MPDZ;DDAH1;RBFOX2;TEAD4;FJX1;NR2F2;MAGI1;ANTXR1;PTPRF
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.7656806602409204,1.4813034234730507,0.05714285714285714,0.7988485477847727,1.0,1/15,0.23%,ARC
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),0.8112529042650948,1.480168873001003,0.058823529411764705,0.8010506663757991,1.0,2/7,9.19%,SLC38A5;SFXN2
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.7374210594572125,-1.4800925958766784,0.0,0.8455123230047422,1.0,5/21,8.67%,DUOX1;CLDN1;VTN;ACTG1;ANXA1
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),0.570954776128263,1.4799160931886661,0.08108108108108109,0.797991164452028,1.0,23/49,21.10%,FOXO1;PER2;MAFB;METRNL;PID1;PPARG;SDF4;SIRT1;BBS9;NR4A2;AKT2;CTBP2;OSBPL11;GDF6;NR4A3;CLIP3;IL11;FAM120B;NR4A1;EP300;OSBPL8;PRDM16;ZBTB7A
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.5694898169942609,1.4798773358436181,0.0625,0.7936653118149122,1.0,6/54,3.51%,GCK;GRP;PER2;ITPR2;HTR2C;KCNC2
prerank,GO_Biological_Process_2021__cerebellar granule cell differentiation (GO:0021707),0.9174787930927397,1.4789917357978415,0.022222222222222223,0.7938750420477116,1.0,2/5,6.26%,GRID2;PROX1
prerank,GO_Biological_Process_2021__purine nucleobase transport (GO:0006863),-0.9596147204951915,-1.4789124168095915,0.01818181818181818,0.8434411961950469,1.0,3/6,2.79%,SLC28A2;SLC28A1;SLC28A3
prerank,PanglaoDB_Augmented_2021__Follicular Cells,-0.5998232019848432,-1.4788242992080527,0.014925373134328358,0.832706620545756,1.0,36/78,17.77%,SLC28A1;BHMT;IYD;LECT2;ABCC6;ITIH2;SMLR1;FMO5;CYP3A5;RORC;ALDOB;TSHR;OIT3;SLC5A9;PON3;SLC3A1;SERPINA10;PDZK1;PLG;CYP3A4;HNF1A;SLC22A7;CYP4F12;SLC6A4;C4BPB;HAO2;PIK3C2G;NR1H4;TMEM45B;DIO1;TG;SLC10A1;ACKR2;ANGPTL3;ASGR1;PRODH2
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.7189108392682798,1.4787913705219837,0.045454545454545456,0.7909942431464634,1.0,3/20,0.87%,ADRA1A;ADRA1B;PER2
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.6764844933253156,1.476922811676223,0.05714285714285714,0.7975286860695772,1.0,10/20,27.55%,GATAD2A;DNMT1;TEX15;BAZ2A;ATF7IP;FOS;METTL4;DMAP1;DNMT3A;PPM1D
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),0.7364699902779837,1.4758548598446262,0.023255813953488372,0.7995791729095049,1.0,6/15,10.67%,IRS1;PLIN5;TWIST1;AKT2;ABCD2;IRS2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),0.9103784819544443,1.4748045542710764,0.0,0.8000042105365395,1.0,2/5,3.05%,FOXO1;TRPC3
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),0.7189421487612991,1.4747919174487183,0.0967741935483871,0.7955597427002253,1.0,4/19,4.30%,SLC30A10;SLC39A8;TRPM2;SLC39A11
prerank,GO_Biological_Process_2021__AV node cell action potential (GO:0086016),-0.8889204623139048,-1.4736633543079718,0.01639344262295082,0.8701060277578411,1.0,1/7,1.19%,SCN5A
prerank,PanglaoDB_Augmented_2021__Trichocytes,0.5291307954372507,1.4731873542574716,0.030303030303030304,0.8013406691355014,1.0,5/53,3.43%,ADGRF4;ADGRG6;LAMA3;FAM83H;PERP
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),0.8928304492177934,1.4731735313682959,0.024390243902439025,0.7969376984259656,1.0,4/6,8.93%,LHFPL4;APOE;NLGN1;GPHN
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.5230562882456793,1.4731362768807443,0.043478260869565216,0.7930778509547188,1.0,32/87,20.13%,GCK;FOXO1;CPEB1;IRS1;SLC30A10;RAB31;CAPN10;PPARG;SLC25A33;FER;MGARP;ADCY2;NR4A2;AKT2;PRKAR2A;IRS2;ADCY3;TBC1D4;RAB10;NFKB1;INSR;NR4A3;LPIN2;GPLD1;SYAP1;ADCY6;MYO5A;NR4A1;PDE3B;KAT2B;HDAC5;MARS1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.7645571700059905,1.4730383464051262,0.05,0.7895881670834777,1.0,3/11,9.39%,NAA40;METAP1D;AANAT
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),-0.7073726950821452,-1.4729733142685428,0.04477611940298507,0.8648309719264307,1.0,8/31,8.12%,SCN5A;MYH7;CASQ2;ACTC1;MYBPC3;TRDN;CSRP3;KCNQ1
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),-0.8165790327733384,-1.472760232274851,0.0,0.8564041692763733,1.0,3/11,6.09%,TBX1;WNT5A;STAT1
prerank,GO_Biological_Process_2021__lymphocyte apoptotic process (GO:0070227),0.9550434798513802,1.472654569755671,0.044444444444444446,0.7879316000163681,1.0,1/5,1.59%,CLC
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),0.6748919919922504,1.472598601076615,0.0,0.7838577484234268,1.0,11/26,25.85%,IRS1;PID1;KANK1;PTPRE;PIP4K2A;NCK1;SLC27A4;APPL2;ENPP1;PRKCD;RPS6KB1
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.6998212678622414,1.4717342206662938,0.044444444444444446,0.7853982403162904,1.0,7/14,22.82%,APOB;PPARG;ABCA1;LPL;NR1H3;SREBF2;SCARB1
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.6416993972146983,-1.4713369080126932,0.025974025974025976,0.8600815244975023,1.0,31/76,13.88%,LILRB3;RASGRP4;MPL;TGFB1;GMFG;IL21R;ALOX12;ITGB2;HCK;ARHGAP9;TAGAP;PDE6B;TNFRSF1B;PARVG;FCGR3A;GP1BA;WAS;NFAM1;SELP;MYO1F;FPR1;VWF;ITGA2B;SLC11A1;SPI1;CLEC12A;ITGAM;F13A1;CD300LF;ADGRE3;PSTPIP1
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.8237366826333329,1.4710395797540585,0.045454545454545456,0.7859586672827639,1.0,2/8,4.17%,SLC39A8;SLC25A37
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.5203605177250248,1.4710041608129105,0.041666666666666664,0.7820398002897012,1.0,41/139,20.61%,CDH20;PCDH15;VWC2L;SLC17A6;SPHKAP;SEZ6L;ELAVL3;CNTNAP2;CADM2;MAGI2;PAK5;HCN1;PROX1;RNF152;PCBP3;CELF4;RAB3C;OLFM3;SGIP1;SAG;SNAP91;RBFOX1;FRRS1L;SCRT1;VSTM2B;SRRM4;NCAM1;NRXN1;AP3B2;PPFIA2;LSAMP;SLC24A2;MMD2;ST8SIA3;ADGRB3;GRM5;CTNNA2;UNC79;PAK3;TNR;LIN7A
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.654645710493076,1.4708499737325997,0.029411764705882353,0.779036256215044,1.0,1/25,0.23%,ARC
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.5960172916817796,1.4707923488486008,0.06060606060606061,0.775273712504277,1.0,4/29,7.88%,ARC;APOE;PPFIA3;GRIK2
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.7736708600852062,1.47078628553365,0.09090909090909091,0.771235828584984,1.0,3/8,10.27%,EFS;CASS4;MCU
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.6221529648904645,1.470567994435686,0.023255813953488372,0.7691172100158968,1.0,10/34,15.15%,DUSP4;DUSP2;PTPRO;PTPRZ1;PTPN9;DUSP18;PTPRB;UBASH3B;PTPRT;PTPRF
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.5251549477805646,1.4703320929405188,0.05,0.7666313194252378,1.0,26/92,16.07%,CDH20;SLITRK6;CDH19;CDH12;CDH7;NLGN1;CDH5;FZD5;SDK1;CDH6;DSCAM;FLNA;FARP1;LIMS1;NLGN3;CDH2;CDH24;CDH10;RYK;PKP4;FSCN1;CDH11;ACHE;NRXN1;PARD6B;CDHR3
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),-0.8295763587999659,-1.469169835342831,0.01639344262295082,0.8700771594027928,1.0,1/10,0.44%,BUB1
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.6509361042444448,1.469040467649749,0.030303030303030304,0.7713713198837692,1.0,8/19,15.58%,CEL;LHFPL4;APOE;NLGN1;GPHN;NLGN4X;NLGN3;NRXN1
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),0.7691231292807515,1.4687288520966157,0.044444444444444446,0.7689763235440185,1.0,1/9,10.75%,STARD3NL
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.8222338085081429,1.4677830521125963,0.08695652173913043,0.7708207083983507,1.0,4/10,7.88%,ROBO2;PKD2;OSR1;SLIT2
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),0.8111497242108822,1.4676912455652795,0.08571428571428572,0.7676139291477614,1.0,1/10,0.49%,GRP
prerank,GO_Biological_Process_2021__regulation of fat cell proliferation (GO:0070344),0.8897314028956205,1.467551174452557,0.06521739130434782,0.7647428482185779,1.0,2/5,3.92%,PER2;PID1
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),0.6720204104317754,1.467321267430422,0.0,0.7625798701825945,1.0,10/25,25.85%,IRS1;PID1;KANK1;PTPRE;PIP4K2A;NCK1;SLC27A4;ENPP1;PRKCD;RPS6KB1
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),0.7763415870401518,1.4671085873057697,0.06382978723404255,0.7606637516573868,1.0,3/11,8.20%,PKD2;LATS1;FLNA
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",0.9155825215995859,1.4656856448352253,0.022727272727272728,0.7653437776922684,1.0,4/6,7.25%,HS6ST2;HS3ST3B1;HS3ST5;HS2ST1
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.621413597271243,1.4655310486780135,0.09090909090909091,0.7624660803754374,1.0,17/44,22.08%,PER2;HDAC3;HDAC10;PRDM5;SIRT1;SIRT7;MIER2;HDAC1;HDAC4;HDAC11;BAZ2A;SIRT6;BRMS1L;HDAC5;TBL1X;RCOR2;SMARCAD1
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),-0.811703108730981,-1.465331859664154,0.04477611940298507,0.898811197751128,1.0,4/10,16.13%,TGFB1;ITGB2;ITGAM;F2RL1
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.6318463920399406,-1.4648045838718666,0.041666666666666664,0.8932387315947801,1.0,12/42,15.16%,AQP3;TGFB1;WNT8B;CYP1B1;CYP24A1;ESR1;ANXA1;CDKN2D;GLDC;GGT5;FGFR4;IL18
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),-0.8677285319529594,-1.4645528193538335,0.030303030303030304,0.8841897999332282,1.0,4/10,8.41%,MCM2;DONSON;MCM3;MCMDC2
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.6553377805857316,1.4640106236234025,0.06666666666666667,0.7680534909370467,1.0,2/19,5.35%,GCK;CRY1
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.8160855692762635,1.4639864901176358,0.06666666666666667,0.7644541822189599,1.0,3/11,7.70%,IRS1;EIF2AK3;PLCB1
prerank,GO_Biological_Process_2021__intestinal cholesterol absorption (GO:0030299),0.8435389774572624,1.4632249188339141,0.07894736842105263,0.7657269139887466,1.0,4/9,9.94%,CEL;AKR1C1;SOAT2;LDLR
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),-0.8981840901868933,-1.463200458668131,0.01818181818181818,0.888081033768419,1.0,1/7,0.09%,ENPP2
prerank,GO_Biological_Process_2021__positive regulation of cAMP-mediated signaling (GO:0043950),-0.9522948483070887,-1.4623011838901783,0.0,0.8862848427369021,1.0,2/6,3.68%,GPR62;SCTR
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle remodeling (GO:0034372),0.881368646812814,1.4616834591704462,0.02,0.770852918392765,1.0,3/5,9.91%,LIPC;APOE;LPL
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,-0.6218909187641565,-1.4612931742792994,0.057971014492753624,0.8836819123393241,1.0,25/57,19.98%,PLEKHS1;DUOX1;ST6GALNAC1;CLCA4;TMC4;DUOXA1;FUT2;SLC5A1;CYP2B7P;MAP3K19;BPIFB1;MS4A8;CP;ZNF750;TRIM29;CYP4F12;MUC4;PROM2;ADH7;CYP4B1;MUC15;CAPN13;FAM3D;CBLC;FAM83F
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication initiation (GO:0030174),-0.959617862794804,-1.4606221058916828,0.0,0.8797971136284296,1.0,1/5,0.45%,TICRR
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),-0.8926626027729143,-1.460511730227267,0.016129032258064516,0.8700275737576512,1.0,2/6,2.89%,DNAH11;CCDC39
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),0.7495253053525752,1.4601728386209467,0.075,0.778687850018168,1.0,5/15,4.73%,SELPLG;PODXL2;SLC39A8;CX3CR1;ITGA4
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),0.6434311891891894,1.460158818552549,0.075,0.7751787828199657,1.0,4/21,7.94%,APOE;CSK;DRD4;WWP2
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.6934622499873964,1.4593629524712017,0.07894736842105263,0.7762324158687551,1.0,6/19,12.41%,GANC;PRKCSH;ST8SIA4;MAN1A2;MAN2A1;MAN1A1
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),-0.7531199133168189,-1.4590336279254126,0.046153846153846156,0.8727907701826056,1.0,3/12,9.78%,WNT5A;TAFA3;THBS1
prerank,GO_Biological_Process_2021__response to vitamin (GO:0033273),-0.8401692309988863,-1.4585717667989972,0.08771929824561403,0.8672188604328465,1.0,3/7,11.88%,AQP3;CYP24A1;CDKN2D
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.6191105073740569,1.4584225613406527,0.075,0.7778484827982057,1.0,6/25,14.65%,FGF10;ANGPT1;FLNA;GGA1;SMURF1;ANK2
prerank,GO_Biological_Process_2021__bundle of His cell action potential (GO:0086043),-0.9675699353905799,-1.457949015048219,0.0,0.8628959991913149,1.0,2/5,2.14%,SCN5A;KCNA5
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),-0.6671757913742716,-1.4572495762196827,0.05263157894736842,0.8611277013853561,1.0,6/29,13.78%,EPN1;ALOX5;CEACAM1;THBS1;PIK3CB;ITGA5
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.5174501292450289,1.4561561085703223,0.0,0.7873541802612191,1.0,37/109,22.41%,NGF;ZNF804A;ROBO2;APOE;GRIP1;MAGI2;TOX;EPHA3;RAPGEF1;FZD1;SLIT2;TENM3;ARSB;STYXL1;PLXNB1;ABL2;RETREG3;AVIL;MAP3K13;RET;RAP1A;ARHGAP35;MAP6;FUT9;CUX1;PTPRD;RIT2;ROR1;PLXNA4;EP300;CHODL;MARK2;NTRK2;PTK7;PLPPR5;CARMIL2;LRRC7
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),-0.8942404518292268,-1.4561172152201003,0.029411764705882353,0.8615936424022973,1.0,1/6,7.40%,CEACAM1
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.6823859642935726,1.4552861456493367,0.07317073170731707,0.7888319772370733,1.0,5/20,11.51%,DUSP4;DUSP2;PPP5C;DUSP18;PPM1A
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),0.7253985597964255,1.4549688407499528,0.14285714285714285,0.7873328822864497,1.0,5/20,7.70%,IL7R;KIT;HES1;F2;OCIAD2
prerank,GO_Biological_Process_2021__gamma-delta T cell activation (GO:0046629),-0.9577422434170805,-1.4548479988887604,0.041666666666666664,0.8639100484372247,1.0,2/6,0.67%,MICB;TCF7
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),-0.7714614365762735,-1.453218768512946,0.08333333333333333,0.8715441657118569,1.0,8/20,17.71%,TEKT5;CCDC39;TEKT3;DRC1;DNAH17;DNAH3;DNAH2;RSPH9
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),0.8004527962598569,1.4530363183458146,0.08163265306122448,0.7958893931802153,1.0,2/7,0.95%,PNP;SLC16A9
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),-0.7439799868119042,-1.4517642983044285,0.03225806451612903,0.8759796245742993,1.0,2/19,1.19%,PKP2;SCN5A
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.8696241641610165,1.4514142797821037,0.0,0.8022697879733954,1.0,2/5,6.40%,IMMP2L;IMMP1L
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.6640795578615215,1.4513950703747691,0.0,0.7985726921762831,1.0,10/29,12.79%,APOE;MFSD2A;LCN12;PPARG;SLC27A2;ACACB;ABCD3;ABCD2;ACSL1;CPT1A
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.716432434277978,1.4509121707980857,0.07894736842105263,0.7987877977370313,1.0,3/11,13.00%,SIRT7;SPAST;EPS8
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),0.6718945020112218,1.4500653905083778,0.03333333333333333,0.80010396000423,1.0,4/16,5.35%,GCK;WNT4;BCKDK;CRY1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte proliferation (GO:0010838),0.878189898422091,1.4491532666230393,0.0,0.8008591534557404,1.0,1/7,1.19%,FGF10
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),-0.8090165433971205,-1.4478481158746779,0.05555555555555555,0.9038879984886842,1.0,2/11,2.54%,ARIH2;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),0.6448057604875213,1.4474003365312884,0.05555555555555555,0.8071410227630526,1.0,3/16,4.44%,RAB27A;NLGN1;DOC2B
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.5344874021687473,1.4473975910430612,0.10526315789473684,0.8036412668214589,1.0,29/102,14.87%,LGR5;MEGF10;LHFPL4;LRRC4C;UNC5D;ELAVL3;CADM2;PCLO;HES1;PAK5;SLC35F1;PTPRZ1;ERC2;CASKIN1;CELF5;GALNT13;WNK2;STOX2;CSPG5;RIMS4;RHBDL3;CRABP1;SAG;SNAP91;MAP6;MSI1;SCRT1;ANK2;SRRM3
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),-0.6566526636158706,-1.4470175469037065,0.057971014492753624,0.901205767924636,1.0,4/46,4.05%,CD44;MMP9;MMP19;SCUBE3
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),0.8431557628187228,1.4468709235100226,0.03636363636363636,0.8032195000986618,1.0,2/8,6.49%,SAMD9;VPS8
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.5268176569901616,1.4468678230654604,0.043478260869565216,0.79970109876726,1.0,31/117,15.95%,ZNF385D;SLC17A6;RAB27A;FGF10;ROBO2;CNGA3;NOVA1;ANGPT1;UNC5D;CADM2;MAGI2;HFM1;RSPO2;CELF4;PDZRN3;RAB3C;RNF150;OLFM3;SGIP1;PDZRN4;SNAP91;MAP6;RBFOX1;ASXL3;NKTR;CDH11;CFC1;NRXN1;FGF14;NREP;PTPRD
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),-0.6955821301688377,-1.4468143128075122,0.030303030303030304,0.8937289843895861,1.0,4/26,3.06%,IHO1;MEIOB;SYCP1;STAG3
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),-0.6640431535120654,-1.4466764872904183,0.030303030303030304,0.8855335561920084,1.0,4/46,4.05%,CD44;MMP9;MMP19;SCUBE3
prerank,GO_Biological_Process_2021__negative regulation of striated muscle tissue development (GO:0045843),-0.9025538924037746,-1.4465900465373864,0.0,0.8768574574015089,1.0,1/5,1.49%,TGFB1
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),0.8667514612866867,1.4460521933307613,0.06818181818181818,0.8007768029001151,1.0,3/6,9.94%,APOE;MFSD2A;LDLR
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.6274738769164432,1.445800870308005,0.05714285714285714,0.7982355959313955,1.0,7/38,8.03%,SMYD2;RFWD3;CRY1;SIRT7;RADX;ABL1;MYC
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),0.801258467205135,1.444254413836433,0.125,0.8030993062354146,1.0,4/10,8.09%,PNP;ZBTB7B;CBFB;NKAP
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,-0.6050978504633616,-1.4440671411272072,0.05555555555555555,0.8908761816420973,1.0,30/75,16.09%,LILRB3;CLEC5A;C1QB;ITGB2;HCK;CHIT1;TNFRSF1B;PTAFR;C3AR1;MS4A4A;PARVG;FCGR3A;LY86;VSIG4;NFAM1;ADGRE1;MYO1F;IGSF6;FPR1;SLC11A1;SPI1;GPIHBP1;CLEC12A;ITGAM;TLR2;CD300LF;VDR;STARD5;CD4;HK3
prerank,GO_Biological_Process_2021__AV node cell to bundle of His cell communication (GO:0086067),-0.9453912328398948,-1.4438951043860164,0.017857142857142856,0.8842956275573974,1.0,2/5,2.05%,SCN5A;GJC3
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.7332871486184456,-1.443313700090407,0.015873015873015872,0.8819667212935035,1.0,1/24,0.01%,CD44
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),0.5570369009714382,1.4425047671838955,0.0,0.809178485902679,1.0,10/64,7.88%,GCK;ROBO2;URI1;AKR1C3;STAT5B;NCOA3;NCOA2;AKR1C1;MGARP;SLIT2
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.5141806694687627,1.4424745255355604,0.03571428571428571,0.8059086689662417,1.0,35/154,14.87%,SLC17A6;NGF;THEM4;POU6F2;NKAIN3;YDJC;GRIP1;CDK14;CPNE4;HRH3;ELAVL3;DTX1;PAK5;SLC35F1;KCTD8;ERC2;ADGRA1;CSDC2;GPHN;CELF5;DPP10;BTBD10;BRINP1;NXPH1;FGF12;AKAP7;OLFM3;FBLL1;SNAP91;MAP6;RBFOX1;RTN2;SCRT1;VSTM2B;SRRM3
prerank,GO_Biological_Process_2021__carbohydrate transport (GO:0008643),-0.7925258269320512,-1.4423711818942881,0.06779661016949153,0.8825193835125192,1.0,2/12,6.12%,AQP3;SLC5A1
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.5163325393936178,1.441837204592357,0.06896551724137931,0.8064088648130955,1.0,29/112,15.51%,NTSR2;SLC17A6;SPHKAP;SPTBN4;LRRTM3;KCNC2;ELAVL3;NKAIN2;CADM2;PAK5;DLX1;KCNIP1;LRFN5;ADGRA1;PARM1;ABCC8;BRINP1;RGS7BP;NXPH1;OLFM3;SNAP91;MAP6;RBFOX1;SYN2;PTPRT;SCRT1;ANK2;VSTM2B;UBE2QL1
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.5653700226703081,1.4414217638927846,0.08,0.8057936510348735,1.0,38/107,22.61%,SLC17A6;SPHKAP;GRM3;LRRTM3;KCNC2;ELAVL3;MAGI2;PAK5;ADGRA1;CELF5;CELF4;GRIN1;GABRG1;NXPH1;OLFM3;SNAP91;FUT9;RBFOX1;FRRS1L;SCRT1;SRRM4;NRXN1;RIT2;DLG2;GABRA2;PPFIA2;LSAMP;MMD2;ST8SIA3;GRM5;CTNNA2;UNC79;TNR;HPCA;GRM1;TMEM196;GRIA4;NOL4
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),-0.7345270180838372,-1.4407317790714318,0.07692307692307693,0.8898425019944315,1.0,3/18,2.76%,CASQ2;MMP9;CAV3
prerank,GO_Biological_Process_2021__SA node cell action potential (GO:0086015),-0.8950259433693579,-1.4406327277587947,0.045454545454545456,0.8823717356205789,1.0,2/7,2.14%,SCN5A;KCNA5
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),-0.8118255898916265,-1.4404591153972817,0.07272727272727272,0.8754464224125869,1.0,2/11,6.24%,BUB1;ZWILCH
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.7648620133786065,-1.4402070704704488,0.07547169811320754,0.8693173580334823,1.0,2/13,7.32%,ZWILCH;TTK
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),0.7001675039752455,1.4399388703408444,0.05128205128205128,0.8115611760941104,1.0,5/14,15.83%,GLA;ACER2;ACER3;NEU4;NEU3
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.6384851485035952,1.439728966485619,0.06060606060606061,0.8093740124082673,1.0,5/27,7.88%,FGF10;SCRIB;PKD2;HES1;SLIT2
prerank,GO_Biological_Process_2021__negative regulation of amino acid transport (GO:0051956),0.8721306474056545,1.4395325988228893,0.06976744186046512,0.807270062095229,1.0,2/5,9.91%,HRH3;GRM7
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),0.7412009389653498,1.4392980496055936,0.04878048780487805,0.8051840177423015,1.0,4/10,12.14%,PACSIN2;WASHC2C;RAB35;WASHC2A
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.5877315201737418,1.437991733738532,0.0,0.8104085611066367,1.0,14/38,21.17%,APOE;SPOPL;MAPK8;CHMP6;LDLR;ODC1;SSH1;FURIN;SNF8;SPOP;FAF1;ABCA7;GSAP;ACE
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),0.7456950684431616,1.4376545406326748,0.08333333333333333,0.8090913134291103,1.0,2/12,4.57%,PNP;NT5C1A
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,-0.5794832906654143,-1.437610688438054,0.027777777777777776,0.8848639977258325,1.0,22/60,14.69%,SLC28A2;CLCA1;IYD;ABCC6;SCTR;FMO5;CYP3A5;ALDOB;PBLD;SLC5A1;SLC5A9;SLC3A1;CYP3A4;HNF1A;ACSM3;SLC18A2;VIL1;SLC22A3;SLC6A4;MUC17;TFPI;NR1H4
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),0.6849911734492546,1.4364798417850635,0.09090909090909091,0.8122890414984073,1.0,5/17,17.02%,AOAH;NEU4;NGLY1;FBXO27;SAMHD1
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.5668303863881049,1.4364629231506993,0.10714285714285714,0.8089535124622826,1.0,9/48,10.13%,TGFBR1;ZSWIM5;NRG2;ERBB2;NRG1;CDK6;ABL1;ABL2;PKN2
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),-0.8430819474292524,-1.43608156591359,0.046153846153846156,0.890781162450924,1.0,2/10,1.19%,PKP2;SCN5A
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.6588182435769616,-1.4354404685578166,0.06349206349206349,0.8804858330873081,1.0,17/42,22.43%,IRF4;SP100;IRF1;STAT1;OAS2;IFIT3;HLA-A;IFIT1;OAS1;HLA-F;IFIT2;IFI35;IFI27;MX1;IFI6;ISG15;HLA-C
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.6588182435769616,-1.4354404685578166,0.06349206349206349,0.8804858330873081,1.0,17/42,22.43%,IRF4;SP100;IRF1;STAT1;OAS2;IFIT3;HLA-A;IFIT1;OAS1;HLA-F;IFIT2;IFI35;IFI27;MX1;IFI6;ISG15;HLA-C
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),0.9093699632403088,1.4348018146805142,0.0,0.8140752738758791,1.0,1/5,3.83%,AK3
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),0.6432628331701612,1.4347081650394888,0.0,0.8113864703349457,1.0,7/27,15.58%,NLGN1;SLC8A3;GRIN1;NLGN4X;RIMS2;NLGN3;NRXN1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.7765783837554094,-1.434598274456413,0.08064516129032258,0.8789095417483321,1.0,2/10,4.03%,FOXM1;SP100
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),-0.7970896837232077,-1.4344624349857615,0.03571428571428571,0.8719440319936556,1.0,4/14,7.99%,NRAP;ACTC1;CSRP3;NEB
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),-0.8134031727390791,-1.4335599870332285,0.045454545454545456,0.8727813323070882,1.0,2/10,3.87%,TGFB1;TAF7
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),-0.7141446560114042,-1.4329091142120585,0.03508771929824561,0.8710665556612588,1.0,1/20,0.09%,ENPP2
prerank,GO_Biological_Process_2021__negative regulation of steroid biosynthetic process (GO:0010894),0.8147838977431805,1.4327799081465746,0.024390243902439025,0.8206981509472824,1.0,4/8,14.09%,WNT4;PROX1;SNAI2;NFKB1
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),0.7233506506087933,1.4316200746511685,0.08333333333333333,0.8241550976722303,1.0,4/18,4.30%,SLC30A10;SLC39A8;TRPM2;SLC39A11
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.5804066097031647,1.4314777850990728,0.06896551724137931,0.8216436686903967,1.0,11/33,10.01%,VWC2;NGF;NEUROD2;FGFR1;BRINP3;ZC4H2;PROX1;DLX1;ZEB1;BEND6;BRINP1
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.725229792867587,1.4311544158977363,0.08823529411764706,0.8205700670589722,1.0,3/12,10.12%,PKIA;SIRT1;PRKAR2A
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.6486939044481181,1.4309756224220636,0.046511627906976744,0.817909512398208,1.0,12/20,28.94%,ACACB;ABCD3;ABCD2;CPT1A;PRKAA2;PRKAG2;NPC2;THRSP;ACACA;CERT1;ARV1;MID1IP1
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.5573703683502319,1.4305611757955459,0.08333333333333333,0.81692084583326,1.0,24/65,19.70%,SLITRK6;GRID2;NLGN1;LRRTM3;FZD5;SDK1;DSCAM;FZD1;PLXNB1;WNT3A;NPAS4;NLGN4X;FARP1;NLGN3;CDH2;RYK;ACHE;NRXN1;GABRB2;GABRA2;KIRREL3;CDK5;PCDHB6;NRCAM
prerank,GO_Biological_Process_2021__regulation of T cell tolerance induction (GO:0002664),0.9125412817438553,1.4304323287254506,0.046511627906976744,0.813931197298945,1.0,1/5,1.59%,CLC
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),0.8406630080249853,1.4301313934007915,0.029411764705882353,0.8121782207901775,1.0,1/7,1.23%,ACADS
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),0.6694987388309795,1.4297983424275968,0.09090909090909091,0.8114055146128165,1.0,5/18,7.63%,TSKU;APOE;SOAT1;SOAT2;ABCA1
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.6458216220221549,-1.4294784316233071,0.015151515151515152,0.89435078558715,1.0,7/34,13.03%,MMP9;CIDEB;GPER1;PINK1;CLU;BIK;MOAP1
prerank,GO_Biological_Process_2021__regulation of animal organ morphogenesis (GO:2000027),-0.8695740665567819,-1.42803760157345,0.01639344262295082,0.9000821897006986,1.0,1/7,0.55%,TBX1
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.6985517329103572,1.4279729647923072,0.1111111111111111,0.8184584405261206,1.0,7/14,11.69%,VCAN;CSGALNACT1;CHST12;UST;CSPG5;B3GAT3;DSEL
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle contraction (GO:0060452),0.9203768537710175,1.4279247758048148,0.05,0.8154502340456938,1.0,1/5,0.05%,ADRA1A
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.6453184190550799,1.4277882381511746,0.075,0.8131818996416955,1.0,8/22,14.26%,TGFBR1;ADAMTS12;WNT9A;GREM1;SNAI2;GDF6;EFEMP1;SOX5
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),0.5743230188909708,1.4277178172902505,0.1,0.8105747898739971,1.0,12/38,20.40%,RIPK2;TNFRSF19;MAPK8;MAP3K10;MAP3K13;TAB3;MAP4K2;CRKL;MAP2K7;TAB1;TAB2;TRAF6
prerank,GO_Biological_Process_2021__fat-soluble vitamin catabolic process (GO:0042363),-0.8633835527436875,-1.427551324490672,0.08771929824561403,0.8967911262926286,1.0,4/7,13.26%,CYP26B1;CYP24A1;CYP3A4;CYP4F12
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.7749599995262377,-1.4270859419463435,0.07547169811320754,0.8936156332384634,1.0,2/11,7.32%,ZWILCH;TTK
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.5027953855902192,1.4262752013616988,0.05263157894736842,0.81633621376296,1.0,45/127,19.93%,SLC17A6;SEZ6L;PCDH17;ROBO2;NOVA1;MAFB;PLPPR1;KCNB2;EDARADD;LRRC4C;UNC5D;ELAVL3;RGS16;CADM2;CXXC4;PAK5;PROX1;WSCD2;KCNIP1;ADGRA1;EFNA5;ABCC8;CELF4;FGF12;ELAVL4;RAB3C;SNAP91;MAP6;RBFOX1;ASXL3;PTPRT;DPP6;CFC1;UBE2QL1;NRXN1;IAPP;PAX6;SCGN;LSAMP;SERTM1;ST8SIA3;ADGRB3;CNTN1;UNC79;PAK3
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",0.9166561634197692,1.4258767428675876,0.04878048780487805,0.8159782007775671,1.0,2/6,2.68%,ADRA1A;NLGN1
prerank,GO_Biological_Process_2021__mesonephros development (GO:0001823),0.792813787888309,1.4248269739785646,0.058823529411764705,0.8171503577316731,1.0,2/8,6.85%,FGF10;OSR1
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.47507143958713793,1.4247272360688874,0.041666666666666664,0.814392733139893,1.0,41/150,20.68%,GCK;CTDNEP1;PRR16;IRS1;MFSD2A;SAMD4A;SLC25A37;DDAH2;PLIN5;SIRT1;ERBB2;ZEB2;PKD2;SNCA;PCIF1;PPP1R3E;SP1;MYC;AKT2;LDLR;CTC1;IRS2;DDAH1;MLXIPL;EIF3E;STARD4;YTHDF1;ABCB10;INSR;NR1H3;GPLD1;OPN3;ZCCHC4;FAF1;AGXT2;EIF4A3;ELOVL5;DNA2;HIF1A;PIWIL2;FXR2
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),-0.7052409381802875,-1.4246198265556276,0.031746031746031744,0.9096432703794016,1.0,5/29,8.12%,PKP2;SCN5A;KCNA5;CAV3;KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.7448021977662069,-1.4243694770913204,0.078125,0.9046498072725968,1.0,3/12,8.55%,ITGB2;ALOX5;SELP
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),0.7490545663018429,1.4237722128882302,0.15,0.8178353442501773,1.0,2/10,5.48%,ZNF692;SIRT7
prerank,GO_Biological_Process_2021__negative regulation of heart rate (GO:0010459),0.8428121544184488,1.4236695066126799,0.06976744186046512,0.8155027714880799,1.0,2/6,3.11%,RNLS;SPTBN4
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),0.9202461281840103,1.4235522597797374,0.027777777777777776,0.813245918064637,1.0,1/6,0.05%,ADRA1A
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,-0.6004781458974694,-1.4225883649228936,0.04477611940298507,0.9134410800186592,1.0,26/69,19.93%,PLEKHS1;TMEM184A;MISP;CAPN8;SMIM22;TMC4;LIPH;FUT2;EPN3;MUC5B;SERPINB5;CEACAM1;BPIFB1;MS4A8;ITGB6;TRIM29;MUC4;GPX2;PROM2;TJP3;GALNT6;SCNN1A;CAPN13;GALNT5;FAM3D;CBLC
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),0.6160738174971664,1.4223092974373068,0.02857142857142857,0.8172297314664888,1.0,8/31,10.84%,GCK;GRP;CAPN10;DOC2B;GLUD1;MCU;IRS2;UCN
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),0.778841034554983,1.4220390482419356,0.1282051282051282,0.8157297433324328,1.0,5/11,17.42%,MAFB;CBFB;GFI1B;RUNX1;LGALS3
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),0.6397312581299409,1.4216116216499102,0.06451612903225806,0.8153276885760132,1.0,8/17,25.43%,ST6GALNAC3;ST8SIA4;NEU4;NEU3;ST8SIA3;ST6GALNAC5;ABCA2;B4GALNT1
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),-0.7834249724867823,-1.421537780297896,0.045454545454545456,0.9163053032569093,1.0,4/11,16.13%,TGFB1;ITGB2;ITGAM;F2RL1
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.48459896022834337,1.419028098531559,0.0,0.8263230846967238,1.0,43/149,17.40%,TEAD2;MYO10;KIT;ADGRL2;PARD3;ALDH7A1;DCBLD2;PRDM5;MID1;IL17RD;FZD5;ITGA4;ERBB2;HES1;KCNIP3;FBXO15;DSP;RAI14;PML;FZD1;MYC;TENM3;LRP6;PIWIL1;KITLG;PRTG;RND3;ARHGAP42;TSPAN6;RBFOX2;LRIG3;TEAD4;CDK8;SMAD2;MAGI1;ANTXR1;PTPRF;SPRY4;NR6A1;FRAS1;ZFX;PAWR;ROR1
prerank,GO_Biological_Process_2021__modulation by symbiont of host autophagy (GO:0075071),0.902438691662305,1.4187570616530099,0.05,0.8244085228713874,1.0,1/5,0.82%,IRGM
prerank,GO_Biological_Process_2021__lipoprotein metabolic process (GO:0042157),0.9018517138060651,1.418342742656996,0.08,0.8235826635145107,1.0,1/5,2.66%,APOE
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),-0.8095191280788016,-1.4179654778463702,0.015873015873015872,0.9418371755324682,1.0,3/12,5.61%,ALOX5;ACOX2;PINK1
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.5445756054607787,-1.417433273199859,0.0,0.9393624059315199,1.0,35/130,15.61%,SLC28A2;SLC28A1;TREH;CLCA1;SLC51A;CDHR5;DEGS2;NR1I3;SOX10;ACSL5;TMC4;ALDOB;COL18A1;SLC5A1;CA1;ASPN;CEACAM1;CLDN2;RBP2;ABCG2;PDZK1;ART3;CYP3A4;HNF1A;LCT;VIL1;CYP4F12;GPX2;MUC17;VDR;NR1H4;GATA4;SDSL;TMEM45B;AQP11
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,-0.5999164090821911,-1.4166484486285478,0.013513513513513514,0.9395235370238033,1.0,23/75,15.90%,DENND1C;AQP3;UMODL1;TMEM184A;ELMO3;UPK1B;CARD14;TMC4;LRP10;TRIM25;DTX2;ALOX15;UPK1A;SLC14A1;UPK3A;SPINT1;TMCO4;SYTL1;TMEM79;PROM2;EPHA1;TJP3;PRRG4
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),0.8152238729329206,1.4166339486483008,0.07317073170731707,0.8315511235964268,1.0,6/9,15.86%,SELPLG;PID1;NFKB1;PTPRT;ST3GAL6;PTGIS
prerank,GO_Biological_Process_2021__tachykinin receptor signaling pathway (GO:0007217),0.8295559925964094,1.4165109125011859,0.1276595744680851,0.8291333544469068,1.0,2/7,1.09%,TACR3;GRK5
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.5220584465926793,1.4161547488329396,0.0,0.8281314207970717,1.0,21/72,19.93%,SLITRK6;LLGL1;MFSD2A;PARD3;DSCAML1;SPTBN4;DCC;NTNG2;CDHR1;FARP1;MAP6;RAB10;RYK;PARD6B;DCDC2;SLITRK2;S100B;CDK5;CTNNA2;NRCAM;PAK3
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,-0.5723428945894627,-1.416008544051498,0.0,0.9379463134695193,1.0,30/118,13.55%,CD44;C1QB;MPL;MGST1;LYVE1;HCK;HMGB3;TAF7;PROCR;C3AR1;DAB2;MS4A4A;FCGR3A;VSIG4;IL3RA;SELP;ABCG2;PTPRC;VWF;ITGA2B;SPI1;CLEC12A;ENG;TLR2;FPR3;ABCB1;F13A1;GNL3;CD300LF;TEK
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),0.6825386015807928,1.4159073163132392,0.15,0.827081170783528,1.0,5/15,20.60%,KLHL20;GBF1;MON2;DOP1B;KIF16B
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),0.7654221147559532,1.4158928843635408,0.06451612903225806,0.8240959370742675,1.0,1/8,3.83%,AK3
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.7379968583006046,-1.4156631968985824,0.03076923076923077,0.9332829847987821,1.0,5/16,18.68%,SCIMP;TRIM5;LY86;CACTIN;CARD8
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),-0.692438507246024,-1.4153522129339895,0.043478260869565216,0.9290783505183084,1.0,1/31,0.01%,CD44
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),0.7612306112106374,1.414956236226133,0.04,0.8253355685999175,1.0,6/11,12.82%,TGFBR1;ADAMTS12;WNT9A;GREM1;SNAI2;EFEMP1
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),-0.7763343169284925,-1.4149347958191347,0.1,0.9257045822671796,1.0,1/9,0.45%,TICRR
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),-0.7746234981473509,-1.4143837257434941,0.05454545454545454,0.9239565648614042,1.0,3/10,10.05%,SLC5A2;SLC5A1;HNF1A
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.5080389563318584,1.4142517877481924,0.0,0.8257947414060195,1.0,27/66,23.53%,VWC2L;BAMBI;VWC2;PPARG;ADAMTS12;DLX1;GREM1;SLIT2;FSTL3;CRIM1;BMPER;SMURF1;SPRY4;NOTCH1;NEDD4;SKI;ACVR2A;EMILIN1;CASK;SULF2;BMPR2;SPRY1;SMAD5;SMAD7;CREB3L1;BMPR1A;SPRY3
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),0.8047484240216144,1.4140087448639047,0.1111111111111111,0.8241643606976915,1.0,5/7,18.13%,SLC27A2;ABCD3;ABCD2;SLC27A4;ACOX1
prerank,GO_Biological_Process_2021__endoderm development (GO:0007492),0.8060567144129529,1.4138816032169381,0.0625,0.8216705710458219,1.0,2/9,1.22%,DUSP4;DUSP2
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.7563435328782578,1.4127963868437072,0.023255813953488372,0.8246451848804758,1.0,4/12,11.41%,PPARG;PLIN5;LPL;OSBPL11
prerank,GO_Biological_Process_2021__regulation of myoblast proliferation (GO:2000291),0.8592360659375273,1.4125562280183939,0.06976744186046512,0.8227649937021024,1.0,2/5,5.36%,MEGF10;KLHL41
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.6856523540520831,1.4122147659515634,0.0975609756097561,0.8211688469383522,1.0,5/15,7.74%,FGFR1;PPARG;ITGA4;HMGB1;SP1
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.7007791363479363,1.4121038954536824,0.058823529411764705,0.8187753011230235,1.0,7/18,17.09%,SLC17A6;GRID2;GRIK1;GRIK2;UNC13B;GRIK3;UNC13C
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.8141396821721818,1.4120545324099993,0.045454545454545456,0.8161838787389125,1.0,3/7,13.66%,ARRB2;SAG;ARRB1
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),-0.827480062143652,-1.4120100407533562,0.05357142857142857,0.9382844113358217,1.0,1/7,0.77%,POLQ
prerank,GO_Biological_Process_2021__iron import into cell (GO:0033212),0.8223706735050311,1.4118616965101067,0.175,0.8147351247375159,1.0,1/6,3.19%,SLC39A8
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),0.5758742677927642,1.4117841788309107,0.17647058823529413,0.812443034616574,1.0,1/23,0.97%,AUP1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.5917081532099765,-1.4115663741211024,0.07894736842105263,0.934703783570734,1.0,8/68,9.78%,CD44;NODAL;NLRP12;GPER1;UACA;BEX3;REST;THBS1
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.6283363921717678,-1.4113670623844523,0.02631578947368421,0.9295856069875403,1.0,7/48,8.55%,CD44;TGFB1;LYVE1;OGN;SDC2;DCN;GPC3
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),-0.7366262749778931,-1.4090350688763278,0.109375,0.9441298291548035,1.0,2/12,1.19%,TBX1;SCN5A
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.7553286143111907,-1.4083981614548882,0.04918032786885246,0.943041717596182,1.0,2/15,4.13%,AMACR;ACOX2
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),0.7341699553880251,1.4081145086279856,0.11904761904761904,0.8323882042127387,1.0,3/7,10.69%,ALDH1A1;NPL;NAGK
prerank,GO_Biological_Process_2021__metanephric nephron tubule development (GO:0072234),0.8026969129246798,1.407500675241056,0.06666666666666667,0.832169219970225,1.0,2/5,6.85%,PKD2;OSR1
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.8402369040610015,1.4071367937485049,0.06666666666666667,0.8315294565443823,1.0,1/8,0.53%,PHLDB2
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),-0.8537460442341109,-1.4067940733669788,0.08064516129032258,0.950425442354389,1.0,3/9,7.40%,C1QTNF1;ALOX12;CEACAM1
prerank,GO_Biological_Process_2021__negative regulation of retinoic acid receptor signaling pathway (GO:0048387),-0.9464000781836094,-1.4066065574924604,0.019230769230769232,0.9454964378323845,1.0,2/5,2.44%,PRAME;CYP26B1
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),0.8910131988879764,1.406573832799608,0.0,0.8320514588602592,1.0,4/6,10.16%,PER2;PPARG;SIRT1;CTBP2
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.5967288455144222,1.4063851707745405,0.10344827586206896,0.829948724725222,1.0,7/27,11.15%,LGR5;DRD5;RXFP1;EDNRA;ADCY2;CAP2;ADCY3
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.6059024244427731,1.4061668624318042,0.1,0.8285396732632306,1.0,6/33,8.03%,TGFBR1;URI1;HTRA2;ERBB2;STAT5B;MYC
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),0.7955368778149943,1.405450972428263,0.08108108108108109,0.8291186458487565,1.0,4/9,7.58%,APOB;MFSD2A;SOAT1;SOAT2
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),0.7337867808019309,1.4054285741378862,0.023809523809523808,0.8264769680536012,1.0,3/12,7.88%,GREM1;PLCB1;SLIT2
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.551853481702642,1.4050593326787661,0.10344827586206896,0.8262317732768135,1.0,10/48,11.09%,NGF;PLCH1;FGFR1;IRS1;PI4KB;PLCL2;PIK3C2B;PLCB1;IRS2;PLCH2
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),-0.8136573365873847,-1.404997225556509,0.030303030303030304,0.9521929952417267,1.0,6/10,18.04%,DUOX1;IYD;CGA;DIO1;TG;CPQ
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),0.8987543582492874,1.4044368218720396,0.07692307692307693,0.8257821415788485,1.0,3/5,9.20%,SMARCB1;ZNF274;PIH1D1
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),0.8056109038533181,1.4041512077718523,0.046511627906976744,0.8240004065302562,1.0,5/7,19.11%,DRD4;NPAS4;NLGN3;INSYN2A;INSYN1
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.6149330716996493,1.4041194430984467,0.1,0.8213095414360155,1.0,12/29,22.83%,SCRIB;PARD3;PDZD11;RAP2A;DLG2;MARK2;LIN7A;MYO9A;CAMSAP3;DLG1;LRRC7;ANK1
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),0.8296660185757188,1.4040030933951089,0.10256410256410256,0.8199629985670077,1.0,1/5,6.54%,CEP120
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),-0.8909529183016018,-1.4036711766057035,0.0,0.9587424426527719,1.0,1/6,0.65%,BHMT
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),0.7923791184106262,1.4034999941987039,0.12195121951219512,0.819794697881921,1.0,3/6,14.59%,BICD1;CEP250;MARK4
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.4796173947130751,1.402991685641767,0.08695652173913043,0.8197288529186446,1.0,53/115,23.00%,ESRRG;SLITRK6;PCDH17;NOVA1;ADGRL2;PLCXD3;PLPPR1;ARX;UNC5C;CXXC4;PCLO;PAK5;PROX1;CNTN3;ETV1;ADGRA1;ABCC8;GUCY1A2;RGS7BP;STOX2;FGF12;PXK;NFIB;RNF180;PDZRN4;SNAP91;MAP6;MAGI1;ASXL3;PTPRT;ANK2;CFC1;NRXN1;FGF14;PPP1R9A;PTPRD;PBX1;PAX6;PPFIA2;SCGN;SERTM1;ST8SIA3;CNTN1;ENTPD2;NTRK2;ABCC9;TMEM196;FAM149A;RAPGEF4;SYT7;NOL4;PLPPR4;NME5
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),-0.7150711297760459,-1.4026968991542363,0.078125,0.9603604922816409,1.0,3/19,6.40%,CASQ2;CAV3;TRDN
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.44628479841447205,1.4020582660583412,0.0,0.8232484976621087,1.0,45/223,16.67%,EFNB1;SLITRK6;LLGL1;ROBO2;LAMA3;PTPRO;EPHA7;PARD3;DSCAML1;SPTBN4;SEMA6C;AUTS2;UNC5C;BSG;SEMA5A;UNC5D;NTN4;DCC;EPHA3;DSCAM;SLIT2;DOK5;EFNA5;DOK6;SEMA4A;NTNG2;SH3KBP1;IRS2;EVL;RET;GAB1;NLGN3;ARHGAP35;ANOS1;RAB10;RYK;EMB;PIK3CA;NCAM1;NRXN1;CNTN6;EFNA2;PARD6B;EPHB2;NOTCH1
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.5499205577075917,1.4020061492169944,0.03571428571428571,0.8208062880405277,1.0,11/51,13.81%,FGF10;TGFBR1;ROBO2;IFT88;ITGA8;WNT4;PROX1;OSR1;CEP290;GDF6;NF1
prerank,GO_Biological_Process_2021__hexose import across plasma membrane (GO:0140271),-0.8693964243835557,-1.4006258517971841,0.06666666666666667,0.9713124540763562,1.0,2/5,6.12%,SLC5A2;SLC5A1
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),-0.8602289767221385,-1.4005210673990502,0.11940298507462686,0.9654162278078438,1.0,3/8,8.41%,MCM2;MCM3;MCMDC2
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.6949955023388675,1.4001690843901102,0.06451612903225806,0.8283116185798783,1.0,8/18,20.80%,HDAC3;SMYD1;MAML1;HDAC1;HDAC4;NOTCH1;HDAC5;RBM24
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),-0.8983458443216399,-1.4001027828841797,0.0,0.962464005730411,1.0,2/5,9.69%,PINK1;REST
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.6274045759058872,-1.399971917179503,0.05714285714285714,0.956809107592261,1.0,13/66,8.84%,CD44;TCF7;SIRPG;GMFG;ITGB2;CYTIP;ARHGAP9;TAGAP;KLRB1;PARVG;CD5;TRAF3IP3;MYO1F
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),-0.7273587711672644,-1.3995995869347795,0.03571428571428571,0.9539569652691072,1.0,2/16,8.41%,MCM2;MCMDC2
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),-0.8641459252293375,-1.3989363556655987,0.06451612903225806,0.9534634029595669,1.0,2/6,7.52%,SCIMP;LY86
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.7826330639803366,-1.398101175900579,0.06896551724137931,0.9549923200533783,1.0,2/9,4.03%,FOXM1;SP100
prerank,GO_Biological_Process_2021__water transport (GO:0006833),-0.8136048670135472,-1.3975446906976214,0.034482758620689655,0.9527346381281911,1.0,5/11,15.61%,AQP3;SLC5A1;UPK3A;AQP4;AQP11
prerank,GO_Biological_Process_2021__negative regulation of monocyte chemotaxis (GO:0090027),0.8556361874398762,1.397452455360212,0.06,0.8414663396870747,1.0,2/6,7.88%,GREM1;SLIT2
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),0.8362380389780968,1.3973685272562082,0.075,0.8391874937430458,1.0,5/6,11.22%,SLC38A5;SLC3A2;SLC16A10;SLC25A29;SLC7A8
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),0.7100441754429944,1.3972049796474562,0.10810810810810811,0.8373209455187707,1.0,1/14,0.68%,CTDNEP1
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),-0.765792980528676,-1.3966710054677878,0.08928571428571429,0.9548161258930029,1.0,2/9,13.26%,PTPRC;PALM3
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.5903495026419974,1.3963772175972282,0.06666666666666667,0.8393771633395922,1.0,4/21,8.46%,RASSF2;PDGFD;GREM1;RAP2A
prerank,GO_Biological_Process_2021__chylomicron assembly (GO:0034378),0.8960154394725597,1.3962430202249725,0.0,0.8375221949416308,1.0,2/6,2.66%,APOB;APOE
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),-0.7821994372627578,-1.395269844303557,0.07142857142857142,0.9605385514588145,1.0,4/10,14.65%,CYP24A1;CYP3A4;LRP2;VDR
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),0.8528529378462568,1.395234795012448,0.08108108108108109,0.8414822980642641,1.0,2/8,8.06%,GLYATL1;GLUD1
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),0.7113141023032519,1.3951091444896229,0.08823529411764706,0.8394854854990214,1.0,5/16,14.75%,FOXO1;KCNC2;MTR;TIMELESS;SPIDR
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),0.8355219360619709,1.3950715733111603,0.07317073170731707,0.8369152826514318,1.0,1/6,1.04%,SLC38A5
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.8252372913329793,-1.3941813299002876,0.03571428571428571,0.9636154176002208,1.0,4/9,13.53%,EPN1;ALOX5;THBS1;PIK3CB
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.6787178374721261,1.3940668774576161,0.13157894736842105,0.8394753656150735,1.0,5/18,12.41%,NGF;MAGI2;RAPGEF1;CASP3;RAP1A
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.5636389015109867,1.3938639359617526,0.07142857142857142,0.8378926308153033,1.0,7/31,9.44%,IRGM;HTRA2;DOC2B;SORBS3;MGARP;STX18;AKT2
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.8063408806173353,1.393316746202351,0.02702702702702703,0.8373846162418839,1.0,3/8,10.21%,FOXO1;KCNC2;MTR
prerank,GO_Biological_Process_2021__kynurenine metabolic process (GO:0070189),0.7947722162345345,1.3931825747629332,0.10256410256410256,0.8355774987253393,1.0,3/9,8.21%,TDO2;KYAT1;AADAT
prerank,GO_Biological_Process_2021__polyol transport (GO:0015791),-0.8213054218472465,-1.392503949865021,0.07142857142857142,0.9720824267431836,1.0,2/9,6.12%,AQP3;SLC5A1
prerank,GO_Biological_Process_2021__negative regulation of vitamin metabolic process (GO:0046137),0.859049599828007,1.3922116197771444,0.045454545454545456,0.8388785341791263,1.0,3/5,14.09%,AKR1C3;SNAI2;NFKB1
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),0.8925339871957323,1.3920772268163293,0.0625,0.8370781478279652,1.0,2/5,7.35%,SEMA5A;DSCAM
prerank,PanglaoDB_Augmented_2021__Podocytes,0.494825043970477,1.3920157310175651,0.18181818181818182,0.8347158296740405,1.0,51/168,16.88%,EFNB1;LAMA3;MAFB;ADGRL2;PTPRO;CCN2;CDH13;PARVA;GOLIM4;MID1;COL12A1;RASSF8;MAGI2;NTN4;RAI14;EDNRA;TRIB2;ITGA3;KANK1;KITLG;RND3;EHD4;EPB41L5;CAP2;COL16A1;CHST3;MPDZ;DDAH1;DACH1;RBFOX2;UNC13B;SYNPO;RASAL2;LRIG3;EFEMP1;NFIB;DST;EMC2;NR2F2;MAGI1;WWTR1;ETF1;BCAM;PRICKLE2;ANTXR1;PTPRF;PLSCR4;CALD1;GPRC5A;CORO2B;ADAMTS13
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.5077764180165595,1.3903557683553491,0.043478260869565216,0.8429891261955764,1.0,31/113,16.63%,SLC38A5;EDIL3;PCDH17;CNGA3;MAFB;PLPPR1;KCNB2;ARX;RESP18;ALDH1A1;GPC6;KLHL41;PROX1;CNTN3;KCNIP1;ABCC8;PDZRN3;RGS7BP;DDAH1;RAB3C;MAP6;MAGI1;ASXL3;PTPRT;RFX6;CFC1;RAI2;FGF14;PTPRD;DEPP1;MAGEL2
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),-0.6809238471491897,-1.390073302222542,0.03125,0.9872172574454385,1.0,3/28,1.19%,AQP3;TBX1;SCN5A
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.6031309986638571,1.3900643338018759,0.06896551724137931,0.8417150423209813,1.0,11/30,19.66%,CTDNEP1;APOE;MFSD2A;PLIN5;ZBTB20;LDLR;MLXIPL;NR1H3;GPLD1;CREB1;ELOVL5
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.46111144611943083,1.390017479572133,0.05555555555555555,0.8394077325113619,1.0,24/183,7.93%,CPA1;MLPH;MXRA5;KIT;ST6GALNAC3;ESYT3;PAPSS2;MITF;CDH5;HNMT;ALDH1A1;RIN2;HS6ST2;PID1;EXT1;HS3ST1;TPH1;PCDH7;OLFML2B;HS2ST1;CFH;ABCA1;GRIK2;EDNRA
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),0.7677186757996074,1.3893895576577466,0.0967741935483871,0.8400400037493253,1.0,4/8,16.57%,NFIB;RYK;NCAM1;EPHB2
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.6289033281495849,1.3891966455207028,0.14814814814814814,0.8383637172494603,1.0,3/27,7.57%,ARC;APOE;ABL1
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),0.8454248505160089,1.3889141337711701,0.11363636363636363,0.837166712090111,1.0,2/5,12.97%,PPP5C;PLSCR1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.7659555338683451,1.3885576945175557,0.07692307692307693,0.8363043113374835,1.0,1/10,3.49%,BIN1
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),0.7984059243361104,1.3884506055647239,0.0975609756097561,0.8343288931674302,1.0,3/8,9.62%,FGFR1;PLIN5;FGFR3
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.6054274095961696,-1.3881547231287739,0.05555555555555555,0.9977116879461891,1.0,25/72,20.84%,CRLF1;SFTPA1;C1QB;INMT;CAPN8;PGC;DUOXA1;SLCO2B1;SFTPD;MS4A4A;VSIG4;SPINT1;STEAP4;CXCL16;FPR3;CLDN18;ADGRF5;ALOX15B;SCNN1A;CYP4B1;CSF1R;FAM3D;NRN1;IFI27;AGER
prerank,GO_Biological_Process_2021__secretion (GO:0046903),-0.7617605532716596,-1.386635044282866,0.08333333333333333,1.0,1.0,3/11,18.26%,SLC22A6;SLC22A4;ABCB11
prerank,GO_Biological_Process_2021__regulation of response to wounding (GO:1903034),-0.8823367573144155,-1.3863971704729736,0.05263157894736842,1.0,1.0,3/5,11.76%,ALOX5;PLAU;VIL1
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.676921884023138,1.3863325757373666,0.058823529411764705,0.8414829014735431,1.0,9/18,27.55%,GATAD2A;DNMT1;TEX15;BAZ2A;ATF7IP;FOS;DMAP1;DNMT3A;PPM1D
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.676921884023138,1.3863325757373666,0.058823529411764705,0.8414829014735431,1.0,9/18,27.55%,GATAD2A;DNMT1;TEX15;BAZ2A;ATF7IP;FOS;DMAP1;DNMT3A;PPM1D
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),0.7898781867494619,1.385993453069378,0.11428571428571428,0.8407101906822498,1.0,3/9,12.24%,CEL;APOE;ADH4
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.8255178981878784,1.385824371653322,0.14634146341463414,0.8387914596926845,1.0,2/7,6.20%,AKR1C3;H6PD
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),0.7513368033669818,1.384162535315304,0.05357142857142857,0.8449150320109913,1.0,1/8,1.13%,ADAMTS1
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.5424414439999387,1.3840944939013822,0.10714285714285714,0.8429494374419889,1.0,9/40,9.90%,GCK;GLA;WNT4;AKR1C3;CRY1;PROX1;KHSRP;SNAI2;WDTC1
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.641683161091798,1.3830510353910164,0.07692307692307693,0.8460130495021334,1.0,8/29,9.07%,BAMBI;TWIST2;PPARG;RORB;GREM1;CDK6;TWIST1;CRIM1
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,-0.5937110820323267,-1.3822101895595031,0.02666666666666667,1.0,1.0,25/71,14.98%,ECT2L;CFAP126;CCDC39;ANKUB1;CCDC187;DYDC2;VWA3B;VWA3A;CCDC60;MAP3K19;RSPH10B;BPIFB1;DRC1;DCDC2B;C11ORF16;AKAP14;SNTN;CFAP77;FAM81B;ATP5MK;APOBEC4;DRC3;DNAH3;EFHB;DNAI1
prerank,GO_Biological_Process_2021__water homeostasis (GO:0030104),-0.7831529947835789,-1.3821865130418454,0.12698412698412698,1.0,1.0,3/7,15.61%,SCTR;AQP4;AQP11
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.6752071339956458,1.3821322678876642,0.16216216216216217,0.8479213384576509,1.0,7/17,20.52%,PCGF1;RNF168;PCGF5;RYBP;BCOR;RNF2;PCGF6
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),-0.7606166576958171,-1.3820517201334208,0.1111111111111111,1.0,1.0,1/11,2.86%,DOCK8
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),0.7503100760587701,1.3812020332818309,0.15555555555555556,0.8509969579554193,1.0,5/10,18.84%,ZBTB1;TFCP2;HSF1;TP53;C5AR1
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),0.8334339479333914,1.3809147655154743,0.10204081632653061,0.8501215517010359,1.0,2/5,12.12%,PRPF39;SFSWAP
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),-0.8972456014183361,-1.3808497427484805,0.034482758620689655,1.0,1.0,2/6,6.09%,IL21R;STAT1
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),-0.8972456014183361,-1.3808497427484805,0.034482758620689655,1.0,1.0,2/6,6.09%,IL21R;STAT1
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),-0.8478902961310334,-1.3806851370936861,0.05,1.0,1.0,3/7,8.44%,DNAH11;CCDC39;DRC1
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),-0.8541133667079386,-1.3801801296413327,0.01639344262295082,1.0,1.0,3/9,8.41%,MCM2;MCM3;MCMDC2
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.6413519913762226,1.3796257258865463,0.0967741935483871,0.8542989281969441,1.0,7/22,21.78%,HES1;PKN2;KLHL18;HSF1;EIF4EBP1;PPP1R10;EIF4E
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.8128575104645622,1.3795420799242146,0.0625,0.8520259718963217,1.0,3/8,10.12%,PKIA;SIRT1;PRKAR2A
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),-0.7912578032805777,-1.3793913954741688,0.1111111111111111,1.0,1.0,2/7,3.78%,PKP2;CTNNA3
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),-0.8357689204248929,-1.3793262536454467,0.03278688524590164,1.0,1.0,2/8,2.76%,CASQ2;CAV3
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.5320047437506572,-1.378972401573287,0.013888888888888888,1.0,1.0,40/134,17.59%,CD44;TGFB1;XCR1;ITGB2;CXCL13;TAC4;CIITA;C3AR1;LTB4R;ALOX15;NFAM1;ANXA1;PTX3;THBS1;CYBA;TRAF3IP2;FPR1;NLRC4;SLC11A1;MMP25;PTGDR;HPR;TLR2;BLNK;FPR3;NLRP3;PTGER3;NOS2;GPR68;GGT5;AFAP1L2;HYAL1;IL18;HRH4;NAIP;PARP4;RAC1;IL10RB;PIK3CG;ABCF1
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.65609811516838,1.378675907718399,0.02857142857142857,0.8541569054928364,1.0,8/17,25.20%,SCRIB;PARD3;FSCN1;DLG2;MARK2;DLG1;LRRC7;DLG3
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.778897194105114,1.3784310363343932,0.058823529411764705,0.8528805029683301,1.0,2/11,5.34%,HDAC3;PKD2
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),0.6663546655975449,1.3783142864796765,0.15151515151515152,0.8511217381563255,1.0,3/22,3.19%,MT1G;SLC30A10;SLC39A8
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.6188143603946235,1.3780210478944088,0.10526315789473684,0.8501726038242837,1.0,3/19,7.70%,CHRM2;LYPD1;PLCB1
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),0.6693539959798268,1.377383418495134,0.09302325581395349,0.8501588006002226,1.0,1/12,0.09%,COL22A1
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),0.7477730066502132,1.3772914492929043,0.061224489795918366,0.8479819713968665,1.0,4/8,16.04%,NLGN1;INSL5;SGIP1;NR4A3
prerank,GO_Biological_Process_2021__centromeric sister chromatid cohesion (GO:0070601),-0.8636055406538915,-1.377199198026324,0.09803921568627451,1.0,1.0,1/5,0.44%,BUB1
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),0.6946317452891085,1.3771398422893684,0.10526315789473684,0.846302014726798,1.0,4/12,15.58%,NLGN1;PCLO;ZDHHC12;NRXN1
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),0.5289349553594939,1.3768881651735128,0.07692307692307693,0.8453340392868873,1.0,7/62,7.63%,TSKU;CEL;APOB;APOE;SOAT1;SOAT2;ABCA1
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),0.6511127941984425,1.3767243899461201,0.10256410256410256,0.8434964520023018,1.0,4/15,8.27%,CCN1;HPSE;GREM1;PLXNB1
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.6557963675350332,1.3760852500611465,0.05128205128205128,0.8441130291078566,1.0,7/20,9.51%,MRAP2;KLK14;CRY1;SNCA;BICD1;RGS14;RPGRIP1L
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),0.769719199924388,1.3746927424544562,0.16129032258064516,0.8468539896483593,1.0,3/8,8.93%,CACNG4;CACNG2;GPHN
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),0.769719199924388,1.3746927424544562,0.16129032258064516,0.8468539896483593,1.0,3/8,8.93%,CACNG4;CACNG2;GPHN
prerank,GO_Biological_Process_2021__triglyceride-rich lipoprotein particle remodeling (GO:0034370),0.7715637296871509,1.3740791977859725,0.18181818181818182,0.8479747614628338,1.0,4/7,9.91%,LIPC;APOB;APOE;LPL
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.5471777640771889,1.3739184880039415,0.08108108108108109,0.8467597845792534,1.0,16/51,21.06%,DCP1B;SAMD4A;DCPS;EXOSC1;CNOT9;LSM2;CNOT4;PATL1;LSM7;DIS3;RC3H1;SAMD4B;CNOT6;EXOSC5;TUT7;LSM6
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),-0.8613492217161722,-1.3737982889808493,0.02,1.0,1.0,4/6,13.34%,HK2;PINK1;TOMM7;ATP5IF1
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),0.7215924712945987,1.3734962004985323,0.15384615384615385,0.8468851370733675,1.0,3/11,13.71%,NOX4;CBS;MTHFR
prerank,GO_Biological_Process_2021__lymphocyte activation involved in immune response (GO:0002285),-0.8086882847643834,-1.3733045652816767,0.03773584905660377,1.0,1.0,4/8,16.13%,IFNK;GPR183;LCP1;F2RL1
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),-0.8545856868581327,-1.37239500491474,0.05454545454545454,1.0,1.0,1/7,3.02%,CHIT1
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell differentiation (GO:0046637),0.8144746714173328,1.37232551852618,0.07894736842105263,0.8508699596323361,1.0,3/6,8.09%,PNP;SH3RF1;NKAP
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.5609226807867645,-1.3719289871614646,0.0136986301369863,1.0,1.0,15/90,10.72%,CD44;RASGRP4;TRIM58;GMFG;TMC8;RAB44;SLFN14;DOCK2;GYPB;ICAM3;SNAP23;CGA;MFSD2B;ALAS2;ITGA2B
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.6008210817249656,-1.371817840017163,0.014084507042253521,1.0,1.0,12/49,23.78%,MCM2;MCMDC2;ANXA1;PIF1;RBX1;RPS27A;DDX1;RECQL4;HMGA1;DDX11;BLM;DDB1
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.5887067080473048,1.3717978103957633,0.06451612903225806,0.8518811159766371,1.0,14/35,21.29%,PHLDB2;ERBB2;BICD1;EPHA3;MAP10;EFNA5;MACF1;KLHL42;MAP6;MARK4;PRKAA2;MARK2;IGBP1;CAMSAP3
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.5325867690336878,-1.3717134797989021,0.038461538461538464,1.0,1.0,16/131,9.19%,CD44;OLFML1;C1QTNF1;LMOD1;TIMP3;ANGPTL2;WNT5A;ESR1;COL1A1;GPER1;COL5A1;LOX;DCN;PHEX;SFRP4;OSMR
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.7741496421657761,1.3715737150823704,0.1,0.850668832745657,1.0,5/9,18.48%,CPNE7;CRLS1;CPNE6;HDHD5;CPNE1
prerank,GO_Biological_Process_2021__inner ear receptor cell development (GO:0060119),0.7146143166244939,1.3707517322930856,0.13157894736842105,0.8530782980356792,1.0,6/9,14.36%,TSKU;IFT88;WHRN;SLC4A7;ADGRV1;PDZD7
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),0.7813571192259241,1.3707257666316768,0.0,0.8507668286696498,1.0,3/9,12.09%,APOE;SIRT1;MLXIPL
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),-0.7732662729313217,-1.3706939583746371,0.10344827586206896,1.0,1.0,8/17,14.91%,FLG;ALOX12;FLG2;CLDN1;ALOX12B;HRNR;TMEM79;ABCA12
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),-0.7732662729313217,-1.3706939583746371,0.10344827586206896,1.0,1.0,8/17,14.91%,FLG;ALOX12;FLG2;CLDN1;ALOX12B;HRNR;TMEM79;ABCA12
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.6649014398733692,1.3705802806033973,0.11627906976744186,0.8493564029391649,1.0,5/21,19.06%,APOE;NLGN1;LRP8;DLG5;FOXO6
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),0.8126123932085186,1.3701054698829866,0.17142857142857143,0.8498515999331757,1.0,1/6,2.66%,APOE
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.7231451846646393,-1.369999229646141,0.11764705882352941,1.0,1.0,8/18,14.24%,PKP2;TGFB1;MYH7;ACTC1;MYBPC3;ZFPM1;ENG;TTN
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),0.8089733813037616,1.369632755720371,0.13043478260869565,0.8501758197643827,1.0,3/7,11.41%,PLIN5;LPL;OSBPL11
prerank,PanglaoDB_Augmented_2021__Basophils,-0.5750251211679562,-1.3693801178349545,0.05263157894736842,1.0,1.0,27/99,13.64%,CD44;LILRB3;CLEC5A;HCK;TEC;PTAFR;C3AR1;RNF39;GPR183;MS4A4A;FCGR3A;VSIG4;HTR1B;NFAM1;IL3RA;MYO1F;PLG;FPR1;ID1;SPI1;CLEC12A;ITGAM;TLR2;H1-3;F13A1;CD300LF;ADGRE3
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),0.7562799630731303,1.3693106148666512,0.08888888888888889,0.849785296064031,1.0,3/10,6.26%,SCUBE1;JAG1;PROX1
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,-0.541588255088204,-1.3684813234003312,0.0273972602739726,1.0,1.0,41/135,21.21%,PLEKHS1;AQP3;VSIG2;TMEM184A;PLEKHG6;MISP;FMO5;CLDN1;TMC4;LIPH;EPN3;SERPINB5;CEACAM1;ALOX15;BRCA1;MYO5B;SPINT1;LAMC2;ITGB6;STAP2;BAIAP2L1;TRIM29;ITGA5;F5;PRG4;INCENP;GPX2;ECT2;CD24;SCNN1A;LGALS4;SCNN1G;PLA2G4A;ANPEP;FAM3D;CBLC;MECOM;COL17A1;AGER;EMILIN2;CRYBA1
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),0.581918891272062,1.3684195556783336,0.07142857142857142,0.8526590216513302,1.0,2/23,4.74%,PNP;AMPD1
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),0.7262879347986426,1.3681979824125117,0.075,0.8520135593717684,1.0,5/11,17.84%,ELOF1;CDCA4;ARID1A;SERTAD2;ARID1B
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.4710555160238325,1.367638469372471,0.05555555555555555,0.8533680304642767,1.0,11/111,5.65%,GCK;ATP6V0D2;FOXO1;SH2B2;CPEB1;TCIRG1;IRS1;RAB31;CAPN10;PPARG;SLC25A33
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),0.6660234701755051,1.3675578449150085,0.1111111111111111,0.8514383820801615,1.0,9/17,25.97%,PCM1;C2CD3;PIBF1;GOLGB1;CCDC14;CEP192;HOOK3;KIAA0753;CEP83
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.9491711255690762,1.3673859629402856,0.0625,0.8478994708402292,1.0,1/5,0.53%,PHLDB2
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.9491711255690762,1.3673859629402856,0.0625,0.8478994708402292,1.0,1/5,0.53%,PHLDB2
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.73668016490673,1.3669462527772667,0.1282051282051282,0.8478105635646158,1.0,1/14,1.51%,CPEB1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to synapse (GO:1902474),-0.9002452158932801,-1.366775886885268,0.09836065573770492,1.0,1.0,1/5,2.54%,WNT5A
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),0.6271114048277154,1.3663708022554013,0.13513513513513514,0.8483785569530933,1.0,4/20,10.37%,PEX13;GDAP1;ABCD3;ABCD2
prerank,GO_Biological_Process_2021__regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371),-0.9165099965124839,-1.3661451929390325,0.016666666666666666,1.0,1.0,1/5,1.19%,SCN5A
prerank,GO_Biological_Process_2021__tRNA thio-modification (GO:0034227),0.8346017742226104,1.3655192368753233,0.15217391304347827,0.850130004182485,1.0,1/5,7.06%,CTU1
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.659178274450522,1.3647511197044748,0.08571428571428572,0.8517903754708278,1.0,8/16,18.67%,CEL;NLGN1;NLGN4X;RET;NLGN3;NCAM2;NRXN1;ASTN2
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.6038983324995263,1.3644588826894386,0.10810810810810811,0.8513663843934756,1.0,8/28,16.93%,SLC44A5;MFSD2A;ABHD3;CHPT1;CEPT1;CHKA;ACHE;LPIN2
prerank,GO_Biological_Process_2021__proton-transporting V-type ATPase complex assembly (GO:0070070),-0.9085174911109437,-1.3644043184388275,0.017857142857142856,1.0,1.0,1/5,4.68%,ALDOB
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.5649798109316344,-1.3640484495481153,0.0684931506849315,1.0,1.0,38/90,20.41%,JCHAIN;GMFG;ITGB2;HCK;DOCK8;CYTIP;ARHGAP9;TAGAP;CLEC4C;GPR183;PARVG;WAS;LY86;CD37;NFAM1;IL3RA;TRAF3IP3;MYO1F;PTPRC;SPI1;ITGAM;BLNK;CD300LF;PSTPIP1;NIBAN3;CD80;ITM2C;IKZF1;IGLL1;CD4;NAPSB;ALOX5AP;SERPINF1;CARD6;SASH3;ITGAX;IL17RB;CD86
prerank,GO_Biological_Process_2021__gas transport (GO:0015669),0.7479629920034204,1.3639478066579815,0.17073170731707318,0.8522839762292619,1.0,3/6,15.23%,NGB;MYC;CA2
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),0.7874658890565444,1.3638164272804376,0.06666666666666667,0.8505656986149873,1.0,3/8,10.68%,KIT;CLMP;COBL
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.716858860725948,1.3637052295731023,0.09375,0.8488566096510565,1.0,4/11,17.05%,DNMT1;RESF1;MPHOSPH8;ATF7IP
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.5786427517948689,1.3631861296842545,0.12903225806451613,0.8495319918549689,1.0,7/29,15.71%,NRG2;ERBB2;NRG1;PTPRR;GAB1;PIK3CA;MATK
prerank,GO_Biological_Process_2021__regulation of barbed-end actin filament capping (GO:2000812),0.8019512601294139,1.3631769850139348,0.1590909090909091,0.8473529046525068,1.0,2/5,8.07%,WASHC2C;CRACD
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.6104978250591031,-1.3629467556872847,0.05263157894736842,1.0,1.0,15/49,17.92%,PSMB9;TIMP3;SERPIND1;VTN;SERPINB5;SERPINA10;TIMP4;SERPINE3;A2ML1;SPOCK3;AGT;PSMA3;VSIR;SERPINB7;SERPINF1
prerank,GO_Biological_Process_2021__sequestering of BMP from receptor via BMP binding (GO:0038098),0.8211126196767832,1.3628509481525692,0.09803921568627451,0.8466671050983109,1.0,2/6,7.18%,GREM2;GREM1
prerank,GO_Biological_Process_2021__negative regulation of ruffle assembly (GO:1900028),0.7689845301879294,1.3627553988750476,0.10638297872340426,0.8448665932343232,1.0,3/6,11.56%,KANK1;ABI3;EVL
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),-0.7516227848753602,-1.361515145390073,0.08196721311475409,1.0,1.0,4/16,8.12%,PKP2;SCN5A;CAV3;KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.6841984545451077,-1.3614237371417521,0.03636363636363636,1.0,1.0,6/21,13.03%,MMP9;CIDEB;GPER1;PINK1;BIK;MOAP1
prerank,GO_Biological_Process_2021__tongue development (GO:0043586),-0.8578730175424992,-1.3608943794254322,0.06060606060606061,1.0,1.0,1/5,0.55%,TBX1
prerank,GO_Biological_Process_2021__negative regulation of lens fiber cell differentiation (GO:1902747),0.7931774756962798,1.3607091643663387,0.14285714285714285,0.854189648504796,1.0,3/5,11.02%,SPRED3;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),0.7684313886691853,1.3606468006835202,0.08108108108108109,0.8525377389770714,1.0,1/7,0.05%,ADRA1A
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),0.8554265770214515,1.359281861625651,0.05128205128205128,0.8578687211743622,1.0,1/7,1.32%,EMP1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),-0.7923926858513155,-1.3590222859693226,0.16326530612244897,1.0,1.0,2/9,3.57%,WNT5A;CXCL13
prerank,GO_Biological_Process_2021__radial glial cell differentiation (GO:0060019),0.7627242715389166,1.3588208541242979,0.10204081632653061,0.8579943426159946,1.0,2/6,5.56%,FGF10;HES1
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),0.6559553481921667,1.35860510157132,0.1111111111111111,0.8549017055848231,1.0,2/14,0.97%,MLPH;RAB27A
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),0.6559553481921667,1.35860510157132,0.1111111111111111,0.8549017055848231,1.0,2/14,0.97%,MLPH;RAB27A
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),0.6448687679695676,1.3580433594922663,0.15555555555555556,0.8555438438459487,1.0,5/12,18.39%,GMNC;SLFN11;TERF1;RAD17;ATR
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.6200961235265215,1.3580126407185287,0.0967741935483871,0.8535620867665235,1.0,10/18,24.23%,PARD3;RAP2A;SIPA1L3;FERMT1;CYTH1;MYO9A;FBF1;CAMSAP3;MYO18A;CYTH3
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),0.8236595390190787,1.3575148905507273,0.08695652173913043,0.8542823918132443,1.0,3/8,6.55%,PNP;NT5C1A;PRTFDC1
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.568531719051577,1.356543680279196,0.13333333333333333,0.8571391079230096,1.0,11/22,23.49%,CDH5;CCN1;UBE2O;SMAD2;ELAPOR2;NOTCH1;RBPJ;ACVR2A;BMPR2;BMP4;BMPR1A
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell apoptotic process (GO:0034392),0.9079102191461121,1.3565069709103277,0.022222222222222223,0.8550520994337317,1.0,4/5,8.53%,APOH;DNMT1;DIPK2A;LRP6
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),-0.7940994342784389,-1.3564138184916812,0.0967741935483871,1.0,1.0,2/10,4.89%,TGFB1;TNFRSF1B
prerank,GO_Biological_Process_2021__G protein-coupled receptor internalization (GO:0002031),0.8236250693657002,1.3553109998319637,0.08,0.8591696814965559,1.0,3/5,13.66%,ARRB2;SAG;ARRB1
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),-0.8706520624730257,-1.3546756667364304,0.07575757575757576,1.0,1.0,3/6,8.41%,MCM2;MCM3;MCMDC2
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),-0.8706520624730257,-1.3546756667364304,0.07575757575757576,1.0,1.0,3/6,8.41%,MCM2;MCM3;MCMDC2
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.48467161605842646,1.3545215460419466,0.07142857142857142,0.8614514005113917,1.0,19/81,13.60%,ZNF804A;APOE;MAGI2;TOX;EPHA3;RAPGEF1;FZD1;TENM3;ARSB;STYXL1;ABL2;RETREG3;COBL;AVIL;RET;RAP1A;ARHGAP35;FUT9;LRP8
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.5728204137416438,1.3542105747928013,0.030303030303030304,0.8612950778030094,1.0,11/28,23.05%,DCP1B;DCPS;EXOSC1;LSM2;PATL1;LSM7;DIS3;CNOT6;EXOSC5;LSM6;DCP1A
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),0.7597962941719,1.3539728214758215,0.14634146341463414,0.8604480574148646,1.0,3/8,13.77%,RGS14;RPS6KA3;TCIM
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),-0.7728232125168549,-1.353884224047405,0.0847457627118644,1.0,1.0,1/10,2.89%,CCDC39
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.663319619478985,1.3536719675441105,0.11904761904761904,0.8603333935653096,1.0,5/21,19.46%,DGKD;PGS1;PLA2G15;DGKH;DGKZ
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.7301099743045939,1.3536717616714944,0.14814814814814814,0.8581553343410936,1.0,4/9,22.14%,ZNF703;PAK2;VCL;SMAD7
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.5540998465638537,1.3530054240457978,0.06451612903225806,0.8592670475381071,1.0,15/42,12.56%,GPC4;SDC4;HS6ST2;HS3ST3B1;EXT1;HS3ST1;GPC6;HS3ST5;HS2ST1;HS3ST2;GPC5;B3GAT3;UGDH;SDC3;EXT2
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),0.8056917981121567,1.3524033266907833,0.08108108108108109,0.8602590724933372,1.0,4/5,17.21%,HES1;RNF10;NOTCH1;SKI
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),-0.6221524613799589,-1.3516068966254104,0.06451612903225806,1.0,1.0,11/43,12.50%,SIRPG;TULP1;HCK;DOCK2;SFTPD;TGM2;CYBA;OLFM4;PTPRC;SLC11A1;TLR2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.5663067728429771,1.3508072881207653,0.1,0.867012030698602,1.0,6/27,7.77%,SLFN11;PKD2;GFI1B;CDK6;CDK4;RBL1
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),-0.6991642996233258,-1.3507820572663505,0.14285714285714285,1.0,1.0,7/20,16.13%,DUOX1;TGFB1;P2RY12;CAVIN1;THBS1;NTN1;F2RL1
prerank,GO_Biological_Process_2021__protein side chain deglutamylation (GO:0035610),0.8284126378658265,1.350275413467178,0.06666666666666667,0.8676391247018206,1.0,1/5,11.19%,AGBL4
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.5700768710881035,1.350264945864956,0.0,0.8656210029087121,1.0,11/30,23.05%,DCP1B;DCPS;EXOSC1;LSM2;PATL1;LSM7;DIS3;CNOT6;EXOSC5;LSM6;DCP1A
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),0.5608749490228436,1.3500626763886294,0.15625,0.8645165436800364,1.0,6/33,8.09%,PNP;BCL6;SOX12;HLA-DRA;ZBTB1;NKAP
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.5536401572309453,1.3497232459884447,0.10810810810810811,0.8644315973090783,1.0,12/38,16.75%,MFSD2A;KIAA0319;BCL11A;SARM1;DCC;RAP2A;TNIK;COBL;CSMD3;LRP8;MARK1;NEDD4
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),0.49134517155072266,1.3483459434972525,0.14285714285714285,0.8691798036261583,1.0,25/82,21.50%,LLGL1;KLHL20;COMMD1;ACBD3;GBF1;SORCS1;CCDC22;ARRB1;RAB10;RP2;ARL3;EXOC6B;CLINT1;GOLGB1;MON2;AP4S1;CLVS1;MYO5A;AP4B1;DOP1B;VAMP8;AP1B1;EXOC6;KIF16B;EXOC4
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.4474649815674552,1.3483013164732867,0.0,0.8672152199768935,1.0,25/141,9.08%,CDH20;GPC4;GRID2;CDH19;CDH12;ROBO2;ALCAM;CDH7;NLGN1;CDH5;DSCAML1;CDH13;LRRC4C;BSG;UNC5D;GPC6;SDK1;CDH26;CADM1;CDH6;DSCAM;LRFN5;TENM3;TENM1;PTPRM
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),-0.7194825949637296,-1.3476661518379676,0.1746031746031746,1.0,1.0,2/12,10.45%,NUF2;CENPH
prerank,GO_Biological_Process_2021__regulation of norepinephrine secretion (GO:0014061),0.8802326911010959,1.3474968551092446,0.06521739130434782,0.8695473113442492,1.0,1/5,3.50%,HRH3
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.5195349618034446,1.3472344815475739,0.05263157894736842,0.8692648797725431,1.0,8/47,7.95%,NXPH2;NXPH4;GRP;GALR3;UTS2R;OPRD1;NMU;SORCS1
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.7012014305793443,1.3469840367222292,0.11428571428571428,0.868167749483691,1.0,8/14,21.59%,GRM3;GRM8;GRM4;GRM2;GRM7;GRIK3;GRM5;GRM1
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.7302851406662039,-1.3465264038475364,0.07142857142857142,1.0,1.0,3/14,10.71%,TGFB1;ESR1;TERT
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),0.640832357098514,1.3464438955225166,0.05263157894736842,0.8692592289266797,1.0,7/22,20.42%,ERBB2;SMARCB1;EIF2AK3;PIH1D1;SMARCA4;MARS1;IPPK
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),-0.8648930107580087,-1.346429479518583,0.07142857142857142,1.0,1.0,3/5,5.93%,NLRP12;TAF7;CIITA
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),0.7941491792850324,1.3463845602627935,0.17391304347826086,0.8678352563264383,1.0,2/6,4.83%,SMYD1;MAML1
prerank,GO_Biological_Process_2021__granulocyte migration (GO:0097530),-0.8036608844361386,-1.3460888024541617,0.07017543859649122,1.0,1.0,3/7,8.67%,UMODL1;ITGB2;ANXA1
prerank,GO_Biological_Process_2021__hydrogen peroxide biosynthetic process (GO:0050665),-0.8489725403164399,-1.3457926132178781,0.09523809523809523,1.0,1.0,2/5,10.17%,DUOX1;CYBA
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),0.7383632234422829,1.3454838425706628,0.09090909090909091,0.8694745737261118,1.0,2/8,13.78%,MTO1;TRMT61B
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),0.8258929998666599,1.3451155189466086,0.18604651162790697,0.8692324888632655,1.0,1/5,5.35%,CRY1
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.8312502707610496,1.3449885076704486,0.19047619047619047,0.8679655285574966,1.0,1/5,2.90%,HIP1
prerank,GO_Biological_Process_2021__membrane depolarization during SA node cell action potential (GO:0086046),-0.8716536762479834,-1.3448644815299176,0.15789473684210525,1.0,1.0,1/5,1.19%,SCN5A
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.7500794374948447,-1.3438507615398583,0.15625,1.0,1.0,2/13,2.05%,PKP2;GJC3
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),0.8006059462184202,1.3437914402748847,0.06818181818181818,0.8721880941604604,1.0,2/5,13.36%,TOX;ASCL1
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),-0.8205305785155941,-1.343535223452951,0.13846153846153847,1.0,1.0,2/7,2.55%,TGFB1;ACMSD
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),-0.8435765096537281,-1.342936427124526,0.109375,1.0,1.0,1/6,1.49%,TGFB1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.6429632989732572,-1.3413876068986128,0.05084745762711865,1.0,1.0,1/31,0.09%,ENPP2
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),-0.6995225125954689,-1.3411942076074956,0.04477611940298507,1.0,1.0,6/25,8.12%,SCN5A;MYH7;CASQ2;MYBPC3;CSRP3;KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.6258828446670935,-1.3410414269065938,0.12307692307692308,1.0,1.0,1/34,0.37%,NEK2
prerank,GO_Biological_Process_2021__lipoxin metabolic process (GO:2001300),-0.8317405816579271,-1.340988319312725,0.05263157894736842,1.0,1.0,3/6,4.48%,ALOX12;ALOX5;PTGR1
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.5071696128353586,1.3401564496228247,0.07407407407407407,0.8876952284755741,1.0,27/75,23.49%,BAMBI;CCN4;TWIST2;CCN1;PPARG;WNT4;RORB;GREM1;CDK6;TWIST1;SNAI2;CRIM1;SUCO;WWTR1;MEN1;NOTCH1;SKI;ZHX3;ACVR1;PTCH1;ACVR2A;BMPR2;HDAC7;BMP4;TNN;LRP3;BMPR1A
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),-0.8543126106612795,-1.3401456508924388,0.14035087719298245,1.0,1.0,2/5,10.72%,COL5A1;SLC11A1
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.5007020538135426,1.3399497511750416,0.1,0.8865384574439343,1.0,40/128,20.33%,CDH20;NTSR2;GRIN3A;SPHKAP;GJB6;GRM3;LRRTM3;LRRC4C;BAALC;ELAVL3;CADM2;ZEB2;MAGI2;PTPRZ1;KCNIP1;ADCY2;ADGRA1;GABRG1;RGS7BP;NPAS3;RBFOX1;DPP6;NRXN1;TTC21B;KCND3;DLG2;SLITRK2;PPFIA2;S100B;LSAMP;MMD2;ST8SIA3;ADGRB3;GRM5;PTCH1;CTNNA2;SLC1A3;TNR;KCNJ10;PMP2
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.5648030299874913,1.339765849865494,0.11538461538461539,0.8856050016845328,1.0,10/34,17.20%,PCM1;CAPN10;STX18;TENM1;CEP290;B3GAT3;PLK3;PGAP1;NEDD4;ICE1
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),0.5967047221307661,1.3396074532964501,0.03125,0.8844225859694149,1.0,2/14,12.34%,STAT5B;PXN
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),-0.68712617737628,-1.3394201726846262,0.09375,1.0,1.0,5/17,21.21%,KIF14;STMN4;KIF18A;STMN1;STMND1
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.4914910976813435,1.3389244784035381,0.15789473684210525,0.8864965075730704,1.0,35/163,15.53%,SLC17A6;MEGF10;EDIL3;GRID2;LINGO2;NOVA1;NLGN1;EPHA7;ELAVL3;CNTNAP2;CADM2;NRG1;PAK5;KCNH7;SLC35F1;RALGPS2;MAPK8;ERC2;SYT1;GALNT13;BRINP1;ISOC1;GNL3L;TRIM44;DACH1;RIMS4;OLFM3;CLSTN2;SNAP91;MAP6;FUT9;SCRT1;ANK2;INSYN2A;ACHE
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.7102187128879307,-1.338788093029644,0.12698412698412698,1.0,1.0,4/19,5.16%,DTL;CCND1;CDC25A;RAB11A
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),0.6545548473285292,1.338462863945395,0.11428571428571428,0.8846116292541537,1.0,2/15,0.97%,MLPH;RAB27A
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),0.6545548473285292,1.338462863945395,0.11428571428571428,0.8846116292541537,1.0,2/15,0.97%,MLPH;RAB27A
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),0.6821588540767425,1.3383007408788168,0.1935483870967742,0.8829048881407495,1.0,6/13,22.33%,DNMT1;RESF1;MPHOSPH8;ATF7IP;SIRT6;TPR
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),0.7574998813265704,1.3382949211859594,0.08571428571428572,0.8808126964626909,1.0,3/7,13.71%,CBS;MTR;MTHFR
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),0.7387219496554343,1.338230199517936,0.06976744186046512,0.8791943894361601,1.0,6/13,12.82%,TGFBR1;ADAMTS12;WNT9A;GREM1;SNAI2;EFEMP1
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.5378748213501807,-1.3381990726156694,0.05555555555555555,1.0,1.0,3/82,2.96%,CD44;TGFB1;TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of autophagosome maturation (GO:1901098),0.8888369206151718,1.3380241300234348,0.08695652173913043,0.8780822216552849,1.0,1/5,0.82%,IRGM
prerank,GO_Biological_Process_2021__medium-chain fatty acid catabolic process (GO:0051793),0.8541077572550406,1.3380069017828926,0.11904761904761904,0.8760516696087188,1.0,3/5,10.45%,GLYATL2;ABHD3;ACADM
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),-0.8566547435678504,-1.3379995845689208,0.046153846153846156,1.0,1.0,1/6,9.91%,NDUFS2
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.4685737977894717,1.3378235762862976,0.07407407407407407,0.8747748986495948,1.0,22/146,10.40%,CDH20;NTSR2;SPHKAP;GJB6;NFATC3;APOE;LRRTM3;BAALC;TMEM132C;CADM2;SRR;PTPRZ1;KCNIP1;LUZP2;PLXNB1;ADGRA1;SYNDIG1;AANAT;FGFR3;BRINP1;GABRG1;RGS7BP
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.7680827717087019,1.3377643360133962,0.13043478260869565,0.8731151766867409,1.0,2/6,7.38%,FOXO1;EIF2AK3
prerank,GO_Biological_Process_2021__glycerol transport (GO:0015793),-0.8897357371300543,-1.3376277364494698,0.1320754716981132,1.0,1.0,1/5,0.34%,AQP3
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),0.7219644475969912,1.3374230042175532,0.21052631578947367,0.8728742012624641,1.0,2/7,2.55%,KIT;NFATC3
prerank,GO_Biological_Process_2021__regulation of ribonuclease activity (GO:0060700),-0.8302929822377065,-1.3357507932621147,0.10416666666666667,1.0,1.0,2/5,12.20%,OAS2;OAS1
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.6385008196041915,1.335608142306268,0.1111111111111111,0.8795672806591224,1.0,7/13,20.31%,TGFBR1;GDF6;SMAD2;CFC1;HJV;ACVR1;ACVR2A
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),-0.7397016988153121,-1.3355840742124672,0.12280701754385964,1.0,1.0,3/10,10.86%,ATP1A4;ATP6AP1;LACC1
prerank,GO_Biological_Process_2021__fluid transport (GO:0042044),-0.7807953000597572,-1.3355814862108792,0.06896551724137931,1.0,1.0,4/11,15.61%,AQP3;UPK3A;AQP4;AQP11
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),0.5881791299491711,1.3350253052484067,0.2,0.8799795244960181,1.0,6/36,7.63%,TSKU;APOB;APOE;SOAT1;SOAT2;ABCA1
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),-0.6563187086538114,-1.3347545743747915,0.11267605633802817,1.0,1.0,8/25,20.41%,WNT5A;SCIMP;CLCF1;PTPRC;LACC1;F2RL1;SASH3;CD86
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.6010085079900698,1.3344851949175012,0.09375,0.880740147755124,1.0,2/18,1.86%,ATP6V0D2;TCIRG1
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),0.7472688702887659,1.334343464052856,0.14,0.87950520491978,1.0,4/7,22.40%,LETM2;TESMIN;SLC4A11;CLDN16
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),0.5903565526885146,1.334198055381906,0.06666666666666667,0.8785200382939583,1.0,9/32,6.11%,HGFAC;TBC1D10A;APOH;PRSS3;PERP;RIPK2;KLKB1;IFI16;F11
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta clearance (GO:1900222),-0.8717874952847591,-1.3341826448819294,0.08064516129032258,1.0,1.0,1/5,2.65%,LRPAP1
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.68192496998079,1.33383749643335,0.18181818181818182,0.8782699407289867,1.0,3/14,11.15%,TDO2;ACACB;PPCS
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),-0.8311754728607601,-1.3336881367720754,0.10526315789473684,1.0,1.0,1/8,2.54%,WNT5A
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.729118461961767,1.3336449906607561,0.125,0.8771880219005179,1.0,8/14,17.85%,SHLD2;SHLD1;SETMAR;KMT5C;SMCHD1;WRAP53;KMT5B;PNKP
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),0.6736002040715614,1.3331151149519795,0.16666666666666666,0.8761100358929499,1.0,2/12,8.39%,PER2;GYS1
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),0.6736002040715614,1.3331151149519795,0.16666666666666666,0.8761100358929499,1.0,2/12,8.39%,PER2;GYS1
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),0.5876782891481578,1.3331074320409202,0.06896551724137931,0.8741097846694499,1.0,4/32,5.56%,FOXO1;PER2;CX3CR1;HES1
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),0.6916681217507723,1.3326597925240413,0.18181818181818182,0.8740789270877064,1.0,4/10,22.90%,SKAP1;FUT9;MIA3;WNK1
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),-0.7747420663801752,-1.3322374410385207,0.10909090909090909,1.0,1.0,1/10,2.75%,P2RY12
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),-0.8153091914079287,-1.3322330158200415,0.06666666666666667,1.0,1.0,3/11,8.41%,MCM2;MCM3;MCMDC2
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.6404786327770886,1.3319432199315786,0.06818181818181818,0.8754550317596299,1.0,7/14,25.69%,HDAC3;HDAC1;HDAC4;NOTCH1;HDAC5;FZD7;BMP2
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),0.7593282775538388,1.3318419074321532,0.0851063829787234,0.8742230413044423,1.0,2/7,7.57%,APOE;ABL1
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),0.6603716272034642,1.3317979565483333,0.1282051282051282,0.8723817910016234,1.0,7/17,23.91%,CHMP6;ODC1;FURIN;SNF8;FAF1;FAP;HPGD
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),-0.7156944554705705,-1.3312549354332839,0.11290322580645161,1.0,1.0,8/15,17.79%,ALOX12;ALOX5;ALOX12B;ALOX15;PON3;PON1;ALOX15B;ALOX5AP
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),0.7975555951807971,1.3312311923894509,0.1568627450980392,0.8732752825718888,1.0,2/6,18.99%,JADE3;JADE2
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),0.6371810368471532,1.3309142711170705,0.11428571428571428,0.8729406195244349,1.0,5/21,13.47%,MYO10;CCDC88B;DYNC1I2;CCDC88A;MAP6
prerank,GO_Biological_Process_2021__regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372),-0.8236086695443878,-1.3306241659761817,0.09259259259259259,1.0,1.0,3/6,8.12%,SCN5A;KCNA5;KCNQ1
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.49750336175658616,1.3305105152286913,0.07142857142857142,0.8734217132653992,1.0,13/66,12.05%,NGF;PLCH1;NYAP2;FGFR1;IRS1;ERBB2;PI4KB;PLCL2;PIK3C2B;PLCB1;IRS2;PLCH2;TYRO3
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),-0.6733674158020329,-1.3304063202148677,0.13114754098360656,1.0,1.0,2/20,5.18%,SCN5A;GPER1
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),0.6577904643923843,1.3298471835916421,0.15,0.8749500345182954,1.0,1/11,0.87%,PER2
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.5453803985325996,-1.3297388395145253,0.06578947368421052,1.0,1.0,3/56,4.42%,MCM2;PSMB9;MCM3
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),0.6240512455943494,1.329587146980344,0.10810810810810811,0.8744112185088911,1.0,8/16,22.16%,SAMSN1;PAG1;PIBF1;BANK1;LGALS3;LAPTM5;LST1;IL4I1
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),0.7587908810178895,1.3293255776319726,0.061224489795918366,0.8737400079114518,1.0,3/8,11.02%,SPRED3;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.4304797950366544,1.3283761688942775,0.0,0.8769386561906886,1.0,15/221,5.55%,CPA1;HGFAC;PRSS3;CPN1;KLK14;NAALAD2;CAPN10;TMPRSS7;MMP17;HTRA2;KLKB1;ADAMTS12;MMP2;PRSS57;CAPN2
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),0.6633802271850766,1.3283706376930347,0.1111111111111111,0.8750234538477418,1.0,8/15,25.97%,PCM1;C2CD3;PIBF1;CCDC14;CEP192;HOOK3;KIAA0753;CEP83
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),0.7247462298985256,1.328368595710542,0.14634146341463414,0.8730832688059509,1.0,4/14,4.73%,SELPLG;PODXL2;CX3CR1;ITGA4
prerank,GO_Biological_Process_2021__diadenosine polyphosphate catabolic process (GO:0015961),0.767514247685637,1.3280839560493107,0.21951219512195122,0.8723875342930867,1.0,2/6,5.02%,FHIT;NUDT4B
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),0.7193934766125938,1.3279383882705158,0.15625,0.8711282947853596,1.0,5/13,14.06%,TFB1M;TEFM;SLC25A33;EARS2;PNPT1
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.5460547008513377,-1.327893183211775,0.07575757575757576,1.0,1.0,16/91,15.49%,BUB1;TICRR;ERCC6L;HK2;SALL4;MCM3;SLC7A3;ZNF296;CLDN6;CENPH;TERT;PIF1;CHAF1A;ATAD5;CCNF;ZGRF1
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.5362642459784276,1.3274998303304566,0.05128205128205128,0.8717036072194171,1.0,13/33,21.62%,KPTN;IFI16;EIF2AK3;TP53;MTMR3;SIK2;IMPACT;SESN2;PRKAA2;NIM1K;PRKAG2;SZT2;PIK3R4
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),0.6498423437113947,1.3274702563495342,0.15151515151515152,0.8699868643709959,1.0,7/14,27.43%,PDSS2;UBIAD1;AIFM2;COQ2;COQ9;COQ6;COQ3
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),0.731397959975204,1.327176615292564,0.2391304347826087,0.8697675460173231,1.0,5/9,16.04%,LEPR;INSL5;UCN;SGIP1;NR4A3
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),-0.7807430724651421,-1.327121421790041,0.10344827586206896,1.0,1.0,1/13,1.36%,SLC37A2
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.5114146928924872,-1.326652817214202,0.08450704225352113,1.0,1.0,26/120,23.66%,BUB1;ERCC6L;SPC25;CENPU;GPSM2;ITGB3BP;ZWILCH;TTK;NUF2;CENPH;DYNLL1;RPS27;INCENP;NDEL1;CDCA8;CENPN;KIF18A;BUB1B;STMN1;SKA2;SEC13;CENPL;DYNLL2;SBDS;CENPM;AURKA
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),-0.7895489827222362,-1.3266414302476288,0.061224489795918366,1.0,1.0,1/10,0.36%,MICB
prerank,GO_Biological_Process_2021__positive regulation of type I interferon-mediated signaling pathway (GO:0060340),-0.7983521930517774,-1.3264602131937333,0.2037037037037037,1.0,1.0,1/5,2.54%,WNT5A
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.552625986204578,-1.3262298329438376,0.04054054054054054,1.0,1.0,54/104,27.27%,RPL37A;RPL38;RPL15;RPS4X;RPL3;RPL35A;RPS9;RPS27;RPS21;RPL13A;RPL27A;RPS16;RPL36;RPS20;RPL7A;RPL9;RPL13;RPS8;RPS27A;RPL21;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;RPL27;RPL35;RPS14;RPL11;RPS15;RPLP1;RPS12;RPL24;RPL18A;RPS13;RPL29;RPLP2;RPL28;RPL12;RPL18;RPS3;RPL22;RPSA;RPS28;RPS19;RPS24;RPS3A;RPL19;RPL8;RPS6;RPL10
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.635125337269305,1.325947939066959,0.058823529411764705,0.8737117648007426,1.0,8/31,19.39%,ARC;NLGN1;LZTS3;ABI3;LRP8;SRCIN1;PPFIA2;CDK5
prerank,GO_Biological_Process_2021__bundle of His cell to Purkinje myocyte communication (GO:0086069),-0.7942390442862048,-1.325880766224312,0.19607843137254902,1.0,1.0,2/6,3.78%,PKP2;CTNNA3
prerank,GO_Biological_Process_2021__bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073),-0.7942390442862048,-1.325880766224312,0.19607843137254902,1.0,1.0,2/6,3.78%,PKP2;CTNNA3
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.6582302574662102,1.325694725295368,0.2,0.8731885934328689,1.0,8/18,19.18%,FGF10;ROBO2;PKD2;OSR1;GDF6;NF1;NIPBL;PTCH1
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.7245776139328521,-1.3256741170528898,0.07575757575757576,1.0,1.0,3/15,10.71%,TGFB1;ESR1;TERT
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),0.6786381339682108,1.3256078730329233,0.1724137931034483,0.8715493607999367,1.0,4/13,16.49%,SDC4;RAB7A;SMPD3;SNF8
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.48007831964825654,1.3255307726217018,0.07692307692307693,0.8700813596335026,1.0,30/103,16.74%,DUSP15;CACNG4;ARX;HS6ST2;RGS16;CXXC4;PCLO;HES1;JPH1;CKMT1A;PLXNB1;ABCC8;FGFR3;WNK2;COBL;DDAH1;PRR36;LRIG3;TSPAN12;NR2F2;MSI1;MAGI1;NKD2;RFX6;PTPRF;CGN;EFNA2;WWC1;CKMT1B;MARK1
prerank,PanglaoDB_Augmented_2021__Macrophages,-0.5481683405293267,-1.3253314345653207,0.05555555555555555,1.0,1.0,38/120,13.42%,CLEC5A;SLC37A2;AHR;LYVE1;ITGB2;HCK;MMP9;CYTIP;CHIT1;TAGAP;SLC7A7;SCIMP;CPM;TNFRSF1B;PTAFR;SLCO2B1;C3AR1;DAB2;MS4A4A;PARVG;FCGR3A;LY86;VSIG4;NFAM1;ADGRE1;MYO1F;IGSF6;P2RY6;PTPRC;FPR1;SLC11A1;SPI1;CLEC12A;ITGAM;CXCL16;TLR2;F13A1;CD300LF
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.5625512004468026,1.324721170352552,0.11764705882352941,0.8722876912461829,1.0,10/28,26.74%,RBM20;TRA2A;CELF4;ERN1;HSPA1A;U2AF2;SF3B4;SETX;DYRK1A;NUP98
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.5132445324189008,1.3247073986134368,0.07407407407407407,0.8704323014423268,1.0,9/75,5.34%,GRIN3A;NIPAL1;TRPC3;SLC39A8;SLC3A2;TRPM2;SLC8A1;SLC8A3;PKD2
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),0.4986071252340125,1.3245602592341652,0.058823529411764705,0.8691392658745536,1.0,17/61,24.33%,CPSF1;TRDMT1;METTL1;CTU1;POP1;TRMT9B;CDKAL1;TRMT61A;ANKRD16;TSEN2;DTWD1;FARS2;THUMPD1;THG1L;NSUN2;ADAT2;TRMT1
prerank,GO_Biological_Process_2021__response to indole-3-methanol (GO:0071680),-0.8492084235643929,-1.3245165885555306,0.06,1.0,1.0,2/5,8.63%,CTNNA1;BRCA1
prerank,GO_Biological_Process_2021__cellular response to indole-3-methanol (GO:0071681),-0.8492084235643929,-1.3245165885555306,0.06,1.0,1.0,2/5,8.63%,CTNNA1;BRCA1
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),-0.802379296811605,-1.32432812856664,0.12121212121212122,1.0,1.0,1/6,1.65%,GMFG
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),0.8457315543097584,1.3241452086725465,0.13333333333333333,0.8654230493735343,1.0,1/5,2.66%,APOE
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),0.8457315543097584,1.3241452086725465,0.13333333333333333,0.8654230493735343,1.0,1/5,2.66%,APOE
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),0.8457315543097584,1.3241452086725465,0.13333333333333333,0.8654230493735343,1.0,1/5,2.66%,APOE
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),-0.7123192298919365,-1.3238712281672058,0.16666666666666666,1.0,1.0,1/12,0.45%,TICRR
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),-0.7612867675117583,-1.3237922141953857,0.1,1.0,1.0,2/10,6.09%,TBX1;STAT1
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.6658837383716635,1.3237633403357187,0.12121212121212122,0.8653803141594999,1.0,5/12,11.69%,VCAN;CHST12;UST;CSPG5;DSEL
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),0.7789073450338312,1.323609755667985,0.12244897959183673,0.8641441477519539,1.0,3/6,18.70%,PCLO;ERC2;ERC1
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),0.7483637676853901,1.3234102316092677,0.08888888888888889,0.8632029722817146,1.0,5/10,17.45%,TGFBR1;POU3F2;MYT1L;ASCL1;PAX6
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.6701492247818467,1.323129193383621,0.0967741935483871,0.863100988299605,1.0,5/11,11.69%,VCAN;CHST12;UST;CSPG5;DSEL
prerank,GO_Biological_Process_2021__leukocyte chemotaxis involved in inflammatory response (GO:0002232),-0.8414638304804992,-1.3218888636908463,0.17543859649122806,1.0,1.0,1/5,4.10%,ALOX5
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),0.7254591059243145,1.3215921988183195,0.11764705882352941,0.8688012758789873,1.0,1/10,0.43%,PCDH15
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.7201595436668438,1.3213120453876415,0.16666666666666666,0.8682400529948906,1.0,5/8,15.67%,CBFB;HMGB1;TWSG1;LGALS9;RUNX1
prerank,GO_Biological_Process_2021__C-terminal protein lipidation (GO:0006501),0.8222795701149685,1.3210126773496627,0.2222222222222222,0.8678088784262835,1.0,1/5,0.82%,IRGM
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),0.7177867654044011,1.3206566111279396,0.20833333333333334,0.8677617409283788,1.0,2/10,3.11%,RNLS;SPTBN4
prerank,GO_Biological_Process_2021__response to interleukin-4 (GO:0070670),-0.84170804222723,-1.320515054318097,0.13846153846153847,1.0,1.0,1/5,0.67%,TCF7
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),0.7443111415647985,1.3204897445980799,0.225,0.8647500362129081,1.0,4/6,23.36%,DPH1;DPH5;DPH3;DPH2
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),0.7443111415647985,1.3204897445980799,0.225,0.8647500362129081,1.0,4/6,23.36%,DPH1;DPH5;DPH3;DPH2
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),0.5472122061303515,1.3198247948527955,0.0625,0.8661339099070695,1.0,6/27,7.51%,PER2;ATOH7;OPN5;CRY1;PER3;PML
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),0.87030342047627,1.3197671117496705,0.13725490196078433,0.8644166691030669,1.0,1/5,6.99%,KDM7A
prerank,PanglaoDB_Augmented_2021__Nuocytes,0.5663178235791323,1.3197164795178855,0.11764705882352941,0.8628011554122209,1.0,7/36,5.09%,IL7R;CD247;TRAC;RORA;GPR174;BCL11B;PYHIN1
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.7886359829958453,1.3190523253544415,0.10869565217391304,0.8637086400058588,1.0,1/7,1.51%,CPEB1
prerank,GO_Biological_Process_2021__citrulline metabolic process (GO:0000052),0.8123466740219831,1.3189423436283834,0.075,0.8626976865892475,1.0,3/6,11.24%,DDAH2;ALDH18A1;DDAH1
prerank,GO_Biological_Process_2021__positive regulation of plasminogen activation (GO:0010756),0.7719434145820881,1.31793807025351,0.18421052631578946,0.8657942181334247,1.0,3/5,22.34%,F12;PLGRKT;ENO1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),0.68671842706732,1.3177839075416133,0.10416666666666667,0.8646581009926875,1.0,1/11,1.13%,ADAMTS1
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),-0.6782547764340421,-1.3174879552403205,0.08196721311475409,1.0,1.0,2/18,6.24%,BUB1;ZWILCH
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.7288122736340773,-1.317307189829952,0.10714285714285714,1.0,1.0,7/15,22.78%,ATP5F1E;STOML2;ATP5MC3;ATP5PF;ATP5ME;ATP5PB;ATP5F1A
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),-0.7678452143191534,-1.3169662467123704,0.17307692307692307,1.0,1.0,1/8,0.09%,ENPP2
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.7736655550156138,1.3164138382924273,0.17647058823529413,0.8690791023771278,1.0,2/7,5.38%,BCL2;SNCA
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.7292220752235832,-1.3162456317297389,0.1724137931034483,1.0,1.0,7/14,22.78%,ATP5F1E;STOML2;ATP5MC3;ATP5PF;ATP5ME;ATP5PB;ATP5F1A
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),-0.8172471916092721,-1.3161790598438503,0.13793103448275862,1.0,1.0,2/7,12.20%,SFTPD;OAS1
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),-0.8172471916092721,-1.3161790598438503,0.13793103448275862,1.0,1.0,2/7,12.20%,SFTPD;OAS1
prerank,GO_Biological_Process_2021__regulation of blood vessel remodeling (GO:0060312),-0.8877457063832042,-1.3161561827955333,0.058823529411764705,1.0,1.0,3/5,7.40%,TGFB1;FLT4;CEACAM1
prerank,PanglaoDB_Augmented_2021__Eosinophils,-0.5746482170200052,-1.3161418907276499,0.09722222222222222,1.0,1.0,30/66,19.68%,RASGRP4;GMFG;ITGB2;HCK;CYTIP;ARHGAP9;TAGAP;TNFRSF1B;C3AR1;PARVG;WAS;LY86;NFAM1;TRAF3IP3;MYO1F;PTPRC;FPR1;SPI1;CLEC12A;ITGAM;CD300LF;ADGRE3;PSTPIP1;IL5RA;HK3;PGLYRP1;ALOX5AP;SASH3;IL5;ITGAX
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.5797501704062052,-1.315936261760493,0.11290322580645161,1.0,1.0,12/43,17.49%,WNT5A;SP100;CIITA;STAT1;GBP1;AQP4;SLC11A1;CXCL16;TLR2;HLA-DPA1;RPL13A;GBP6
prerank,GO_Biological_Process_2021__response to vitamin D (GO:0033280),-0.8249150815110646,-1.3153611421659606,0.10204081632653061,1.0,1.0,3/7,11.88%,AQP3;CYP24A1;CDKN2D
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),0.8386707405519935,1.314514976329264,0.07142857142857142,0.8758165535287408,1.0,2/6,5.58%,JAG1;MAGI2
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,0.44585754240286696,1.3142979093540013,0.045454545454545456,0.8747600224407212,1.0,16/95,14.97%,NGF;THEM4;ITPR2;FGF17;RALB;CDK4;PLCB1;MAPK8;ADCY2;ATF1;PRKAR2A;RPS6KA3;PPP2R1B;ARPC3;SMAD2;IRAK4
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.736020466413049,1.3142308164473646,0.21951219512195122,0.8731808092797594,1.0,6/10,20.19%,IRS1;SNCA;AKT2;IRS2;GPLD1;PRKCE
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.5667645414980804,1.3142177384347853,0.15,0.8714843174689278,1.0,11/40,19.01%,NGF;ROBO2;GOLGA4;SLIT2;PLXNB1;MACF1;MAP3K13;MAP6;PLXNA4;LIMK1;CHODL
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.5379822122038873,1.3136551339137217,0.13333333333333333,0.8721103473829819,1.0,17/47,12.56%,GPC4;SDC4;HS6ST2;HS3ST3B1;EXT1;HS3ST1;GPC6;HPSE;HS3ST5;HS2ST1;HS3ST2;GPC5;B3GAT3;UGDH;SDC3;GLB1;EXT2
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.44786781258307096,1.313487065246078,0.0625,0.8711932504540567,1.0,32/157,13.48%,ARC;TSKU;ZNF804A;APOE;PTPRO;MFSD2A;LRRC4C;MAGI2;LZTS3;TOX;DCC;EPHA3;RAPGEF1;FZD1;TENM3;ARSB;STYXL1;ABL2;PTPN9;WNT3A;KANK1;RETREG3;NTNG2;ABI3;AVIL;RET;RAP1A;CSMD3;CCDC88A;CDH2;ARHGAP35;FUT9
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.7761751282612103,-1.3134808436064698,0.15873015873015872,1.0,1.0,3/11,7.40%,C1QTNF1;ALOX12;CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),-0.7869169522528648,-1.3130854726153274,0.140625,1.0,1.0,2/8,9.78%,TGFB1;THBS1
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),0.7788197755620998,1.3126528784096247,0.08108108108108109,0.8715182734907146,1.0,2/5,12.97%,SETMAR;PLSCR1
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),0.7788197755620998,1.3126528784096247,0.08108108108108109,0.8715182734907146,1.0,2/5,12.97%,SETMAR;PLSCR1
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,0.47167901647505023,1.3126038787898138,0.08695652173913043,0.869903607640476,1.0,6/70,5.25%,ADGRF4;NIPAL1;PERP;ANXA3;SIRT1;SERPINE1
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),0.7006970779842783,1.3124099441575634,0.06976744186046512,0.8692123373117749,1.0,8/13,27.44%,ELP4;CTU1;TRMT9B;MTO1;ELP3;DPH3;ELP1;ALKBH8
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.5930389822098542,1.3122038798622357,0.17647058823529413,0.8685543602002902,1.0,10/25,21.08%,FOXO1;SIRT1;NAA40;AANAT;KAT6A;ESCO1;DSCC1;EP300;KAT2B;ESCO2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.6523423015532707,1.3120690849263688,0.1,0.867412016807331,1.0,8/14,28.25%,TGFBR1;RUNX1;NOTCH1;RBPJ;BMPR1A;ZFPM2;TGFBR3;MEF2C
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),0.7520621322002993,1.3118539210159668,0.13953488372093023,0.8664869126494595,1.0,3/7,16.06%,DCP1B;DCPS;PATL1
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.7454769632758764,1.3116477010954974,0.08108108108108109,0.8658080555261918,1.0,3/7,14.86%,HSPB1;GAB1;MYO1C
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.5753360137633996,1.31147009495432,0.043478260869565216,0.8649806406973596,1.0,9/29,16.67%,MT1G;MAPKAPK2;VEGFC;HSPB1;NUS1;ERN1;GAB1;PIK3CA;NOTCH1
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),0.5484776004517457,1.3110275280209363,0.06060606060606061,0.8659984429553281,1.0,6/26,7.51%,PER2;ATOH7;OPN5;CRY1;PER3;PML
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),-0.8084991962612461,-1.3108266660476189,0.16,1.0,1.0,2/8,3.57%,WNT5A;CXCL13
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),-0.8084991962612461,-1.3108266660476189,0.16,1.0,1.0,2/8,3.57%,WNT5A;CXCL13
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),0.7004440883556653,1.310664426355642,0.16216216216216217,0.8659273245114149,1.0,7/13,23.82%,ELP4;CTU1;TRMT9B;MTO1;ELP3;DPH3;ADAT2
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),0.733296755375099,1.3105285096691937,0.18421052631578946,0.8651346917092081,1.0,4/8,20.92%,MLST8;CLEC16A;SMG1;LARP1
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),0.7756893382310348,1.310467723660794,0.17647058823529413,0.8636548629283091,1.0,2/6,14.74%,SLC25A37;ABCB10
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.6284574221414225,1.310209105236271,0.1111111111111111,0.8629897065837335,1.0,6/14,25.43%,ST6GALNAC3;ST8SIA4;ST8SIA3;ST3GAL2;ST6GALNAC5;B4GALNT1
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),0.6685405276184965,1.3098919682045442,0.21621621621621623,0.8628952131067165,1.0,1/9,2.51%,CSGALNACT1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.7330623731786203,-1.3098426004687385,0.08771929824561403,1.0,1.0,4/9,16.13%,ITGB2;SPI1;ITGAM;F2RL1
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.5866212757928219,1.3098290615548438,0.13157894736842105,0.8615180953347881,1.0,9/31,10.67%,RORA;IRS1;ZNF692;BCKDK;SIRT1;SIRT7;AKT2;ADIPOR1;IRS2
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),0.8026876207337477,1.3095380323900885,0.12903225806451613,0.8612482073548423,1.0,3/7,10.07%,P3H3;PLOD3;P3H4
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),0.6066728707024428,1.30942961419803,0.16216216216216217,0.859998632198572,1.0,7/17,25.77%,SLC19A1;DHFR;MTHFR;FPGS;SHMT2;MTHFD1L;MTHFD2L
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),-0.5869375721153478,-1.3092231733388169,0.12121212121212122,1.0,1.0,5/56,5.04%,GPR62;NMUR2;XCR1;P2RY12;ACKR4
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),-0.7534543333758662,-1.3088729535139056,0.08333333333333333,1.0,1.0,1/12,1.82%,TRIM62
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),0.7875711585390668,1.308869340160779,0.2857142857142857,0.861008225788912,1.0,3/10,5.65%,TFB1M;TEFM;SLC25A33
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.6026109195192121,-1.3088100478633158,0.07936507936507936,1.0,1.0,9/33,11.76%,DUOX1;ALOX5;CLDN1;VTN;GP1BA;PLAU;ACTG1;ANXA1;VIL1
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.4763632869237964,-1.3087986090880552,0.022222222222222223,1.0,1.0,63/386,16.23%,CD44;LILRB3;CLEC5A;MGST1;GMFG;ITGB2;TCN1;MMP9;TBC1D10C;FLG2;ARHGAP9;CHIT1;PRDX4;ALOX5;RAB44;TNFRSF1B;DOCK2;CLEC4C;PTAFR;C3AR1;HRNR;OSCAR;PLAU;CEACAM1;NFAM1;ATP6V1D;PSAP;PTX3;SNAP23;CFD;CYBA;OLFM4;PTPRC;FPR1;ENPP4;CD63;PDAP1;SLC11A1;CEACAM8;CTSZ;FTH1;MMP25;PYGL;CLEC12A;ITGAM;SVIP;ACP3;HSPA8;PGAM1;TLR2;HVCN1;ORMDL3;DYNLL1;ADGRE3;ATP6AP2;EEF2;DDX3X;SRP14;GRN;ELANE;HK3;TUBB;CYSTM1
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.592910995941465,1.3083636633452231,0.15151515151515152,0.8614514005113916,1.0,9/32,17.53%,RAB27A;SDC4;SNCA;RAB7A;SMPD3;RAB27B;SNF8;RAB5A;RAB3D
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),-0.6620110500610683,-1.3081669530269642,0.15517241379310345,1.0,1.0,7/17,18.70%,OR52A5;OR51M1;SYT10;OR51I2;OR9Q1;OR2M4;OR8A1
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.6694194750673654,-1.3080894676633323,0.14285714285714285,1.0,1.0,3/14,6.95%,DUOX1;STAT1;KCNJ11
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),0.699638114325221,1.3080295602147465,0.14285714285714285,0.8616269338126842,1.0,2/15,4.57%,PNP;NT5C1A
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.5722120926781671,1.3078893798895144,0.175,0.8605338187804185,1.0,13/24,34.68%,MTMR8;MTMR3;PIP4P2;MTMR1;MTM1;PTEN;MTMR11;MTMR9;SYNJ2;TPTE2;OCRL;INPP5J;MTMR12
prerank,GO_Biological_Process_2021__cellular response to interleukin-4 (GO:0071353),-0.8367194996892915,-1.3075874504976328,0.16666666666666666,1.0,1.0,1/6,0.67%,TCF7
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),0.6883212422124846,1.3075192975769998,0.20512820512820512,0.8609458965847234,1.0,3/12,6.54%,PCM1;CCDC120;BICD1
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.6316870744366178,1.3071204088736084,0.1,0.8613269982071741,1.0,8/20,20.81%,TRIM71;KHSRP;LIN28B;DGCR8;XPO5;TARBP2;AGO2;TUT7
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.6849512280792227,1.307119557718682,0.15625,0.8596545185990049,1.0,5/12,28.81%,MSTO1;TRAK2;MTM1;TRAK1;MEF2A
prerank,GO_Biological_Process_2021__pericardium morphogenesis (GO:0003344),0.7214710715272896,1.30690603395781,0.2,0.8588662890202062,1.0,2/6,16.67%,LRP6;NOTCH1
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),0.6702357285775035,1.306773205574866,0.19047619047619047,0.8579058947372875,1.0,4/12,16.86%,KCNK6;KCNK2;KCNK12;KCNK10
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.7391742408953516,1.306742712213403,0.15555555555555556,0.8564537273981275,1.0,3/8,15.39%,PPARG;ABCA1;NR1H3
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.5291561744824127,1.3065702727424156,0.1,0.8555307723291827,1.0,9/35,18.05%,OLFM2;ABCA1;RAB3C;TVP23B;PREB;RAB10;LTBP2;RAB3D;MIA3
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.6459449396636637,1.3063605866960875,0.2222222222222222,0.8547855701858643,1.0,4/16,11.02%,SPRED3;PARD3;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.4653231408024177,1.3061759917479314,0.06060606060606061,0.8539562943356223,1.0,53/142,24.48%,CTDNEP1;DUSP4;DUSP2;DUSP15;EPHX2;PLPPR1;PTPRO;DUSP23;PTPRZ1;PPP5C;PTPRR;CTDSP2;CTDSP1;PTPN9;PTPRM;PLPP2;PSPH;PPP2R1B;DUSP18;PPM1A;PTPRB;THNSL2;PTPRT;PTPRF;SSH1;PPM1L;CDC14B;PLPPR3;PTPRD;PTPRE;MTMR3;PPP2R5D;PNKP;TAB1;PPP1CB;PPP4R1;PPEF1;MTM1;PLPP3;ALPL;PTPN14;PTPRJ;PLPPR5;DUSP6;PTEN;PTPRA;PLPPR4;PTPN21;PPM1H;PPM1E;CTTNBP2NL;PTPN12;PPP3CC
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.5322964572542145,1.306023907260649,0.19047619047619047,0.8528409696981275,1.0,19/67,21.76%,LLGL1;RFNG;DTX1;MAML1;JAG1;CHAC1;POFUT1;WWP2;BEND6;DLK2;ARRB1;TCIM;NOTCH1;RBPJ;EP300;KAT2B;SREBF2;ZBTB7A;JAG2
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),-0.8006102563769814,-1.3059782139784633,0.13559322033898305,1.0,1.0,5/6,18.80%,C1QB;C1S;IGLL1;ZP3;CD81
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),0.7454174366259503,1.3059418052438587,0.17073170731707318,0.8515855736265063,1.0,5/10,18.93%,APOB;PPARG;ZDHHC3;MIA3;UNC119B
prerank,GO_Biological_Process_2021__acid secretion (GO:0046717),-0.854504329573585,-1.3058180043549124,0.11363636363636363,1.0,1.0,1/5,0.98%,SLC51A
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),-0.7026926520504775,-1.30566113053947,0.14035087719298245,1.0,1.0,4/24,3.78%,PKP2;SCN5A;CAV3;CTNNA3
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),0.7175983876686431,1.3055730019127152,0.14634146341463414,0.8516603311386949,1.0,3/10,24.06%,PID1;APPL2;ENPP1
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.7939216909582067,-1.3053226063080898,0.13333333333333333,1.0,1.0,2/8,5.27%,TBX1;COL5A1
prerank,GO_Biological_Process_2021__meiotic sister chromatid cohesion (GO:0051177),-0.8292990984905637,-1.3049827436571235,0.09090909090909091,1.0,1.0,1/7,0.44%,BUB1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane depolarization (GO:0060373),-0.8962551798621534,-1.3048484583904685,0.058823529411764705,1.0,1.0,2/5,2.76%,SCN5A;CAV3
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.5329239240922192,1.3047603329218918,0.10344827586206896,0.8537478174423118,1.0,9/42,7.51%,EYA4;FGF10;BRCC3;SIRT1;ERCC8;RNF168;SIRT7;RADX;PML
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),-0.8476856784170446,-1.3046905831608073,0.09375,1.0,1.0,1/5,9.78%,THBS1
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),0.6741884768230855,1.304336728061252,0.15,0.8541052066271358,1.0,7/12,25.17%,CILK1;IFT140;TTC21B;TTC21A;WDR19;WDR35;DYNC2I2
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),-0.7733520197301864,-1.3042532219001164,0.11864406779661017,1.0,1.0,1/8,0.82%,CLEC5A
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),0.7356023046649254,1.3041794188108657,0.25,0.8534299042645281,1.0,2/11,6.48%,SIRT1;POLD3
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated immunity (GO:0002716),0.7503889586988972,1.304141686727373,0.17307692307692307,0.8520137173493535,1.0,3/7,11.29%,KLRD1;ARRB2;LGALS9
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.4761500156991923,-1.304119927524614,0.02247191011235955,1.0,1.0,63/388,16.23%,CD44;LILRB3;CLEC5A;MGST1;GMFG;ITGB2;TCN1;MMP9;TBC1D10C;FLG2;ARHGAP9;CHIT1;PRDX4;ALOX5;RAB44;TNFRSF1B;DOCK2;CLEC4C;PTAFR;C3AR1;HRNR;OSCAR;PLAU;CEACAM1;NFAM1;ATP6V1D;PSAP;PTX3;SNAP23;CFD;CYBA;OLFM4;PTPRC;FPR1;ENPP4;CD63;PDAP1;SLC11A1;CEACAM8;CTSZ;FTH1;MMP25;PYGL;CLEC12A;ITGAM;SVIP;ACP3;HSPA8;PGAM1;TLR2;HVCN1;ORMDL3;DYNLL1;ADGRE3;ATP6AP2;EEF2;DDX3X;SRP14;GRN;ELANE;HK3;TUBB;CYSTM1
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.6884539322501892,-1.3037467377717957,0.10344827586206896,1.0,1.0,5/17,12.76%,DUOX1;PRDX4;CYBA;PXDN;GPX3
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),0.6234766411880086,1.3036961781826661,0.12903225806451613,0.8523438179343171,1.0,2/21,1.73%,SLC5A8;RNLS
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),-0.6243591124810534,-1.3033068397555136,0.07462686567164178,1.0,1.0,4/30,7.39%,CLIC1;P2RY12;GP1BA;ACTG1
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),0.7025187118571995,1.3028932262152917,0.14285714285714285,0.8543533492906832,1.0,1/9,2.66%,APOE
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),0.7500278570146595,1.3025731333139299,0.19444444444444445,0.8545640708915226,1.0,3/7,14.23%,SMYD5;NCOA3;MLLT3
prerank,GO_Biological_Process_2021__glycosylceramide metabolic process (GO:0006677),0.7916487713369385,1.3025266278949157,0.16666666666666666,0.8531564001061108,1.0,2/5,2.16%,ST6GALNAC3;GLA
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.6531020491147714,1.3021205150068338,0.15789473684210525,0.8530853196194018,1.0,4/15,9.43%,ZBTB7B;METRNL;SIRT1;TFE3
prerank,GO_Biological_Process_2021__regulation of glucokinase activity (GO:0033131),0.855330587541504,1.3020765155525653,0.14583333333333334,0.8516291448810194,1.0,1/5,2.85%,MIDN
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.7075649256853691,1.3018117246080334,0.16666666666666666,0.851307206449295,1.0,3/9,15.39%,PPARG;ABCA1;NR1H3
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),0.5261363997035053,1.301543121472519,0.11428571428571428,0.850845633442086,1.0,10/39,11.22%,SLC38A5;SLC3A2;TRPM2;PKD2;SLC22A5;ABCC8;SFXN2;SLC6A20;SLC25A29;SLC7A8
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.5100100878205855,1.3015231001668401,0.08333333333333333,0.8494298792106999,1.0,18/56,16.07%,CDH20;CDH19;CDH12;GJB6;CDH7;CDH5;CDH6;ZNF703;PKN2;CLDN12;CDH2;CDH24;CDH10;PKP4;FSCN1;CDH11;PARD6B;CDHR3
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.7610570476269317,1.301200374272657,0.1891891891891892,0.8493102610280795,1.0,5/8,22.90%,COMMD1;WNK2;WNK3;NEDD4;WNK1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.6239494248569387,1.3011011334524234,0.18181818181818182,0.8483787852986888,1.0,3/15,4.59%,HSPB1;HTRA2;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),0.7668403008231165,1.3008989801857338,0.10638297872340426,0.846581978124761,1.0,3/8,15.86%,GLA;KHSRP;PTGIS
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),0.7668403008231165,1.3008989801857338,0.10638297872340426,0.846581978124761,1.0,3/8,15.86%,GLA;KHSRP;PTGIS
prerank,GO_Biological_Process_2021__glial cell migration (GO:0008347),-0.8862987590926641,-1.300786534633234,0.07547169811320754,1.0,1.0,1/5,2.75%,P2RY12
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.6025871207608258,1.3007726057683378,0.11764705882352941,0.8456606918973841,1.0,11/23,24.27%,ATF3;HSF1;TP53;NOTCH1;RBPJ;ATF6;SESN2;HIF1A;NFE2L2;CREB3L1;GCN1
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),-0.7650875256972798,-1.3007054562537828,0.11475409836065574,1.0,1.0,7/15,17.81%,TBX1;HCK;TBX6;GDF11;IKZF1;BMX;MESP1
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),0.5308487326085425,1.3005496578568196,0.14285714285714285,0.8450486435944379,1.0,8/27,14.06%,SLC30A10;SIRT1;VASH1;CDK6;RBL1;TWIST1;ABI3;PNPT1
prerank,GO_Biological_Process_2021__SA node cell to atrial cardiac muscle cell signaling (GO:0086018),-0.8501502653994406,-1.3002545483241044,0.1774193548387097,1.0,1.0,1/5,1.19%,SCN5A
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.6158274561990721,-1.3001674404215737,0.0967741935483871,1.0,1.0,3/32,4.42%,MCM2;RPA3;MCM3
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.5809372375620128,-1.2997664461675553,0.11940298507462686,1.0,1.0,10/35,23.42%,CENPU;ITGB3BP;HAT1;OIP5;CENPH;RBBP7;CENPN;SMARCA5;CENPL;CENPM
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.47139515056949904,-1.2995561161585287,0.02197802197802198,1.0,1.0,63/391,16.23%,CD44;LILRB3;CLEC5A;MGST1;GMFG;ITGB2;TCN1;MMP9;TBC1D10C;FLG2;ARHGAP9;CHIT1;PRDX4;ALOX5;RAB44;TNFRSF1B;DOCK2;CLEC4C;PTAFR;C3AR1;HRNR;OSCAR;PLAU;CEACAM1;NFAM1;ATP6V1D;PSAP;PTX3;SNAP23;CFD;CYBA;OLFM4;PTPRC;FPR1;ENPP4;CD63;PDAP1;SLC11A1;CEACAM8;CTSZ;FTH1;MMP25;PYGL;CLEC12A;ITGAM;SVIP;ACP3;HSPA8;PGAM1;TLR2;HVCN1;ORMDL3;DYNLL1;ADGRE3;ATP6AP2;EEF2;DDX3X;SRP14;GRN;ELANE;HK3;TUBB;CYSTM1
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),0.7091025938214479,1.2995185265572,0.10810810810810811,0.8484630224366709,1.0,4/14,15.27%,MT1G;SNCA;MT4;HSF1
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.4610765931403178,1.2994557305029604,0.09090909090909091,0.8471001237038558,1.0,22/98,16.80%,PER2;TGFBR1;HDAC3;PRICKLE1;ANGPT1;RIPK2;COMMD1;SPOPL;CRY1;ARRB2;SIRT7;DCUN1D1;GNL3L;N4BP1;HSPA1A;FOXF2;ARRB1;HSPBP1;MALT1;FBXO4;MINAR1;UBE2L3
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),-0.713934769377963,-1.299246874778123,0.1111111111111111,1.0,1.0,3/18,2.61%,IHO1;MEIOB;SYCP1
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.6102740445064975,-1.2990703750662618,0.15384615384615385,1.0,1.0,9/29,23.42%,CENPU;ITGB3BP;OIP5;CENPH;RBBP7;CENPN;SMARCA5;CENPL;CENPM
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.8021691217895914,1.298896707078304,0.125,0.8480372739677993,1.0,3/7,7.63%,APOE;ABL1;ABCA1
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),0.745148397374445,1.2988189519002924,0.15,0.8468457411529409,1.0,4/8,16.84%,CDH5;FER;CDH2;MMP24
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),0.6067247547351352,1.298168975784023,0.20512820512820512,0.8485513456764329,1.0,9/19,28.92%,OSBPL6;NUS1;NFKB1;NR1H3;ABCA13;ABCA2;YJEFN3;ABCA8;ARV1
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),-0.6488508586025589,-1.2981676261502517,0.11940298507462686,1.0,1.0,2/19,7.32%,BUB1;TTK
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),-0.6488508586025589,-1.2981676261502517,0.11940298507462686,1.0,1.0,2/19,7.32%,BUB1;TTK
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),-0.6488508586025589,-1.2981676261502517,0.11940298507462686,1.0,1.0,2/19,7.32%,BUB1;TTK
prerank,GO_Biological_Process_2021__forelimb morphogenesis (GO:0035136),0.7363813811118226,1.2978983300264648,0.20454545454545456,0.8465088114573478,1.0,2/5,17.89%,OSR1;NIPBL
prerank,GO_Biological_Process_2021__embryonic forelimb morphogenesis (GO:0035115),0.7363813811118226,1.2978983300264648,0.20454545454545456,0.8465088114573478,1.0,2/5,17.89%,OSR1;NIPBL
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),0.7206043945599858,1.297858281542616,0.16666666666666666,0.8451917007558227,1.0,7/9,25.35%,LRP6;OSBPL7;GPLD1;PTCH1;MLC1;GRAMD1B;GRAMD1A
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.5009556786383259,1.2977116354262987,0.10526315789473684,0.8442622723867396,1.0,18/50,23.19%,GANC;ST6GALNAC3;PRKCSH;ST8SIA4;HPSE;MAN1A2;MAN2A1;NEU4;MAN1A1;NGLY1;FBXO27;ADAMTS13;ST8SIA3;ST3GAL2;HIF1A;FBXO17;ST8SIA1;LARGE1
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),0.7460607063662887,1.2976365025073868,0.24242424242424243,0.8430631927303,1.0,1/9,2.32%,CFLAR
prerank,GO_Biological_Process_2021__neuron fate specification (GO:0048665),0.8225223755644564,1.2974936465242342,0.15789473684210525,0.8421409617705374,1.0,3/5,13.36%,POU3F2;MYT1L;ASCL1
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),0.7613525388939506,1.2969707594377382,0.21951219512195122,0.8430990533163232,1.0,3/6,11.02%,SPRED3;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__response to catecholamine (GO:0071869),0.7915919659403967,1.2969019210857569,0.15217391304347827,0.8418270737542106,1.0,3/6,18.06%,DRD5;NR4A3;ADCY6
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.6313969786200845,1.2967482019891219,0.15625,0.8409662395908298,1.0,5/12,21.29%,SCRIB;RAP2A;RAB10;MYO9A;CAMSAP3
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.648451365770777,-1.296312173158049,0.11764705882352941,1.0,1.0,2/20,7.32%,BUB1;TTK
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),0.7073442089580941,1.2962551869356342,0.16666666666666666,0.8415695490995224,1.0,3/10,16.06%,DCP1B;DCPS;PATL1
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),-0.7718497654952351,-1.2961590858952639,0.09836065573770492,1.0,1.0,3/9,8.58%,AMBP;SLCO2B1;ABCG2
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),-0.7718497654952351,-1.2961590858952639,0.09836065573770492,1.0,1.0,3/9,8.58%,AMBP;SLCO2B1;ABCG2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),-0.6651791129646256,-1.295902577458022,0.12698412698412698,1.0,1.0,3/24,3.78%,PKP2;CAV3;CTNNA3
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),0.8412740245593813,1.2956662106436183,0.17647058823529413,0.8428188976524618,1.0,1/5,3.86%,AUTS2
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),0.8013858112123052,1.2948476220954308,0.1568627450980392,0.8447647443328555,1.0,1/5,4.67%,CNTNAP2
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),0.6923334953957874,1.2942317904158889,0.16129032258064516,0.8462192389153452,1.0,2/8,4.35%,MFSD2A;PLIN5
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),0.6036868755230596,1.2940716652350093,0.1702127659574468,0.8452776559976264,1.0,8/14,35.22%,SMC5;RAD52;NSMCE2;SMC6;TPRKB;RAD54B;RAD50;MSH3
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),0.7063911649778584,1.2937267732565227,0.22727272727272727,0.8435918885851648,1.0,3/8,22.83%,PDZD11;LIN7A;ANK1
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),0.7063911649778584,1.2937267732565227,0.22727272727272727,0.8435918885851648,1.0,3/8,22.83%,PDZD11;LIN7A;ANK1
prerank,GO_Biological_Process_2021__regulation of dopamine uptake involved in synaptic transmission (GO:0051584),0.7112299937274731,1.2934372211910663,0.16279069767441862,0.8430340552695489,1.0,2/8,7.29%,SNCA;DRD4
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),0.5967650451901724,1.2928432444903046,0.1935483870967742,0.8441853424238405,1.0,4/25,10.37%,PEX13;GDAP1;ABCD3;ABCD2
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),-0.8129442775761109,-1.2926495634697925,0.12121212121212122,1.0,1.0,1/6,10.70%,DNAJA1
prerank,GO_Biological_Process_2021__intestinal epithelial cell differentiation (GO:0060575),-0.7845638267782865,-1.2924429223549234,0.11864406779661017,1.0,1.0,2/6,16.08%,GATA4;YAP1
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),-0.7545797975419398,-1.2924298981250097,0.19148936170212766,1.0,1.0,3/11,9.15%,TRIM5;CIITA;PTX3
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),-0.7256169733967031,-1.2921157492862811,0.15,1.0,1.0,3/12,15.16%,MMP9;TNFRSF1B;IL18
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),0.5177158385186149,1.2919620136323533,0.07407407407407407,0.8462112650053355,1.0,7/51,10.45%,TCIRG1;HTRA2;ADAMTS12;CAPN2;RAB7A;CTSV;RSPRY1
prerank,GO_Biological_Process_2021__cilium movement involved in cell motility (GO:0060294),-0.8249550040750319,-1.2918824436956813,0.1346153846153846,1.0,1.0,2/7,6.83%,TEKT5;TEKT3
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.4277855276828442,1.2918536923857558,0.08333333333333333,0.8450935804298064,1.0,41/186,16.67%,EFNB1;ROBO2;LAMA3;ALCAM;PTPRO;EPHA7;DSCAML1;SPTBN4;SEMA6C;UNC5C;BSG;SEMA5A;UNC5D;NTN4;DCC;EPHA3;DSCAM;SLIT2;PLXNB1;DOK5;EFNA5;PTPRM;DOK6;SEMA4A;SH3KBP1;IRS2;EVL;RET;GAB1;NFIB;ARHGAP35;ANOS1;RYK;EMB;PIK3CA;NCAM1;NRXN1;CNTN6;EFNA2;EPHB2;NOTCH1
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.8063569540010402,1.291645122109275,0.13157894736842105,0.8443512944399645,1.0,3/6,13.40%,SNX18;SPIRE2;SNX9
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),0.6528580039719425,1.291215402981007,0.20588235294117646,0.8432975724528781,1.0,6/10,10.85%,APOH;SERPINE1;HPSE;F2;F2R;F12
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),0.6528580039719425,1.291215402981007,0.20588235294117646,0.8432975724528781,1.0,6/10,10.85%,APOH;SERPINE1;HPSE;F2;F2R;F12
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),-0.7782061976804763,-1.2910447483738958,0.13114754098360656,1.0,1.0,2/7,13.70%,WAS;NTN1
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.6021578826693588,1.2910404964318871,0.075,0.8427998691251481,1.0,5/18,15.58%,NLGN1;GRIN1;RIMS2;NLGN3;NRXN1
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),0.7081308036000041,1.2909097459037016,0.16666666666666666,0.8418823294567925,1.0,3/8,11.33%,SPAST;UGDH;MAT2A
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),0.5800264079575882,1.2905916831619946,0.17647058823529413,0.8419411771548619,1.0,9/24,29.79%,NAV3;PIK3CA;CAMSAP3;ATXN7;CIB1;MID1IP1;APC2;FGF13;CLASP2
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),0.7914721301363649,1.2902186869232648,0.19148936170212766,0.8420523335630761,1.0,2/5,14.74%,SLC25A37;ABCB10
prerank,GO_Biological_Process_2021__ganglioside catabolic process (GO:0006689),0.7705835479108061,1.2898531746878834,0.13043478260869565,0.8417437261819662,1.0,2/5,15.83%,NEU4;NEU3
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),-0.7310946480690153,-1.289801454237424,0.14814814814814814,1.0,1.0,3/10,14.82%,PINK1;REST;GATA4
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.5709600183919027,1.2896958169039856,0.24,0.8412268629946955,1.0,10/21,26.09%,CBLB;TGFA;CHMP6;GPRC5A;ZFYVE28;SOCS4;NCK2;TSG101;CBL;BTC
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),-0.740537388460994,-1.2896391103390965,0.140625,1.0,1.0,5/10,21.70%,IFNK;SLC11A1;LCP1;F2RL1;TNFSF18
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),0.7211588450648669,1.2895789130975257,0.12,0.8403983432399489,1.0,4/12,17.93%,KHSRP;MOV10;PNPT1;RC3H1
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),0.7518252339006827,1.289345794172773,0.13953488372093023,0.8396509113005797,1.0,2/6,16.82%,STAT5B;CSAD
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.4957562697662523,1.2891643464868665,0.13793103448275862,0.8390622388009801,1.0,15/49,22.04%,NGF;ROBO2;LRRC4C;SLIT2;PLXNB1;CDH2;ARHGAP35;MAP6;PLXNA4;CHODL;PAK3;PAK2;MARK2;NTRK2;PTEN
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.6740885967946613,1.2888901806060653,0.14583333333333334,0.8389693180749214,1.0,7/10,28.94%,ACACB;CPT1A;PRKAA2;PRKAG2;THRSP;ACACA;MID1IP1
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.6134810095032556,-1.2886159225652827,0.19672131147540983,1.0,1.0,9/27,23.42%,CENPU;ITGB3BP;OIP5;CENPH;RBBP7;CENPN;SMARCA5;CENPL;CENPM
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.6134810095032556,-1.2886159225652827,0.19672131147540983,1.0,1.0,9/27,23.42%,CENPU;ITGB3BP;OIP5;CENPH;RBBP7;CENPN;SMARCA5;CENPL;CENPM
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.593621151608918,1.2884625802029843,0.15384615384615385,0.8397587071510099,1.0,2/21,4.88%,PLD6;GDAP1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),-0.6274652412494517,-1.2884599890427053,0.15,1.0,1.0,1/31,0.37%,NEK2
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),-0.6856668958530489,-1.2880688538898446,0.11764705882352941,1.0,1.0,2/13,8.12%,SLC5A1;KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.7473918479719311,1.287889083026106,0.2391304347826087,0.8406230774062436,1.0,2/10,4.16%,IRGM;JMJD4
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),-0.6883582354741941,-1.287659838018565,0.14285714285714285,1.0,1.0,4/16,18.33%,NEK2;CAV2;BORA;PKMYT1
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),-0.6508290370234893,-1.287459187331467,0.2,1.0,1.0,1/14,0.45%,TICRR
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),0.4886605480438961,1.2874238801307463,0.13636363636363635,0.8417688601272316,1.0,24/85,21.06%,LSM10;PCF11;RIDA;DXO;SNRPB;PCBP3;U2AF1;ERN1;LSM2;HSPA1A;SRSF4;PNPT1;SRRM4;HSF1;TP53;PTBP1;TBRG4;AGO3;AURKAIP1;METTL16;U2AF2;SF3B4;CPSF6;LSM6
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.5734386396520997,1.2873534673746514,0.14285714285714285,0.8406396333960323,1.0,4/23,5.25%,ANGPT1;CDH5;SEMA5A;SERPINE1
prerank,GO_Biological_Process_2021__regulation of extracellular exosome assembly (GO:1903551),0.7469621654199344,1.2870397392433677,0.23684210526315788,0.8404417584064526,1.0,1/5,3.30%,SDC4
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.5784745806963081,-1.2864415362778663,0.15942028985507245,1.0,1.0,9/34,23.42%,CENPU;ITGB3BP;OIP5;CENPH;RBBP7;CENPN;SMARCA5;CENPL;CENPM
prerank,GO_Biological_Process_2021__delamination (GO:0060232),-0.817463149225632,-1.2862219422319678,0.16417910447761194,1.0,1.0,2/6,14.91%,SPI1;ABCA12
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.48154045495597975,1.2862113165129352,0.12,0.8425336318256149,1.0,15/59,15.10%,EYA4;FGF10;BRCC3;SIRT1;ERCC8;RNF168;TOX;HMGB1;PML;MYC;H2AX;SMCHD1;WRAP53;MECP2;EYA3
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.5082179653247673,1.2858265724893743,0.12121212121212122,0.8424359135690423,1.0,9/56,11.88%,FOXO1;MFSD2A;KLF10;SIRT1;AKR1C3;RALB;FADS1;LPL;CLEC16A
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),-0.7106015920926279,-1.2854907548993375,0.22580645161290322,1.0,1.0,6/9,16.03%,PLA2G10;POMZP3;SERPINA10;ZP3;SPINK13;IQCF1
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.7136682963037999,-1.2853638025782166,0.19642857142857142,1.0,1.0,2/11,14.26%,STAT1;IL12A
prerank,GO_Biological_Process_2021__striated muscle hypertrophy (GO:0014897),-0.8096902104084203,-1.2853036400535636,0.23636363636363636,1.0,1.0,3/5,14.24%,CSRP3;HTR2B;TTN
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),0.7221609328020591,1.2852437205340737,0.25,0.8439533809728855,1.0,4/8,23.36%,DPH1;DPH5;DPH3;DPH2
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),-0.666640082846207,-1.284826476050928,0.14705882352941177,1.0,1.0,7/15,29.01%,ODAD1;DNAH17;DNAI1;ZMYND10;ODAD2;DNAAF1;ODAD4
prerank,GO_Biological_Process_2021__monoamine transport (GO:0015844),-0.8386831571047411,-1.2846607037904763,0.09523809523809523,1.0,1.0,3/5,14.15%,SLC18A2;SLC22A3;SLC6A4
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),0.6739508553880895,1.284236703750921,0.17391304347826086,0.8470522320729994,1.0,6/15,22.28%,ADAMTS12;NEU4;NGLY1;FBXO27;EDEM1;FBXO17
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.5104541298501051,-1.2841555954989181,0.075,1.0,1.0,64/145,27.27%,RPL37A;RPL38;RPL15;COPS5;WARS1;RPS4X;RPL3;RPL35A;RPS9;RPS27;RPS21;GGT5;RPL13A;YARS2;RPL27A;RPS16;RPL36;RPS20;RPL7A;RPL9;ABCF1;RPL13;RPS8;RPS27A;RPL21;RPL34;MRPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;RPL27;RPL35;RPS14;RPL11;ASMT;RPS15;RPLP1;RPS12;RPL24;RPL18A;RPS13;RPL29;RPLP2;RPL28;RPL12;IGF2BP3;RPL18;RPS3;RPL22;EEF1A1;RPSA;RPS28;RPS19;RPS24;RPS3A;RPL19;RHCE;RPL8;RPS6;RPL10
prerank,GO_Biological_Process_2021__columnar/cuboidal epithelial cell differentiation (GO:0002065),-0.8330614236728808,-1.2841403271346568,0.13793103448275862,1.0,1.0,2/5,14.82%,ROS1;GATA4
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),0.7418799086214249,1.2836719658894482,0.21739130434782608,0.8478925608951301,1.0,1/7,5.59%,FKTN
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),0.658884051387965,1.283643333990068,0.20754716981132076,0.8465878234769341,1.0,2/15,1.13%,CCN4;ADAMTS1
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),0.7404451789820377,1.2832806427439407,0.14634146341463414,0.8465350118027576,1.0,1/6,2.76%,HDAC10
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.7069289515783272,1.2830962921105684,0.29411764705882354,0.8455419549338957,1.0,3/12,9.27%,PCM1;BICD1;GCC2
prerank,PanglaoDB_Augmented_2021__Germ Cells,-0.5264795215037497,-1.282585946613446,0.07692307692307693,1.0,1.0,29/115,17.30%,NEK2;C2ORF78;TOPAZ1;BANF2;SYCP1;SLC25A31;BCL2L14;DAZL;TNP1;BRCA1;GAPDHS;TAF7L;GSG1;GGNBP1;MEIOC;STRA8;TULP2;WDR87;DEPDC4;TSSK3;GALNTL5;DNAH3;SMC1B;AQP11;IQCF1;PGAM2;PDCL2;MOV10L1;MAEL
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),-0.6996420555551004,-1.2823393914416978,0.13432835820895522,1.0,1.0,6/18,9.30%,ELOVL2;ALOX12;ALOX5;ALOX12B;ALOX15;CYP2J2
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),-0.6322655022802063,-1.2821736976497577,0.17142857142857143,1.0,1.0,7/23,14.93%,AQP3;RAB11A;MYO5B;AQP4;WFS1;CYP4F12;ADCY7
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),-0.8041046331854,-1.282085073219096,0.15,1.0,1.0,1/7,2.49%,RIN3
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),0.7808103836208303,1.2820124484073234,0.16666666666666666,0.8488912107248485,1.0,2/6,12.52%,TSHZ3;NLGN3
prerank,GO_Biological_Process_2021__regulation of nuclease activity (GO:0032069),-0.8443016292695947,-1.2815202245373531,0.20454545454545456,1.0,1.0,2/6,12.20%,OAS2;OAS1
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),0.5398985943767922,1.2809315139255413,0.18421052631578946,0.8514186179063215,1.0,6/32,15.82%,KIFC1;TOP2A;LATS1;SGO2;KLHL22;ESPL1
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),-0.7246737536757442,-1.2805023844026238,0.16666666666666666,1.0,1.0,3/12,8.12%,SCN5A;KCNA5;KCNQ1
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),0.7340255169573007,1.2802848874901056,0.21153846153846154,0.8529512825633662,1.0,2/6,20.31%,GSTM2;CRYZ
prerank,GO_Biological_Process_2021__exocrine system development (GO:0035272),0.8497748114643077,1.2802095177423096,0.1956521739130435,0.8516511767552722,1.0,1/5,1.19%,FGF10
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),-0.6787247969454969,-1.2799096349008086,0.24528301886792453,1.0,1.0,2/12,8.12%,CASQ2;KCNQ1
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.5157504261846573,-1.279396509995365,0.075,1.0,1.0,7/118,5.54%,CD44;NOTUM;LECT2;WNT5A;HHIP;COL1A1;CNMD
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),0.6428416974387278,1.2793307884087965,0.15625,0.8539596807606318,1.0,5/17,23.46%,ACER2;PLPP2;ACER3;PLPP3;ABCA2
prerank,GO_Biological_Process_2021__positive regulation of vasoconstriction (GO:0045907),0.7437283504346538,1.2788757418206727,0.18604651162790697,0.854448777528884,1.0,2/9,0.48%,ADRA1A;ADRA1B
prerank,GO_Biological_Process_2021__glucocorticoid biosynthetic process (GO:0006704),-0.7747399131086983,-1.2779861084120312,0.22807017543859648,1.0,1.0,5/7,22.45%,CYP21A2;HSD11B1;HSD3B1;CYP17A1;HSD11B2
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),0.778222610638836,1.277588126295227,0.2916666666666667,0.8591062997813171,1.0,4/5,19.29%,CSGALNACT1;B3GAT3;DSEL;CSGALNACT2
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.6510955265922266,-1.2775086025437938,0.21818181818181817,1.0,1.0,2/15,7.32%,ZWILCH;TTK
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),0.7670479235152781,1.2774420935916373,0.24242424242424243,0.8582058734347656,1.0,4/5,22.74%,NOTCH1;RBPJ;HIF1A;NFE2L2
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),0.5344603942712305,1.2773707695639231,0.1388888888888889,0.8570580587532999,1.0,8/25,17.91%,SMYD2;SMYD1;SIRT7;NSD1;FBLL1;CARM1;FBL;PRMT5
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.4871217344269678,1.27736569539853,0.1,0.8556890805165052,1.0,8/64,4.29%,ADRA1A;GPR33;ADRA1B;CHRM2;GPR174;HTR2C;DRD5;CX3CR1
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),-0.7575456750124743,-1.2773397313657573,0.18181818181818182,1.0,1.0,2/9,16.13%,C15ORF62;F2RL1
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),-0.7575456750124743,-1.2773397313657573,0.18181818181818182,1.0,1.0,2/9,16.13%,C15ORF62;F2RL1
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),0.8032394270301504,1.2766294083261072,0.23529411764705882,0.8573940576281788,1.0,2/5,10.33%,MAPK8;CAP2
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.4671539689754123,1.2765698383122828,0.12,0.8562283512932253,1.0,30/85,17.40%,MYO10;GPR161;VEGFC;ADGRL2;LOXL1;PARVA;MID1;IL17RD;ADAMTS12;MMP2;P3H2;RAI14;SLIT2;EDNRA;PDLIM4;ZNF462;TENM3;EFNA5;SNAI2;CXCL14;RND3;CHST3;FJX1;WWTR1;CDH11;ANTXR1;CSRP2;CALD1;CDR2L;ROR1
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.7332725000938486,1.2765649982412923,0.23076923076923078,0.8548177609286566,1.0,2/6,18.69%,DNMT1;ZNF445
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),0.8007627612340779,1.2764696438358818,0.1794871794871795,0.854007768632312,1.0,4/7,8.53%,APOH;SIRT1;DIPK2A;LRP6
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.4873909637160826,1.2762462152143217,0.1111111111111111,0.8537210433700396,1.0,42/118,19.93%,SLITRK6;GPC4;NLGN1;LRRC4C;PPFIBP2;CX3CR1;FZD5;GPC6;SDK1;ZC4H2;SLC8A3;SNCA;CACNB4;DSCAM;PPFIA3;LRFN5;PPFIBP1;GPHN;PDZRN3;F2R;NLGN4X;UNC13B;FARP1;NLGN3;CDH2;RYK;PTPRF;ACHE;NRXN1;CHRNA1;PTPRD;NEDD4;UNC13C;SLITRK2;PPFIA2;KIRREL3;C5AR1;GRM5;CDK5;PCDHB6;NRCAM;PAK3
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),0.7162863655024027,1.276223902396644,0.24489795918367346,0.8525195020119201,1.0,5/8,25.83%,SLIT2;RNF113A;HIF1A;SLIT3;EDN1
prerank,GO_Biological_Process_2021__protein K29-linked ubiquitination (GO:0035519),0.8145308097632086,1.2759210636724396,0.20833333333333334,0.8525079573350093,1.0,1/5,9.95%,UBE2D4
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),0.7645166720116333,1.2758549122867457,0.13043478260869565,0.8498743026800626,1.0,2/5,15.58%,CNTNAP2;NRXN1
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),0.7645166720116333,1.2758549122867457,0.13043478260869565,0.8498743026800626,1.0,2/5,15.58%,CNTNAP2;NRXN1
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.5593746695220009,1.2757503209344947,0.11428571428571428,0.8489327432841073,1.0,8/27,24.64%,PEX13;GDAP1;ABCD3;ABCD2;ZFAND6;SLC25A17;PEX3;PEX14
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.7336499248520616,-1.2756291456801259,0.19298245614035087,1.0,1.0,3/9,22.78%,ATP5MC3;ATP5PB;ATP5F1A
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),0.7127881984756921,1.2754765156785357,0.20512820512820512,0.8487061653074465,1.0,5/9,20.08%,HDAC3;HDAC1;HDAC4;NOTCH1;HDAC5
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.6711166774498499,1.2752875153959502,0.175,0.8483332684099505,1.0,4/13,22.18%,PPP5C;PPP1R15B;NCK1;PPP2R2B
prerank,GO_Biological_Process_2021__equilibrioception (GO:0050957),0.8285029721677754,1.2743683673927606,0.15555555555555556,0.8508244966533897,1.0,1/5,0.43%,PCDH15
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.5466201590536164,-1.2742678029730996,0.1125,1.0,1.0,15/54,24.68%,COX6A1;NDUFS2;COX6C;NDUFA2;NDUFB4;NDUFC1;COX7C;NDUFA1;NDUFB9;COX4I1;NDUFB10;NDUFS5;NDUFB11;SDHC;NDUFB2
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),0.743519768182688,1.273813207270417,0.23076923076923078,0.8524526204927043,1.0,3/9,11.08%,KDM7A;KDM8;KDM2A
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.544318181226592,1.2737373944442674,0.05405405405405406,0.8513925497394693,1.0,3/41,4.13%,GCK;NUP210;NUP42
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.5142561612716472,-1.2736437505519733,0.06493506493506493,1.0,1.0,21/132,13.80%,CD44;TIMP3;CCND1;IRF1;BCL2L2;DCN;ENO2;H1-0;SOD2;BRCA1;ANXA1;CCND2;CLU;PPT1;CASP7;DNAJA1;BIK;CDKN1A;GPX3;PLAT;LEF1
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),0.7040221793100265,1.272929221891396,0.20454545454545456,0.8534041208837346,1.0,5/8,19.92%,CRY1;ABL1;MAPK12;ATM;MAP2K6
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.7828435306452424,-1.272697467955408,0.15625,1.0,1.0,3/8,10.71%,TGFB1;ESR1;TERT
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),0.7550989472221142,1.272278210410689,0.2641509433962264,0.855190407713877,1.0,3/6,18.84%,ZBTB1;TFCP2;C5AR1
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),-0.7745172057540848,-1.2721731898365825,0.16666666666666666,1.0,1.0,3/10,9.15%,TRIM5;CIITA;PTX3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.6592593583346803,-1.27183806643772,0.1724137931034483,1.0,1.0,4/19,8.12%,SCN5A;KCNA5;CAV3;KCNQ1
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.5132336523716317,1.271752304408045,0.10714285714285714,0.855927225968715,1.0,7/42,11.34%,CSTA;URI1;PPP1R35;PLIN5;ECM1;RRP1B;GPSM1
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),0.6446762960859554,1.2715787410449777,0.16,0.8553045910278401,1.0,3/12,17.89%,ZBTB7B;FNTA;NIPBL
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),-0.7562952012551261,-1.2713623614486738,0.21428571428571427,1.0,1.0,2/8,9.91%,ATP6AP1;NDUFS2
prerank,GO_Biological_Process_2021__regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),0.8427558613267602,1.2712400217484914,0.13157894736842105,0.8539203614636219,1.0,4/5,12.39%,CD14;TICAM2;SARM1;TICAM1
prerank,GO_Biological_Process_2021__negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),0.8427558613267602,1.2712400217484914,0.13157894736842105,0.8539203614636219,1.0,4/5,12.39%,CD14;TICAM2;SARM1;TICAM1
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),0.7147851563094813,1.271148844356798,0.1891891891891892,0.8529180350522895,1.0,4/11,15.27%,MT1G;SNCA;MT4;HSF1
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),0.5374329620091012,1.270739499896076,0.06451612903225806,0.8529302284673322,1.0,8/37,11.91%,SKAP1;UTRN;CDH13;RIN2;CDK6;ABL1;COL16A1;LIMS1
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),-0.8368705913729124,-1.2706672545318816,0.16666666666666666,1.0,1.0,1/5,11.79%,SVIP
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),-0.649353008573579,-1.2705858229816853,0.2222222222222222,1.0,1.0,2/15,5.36%,ERN2;SLFN14
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),0.8055638678332249,1.2705228459847677,0.20454545454545456,0.851106302890316,1.0,3/5,16.13%,SMYD5;KMT5C;KMT5B
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),0.8055638678332249,1.2705228459847677,0.20454545454545456,0.851106302890316,1.0,3/5,16.13%,SMYD5;KMT5C;KMT5B
prerank,GO_Biological_Process_2021__negative regulation of macrophage cytokine production (GO:0010936),-0.8188363304517743,-1.270251557363796,0.16666666666666666,1.0,1.0,2/5,14.43%,TGFB1;TGFB3
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),0.7386425228033447,1.2701545662613456,0.19047619047619047,0.8513369940334515,1.0,4/8,20.52%,PCGF1;PCGF5;RNF2;PCGF6
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),0.48401521595290714,1.2700503483847656,0.12121212121212122,0.8502988511336208,1.0,10/95,10.02%,ARC;CPSF1;NUP210;NXF5;NUP42;NXT1;NXF1;U2AF1;SRRM1;AAAS
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),0.6122171877216911,1.2699641850828116,0.14285714285714285,0.8491923276644953,1.0,3/12,9.27%,CDH5;SNCA;MAPRE1
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.6567919226918344,1.2697123550860312,0.1891891891891892,0.8494488000140464,1.0,4/17,8.97%,MRAP2;PID1;MYC;LEPR
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),0.726616413158123,1.2694052448971878,0.16666666666666666,0.8493710777724243,1.0,2/9,8.03%,RGN;GSTO2
prerank,PanglaoDB_Augmented_2021__Interneurons,0.4302486979783609,1.2693756316028577,0.06666666666666667,0.8481761400297712,1.0,69/278,19.40%,NXPH4;SLC17A6;LYPD1;GABRA5;RORA;ADGRL2;GRM3;PTPRO;LRRTM3;CCN2;ARX;KCNC2;PCF11;ELAVL3;CALN1;CADM2;RORB;PAK5;DEPTOR;SLC35F1;DLX1;HIVEP2;NCALD;ETV1;NAT14;PDE1A;ERC2;ADGRA1;SYT1;CACNG2;PARM1;PCBP3;CELF5;CELF4;CXCL14;BRINP1;RGS7BP;NXPH1;FGF12;ELAVL4;CDHR1;TIMELESS;RAB3C;SLC22A15;OLFM3;OXR1;ARHGAP21;KCNQ5;SNAP91;RBFOX1;FRRS1L;SCRT1;VSTM2B;FAM81A;NRXN1;FCHSD2;RIT2;DZANK1;SYN1;CDH4;PAX6;PPFIA2;MMD2;ST8SIA3;ADGRB3;ELMO1;GRM5;FBXO11;CTNNA2
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),-0.780759751938352,-1.269152754365839,0.10714285714285714,1.0,1.0,1/12,1.36%,SLC37A2
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.6243812273657452,-1.2689211647360332,0.14084507042253522,1.0,1.0,11/30,27.00%,NDUFS2;NDUFA2;NDUFB4;NDUFC1;NDUFA1;NDUFB9;NDUFB10;NDUFS5;NDUFB11;NDUFB2;NDUFS6
prerank,GO_Biological_Process_2021__lipid hydroxylation (GO:0002933),-0.7981319181290837,-1.2685205475383707,0.2222222222222222,1.0,1.0,3/5,14.77%,CYP3A5;CYP3A4;CYP2E1
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),0.7582610905641949,1.2685018305998539,0.15384615384615385,0.851352819611926,1.0,4/8,20.40%,TEFM;POLG;PRIMPOL;DNA2
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),-0.6340683455786313,-1.2683140081375255,0.1875,1.0,1.0,7/17,30.71%,THBS1;CSF1R;BST1;CXCL17;CCL5;CSF1;MAPK3
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),-0.5488660817412654,-1.2682233903460849,0.11594202898550725,1.0,1.0,12/37,22.36%,ACTC1;STAT1;C3AR1;TRDN;COL4A3;F5;PLN;SCPEP1;SGCG;ACE2;ELN;LPA
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.5022292086312266,1.268075629369645,0.2,0.8514383820801615,1.0,14/46,20.02%,PER2;SPOPL;CRY1;ARRB2;SIRT7;ABL1;GNL3L;N4BP1;HSPA1A;ARRB1;MINAR1;LIMK1;MARCHF7;U2AF2
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.6050579014262468,1.2678462242691029,0.23333333333333334,0.8509794054138782,1.0,3/16,5.50%,ADGRG6;TGFBR1;NRG1
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),0.5624784264475887,1.2677913892797739,0.2,0.8498603115349546,1.0,3/17,10.75%,AKR1C3;AKR1C1;STARD3NL
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),0.52525153816186,1.2677252717487082,0.1282051282051282,0.8489570248506241,1.0,6/39,11.79%,GCK;ZBTB20;ERN1;LPL;IRS2;UNC13B
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.41673762696949623,1.2675818924491606,0.058823529411764705,0.8481272161365937,1.0,57/370,13.62%,ARC;AUP1;HPS3;TTC29;KLHL20;TOR1B;APOE;TFB1M;PACSIN2;RAB31;FGD4;BIN1;TICAM2;SYNE3;PLIN5;BLZF1;PCLO;PKD2;RAB7A;MSTO1;SLC25A33;GBF1;PAK5;UBXN2A;REEP6;SMPD4;FGD5;EIF2AK3;MAST1;TRAPPC12;PNPLA3;MAST2;MYC;FGD1;SIPA1;ABCD3;FAM161B;CHMP6;TTC17;TNIK;ZFYVE16;WASF3;IRAG2;DYRK3;TMED3;ABCD2;SH3KBP1;CSPG5;PI4K2B;PDZD8;MNS1;ARHGAP21;CFAP410;DST;MIEF2;COG7;FAM174B
prerank,GO_Biological_Process_2021__purine deoxyribonucleotide catabolic process (GO:0009155),0.7999349608277588,1.267282456697548,0.17391304347826086,0.84805252093829,1.0,2/6,4.57%,PNP;NT5C1A
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.6600513340281733,1.2672598092674718,0.15151515151515152,0.8468275409795346,1.0,8/13,32.46%,DNMT1;RESF1;MPHOSPH8;ATF7IP;APOBEC1;PPHLN1;SETDB2;SETDB1
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),0.6964090407233091,1.2670830237019233,0.14705882352941177,0.8463096697410531,1.0,3/9,20.11%,ABL1;ABL2;SZT2
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),0.6739090433303432,1.2668708047685677,0.19444444444444445,0.8443672720856231,1.0,2/9,15.73%,STAT5B;IL2RB
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),0.6739090433303432,1.2668708047685677,0.19444444444444445,0.8443672720856231,1.0,2/9,15.73%,STAT5B;IL2RB
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.5366245961486389,1.2665623372211143,0.17857142857142858,0.8441822915870401,1.0,6/30,7.77%,SLFN11;PKD2;GFI1B;CDK6;CDK4;RBL1
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),0.657754182256048,1.2664727329654288,0.22857142857142856,0.843135827588466,1.0,2/13,7.93%,NGF;CASP3
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),0.4761036199314629,1.2663320131317783,0.09375,0.8427206858985855,1.0,15/59,21.68%,RIPK2;TNFRSF19;MAPK8;MAP3K10;LGALS9;MAP3K13;TAB3;NFKB1;MAP4K2;CRKL;MAP2K7;TAB1;TAB2;TRAF6;CUL1
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.7825863954160397,-1.2662713775558476,0.15,1.0,1.0,3/8,14.26%,DCN;PIK3CB;IL12A
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.6066764314674695,1.2661155003922444,0.07894736842105263,0.8424461840465012,1.0,5/18,12.09%,APOE;PPARG;ZBTB20;F2;MLXIPL
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),0.6323025442164245,1.2658261990520405,0.20930232558139536,0.8423812481245028,1.0,2/13,5.09%,KLHL20;PYHIN1
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.6681311879643772,1.2656958236641598,0.2653061224489796,0.8415292131357046,1.0,1/9,3.49%,BIN1
prerank,GO_Biological_Process_2021__type B pancreatic cell differentiation (GO:0003309),0.6935441393215517,1.2654405610332753,0.2727272727272727,0.841327158119628,1.0,6/8,28.82%,CDK6;CDH2;RFX6;BMP4;INSM1;DLL1
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.4944420827377221,1.2653501983293953,0.18518518518518517,0.8405255105371167,1.0,8/45,7.88%,RSPO3;VEGFC;ANGPT1;CDH13;PARVA;SEMA5A;GREM1;SLIT2
prerank,GO_Biological_Process_2021__caveolin-mediated endocytosis (GO:0072584),0.7719413195988833,1.2653033941295113,0.25,0.8393575143520573,1.0,1/5,2.80%,PACSIN2
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.6139845137363256,-1.2651823572584948,0.17857142857142858,1.0,1.0,3/21,10.18%,AIM2;STAT1;TRAF3IP2
prerank,GO_Biological_Process_2021__skeletal muscle cell differentiation (GO:0035914),0.7879459781817917,1.2650982363162402,0.26666666666666666,0.838952562151606,1.0,2/5,5.36%,MEGF10;KLHL41
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,0.5812180257043311,1.265063348461438,0.1388888888888889,0.8376985972196624,1.0,4/30,5.34%,GCK;FOXO1;MAFB;ELP4
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),0.5524946644031951,1.2649175645356703,0.16129032258064516,0.8371138395581417,1.0,1/41,0.03%,IL7R
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),-0.7979406019370219,-1.2649022599153619,0.1509433962264151,1.0,1.0,1/6,5.36%,SLFN14
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.5064555229547234,-1.2646319822631669,0.14666666666666667,1.0,1.0,24/105,15.53%,AMBP;MICB;AHR;ITGB2;IRF4;CXCL13;KLRB1;IRF1;COL1A1;SFTPD;CD160;FCGR3A;OSCAR;ICAM3;HLA-A;C17ORF99;GPR151;HLA-DRB1;CD300LF;SH2D1B;COLEC12;FGL1;ADCY7;HLA-F
prerank,GO_Biological_Process_2021__phasic smooth muscle contraction (GO:0014821),-0.7521569932313293,-1.2645966594709177,0.21428571428571427,1.0,1.0,3/8,13.45%,HTR2B;EDNRB;PTGER3
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),-0.6558076245041814,-1.2645548124223616,0.18032786885245902,1.0,1.0,5/14,10.86%,TRIL;WNT5A;SCIMP;TNFRSF1B;LACC1
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),0.6893090575837859,1.2643595173262447,0.22857142857142856,0.8383636458791605,1.0,5/11,18.56%,HTRA2;F12;TMPRSS2;HJV;SPRTN
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),-0.6026938591409388,-1.2638846857257615,0.11475409836065574,1.0,1.0,9/28,14.75%,TGFB1;WNT8B;ESR1;GPER1;ANXA1;FAM210B;H2AZ1;SSTR1;GGT5
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),0.6894541534366969,1.2638361401717368,0.11764705882352941,0.8391292866671501,1.0,2/11,2.66%,LIPC;APOE
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),0.652466665360176,1.263689769336609,0.19047619047619047,0.8384079752572923,1.0,8/11,25.49%,PSAT1;SRR;CBS;PSPH;SERINC5;SEPHS1;CTH;PHGDH
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),0.5004082359223205,1.2635658794992146,0.14705882352941177,0.8376660369908712,1.0,14/63,9.94%,CYP7B1;TSKU;LIPC;EPHX2;RORA;APOB;APOE;SOAT1;SIRT1;AKR1C1;SOAT2;ABCA1;LPL;LDLR
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.6086067468396279,1.263545087871665,0.15625,0.8364709039118412,1.0,9/17,24.46%,DPM3;TMTC2;FKTN;FKRP;TMTC3;POMT2;RXYLT1;LARGE1;CRPPA
prerank,GO_Biological_Process_2021__regulation of inositol phosphate biosynthetic process (GO:0010919),0.8049895712597389,1.263366717274309,0.22727272727272727,0.8362343394238843,1.0,1/5,5.38%,SNCA
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.6423457323049789,1.2633604390595827,0.21621621621621623,0.834999547337329,1.0,4/11,20.63%,PKD2;GRIN1;CPSF7;CPSF6
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),0.6971096554760696,1.2631648311826829,0.20454545454545456,0.8348792478566899,1.0,8/12,25.97%,IWS1;SETD2;KHDRBS1;CPSF6;NRDE2;TPR;NSUN2;NUP153
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.7300817208725757,-1.2629979910220617,0.14285714285714285,1.0,1.0,2/11,17.04%,SNAP23;STX19
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,-0.5175608902292504,-1.2620249146544678,0.15942028985507245,1.0,1.0,22/57,19.93%,PTPRH;TMEM184A;MISP;CAPN8;SMIM22;PTGR1;PGC;LIPH;ANXA10;SLC5A1;CLDN2;MS4A8;GPR39;ITGB6;CLDN18;GPX2;SCNN1A;LGALS4;SLC44A3;FAM3D;ACE2;CBLC
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),0.6281019620507163,1.261960449342741,0.24324324324324326,0.8386978139283855,1.0,3/11,12.54%,AADAT;OGDH;IDH2
prerank,MSigDB_Hallmark_2020__UV Response Dn,0.4303057690200245,1.2618185454887796,0.0,0.8382785226934498,1.0,63/138,27.01%,GRK5;KIT;IRS1;ADGRL2;CCN1;ATXN1;PPARG;TENT4A;ERBB2;SFMBT1;SERPINE1;MAGI2;RASA2;LTBP1;MYC;SNAI2;PTPRM;FHL2;LDLR;RND3;CAP2;PHF3;DDAH1;MMP16;ABCC1;EFEMP1;NFIB;NR3C1;NFKB1;CELF2;VAV2;RUNX1;MGMT;SPOP;NIPBL;BCKDHB;PRKCE;ACVR2A;PLPP3;ADD3;DLG1;PTEN;SMAD7;LAMC1;PTPN21;CACNA1A;MT1E;BMPR1A;CDC42BPA;DYRK1A;PEX14;PIK3CD;CDK13;ANXA4;RXRA;SYNE1;AKT3;NR1D2;INSIG1;SYNJ2;COL11A1;TGFBR3;DLC1
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.5405869032250997,1.2616245338812706,0.08695652173913043,0.8377927826945023,1.0,14/32,29.79%,CDH5;SNCA;MAPRE1;NAV3;CLIP3;CAMSAP3;ATXN7;DYRK1A;MAP2;CIB1;MID1IP1;APC2;FGF13;CLASP2
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),0.6571949521274136,1.261475854159918,0.1951219512195122,0.8370155541220586,1.0,3/11,14.25%,ECM1;GREM1;BCOR
prerank,GO_Biological_Process_2021__hepoxilin metabolic process (GO:0051121),-0.7820015434808699,-1.2609763388352484,0.1935483870967742,1.0,1.0,4/8,7.49%,ALOX12;ALOX5;ALOX12B;ALOX15
prerank,GO_Biological_Process_2021__hepoxilin biosynthetic process (GO:0051122),-0.7820015434808699,-1.2609763388352484,0.1935483870967742,1.0,1.0,4/8,7.49%,ALOX12;ALOX5;ALOX12B;ALOX15
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),0.6444206228003629,1.2609025381475265,0.23076923076923078,0.8380406543220674,1.0,5/9,25.08%,KYAT1;ASRGL1;GSTZ1;IL4I1;PAH
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.5473799740397272,-1.260592758179687,0.1282051282051282,1.0,1.0,15/53,24.68%,COX6A1;NDUFS2;COX6C;NDUFA2;NDUFB4;NDUFC1;COX7C;NDUFA1;NDUFB9;COX4I1;NDUFB10;NDUFS5;NDUFB11;SDHC;NDUFB2
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),0.7220940665347159,1.2604543483800328,0.1794871794871795,0.838545970231471,1.0,4/7,20.60%,ARL13B;ARL3;BBIP1;WDR19
prerank,GO_Biological_Process_2021__cochlea morphogenesis (GO:0090103),-0.75914383793268,-1.2603822277696561,0.23880597014925373,1.0,1.0,2/7,12.02%,TBX1;MYO3B
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),0.5919705251352156,1.2598774846888228,0.1891891891891892,0.839453583617464,1.0,5/13,15.24%,GLYATL2;CYP4Z1;ABHD3;ACADM;OXSM
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.5774278986603538,1.2597246447494264,0.1935483870967742,0.8388577036033051,1.0,5/21,11.93%,SEMA5A;GOLGA4;DSCAM;MACF1;MAP3K13
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.45766952422442203,1.2596202115499187,0.14285714285714285,0.8380175541662089,1.0,31/106,20.33%,MCOLN3;SEZ6L;KCNC2;CACNB4;HCN1;PROX1;KCNJ6;WSCD2;CATSPER2;ADCY2;GRM4;CACNG2;CELF4;MYT1L;XKR4;CPNE6;FRRS1L;NR3C1;DPP6;SRRM4;SEZ6;NRXN1;AP3B2;SLC7A14;UNC13C;GNG7;SLC24A2;ST8SIA3;CTNNA2;TNR;PMP2
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),0.6676941150264712,1.2593293252043951,0.175,0.8378052348342664,1.0,3/8,15.83%,GLA;NEU4;NEU3
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.5445222271810353,1.2592815456053104,0.225,0.83681301679243,1.0,2/27,0.55%,TACR3;LHFPL2
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),0.5542251144234571,1.259046104274183,0.15555555555555556,0.8366253682243552,1.0,8/23,15.39%,LIPC;RORA;APOE;SIRT1;LPL;MLXIPL;ACSM2A;NR1H3
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),-0.6890898505898051,-1.2587003258118064,0.18333333333333332,1.0,1.0,9/17,24.26%,C3AR1;NLRP3;PSTPIP1;IL18;TXNIP;NT5E;TXN;ENTPD5;HSP90AB1
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.5935269104231327,1.2583170902612275,0.25806451612903225,0.8386395427516188,1.0,7/17,21.29%,STX5;STX18;AKAP9;MYO5A;PDE4DIP;USP6NL;CAMSAP3
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),-0.7578966468347745,-1.2578954280795343,0.14705882352941177,1.0,1.0,3/9,15.82%,PPT1;ATP6AP2;GRN
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),-0.6170703114625823,-1.257848282998156,0.17543859649122806,1.0,1.0,9/22,20.51%,OR52A5;OR51M1;SYT10;OR51I2;OR9Q1;OR2M4;GNAL;OR8A1;OR3A2
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.4142734055157579,1.257845547742724,0.0,0.8395820801633577,1.0,27/118,14.12%,ADAMTS1;PC;EPHX2;RORA;ADGRL2;TBC1D16;PLIN5;GPC6;B4GALT2;BCAT1;ECHS1;AADAT;PLXNB1;RND3;CAP2;CHST3;MPDZ;DDAH1;CLDN12;CITED4;RBFOX2;UNC13B;CHKA;LRIG3;KCTD3;TSPAN12;MAGI1
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),-0.5119760084758189,-1.2574412439808356,0.14925373134328357,1.0,1.0,5/56,2.81%,AQP3;MICB;TBX1;WNT5A;WNT8B
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),0.710613928503765,1.2573906537173596,0.23684210526315788,0.8407213772549177,1.0,1/10,1.51%,CPEB1
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,0.4709205703828655,1.2573703986292795,0.12,0.8395329224550266,1.0,29/122,16.94%,SLC17A6;MEGF10;APOE;CACNG4;POU3F2;ARX;ELAVL3;PAK5;SLC35F1;DLX1;PTPRZ1;KCNIP1;ADGRA1;RND3;STOX2;NXPH1;CSPG5;NPAS3;RIMS4;RHBDL3;ASCL1;SNAP91;MAP6;MSI1;SCRT1;SRRM3;MAGEL2;IFI44;GRIK3
prerank,GO_Biological_Process_2021__cellular water homeostasis (GO:0009992),-0.7907308100167834,-1.2572938001979768,0.16666666666666666,1.0,1.0,3/5,15.61%,SCTR;AQP4;AQP11
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),-0.5176599229935493,-1.2571228003181039,0.1111111111111111,1.0,1.0,18/112,11.15%,NLRP4;EOLA1;TRIL;S100A13;PLD4;NLRP12;ALOX5;TNFRSF1B;SFTPD;LRRC19;NFAM1;IGF2BP2;ANXA1;HTR2B;HLA-DRB1;PTPRC;SLC11A1;BTN3A3
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.6526464089423323,1.2564544490718836,0.3023255813953488,0.8421720841004963,1.0,5/9,15.58%,CEL;NLGN1;NLGN4X;NLGN3;NRXN1
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),-0.6795210269177256,-1.255914738111658,0.18333333333333332,1.0,1.0,6/10,29.66%,CCDC39;RSPH9;ZMYND10;BBOF1;DNAAF1;SPATA6
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),0.6405633801800776,1.2558914980747173,0.1702127659574468,0.8432805252021783,1.0,5/13,11.80%,MEGF10;XKR7;RHOBTB1;XKR6;XKR4
prerank,GO_Biological_Process_2021__regulation of lymphocyte apoptotic process (GO:0070228),-0.8051829769296897,-1.2558323716784847,0.15254237288135594,1.0,1.0,1/6,2.65%,BLK
prerank,GO_Biological_Process_2021__androgen biosynthetic process (GO:0006702),-0.7812883919472728,-1.255059744190353,0.24074074074074073,1.0,1.0,2/6,19.39%,HSD3B1;CYP17A1
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.6181870811016452,1.2550003094888305,0.18181818181818182,0.8460387520814429,1.0,7/15,29.71%,TENT4A;TNRC6C;TNRC6A;AGO2;PABPC1;TNRC6B;TOB1
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),-0.7439863318100396,-1.2548506354185307,0.23076923076923078,1.0,1.0,1/5,13.77%,VDAC1
prerank,PanglaoDB_Augmented_2021__Myocytes,-0.5159894661282137,-1.2548271898792442,0.12,1.0,1.0,18/115,8.67%,MYH1;NRAP;LMOD1;MYH4;MYH7;CASQ2;ACTC1;MYH8;ANGPTL2;MMP9;CAV3;TMOD4;NID1;KLHL38;TRDN;CSRP3;NEB;ACTN3
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),0.6148154011210283,1.2545143036694435,0.13793103448275862,0.8468522188763838,1.0,12/26,25.48%,UBE2E3;UBE2D4;ANAPC13;UBE2E2;UBE2A;CDC26;UBE2L3;ANAPC7;FZR1;ANAPC4;UBE2D3;ANAPC2
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.5132691660612291,1.254242081135408,0.12121212121212122,0.8464326541749501,1.0,9/34,16.10%,GRID2;ALCAM;NLGN1;CADM1;TENM3;TENM1;NECTIN3;PTPRD;AMIGO2
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),0.7524797502351932,1.2538208674606546,0.175,0.8469579092548856,1.0,5/6,22.25%,TENT4A;ELAVL4;METTL16;RBM24;LARP4B
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),0.5330255292640214,1.2534296327162262,0.16666666666666666,0.8470872175369645,1.0,8/29,15.86%,GLA;DDAH2;CX3CR1;PKD2;KHSRP;DDAH1;INSR;PTGIS
prerank,GO_Biological_Process_2021__tryptophan catabolic process to kynurenine (GO:0019441),0.8686140069287789,1.252908664376771,0.125,0.8476318820782663,1.0,1/5,2.79%,TDO2
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.670899092041626,-1.2526774955547466,0.14545454545454545,1.0,1.0,1/11,2.76%,CAV3
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),0.6666369372785207,1.2525375013342064,0.24,0.8477598407374978,1.0,2/12,4.57%,PNP;NT5C1A
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),-0.762389760805106,-1.2524197389435539,0.1935483870967742,1.0,1.0,1/7,1.65%,GMFG
prerank,GO_Biological_Process_2021__lipid transport across blood-brain barrier (GO:1990379),0.7737471123839518,1.2522930369640541,0.2553191489361702,0.8476910734803995,1.0,2/5,17.52%,MFSD2A;SLC27A4
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.7190815880381933,1.2522752805530193,0.14814814814814814,0.8466639267896366,1.0,3/13,8.64%,RAB27A;NLGN1;SYNDIG1
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.5571151486159057,1.251269807938383,0.14285714285714285,0.8495120357549056,1.0,12/28,25.92%,PUS10;TRIM71;LIN28B;DGCR8;SMAD2;AGO3;TARBP2;AGO2;TUT7;ADAR;ZC3H7B;LIN28A
prerank,GO_Biological_Process_2021__positive regulation of cell activation (GO:0050867),-0.773223714107117,-1.2511434541373534,0.1935483870967742,1.0,1.0,2/6,17.74%,SELP;PLA2G4A
prerank,GO_Biological_Process_2021__protein localization to non-motile cilium (GO:0097499),0.7882872305378142,1.2510223497218769,0.23809523809523808,0.8490717503324192,1.0,4/5,18.14%,SPATA7;ARL13B;ZDHHC3;BBIP1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),0.6604128235756552,1.2509332021858866,0.18181818181818182,0.848198890963887,1.0,3/11,5.58%,PTPRO;JAG1;MAGI2
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),-0.6742148394900402,-1.2508982895169134,0.13636363636363635,1.0,1.0,4/12,15.82%,TAFA3;TNFRSF1B;PTPRC;GRN
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),-0.7423134095510149,-1.2508383487432004,0.18032786885245902,1.0,1.0,1/9,1.12%,JCHAIN
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.502080426396466,-1.2505444019795298,0.13157894736842105,1.0,1.0,31/118,13.42%,XCR1;ITGB2;HCK;CYTIP;PDCD1LG2;TAGAP;SCIMP;TNFRSF1B;PTAFR;HLA-DMA;DAB2;PARVG;FCGR3A;HLA-A;LY86;VSIG4;NFAM1;HLA-DPB1;ADGRE1;ANXA1;MYO1F;IGSF6;HLA-DRB1;PTPRC;SLC11A1;SPI1;CLEC12A;ITGAM;CXCL16;HLA-DPA1;CD300LF
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),-0.7264517665899742,-1.249963549135885,0.125,1.0,1.0,5/10,20.27%,STEAP4;COX17;STEAP2;ATOX1;CUTC
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.5119351308859121,1.2495456217890508,0.15384615384615385,0.852223884881071,1.0,16/38,26.78%,EPHX2;PLPPR1;MTMR8;PLPP2;PLPPR3;MTMR3;PIP4P2;MTMR1;MTM1;PLPP3;PLPPR5;PTEN;PLPPR4;MTMR11;MTMR9;SYNJ2
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.5646664212814984,-1.2493977551794129,0.14516129032258066,1.0,1.0,5/29,13.53%,TRIM62;WNT5A;IFNK;SPI1;SH2D1B
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,-0.5614291569357996,-1.2491024329059006,0.1267605633802817,1.0,1.0,13/39,17.99%,CLCA2;DUOXA1;MUCL1;SERPINB5;THBS1;ZNF750;LAMC2;ITGB6;TRIM29;PROM2;ADIRF;SERPINB7;DSG3
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.45086096030310024,1.2482995286654306,0.08823529411764706,0.8560643074476083,1.0,20/121,7.95%,GPR3;LGR5;ADRA1B;ADGRG6;CHRM2;GRK5;GPR161;CRHR2;ADGRL2;HTR1F;GALR3;ADGRG3;DRD5;GRM8;GPR26;GPR78;RXFP1;S1PR5;ABCA1;ADCY2
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),0.5081831480467103,1.2481130158749247,0.16666666666666666,0.8554227780383055,1.0,20/42,29.72%,RIDA;NANOS3;KHSRP;MOV10;TNRC6C;PNPT1;YTHDF1;TNRC6A;RC3H1;METTL16;AGO2;NANOS1;RBM24;MEX3D;PABPC1;ROCK1;TNRC6B;YTHDF3;TOB1;ZFP36L2
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.6582439893969716,1.2480871153174353,0.14285714285714285,0.8530683484397064,1.0,2/10,6.91%,SLC12A1;SLC12A9
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.6582439893969716,1.2480871153174353,0.14285714285714285,0.8530683484397064,1.0,2/10,6.91%,SLC12A1;SLC12A9
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),0.6149142160129105,1.2478974739370492,0.19047619047619047,0.8524983480230386,1.0,4/17,12.76%,TET2;NT5C1A;UPP2;NT5C3A
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),0.6504172527834674,1.2478484356465107,0.22580645161290322,0.8515004499727161,1.0,6/11,10.85%,APOH;KLKB1;SERPINE1;F11;F2;F12
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),0.7538201704841181,1.2475857655734284,0.17073170731707318,0.8514489869765762,1.0,2/6,7.94%,SNCA;WWP2
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),-0.5831692483776642,-1.2475002868151606,0.19402985074626866,1.0,1.0,6/23,17.23%,MEIOB;SLC25A31;BTBD18;MEIOC;SYCP3;MOV10L1
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),0.6571027544303866,1.2474977048673066,0.2857142857142857,0.8507552188315756,1.0,5/13,9.00%,SLC30A10;SIRT1;CDK6;RBL1;TWIST1
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.67519734290046,1.2471007976329487,0.32558139534883723,0.8511968054105347,1.0,5/9,21.95%,SIRT1;ESCO1;EP300;KAT2B;BAG6
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),-0.7658064262945846,-1.2470608959893725,0.19607843137254902,1.0,1.0,1/7,2.13%,STAC
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),-0.6415947213101532,-1.2470117132383303,0.13043478260869565,1.0,1.0,3/20,4.27%,BUB1;TERF2IP;SHCBP1L
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.5421867911052991,1.2465897078199122,0.10714285714285714,0.8521496497993853,1.0,9/19,23.53%,LZTR1;CGNL1;SLIT2;SPRY4;EPHB2;STAMBP;SPRY1;ARHGAP25;SPRY3
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.6754020393891288,-1.2463662465691694,0.20634920634920634,1.0,1.0,3/15,9.22%,ENPP2;PDXDC1;PPT1
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.4430769662520236,1.2458092501890061,0.08695652173913043,0.8537182071335702,1.0,25/92,11.69%,VCAN;PAPSS2;CSGALNACT1;ANGPT1;CHST6;CHSY3;PRELP;GSTM5;CHSY1;CHST12;CBS;ST3GAL3;B4GALT2;CHAC1;UST;GSTO2;B4GALT3;CHPF2;GSTM2;CHST11;CSPG5;CHST3;UGDH;MAT2A;DSEL
prerank,GO_Biological_Process_2021__interleukin-18-mediated signaling pathway (GO:0035655),-0.8068543329789506,-1.2455502437891444,0.16071428571428573,1.0,1.0,3/6,15.16%,ALOX5;IL18BP;IL18
prerank,GO_Biological_Process_2021__cellular response to interleukin-18 (GO:0071351),-0.8068543329789506,-1.2455502437891444,0.16071428571428573,1.0,1.0,3/6,15.16%,ALOX5;IL18BP;IL18
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.6338794707686435,-1.2455117756338947,0.15625,1.0,1.0,4/19,13.78%,CNMD;VTN;TMEM204;ITGA5
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.5763975861379202,1.2454773763319913,0.1,0.8539620981345031,1.0,8/21,12.47%,EYA4;BCL2;FGFR1;HTRA2;SNAI2;PPP2R1B;RET;HSPA1A
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),0.6357309214738928,1.245454932158961,0.1875,0.8516236573599951,1.0,6/13,27.43%,PDSS2;UBIAD1;COQ2;COQ9;COQ6;COQ3
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),0.6357309214738928,1.245454932158961,0.1875,0.8516236573599951,1.0,6/13,27.43%,PDSS2;UBIAD1;COQ2;COQ9;COQ6;COQ3
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),0.7329453919995872,1.2453740740762909,0.1951219512195122,0.8506820106816464,1.0,3/6,14.09%,LIN28B;PNPT1;NFKB1
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),-0.6572537735260764,-1.244919927811499,0.203125,1.0,1.0,3/16,20.81%,SNAP23;STX19;TOR1A
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.49600848411768483,1.2448066921942875,0.13333333333333333,0.8520934034147013,1.0,11/59,7.74%,TGFBR1;VEGFC;FGFR1;CDH13;SEMA5A;SIRT1;ITGA4;PROX1;HMGB1;ECM1;SP1
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),-0.7116495756211519,-1.2445407570245401,0.2545454545454545,1.0,1.0,4/8,13.80%,RORC;GPR183;ZFPM1;LEF1
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.6039289411277329,1.2442128562240955,0.14634146341463414,0.8532893916602037,1.0,8/26,16.46%,TEAD2;AMOTL1;LATS1;CASP3;TEAD4;WWTR1;MOB1A;WWC1
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.521009284693827,1.2438121966314868,0.14705882352941177,0.8538063376173716,1.0,11/30,21.55%,IRS1;CAPN10;PID1;AKT2;IRS2;RTN2;INSR;PRKAG2;OSBPL8;APPL2;OCLN
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),0.6458934607185268,1.243811041023564,0.1875,0.8526138706653921,1.0,5/16,14.25%,PCGF1;RNF168;UBE2A;RYBP;BCOR
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.5249728917232359,-1.243547525544486,0.2,1.0,1.0,8/92,11.55%,NEK2;BUB1;IHO1;RAB11A;GPER1;CAV2;ANKK1;ATF5
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),0.6592939759086356,1.2435225436723387,0.25,0.8515636216070928,1.0,2/11,10.38%,ACER2;ACER3
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),0.6592939759086356,1.2435225436723387,0.25,0.8515636216070928,1.0,2/11,10.38%,ACER2;ACER3
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,-0.4954101130066535,-1.2434747556643693,0.125,1.0,1.0,28/102,14.77%,AMBP;SLC28A1;SLC22A8;BHMT;F7;SLC22A6;SMLR1;SLC5A2;TGFBI;ALDOB;C3P1;SLC5A1;OIT3;CLDN2;DAO;PDZK1;CYP3A4;HNF1A;SLC22A7;SCIN;LRP2;PON1;HSD11B1;HAAO;PPIC;HAO2;NR1H4;CYP2E1
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),0.516515545992459,1.2434361483805427,0.16666666666666666,0.850652224114232,1.0,5/38,8.45%,MLF1;DTX1;PPP5C;TAF1B;NR4A2
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.6298317269769184,1.243214774959863,0.20930232558139536,0.8500788605447321,1.0,5/12,16.67%,TCOF1;NRG1;SNAI2;CDH2;NOTCH1
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),0.6990020691433902,1.242682858732231,0.23076923076923078,0.8508472351811623,1.0,3/6,23.37%,MTR;MTHFR;PLOD2
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.58641190317051,-1.2426173901005857,0.19718309859154928,1.0,1.0,5/27,10.28%,NOTUM;CYP26B1;TGM2;SFRP4;PTPRC
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.4062454580061078,1.242529881029788,0.125,0.8502542789720605,1.0,74/250,21.50%,PCM1;EMP1;KIT;IFT88;PTPRO;DZIP1L;CDH13;FGD4;PARVA;VSTM5;SCLT1;SRGAP2;FHDC1;GBF1;CILK1;BBS9;FGD5;SPAG16;FLNA;FGD1;RAP2A;CNGA4;TNIK;CEP290;EHD4;RPGR;CEP250;RAB11FIP3;AVIL;PPP1R9B;MKS1;RAP1A;CFAP410;CEP20;TTC36;CCDC88A;RILPL1;PIBF1;ARL13B;EXOC7;KIAA0586;RP2;PTPN23;CEP41;CEP162;FSCN1;CDC14B;IFT140;S1PR1;NEK1;ARL3;NOTCH1;CFAP70;DCDC2;KIF3B;BBIP1;CFAP221;PDE6D;DZIP1;UNC119B;CFAP43;ARFIP2;TMEM67;PTPDC1;VCL;EXOC6;TMEM138;WDR19;TTC39C;IQCB1;POC1B;FBF1;KIF27;EXOC4
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),0.8079614134130422,1.2425261326305612,0.18,0.849099152171082,1.0,3/5,18.26%,PPP1R15B;NCK1;ABCA7
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.5198571211740474,1.2423927258998115,0.07407407407407407,0.8483851301943567,1.0,17/39,24.95%,MYO10;NLGN1;TRPM2;RALA;TENM1;FSCN1;MIEN1;DOCK11;RAB5A;FXR2;PLPPR5;PALM;GPM6A;PRKCD;PPP1R16B;CAPZB;TENM2
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),0.6306383978736683,1.2423452511437665,0.23809523809523808,0.8474231865922214,1.0,4/18,7.88%,SERPINE1;HMGB1;GREM1;SLIT2
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,-0.48122415907122806,-1.2423296923758358,0.07317073170731707,1.0,1.0,22/183,16.15%,NEK2;BUB1;MCM2;POLQ;TGFB1;HMGB3;TRAIP;CCND1;MCM3;CDC25A;TTK;SUV39H1;ATF5;SAP30;HSPA8;H2AZ1;CHAF1A;INCENP;CCNF;CDKN3;CKS1B;SMAD3
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.6201515051063353,1.2418618391565592,0.17073170731707318,0.8485850436476575,1.0,5/14,8.76%,KIT;FGFR1;BICD1;ABL1;ABL2
prerank,GO_Biological_Process_2021__regulation of microvillus organization (GO:0032530),-0.7461173492255143,-1.2416924221858066,0.30434782608695654,1.0,1.0,1/8,1.01%,CDHR5
prerank,GO_Biological_Process_2021__endothelium development (GO:0003158),0.7563301044902002,1.2413987876288173,0.21951219512195122,0.8494321995447989,1.0,2/8,5.28%,SCUBE1;JAG1
prerank,GO_Biological_Process_2021__regulation of complement-dependent cytotoxicity (GO:1903659),0.7114884084435289,1.2412117264719082,0.2,0.84886681253179,1.0,3/7,21.96%,CFH;IL11;CD55
prerank,GO_Biological_Process_2021__epithelial tube branching involved in lung morphogenesis (GO:0060441),0.7745390962862112,1.2410921822791734,0.19672131147540983,0.8482408466003066,1.0,1/5,1.19%,FGF10
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),-0.8376893124583056,-1.240928455660232,0.19672131147540983,1.0,1.0,3/7,8.12%,SCN5A;KCNA5;KCNQ1
prerank,PanglaoDB_Augmented_2021__T Cells,0.46656647391816247,1.2405276508257927,0.05263157894736842,0.8493124906479506,1.0,15/91,5.28%,IL7R;SELPLG;DUSP2;SKAP1;CD247;TRAC;EEF1B2P3;BCL2;RORA;GPR174;TGIF1;IL16;CCL4L2;PYHIN1;SYT3
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),0.47996063040796383,1.2402791093866086,0.10714285714285714,0.848997427974629,1.0,15/62,14.49%,PHLDB2;BAMBI;TGFBR1;SPRED3;IL17RD;EPHA3;ZNF703;GREM1;SPRED2;TWIST1;ADIPOR1;SPRED1;BCL9L;SMAD2;WWTR1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.39246315840943213,1.2400936692229978,0.0,0.8487244764066024,1.0,65/290,18.53%,TEAD2;ESRRG;CPSF1;INTS11;HDAC3;PKNOX1;LSM10;MED17;RORA;HDAC10;RARB;ZBTB7B;CCN2;CBFB;PPARG;PCF11;DTX1;ELOF1;MAML1;RORB;IWS1;GTF2I;ELP4;ARRB2;ZBTB1;SP1;TAF3;NR4A2;SNRPB;TAF12;ELOA;CCNH;INTS14;INTS9;CPSF7;TEAD4;NR3C2;HDAC1;MED16;TRIP13;NR3C1;NFKB1;MLLT3;GTF2F2;SOX5;WWTR1;TFCP2;THRB;SNAPC3;NFIC;NR1H3;NR6A1;NRBF2;NR4A3;SETD2;NOTCH1;ICE1;NR2C1;PAPOLA;TAF4;ERCC3;RBPJ;NFX1;RPRD2;NR4A1
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431),0.7780988705879988,1.2391118733312216,0.2549019607843137,0.8510062977367349,1.0,2/5,3.92%,IRGM;RIPK2
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),0.5920302175535084,1.238498165096141,0.24324324324324326,0.8522328856366812,1.0,3/18,3.26%,NEUROD2;RGN;CDH13
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),0.6032040752487822,1.2384747252910737,0.2564102564102564,0.8511144670218412,1.0,6/12,28.92%,ABCA1;STARD4;NPC2;ABCG1;SERAC1;ARV1
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),-0.5235546515810153,-1.238434295506827,0.18840579710144928,1.0,1.0,11/45,17.71%,DNAH11;TEKT5;CCDC39;TEKT3;DNHD1;ODAD1;DNAH17;CFAP61;DNAI1;ZBBX;RSPH9
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),0.5337687163041702,1.2382113888924875,0.15151515151515152,0.8506144789683717,1.0,6/27,8.91%,SLC17A6;NLGN1;PCLO;SNCA;SYNDIG1;WNT3A
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),0.7445644912495188,1.237919588203204,0.2857142857142857,0.8506894336941648,1.0,2/7,20.51%,SESN2;HIF1A
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.4867671554793385,1.2376952756512032,0.15625,0.8503550361885974,1.0,10/55,9.71%,TSKU;APOE;NLGN1;PTPRO;KIAA0319;BCL11A;DCC;PTPN9;WNT3A;KANK1
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.6027010444020164,1.2376946210872715,0.2391304347826087,0.8492247825562239,1.0,8/15,30.63%,ITPKB;ACER3;IP6K1;IPPK;IP6K2;CYP27A1;PPIP5K1;ISYNA1
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.4618957313394171,1.2376535582981065,0.125,0.848240398816171,1.0,9/46,13.66%,PER2;SPOPL;CRY1;ARRB2;SIRT7;GNL3L;N4BP1;HSPA1A;ARRB1
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),0.7563016355665941,1.2375422597870238,0.20588235294117646,0.8476457899788281,1.0,3/5,18.76%,BCAT1;HIBADH;HIBCH
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),-0.7326824343180602,-1.2374006415116128,0.2033898305084746,1.0,1.0,3/11,15.53%,TGFB1;TGFB3;HLA-F
prerank,GO_Biological_Process_2021__thiamine-containing compound metabolic process (GO:0042723),-0.7664644674147048,-1.2370167637689538,0.1724137931034483,1.0,1.0,3/6,16.49%,ACP3;SLC25A19;SLC19A3
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),0.7489819998005017,1.236716227540532,0.1956521739130435,0.8496165275735855,1.0,2/6,12.75%,MAPK8;FNTA
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),-0.5820897203526566,-1.2365373183729877,0.12903225806451613,1.0,1.0,2/25,3.70%,ENPP2;CYP1B1
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),-0.5973761922515246,-1.2363628689556612,0.2112676056338028,1.0,1.0,8/27,23.93%,KIF14;VIL1;CFL1;STMN4;KIF18A;STMN1;STMND1;DSTN
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),-0.8001377096358494,-1.2363491921876757,0.23076923076923078,1.0,1.0,1/6,9.15%,PTX3
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.49826909866379143,-1.23627716282101,0.12,1.0,1.0,14/69,17.12%,DENND1C;IRF1;LRP10;DTX2;NFKB2;ST6GALNAC2;DEF6;MMP25;CXCL16;FOXO4;SYTL1;HLA-F;LITAF;VASP
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),-0.6691857590149114,-1.2346048946487642,0.21818181818181817,1.0,1.0,5/16,25.89%,P2RY12;THBS1;CSF1R;CXCL17;CCL5
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),0.4673995843023434,1.234535237411183,0.11538461538461539,0.8574340590604352,1.0,24/87,20.92%,CSTA;APOE;SAMD4A;PCIF1;DHFR;TRIM71;RIDA;F2;EIF2AK3;NANOS3;CNOT9;NFKB1;PUS7;MALSU1;SYNCRIP;LSM14A;SAMD4B;DNAJC1;CDK5;EIF4A3;NANOS1;RNF139;FXR2;LARP1
prerank,GO_Biological_Process_2021__L-alanine transport (GO:0015808),0.7447891018191954,1.2343154006673567,0.20512820512820512,0.8571338779035188,1.0,1/7,1.04%,SLC38A5
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.5900796961544095,1.234265933245293,0.21875,0.8561049540555783,1.0,8/21,29.79%,NAV3;CAMSAP3;ATXN7;CIB1;MID1IP1;APC2;FGF13;CLASP2
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),-0.6522975899416203,-1.2338495574798827,0.2,1.0,1.0,4/12,17.79%,ALOX5;GGT5;PLA2G4A;ALOX5AP
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106070),0.7533558470054373,1.233738364942416,0.1956521739130435,0.8572442624425056,1.0,1/5,1.07%,MRAP2
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.736952573857878,-1.2331792126603953,0.21568627450980393,1.0,1.0,3/7,18.50%,HLA-A;ERAP2;ERAP1
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),-0.6938541586719175,-1.2331367269662397,0.22807017543859648,1.0,1.0,2/12,12.51%,DOCK8;APOD
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),0.5349649726656786,1.2330603775451494,0.15151515151515152,0.8586634741886447,1.0,7/32,11.11%,DGKD;APOH;APOE;PNPLA3;LPL;PGS1;AWAT2
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),0.7022896212583534,1.2326632657510386,0.1875,0.8586458301114133,1.0,2/7,12.32%,DNAJC30;ATPSCKMT
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.42249811180043356,1.23263334837229,0.05555555555555555,0.8575599115206021,1.0,28/125,17.99%,KLHL17;ROBO2;ADGRL2;EPHA7;MFSD2A;DSCAML1;DNAJC30;PITPNM1;CX3CR1;ATXN1;CNTNAP2;SPEF2;JHY;PROX1;MAST1;SLC6A17;GRIN1;BPTF;NFIB;CDH2;UTP3;NF1;SMG9;AMIGO2;MDGA1;PBX1;NIPBL;MACROH2A2
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),0.5610006354934319,1.2323036630377733,0.06451612903225806,0.8579866488991631,1.0,7/33,8.45%,TGFBR1;BCL2;DAPK2;CX3CR1;DEPTOR;STYXL1;NR4A2
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.6333850702161025,1.2322107854959508,0.14285714285714285,0.8570653266243453,1.0,1/15,1.41%,CPSF1
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),0.48225394984477993,1.2320797027239159,0.09090909090909091,0.85644760364809,1.0,14/80,11.34%,BAMBI;NGF;APOE;RIPK2;PPARG;RALB;PYHIN1;HES1;HMGB1;MED25;WNT3A;EPB41;ZNF618;GPSM1
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),0.7304409099972307,1.231515767110509,0.23214285714285715,0.8574756161284781,1.0,2/5,25.38%,SEC22B;TAPBP
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.6262961165766091,1.2314973864335144,0.2,0.856398450597265,1.0,10/19,22.14%,RASSF2;NLRP2B;MLXIPL;GADD45A;NCK1;DMD;PDE4D;NCK2;PTEN;SMAD7
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),0.7548101060387425,1.2311826963960906,0.20930232558139536,0.8564439606097367,1.0,3/7,13.92%,STX5;GBF1;PLK3
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.5836875748078212,1.2311496881822566,0.21428571428571427,0.8553310686008146,1.0,5/18,22.38%,OPRD1;LRP8;RPS6KA4;TSSK4;CRTC1
prerank,GO_Biological_Process_2021__T cell apoptotic process (GO:0070231),0.7343636536905399,1.2310601334149394,0.16666666666666666,0.854619996699304,1.0,1/6,1.59%,CLC
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),0.5004144192396096,1.230875173579535,0.15625,0.8544684960326387,1.0,14/62,9.94%,CYP7B1;TSKU;LIPC;EPHX2;RORA;APOB;APOE;SOAT1;SIRT1;AKR1C1;SOAT2;ABCA1;LPL;LDLR
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),0.5367447567347414,1.2308354525009846,0.17142857142857143,0.8535416284735,1.0,7/17,17.08%,SYT3;SYT17;SYT1;RIMS2;CPNE6;SMURF1;CPNE9
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.5932804713483936,1.230613832900323,0.16129032258064516,0.8533720801327485,1.0,2/15,12.02%,HIP1;SGIP1
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),-0.6293592680626465,-1.2305948865037002,0.19642857142857142,1.0,1.0,2/23,6.32%,ENPP2;PLA2G10
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),-0.7060059244321604,-1.230554017827485,0.2222222222222222,1.0,1.0,2/8,5.55%,MISP;GPSM2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),-0.6469207048445274,-1.2298706067598568,0.19047619047619047,1.0,1.0,2/13,9.78%,WNT5A;THBS1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),-0.6334250599756392,-1.229833249729954,0.1935483870967742,1.0,1.0,4/17,10.28%,SFTPD;VSIG4;GBP1;PTPRC
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.5532615094719391,1.2296987350537774,0.1935483870967742,0.855821746697139,1.0,6/21,13.48%,CSGALNACT1;EXT1;NDST3;HS2ST1;EXT2;FUT9
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),-0.6365490716822431,-1.2296567671784175,0.2112676056338028,1.0,1.0,7/23,19.66%,KCNA5;ATP1A4;KCNQ1;SLC11A1;KCNE3;ATP4A;ATP1A1
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),0.7229201610178266,1.229503582520031,0.25,0.8555109592033762,1.0,2/8,12.48%,MAN2A1;NGLY1
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.42963046638089936,1.2292923748892277,0.18518518518518517,0.8551614120389165,1.0,40/125,21.18%,IRGM;FOXO1;IRS1;APOE;PLIN5;SNCA;ZBTB20;TRIM8;HMGB1;DHRSX;DXO;KHSRP;RNF152;TWIST1;MOV10;AKT2;ABCD2;LIN28B;IRS2;TRIM65;PIM2;MLXIPL;TICAM1;SNX9;PNPT1;INSR;FURIN;GPLD1;TFEB;RC3H1;FAF1;ATF6;PFKFB4;PRKAA2;MID2;TRIM14;HIF1A;LAPTM5;PFKFB3;MTDH
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),-0.5887069459806039,-1.229269929937383,0.2191780821917808,1.0,1.0,1/30,0.37%,NEK2
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.5054067494487493,-1.2286530837703502,0.16176470588235295,1.0,1.0,7/79,8.58%,SLC28A2;SLC22A8;SLC7A3;SLCO2B1;SLC5A1;ATP1A4;ABCG2
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.4582826339527642,1.2285019293106914,0.17857142857142858,0.8574805498823814,1.0,15/65,14.12%,NGF;EGLN3;CFLAR;HIP1;PPARG;SNCA;ACER2;EIF2AK3;SENP1;ANP32B;F2R;FADD;CRADD;CASP8AP2;BID
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),-0.7543409547424158,-1.2283922073050442,0.22580645161290322,1.0,1.0,1/7,2.76%,CAV3
prerank,GO_Biological_Process_2021__glucocorticoid metabolic process (GO:0008211),-0.7460225380207534,-1.2281210595513454,0.23636363636363636,1.0,1.0,5/7,22.45%,CYP21A2;HSD11B1;HSD3B1;CYP17A1;HSD11B2
prerank,GO_Biological_Process_2021__positive regulation of muscle contraction (GO:0045933),0.7025765114616821,1.2279456409280316,0.2391304347826087,0.858333203002095,1.0,5/6,29.33%,NMU;F2R;ENO1;SRF;MYOCD
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.4464043503874658,1.2277872995440273,0.08695652173913043,0.858099598407978,1.0,15/79,9.01%,RSPO3;FIBIN;TPM2;ADAMTS1;LAMA4;VEGFC;LOXL1;MRGPRF;TWIST2;ITGA8;COL12A1;MMP2;CNN1;EDNRA;SNAI2
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.6021777492849326,1.2270521611533398,0.22857142857142856,0.8598743674766781,1.0,6/18,20.11%,MSTO1;TRAK2;MARK1;BRAT1;MARK2;MTM1
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),-0.641460149698714,-1.227036085963071,0.17391304347826086,1.0,1.0,3/13,12.70%,CEP55;CHMP3;MITD1
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),0.6916665904867204,1.2270226976779228,0.2702702702702703,0.8589316644158774,1.0,4/8,25.48%,NEUROD2;NRXN1;ADGRL1;ANAPC2
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),0.7041726341369587,1.2268585936882312,0.15789473684210525,0.8584037013359335,1.0,1/8,1.01%,MEGF10
prerank,GO_Biological_Process_2021__intermediate filament bundle assembly (GO:0045110),-0.8069953994140877,-1.2267319322759542,0.21428571428571427,1.0,1.0,1/5,1.00%,PKP2
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),0.5331600852436307,1.2265638948775535,0.19444444444444445,0.8582300405413444,1.0,6/42,14.06%,RNASET2;HTRA2;NEU4;NGLY1;FBXO27;PNPT1
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.4844820938885227,1.2264235605518035,0.2647058823529412,0.8576651933450647,1.0,18/49,18.39%,EYA4;FGF10;BRCC3;SPRED3;SIRT1;ERCC8;RNF168;MYC;SPRED2;SPRED1;ANKLE1;H2AX;SMCHD1;WRAP53;EYA3;ATM;FBH1;ATR
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),0.8045693321880352,1.2261388627988268,0.22950819672131148,0.8576102779400713,1.0,1/5,9.27%,GCC2
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.5917084730919111,1.2260933871649042,0.1875,0.8566961327145943,1.0,1/10,6.32%,STAT5B
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.7738820907434025,-1.2259636245638341,0.30357142857142855,1.0,1.0,2/5,13.34%,PINK1;ATP5IF1
prerank,GO_Biological_Process_2021__hydrogen sulfide metabolic process (GO:0070813),-0.8679345828176318,-1.2259625943428447,0.09803921568627451,1.0,1.0,1/5,0.11%,SQOR
prerank,GO_Biological_Process_2021__endothelial cell morphogenesis (GO:0001886),0.740202275673862,1.225866591210406,0.2564102564102564,0.8565255755528214,1.0,1/5,0.09%,COL22A1
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.6245431005171058,1.225814277636427,0.21875,0.8557125929107783,1.0,5/12,21.29%,SCRIB;RAP2A;FSCN1;MYO9A;CAMSAP3
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.5671807388772421,1.2246047824323734,0.09090909090909091,0.8596099783312678,1.0,8/33,18.08%,HSPB1;MGARP;SPAST;TRAK2;RAB27B;AP3B2;DLG2;KIF3B
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),0.4955367056309445,1.2243998191612993,0.125,0.8593780376692051,1.0,9/35,18.48%,CPNE7;NUS1;FADS1;CRLS1;CPNE6;AGPAT5;SAMD8;HDHD5;CPNE1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.6976944713250148,-1.2243520768382807,0.15873015873015872,1.0,1.0,1/10,3.70%,CYP1B1
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.5776259719551935,1.224265065695673,0.2619047619047619,0.8588556083867754,1.0,2/16,7.26%,MAFB;CDK6
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),0.5329278576749483,1.224230667298169,0.20588235294117646,0.8578500017127528,1.0,7/18,17.08%,SYT3;SYT17;SYT1;RIMS2;CPNE6;SMURF1;CPNE9
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),0.6632878098875739,1.2240399000349473,0.2631578947368421,0.8576792772099191,1.0,5/10,20.42%,SMARCB1;PIH1D1;SMARCA4;MARS1;IPPK
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),-0.7840244786161283,-1.2239222029350634,0.2459016393442623,1.0,1.0,1/6,10.40%,CD63
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),-0.7840244786161283,-1.2239222029350634,0.2459016393442623,1.0,1.0,1/6,10.40%,CD63
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),0.6347672792848593,1.2237934963966357,0.1794871794871795,0.8572770165055871,1.0,8/14,28.94%,PPARG;MLXIPL;NR1H3;NR4A3;ELOVL5;SLC45A3;MLYCD;MID1IP1
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),0.6140420361218738,1.2237848252269827,0.20512820512820512,0.8562000607323891,1.0,4/12,9.91%,LIPC;PLIN5;SNCA;LPL
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.5077493992156793,-1.2235445738075021,0.1323529411764706,1.0,1.0,16/76,18.41%,DISC1;LRPAP1;TMC8;SP100;DAB2;ZFPM1;CTSZ;CDKN1A;IFIT1;ARHGAP28;MITD1;LEF1;EFHB;PLN;IFIT2;HMGA2
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),0.6246685422621379,1.2232536861875314,0.25,0.8569190575581145,1.0,1/12,3.16%,ZBTB7B
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.5615360698439574,1.2230936159478971,0.15384615384615385,0.8565193057846052,1.0,9/31,14.40%,SCRIB;SNCA;NMU;GRIK2;SYT1;RIMS2;CLSTN2;WLS;PTPN23
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.5619762046476859,1.2230437740924327,0.20588235294117646,0.8555820592994235,1.0,9/23,26.08%,AUP1;NGLY1;POMT2;RNF185;ZER1;BAG6;LONP1;FBXL17;ZYG11B
prerank,GO_Biological_Process_2021__cellular response to magnesium ion (GO:0071286),-0.7823864020583267,-1.2229528286700035,0.25925925925925924,1.0,1.0,1/5,5.36%,SLFN14
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),-0.5836728838161961,-1.222838276949607,0.13043478260869565,1.0,1.0,5/28,14.98%,CCDC39;ODAD1;DRC1;DNAH17;DNAI1
prerank,PanglaoDB_Augmented_2021__Osteoclasts,-0.5007986257930807,-1.2227734374311314,0.0975609756097561,1.0,1.0,33/105,18.10%,CLEC5A;C1QB;HCK;MMP9;SLC7A7;MMP19;TGFBI;ESR1;C3AR1;DAB2;MS4A4A;FCGR3A;LTB4R;OSCAR;VSIG4;PSAP;P2RY6;VWF;CTSZ;ENG;TLR2;FPR3;F13A1;VDR;ITPR3;HK3;ITGB5;THRA;CASR;TNFRSF11A;COL8A2;SERPINF1;ANPEP
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),0.6572596475967869,1.2223954923727955,0.3023255813953488,0.8567216773108713,1.0,2/10,6.06%,PCM1;CCDC120
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.46015578872391116,1.2223658852266859,0.16666666666666666,0.855729004289286,1.0,8/41,8.69%,FGFR1;HSPB1;ANGPT1;SIRT1;HMGB1;SP1;FGF18;NUS1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.629215276280968,-1.2222606607195534,0.31343283582089554,1.0,1.0,4/22,5.16%,DTL;CCND1;CDC25A;RAB11A
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),0.7190566176317167,1.2218517475363504,0.1951219512195122,0.8565589930991514,1.0,2/7,11.98%,GALE;GALT
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),0.6981346495942123,1.221567230772975,0.2857142857142857,0.8564875278339124,1.0,2/6,18.05%,GBF1;MIA3
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.681520401007411,1.2213711669006881,0.24489795918367346,0.8561104692784155,1.0,4/9,22.88%,RALB;PIP4K2A;LRSAM1;ELAPOR1
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),-0.7058012908424984,-1.2209589205689149,0.28125,1.0,1.0,2/9,1.83%,F8;F7
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),-0.6356845430708248,-1.220854254863101,0.22413793103448276,1.0,1.0,5/18,21.57%,DAB2;CHMP3;MSN;DENND10;MAP2K1
prerank,GO_Biological_Process_2021__tyrosine phosphorylation of STAT protein (GO:0007260),0.7366859240451546,1.2207426403310493,0.2857142857142857,0.8574712563446539,1.0,1/6,7.46%,FER
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),0.5001739144529163,1.2207225764453746,0.03225806451612903,0.8564839037600308,1.0,15/47,18.22%,NGF;SYT3;SYT17;GOLGA4;PLCB1;SYT1;PPIB;RIMS2;MACF1;MAP3K13;CPNE6;SMURF1;INSR;CPNE9;LIMK1
prerank,GO_Biological_Process_2021__pyridine-containing compound metabolic process (GO:0072524),-0.7597098497286696,-1.220153533449972,0.24561403508771928,1.0,1.0,2/5,12.80%,AOX1;HAAO
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.6047057714879646,1.2199685200443044,0.13333333333333333,0.8581834825349065,1.0,2/16,9.53%,CPSF1;ERN1
prerank,GO_Biological_Process_2021__regulation of adherens junction organization (GO:1903391),0.7272515199634042,1.2199535458923667,0.2564102564102564,0.8571406761384257,1.0,2/5,19.27%,PTPN23;ADD1
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.505504877164042,-1.219334022988306,0.16176470588235295,1.0,1.0,7/77,8.58%,SLC28A2;SLC22A8;SLC7A3;SLCO2B1;SLC5A1;ATP1A4;ABCG2
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",-0.7856196809327765,-1.2192777152091672,0.21818181818181817,1.0,1.0,3/6,15.84%,COL5A1;ITGA5;PLET1
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),0.781003314063828,1.2192194542913612,0.18867924528301888,0.858002783354757,1.0,1/5,2.21%,PAPSS2
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),0.781003314063828,1.2192194542913612,0.18867924528301888,0.858002783354757,1.0,1/5,2.21%,PAPSS2
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.662317784738616,1.219190652398038,0.1388888888888889,0.8570209580422959,1.0,4/13,19.29%,NAA40;AANAT;EP300;KAT2B
prerank,PanglaoDB_Augmented_2021__Adipocytes,-0.46339913473293504,-1.2188262741558806,0.0759493670886076,1.0,1.0,33/150,14.86%,OLFML1;TBX1;C1QTNF1;TRIP10;LMOD1;TIMP3;ECM2;ANGPTL2;CYP1B1;ACOX2;PLAC9;COL1A1;LOX;PTGES;DAB2;ADAM33;NQO1;DCN;CAVIN1;ASPN;CFD;METRN;AOX1;UCP1;STEAP4;TLR2;HSD11B1;GPX3;COX7A1;APOL6;C1S;ACTA2;ADGRF5
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),0.6424929449524462,1.2185903829278495,0.2631578947368421,0.8584821832200134,1.0,2/9,14.53%,ZSWIM5;YTHDF1
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),-0.7126514602609115,-1.2185684352515962,0.2413793103448276,1.0,1.0,2/11,2.65%,RIN3;LRPAP1
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.46316694642762585,-1.2185285600387414,0.09302325581395349,1.0,1.0,25/190,9.52%,CD44;C1QTNF1;LMOD1;TIMP3;ANGPTL2;HCK;INMT;HHIP;CYP1B1;PLAC9;TNFRSF1B;COL1A1;CTHRC1;COL5A1;LOX;VTN;DAB2;ADAM33;DCN;ASPN;COL4A4;TNXB;PTX3;COL4A3;ITGBL1
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),0.643236707960513,1.218086953203749,0.2564102564102564,0.8593539864851409,1.0,2/9,5.35%,PER2;CRY1
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),-0.7379613663490281,-1.2178607473301026,0.2,1.0,1.0,4/9,13.30%,P2RY12;SFTPD;TAFA4;EDNRB
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),0.5453474105453402,1.2178007500093448,0.12121212121212122,0.859506474153536,1.0,2/28,3.99%,ADRA1A;SLC8A1
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),-0.5847185150448732,-1.2175178075159838,0.21621621621621623,1.0,1.0,7/28,19.47%,CCDC39;MMP21;TBX6;ENG;GATA4;MESP1;DAND5
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),0.5649807705335677,1.217240811432995,0.16129032258064516,0.860883729794296,1.0,7/28,9.62%,APOE;MFSD2A;STAT5B;ABL1;LATS1;PLCB1;FGFR3
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.6926353314141058,1.2169869261074964,0.23076923076923078,0.8606950808639262,1.0,3/8,20.51%,CARD9;TICAM1;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),0.645399111196589,1.216842409325687,0.2558139534883721,0.8600744673693899,1.0,4/16,16.39%,CEP135;CEP120;WRAP53;CORO2B
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.5983279695538786,1.2168049148088202,0.21212121212121213,0.8590986135658497,1.0,3/13,12.41%,RAP2A;TNIK;RAP1A
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),-0.7957289884050314,-1.2166443005187435,0.25,1.0,1.0,3/7,13.34%,PINK1;DNAJA1;ATP5IF1
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),0.6641623178451963,1.2164735088434062,0.28888888888888886,0.8596068122528848,1.0,2/9,12.94%,TNFSF14;FADD
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),0.5391936340280519,1.2164244068827874,0.09523809523809523,0.858671423171991,1.0,5/31,10.90%,ABL1;MAPK8;ABL2;PHACTR4;B3GAT3
prerank,GO_Biological_Process_2021__mitochondrial respirasome assembly (GO:0097250),-0.752518377375134,-1.2163120329801598,0.2542372881355932,1.0,1.0,3/6,16.73%,HIGD1C;COX7A1;COX7A2
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.6117743221696927,1.216055021567391,0.21621621621621623,0.8589169754735427,1.0,6/15,20.98%,RGS14;NXT1;ANP32A;AAAS;NUTF2;XPO1
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),0.5743153851657966,1.2159067078138954,0.23333333333333334,0.8584145139394653,1.0,8/25,29.79%,NAV3;CAMSAP3;ATXN7;CIB1;MID1IP1;APC2;FGF13;CLASP2
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.4948526301265143,1.2158010083964255,0.13793103448275862,0.8577639981509394,1.0,13/44,21.08%,GMNC;SLFN11;RBBP6;CTC1;TERF1;CCDC88A;ESCO1;DSCC1;RAD17;FAF1;ATR;DNA2;ESCO2
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),-0.49240036774768964,-1.2157364308290042,0.18421052631578946,1.0,1.0,20/90,14.90%,AQP3;MICB;TGFB1;WNT8B;CYP24A1;MAPKAPK3;ESR1;SELP;ANXA1;SMAD6;SLC11A1;WNT8A;CDKN2D;GPX3;PALM3;RXRG;NOS2;IL12A;GGT5;FGFR4
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),-0.6539437259321746,-1.2157062883741285,0.2777777777777778,1.0,1.0,3/9,25.54%,VDAC1;CAMKK2;PARK7
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.5975154876361222,1.2155345533654192,0.21621621621621623,0.8575810639404293,1.0,6/18,20.63%,CPEB1;CPSF7;HSF1;ZC3H14;RNF40;CPSF6
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.4932683071577643,-1.215453468100803,0.15789473684210525,1.0,1.0,4/137,2.54%,CD44;TBX1;TGFB1;WNT5A
prerank,GO_Biological_Process_2021__cellular response to vitamin D (GO:0071305),-0.7611994295740292,-1.215294908740448,0.2608695652173913,1.0,1.0,2/5,14.65%,CYP24A1;VDR
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.43360078276367997,1.215255899223909,0.14814814814814814,0.8574916610218354,1.0,18/85,10.72%,ADGRF4;EMP1;MXRA5;LAMA3;SDC4;PARVA;PERP;CA3;COL12A1;ERBB2;NTN4;CNN1;DSP;SNAI2;ITGA3;FHL2;RND3;COL16A1
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.6171865041365997,-1.2150988804522993,0.23529411764705882,1.0,1.0,5/20,18.80%,NFAM1;PTPRC;PRKCH;TESPA1;CD81
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),-0.6773888545146878,-1.2149150275570992,0.2835820895522388,1.0,1.0,3/11,21.57%,CHMP3;DENND10;MAP2K1
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),-0.569328342177854,-1.214867382155044,0.25396825396825395,1.0,1.0,5/36,8.12%,PKP2;SCN5A;KCNA5;CTNNA3;KCNQ1
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),0.6879915525942658,1.2147353168517503,0.2727272727272727,0.858071830114281,1.0,3/7,22.65%,MTR;MTHFR;SMS
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.6681864938075366,1.2144858622580452,0.2571428571428571,0.8581491756045988,1.0,4/11,27.48%,APOE;ABCA7;ABCA2;ROCK1
prerank,PanglaoDB_Augmented_2021__Mller Cells,-0.49480092971130557,-1.214452939358468,0.14666666666666667,1.0,1.0,11/134,5.75%,CD44;SFTPA1;TRIL;LMOD1;TIMP3;ANGPTL2;TSPAN11;SPC25;COL1A1;COL5A1;FBXL7
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),-0.4868208260269484,-1.2143325837782901,0.14864864864864866,1.0,1.0,10/77,8.58%,SLC22A25;SLC22A24;MGST1;ABCC6;SLC22A6;SLCO2B1;CA14;SLCO2A1;CA1;ABCG2
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.4964908437853695,-1.2138995980643636,0.1791044776119403,1.0,1.0,24/81,19.93%,AQP3;TMEM184A;MISP;WNT5A;CLDN1;TMC4;ESR1;EPN3;SERPINB5;ANXA1;MYO5B;LAMC2;SOWAHB;ITGB6;TRIM29;FGFR4;SCNN1A;ANKRD30A;ANPEP;CAPN13;SLC44A3;FAM3D;HMGA1;CBLC
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),-0.7945404782059877,-1.2137288490006144,0.14754098360655737,1.0,1.0,3/6,17.52%,TGFB1;TGFB3;MSN
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.6072093630504389,-1.21371788509467,0.2465753424657534,1.0,1.0,12/23,33.37%,COPS5;RBX1;COPS4;RPS27A;DDB1;COPS7A;UBB;COPS7B;CETN2;UBC;GPS1;RAD23B
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.4042662636330736,1.2136553425256553,0.14285714285714285,0.8599883361884786,1.0,26/116,15.95%,SLC17A6;BCHE;POU3F1;PCDH17;PLPPR1;KCNB2;RESP18;UNC5D;PROX1;ETV1;KCNIP1;ADGRA1;LEPR;ABCC8;LCORL;RGS7BP;ELAVL4;RAB3C;SNAP91;MAP6;ASXL3;PTPRT;RFX6;CFC1;NRXN1;PTPRD
prerank,GO_Biological_Process_2021__deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),0.7652793400818264,1.2136456771696342,0.2571428571428571,0.8589331357759774,1.0,1/5,3.60%,DCP1B
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),-0.6790010563707947,-1.2135768379778975,0.18867924528301888,1.0,1.0,5/9,30.12%,HTR2B;ADGRG1;FLOT1;AZU1;MAS1
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),0.7395512749455516,1.2132388801235843,0.2702702702702703,0.8595642002783126,1.0,4/9,18.93%,APOB;PPARG;MIA3;UNC119B
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),0.7566473736815764,1.2131661142326255,0.2857142857142857,0.8587338539161306,1.0,3/6,11.22%,SLC3A2;SLC6A17;SLC7A8
prerank,GO_Biological_Process_2021__lipoxin biosynthetic process (GO:2001301),-0.7580651266757419,-1.2128251138894812,0.30357142857142855,1.0,1.0,5/7,17.79%,ALOX12;ALOX5;ALOX15;ALOX15B;ALOX5AP
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),0.5684314726447696,1.2125933731080327,0.21052631578947367,0.8595850998062785,1.0,6/18,23.37%,CHAC1;PLSCR1;FPGS;GAMT;PTDSS2;PLOD2
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),0.4725857579974146,1.212344784013677,0.1111111111111111,0.8594019522944732,1.0,8/54,7.63%,CYP7B1;CYP4V2;TSKU;APOB;APOE;SOAT1;SOAT2;ABCA1
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),0.6456657319296747,1.2119803373436375,0.25,0.8585220958005352,1.0,1/15,3.84%,JADE3
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),0.6456657319296747,1.2119803373436375,0.25,0.8585220958005352,1.0,1/15,3.84%,JADE3
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),0.6606336099715796,1.2119687012701772,0.20588235294117646,0.8574960319392994,1.0,4/8,22.90%,WNK2;WNK3;DLG1;WNK1
prerank,GO_Biological_Process_2021__chylomicron remodeling (GO:0034371),0.7120391036300519,1.211877147576241,0.30612244897959184,0.8567843196690975,1.0,3/5,9.91%,APOB;APOE;LPL
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),0.6981225766907571,1.2117157658414084,0.20833333333333334,0.8566423271590222,1.0,4/8,9.73%,CYP1A2;EPHX2;STS;ALLC
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),-0.7058881360513489,-1.21132087693996,0.21153846153846154,1.0,1.0,3/7,26.31%,TRMT10A;TRNT1;TRMT10B
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell cytokine production (GO:0002729),-0.7768886990698397,-1.2110763243844602,0.21666666666666667,1.0,1.0,2/5,15.53%,CD160;HLA-F
prerank,GO_Biological_Process_2021__regulation of natural killer cell cytokine production (GO:0002727),-0.7768886990698397,-1.2110763243844602,0.21666666666666667,1.0,1.0,2/5,15.53%,CD160;HLA-F
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.6113578614643191,1.2110315823810616,0.24390243902439024,0.8583855915908588,1.0,9/14,33.25%,PPARG;ABCA1;NR1H3;OSBPL8;ABCG1;ITGAV;PTPN2;NR1H2;ABHD5
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),0.741187542016476,1.2109867433652959,0.2972972972972973,0.8576571093149604,1.0,2/8,6.37%,CX3CR1;TMEM106A
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),0.661368198460475,1.2106509913774557,0.3333333333333333,0.8578614379938965,1.0,3/12,12.54%,ACO1;GLUD1;IDH2
prerank,GO_Biological_Process_2021__regulation of chloride transport (GO:2001225),0.7973509178154713,1.2100207184665999,0.3111111111111111,0.8590134316965076,1.0,1/5,0.42%,GABRE
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),-0.7864372702457421,-1.2099992281922411,0.2653061224489796,1.0,1.0,1/6,1.82%,TRIM62
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),0.7534462538787359,1.209984932521178,0.36585365853658536,0.8581047100817377,1.0,4/6,24.65%,SLC16A10;SLC7A8;SLC16A2;SLC7A5
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),0.5868385714679245,1.2098900306173819,0.23076923076923078,0.8573800769752522,1.0,5/22,11.02%,SPRED3;IL17RD;SPRED2;ADIPOR1;SPRED1
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.42200778161386526,1.2097214567769368,0.08,0.8572748996204039,1.0,32/115,16.89%,FIBIN;VCAN;MEGF10;EDIL3;ADGRL2;CCN2;LHX2;VAT1L;LRFN5;SLIT2;EDNRA;EFS;DOK5;SYNDIG1;GUCY1A2;PDZRN3;WASF3;BRINP1;RGS7BP;STOX2;MPDZ;PAMR1;SCN7A;MAP6;ASXL3;ANK2;PRICKLE2;CDH11;PTPRD;MAGEL2;MARK1;PBX1
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),0.716688860001724,1.209654454019483,0.20512820512820512,0.8565530057887674,1.0,4/8,24.65%,SLC16A10;SLC7A8;SLC16A2;SLC7A5
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),-0.6858440170487632,-1.2095791458835263,0.24615384615384617,1.0,1.0,2/11,6.40%,CASQ2;TRDN
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.5417558960895335,1.2093930055216038,0.09375,0.8563584519832264,1.0,11/26,11.08%,VCAN;CSGALNACT1;CHSY3;CHSY1;CHST12;CHPF2;CHST11;CSPG5;B3GAT3;CHST3;UGDH
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),0.6564535973806338,1.2093544104456555,0.2619047619047619,0.8555126696890573,1.0,4/10,15.36%,ALDH1A1;ACSS2;ADH4;SULT2A1
prerank,GO_Biological_Process_2021__negative regulation of B cell proliferation (GO:0030889),-0.7304183017962077,-1.209263081349669,0.2727272727272727,1.0,1.0,1/6,2.65%,BLK
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.4852660890212057,1.2087995466405614,0.13043478260869565,0.8567120617365552,1.0,11/44,8.69%,FGFR1;HSPB1;APOE;ANGPT1;PPARG;SIRT1;HMGB1;VASH1;SP1;FGF18;NUS1
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),0.6322455905384591,1.2084730657116782,0.3076923076923077,0.8569694991416418,1.0,6/10,29.74%,IMPACT;SESN2;RRAGD;GCN1;SESN3;EIF2AK4
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.6202837750779794,1.2084667094284367,0.2222222222222222,0.8559997539880603,1.0,2/7,27.93%,PXN;STAT3
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),0.6435083219497768,1.2080677829857582,0.2826086956521739,0.8566357678514949,1.0,5/10,14.36%,TSKU;IFT88;WHRN;ADGRV1;PDZD7
prerank,GO_Biological_Process_2021__pteridine-containing compound biosynthetic process (GO:0042559),0.7026591342026071,1.207941817259788,0.1951219512195122,0.8562445643919129,1.0,2/6,18.58%,DHFR;FPGS
prerank,GO_Biological_Process_2021__regulation of response to reactive oxygen species (GO:1901031),0.686022632366804,1.2077178206463839,0.2727272727272727,0.8558542923691391,1.0,1/6,6.34%,DHFR
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.6933684606016701,1.2076026222789844,0.3111111111111111,0.8551777170338941,1.0,4/9,20.19%,COMMD1;OSR1;NEDD4;PRKCE
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.7466817267041899,1.2075922374140409,0.26666666666666666,0.8541979278256938,1.0,3/5,21.97%,PXN;NCK1;NCK2
prerank,GO_Biological_Process_2021__prepulse inhibition (GO:0060134),0.7829728578925799,1.2075710173514151,0.2619047619047619,0.8532562818940602,1.0,1/6,1.38%,GRID2
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.6990449690088303,1.2075413214636226,0.3333333333333333,0.8523705318124943,1.0,7/8,30.00%,MALT1;RC3H1;SMAD7;NFKBID;RC3H2;NFKBIZ;FOXP3
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.5330010393855676,1.20745760007901,0.16666666666666666,0.851719148978743,1.0,5/45,7.30%,CSTA;TBC1D10A;PERP;SPOPL;F2
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),-0.7390424601346406,-1.2073459923033532,0.30357142857142855,1.0,1.0,3/7,14.24%,CAV3;CSRP3;TTN
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),0.622078846336168,1.2069347935261572,0.2,0.852604050454715,1.0,1/11,0.80%,SMYD2
prerank,GO_Biological_Process_2021__icosanoid secretion (GO:0032309),-0.6576390278445577,-1.2067757671532984,0.20634920634920634,1.0,1.0,3/11,14.17%,NMUR2;ANXA1;NOS2
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),-0.7660496401634173,-1.2067155680598258,0.25,1.0,1.0,3/7,18.80%,NFAM1;PRKCH;CD81
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),-0.7485145584035942,-1.2065235209739686,0.2641509433962264,1.0,1.0,2/5,16.69%,YAP1;WBP2
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),0.701809686221625,1.206463614401934,0.2564102564102564,0.8530412425451288,1.0,4/7,21.12%,SLC7A8;SLC4A11;CNNM4;TRPM7
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.7243150484646514,-1.2062480976871421,0.22580645161290322,1.0,1.0,1/10,1.49%,TGFB1
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),0.6278105189553069,1.2062381834228193,0.20930232558139536,0.8528898789212577,1.0,3/11,7.55%,GREM2;GREM1;LTBP1
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),0.5334384171894296,1.2062184495717758,0.18181818181818182,0.8519564284248352,1.0,3/20,6.20%,GCK;G6PC3;H6PD
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),0.5868472790137639,1.206103176628607,0.21875,0.8513448882043612,1.0,8/17,29.51%,APOE;SEC14L2;SREBF2;ABCA2;LPCAT3;ERLIN1;ABCG1;PRKAA1
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.6601932894348429,1.2059160440330412,0.17073170731707318,0.8510896054665353,1.0,6/12,20.19%,IRS1;PPARG;AKT2;IRS2;GPLD1;PRKCE
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),-0.6406790224339316,-1.205711757999552,0.2033898305084746,1.0,1.0,10/19,31.52%,THBS1;MTUS1;CSF1R;MST1;CXCL17;CCL5;PTK2B;CSF1;MAPK3;C5
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),0.6254355276493943,1.2056066038998188,0.20930232558139536,0.8512956469234936,1.0,5/14,22.37%,SHLD2;SHLD1;KMT5C;KMT5B;SLC15A4
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),0.6548322675738489,1.2054647220309191,0.28205128205128205,0.8510233210495504,1.0,2/7,3.72%,CFLAR;EYS
prerank,GO_Biological_Process_2021__progesterone metabolic process (GO:0042448),0.6879387845775691,1.2053271319630703,0.29545454545454547,0.8505571673433319,1.0,2/5,7.00%,AKR1C3;AKR1C1
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),-0.6972976775236339,-1.2052186918559333,0.24489795918367346,1.0,1.0,2/12,2.76%,CASQ2;CAV3
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.6792195704522692,-1.2049361277033777,0.24615384615384617,1.0,1.0,2/12,2.44%,PRAME;CYP26B1
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),0.5566419487277513,1.2048722763549307,0.2571428571428571,0.8513281650265132,1.0,12/32,24.56%,APOE;LRRTM3;BIN1;SP1;CASP3;RTN2;ABCA7;GSAP;NTRK2;RTN1;ABCA2;SLC2A13
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),0.646595424024887,1.2048431237309005,0.25,0.8504570844751416,1.0,2/8,4.97%,NFATC3;DNMT1
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.4277689658554099,-1.204693900994975,0.12195121951219512,1.0,1.0,41/306,15.80%,CD44;ENPP2;TBX1;FGF20;TGFB1;NODAL;MMP9;SPDYA;TERF2IP;CCND1;CARD14;TEC;GPER1;PINK1;VTN;DAB2;TTK;FLT4;CDK2AP1;PIK3R3;MTCP1;CCND2;HLA-DRB1;PTPRC;GDF11;ENG;BMP3;CDKN1A;FAXDC2;ATG14;TEK;RSPO1;ITGA5;TGFB3;CD80;TOM1L1;DDX3X;FGF22;PROM2;CD4;AGT
prerank,GO_Biological_Process_2021__positive regulation of cholesterol storage (GO:0010886),0.7322869323194596,1.204602142201966,0.325,0.8502398585679873,1.0,4/6,22.82%,APOB;LPL;SREBF2;SCARB1
prerank,MSigDB_Hallmark_2020__Spermatogenesis,-0.4877563578923671,-1.204275826411792,0.13095238095238096,1.0,1.0,16/107,12.08%,NEK2;BUB1;HSPA1L;GAD1;SYCP1;MEP1B;ZC2HC1C;TTK;ALOX15;TNP1;GAPDHS;ART3;GSG1;PEBP1;ARL4A;TULP2
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),-0.567384447911579,-1.2041912853137404,0.19117647058823528,1.0,1.0,4/22,19.39%,AKR1B15;CYP21A2;HSD3B1;CYP17A1
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),-0.6340629963552473,-1.2040864671194267,0.21212121212121213,1.0,1.0,2/23,1.49%,NOTUM;TGFB1
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),-0.5665899059267581,-1.203863599338661,0.2647058823529412,1.0,1.0,3/30,8.12%,PKP2;SCN5A;KCNQ1
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),-0.5933947814779327,-1.2034690557982284,0.19696969696969696,1.0,1.0,4/29,4.08%,PKP2;TGFB1;MYH7;MYBPC3
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.46564238278035514,1.2032739168222752,0.14814814814814814,0.8541934556139007,1.0,17/51,18.20%,ROBO2;DSCAML1;CDH13;BSG;SDK1;CADM1;DSCAM;TENM3;PTPRM;CDH2;NECTIN3;PTPRT;EMB;CNTN6;AMIGO2;CDH4;KIRREL3
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),0.712589929926736,1.203032687894932,0.37254901960784315,0.8540602647358483,1.0,2/6,22.04%,NLGN4X;PTEN
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.5230859625747575,1.202952925648281,0.1875,0.853418278424868,1.0,4/25,5.56%,ATP6V0D2;TCIRG1;RAB20;RAB7A
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.5693932017600397,1.2027032148090226,0.1891891891891892,0.8532336923706847,1.0,4/24,7.57%,MSH4;POLD3;PMS1;ABL1
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),-0.739757085955989,-1.2025626238305847,0.28846153846153844,1.0,1.0,3/7,19.63%,SOX10;PLP1;MYRF
prerank,GO_Biological_Process_2021__regulation of T-helper 1 cell differentiation (GO:0045625),-0.7765727629192725,-1.2019641975504254,0.2631578947368421,1.0,1.0,3/5,14.67%,ANXA1;IL27;CD80
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),0.6207076911889189,1.201708597689787,0.2631578947368421,0.853661046172336,1.0,4/10,20.40%,SMARCAL1;TERF1;EXO1;DNA2
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),0.6207076911889189,1.201708597689787,0.2631578947368421,0.853661046172336,1.0,4/10,20.40%,SMARCAL1;TERF1;EXO1;DNA2
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),0.6207076911889189,1.201708597689787,0.2631578947368421,0.853661046172336,1.0,4/10,20.40%,SMARCAL1;TERF1;EXO1;DNA2
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),-0.5840511550313998,-1.201116156312619,0.15384615384615385,1.0,1.0,3/22,12.51%,SP100;USP17L2;APOD
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.6403096770063514,-1.201115193564632,0.24193548387096775,1.0,1.0,5/16,15.80%,AQP3;ANXA1;GPR151;PIK3CB;ZP3
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),0.5207410044176536,1.200891975644841,0.21212121212121213,0.8549606124129077,1.0,1/23,0.09%,COL22A1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.44562394891120544,1.2008068108470542,0.06896551724137931,0.8541825646184072,1.0,17/64,21.10%,TBC1D10A;MYO10;IFT88;TBC1D16;TRPM2;FER;SDCCAG8;TBC1D22B;FSCN1;IFT140;RAB5A;TBC1D2;DCDC2;TBC1D8;USP6NL;FXR2;TBC1D5
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.5667187558082372,1.2006636087838318,0.20588235294117646,0.8538416519360232,1.0,5/12,19.70%,SEMA5A;EPHA3;ARHGAP35;EPHB2;NRCAM
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.43653280096292657,1.2006129231376963,0.17857142857142858,0.85306668600335,1.0,30/100,19.93%,GRID2;PCDH17;ROBO2;NOVA1;UNC5D;ELAVL3;MAGI2;SLC35F1;KCNIP1;CPT1C;GUCY1A2;BRINP1;DENND2A;RAB3C;SNAP91;RBFOX1;ASXL3;ANK2;SRRM4;NRXN1;PTPRD;MAGEL2;EFR3B;LSAMP;FAT3;ST8SIA3;ADGRB3;CTNNA2;CNTN1;PAK3
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),0.7266535604324741,1.2005479144967666,0.18421052631578946,0.8524498654661277,1.0,3/8,24.06%,PID1;APPL2;ENPP1
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),0.6575641483087531,1.2005092420574082,0.3191489361702128,0.8516088665574506,1.0,2/11,8.28%,SPEF2;DYNC1I2
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.5963386871902381,-1.200391422723102,0.2542372881355932,1.0,1.0,7/29,17.21%,ESR1;TRIM25;ZNF366;BRCA1;GHRL;WBP2;CD24
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.6447117492294527,1.1997952097128675,0.23076923076923078,0.8535605150632662,1.0,7/9,34.02%,STX18;PGAP1;RNF139;GAS1;SCFD1;SORL1;TBC1D20
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),-0.7262542074190075,-1.1996448938333593,0.2037037037037037,1.0,1.0,1/5,5.61%,PINK1
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),0.5462441132938811,1.1995324514803394,0.17142857142857143,0.8534992907327185,1.0,7/22,19.85%,METTL8;PCIF1;TRMT61B;PUS7;ZC3H13;TRMT61A;METTL16
prerank,GO_Biological_Process_2021__negative regulation of anion transport (GO:1903792),0.7586262672401601,1.1992157303682351,0.28205128205128205,0.8535246763196784,1.0,3/5,9.91%,GABRE;HRH3;GRM7
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),0.5512312466409108,1.1990221948811013,0.21212121212121213,0.8531526985038231,1.0,11/31,23.02%,PLEKHG2;ABL1;LATS1;HCLS1;COTL1;TPPP3;FCHSD2;GBA2;PAK3;CAMSAP3;ARHGAP18
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),0.7071812516681164,1.1990041371389513,0.3111111111111111,0.8522294300547831,1.0,4/6,25.08%,KYAT1;ASRGL1;IL4I1;PAH
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),0.4755850507336927,1.1988645652011507,0.125,0.851652963631075,1.0,15/46,13.60%,GPC4;CYP4V2;APOB;APOE;SDC4;ALDH1A1;GPC6;AKR1C3;AKR1C1;GPC5;LPL;AWAT2;SDC3;ADH4;LRP8
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),-0.8001943334324921,-1.198798980908425,0.26229508196721313,1.0,1.0,1/5,2.75%,P2RY12
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),0.7068231286079303,1.1987817934016813,0.35,0.8509917365728451,1.0,5/5,29.33%,GREM1;NOTCH1;RBPJ;SRF;MYOCD
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.5429037103901334,1.1985773326549145,0.21951219512195122,0.8506931200992094,1.0,8/28,20.87%,KPTN;RAB7A;GCC2;ZFYVE16;RNF128;NEDD4;SZT2;LAPTM5
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.6894606009273448,1.1982204241040226,0.21052631578947367,0.8510822184236768,1.0,3/8,15.99%,WASF3;WASF2;FCHSD2
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.6392623503690985,1.198135787012845,0.1935483870967742,0.8504238941226991,1.0,3/11,11.98%,CSGALNACT1;GMDS;GALT
prerank,GO_Biological_Process_2021__glandular epithelial cell development (GO:0002068),0.7058791662684729,1.1979521470317218,0.2765957446808511,0.8502640341834425,1.0,4/7,21.65%,CDK6;CDH2;PAX6;BMP4
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),-0.7156197977638978,-1.1977479296406974,0.2711864406779661,1.0,1.0,2/9,6.32%,ENPP2;PLA2G10
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),0.7398825275018217,1.1977247428845628,0.34782608695652173,0.8500703018135163,1.0,3/5,20.09%,MOV10;AGO3;AGO2
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.48525178393283697,1.1976829061823318,0.17857142857142858,0.8492443794048001,1.0,10/41,19.92%,LAMA4;NOVA1;ALDH1A1;PLCL2;TFE3;NR1H3;NOTCH1;IP6K1;RBPJ;MAP2K6
prerank,GO_Biological_Process_2021__heart trabecula formation (GO:0060347),0.7283497439590987,1.1974194858583656,0.26666666666666666,0.849171789945022,1.0,1/5,0.91%,ADGRG6
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),-0.6326033527734394,-1.1968005943540505,0.19402985074626866,1.0,1.0,6/19,15.80%,IRF4;ZFPM1;HLA-DRB1;NLRP3;LEF1;ZP3
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),0.7171853413522291,1.196751567168387,0.2222222222222222,0.8505494166857108,1.0,3/6,24.96%,SLIT2;RNF113A;SLIT3
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),0.6326081529384985,1.1966572566836138,0.2222222222222222,0.8498620715538242,1.0,4/11,11.85%,MFSD2A;MOV10;NTNG2;MACF1
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),0.7901070782803337,1.1966115657341247,0.2391304347826087,0.849125213326864,1.0,2/5,8.66%,SLIT2;MYO9B
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.4769757195326419,-1.1963859394105112,0.18055555555555555,1.0,1.0,38/100,25.59%,HCK;WNT5A;P2RY12;PDE6B;ALOX5;IRF1;GRK7;TRIM5;PTGES;LRRC19;GP1BA;ALOX15;ANXA1;LACC1;PDE6A;GRN;F2RL1;SPATA2;CALM1;GUCY2F;ERAP1;NMT1;CASP8;ACE2;DHX58;PIK3AP1;SPAAR;BST1;PDE6G;SEMA7A;TMSB4X;CNGB1;IL1R1;TKFC;TNFSF4;USP18;PARK7;UFL1
prerank,GO_Biological_Process_2021__T cell chemotaxis (GO:0010818),-0.7612276154798724,-1.1962171158979942,0.2708333333333333,1.0,1.0,3/5,17.46%,GPR183;CXCL16;PIK3CG
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),0.7426081651108822,1.1961931067049543,0.2391304347826087,0.8496991535909294,1.0,2/5,13.81%,CDK6;NF1
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),0.6416518824876558,1.1961892752224308,0.2702702702702703,0.8487603441964117,1.0,3/11,10.37%,MGARP;SPAST;TRAK2
prerank,GO_Biological_Process_2021__estrogen biosynthetic process (GO:0006703),-0.7218721696577899,-1.1959530140750383,0.30357142857142855,1.0,1.0,2/7,17.21%,AKR1B15;HSD3B1
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),0.6387480855464014,1.1953378530403163,0.2682926829268293,0.8506396016876445,1.0,1/10,1.53%,KIT
prerank,GO_Biological_Process_2021__gastro-intestinal system smooth muscle contraction (GO:0014831),-0.7509890634005979,-1.1949612142235908,0.2727272727272727,1.0,1.0,2/5,13.45%,HTR2B;PTGER3
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),0.6017213524575398,1.1948550026407616,0.2571428571428571,0.8515149119005432,1.0,4/16,7.57%,PDGFD;RGS14;FER;ABL1
prerank,GO_Biological_Process_2021__lysosomal lumen acidification (GO:0007042),-0.7693549193018204,-1.1945247751824324,0.2857142857142857,1.0,1.0,3/6,15.82%,PPT1;ATP6AP2;GRN
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),0.6697703536683765,1.1942879239901258,0.21428571428571427,0.852320557283975,1.0,4/11,8.00%,KLRD1;BTN3A2;JAG1;CD8A
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),-0.6927107681000247,-1.1942860894029963,0.17647058823529413,1.0,1.0,3/9,16.13%,GPER1;SOD2;F2RL1
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),-0.6513349902910786,-1.1939740544425836,0.3064516129032258,1.0,1.0,5/14,26.11%,PTPRC;TERT;HMGA2;EPCAM;KDM1A
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.5095395726138424,1.1938639170160792,0.12903225806451613,0.8529384256111048,1.0,8/36,15.95%,CEL;NLGN1;UBXN2A;SPAST;NLGN4X;NLGN3;NRXN1;PTPRD
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),0.5703050554540346,1.1938389896642567,0.2,0.8520687942729751,1.0,4/17,18.68%,TERF1;ATM;SMG5;SMG6
prerank,GO_Biological_Process_2021__regulation of morphogenesis of an epithelium (GO:1905330),0.803666167970095,1.1933841031424433,0.29545454545454547,0.8524831372414245,1.0,2/5,12.85%,ADAMTS12;RNF207
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.5241497101532528,1.193342675493543,0.17647058823529413,0.8515991051769348,1.0,12/30,22.60%,CEL;NLGN1;SNCA;SYT1;WNT3A;NLGN4X;NLGN3;RAB5A;CDK5;PLD2;SNCB;SYT7
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),0.6506276007589199,1.1932563055641792,0.2222222222222222,0.8509358500225556,1.0,5/10,13.19%,CD151;LAMA3;PLEC;ITGB4;DST
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),-0.6434180254969047,-1.1932331515281784,0.23333333333333334,1.0,1.0,2/11,9.57%,ART1;ART3
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),-0.7175733336121697,-1.193136877460781,0.2807017543859649,1.0,1.0,2/7,12.09%,STAT1;IFIT1
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),0.6313433216844644,1.1930643882658551,0.2702702702702703,0.8506943839070676,1.0,4/9,30.66%,CBS;CTH;TST;MPST
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",-0.7779051413464506,-1.1928442154455838,0.16393442622950818,1.0,1.0,2/7,13.70%,P2RY12;NTN1
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),0.7574294259629731,1.192781578290784,0.22916666666666666,0.8507893304384361,1.0,1/5,7.32%,PLEKHM1
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),-0.4887703150595053,-1.1927020065738483,0.19736842105263158,1.0,1.0,8/89,8.63%,MCM2;POLQ;MEIOB;RPA3;MCM3;RAD51AP2;MCMDC2;BRCA1
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),0.6744382262320061,1.1926610150402495,0.3235294117647059,0.8502466116765613,1.0,5/9,27.45%,NEUROD2;NRXN1;ADGRL1;ANAPC2;YWHAZ
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),-0.6833490682682256,-1.1925715743407423,0.30612244897959184,1.0,1.0,1/7,2.54%,WNT5A
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),0.760802222502797,1.1923199939527822,0.2608695652173913,0.8507775132885603,1.0,3/6,17.09%,UNC13B;SNPH;UNC13C
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.6149104884186998,1.1923051478612452,0.23255813953488372,0.8498343009678414,1.0,11/14,35.19%,LIN28B;AGO3;TARBP2;AGO2;TUT7;ADAR;LIN28A;DROSHA;PRKRA;TUT4;DICER1
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),0.45160549878192374,1.1922887211769873,0.0967741935483871,0.8490102133843249,1.0,25/86,20.92%,CPEB1;SAMD4A;PCIF1;DHFR;TRIM71;RIDA;EIF2AK3;NANOS3;CNOT9;EIF3E;YTHDF1;PUS7;MALSU1;SYNCRIP;EIF4EBP1;LSM14A;SAMD4B;EIF4A3;METTL16;AGO2;NANOS1;RNF139;FXR2;RBM24;LARP1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.7166993450560559,-1.192196263955832,0.24561403508771928,1.0,1.0,2/8,13.78%,VTN;ITGA5
prerank,GO_Biological_Process_2021__negative regulation of hormone secretion (GO:0046888),0.7532512786326147,1.1919192864153396,0.3137254901960784,0.8495908235129722,1.0,3/6,17.52%,RAB11FIP3;RAB11FIP1;IL11
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),-0.7128509767190133,-1.1918650310114671,0.2916666666666667,1.0,1.0,2/8,8.82%,GPR183;C17ORF99
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),-0.6963803610442441,-1.1915303810831896,0.22807017543859648,1.0,1.0,2/8,7.50%,SEMA3F;SEMA3A
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),-0.6189229704981185,-1.191512696096305,0.20588235294117646,1.0,1.0,1/14,1.49%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.5731960251353461,1.1911776466223578,0.19230769230769232,0.8511877789382885,1.0,6/24,13.77%,CHAC1;WWP2;BEND6;DLK2;ARRB1;TCIM
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),-0.7938662800007822,-1.191053601292117,0.23728813559322035,1.0,1.0,2/5,20.44%,SOD2;PRDX1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),-0.720693114723864,-1.1906192644499245,0.2909090909090909,1.0,1.0,2/7,15.25%,DOCK8;JAM2
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.6074445465223411,1.1902006788106079,0.30434782608695654,0.8538643703573691,1.0,4/11,22.10%,ITPKB;IP6K1;IPPK;IP6K2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte migration (GO:0002686),0.6914000298469389,1.190139853138985,0.34782608695652173,0.8531892846456566,1.0,2/7,20.62%,SLIT2;EMILIN1
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),-0.7681243633025738,-1.1897463438962737,0.3148148148148148,1.0,1.0,1/6,0.65%,BHMT
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.5362670321915171,-1.189589736618974,0.22535211267605634,1.0,1.0,6/44,8.63%,DTL;PCLAF;RPA3;UBE2L6;TRIM25;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),0.6116400650627387,1.1895241091930369,0.2631578947368421,0.8530145053517441,1.0,8/12,35.24%,ESPL1;NSMCE2;ANAPC7;ANAPC4;RB1;DLGAP5;CDC16;ANAPC11
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.6116400650627387,1.1895241091930369,0.2631578947368421,0.8530145053517441,1.0,8/12,35.24%,ESPL1;NSMCE2;ANAPC7;ANAPC4;RB1;DLGAP5;CDC16;ANAPC11
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.6116400650627387,1.1895241091930369,0.2631578947368421,0.8530145053517441,1.0,8/12,35.24%,ESPL1;NSMCE2;ANAPC7;ANAPC4;RB1;DLGAP5;CDC16;ANAPC11
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),-0.6212840277858729,-1.1892111376676093,0.2571428571428571,1.0,1.0,3/16,16.36%,TBX1;MYO3B;USH1C
prerank,GO_Biological_Process_2021__peptidyl-glutamine methylation (GO:0018364),0.731294588757307,1.189210796037943,0.23255813953488372,0.8531222269896366,1.0,3/5,16.33%,SIRT7;FBLL1;FBL
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),0.7563204540016895,1.188882556876513,0.25,0.8532131580078576,1.0,3/6,17.99%,PIH1D1;NIPBL;MACROH2A2
prerank,GO_Biological_Process_2021__double-strand break repair via synthesis-dependent strand annealing (GO:0045003),-0.7335334503615989,-1.188820412124455,0.3090909090909091,1.0,1.0,1/5,18.73%,RAD54L
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.7290323413070517,-1.1883982192258318,0.2982456140350877,1.0,1.0,3/7,22.43%,HLA-A;HLA-F;HLA-C
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),0.6707397613122923,1.188221262797321,0.18421052631578946,0.854726007863233,1.0,3/10,9.62%,FGFR1;SNCA;FGFR3
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),0.5460318047290633,1.187938153872157,0.2702702702702703,0.854781948896072,1.0,6/14,27.56%,PANK1;PPCS;SLC25A16;ACOT7;PANK3;CROT
prerank,PanglaoDB_Augmented_2021__Platelets,-0.4790153316787351,-1.1878152773738166,0.13095238095238096,1.0,1.0,41/136,19.76%,MPL;GMFG;F7;ALOX12;ITGB2;HCK;P2RY12;TNFRSF1B;C3AR1;DAB2;FCGR3A;GP1BA;HLA-A;LY86;NFAM1;SELP;MYO1F;THBS1;FPR1;MFSD2B;VWF;ITGA2B;SPI1;CLEC12A;ITGAM;CDKN2D;F13A1;CD300LF;ADGRE3;F5;RTL8B;HK3;SMOX;TBXAS1;ALOX5AP;MYL9;CLEC1B;SASH3;P2RX1;ITGAX;TMEM71
prerank,GO_Biological_Process_2021__L-arginine import across plasma membrane (GO:0097638),-0.7375829286504421,-1.1876427625189652,0.21153846153846154,1.0,1.0,1/5,5.15%,SLC7A3
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.5155807014050493,1.1872198220624224,0.1111111111111111,0.8564217783408662,1.0,3/41,4.13%,GCK;NUP210;NUP42
prerank,GO_Biological_Process_2021__positive regulation of protein kinase A signaling (GO:0010739),0.729865475730167,1.1871725335892684,0.2564102564102564,0.8556021947543065,1.0,3/5,17.11%,ADGRV1;TCIM;IAPP
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),0.5105766253324897,1.1871652119653247,0.15625,0.8547350063275937,1.0,11/35,28.79%,TEFM;SLC25A33;LARS2;NOA1;MRPL2;QRSL1;MRPS7;TFB2M;FOXO3;MRPS16;MRPS18A
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.4047761566210991,1.1869571656081972,0.125,0.8543959852609261,1.0,24/73,16.07%,CDH20;CDH19;CDH12;CDH7;CDH5;CDH13;CSK;SDK1;CADM2;CADM1;CDH6;DSP;F2R;NLGN4X;LIMS1;CDH2;CDH24;NECTIN3;CDH10;PKP4;FSCN1;CDH11;PARD6B;CDHR3
prerank,GO_Biological_Process_2021__negative regulation of calcium ion import (GO:0090281),-0.7568750049420356,-1.1868536560890737,0.25,1.0,1.0,3/5,20.55%,VDAC1;PLN;MRLN
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),0.7036415536351237,1.1868029464805359,0.3409090909090909,0.8539919888239373,1.0,2/5,19.40%,FRMPD4;CTNNA2
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),-0.6939470321873116,-1.1867760200517508,0.2857142857142857,1.0,1.0,5/13,14.24%,TBX1;ACTC1;ZFPM1;HEY2;TTN
prerank,GO_Biological_Process_2021__detection of stimulus involved in sensory perception of pain (GO:0062149),-0.7161927647925508,-1.1866182135877192,0.3148148148148148,1.0,1.0,1/6,5.91%,PRDM12
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.5986911966888976,1.18649288955265,0.25,0.8542781089860666,1.0,4/14,15.74%,RAP2A;TNIK;RAP1A;ESPN
prerank,GO_Biological_Process_2021__proline transmembrane transport (GO:0035524),0.7228719082512091,1.1863179551149834,0.2727272727272727,0.8540390440233395,1.0,2/5,11.22%,SLC6A20;SLC7A8
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.5534596222404667,1.1860074345751712,0.19230769230769232,0.8543081176590173,1.0,12/26,11.69%,VCAN;CSGALNACT1;CHSY3;CHSY1;CHST12;ARSB;CHPF2;CHST11;CSPG5;CHST3;UGDH;DSEL
prerank,GO_Biological_Process_2021__lymphatic endothelial cell differentiation (GO:0060836),0.7323019240761807,1.1859651399905864,0.275,0.8535788252480927,1.0,3/6,21.51%,PROX1;NR2F2;BMPR2
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),-0.7230275151497159,-1.1859384903094434,0.25,1.0,1.0,1/9,0.37%,NEK2
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.6131242333148181,1.1859048139526303,0.19444444444444445,0.8528347719962127,1.0,5/14,9.91%,FOXO1;IRS1;PID1;PPP5C;LPL
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.49478521879242743,1.185729510116064,0.22580645161290322,0.8524514056065227,1.0,18/42,23.46%,ST6GALNAC3;GLA;ESYT3;STS;SMPD4;SMPD3;ESYT2;NEU4;GLB1;NEU3;GBA2;ST8SIA3;ESYT1;ST6GALNAC5;ST8SIA1;LARGE1;SUMF2;ABCA2
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.4276585274384916,1.1856524718019672,0.15151515151515152,0.8517590892139723,1.0,46/131,24.48%,CTDNEP1;EYA4;DUSP4;DUSP2;PTPRO;PTPRZ1;PPP5C;PTPRR;CTDSP2;CTDSP1;PTPN9;PTPRM;PPP2R1B;DUSP18;PPM1A;PTPRB;UBASH3B;PPP1R15B;PTPRT;EYA3;PTPRF;SSH1;PPM1L;CDC14B;PTPRD;PTPRE;MTMR3;NCK1;PPP2R5D;TAB1;PPP1CB;PPP4R1;PPEF1;MTM1;PTPN14;PTPRJ;DUSP6;PTEN;PPP2R2B;PTPRA;PTPN21;PPM1H;PPM1E;CTTNBP2NL;PTPN12;PPP3CC
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.594768930918682,1.1853606249783983,0.2564102564102564,0.8500486147809201,1.0,5/11,23.80%,PANK1;PPCS;SLC25A16;ACOT7;PANK3
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.594768930918682,1.1853606249783983,0.2564102564102564,0.8500486147809201,1.0,5/11,23.80%,PANK1;PPCS;SLC25A16;ACOT7;PANK3
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),0.594768930918682,1.1853606249783983,0.2564102564102564,0.8500486147809201,1.0,5/11,23.80%,PANK1;PPCS;SLC25A16;ACOT7;PANK3
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),0.720194163259299,1.1850789726835949,0.2978723404255319,0.85030343060831,1.0,4/6,17.42%,LGALS1;HMGB1;LGALS9;LGALS3
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.5471485336038744,-1.1847279240198052,0.18181818181818182,1.0,1.0,20/60,13.92%,CLEC5A;ITGB2;HCK;SP100;IRF1;TNFRSF1B;PTAFR;CIITA;C3AR1;GPR183;MS4A4A;NFKB2;LY86;IGSF6;PTPRC;ITGAM;TLR2;FPR3;NLRP3;APOL6
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),0.5027004444306371,1.1845099345886827,0.2222222222222222,0.8515631247213632,1.0,4/39,5.33%,NTSR2;PCDH15;WHRN;USH2A
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),0.6518650786152214,1.1844947798408676,0.3023255813953488,0.8506818286687965,1.0,1/10,2.66%,APOE
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.5529007324514366,1.1834944192501577,0.13157894736842105,0.853281504741633,1.0,4/18,7.30%,GRP;MRAP2;KLK14;F2
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),0.7039959628547975,1.1834178838166327,0.3181818181818182,0.8527720385123763,1.0,4/6,28.51%,PIH1D1;FBL;NOP58;ZNHIT6
prerank,PanglaoDB_Augmented_2021__Ionocytes,-0.4948106647455944,-1.1833625447122311,0.26229508196721313,1.0,1.0,19/78,16.78%,PLEKHS1;CHST9;VWA3B;FUT2;MROH9;CCDC60;MAP3K19;BPIFB1;MS4A8;MYO5B;AKAP14;SNTN;APOBEC4;EYA2;DNAH3;MUC4;DNAI1;ADH7;ZBBX
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.47417761255167784,1.1833005209968623,0.09375,0.8522798092182244,1.0,11/46,15.84%,WASHC2C;CRK;ABL1;FLNA;EFNA5;CASS4;KANK1;CSPG5;LIMS1;SPRY4;CRKL
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.5250550004069978,1.183252412914524,0.21212121212121213,0.8515789427812822,1.0,6/27,12.91%,ARC;ABHD17A;LZTS3;ABHD17C;ABI3;ABHD17B
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.5590970898696251,-1.182787664479711,0.20967741935483872,1.0,1.0,10/35,20.83%,SCIMP;IFNK;LY86;CYBA;USP17L2;SH2D1B;GRN;IFI35;DHX58;DDX60
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),0.4677498955597709,1.1826477427947633,0.18421052631578946,0.852571406044084,1.0,11/36,25.17%,PCM1;IFT88;IFT140;TTC21B;KIF3B;TRIP11;WDR19;WDR35;IFT57;CLUAP1;DYNC2I2
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.742067929785736,1.1826155209521652,0.28888888888888886,0.8517107678772928,1.0,2/5,20.00%,PPARG;OSBPL8
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),0.47543052289509713,1.182309443526345,0.14893617021276595,0.8516237252012746,1.0,11/44,13.96%,SPRED3;HSPB1;CDH5;FKTN;FER;PML;SPRED2;PPIB;SPRED1;CCDC88A;PUM3
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),0.6377331170144294,1.1822167899121934,0.3409090909090909,0.8511674583151133,1.0,4/6,30.66%,CBS;CTH;TST;MPST
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),-0.7089598222173907,-1.1819897262766854,0.32727272727272727,1.0,1.0,1/7,4.81%,ESR1
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),0.5797302624370132,1.1819126184163669,0.2857142857142857,0.850920735911431,1.0,5/22,6.41%,PHLDB2;APOH;APOE;SERPINE1;CRK
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),-0.6226976125556591,-1.1817423621245964,0.25396825396825395,1.0,1.0,3/16,19.39%,CYP3A4;HSD3B1;CYP17A1
prerank,GO_Biological_Process_2021__arachidonate transport (GO:1903963),-0.70099846690578,-1.1816429565471713,0.2631578947368421,1.0,1.0,2/8,8.67%,NMUR2;ANXA1
prerank,GO_Biological_Process_2021__arachidonic acid secretion (GO:0050482),-0.70099846690578,-1.1816429565471713,0.2631578947368421,1.0,1.0,2/8,8.67%,NMUR2;ANXA1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.7623194322312417,1.18150418143234,0.28205128205128205,0.8514758962445202,1.0,3/6,20.87%,HSPA1A;CPNE1;LAPTM5
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.45138220670829104,-1.1810119072282474,0.15853658536585366,1.0,1.0,15/122,10.28%,CD44;TGFB1;NODAL;SCIMP;GPER1;GPR183;ALKAL2;FLT4;ALOX15;ATP6AP1;HTR2B;P2RY6;PRXL2C;HLA-DRB1;PTPRC
prerank,MSigDB_Hallmark_2020__Myogenesis,-0.4744362726778972,-1.1803584477755433,0.1794871794871795,1.0,1.0,27/162,13.55%,MYH1;MYBPH;MYH4;TGFB1;MYH7;CASQ2;ACTC1;MYH8;CAV3;MYBPC3;COL1A1;NQO1;CSRP3;ATP6AP1;ACTN3;CLU;CFD;CKB;SVIL;TPD52L1;CKMT2;CDKN1A;APOD;GPX3;FOXO4;COX7A1;IFRD1
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),-0.6966058045201773,-1.1803476437225782,0.30303030303030304,1.0,1.0,3/10,10.22%,LMOD1;TMOD4;LMOD3
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),-0.6253912757766986,-1.1802592881371572,0.234375,1.0,1.0,5/17,13.03%,C1QTNF1;BLK;TEC;SELP;TXK
prerank,GO_Biological_Process_2021__myeloid leukocyte mediated immunity (GO:0002444),0.7228557273802283,1.180127372447682,0.35,0.855119844318021,1.0,3/6,21.17%,CARD9;IRAK4;ACE
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.6741079939237195,1.1798714041802927,0.2903225806451613,0.855029651363337,1.0,1/11,0.97%,AUP1
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.45540469619249946,1.1798077167800312,0.13043478260869565,0.8543005973624349,1.0,41/115,27.79%,TICAM2;STX5;BLZF1;STX6;FHDC1;GBF1;UBXN2A;TRAPPC12;GCC2;TMED3;BET1;PI4K2B;ARHGAP21;VTI1A;COG7;FAM174B;PLK3;SEC22B;GOLGB1;PRMT5;COG4;UBXN2B;TRIP11;USP6NL;TRAPPC11;COG2;VPS51;MYO18A;COG3;VMP1;ZNF501;GOLGA8H;CUL7;SYNE1;TRAPPC8;DNAJC28;SEC23IP;YWHAZ;ATP8B1;GOLPH3L;GORASP1
prerank,GO_Biological_Process_2021__positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870),0.7496228333599619,1.1795420521310809,0.2978723404255319,0.8542274205121162,1.0,4/5,22.25%,TENT4A;ELAVL4;RBM24;LARP4B
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),-0.659171745006055,-1.1793256364620046,0.23214285714285715,1.0,1.0,2/14,3.06%,SYCP1;STAG3
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),-0.659171745006055,-1.1793256364620046,0.23214285714285715,1.0,1.0,2/14,3.06%,SYCP1;STAG3
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),-0.6441176189030571,-1.1792132359947898,0.19642857142857142,1.0,1.0,4/12,16.13%,OAS1;APOD;ELANE;F2RL1
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.4954603588640708,1.1791183409951373,0.25,0.854823985617463,1.0,8/38,14.95%,HDAC3;SIK3;MLST8;TELO2;PIH1D1;CLEC16A;KLHL22;PIK3CA
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),0.6809336856475342,1.1789858337378691,0.3142857142857143,0.8543681932826446,1.0,3/7,16.35%,TOP2A;MGMT;LIG4
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),-0.5572072964420798,-1.1789467095303698,0.3064516129032258,1.0,1.0,7/24,17.25%,AQP3;PLAAT4;ETV4;PRKCH;VDR;ABCA12;ZFP36L1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),-0.6029491067447399,-1.1789128235107378,0.25,1.0,1.0,4/23,15.88%,MISP;GPSM2;DCTN1;NDEL1
prerank,GO_Biological_Process_2021__negative regulation of T-helper 17 type immune response (GO:2000317),0.69801024395645,1.1787434611973586,0.24390243902439024,0.8544542661196569,1.0,4/5,30.00%,RC3H1;SMAD7;RC3H2;FOXP3
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),0.46846537818435463,1.1786964740175305,0.20833333333333334,0.8537137627012639,1.0,6/45,9.31%,GPC4;TRIM67;GPC6;RALB;GBF1;GPC5
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),0.6361405635260622,1.1786360869635444,0.3333333333333333,0.8531176961110712,1.0,2/8,24.00%,PDSS2;MVK
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),-0.69885169437706,-1.1781827087429608,0.23214285714285715,1.0,1.0,3/8,14.24%,CSRP3;HTR2B;TTN
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),0.5433141018974711,1.1781562980614422,0.18421052631578946,0.8538867407535873,1.0,3/22,4.77%,IBA57;CIAO3;HSCB
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.6414195404098602,1.1777751018870553,0.2727272727272727,0.8541630637307428,1.0,4/10,18.20%,RAPGEF1;RAP2A;RAP1A;RAPGEF3
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),0.6787464209233603,1.17775650236772,0.2653061224489796,0.8532993657642843,1.0,1/5,2.16%,GLA
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),0.43775220298895656,1.1775121835706541,0.16,0.8532121179415953,1.0,23/82,13.81%,COL22A1;COL8A1;TGFBR1;CD151;LAMA3;LOXL1;COL9A2;COL12A1;P3H2;COLGALT1;GREM1;PLOD3;COLGALT2;P3H4;PPIB;COL16A1;PLEC;TLL1;COL13A1;COL5A3;ITGB4;DST;NF1
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),0.6476960648367902,1.1774515110333583,0.1891891891891892,0.8525091462935135,1.0,7/11,22.57%,KIT;DSP;SERPINB8;VCL;JUP;CAMSAP3;THBS4
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),0.6884533399516076,1.1772267738580102,0.2857142857142857,0.8524702344381286,1.0,2/7,7.35%,PEX13;SLC27A2
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),0.7218850923358161,1.1770717208283692,0.25,0.8522580493084221,1.0,3/6,26.50%,DDAH1;ENO1;CD34
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),0.5487979915533994,1.1769629485908373,0.23529411764705882,0.8517786745421781,1.0,4/15,6.95%,SCRIB;CDH5;CGNL1;DSP
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),0.7000791140743103,1.1766888336416774,0.3333333333333333,0.8517249185258068,1.0,2/7,12.11%,HPSE;ADIPOR2
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),-0.766141599472542,-1.1766867603286983,0.3384615384615385,1.0,1.0,2/6,12.50%,PRDX4;TLR2
prerank,GO_Biological_Process_2021__regulation of antifungal innate immune response (GO:1905034),-0.7655768129195323,-1.176639158639013,0.32075471698113206,1.0,1.0,2/5,10.89%,TRIM62;SPI1
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.4103195609622069,1.176579575513142,0.11538461538461539,0.8514041992215413,1.0,20/108,14.95%,GCK;PRR16;IRS1;SAMD4A;SLC25A37;SIRT1;ERBB2;PCIF1;TMEM106A;PPP1R3E;MYC;AKT2;CTC1;IRS2;NAMPT;EIF3E;NFKB1;YTHDF1;ABCB10;INSR
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.5499253722403252,1.1764132052836134,0.22857142857142856,0.8510370647748795,1.0,5/23,7.88%,TGFBR1;ROBO2;HES1;PROX1;SLIT2
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),-0.6310782088657569,-1.1763893683271176,0.22857142857142856,1.0,1.0,3/22,4.08%,MYBPH;CAV3;MYBPC3
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),0.6817675856925715,1.1761337197920294,0.35555555555555557,0.8509999240022057,1.0,3/8,14.47%,PTPRO;PTPRB;PTPRT
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),0.5617447637098169,1.1760706614010568,0.23684210526315788,0.8503833880143391,1.0,6/19,17.37%,NLGN1;RIMS2;RIMS4;RAP1A;RAB5A;SYN1
prerank,GO_Biological_Process_2021__negative regulation of T-helper 17 cell differentiation (GO:2000320),0.6929913983360844,1.1760373906525932,0.2631578947368421,0.8496429683550307,1.0,4/6,30.00%,RC3H1;SMAD7;RC3H2;FOXP3
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),0.6436828950445767,1.175934880237567,0.3225806451612903,0.8491228874798047,1.0,5/7,34.01%,IMPACT;BCL3;MAP3K4;YY1;POLH
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),0.6067096009977562,1.1755372030614466,0.35555555555555557,0.8492283952667664,1.0,2/6,10.69%,NPL;NAGK
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),-0.6360761133688585,-1.1751276071498329,0.2857142857142857,1.0,1.0,4/14,9.43%,DUOX1;STAT1;KCNJ11;P2RY6
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),-0.6505738402344361,-1.1749990024373864,0.32727272727272727,1.0,1.0,6/13,30.71%,THBS1;CSF1R;CXCL17;CCL5;CSF1;MAPK3
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),-0.6176342765930156,-1.1749608507773255,0.27419354838709675,1.0,1.0,5/14,14.65%,PLAAT4;SFRP4;ETV4;PRKCH;VDR
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),0.6711012817532896,1.174579344606554,0.28888888888888886,0.8517979630527344,1.0,3/8,12.24%,ALDH1A1;ACSS2;ADH4
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),0.5433494915131498,1.1744771067775241,0.1891891891891892,0.8514330744030749,1.0,3/21,4.77%,IBA57;CIAO3;HSCB
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.5928827996464445,1.1741908879095768,0.22857142857142856,0.851426922475257,1.0,6/13,29.71%,TNRC6C;TNRC6A;AGO2;PABPC1;TNRC6B;TOB1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.6471805741946363,-1.173921864645138,0.288135593220339,1.0,1.0,3/15,8.12%,SCN5A;CAV3;KCNQ1
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),0.5637870744297436,1.173869897788927,0.2608695652173913,0.8516851078652085,1.0,5/33,8.53%,FGF10;PKD2;SLIT2;MYC;LRP6
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),0.5263822303583439,1.1738138574880619,0.34146341463414637,0.8509486812282914,1.0,5/21,10.74%,ITPR2;HTR2C;TRPM2;PKD2;F2R
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),-0.6339735100893358,-1.1738089015537738,0.29310344827586204,1.0,1.0,2/15,11.03%,IHO1;STRA8
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.6204105489536116,1.1737896459596715,0.34375,0.8502448014125489,1.0,7/14,20.42%,SIRT7;SMARCB1;PIH1D1;SMARCA4;MACROH2A2;MARS1;IPPK
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),-0.7555633676544958,-1.1736967397983882,0.24561403508771928,1.0,1.0,1/6,7.96%,RNF213
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.5342492565408047,-1.1734693298583494,0.2,1.0,1.0,10/44,16.57%,MGST1;PRDX4;NQO1;SOD2;NDUFS2;GLRX;CDKN2D;GPX3;NDUFB4;ATOX1
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),0.43388061644442577,1.1731289973076722,0.16666666666666666,0.8516814522096923,1.0,28/96,26.04%,CPSF1;NUP210;NXF5;NUP42;IWS1;NXT1;NXF1;U2AF1;SRRM1;AAAS;SRSF4;SMG1;SMG5;RANBP2;SMG6;EIF4A3;U2AF2;SYMPK;EIF4E;NUP214;TPR;MAGOHB;PCID2;SEH1L;THOC1;WDR33;NUP153;RBM8A
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.4797557319009195,1.1730947629544128,0.17857142857142858,0.8510092341297236,1.0,17/54,18.27%,CD151;APOE;PACSIN2;HIP1;CDH13;SNCA;EPHA3;ABL1;ABL2;ZFYVE16;CD22;RAB5A;RIT2;CLIP3;LGALS3;ABCA7;LRSAM1
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),-0.7156000781933872,-1.1730096425358294,0.3090909090909091,1.0,1.0,4/7,24.62%,USP17L2;DHX58;DDX60;TKFC
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),0.6102383867221356,1.1729850497520924,0.27906976744186046,0.8505240197982544,1.0,2/13,3.11%,TSKU;SPTBN4
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.6071174161007973,-1.1729037976881826,0.21428571428571427,1.0,1.0,2/13,7.35%,TGFB1;H1-0
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),0.6612975524042808,1.1726761047198415,0.3,0.8500351217526909,1.0,2/7,23.16%,TPR;PCID2
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),0.6612975524042808,1.1726761047198415,0.3,0.8500351217526909,1.0,2/7,23.16%,TPR;PCID2
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),0.5963368859881205,1.1725173790915875,0.24390243902439024,0.8495986536530555,1.0,5/12,25.25%,H6PD;SEC14L2;SREBF2;ABCA2;LPCAT3
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),0.5376172515264867,1.1723941089723622,0.23076923076923078,0.8490090191427597,1.0,5/20,10.74%,ITPR2;HTR2C;TRPM2;PKD2;F2R
prerank,GO_Biological_Process_2021__lung epithelium development (GO:0060428),0.7157915385198933,1.1723715621583572,0.30612244897959184,0.8481897365601412,1.0,2/7,13.36%,FGF10;ASCL1
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),0.549544740584992,1.1723390198987995,0.3055555555555556,0.8473874969174716,1.0,2/22,2.08%,PHLDB2;ROBO2
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.41047750286374496,1.1723340231022374,0.15151515151515152,0.8465408134026671,1.0,43/150,19.40%,SLC17A6;GRID2;SEZ6L;GRM3;LRRTM3;HRH3;ELAVL3;CNTNAP2;CADM2;PAK5;HCN1;HIVEP2;PDE1A;ADGRA1;CACNG2;PCBP3;CELF5;CELF4;PDE9A;GRIN1;BRINP1;NXPH1;ELAVL4;GPSM1;RAB3C;SLC22A15;OLFM3;SNAP91;RBFOX1;SCRT1;VSTM2B;PKP4;SRRM4;NRXN1;RIT2;GRIK3;SYN1;SLC24A2;MMD2;ST8SIA3;ADGRB3;GRM5;CTNNA2
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.5330890509829349,-1.172316901910144,0.23529411764705882,1.0,1.0,11/35,25.05%,CENPU;ITGB3BP;OIP5;CENPH;RBBP7;ANP32E;CENPN;SMARCA5;CENPL;CENPM;RNF8
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),0.6223435320478828,1.1722442941905007,0.23684210526315788,0.8459720264331807,1.0,3/17,9.71%,LLGL1;CDH5;KANK1
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),-0.5913012835022227,-1.171942237469598,0.2903225806451613,1.0,1.0,6/25,16.13%,TGFB1;P2RY12;GPR183;THBS1;ELANE;F2RL1
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),0.6848904973709922,1.1719299157260312,0.3181818181818182,0.84620142511943,1.0,3/7,12.94%,SKAP1;SIRT1;FADD
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),0.6121771880001052,1.1718900028266772,0.28205128205128205,0.8454350804805543,1.0,3/12,9.43%,ZBTB7B;METRNL;TFE3
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.49976753090415066,1.1717397198767865,0.14705882352941177,0.8449762178341509,1.0,10/36,20.81%,PLD6;TRIM71;KHSRP;PIWIL1;DGCR8;XPO5;TARBP2;AGO2;PIWIL2;TUT7
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),-0.5159753655221259,-1.1714955043990773,0.28378378378378377,1.0,1.0,1/50,0.13%,DENND1C
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),0.6122976486183962,1.1708992303054575,0.22448979591836735,0.8460152632335095,1.0,4/9,24.44%,NSMAF;SMPD3;PLA2G6;PRKCD
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),0.6122976486183962,1.1708992303054575,0.22448979591836735,0.8460152632335095,1.0,4/9,24.44%,NSMAF;SMPD3;PLA2G6;PRKCD
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.6362755736831143,1.1707510632137474,0.3111111111111111,0.8458469569917669,1.0,2/10,4.35%,MFSD2A;PLIN5
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),0.4476573339831988,1.1707170003625602,0.20689655172413793,0.8451000712763892,1.0,13/51,20.90%,LLGL1;SNCAIP;RALA;SYT1;RIMS2;RAB3C;RAB10;ARFIP1;SYN1;RAB3D;DNAJC1;VAMP8;RAB26
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),0.5871082358664571,1.1707055700392073,0.2391304347826087,0.844278594595394,1.0,5/15,15.39%,APOH;LIPC;LPL;FURIN;NR1H3
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.6857214992041402,1.170504686467315,0.358974358974359,0.8442949941036404,1.0,5/6,31.02%,NBDY;CNOT6;ATXN2;CNOT2;CNOT6L
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.5694179224634953,1.170354264539778,0.26666666666666666,0.8440227746637535,1.0,3/17,5.50%,ZBTB7B;WNT4;NRG1
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.4790637288926872,-1.1701199959949402,0.21621621621621623,1.0,1.0,24/97,22.47%,TICRR;MCM2;DONSON;PCLAF;RPA3;MCM3;CDK2AP1;BRCA1;GRWD1;PIF1;RAD1;POLE2;POLD4;CDC6;RECQL4;SET;RMI1;ORC6;TOPBP1;POLE3;RPA2;PTMS;BAZ1A;BLM
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.42589509294508665,1.1700652796065711,0.16666666666666666,0.8439635309675697,1.0,20/129,9.32%,PHLDB2;NGF;MEGF10;SMYD5;TGFBR1;BCL6;FGFR1;MAFB;NLGN1;CCN2;BIN1;CBFB;KLHL41;DLX1;EPHA3;GREM1;CDK6;SNAI2;ANP32B;FADS1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.4669980023410329,-1.1699283900603614,0.16666666666666666,1.0,1.0,37/173,14.86%,F8;TBX1;C1QTNF1;CYYR1;LMOD1;LYVE1;TIMP3;S100A13;ANGPTL2;INMT;ELK3;CYP1B1;NOSTRIN;PROCR;LOX;OIT3;DCN;SLCO2A1;CLDN5;FLT4;USHBP1;ABCG2;ARAP3;ID1;VWF;GPIHBP1;ENG;APOLD1;PRKCH;COX7A1;EDNRB;TEK;A2M;PALMD;C1S;GGT5;ADGRF5
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.4816251808636991,1.1697994417103168,0.2692307692307692,0.8438437732954162,1.0,10/37,11.22%,LETM2;SLC12A1;TMTC2;SLC8A1;SNCA;SLC12A9;CNNM2;TESMIN;GRIN1;SLC7A8
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.6498258023676313,1.1697840977125735,0.3333333333333333,0.8430428194662267,1.0,4/11,7.88%,ROBO2;PKD2;OSR1;SLIT2
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),0.6418588019876954,1.1697795628169196,0.32432432432432434,0.8421980871821925,1.0,3/7,22.90%,WNK2;WNK3;WNK1
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),0.7718727073353092,1.169609440077085,0.3142857142857143,0.8419595546370506,1.0,1/5,2.66%,APOE
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.4415181927768079,-1.169364064437744,0.17105263157894737,1.0,1.0,16/148,14.09%,BUB1;ERCC6L;MISP;SPC25;CENPU;ABRAXAS1;RAB11A;GPSM2;ITGB3BP;ZWILCH;TTK;NUF2;CENPH;DYNLL1;RPS27;INCENP
prerank,GO_Biological_Process_2021__cellular nitrogen compound catabolic process (GO:0044270),-0.7032279251890317,-1.1691063506113015,0.3125,1.0,1.0,3/7,19.10%,CYP3A5;CYP3A4;NIT1
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),0.6968400860144051,1.1689660142569593,0.358974358974359,0.8435030161770254,1.0,2/5,27.63%,FSCN1;ATP8B1
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),-0.612506793035384,-1.1689276069636938,0.26865671641791045,1.0,1.0,3/18,10.85%,LMOD1;LMOD3;SCIN
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),-0.6329953364519609,-1.168629660406941,0.27586206896551724,1.0,1.0,3/16,4.01%,MMP9;CAV3;HAMP
prerank,GO_Biological_Process_2021__dopamine transport (GO:0015872),-0.7244909266814011,-1.1686105457013123,0.3793103448275862,1.0,1.0,3/6,24.50%,SLC18A2;SLC22A3;SLC22A1
prerank,GO_Biological_Process_2021__apoptotic chromosome condensation (GO:0030263),-0.7296418901314983,-1.1684802754249428,0.288135593220339,1.0,1.0,2/5,5.18%,ERN2;GPER1
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),-0.6137686523897478,-1.168401499969222,0.2777777777777778,1.0,1.0,4/17,15.60%,GPSM2;ANKRD53;DCTN1;BORA
prerank,GO_Biological_Process_2021__positive regulation of skeletal muscle tissue development (GO:0048643),-0.7270866367782867,-1.1683479400319425,0.2698412698412698,1.0,1.0,2/6,10.22%,ACTN3;LMOD3
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),0.44668757660070385,1.168326989863261,0.15151515151515152,0.8443345154685311,1.0,9/43,19.24%,ZBTB7B;METRNL;PPARG;TFE3;LPL;CARM1;SYAP1;SOX13;CREB1
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),0.5960226233764111,1.1683069637143786,0.3333333333333333,0.8435521361192198,1.0,7/13,29.74%,EIF3E;EIF4EBP1;AGO2;LARP1;TPR;FMR1;EIF2AK4
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),0.5082089494807348,1.1682021822708448,0.1875,0.8430723657389924,1.0,8/38,11.59%,PER2;FBP2;PC;ENO3;CRY1;G6PC3;SLC25A1;SLC25A12
prerank,GO_Biological_Process_2021__pharyngeal arch artery morphogenesis (GO:0061626),0.7301033912353943,1.1676450451996827,0.3,0.8439769966658434,1.0,4/5,23.49%,HES1;BMPR2;BMP4;BMPR1A
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),0.6065855043806169,1.1674656572123867,0.32432432432432434,0.8438282530729154,1.0,4/13,13.56%,IWS1;SAFB2;SLTM;CDK11A
prerank,GO_Biological_Process_2021__regulation of angiotensin levels in blood (GO:0002002),-0.6805802130966365,-1.167110830920937,0.375,1.0,1.0,4/8,19.87%,CTSZ;ATP6AP2;REN;ACE2
prerank,GO_Biological_Process_2021__angiotensin maturation (GO:0002003),-0.6805802130966365,-1.167110830920937,0.375,1.0,1.0,4/8,19.87%,CTSZ;ATP6AP2;REN;ACE2
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),-0.6591698311464902,-1.1666588375128475,0.2786885245901639,1.0,1.0,2/13,11.75%,SCTR;UCP1
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.6264031204231666,1.166394867120098,0.2,0.846696324054517,1.0,1/12,0.82%,IRGM
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.4016932552288079,1.1663747737959582,0.14285714285714285,0.8458854987115924,1.0,8/98,5.34%,GRIN3A;MCOLN3;TRPC3;SLC3A2;TRPM2;SLC8A1;SLC8A3;PKD2
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.46277715122680657,1.166181986117718,0.16666666666666666,0.8457203266730972,1.0,11/57,14.99%,TGFBR1;BCL2;MFSD2A;ERBB2;SLC25A33;PLCB1;RPS6KA3;ADNP2;KLHL22;INSR;DNPH1
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.4139436138439126,1.1659532919134141,0.1724137931034483,0.8456302967093295,1.0,34/101,25.60%,TEAD2;LLGL1;CD247;MATN1;MITF;PARD3;HES1;SLC7A9;PML;WASF3;GEMIN5;SNX9;MAGI1;TP53;IL2RB;PARD6B;NDUFAF1;SKAP2;WDR19;LIN7A;PPIH;CAPZA1;MDM4;OCLN;LAMC1;TPR;TFAP4;SEH1L;IL1RAP;PEX14;TRAF1;MDN1;TAPBP;KMT2A
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),0.6054062663561512,1.1657995941673203,0.3055555555555556,0.845226534488899,1.0,3/13,9.93%,GRIN3A;SDF4;GRIN1
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),0.56156687246057,1.1657578005383322,0.2972972972972973,0.8445099709680562,1.0,6/15,10.85%,APOH;SERPINE1;HPSE;F2;F2R;F12
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),0.4954413850682098,1.1657388093766219,0.21875,0.8437053121071485,1.0,14/34,26.51%,IWS1;SAFB2;KHDRBS2;SLTM;CDK11A;PAPOLA;KHDRBS1;METTL16;KHDRBS3;SRPK2;RBM39;PTCD2;SF1;SON
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),0.6843586500658483,1.165675653965097,0.2926829268292683,0.8431407035399779,1.0,2/9,5.35%,RFWD3;CRY1
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),-0.7911152468221806,-1.1656056782821997,0.3,1.0,1.0,2/5,10.59%,P2RY12;VWF
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.4431051213074125,-1.1655340693981753,0.19753086419753085,1.0,1.0,58/154,27.27%,ERN2;RPL37A;SLFN14;SENP3;RPL38;PWP2;EMG1;RPL15;NOB1;RPL3;RPL35A;RPS9;RPS27;RPL13A;RPL27A;RPS16;RPL36;LAS1L;RPL7A;RPL9;RPL13;RPL21;WDR12;NOP53;EXOSC8;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPL27;RPL35;RPS14;RPL11;RPS15;EXOSC2;RPLP1;RPL24;SBDS;RPL18A;RPL29;RPLP2;PDCD11;RPL28;RPL12;RPL18;EBNA1BP2;RPL22;IMP3;RPS28;RPS19;RPS24;RPL19;RPL8;RPS6;RPL10
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.48668472119791034,1.1654666197391306,0.17142857142857143,0.8430685506716902,1.0,9/26,33.74%,SGIP1;SNAP91;FCHSD2;DNAJC6;FNBP1L;DLL1;ITSN1;LMBRD1;ITSN2
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.47187389318120476,1.1651322420184704,0.14705882352941177,0.8434130255452214,1.0,18/47,21.13%,NOVA1;PUF60;KHDRBS2;CELF5;CELF4;HNRNPL;NSRP1;RBFOX2;RBFOX1;CELF2;SRRM4;PTBP1;KHDRBS1;RBM25;FXR2;RBM24;ZBTB7A;KHDRBS3
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),0.7114216374898567,1.1650811271091839,0.34146341463414637,0.8429098111903757,1.0,4/6,25.87%,COLGALT1;AEBP1;EMILIN1;RB1
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),-0.7374459679356715,-1.1648655166223447,0.40384615384615385,1.0,1.0,1/6,1.49%,TGFB1
prerank,MSigDB_Hallmark_2020__E2F Targets,-0.4526543247354814,-1.164633339840499,0.125,1.0,1.0,30/189,19.73%,CDCA3;MCM2;HMGB3;PRDX4;DONSON;SPC25;RPA3;MCM3;CDC25A;DEPDC1;SUV39H1;BRCA1;CDKN1A;PSMC3IP;H2AZ1;RAD1;NAA38;RBBP7;TK1;ANP32E;CDKN3;CKS1B;TUBB;PAICS;CDCA8;PRPS1;EXOSC8;BUB1B;STMN1;HMGA1
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),0.5205740910716135,1.1645117814403287,0.2222222222222222,0.8440108715947139,1.0,9/32,20.69%,GSTM5;CHAC1;GSTM2;GSTA4;GPX1;GSTZ1;ETHE1;GSR;GSTT2
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),-0.6608165246354515,-1.1642733341540816,0.27586206896551724,1.0,1.0,2/11,6.30%,WNT5A;IL7
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.5978490862882629,1.1641095075223986,0.275,0.8447983251621503,1.0,2/13,5.58%,PPP1R14D;MAGI2
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),-0.5789239614675912,-1.1640200484307808,0.3448275862068966,1.0,1.0,7/28,14.72%,NRAP;TBX1;NEB;TMEM204;POPDC2;HEY2;FBXO40
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.59184385090063,-1.1640133836436886,0.2542372881355932,1.0,1.0,2/15,10.71%,TERF2IP;TERT
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell proliferation (GO:0046642),0.6681850281417163,1.1638632239409097,0.2727272727272727,0.8449026927699126,1.0,3/6,11.29%,ZBTB7B;TWSG1;LGALS9
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),-0.6274952139385678,-1.16364225296805,0.22950819672131148,1.0,1.0,6/17,25.59%,TOMM20;PAM16;TIMM17A;ROMO1;DNAJC19;TIMM21
prerank,GO_Biological_Process_2021__skeletal muscle contraction (GO:0003009),-0.6290407018436704,-1.1636349249574232,0.3103448275862069,1.0,1.0,3/15,2.13%,MYH7;MYH8;STAC
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),0.5580673457877673,1.163535336352307,0.23333333333333334,0.8451400698694063,1.0,1/13,3.83%,AK3
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.4473188284227442,-1.1632633359384696,0.11627906976744186,1.0,1.0,72/195,27.27%,RPL37A;NARS1;DARS2;RPL38;RPL15;COPS5;WARS1;RPS4X;RPL3;RPL35A;RPS9;RPS27;EEF2;RPS21;RPL13A;YARS2;RPL27A;RPS16;RPL36;RPS20;RPL7A;RPL9;ABCF1;RPL13;MRPS34;RPS8;RPS27A;RPL21;RPL34;MRPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;RPL27;RPL35;TMA7;RPS14;RPL11;ASMT;DRG1;RPS15;RPLP1;RPS12;RPL24;PPA1;RPL18A;RPS13;RPL29;RPLP2;ZC3H15;RPL28;RPL12;IGF2BP3;RPL18;RPS3;RPL22;EEF1A1;RPSA;RPS28;RPS19;RPS24;MRPS2;RPL26L1;RPS3A;RPL19;RPL8;RPS6;RPL10
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),0.39806526775870127,1.1631550808155973,0.08333333333333333,0.8456283622260006,1.0,24/71,25.54%,RBM20;HNRNPF;KHDRBS2;HNRNPH1;ESRP1;ERN1;HNRNPL;RRP1B;FASTK;HSPA1A;SRRM4;PTBP1;FUS;CLK2;KHDRBS1;METTL16;U2AF2;KHDRBS3;METTL4;SRPK2;SETX;DYRK1A;RBM39;SF1
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),-0.6134334975359468,-1.1630351611070382,0.2,1.0,1.0,1/12,2.96%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),0.508062601752383,1.1630207829564065,0.2903225806451613,0.8453179783737855,1.0,10/36,21.29%,PHLDB2;BICD1;EPHA3;EFNA5;MAPRE1;MAP6;SKA1;PRKAA2;MARK2;CAMSAP3
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),-0.5331314287775026,-1.1627417692036202,0.25,1.0,1.0,9/31,24.59%,GPSM2;ANKRD53;CHMP3;DCTN1;BORA;EML3;DRG1;PSRC1;RAE1
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.4975356301328127,1.1625850565901423,0.25,0.8459822401625969,1.0,10/25,21.55%,IRS1;CAPN10;AKT2;IRS2;INSR;NR4A3;CLIP3;BRAF;OSBPL8;OCLN
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.5519799090123452,1.1625747157814577,0.14705882352941177,0.845215060638472,1.0,6/23,12.52%,CEL;NLGN1;SNCA;SYT1;NLGN4X;NLGN3
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),-0.6053636779596414,-1.1623609039948783,0.2698412698412698,1.0,1.0,3/21,5.72%,CYP1B1;ALOX12B;FUT2
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),-0.4956255148203458,-1.162284712554335,0.21739130434782608,1.0,1.0,3/48,7.40%,ENPP2;RAB11A;CEACAM1
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.5782932172750846,1.161691622931205,0.2857142857142857,0.8470270173927459,1.0,3/13,6.54%,PCM1;SYNE3;CEP120
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-0.7209418657508604,-1.1616708720504643,0.2909090909090909,1.0,1.0,2/7,12.38%,PINK1;TOMM7
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),-0.6089176004583882,-1.1612152944199363,0.288135593220339,1.0,1.0,1/15,3.57%,CXCL13
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),0.6485981877916902,1.1609430766119713,0.14285714285714285,0.8487765820213207,1.0,3/13,14.89%,PUS7L;PUS10;PUS7
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.5491962954016203,1.1603954736942312,0.225,0.8496995012422263,1.0,8/18,24.93%,ACACB;ABCD3;ABCD2;CPT1A;PRKAA2;PRKAG2;THRSP;ACACA
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),0.5971177738033899,1.16039218786536,0.2564102564102564,0.8488876316903026,1.0,3/11,5.38%,BCL2;ACO1;SNCA
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),0.6371212941069615,1.1603491770294556,0.22857142857142856,0.8481800448907173,1.0,3/9,4.74%,PNP;NT5C1A;AMPD1
prerank,GO_Biological_Process_2021__multi-ciliated epithelial cell differentiation (GO:1903251),0.7217567622387118,1.1603436374154348,0.28888888888888886,0.8473565691189788,1.0,2/6,9.19%,CEP152;CCDC78
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.44294307023022866,1.1601580534644311,0.1875,0.847149724026055,1.0,33/79,26.74%,NOVA1;TRA2A;PUF60;KHDRBS2;CELF5;CELF4;HNRNPL;NSRP1;RBFOX2;SFSWAP;SRSF4;RBFOX1;CELF2;SRRM4;PTBP1;PCBP4;KHDRBS1;METTL16;U2AF2;RBM25;SF3B4;FXR2;RBM24;ZBTB7A;KHDRBS3;SRPK2;RBM39;SF1;RBM8A;RBM11;SMU1;SON;NUP98
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),-0.6065193227667524,-1.1600673970498685,0.296875,1.0,1.0,1/13,0.55%,TBX1
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),-0.5599755830544528,-1.1597769023732984,0.22535211267605634,1.0,1.0,7/26,8.67%,MYH4;MYH7;ACTC1;MYH8;MYBPC3;NEB;ACTN3
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),-0.5599755830544528,-1.1597769023732984,0.22535211267605634,1.0,1.0,7/26,8.67%,MYH4;MYH7;ACTC1;MYH8;MYBPC3;NEB;ACTN3
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.5387995109225348,-1.1596230084879524,0.24285714285714285,1.0,1.0,6/43,6.02%,DTL;SYCP1;PCLAF;RPA3;UBE2L6;TRIM25
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.45393941844707675,1.159301650178596,0.14285714285714285,0.8494595467731532,1.0,16/45,16.03%,EYA4;FGF10;BRCC3;HDAC10;SIRT1;ERCC8;RNF168;HMGB1;TIMELESS;SPIRE2;H2AX;SMCHD1;WRAP53;SPIDR;EYA3;MGMT
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.6613664426766133,1.1590438583889695,0.28205128205128205,0.8494264499231213,1.0,2/8,9.48%,GALNT1;GALNT13
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.5268248698237096,-1.1589549527106018,0.2463768115942029,1.0,1.0,4/37,7.39%,CLIC1;P2RY12;GP1BA;ACTG1
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),0.6648811233083317,1.1587218412410119,0.3333333333333333,0.8497438449864851,1.0,4/8,23.79%,ADIPOR1;PTPRT;BCL3;NF2
prerank,GO_Biological_Process_2021__regulation of keratinocyte apoptotic process (GO:1902172),-0.7351627023843799,-1.1585981685101285,0.3275862068965517,1.0,1.0,2/5,17.25%,SFRP4;ZFP36L1
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.4011342556785654,1.1584098132224194,0.21428571428571427,0.84992934323158,1.0,15/134,9.32%,ATP6V0D2;FOXO1;TCIRG1;KPTN;MFSD2A;KLF10;SIRT1;AKR1C3;IFI16;RALB;EIF2AK3;MAPK8;MLST8;RNF152;FADS1
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.5504242071997761,1.1582391970611503,0.28125,0.8496481481792245,1.0,11/24,17.09%,PPFIBP2;ZC4H2;CACNB4;PPFIBP1;GPHN;PDZRN3;F2R;UNC13B;CHRNA1;NEDD4;UNC13C
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid transport (GO:0015812),-0.7783396712593698,-1.15815121402537,0.3225806451612903,1.0,1.0,1/5,8.18%,SLC6A12
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.5647827164205785,-1.15766493871467,0.2459016393442623,1.0,1.0,6/24,13.78%,PKP2;ITGB2;CTNNA3;RNASE10;IZUMO1;ITGA5
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.6243886800374765,1.1575927076572337,0.2702702702702703,0.8511000071403659,1.0,2/11,12.46%,TBCCD1;ARHGAP21
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),-0.7010046781530489,-1.1575253933060878,0.32075471698113206,1.0,1.0,6/7,28.50%,ANXA1;NLRP3;IL18;CD86;TNFSF4;RARA
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),0.7007708502427163,1.15721702361334,0.3076923076923077,0.8513563872278825,1.0,2/8,3.50%,CHRM2;HRH3
prerank,GO_Biological_Process_2021__blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043),0.7263443816377235,1.1567456993779934,0.38461538461538464,0.8519610153275036,1.0,3/5,21.65%,SEMA5A;BMPER;BMP4
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.4328072315517894,1.1566293985001077,0.21052631578947367,0.851664431338849,1.0,13/64,14.95%,ATP6V0D2;FOXO1;SH2B2;TCIRG1;IRS1;FER;AKT2;IRS2;NAMPT;GAB1;IRS4;INSR;PIK3CA
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),-0.5619078786924242,-1.1565926033600678,0.3114754098360656,1.0,1.0,3/28,10.72%,TENT5B;MEIOC;SLC11A1
prerank,GO_Biological_Process_2021__Schwann cell differentiation (GO:0014037),0.7292824010536677,1.1565607122210741,0.275,0.8511073635215815,1.0,1/5,0.91%,ADGRG6
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),0.6041945396907185,1.1564598080203257,0.3541666666666667,0.8506672774226938,1.0,6/10,18.77%,PSAT1;SRR;CBS;PSPH;SERINC5;SHMT2
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),0.39049720799912424,1.1563435615207838,0.14285714285714285,0.8502425103785158,1.0,11/91,7.73%,GRID2;AOAH;RORA;APOE;CDH5;METRNL;PPARG;IFI16;SERPINE1;CRK;LRFN5
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),0.4561093317193681,1.1562510850167644,0.22857142857142856,0.849717327933031,1.0,13/55,22.73%,AUP1;IFT88;RAB7A;DYNC1I2;KLHL3;ARL13B;ATG2A;ATM;CALCOCO2;LGALS8;ATG2B;RETREG1;STING1
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell differentiation (GO:2001200),0.7211813281197268,1.1561919948885995,0.3269230769230769,0.8490920183601193,1.0,4/5,17.42%,LGALS1;HMGB1;LGALS9;LGALS3
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),0.5502011998848028,1.1560955464284761,0.1875,0.8486122409457088,1.0,8/24,26.39%,KDM7A;KDM8;KDM2A;KDM3B;JMJD1C;KDM5B;KDM4C;PHF2
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.4915156248377944,1.1559512128550073,0.16666666666666666,0.8482919985602759,1.0,3/34,2.37%,ADRA1A;KIT;FGFR1
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.5641954338434709,1.1552342220166416,0.26666666666666666,0.8498595675575126,1.0,10/20,11.08%,VCAN;CSGALNACT1;CHSY3;CHSY1;CHST12;CHPF2;CHST11;CSPG5;CHST3;UGDH
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),-0.6867138167035584,-1.1550867168118821,0.3225806451612903,1.0,1.0,3/9,18.74%,IL12A;IL5RA;CSF1R
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),0.6237995643625424,1.1550521421682323,0.3611111111111111,0.8497402399330557,1.0,5/9,27.15%,NXF5;RBFOX1;SIDT1;YBX1;ATXN2
prerank,GO_Biological_Process_2021__negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),-0.7516551571906536,-1.1550026232520563,0.40298507462686567,1.0,1.0,2/6,18.68%,CACTIN;CARD8
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),-0.5452603223864716,-1.1548463024790772,0.22727272727272727,1.0,1.0,9/43,10.22%,SCN5A;MYH7;CASQ2;MYH8;STAC;MYBPC3;CSRP3;KCNQ1;LMOD3
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),0.6383049928420581,1.1546927771277713,0.28205128205128205,0.8501243929948,1.0,3/7,9.44%,ZNF703;LATS1;AKT2
prerank,PanglaoDB_Augmented_2021__Spermatocytes,-0.5611584962002275,-1.154228827944246,0.2916666666666667,1.0,1.0,8/26,15.67%,BANF2;SYCP1;SLC25A31;TTC6;TNP1;WDR87;LYZL2;SYCP3
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.5351062953544914,1.1536044956723173,0.28888888888888886,0.8525907382204342,1.0,2/15,9.29%,TRA2A;CELF4
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.43637032323092134,1.1533955578736523,0.2222222222222222,0.8526270193723287,1.0,16/64,14.24%,FGF10;FGFR1;FGF17;HNRNPF;TRIM71;HNRNPH1;ESRP1;FGF18;SPRED2;FGFR3;FLRT2;SPRED1;RBFOX2;TIAL1;ANOS1;GTF2F2
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.6541871418212589,-1.1533286427259273,0.3188405797101449,1.0,1.0,3/11,16.62%,STAT1;IFNGR2;CDC37
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.5335740019657227,-1.1532470848309988,0.2878787878787879,1.0,1.0,10/33,15.80%,C1QB;CXCL13;VTN;C3AR1;CPB2;CLU;C4BPA;C4BPB;C1S;ZP3
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,-0.47325508804155175,-1.153107686027058,0.1780821917808219,1.0,1.0,28/126,14.82%,NRAP;C14ORF180;LMOD1;MYH7;CASQ2;ACTC1;CAV3;CTNNA3;OBSCN;HAMP;MYBPC3;LOX;SLC5A1;KLHL38;TRDN;CSRP3;ART3;CKB;GPIHBP1;CKMT2;COX7A1;NEXN;DHRS7C;ASB5;RXRG;HEY2;TTN;GATA4
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),0.6119323212457131,1.1530383899686902,0.3076923076923077,0.8521837075261761,1.0,5/12,12.14%,HYKK;AASS;ALDH7A1;AADAT;OGDH
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),0.6119323212457131,1.1530383899686902,0.3076923076923077,0.8521837075261761,1.0,5/12,12.14%,HYKK;AASS;ALDH7A1;AADAT;OGDH
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),-0.656159650216517,-1.1523095423514924,0.35,1.0,1.0,1/10,1.12%,JCHAIN
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.4039575427117281,1.1523038689022582,0.2608695652173913,0.8536513236294465,1.0,54/165,26.51%,SNRPN;NOVA1;ATXN1;TENT4A;HNRNPF;BICD1;RBMS1;HNRNPH1;KHSRP;SNRPB;U2AF1;SRRM1;HNRNPL;LIN28B;ELAVL4;ZMAT5;PPP1R9B;SF3B1;SRSF4;CELF2;SRRM4;PTBP1;FUS;NUFIP1;SYNCRIP;AURKAIP1;XRN2;U2AF2;SF3B4;TSEN2;RBM6;CPSF6;PIWIL2;TUT7;LSM6;ADAR;YJU2;NRDE2;PDCD7;PRPF18;MAGOHB;TCERG1;SNRNP48;SRPK2;SETX;RBM39;THOC1;SNRPF;SCAF11;LIN28A;RBM8A;SMU1;APOBEC1;SON
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),-0.6495039004899348,-1.1522138407277407,0.3225806451612903,1.0,1.0,3/14,7.40%,C1QTNF1;ALOX12;CEACAM1
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.4684803075070583,1.1521642030375432,0.2,0.8532861478095357,1.0,4/39,5.39%,GCK;FOXO1;SIRT1;ZBTB20
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),0.537960689303963,1.1521341857859457,0.21212121212121213,0.8525360099284089,1.0,4/23,4.79%,MT1G;TRPM2;PPARG;IFI16
prerank,PanglaoDB_Augmented_2021__Goblet Cells,-0.4915622841164332,-1.152115510532606,0.2328767123287671,1.0,1.0,22/60,19.93%,AQP3;CLCA1;MISP;CAPN8;SMIM22;TMC4;BACE2;PLA2G10;MUC5B;MS4A8;SPINK4;MUC4;GPX2;MUC17;TJP3;USH1C;SCNN1A;LGALS4;CAPN13;FAM3D;ACE2;CBLC
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.6535560203272094,-1.151529785846788,0.36666666666666664,1.0,1.0,2/12,2.54%,TGFB1;WNT5A
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),-0.6100248528159702,-1.1514044127525174,0.30158730158730157,1.0,1.0,2/15,9.22%,CAV3;PPT1
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),-0.6426547153934212,-1.1512466031477153,0.2711864406779661,1.0,1.0,1/12,3.14%,ADAD2
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),0.6878013947830389,1.1512269624773146,0.2708333333333333,0.8546555490326824,1.0,2/7,16.95%,PLIN5;GPLD1
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),-0.6989020365493295,-1.1511980741713626,0.3157894736842105,1.0,1.0,1/7,5.98%,EIF6
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),-0.7528976434761839,-1.1509608969529006,0.26666666666666666,1.0,1.0,2/6,20.44%,SOD2;PRDX1
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),0.6241060262737008,1.1509591283933969,0.36585365853658536,0.854803692352699,1.0,1/9,6.86%,CHAC1
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.6301039303127912,1.150878247082118,0.3125,0.8542109190844132,1.0,2/10,10.32%,DLGAP4;AKAP9
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.6371880124545064,1.1507522261865253,0.3142857142857143,0.8538611663422676,1.0,5/13,21.29%,DYNC1I2;APBA1;ARHGAP21;CLIP3;CAMSAP3
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.49774986989024195,-1.1506248740895444,0.24285714285714285,1.0,1.0,4/46,8.70%,PSMB9;BHMT;NQO1;AZIN1
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.4778120187322396,1.1505888618936388,0.12903225806451613,0.8528511728762564,1.0,12/51,23.62%,NUP210;NUP42;TRIM71;AAAS;TNRC6A;RANBP2;AGO2;IPO8;NUP214;POLR2F;TPR;SEH1L
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.4778120187322396,1.1505888618936388,0.12903225806451613,0.8528511728762564,1.0,12/51,23.62%,NUP210;NUP42;TRIM71;AAAS;TNRC6A;RANBP2;AGO2;IPO8;NUP214;POLR2F;TPR;SEH1L
prerank,GO_Biological_Process_2021__positive regulation of meiotic nuclear division (GO:0045836),-0.7207809610140468,-1.1505686922014888,0.29508196721311475,1.0,1.0,2/7,16.66%,STRA8;PRDM7
prerank,GO_Biological_Process_2021__meiotic sister chromatid segregation (GO:0045144),0.7382180254294342,1.1501528266326804,0.28888888888888886,0.853468568565718,1.0,1/5,10.60%,SGO2
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),0.6755434487225943,1.1500354442390128,0.36585365853658536,0.8531208264916359,1.0,4/7,21.64%,AGO3;TARBP2;AGO2;ADAR
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.4336825968137833,1.149950452635737,0.17391304347826086,0.8525188054781399,1.0,29/124,16.89%,GRID2;POU6F2;EPHA7;POU3F2;IGDCC3;UNC5D;ELAVL3;SIRT1;PROKR2;PAK5;SLC35F1;ERC2;CASKIN1;B4GALNT4;CSPG5;RIMS4;RHBDL3;PRR36;FBLL1;ASCL1;SNAP91;LRP8;MPP2;MSI1;SCRT1;NCAM1;EFNA2;MAGEL2;PBX1
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),-0.558631970219678,-1.1498376550548912,0.25757575757575757,1.0,1.0,11/27,26.90%,ATP1A4;ATP6V0E2;UCP1;HVCN1;ATP4A;NNT;ATP1A1;ATP6V0D1;SLC46A1;SLC36A3;DMAC2L
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),-0.627975012173139,-1.149609759344036,0.328125,1.0,1.0,2/11,9.69%,POU2F3;REST
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.5947096306732583,1.149067682552827,0.32432432432432434,0.854507286042202,1.0,8/13,28.25%,NOTCH1;RBPJ;BMPR1A;AKAP6;EDN1;ZFPM2;TGFBR3;MEF2C
prerank,GO_Biological_Process_2021__response to UV-B (GO:0010224),-0.6780138186192028,-1.1490203495463012,0.35,1.0,1.0,3/9,14.93%,CDKN1A;IL12A;HYAL1
prerank,PanglaoDB_Augmented_2021__Microglia,-0.47285659591681606,-1.1487130558617462,0.2638888888888889,1.0,1.0,25/94,11.77%,C1QB;IL21R;ITGB2;HCK;P2RY12;TAGAP;TNFRSF1B;PTAFR;SLCO2B1;C3AR1;GPR183;MS4A4A;PARVG;FCGR3A;LY86;VSIG4;NFAM1;MYO1F;IGSF6;P2RY6;PTPRC;FPR1;SPI1;CLEC12A;ITGAM
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),0.5658655010144291,1.1486669281184199,0.29545454545454547,0.8548380920938204,1.0,7/18,15.39%,LIPC;RORA;APOE;LPL;MLXIPL;ACSM2A;NR1H3
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),0.44769831342303357,1.1483498102891156,0.17647058823529413,0.8551541561305016,1.0,19/62,31.71%,ELOF1;IWS1;ELP4;ELOA;CCNH;MLLT3;GTF2F2;SETD2;ERCC3;POLR2F;PCID2;CDK13;SSRP1;LEO1;ERCC2;AFF4;CDC73;CCNT1;POLR2C
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),0.7396941988178589,1.1476029255831397,0.3181818181818182,0.8564855427897811,1.0,3/7,20.61%,PDZD11;RAB10;LIN7A
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),-0.6454028262913714,-1.1474712288845894,0.36666666666666664,1.0,1.0,3/10,8.67%,NLRP12;CEACAM1;ANXA1
prerank,GO_Biological_Process_2021__inhibition of cysteine-type endopeptidase activity (GO:0097340),-0.6783042034918676,-1.1474136577084626,0.390625,1.0,1.0,2/6,29.51%,CARD8;BCL2L12
prerank,GO_Biological_Process_2021__positive regulation of activin receptor signaling pathway (GO:0032927),-0.7566904111596406,-1.1471621824644964,0.3333333333333333,1.0,1.0,1/5,1.82%,NODAL
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.4728693080597898,1.1471092420414675,0.23529411764705882,0.8573069607838455,1.0,11/39,19.09%,ST6GALNAC3;GLA;ST6GAL2;ST8SIA4;ST3GAL3;NEU4;FUT9;ST3GAL6;NEU3;ST8SIA3;ST3GAL2
prerank,GO_Biological_Process_2021__positive regulation of neuroinflammatory response (GO:0150078),-0.7513410992611447,-1.1470400568556052,0.33962264150943394,1.0,1.0,2/6,15.16%,TAFA3;IL18
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),0.7130638417435148,1.1470392703883523,0.3333333333333333,0.8566480699796127,1.0,3/5,20.03%,ADIPOR1;ADIPOR2;APPL2
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),0.6334554489629732,1.1470253508285702,0.3125,0.8559059845532183,1.0,5/11,9.91%,IRS1;PID1;AKR1C3;AKR1C1;LPL
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),-0.687848488009973,-1.1468717078321191,0.3050847457627119,1.0,1.0,2/10,5.98%,NODAL;PLAC1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),-0.4675985091769075,-1.1467900331473344,0.21518987341772153,1.0,1.0,16/85,17.46%,ENPP2;MMP9;WNT5A;RAB11A;FLT4;THBS1;VIL1;PIK3CB;TEK;ZNF580;HYAL1;RRAS;AGT;GRN;RAC1;PIK3CG
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),-0.5476978059012533,-1.146780879754172,0.29508196721311475,1.0,1.0,6/28,11.58%,ATP1A4;ATP6AP1;SLC9A2;LACC1;SLC9C1;SLC9B1
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.3768777454830118,1.1466673359042705,0.24,0.856205525485144,1.0,34/154,16.14%,PCDH17;NOVA1;PARVA;LRRC4C;ELAVL3;CADM2;PCLO;PAK5;TOX;NMU;KCNIP1;FSTL5;ADGRA1;EFNA5;HIVEP3;TAFA1;GUCY1A2;BRINP1;RGS7BP;ELAVL4;OLFM3;RET;SCN7A;GOLGA7B;SNAP91;MAP6;RBFOX1;ASXL3;SCRT1;ANK2;PIK3CA;NRXN1;TAFA5;SLC7A14
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),-0.6519174782596262,-1.146659592713838,0.375,1.0,1.0,2/9,5.61%,ALOX5;PINK1
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.6826257418922955,1.146620257049017,0.34146341463414637,0.8555635423177262,1.0,2/8,14.95%,DAPK2;PIK3CA
prerank,GO_Biological_Process_2021__plasma membrane phospholipid scrambling (GO:0017121),0.7571980110038512,1.1466056988246518,0.3541666666666667,0.8548105025995815,1.0,3/6,15.31%,ANO7;PLSCR1;PLSCR4
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),-0.5494762166009258,-1.1466042208828218,0.22950819672131148,1.0,1.0,6/27,10.21%,TRIM62;TRIM5;CIITA;TRIM25;PTX3;HLA-DRB1
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),-0.7702761335465833,-1.1464430180440703,0.3728813559322034,1.0,1.0,1/5,2.90%,TRAIP
prerank,GO_Biological_Process_2021__kidney epithelium development (GO:0072073),0.6469637453577337,1.146147087883712,0.3269230769230769,0.8552784447214175,1.0,1/6,6.85%,OSR1
prerank,GO_Biological_Process_2021__regulation of hair cycle (GO:0042634),0.6552640474719518,1.1460220340043967,0.35135135135135137,0.8549472224735615,1.0,2/8,6.07%,TSKU;HPSE
prerank,GO_Biological_Process_2021__purine ribonucleoside catabolic process (GO:0046130),0.7309080715318372,1.1454612633570433,0.26666666666666666,0.856029828059648,1.0,1/5,0.17%,PNP
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),0.7368469437416741,1.1452210599693962,0.3235294117647059,0.8562017768564999,1.0,2/5,13.07%,CROCC;CCDC88A
prerank,GO_Biological_Process_2021__regulation of respiratory burst (GO:0060263),-0.6944349312377331,-1.1451313471150126,0.37254901960784315,1.0,1.0,3/7,17.19%,JCHAIN;RAC2;RAC1
prerank,GO_Biological_Process_2021__sinoatrial node development (GO:0003163),0.7080120135629432,1.1449466579930696,0.3488372093023256,0.8563594411950184,1.0,1/6,1.92%,GJB6
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),0.4529075788017263,1.1449464809207461,0.17647058823529413,0.855567981452694,1.0,23/65,27.93%,ARC;NXF5;NXF1;U2AF1;SRRM1;SRSF4;RBFOX1;PNPT1;XPO5;SIDT1;EIF4A3;U2AF2;EIF4E;NUP214;TPR;MAGOHB;YBX1;THOC1;NUP153;RBM8A;ATXN2;TST;DDX39A
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),0.4944537481921072,1.1449095991845462,0.19444444444444445,0.8548058643910842,1.0,3/20,4.59%,APOE;PPARG;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.4249271313185271,1.1448375693037764,0.18181818181818182,0.8541983578964799,1.0,40/203,14.49%,BAMBI;VWC2;NGF;CCN4;TGFBR1;NEUROD2;FGFR1;APOB;CCN2;BRINP3;RIN2;CCN1;SMYD1;PPARG;WNT4;ZC4H2;DLX1;ZNF703;ABL1;PLCB1;ZEB1;BEND6;TWIST1;KITLG;LPL;BNIP2;BRINP1;RPS6KA3;SP7;BCL9L;GDF6;RAP1A;CDH2;ASCL1;CARM1;SMAD2;NFKB1;SUCO;SOX5;WWTR1
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),0.7004050192176228,1.1442689161909831,0.34782608695652173,0.8550112849531954,1.0,5/6,29.31%,SLC30A10;NFKB1;PRKCD;ROCK1;RELA
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),-0.7663783660196253,-1.1442549794864696,0.3125,1.0,1.0,2/5,14.99%,USP50;DDX3X
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),0.5854191683424247,1.1441959012557912,0.2894736842105263,0.8544464141842093,1.0,5/11,31.05%,HMGB1;LIG4;DCAF1;LIG3;RAG2
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.5328348109382873,1.1436678424830498,0.2413793103448276,0.8553548419793343,1.0,9/22,23.99%,PPARG;CBLB;CHMP6;GPRC5A;EPHB2;ZFYVE28;SOCS4;TSG101;CBL
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),0.5084203487470937,1.1436040314446714,0.22857142857142856,0.8547351879171986,1.0,6/26,5.25%,ANGPT1;CDH5;SEMA5A;ITGA4;AKR1C3;SERPINE1
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),0.47119747295917075,1.143231538291671,0.2,0.8549762231330531,1.0,16/32,27.24%,LZTR1;ABL2;ITGA3;KANK1;ARHGAP35;SPRY4;EPHB2;CCDC125;STAMBP;RASIP1;SPRY1;SCAI;SPRY3;ARHGAP44;DLC1;SPRY2
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.5393195950830106,1.1431769573446515,0.2619047619047619,0.8543442023967025,1.0,7/15,20.03%,PCM1;ROBO2;WNT3A;ELAPOR2;NOTCH1;PAX6;APPL2
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),0.5430061666005658,1.1431711322277145,0.2702702702702703,0.8536026337470206,1.0,3/16,17.56%,MGARP;DST;DLG2
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.684597796845905,1.1429044148475442,0.26666666666666666,0.8535537054183381,1.0,1/11,0.97%,RAB27A
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),0.4878404671176877,1.142868913095004,0.3,0.8528418429333471,1.0,14/42,15.11%,NOX4;NAALAD2;DDAH2;SRR;CBS;KYAT1;RIMKLB;GLUD1;ALDH18A1;AADAT;DDAH1;SLC25A12;MTHFR;THAP4
prerank,GO_Biological_Process_2021__ADP transport (GO:0015866),0.7403086982664674,1.1427694086190787,0.3333333333333333,0.852365888086993,1.0,3/5,19.08%,SLC25A42;SLC17A9;SLC25A41
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),0.5963604281086419,1.1426780431075774,0.3695652173913043,0.8517115616291799,1.0,2/9,7.70%,SOAT1;PLCB1
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),-0.5943966058741571,-1.1425650833708931,0.28125,1.0,1.0,2/14,5.44%,TGFB1;CLCF1
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),-0.743831560700898,-1.142545856256504,0.3333333333333333,1.0,1.0,1/7,6.02%,TRIM25
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell differentiation (GO:0051152),0.6786180102865983,1.1423911444403123,0.358974358974359,0.8517058628543533,1.0,2/5,6.59%,KIT;OLFM2
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.36101339367616114,1.1420624430196582,0.17647058823529413,0.8520029522641865,1.0,37/258,12.18%,ADRA1A;GPR3;ADRA1B;BAMBI;ESRRG;PER2;ELOVL6;TSKU;TGFBR1;HDAC3;APOE;NLGN1;ZBTB7B;SIRT1;IFI16;CCDC88B;SERPINE1;CADM1;NCOA3;ZNF703;CARD9;ABCA1;PLCB1;ALMS1;SHLD2;LEPR;TWIST1;SHLD1;ADIPOR1;PPIB;F2R;ACSL1;UCN;MAP3K13;ADIPOR2;KMT5C;BCL9L
prerank,PanglaoDB_Augmented_2021__Basal Cells,0.41372188418077877,1.1416845970236547,0.18518518518518517,0.8522857504347808,1.0,10/89,4.24%,ADGRF4;EMP1;CD151;LAMA3;BCL2;HSPB1;SDC4;PERP;SLC25A37;DUSP23
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),-0.5634353248391035,-1.141325958679405,0.3333333333333333,1.0,1.0,1/25,1.49%,TGFB1
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.526407892348646,-1.1412136982234649,0.3382352941176471,1.0,1.0,1/35,0.37%,NEK2
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.5135385674680487,1.1411186057732947,0.225,0.8529526862358289,1.0,4/22,6.95%,NLGN1;PCLO;CGNL1;DSP
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),0.6428798494350512,1.1410491649914587,0.275,0.8524517765549714,1.0,6/10,28.94%,ABCD2;MLXIPL;NR1H3;ELOVL5;SLC45A3;MID1IP1
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),-0.7252299306751632,-1.1402898592983117,0.3181818181818182,1.0,1.0,2/8,4.08%,SCN5A;MYBPC3
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.5794801834364248,-1.1402594146051017,0.2459016393442623,1.0,1.0,5/21,8.63%,TGFB1;NODAL;CYP1B1;FLT4;BRCA1
prerank,GO_Biological_Process_2021__type B pancreatic cell development (GO:0003323),0.6911931249124054,1.1402485334611954,0.3673469387755102,0.8540086707787976,1.0,3/6,21.65%,CDK6;CDH2;BMP4
prerank,GO_Biological_Process_2021__positive regulation of secretion (GO:0051047),-0.6991997628027988,-1.1400723570169151,0.3472222222222222,1.0,1.0,4/8,18.26%,ALOX12B;SCIN;ACSL3;ABCB11
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.6298680668835621,-1.1397955494102272,0.3387096774193548,1.0,1.0,2/12,3.78%,PKP2;CTNNA3
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),0.7151787691750815,1.1397033719043037,0.32608695652173914,0.8550558326456008,1.0,2/6,5.35%,RFWD3;CRY1
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),0.383243776792118,1.139585118332269,0.17391304347826086,0.8547596950505116,1.0,18/84,14.06%,ARC;VSTM5;KCNC2;PKD2;SNCA;ZBTB1;IKZF4;CARD9;MICU1;SPAST;EHD4;MCU;UGDH;MAT2A;CPSF7;TRMT61B;MPP2;PNPT1
prerank,GO_Biological_Process_2021__organic hydroxy compound catabolic process (GO:1901616),-0.6917207651028063,-1.13947541083451,0.375,1.0,1.0,3/9,13.26%,CYP24A1;CYP3A4;CYP4F12
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.6487161900544615,-1.1393765747334954,0.35,1.0,1.0,6/13,15.91%,CLDN1;CLDN6;CLDN5;CLDN2;CLDN18;CLDN20
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.48621805727570877,1.1393553707418516,0.20833333333333334,0.8547512765807371,1.0,12/42,19.73%,HTRA2;PID1;FZD5;MARCHF5;SIRT7;MGARP;USP36;MIEF2;IAPP;EP300;STOX1;SREBF2
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),-0.5703570069619825,-1.1390718664608996,0.26229508196721313,1.0,1.0,6/21,14.65%,CYP24A1;RBP2;CYP3A4;LRP2;CYP4F12;VDR
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.45264556324769756,-1.1390094255356202,0.19480519480519481,1.0,1.0,6/166,3.67%,CD44;AQP3;MICB;ELOVL2;CYP26B1;CCND1
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),0.588571074177225,1.138947489888627,0.32432432432432434,0.8552484039081852,1.0,1/11,3.92%,RIPK2
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.608583434276662,1.1387992067902706,0.2857142857142857,0.8550074980029524,1.0,4/10,24.71%,KDM7A;KDM3B;JMJD1C;KDM4C
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),0.46318005922195643,1.1386847144052832,0.2903225806451613,0.8545351761809278,1.0,4/32,5.56%,ATP6V0D2;TCIRG1;RAB20;RAB7A
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.3557406659366963,1.1384467015600674,0.08333333333333333,0.8546223726983385,1.0,96/381,19.73%,NGF;POU3F1;SLITRK6;ADGRG6;CHRM2;VCAN;TGFBR1;POU6F2;ROBO2;NEUROD2;NLGN1;POU3F2;DSCAML1;IL1RAPL2;SEMA5A;ATXN1;FGF17;FZD5;SDK1;ZEB2;GRIK1;ZC4H2;JAG1;PKD2;NRG1;HES1;FKTN;ST8SIA4;PROX1;TRIM71;PTPRZ1;CHAC1;DSCAM;EFNA5;SCD5;TENM1;CRIM1;NAV3;SNTG2;MTR;RPS6KA3;TRAK2;FGF12;ALDH1A2;CSPG5;EVL;AVIL;DPF1;RBFOX2;MYT1L;FARP1;TYRO3;ADGRV1;APBA1;NLGN3;CPNE6;DPF2;CDH2;ASCL1;RBFOX1;NAV1;CHST8;NF1;MSI1;BTBD2;WWTR1;MARK4;RYK;HDAC4;RPS6KA6;SRRM4;ACHE;NRXN1;CNTN6;NRSN1;ADORA1;LIG4;EPHB2;ATN1;PPP2R5D;PAX6;KIRREL3;LIMK1;S100B;LSAMP;GBA2;EP300;UNC119B;NAV2;DPF3;CDK5;SH3GL1;PCDHB6;PCDH1;NRCAM;SREBF2
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.6417738942281651,-1.1382208228440787,0.2857142857142857,1.0,1.0,2/10,9.69%,PINK1;REST
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.3793880342981177,1.138088648670368,0.15,0.8549000038713578,1.0,32/128,18.53%,TEAD2;ESRRG;HDAC3;MED17;RORA;HDAC10;RARB;CCN2;PPARG;MAML1;RORB;TAF3;NR4A2;TAF12;CCNH;TEAD4;NR3C2;HDAC1;NR3C1;GTF2F2;WWTR1;THRB;NR1H3;NR6A1;NRBF2;NR4A3;NOTCH1;NR2C1;TAF4;ERCC3;RBPJ;NR4A1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.4400080093370737,-1.1380599211383522,0.23376623376623376,1.0,1.0,30/133,20.07%,PDCD1LG2;NLRP12;UBE2L6;SFTPD;TRIM25;CEACAM1;VSIG4;ZFPM1;ANXA1;THBS1;GBP1;HLA-DRB1;PTPRC;SLC11A1;APOD;NLRC3;LEF1;IL12A;NR1H4;ADCY7;ELANE;F2RL1;GHRL;VSIR;RAC1;CACTIN;AXL;INHA;FN1;DHX58
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.5763680041796057,-1.1380406412100623,0.3,1.0,1.0,5/22,8.63%,TGFB1;NODAL;CYP1B1;FLT4;BRCA1
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),-0.6683938298533714,-1.1378710717649445,0.23636363636363636,1.0,1.0,4/10,21.56%,OLFM4;RAC2;RAC1;BST1
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),0.6555093924329379,1.137539418275304,0.37209302325581395,0.8549373772363935,1.0,2/6,15.39%,PPARG;NR1H3
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),0.6555093924329379,1.137539418275304,0.37209302325581395,0.8549373772363935,1.0,2/6,15.39%,PPARG;NR1H3
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.4383965758601051,1.137462073651589,0.16666666666666666,0.8545079731620945,1.0,20/38,33.48%,MFSD2A;HRH3;HLA-DRA;NF1;NIPBL;C5AR1;DOP1B;GRM5;SOBP;METTL23;PTCHD1;RP9;ST3GAL4;MAGT1;TUSC3;CHD7;BBS4;NSUN5;LINS1;FAM107A
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),-0.6586047385227578,-1.1371918669397916,0.3157894736842105,1.0,1.0,4/10,17.52%,GPR183;CXCL16;PIK3CG;MSN
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),-0.6589814028802307,-1.1370666249629966,0.3181818181818182,1.0,1.0,3/10,14.89%,KCNA5;KCNQ1;KCNE3
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),0.7055259921223043,1.1369929823900173,0.3902439024390244,0.8550831345380482,1.0,2/6,14.34%,CEP135;SEPTIN9
prerank,PanglaoDB_Augmented_2021__B Cells,-0.44524868348827695,-1.136959919145783,0.189873417721519,1.0,1.0,29/111,17.79%,JCHAIN;GMFG;IL21R;IRF4;CYTIP;TBC1D10C;ARHGAP9;TAGAP;TMC8;PARVG;CD5;IFIT3;WAS;LY86;CD37;TRAF3IP3;PTPRC;HVCN1;BLNK;CD27;PSTPIP1;NIBAN3;CD80;IKZF1;IGLL1;NAPSB;CD24;POLD4;ALOX5AP
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),0.7454310105468187,1.136947600542508,0.3793103448275862,0.8544239762619071,1.0,3/5,6.42%,ZBTB7B;CBFB;HMGB1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),-0.5599133875606835,-1.1368491950693977,0.2571428571428571,1.0,1.0,6/24,14.67%,BLK;PDCD1LG2;SFTPD;VSIG4;HLA-DRB1;CD80
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.6177915927465675,1.1366990748827113,0.3055555555555556,0.8542399160860482,1.0,4/9,16.45%,CHPT1;LPCAT2;PLA2G4C;DHRS7B
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.43379335492806703,1.1366789337089627,0.22727272727272727,0.8535285814008982,1.0,11/62,7.77%,ADAMTS1;FGF10;LSM10;SLFN11;PKD2;GFI1B;CDK6;CDK4;CCND3;PLCB1;RBL1
prerank,GO_Biological_Process_2021__spinal cord dorsal/ventral patterning (GO:0021513),-0.7601062097863032,-1.1366625599335647,0.3076923076923077,1.0,1.0,1/5,3.07%,RFX4
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),0.5640507627305321,1.1366094160132183,0.2926829268292683,0.8529942310430627,1.0,7/15,23.43%,METTL8;PCIF1;TRMT61B;ZC3H13;TRMT61A;METTL16;NSUN2
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.5923356036905445,1.136592768359053,0.2972972972972973,0.8522582748468966,1.0,6/10,28.25%,NOTCH1;RBPJ;BMPR1A;ZFPM2;TGFBR3;MEF2C
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.4404897046475418,1.1364376625137116,0.20833333333333334,0.8520093477655821,1.0,12/50,18.05%,OLFM2;ABCA1;CYB5R4;RIMS2;RAB3C;TVP23B;PREB;RAB10;LTBP2;WLS;RAB3D;MIA3
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),-0.518425903992944,-1.136366837821592,0.2702702702702703,1.0,1.0,8/42,14.16%,TBX1;TGFB1;CYP1B1;LOX;FLT4;ID1;ENG;HEY2
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),-0.582819174833423,-1.136363255624915,0.3090909090909091,1.0,1.0,4/19,7.97%,TRIM62;TRIM5;TRIM25;CHMP3
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),-0.6614500846569566,-1.1361256530383324,0.3283582089552239,1.0,1.0,3/11,19.66%,ATP1A4;ATP4A;ATP1A1
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.5500832910360876,1.1360145478705497,0.25,0.85247530528515,1.0,2/13,4.26%,HSPB1;SEMA5A
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),0.46798724610096915,1.135997744997362,0.22857142857142856,0.8517417815549484,1.0,9/33,22.73%,STX5;GBF1;DYRK3;MRRF;PLK3;ATG2A;ATG2B;RETREG1;STING1
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),0.4965219588621004,1.135867439244546,0.23529411764705882,0.8514132445479194,1.0,7/34,13.46%,CEL;NLGN1;SNCA;SYT1;NLGN4X;NLGN3;SNAP91
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.5691570053061941,-1.1357397730028798,0.3384615384615385,1.0,1.0,4/18,23.78%,RPA3;RBX1;RPA2;DDB1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.5691570053061941,-1.1357397730028798,0.3384615384615385,1.0,1.0,4/18,23.78%,RPA3;RBX1;RPA2;DDB1
prerank,GO_Biological_Process_2021__regulation of thymocyte apoptotic process (GO:0070243),0.6854635699415386,1.1357341125374771,0.3958333333333333,0.8510449606739448,1.0,3/5,22.36%,TP53;BMP4;ADAM8
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),0.675782599855312,1.1357123280387598,0.3409090909090909,0.8503683954163948,1.0,2/5,17.51%,DUT;DTYMK
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),0.6964505927959972,1.1354675926023843,0.391304347826087,0.8503506173782955,1.0,2/7,21.25%,SLC35G1;SLC8B1
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.49044535172347975,-1.1351417757233206,0.2602739726027397,1.0,1.0,17/58,18.74%,ENPP2;CYP3A5;PDXDC1;PLA2G10;LVRN;ERAP2;PPT1;CYP3A4;SIAH1;ELANE;GGACT;PLA2G4A;RENBP;CPQ;ANPEP;ERAP1;CLN8
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.5013583904008807,-1.1351147271252546,0.22972972972972974,1.0,1.0,8/44,22.81%,POLQ;RPA3;POLD4;SMUG1;HMGA2;OGG1;RPA2;XRCC1
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),-0.6018973301156697,-1.135091492062793,0.3076923076923077,1.0,1.0,2/18,2.65%,RIN3;LRPAP1
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.6416041708178527,-1.1349726305241081,0.31746031746031744,1.0,1.0,2/11,12.48%,CARD14;TNFRSF10A
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.5571903212353232,1.1349261338164653,0.2972972972972973,0.8515530145850967,1.0,6/27,7.66%,FHIT;IFI16;PPP1R13B;ACER2;GREM1;ZNF385B
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),0.6132287215901692,1.134735322138481,0.34285714285714286,0.8513600653958593,1.0,5/11,25.77%,DHFR;MTHFR;SHMT2;MTHFD1L;MTHFD2L
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.47768458037640493,1.1345152492586157,0.25,0.8513280711009074,1.0,3/46,4.13%,GCK;NUP210;NUP42
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.4327541598575618,1.1339078193055931,0.25,0.8524729173309136,1.0,19/59,22.74%,TBC1D10A;IFT88;TBC1D16;CEP120;SDCCAG8;CROCC;TBC1D22B;EVI5L;CCDC88A;ARHGAP35;MARK4;IFT140;TBC1D2;DCDC2;TBC1D8;USP6NL;TBC1D5;RABEP2;LIMK2
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),-0.627850931554526,-1.133759651465615,0.3709677419354839,1.0,1.0,4/11,19.63%,SOX10;CLU;PLP1;MYRF
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),0.6503214259224926,1.1329691244285214,0.38095238095238093,0.8544307405709044,1.0,3/7,14.22%,GREM1;LEPR;SUCO
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.7041092298506175,1.1328334121609758,0.325,0.8541157893073869,1.0,2/7,14.95%,ITGA3;INSR
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.6124919756422398,-1.132734871597074,0.34285714285714286,1.0,1.0,3/15,10.00%,CD160;CEACAM1;GBP1
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.5823419507442276,1.1324638487143885,0.3225806451612903,0.8542815302432105,1.0,7/12,23.99%,CBLB;CHMP6;GPRC5A;ZFYVE28;SOCS4;TSG101;CBL
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.5680352493735076,1.1324234472782577,0.2619047619047619,0.852894683114723,1.0,4/15,15.19%,FHDC1;PHACTR1;ARRB1;FAM171A1
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.5680352493735076,1.1324234472782577,0.2619047619047619,0.852894683114723,1.0,4/15,15.19%,FHDC1;PHACTR1;ARRB1;FAM171A1
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.5468120835305612,1.1323805722130669,0.29411764705882354,0.8522895544252045,1.0,3/19,18.99%,JADE3;MSL2;JADE2
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),0.5668850809863921,1.1322641668660867,0.28205128205128205,0.8520310348077451,1.0,3/10,13.82%,PUS10;DGCR8;SMAD2
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.5660961260532335,1.1321807681005935,0.3125,0.8515605146708494,1.0,5/11,14.95%,VEGFC;NUS1;GAB1;MYO1C;PIK3CA
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),0.5515253522858847,1.1321753077378407,0.325,0.8508652861056363,1.0,3/14,3.19%,SLC30A10;TRPC3;SLC39A8
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),-0.55027047937102,-1.1320573142372798,0.2835820895522388,1.0,1.0,4/27,15.88%,MISP;GPSM2;DCTN1;NDEL1
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.46394090320728626,-1.1318511983713866,0.18840579710144928,1.0,1.0,12/82,19.11%,PSMB9;FBXO48;KIF14;FBXL7;FBXL13;FBXO39;CCNF;RBX1;PSMA3;FBXL18;PSMA7;PSMB6
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),0.437510801447942,1.131829629019514,0.18181818181818182,0.8509930968492362,1.0,10/50,11.22%,SLC16A9;SLC38A5;SLC3A2;SLC16A7;SLC16A5;SLC6A17;SLC6A20;SLC7A6;SLC25A29;SLC7A8
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.737385261026126,1.131815066444934,0.34146341463414637,0.8502863422077842,1.0,3/5,25.95%,MTMR3;MTMR1;MTMR9
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),-0.5374538372715096,-1.1316634324798902,0.3,1.0,1.0,5/33,8.81%,TBX1;SOX10;SEMA3F;SEMA3A;HTR2B
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),0.6133150035614736,1.1315496372271543,0.325,0.8504673639328644,1.0,4/9,21.64%,AGO3;TARBP2;AGO2;ADAR
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,0.379674106607414,1.1314615900006701,0.18181818181818182,0.8499473918380883,1.0,6/80,4.81%,ADGRF4;LAMA3;FAM83H;SDC4;PERP;ERBB2
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell differentiation (GO:0045630),-0.6928446504744774,-1.1313505604903173,0.33962264150943394,1.0,1.0,5/6,28.50%,NLRP3;IL18;CD86;TNFSF4;RARA
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.5489457562930983,1.1313432187174202,0.3611111111111111,0.8496792958409656,1.0,6/19,13.81%,GRM3;DRD5;GRM2;CAP2;ADGRV1;NF1
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),0.6245156640203698,1.1307209295753535,0.2926829268292683,0.8509029526434038,1.0,3/8,11.24%,SLC39A8;DDAH2;DDAH1
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.5230932172257161,-1.1303221090256448,0.2878787878787879,1.0,1.0,6/40,12.07%,TICRR;DTL;DONSON;ABRAXAS1;BRCA1;CDKN1A
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),-0.5833670308877117,-1.1303006406630778,0.38333333333333336,1.0,1.0,4/16,11.21%,SLC5A2;SLC5A1;SLC9A2;SLC9C1
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),0.6519966822326915,1.130273430345471,0.3023255813953488,0.8516761589855779,1.0,2/8,4.67%,SPTBN4;CNTNAP2
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.6704316692364435,1.1301242900169153,0.43478260869565216,0.8513545595969938,1.0,6/9,31.28%,OSR1;NEDD4;PRKCE;STK39;HECW1;HECW2
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),-0.779212111120575,-1.1300749334216589,0.3392857142857143,1.0,1.0,1/5,6.02%,TRIM25
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),-0.5282358817279252,-1.1299791689780434,0.288135593220339,1.0,1.0,1/32,0.37%,NEK2
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),0.6219411735748485,1.1294638738860863,0.35,0.8524550911588523,1.0,3/11,13.92%,STX5;GBF1;PLK3
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),0.6092747382916073,1.1292232281006045,0.375,0.8522122808624212,1.0,1/8,5.52%,ARMC10
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),-0.5138352396507432,-1.1291556938852845,0.25806451612903225,1.0,1.0,8/38,13.42%,SIRPG;TULP1;DOCK2;SFTPD;CYBA;PTPRC;SLC11A1;CD300LF
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),0.6596791747503904,1.1291475879634516,0.40816326530612246,0.8516282590534683,1.0,6/6,34.05%,HRH1;GABRB2;GABRB1;GABRB3;GABRG2;DIAPH1
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.5392066672758061,1.1287784594235906,0.30952380952380953,0.8521480342882086,1.0,3/18,7.70%,CHRM2;HRH3;PLCB1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),-0.5922760096893617,-1.1287087876433628,0.3387096774193548,1.0,1.0,3/16,16.67%,NLRP12;NLRC3;GHRL
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter transport (GO:0051590),-0.7333559898544522,-1.1286650956862405,0.3673469387755102,1.0,1.0,1/5,5.18%,GPER1
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.421417259350909,1.128634699065276,0.21052631578947367,0.8517749541995218,1.0,21/91,14.19%,VWC2L;BAMBI;VWC2;TGFBR1;SPRED3;IL17RD;PPARG;SIRT1;MAGI2;DLX1;GREM1;FSTL3;SPRED2;CRIM1;SPRED1;PPM1A;BCL9L;HSPA1A;SMAD2;BMPER;SMURF1
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.5303181039462159,-1.128633274143348,0.29577464788732394,1.0,1.0,11/32,14.68%,F8;C1QTNF1;F7;VTN;GP1BA;PLAU;CPB2;PLG;PLAT;A2M;TFPI
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.39528502565609686,1.1285757060143902,0.21739130434782608,0.8512321495760583,1.0,29/96,23.62%,NUP210;LOXL1;HDAC10;NUP42;SIRT1;P3H3;SIRT7;BCL11A;PLOD3;SENP1;AAAS;P3H4;ATPSCKMT;LIPT2;RNF212;ESCO1;HDAC4;NSMCE2;RNF113A;RANBP2;EP300;KAT2B;SENP5;NUP214;TPR;PLOD2;CTH;SENP6;SEH1L
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),0.6573894136013076,1.1285179098821252,0.3958333333333333,0.8507426632671701,1.0,4/8,18.70%,MAGI2;FSTL3;SKI;ACVR1
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),-0.6578774755735297,-1.128483799743515,0.3333333333333333,1.0,1.0,1/9,0.88%,IYD
prerank,GO_Biological_Process_2021__kidney mesenchyme development (GO:0072074),0.6283206473450709,1.1283284625147527,0.3055555555555556,0.8505156821661765,1.0,2/5,6.85%,PKD2;OSR1
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),0.5422104998996577,1.1282773795437702,0.35294117647058826,0.8498969486030731,1.0,1/15,1.53%,KIT
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),-0.5997523907578639,-1.1282022993822634,0.3333333333333333,1.0,1.0,5/17,13.13%,BANF2;H1-0;HAT1;H1-3;CHAF1A
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),-0.6146158085216658,-1.1277251437295037,0.3050847457627119,1.0,1.0,2/10,5.18%,TGFB1;GPER1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.5152912118455846,1.1276515564412968,0.3225806451612903,0.8512905577339831,1.0,4/21,13.63%,MED17;MITF;TWIST1;MED16
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),-0.6126577090360859,-1.127587341837874,0.3392857142857143,1.0,1.0,2/13,5.18%,ESR1;GPER1
prerank,PanglaoDB_Augmented_2021__Motor Neurons,0.43901924584293817,1.1271543625104186,0.22580645161290322,0.8519118715076979,1.0,23/70,25.43%,POU3F2;MID1;DLX1;TENM3;AADAT;CSPG5;RIMS4;RBFOX2;FJX1;NR2F2;MPP2;MSI1;SRRM3;EFNA2;CDR2L;FOXO6;RCOR2;CBARP;ABCG4;TUBB2B;FZD7;IGDCC4;B4GALNT1
prerank,GO_Biological_Process_2021__ribosome localization (GO:0033750),-0.7343948899074794,-1.1271307003691104,0.3392857142857143,1.0,1.0,1/5,5.98%,EIF6
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.45751846867267154,1.127060040781605,0.32,0.8515282129402,1.0,3/33,4.24%,ATP6V0D2;TCIRG1;REP15
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,-0.4549390843510148,-1.1270069800233598,0.34545454545454546,1.0,1.0,23/73,21.90%,MISP;CAPN8;SCTR;SMIM22;TMC4;MUC5B;MYO5B;AQP4;SOWAHB;ITGB6;GPX2;TJP3;CD24;SCNN1A;LGALS4;CAPN13;SLC44A3;FAM3D;ACE2;CBLC;HNF1B;SOX9;ALB
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),0.6252099342909909,1.1269745557612094,0.3,0.8510540315979674,1.0,4/7,34.60%,ZDHHC5;SLC15A4;XIAP;SLC15A2
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),0.7463330828201747,1.1264327986379874,0.3333333333333333,0.8516609272535356,1.0,1/5,2.49%,MAFB
prerank,GO_Biological_Process_2021__sensory perception of taste (GO:0050909),-0.6827653155100818,-1.12615125176162,0.3103448275862069,1.0,1.0,3/9,22.20%,GNAT3;PKD1L3;TAS1R1
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),-0.7032835463748267,-1.1261213592602506,0.3220338983050847,1.0,1.0,3/8,15.29%,ITM2A;BACE2;ITM2C
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.5116931292549662,1.1260366651722593,0.3076923076923077,0.8526048804949516,1.0,7/24,15.86%,SELPLG;PID1;FER;NFKB1;PTPRT;ST3GAL6;PTGIS
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),-0.7333676533322733,-1.1258936071653167,0.34615384615384615,1.0,1.0,3/6,15.29%,ITM2A;BACE2;ITM2C
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.636777081043435,1.1257472028477278,0.38095238095238093,0.8528585920794758,1.0,2/6,7.76%,NLGN1;PHACTR1
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.5876885323656826,1.1255539277642714,0.3157894736842105,0.85265751132657,1.0,4/12,28.09%,SENP6;DESI2;SAE1;ATG7
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.6266792528013072,-1.1252794716701875,0.3382352941176471,1.0,1.0,1/13,1.82%,NODAL
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.4703119999015837,1.1249151658117087,0.29545454545454547,0.8540002594253798,1.0,5/20,14.95%,IRS1;CAPN10;AKT2;IRS2;INSR
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.6389081462888782,-1.1248377147494992,0.391304347826087,1.0,1.0,1/8,0.36%,MICB
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),0.6583937034051914,1.124540008549709,0.3157894736842105,0.8544724282785863,1.0,2/7,6.42%,SIRT1;HMGB1
prerank,GO_Biological_Process_2021__cell migration involved in heart development (GO:0060973),0.6890557622779747,1.1242422880633671,0.3170731707317073,0.8546718750247054,1.0,2/5,16.67%,SNAI2;NOTCH1
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),-0.5556516728826234,-1.1239188469823551,0.2807017543859649,1.0,1.0,5/15,12.28%,MSMP;CXCL13;GPR183;HSD3B7;CXCL16
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),0.48240624729784853,1.123917279238467,0.29545454545454547,0.8551426591707089,1.0,7/29,4.75%,COL8A1;DUSP4;DUSP2;LAMA3;COL12A1;ITGA4;MMP2
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),0.5814004619418481,1.1238522183573965,0.2619047619047619,0.8546431850049493,1.0,6/15,21.55%,RTN2;NR4A3;CLIP3;BRAF;PRKAG2;OCLN
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),0.514775221111352,1.1237813236958452,0.20689655172413793,0.8541703953148617,1.0,8/35,11.59%,PER2;FBP2;PC;ENO3;CRY1;G6PC3;SLC25A1;SLC25A12
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),0.5650219091441917,1.1236197898021076,0.4,0.8539306846101962,1.0,2/13,4.97%,AUTS2;DNMT1
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.4990160661118,1.1234185588568473,0.30303030303030304,0.8536269187493273,1.0,5/16,14.09%,APOB;PLIN5;SIRT1;LPL;NFKB1
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),0.4081584850850474,1.1232363992350638,0.25,0.8534009627373574,1.0,10/86,7.29%,MT1G;CDH5;SLC30A10;RGN;SLC39A8;HTR2C;SLC8A1;DRD5;SLC8A3;DRD4
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.6211215239124981,-1.1231275662649043,0.35294117647058826,1.0,1.0,4/12,18.81%,COX6A1;COX6C;COX7C;COX4I1
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),0.56222081106651,1.1229745157810964,0.34146341463414637,0.8533427140879317,1.0,3/11,8.07%,SEMA5A;WASHC2C;CRACD
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),0.6739170255086776,1.1229214651973671,0.38095238095238093,0.8527573060014096,1.0,2/6,27.31%,SMURF1;FNBP1L
prerank,GO_Biological_Process_2021__pericardium development (GO:0060039),0.6440971981746222,1.1228194443704167,0.4,0.8523656296971365,1.0,3/6,25.69%,LRP6;NOTCH1;BMP2
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),0.6501377874330594,1.1223164112600832,0.4523809523809524,0.853053019642215,1.0,2/8,9.27%,MID1;MAPRE1
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),-0.626481331270642,-1.1222638840375654,0.34615384615384615,1.0,1.0,3/14,6.02%,TRIM62;TRIM5;TRIM25
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),-0.6427678283343037,-1.122197223150435,0.3508771929824561,1.0,1.0,3/11,15.16%,IRF4;LEF1;IL18
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),0.44869729947041137,1.121898183165457,0.25806451612903225,0.8535724880884573,1.0,13/54,13.81%,FGF10;TSKU;TGFBR1;CFLAR;DCBLD2;ERBB2;NRG1;HPSE;DSP;PLEC;MACF1;DST;NF1
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),-0.7102439551989923,-1.1218423989463673,0.3275862068965517,1.0,1.0,3/7,21.48%,DDX3X;GPS2;PARP10
prerank,GO_Biological_Process_2021__prostaglandin transport (GO:0015732),-0.741358214244924,-1.1216720357554728,0.2909090909090909,1.0,1.0,2/5,14.17%,SLCO2A1;NOS2
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),-0.6241521263006508,-1.1214449970064224,0.3728813559322034,1.0,1.0,2/11,6.32%,GPER1;PLA2G10
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,0.43738105531554694,1.1212169096087654,0.2962962962962963,0.8549369504109078,1.0,22/95,13.97%,GCK;HGFAC;XKR7;GOLT1A;PLPPR1;CACNG4;HRH3;SEMA6C;PTOV1;REEP6;SYT1;SARDH;ABCC8;PDE9A;WNK2;HID1;EBF4;FAM163B;PRR36;CRABP1;FBLL1;HCN3
prerank,GO_Biological_Process_2021__cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.7206629879508293,1.1212044713766356,0.40476190476190477,0.8542502293381199,1.0,3/5,27.48%,TICAM1;MIA3;AKT1
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),-0.46964963629478096,-1.1211600648914788,0.3150684931506849,1.0,1.0,10/60,13.80%,TCF7;WNT5A;WNT8B;FZD8;TCF7L1;FRAT1;SFRP4;WNT8A;WNT6;LEF1
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.5042136869729027,1.1208612286237376,0.30303030303030304,0.8544347034932476,1.0,11/27,26.65%,TGFA;INSR;ESPL1;NSMCE2;ANAPC7;DMRT1;ANAPC4;EDN1;RB1;BTC;PHIP
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.5024443315351925,1.1206376058054133,0.34782608695652173,0.8543248391291571,1.0,11/29,13.70%,CSGALNACT1;HS3ST3B1;EXT1;NDST3;CHST12;CHST11;B3GAT3;UGDH;EXT2;FAM20B;CHST8
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),0.42951550561941887,1.1202350242858878,0.30303030303030304,0.854904898817028,1.0,23/82,20.92%,APOE;BIN1;SAMD4A;PCIF1;DHFR;TRIM71;RIDA;EIF2AK3;NANOS3;CNOT9;RTN2;PUS7;MALSU1;SYNCRIP;LSM14A;ABCA7;SAMD4B;EIF4A3;NANOS1;RNF139;FXR2;NTRK2;LARP1
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),0.5676425200867097,1.120084459027445,0.24,0.8546033907550803,1.0,6/16,19.16%,PRKAR2A;AKAP7;ADGRV1;TCIM;IAPP;AKAP12
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),0.6199997170469763,1.1200665338253797,0.3170731707317073,0.8539963595270622,1.0,4/9,14.36%,KIT;WHRN;ADGRV1;PDZD7
prerank,GO_Biological_Process_2021__rhodopsin mediated signaling pathway (GO:0016056),-0.66622478975671,-1.1199072702976323,0.41379310344827586,1.0,1.0,5/8,23.57%,PDE6B;GNGT1;PDE6A;PDE6G;CNGB1
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,-0.43144252185873005,-1.1199011105283654,0.1891891891891892,1.0,1.0,9/169,7.24%,GPR62;ENPP2;GJC3;NFE2L3;PPP1R1B;SOX10;SHISA6;SOWAHA;LGI4
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),-0.6853130069916136,-1.1196668827862213,0.40625,1.0,1.0,3/7,16.15%,TGFB1;AGT;SMAD3
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.5497446601393499,-1.1196334865780666,0.328125,1.0,1.0,6/30,12.07%,TICRR;DTL;DONSON;ABRAXAS1;BRCA1;CDKN1A
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),0.4922945424904489,1.1195323882474162,0.29411764705882354,0.8549701862683864,1.0,5/32,12.78%,CPSF1;LSM10;PCF11;SNRPB;CPSF7
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),0.5772218721122333,1.119296932141637,0.3103448275862069,0.8548221440235634,1.0,5/14,21.12%,CD14;TICAM2;TICAM1;ITPK1;TRPM7
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),0.7424947904498731,1.119192057264891,0.4166666666666667,0.8536118010484087,1.0,3/5,22.12%,KHDRBS1;CPSF6;NRDE2
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),0.7424947904498731,1.119192057264891,0.4166666666666667,0.8536118010484087,1.0,3/5,22.12%,KHDRBS1;CPSF6;NRDE2
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),0.6478781283716228,1.1191100845929027,0.39215686274509803,0.8531478315246445,1.0,3/6,31.62%,ETF1;PEX14;TRMT112
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),-0.6583756063643712,-1.1190716983447966,0.3508771929824561,1.0,1.0,2/9,9.14%,TAF7;TAF7L
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.6089710754404156,1.1189345996521531,0.3235294117647059,0.8529383829894013,1.0,2/15,9.71%,CDH5;KANK1
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),-0.5606350554096771,-1.1186370535206493,0.33783783783783783,1.0,1.0,3/21,17.19%,TGFB1;THBS1;RAC1
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,0.44189329178388714,1.1185605361500757,0.18518518518518517,0.8532109896749194,1.0,18/67,15.61%,ALCAM;PPARG;ACSS2;STX5;JAG1;CBS;ATF3;ANTXR2;GSTM2;LPL;LDLR;CHKA;ADH4;SC5D;PLSCR1;STARD4;ETHE1;TM7SF2
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.5339085933995097,-1.118294007806108,0.2903225806451613,1.0,1.0,10/34,14.21%,C1QB;IRF4;VTN;C3AR1;CPB2;CLU;C4BPA;HLA-DRB1;C4BPB;C1S
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.4834685386877653,1.1182299596344558,0.32432432432432434,0.8535844651536807,1.0,10/27,14.40%,APOH;APOE;VASH1;SLIT2;PTPRR;PTPRM;ADIPOR1;EVL;NR2F2;PTPN23
prerank,GO_Biological_Process_2021__one-carbon compound transport (GO:0019755),-0.7234669627432126,-1.1175798846859544,0.38181818181818183,1.0,1.0,4/6,15.61%,SLC14A1;UPK3A;SLC14A2;AQP11
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),-0.6587296709354524,-1.1174774013560036,0.3333333333333333,1.0,1.0,3/9,10.71%,TGFB1;ESR1;TERT
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),-0.6098477068537516,-1.1173870354630058,0.3492063492063492,1.0,1.0,3/13,7.32%,JCHAIN;SFTPD;HLA-A
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),-0.5786559772673726,-1.117134674130284,0.3076923076923077,1.0,1.0,5/15,17.23%,SLC25A31;BTBD18;MEIOC;SYCP3;MOV10L1
prerank,GO_Biological_Process_2021__cardiolipin biosynthetic process (GO:0032049),0.7011506703060155,1.1171068084024691,0.43902439024390244,0.8565010010044737,1.0,2/5,11.05%,PGS1;CRLS1
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),0.6500727480839693,1.116986207297055,0.40625,0.8562135784436636,1.0,4/9,25.77%,MTHFR;SHMT2;MTHFD1L;MTHFD2L
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.61298080426477,1.1166837925071895,0.30303030303030304,0.8564951658653057,1.0,6/12,16.39%,CEP135;CEP120;CEP290;KIAA0586;SPIDR;CORO2B
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),0.38413029537960147,1.1162015390440565,0.25,0.8571676082058111,1.0,30/152,10.29%,BAMBI;FOXO1;TSKU;TGFBR1;SPRED3;RORA;TWIST2;IL17RD;PPARG;SIRT1;DTX1;ADAMTS12;RORB;JAG1;USH2A;HES1;WNT9A;ANKRD26;OSR1;GREM1;CDK6;ABCA1;TRIB2;SPRED2;TWIST1;SNAI2;CRIM1;ANP32B;ADIPOR1;BBS12
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),0.5642667818658061,1.1159151510994594,0.325,0.8572461222486398,1.0,4/9,25.25%,SEC14L2;SREBF2;ABCA2;LPCAT3
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.7332414224895085,1.115912354837668,0.3953488372093023,0.8565431602115914,1.0,3/5,25.01%,ABL1;MARK2;MAP2
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),0.5844752562681522,1.1156560798310557,0.39473684210526316,0.8565716967835695,1.0,4/7,28.69%,SPAST;TMCC1;SH3GLB1;CORO1C
prerank,GO_Biological_Process_2021__cerebral cortex cell migration (GO:0021795),0.6839322334589705,1.115362415132511,0.4339622641509434,0.8568392311574509,1.0,4/6,29.64%,PEX13;EFHC1;HTR6;FGF13
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.4450917494169349,1.1150531348797668,0.22727272727272727,0.8570686074344618,1.0,10/58,8.99%,RASSF2;DUSP15;CCN2;TNFRSF19;SH3RF1;HMGB1;CARD9;SH3RF3;PLCB1;MAP3K10
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),0.56065530091851,1.115047774410462,0.37142857142857144,0.8563555719873449,1.0,1/12,5.00%,STX5
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.528887039041233,-1.1149648201503912,0.3188405797101449,1.0,1.0,12/42,21.63%,DTL;PCLAF;RPA3;UBE2L6;TRIM25;POLE2;POLD4;RPS27A;FAAP20;RPA2;PARP10;ISG15
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.7082740023929028,-1.114831309693211,0.375,1.0,1.0,4/6,27.87%,SVIP;AQP11;UBXN1;USP14
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.661613020356735,-1.1147414051438873,0.3559322033898305,1.0,1.0,1/11,2.50%,DEGS2
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.44446906739674386,-1.1146992719330446,0.26506024096385544,1.0,1.0,20/175,9.78%,CD44;CRLF1;TGFB1;TIMP3;ECM2;WNT5A;FZD8;TGFBI;COL1A1;CTHRC1;COL5A1;LOX;DAB2;RGS4;DCN;ENO2;TGM2;SFRP4;PTX3;THBS1
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.5791877848211731,1.1145771391535464,0.358974358974359,0.8569614677677265,1.0,4/13,13.21%,TCOF1;NRG1;SNAI2;CDH2
prerank,GO_Biological_Process_2021__vesicle localization (GO:0051648),-0.7292977991594295,-1.1145579994951569,0.35,1.0,1.0,1/5,5.16%,RAB11A
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.43988064608875654,-1.1145320838655581,0.22784810126582278,1.0,1.0,19/164,13.70%,CD44;MICB;CYP26B1;CCND1;ACOX2;GPER1;PTGES;PLAC1;PRSS23;ST6GALNAC2;PDZK1;CKB;COX6C;LAMC2;TPD52L1;WFS1;TRIM29;PTGER3;DYNLT3
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),-0.6200079200906476,-1.1143985065097481,0.37037037037037035,1.0,1.0,2/9,24.56%,STOML2;CDC7
prerank,GO_Biological_Process_2021__neurotransmitter reuptake (GO:0098810),-0.6630322072345312,-1.114362693722444,0.3050847457627119,1.0,1.0,3/7,24.50%,SLC22A3;SLC6A4;SLC22A1
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),-0.6065929943253218,-1.1142289612496963,0.3559322033898305,1.0,1.0,4/12,14.43%,WNT5A;WNT8A;LEF1;TGFB3
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),-0.5897928823890297,-1.1141508796655293,0.328125,1.0,1.0,5/18,14.24%,ACTC1;CSRP3;ALPK2;HEY2;TTN
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,-0.45304947589733,-1.1139587552362342,0.2463768115942029,1.0,1.0,9/87,6.82%,ENPP2;TREH;CLCA1;ANGPTL2;SMLR1;PIEZO2;ALDOB;MASP1;DCN
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),0.6925022161439158,1.1134872059354144,0.3958333333333333,0.8596604596609262,1.0,3/5,16.96%,SETMAR;SETD2;ASH1L
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.5381958379012415,1.113485206845346,0.2608695652173913,0.8589470484910832,1.0,6/21,20.81%,SAMD4A;CNOT9;CNOT4;SAMD4B;CNOT6;TUT7
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),-0.6021802133672429,-1.1131496202073778,0.34615384615384615,1.0,1.0,4/11,14.17%,VSIG4;C4BPA;A2M;C4BPB
prerank,GO_Biological_Process_2021__response to alkaloid (GO:0043279),-0.6643853020506255,-1.1129061342683213,0.44642857142857145,1.0,1.0,1/7,8.01%,HTR1B
prerank,MSigDB_Hallmark_2020__Pperoxisome,0.40095003425427045,1.1128832288060964,0.24,0.8598747755190894,1.0,18/100,12.69%,CEL;EPHX2;ALDH1A1;ATXN1;PEX13;STS;CADM1;TOP2A;SLC27A2;ABCD3;ABCC8;FADS1;NUDT19;ABCD2;ISOC1;ACSL1;IDH2;CRABP1
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.4386108267471819,1.112821811322617,0.23809523809523808,0.859324977713556,1.0,19/72,21.29%,STX5;ZEB2;SIRT7;CAPN2;PLXNB1;STX18;AKAP9;CLEC16A;PREB;MIEF2;MYO5A;EP300;STOX1;PDE4DIP;PAK2;MARK2;MTM1;USP6NL;CAMSAP3
prerank,GO_Biological_Process_2021__definitive hemopoiesis (GO:0060216),-0.732200741283851,-1.112667900354139,0.35294117647058826,1.0,1.0,3/5,16.07%,MFAP5;TEK;HIPK1
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.40289381760074994,1.1126360932995036,0.2692307692307692,0.8593010067904114,1.0,14/78,8.65%,ADRA1A;KBTBD12;SMYD1;NT5C1A;CMYA5;CADM2;DTNA;SLC35F1;CTAGE3P;ANO5;HFM1;ACACB;ADCY2;HIF3A
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),0.4386213665022531,1.1126115977338569,0.2571428571428571,0.8586651793333373,1.0,14/41,22.99%,SDC4;RALB;CEP120;STX18;CROCC;CCDC88A;ARHGAP35;MARK4;FSCN1;PIP4K2A;LRSAM1;CNOT6;ELAPOR1;ASAP1
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),-0.7244894797793556,-1.112458411896997,0.35185185185185186,1.0,1.0,1/7,2.89%,CCDC39
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),-0.6140544401100672,-1.1124373678720785,0.3333333333333333,1.0,1.0,4/16,17.88%,PRDM12;PTGES;OPRM1;TRPA1
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),0.4058950881359302,1.112398317870775,0.23076923076923078,0.8585045423934287,1.0,7/98,3.83%,GCK;PER2;LLGL1;ITPR2;APOE;KCNC2;APBB3
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.4802288644194603,1.1122884779969042,0.3333333333333333,0.8580574285179241,1.0,6/35,11.02%,IRGM;SPRED3;PARD3;RIPK2;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),-0.565992170530958,-1.1122713297147164,0.3382352941176471,1.0,1.0,5/20,10.17%,DUOX1;ALOX12;TAFA4;SOD2;CYBA
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),-0.579707045535526,-1.1122379306010084,0.3148148148148148,1.0,1.0,6/17,16.69%,TGFB1;UBE3A;THBS1;TGFB3;YAP1;WBP2
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),0.6737374084629218,1.112002387757117,0.35,0.8581716069787719,1.0,2/7,11.05%,PGS1;CRLS1
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.42379080351040255,1.1117917711747929,0.16666666666666666,0.8582233646925096,1.0,6/80,3.16%,GPR3;ESRRG;PER2;ELOVL6;HDAC3;ZBTB7B
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.4986860034189553,-1.1115771882201495,0.29577464788732394,1.0,1.0,19/48,17.21%,JCHAIN;POU2F3;HCK;ALOX5;PTAFR;FCGR3A;ASIC5;NFAM1;GNAT3;PTPRC;SPI1;ITGAM;KLF3;CD300LF;ADGRE3;HK3;TUBB;RAC2;CD24
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),-0.6757807329983258,-1.1112494736084924,0.4,1.0,1.0,1/8,2.76%,CAV3
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),0.7552677167235318,1.1111779857207045,0.3684210526315789,0.8591207018225303,1.0,2/5,14.34%,CEP135;SEPTIN9
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.42367498792561115,1.1109672061791382,0.16666666666666666,0.8589354990048284,1.0,6/40,9.82%,TGFBR1;IFT88;ITGA8;WNT4;PROX1;CEP290
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.4320003475080924,-1.1108222683725384,0.225,1.0,1.0,21/167,14.47%,CD44;HK2;AHR;AMACR;IRF4;TNFRSF1B;IL3RA;DRC1;TGM2;SELP;CCND2;PTRH2;CTSZ;ARL4A;ETV4;ETFBKMT;ABCB1;PRKCH;NDRG1;GABARAPL1;GALM
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),0.5029482359035383,1.110816536252533,0.34210526315789475,0.8587133534240026,1.0,1/24,0.05%,ADRA1A
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),0.4643411530606839,1.1106600451897541,0.2413793103448276,0.8585039785030176,1.0,3/27,4.59%,APOE;PPARG;SIRT1
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),0.40968124941189415,1.1100985597894506,0.2413793103448276,0.8595592785738508,1.0,13/86,10.67%,GCK;PER2;ITPR2;IRS1;MIDN;KCNC2;CAPN10;DOC2B;GLUD1;EFNA5;ABCC8;MCU;IRS2
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.43543038623436897,1.1099617815733345,0.2702702702702703,0.8591885451626705,1.0,6/35,13.41%,FHIT;QRICH2;PML;N4BP1;EIF3H;RYBP
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),0.6438014267388611,1.109811615778252,0.38,0.858843169678172,1.0,4/8,17.42%,LGALS1;HMGB1;LGALS9;LGALS3
prerank,GO_Biological_Process_2021__negative regulation of trophoblast cell migration (GO:1901164),-0.7388344417417638,-1.1098048462382855,0.44642857142857145,1.0,1.0,1/6,1.82%,NODAL
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),0.6849072840413541,1.1096440936051721,0.3888888888888889,0.8586591042470796,1.0,4/5,9.20%,AUTS2;SIRT1;SMARCB1;PIH1D1
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),-0.49371189731495313,-1.1092962594607816,0.31343283582089554,1.0,1.0,7/38,14.24%,BANF2;ERN2;GPER1;H1-0;H1-3;INCENP;TTN
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),0.5395262353317835,1.1090605072077888,0.4117647058823529,0.8594637264428556,1.0,5/22,9.93%,GRIN3A;TGFBR1;SDF4;SLIT2;GRIN1
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),-0.6904258388599335,-1.1089655393995599,0.34375,1.0,1.0,1/9,1.49%,TGFB1
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),0.5344972242008048,1.1087715805104414,0.3333333333333333,0.8595633833478092,1.0,4/17,9.06%,SDC4;RAB7A;CHMP6;SMPD3
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),-0.6194844883556443,-1.108700585611112,0.3728813559322034,1.0,1.0,1/11,0.42%,DBH
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.5419061913672711,1.1086717324402071,0.2903225806451613,0.8593791806476185,1.0,4/16,9.58%,BCL2;SLC30A10;IL16;EPB41
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),0.6269380743990641,1.1084852369181322,0.4146341463414634,0.8592076032594811,1.0,1/9,8.12%,METAP1D
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),0.5775870644435634,1.1083493854328064,0.2972972972972973,0.858851587964987,1.0,6/12,28.25%,SERPINE1;SLIT2;CORO1B;BMPR1A;PRKG1;MEF2C
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),0.6336933791352961,1.1080545367100632,0.35,0.8589391143964226,1.0,1/9,0.86%,FOXO1
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),0.5430587725194127,1.1079790134145777,0.37142857142857144,0.8584732473940054,1.0,11/16,33.79%,MOB3B;MARK3;DLG5;WWC1;IQCJ-SCHIP1;NF2;WWC2;WWC3;LIMD1;VGLL4;NEK8
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),0.6466174546285385,1.10792709337233,0.4528301886792453,0.8579344317527086,1.0,1/6,1.49%,FHIT
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),0.6505317558194065,1.107890948782361,0.38095238095238093,0.8573596688152236,1.0,1/6,1.27%,THEM4
prerank,GO_Biological_Process_2021__negative regulation of histone deacetylation (GO:0031064),-0.7149692937268154,-1.1077877317673064,0.3584905660377358,1.0,1.0,1/5,11.29%,USP17L2
prerank,GO_Biological_Process_2021__toll-like receptor 2 signaling pathway (GO:0034134),0.6884769348404742,1.1076750059690563,0.43137254901960786,0.8573009487730999,1.0,2/5,11.29%,RIPK2;LGALS9
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),-0.49279895177177047,-1.1074804898787387,0.3484848484848485,1.0,1.0,4/33,8.12%,KCNJ15;CASQ2;KCNJ11;KCNQ1
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.41631492416575033,1.1072760083027895,0.2692307692307692,0.85780603321625,1.0,19/99,16.60%,PHLDB2;SORBS3;CAPN2;RHOBTB3;RHOBTB1;CRK;BICD1;EPHA3;ABL1;PLXNB1;EFNA5;MLST8;RND3;CCDC88A;ARHGAP35;MAP6;FSCN1;CORO2B;IQCJ-SCHIP1
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.45257657587994254,1.106822289257052,0.22727272727272727,0.8584572336800728,1.0,6/44,10.38%,MARVELD1;ADGRG6;PARD3;SLC8A3;ABCD2;ACER3
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),0.5892810466340388,1.106602096019141,0.425,0.8583977669566375,1.0,3/11,7.63%,LIPC;APOE;ABCA1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.5289098030004723,1.1064677896225747,0.22857142857142856,0.8582039239683728,1.0,6/31,7.66%,FHIT;SIRT1;IFI16;PPP1R13B;PML;ZNF385B
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),0.6034843746376435,1.1064152774849096,0.2571428571428571,0.8576195182182217,1.0,4/13,16.78%,SIRT1;SIRT7;HDAC1;CHD1
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),-0.6093091235382113,-1.1063680312264275,0.3050847457627119,1.0,1.0,3/13,14.91%,PSAP;ABCB1;ABCA12
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),-0.6723379514269995,-1.1060688509789285,0.4067796610169492,1.0,1.0,2/6,10.21%,AHR;HLA-DRB1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.5080667867903174,1.105926393795077,0.3076923076923077,0.8584152238845654,1.0,4/20,7.93%,BCL2;BCL2A1;DCC;CASP3
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),0.6183624138991188,1.1058475596431465,0.2926829268292683,0.8580145188933428,1.0,1/8,2.13%,LYPD1
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),0.6988897470524398,1.1053398291247496,0.4090909090909091,0.8587842506971061,1.0,2/6,15.95%,PTPRF;PTPRD
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),-0.6364847515794299,-1.1053182780881228,0.3090909090909091,1.0,1.0,2/9,6.94%,ABCC6;SLCO2A1
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),0.522800730153481,1.1049726284638366,0.20588235294117646,0.8592970558050912,1.0,4/13,14.06%,PACSIN2;PID1;CSPG5;PNPT1
prerank,GO_Biological_Process_2021__phosphate ion homeostasis (GO:0055062),-0.6581988483466531,-1.104968047293799,0.35714285714285715,1.0,1.0,3/7,20.20%,SFRP4;FGFR4;GCM2
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.6190874137928033,1.1046528179720698,0.40425531914893614,0.8595048926158709,1.0,5/10,15.95%,CEL;NLGN1;NLGN4X;NLGN3;PTPRD
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),0.5345027943912721,1.104522848406294,0.3888888888888889,0.8590802890316568,1.0,3/24,3.19%,MT1G;SLC30A10;SLC39A8
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),-0.597227182412783,-1.1041911469529684,0.3548387096774194,1.0,1.0,2/13,15.75%,MPV17L2;RCC1L
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),-0.6439743800081549,-1.104158524840438,0.4098360655737705,1.0,1.0,2/7,3.18%,F7;ANGPT2
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.5101473708094184,1.104045477738301,0.29545454545454547,0.8599195630026238,1.0,8/20,26.17%,RAB7A;STX8;PTPN23;SNF8;RAB5A;KIF16B;HOOK3;WDR81
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),0.43738688538811393,1.1039179459952124,0.25,0.8595559904040245,1.0,17/61,19.41%,SLC38A5;SLC39A8;SLC3A2;SLC19A1;SLC16A7;SFXN2;SLC25A1;SLC6A20;SLC25A29;SLC7A8;SLC25A12;ABCC1;SLC25A42;SLC36A4;LRRC8B;SLC25A41;SLC1A3
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),-0.5932903425639108,-1.1035886201764997,0.2898550724637681,1.0,1.0,3/13,18.02%,PHKG1;PYGL;CALM1
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),-0.6391059631241027,-1.1035274180634453,0.34615384615384615,1.0,1.0,1/9,2.65%,BLK
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.426349681795041,1.1032668146507278,0.2222222222222222,0.8605633062840604,1.0,15/57,17.12%,MED17;MITF;CBFB;MED25;CDK4;TWIST1;MOV10;TNRC6C;MED16;CDK8;NFKB1;MECP2;TP53;TNRC6A;AGO3
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.4655554967658925,1.1028429132180508,0.3235294117647059,0.861108564778369,1.0,8/35,19.93%,ARC;PHACTR1;FARP1;MAP6;EPHB2;DCDC2;CTNNA2;PAK3
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.41757723601665964,1.1027524684214867,0.25806451612903225,0.8606480562544311,1.0,26/90,26.04%,CPSF1;NUP210;NXF5;NUP42;NXT1;NXF1;U2AF1;SRRM1;AAAS;SRSF4;SMG1;SMG5;RANBP2;SMG6;EIF4A3;U2AF2;SYMPK;EIF4E;NUP214;TPR;MAGOHB;SEH1L;THOC1;WDR33;NUP153;RBM8A
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),-0.5354140313095335,-1.1024808296268596,0.3088235294117647,1.0,1.0,9/29,29.49%,TOMM20;PAM16;TIMM17A;ROMO1;CHCHD4;DNAJC19;TIMM21;PEX1;GRPEL1
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),0.5846367023459892,1.1023498411792871,0.4090909090909091,0.861059301217113,1.0,3/12,12.76%,NT5C1A;UPP2;NT5C3A
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.565964562383109,-1.102163371331305,0.323943661971831,1.0,1.0,1/17,1.19%,SCN5A
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,-0.45857278738055474,-1.1020408661325858,0.3333333333333333,1.0,1.0,27/79,22.43%,PSMB9;PROCR;IRF1;TRIM5;UBE2L6;TRIM25;IL7;IFIT3;LPAR6;WARS1;OAS1;SP110;C1S;TXNIP;PSMA3;IFIT2;IFI35;CASP8;TMEM140;DHX58;IFI27;DDX60;MX1;ISG15;EPSTI1;CMTR1;HLA-C
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.5562476588196933,1.1020223167347607,0.425,0.8612643958822579,1.0,4/13,23.38%,CDK5RAP2;TPR;PCID2;USP44
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.500005519698213,-1.1016375293034015,0.25,1.0,1.0,5/35,13.34%,ARIH2;HSPA1L;PINK1;TOMM7;ATP5IF1
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.5352876331583544,-1.1016304742295702,0.3898305084745763,1.0,1.0,8/27,25.22%,WNT5A;OAS1;CDC37;CACTIN;ISG15;HSP90AB1;USP18;PTPN11
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.4451189692117851,1.1015911267313017,0.23076923076923078,0.8617590363517393,1.0,17/53,20.40%,MAP3K14;TBKBP1;CD14;RIPK2;TICAM2;SHARPIN;TICAM1;TANK;NKIRAS2;TAB3;IRAK1BP1;ZNF675;FAIM;TAB1;ERC1;TAB2;TRAF6
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),-0.6846050651211473,-1.101552887929359,0.36507936507936506,1.0,1.0,1/7,4.89%,TNFRSF1B
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),-0.5425175470293073,-1.1013897674205435,0.36764705882352944,1.0,1.0,1/25,0.57%,IHO1
prerank,GO_Biological_Process_2021__membrane repolarization during atrial cardiac muscle cell action potential (GO:0098914),-0.7005501195650314,-1.1013642026480712,0.34545454545454546,1.0,1.0,2/5,8.12%,KCNA5;KCNQ1
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell membrane repolarization (GO:0099624),-0.7005501195650314,-1.1013642026480712,0.34545454545454546,1.0,1.0,2/5,8.12%,KCNA5;KCNQ1
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),-0.6235586782372302,-1.101231248119356,0.3584905660377358,1.0,1.0,1/7,2.12%,ABCC6
prerank,GO_Biological_Process_2021__negative regulation of leukocyte degranulation (GO:0043301),-0.6661162110526393,-1.1011487983905575,0.3392857142857143,1.0,1.0,3/5,15.53%,CEACAM1;SPI1;HLA-F
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),0.5945849558249071,1.1009692484206746,0.37209302325581395,0.8631338811818755,1.0,3/11,12.76%,NT5C1A;UPP2;NT5C3A
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",0.5940583240884488,1.1008779569899438,0.4,0.8626494765097644,1.0,1/7,3.60%,DCP1B
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),0.44833587795593605,1.10065763933522,0.2926829268292683,0.8627201065504364,1.0,8/44,6.54%,CD151;APOE;NLGN1;HIP1;RAB31;SERPINE1;SNCA;BICD1
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.49770472330470944,-1.1005864426002856,0.34285714285714286,1.0,1.0,6/45,9.82%,KIF14;CEP55;RAB11A;ANKRD53;CHMP3;NUF2
prerank,GO_Biological_Process_2021__nucleoside triphosphate catabolic process (GO:0009143),0.6812718178458259,1.100209936928127,0.37777777777777777,0.8633564830245666,1.0,4/5,31.88%,SMPDL3A;ENPP1;ITPA;DCTPP1
prerank,GO_Biological_Process_2021__positive regulation of catecholamine secretion (GO:0033605),-0.6701587288053098,-1.1000877927452555,0.36666666666666664,1.0,1.0,2/7,25.02%,CARTPT;CHRNB2
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),0.5055952917304976,1.1000646373231753,0.3142857142857143,0.8632339577692782,1.0,7/26,15.37%,PRPF39;PUF60;CELF5;CELF4;SFSWAP;CELF2;LUC7L
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),0.48574634722063204,1.1000229863249844,0.3157894736842105,0.8625947511209417,1.0,6/21,10.37%,RAB27A;SLC30A10;SNCA;SLC25A33;GRIN1;ABCD2
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),0.6951600435907389,1.0999759739173587,0.3877551020408163,0.8620886805376867,1.0,4/6,16.43%,PSAT1;SRR;PSPH;SERINC5
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.6282269796906712,1.0997899909522615,0.3673469387755102,0.8612708190005125,1.0,6/8,31.42%,PTBP1;CAMTA1;AKAP6;CIB1;SPPL3;SLC9A1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.6282269796906712,1.0997899909522615,0.3673469387755102,0.8612708190005125,1.0,6/8,31.42%,PTBP1;CAMTA1;AKAP6;CIB1;SPPL3;SLC9A1
prerank,GO_Biological_Process_2021__regulation of digestive system process (GO:0044058),0.6270389799177488,1.099738297607796,0.42,0.8607310574158896,1.0,3/6,9.58%,FGF10;SGK1;EPB41
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),-0.6444560382286031,-1.0996944877536607,0.35,1.0,1.0,4/9,10.17%,DUOX1;ALOX12;TAFA4;CYBA
prerank,GO_Biological_Process_2021__rRNA 5'-end processing (GO:0000967),0.6568682950555188,1.0996192576033306,0.38461538461538464,0.8589734558897641,1.0,3/5,22.56%,NOP9;NOP14;TBL3
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)",0.6568682950555188,1.0996192576033306,0.38461538461538464,0.8589734558897641,1.0,3/5,22.56%,NOP9;NOP14;TBL3
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)",0.6568682950555188,1.0996192576033306,0.38461538461538464,0.8589734558897641,1.0,3/5,22.56%,NOP9;NOP14;TBL3
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),0.5456071604592686,1.0995640866621157,0.3,0.8584133313349828,1.0,7/19,14.95%,ANGPT1;ARRB2;MAGI2;GREM1;WNT3A;ARRB1;INSR
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),-0.5098973583821198,-1.0994154870475412,0.36363636363636365,1.0,1.0,9/37,14.24%,TBX1;ACTC1;MYBPC3;ZFPM1;HTR2B;ALPK2;ENG;HEY2;TTN
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),0.6348146797119926,1.0992923318259755,0.47058823529411764,0.858665663045739,1.0,1/11,4.55%,PEX13
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.4180629762763039,1.0991896573831672,0.2857142857142857,0.8582378462812141,1.0,21/88,15.44%,SCRIB;APOE;ANGPT1;PID1;PPARG;AKR1C3;SNCA;ARRB2;MAGI2;AKR1C1;GREM1;F2;ACACB;WNT3A;LIPT2;ARRB1;STARD4;INSR;NR1H3;GADD45A;TP53
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.45349151058521747,1.0990145482348115,0.25,0.8581324374755481,1.0,14/46,18.08%,GRID2;NLGN1;CNTNAP2;ABL1;SYNDIG1;COL16A1;LIMS1;NLGN3;CLSTN2;NRXN1;PTPRD;DLG5;EPHB2;SLITRK2
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),-0.7002462745122711,-1.0989720396259761,0.37735849056603776,1.0,1.0,1/7,11.01%,CAV2
prerank,MSigDB_Hallmark_2020__Glycolysis,-0.4325258295427538,-1.0987005285458615,0.27380952380952384,1.0,1.0,20/181,12.30%,CD44;PKP2;HK2;TGFBI;ALDOB;SDC2;COL5A1;DEPDC1;DCN;ENO2;GPC3;GAPDHS;GPR87;LCT;BIK;PYGL;GLRX;SAP30;SLC16A3;PGAM1
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),-0.6134560691800102,-1.0975073975173897,0.39622641509433965,1.0,1.0,1/12,0.42%,DBH
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.5022308014543032,-1.097451568253438,0.36923076923076925,1.0,1.0,8/37,14.43%,TGFB1;NODAL;DAB2;TTK;GDF11;ENG;BMP3;TGFB3
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.5713899273116617,1.0974154110282275,0.41379310344827586,0.8623850200737203,1.0,1/19,0.97%,AUP1
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),0.6425359313222462,1.0972163594678113,0.40425531914893614,0.8622408176023529,1.0,2/8,19.22%,SNCA;VAMP8
prerank,GO_Biological_Process_2021__receptor guanylyl cyclase signaling pathway (GO:0007168),-0.7095965947886953,-1.097024475467452,0.3673469387755102,1.0,1.0,3/6,24.71%,GUCY2C;GUCY2F;NPR2
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.5533485592892803,-1.0966427317192187,0.265625,1.0,1.0,3/27,3.57%,UMODL1;ITGB2;CXCL13
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),0.6185637389457002,1.0964307262906163,0.325,0.8639275750460217,1.0,3/8,27.93%,IL23A;TYK2;STAT3
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),0.4978343171835036,1.0963606735280593,0.25,0.8634022731177717,1.0,4/28,6.96%,PHLDB2;SERPINE1;JAG1;ACER2
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.44939956190912805,1.0962615641434206,0.28205128205128205,0.86302022734222,1.0,10/45,18.57%,CRK;ABL1;FLNA;CASS4;CSPG5;LIMS1;CUX1;CRKL;PTPRD;DOCK1
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),-0.5113712782069533,-1.0957951397353403,0.328125,1.0,1.0,7/28,15.67%,TOPAZ1;SOX30;TNP1;MEIOC;GALNTL5;JAM2;SYCP3
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.5589088506840023,1.0955582380800608,0.3333333333333333,0.8645600791264652,1.0,4/14,13.68%,ABCA1;LRP6;LDLR;STARD4
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),-0.6849869322906406,-1.095502844952622,0.43661971830985913,1.0,1.0,1/7,10.20%,OLFM4
prerank,GO_Biological_Process_2021__positive regulation of DNA ligation (GO:0051106),0.6874756146474746,1.0954287529915994,0.40384615384615385,0.8643317814747614,1.0,1/5,6.42%,HMGB1
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.5124317341981165,-1.0954049737988616,0.3333333333333333,1.0,1.0,3/28,5.61%,ARIH2;HSPA1L;PINK1
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),0.5170069656920895,1.0953501097830685,0.32432432432432434,0.8639262230915551,1.0,4/19,21.85%,APOB;LDLR;NPC2;ABCG8
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.512154665647466,1.095112084647826,0.3684210526315789,0.8638525957185179,1.0,4/20,9.62%,KIT;FGFR1;ABL2;FGFR3
prerank,GO_Biological_Process_2021__tyrosine metabolic process (GO:0006570),-0.6204505476071467,-1.0947854806148234,0.41935483870967744,1.0,1.0,1/10,0.88%,IYD
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),-0.6629405395256667,-1.0940681049622984,0.4426229508196721,1.0,1.0,1/6,5.61%,PINK1
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.4494806877516304,1.0938740610729059,0.32142857142857145,0.8670303291657785,1.0,9/32,11.24%,ADGRG6;KSR1;APOE;HTR2C;PDE7A;ADCY2;PDE9A;CAP2;RIMS2
prerank,GO_Biological_Process_2021__response to cocaine (GO:0042220),-0.6792804901517768,-1.0938122840374347,0.39215686274509803,1.0,1.0,1/5,8.48%,TGM2
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),0.41858051792883494,1.0936859359637943,0.2413793103448276,0.8668598804576513,1.0,27/93,26.04%,CPSF1;NUP210;NXF5;NUP42;NXT1;NXF1;U2AF1;SRRM1;AAAS;SRSF4;XPO5;SMG1;SMG5;RANBP2;SMG6;EIF4A3;U2AF2;SYMPK;EIF4E;NUP214;TPR;MAGOHB;SEH1L;THOC1;WDR33;NUP153;RBM8A
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.362388177701006,1.0932882171890619,0.10526315789473684,0.867138258777102,1.0,41/161,20.19%,TGFBR1;MAPKAPK2;SBK1;POGLUT3;VRK2;GALNT1;POGLUT2;SGK1;EIF2AK3;LATS1;MAST1;MAST2;MAPK8;MAP3K10;AKT2;GALNT13;DYRK3;PKN2;RPS6KA3;STK32C;SGK2;CAMK1G;MAP3K13;MARK3;RPS6KA4;RPS6KA2;RPS6KA6;CLSPN;MAPK12;SMG1;MARK1;ATM;CSNK1G1;MAST4;ATR;MORC3;PNCK;CDK5;PAK2;MARK2;PRKCE
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.6247765582025047,-1.0932424021689469,0.3492063492063492,1.0,1.0,8/11,20.40%,AIM2;GSDMA;GSDME;NLRP9;NLRC4;NAIP;CASP8;APIP
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.6144470849156889,-1.0931904443651805,0.328125,1.0,1.0,1/10,2.28%,ITGB2
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),0.6945976723091786,1.0929042441836232,0.4146341463414634,0.867451587134799,1.0,3/6,21.10%,ERCC8;LIG4;ZBTB7A
prerank,GO_Biological_Process_2021__protein localization to ciliary transition zone (GO:1904491),0.6419289195658888,1.0928152213561038,0.3958333333333333,0.8670219212893834,1.0,1/6,6.20%,SPATA7
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.4572292928012008,1.092629150679533,0.2692307692307692,0.8669462237650517,1.0,15/46,25.87%,LAMA4;NOVA1;ALDH1A1;PLCL2;TFE3;NR1H3;NOTCH1;IP6K1;RBPJ;MAP2K6;CCDC3;NR1D1;PCTP;TLE3;RB1
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide metabolic process (GO:0010310),-0.7004353174978707,-1.092352341592633,0.45454545454545453,1.0,1.0,5/5,29.98%,RAC2;RAC1;NOXA1;NOXO1;HDAC6
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.5962911185402235,1.0922372379018448,0.35135135135135137,0.8671765972021613,1.0,2/12,18.39%,ERN1;ATF6
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.6145379374192116,1.0922185651652607,0.37777777777777777,0.8665835338188671,1.0,5/11,15.95%,CEL;NLGN1;NLGN4X;NLGN3;PTPRD
prerank,"GO_Biological_Process_2021__phototransduction, visible light (GO:0007603)",-0.616341489163098,-1.0922177302541816,0.4067796610169492,1.0,1.0,7/12,24.01%,PDE6B;GNGT1;RP1;PDE6A;PDE6G;CNGB1;ABCA4
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.43783064645211506,-1.0918078814104517,0.3076923076923077,1.0,1.0,19/110,22.24%,MCM2;PSMB9;RPA3;MCM3;NAP1L2;GRWD1;CHAF1A;RBX1;PSMA3;RPS27A;CDC6;PSMA7;PSMB6;SMARCA5;H2BC18;ORC6;SOX9;RPA2;PSMA5
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.37010833788382136,1.091761298114759,0.21052631578947367,0.8672015514618949,1.0,47/177,19.26%,MRAP2;FRMPD1;SCRIB;NLGN1;KCNB2;SPTBN4;ABHD17A;BSG;SYNE3;ITGA4;TMEM150A;MAGI2;KCNIP3;PDZD11;FLNA;RAP2A;LRP6;TNIK;DPP10;KCNIP4;TSPAN17;EHD4;RAB3C;RAP1A;ARL5A;TESC;RAB10;BID;SMURF1;NKD2;ANK2;DPP6;NRXN1;WNK3;ARL3;ZDHHC3;RAB11B;TTC7B;BRAF;RAB3D;DLG2;EFR3B;MYO5A;SLMAP;RAB40A;PTCH1;PACS1
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.5099643185497522,-1.0916527678447594,0.36619718309859156,1.0,1.0,9/48,9.30%,ELOVL2;ALOX12;CYP1B1;ALOX5;PTGR1;ALOX12B;PLA2G10;ALOX15;CYP2J2
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.5158220535570649,1.091637046182015,0.3684210526315789,0.8670907297962965,1.0,7/24,20.40%,IRGM;RIPK2;TAB3;TAB1;TAB2;MAP2K6;TRAF6
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.5427181276846548,-1.0915374167897758,0.40298507462686567,1.0,1.0,6/23,11.81%,PKP2;TGFB1;MYH7;MYBPC3;LRP2;ENG
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),-0.5280501024100475,-1.091124941980489,0.36,1.0,1.0,5/25,17.81%,CCDC39;TBX6;ENG;GATA4;MESP1
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.5500428703109409,1.091111841758215,0.3611111111111111,0.8678247014310748,1.0,3/13,16.49%,CHMP6;VTA1;SNF8
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.6937537055729086,-1.0910546787425142,0.4,1.0,1.0,3/6,22.43%,HLA-A;HLA-F;HLA-C
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.6937537055729086,-1.0910546787425142,0.4,1.0,1.0,3/6,22.43%,HLA-A;HLA-F;HLA-C
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),-0.6926171014522382,-1.0906700366798687,0.41509433962264153,1.0,1.0,3/6,5.45%,RAB34;MAPKAPK3;DOCK2
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.4603875507309769,1.0905749813715078,0.22857142857142856,0.8686278638018144,1.0,10/27,25.41%,CD14;TICAM2;TICAM1;TANK;FADD;TNIP3;UBE2D2;IKBKB;TRAF3;UBE2D3
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),0.5852001548363436,1.0902388694463334,0.40540540540540543,0.8689378488234027,1.0,7/11,25.17%,RGN;FADS1;UGDH;SLC35D1;CYP2C8;PAH;NANP
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.45853503510860794,1.0902295624846605,0.4,0.8682993642937675,1.0,16/39,18.08%,GRID2;NLGN1;CX3CR1;RGS14;SYNDIG1;SPEN;NUMB;NLGN3;CLSTN2;NRXN1;PTPRD;DLG5;LIG4;EPHB2;FAIM;SLITRK2
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.5910404525398296,1.09021604444211,0.3783783783783784,0.8676501743940274,1.0,2/11,3.01%,ADGRG6;PARD3
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.4984664214560517,1.0901428132720359,0.29411764705882354,0.8671772711876069,1.0,11/31,21.75%,KPTN;EPM2A;SIRT1;DEPTOR;RNF152;MINAR1;ATM;SESN2;PRKAA2;SZT2;NPRL2
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.4605427015575394,1.0901087669990275,0.3125,0.8665649825086705,1.0,4/45,2.94%,TEAD2;KIT;RARB;MFSD2A
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.40674488417607113,1.0898640022126036,0.14814814814814814,0.8664320031448873,1.0,15/64,18.70%,EYA4;TGFBR1;BCL2;CFLAR;SERPINE1;SH3RF1;SNAI2;HSPA1A;FADD;GPX1;ZMYND11;EYA3;LGALS3;FAIM;ACVR1
prerank,GO_Biological_Process_2021__macrophage chemotaxis (GO:0048246),-0.6791365298346084,-1.089660767206267,0.44,1.0,1.0,3/7,13.30%,SFTPD;TAFA4;EDNRB
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),-0.6133416030900514,-1.0895519015549282,0.39655172413793105,1.0,1.0,3/10,12.76%,PRDX4;PXDN;GPX3
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.5894269523765695,-1.0892353377943418,0.38596491228070173,1.0,1.0,2/14,2.29%,TGFB1;HCK
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.4290482190997667,-1.0890670819640909,0.3058823529411765,1.0,1.0,33/180,12.60%,CD44;ECM2;ITGB2;MMP9;MMP21;MMP19;TGFBI;COL18A1;NID1;COL1A1;COL5A1;COL27A1;LOX;VTN;DCN;HRNR;ICAM3;COL4A4;ITGA9;COL4A3;THBS1;MATN4;VWF;ITGA2B;PXDN;MMP25;LAMC2;FBN2;ITGAM;ITGB6;MARCOL;COL23A1;VIT
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),0.6194659420258242,1.0887544684175627,0.40425531914893614,0.8693653830468384,1.0,3/6,23.09%,AMPD1;HPRT1;AMPD3
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),0.6108914221006008,1.088630133924193,0.3953488372093023,0.8691605517903095,1.0,3/9,8.97%,GCK;SIRT1;LEPR
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),-0.6556599889184502,-1.0885625409681892,0.4339622641509434,1.0,1.0,1/7,2.54%,WNT5A
prerank,GO_Biological_Process_2021__neurotransmitter loading into synaptic vesicle (GO:0098700),0.688347263100737,1.0885591351790807,0.4583333333333333,0.8686883071333383,1.0,1/5,0.54%,SLC17A6
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.4548428700982825,1.0884445074320626,0.2857142857142857,0.8683214730357629,1.0,5/33,5.56%,ATP6V0D2;TCIRG1;RAB31;RAB20;RAB7A
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),0.5819010108844008,1.0881711227906787,0.34210526315789475,0.8683387455815501,1.0,2/8,8.27%,GREM1;PLXNB1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.5841562579062523,-1.0881035474497118,0.40298507462686567,1.0,1.0,4/17,14.26%,DCN;CD63;PIK3CB;IL12A
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),0.5914188284791144,1.0878234108214258,0.36363636363636365,0.8688786008495041,1.0,2/12,2.41%,LAMA3;SCRIB
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),-0.5728561259720895,-1.087751617078408,0.3380281690140845,1.0,1.0,2/17,6.32%,SLC28A1;PLA2G10
prerank,GO_Biological_Process_2021__regulation of neutrophil extravasation (GO:2000389),-0.6818914870115445,-1.087442694192721,0.37037037037037035,1.0,1.0,1/6,10.20%,OLFM4
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),0.7162937576525931,1.087257733579014,0.4666666666666667,0.8689701890427843,1.0,4/6,23.43%,IWS1;SETD2;TPR;NSUN2
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),0.7162937576525931,1.087257733579014,0.4666666666666667,0.8689701890427843,1.0,4/6,23.43%,IWS1;SETD2;TPR;NSUN2
prerank,GO_Biological_Process_2021__positive regulation of respiratory burst (GO:0060267),-0.7845325002639633,-1.0870196154556708,0.30434782608695654,1.0,1.0,1/5,1.12%,JCHAIN
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.5434292373147653,1.0867057596411445,0.2972972972972973,0.8697400527743052,1.0,8/18,12.52%,CEL;NLGN1;LRRTM3;PCLO;FZD1;WNT3A;NLGN4X;NLGN3
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),-0.5584145304360211,-1.0865985483828853,0.34375,1.0,1.0,5/29,10.89%,CAV3;CTNNA1;LATS2;DNAJA1;SPI1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.5818014806721882,-1.086243609634625,0.3584905660377358,1.0,1.0,5/12,18.50%,HLA-A;ERAP2;HLA-DRB1;HLA-F;ERAP1
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.4592724373706182,1.0858536365975002,0.3076923076923077,0.8710760535947094,1.0,12/40,21.06%,RNASET2;RIDA;DXO;ERN1;LSM2;HSPA1A;PNPT1;AGO3;XRN2;METTL16;DNA2;LSM6
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.4163541512809781,1.085583519411764,0.25,0.871102704980367,1.0,18/65,16.47%,LAMB4;PARVA;ITGA8;ITGA4;USH2A;SRGAP2;NTN4;PROX1;FER;NTNG2;TYRO3;PXN;RILPL1;ARL13B;SIPA1L3;ANTXR1;TMEFF2;SRCIN1
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),-0.574368829582862,-1.0854289005285982,0.36231884057971014,1.0,1.0,3/16,7.40%,TGFB1;FLT4;CEACAM1
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),0.6296680696324767,1.085425653823377,0.38235294117647056,0.8707247090704402,1.0,2/10,14.02%,CHAC1;BDH2
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.41604049858829234,1.085054122969166,0.20689655172413793,0.8710981287022279,1.0,16/66,25.25%,TOR1B;STX5;REEP6;SMPD4;EIF2AK3;STX18;MOSPD3;RAB10;MIA3;DOP1B;TMCC1;UBE2J2;SEC61A1;SEC31A;BNIP1;LPCAT3
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),-0.6836309531077213,-1.0848539904313041,0.43478260869565216,1.0,1.0,1/6,2.65%,BLK
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),-0.6425581758817888,-1.0846190112154768,0.4883720930232558,1.0,1.0,1/7,2.65%,BLK
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.5097898940036885,-1.0842615045141795,0.38028169014084506,1.0,1.0,9/35,19.12%,SIRPG;TNFRSF1B;HLA-DPB1;IL27;HLA-DPA1;FGL1;CD4;TNFSF8;CRTAM
prerank,GO_Biological_Process_2021__mitotic spindle elongation (GO:0000022),0.6724357921453836,1.0839060460448344,0.40816326530612246,0.8730312265404911,1.0,3/7,22.16%,MAP10;KIF4B;AURKC
prerank,GO_Biological_Process_2021__mitotic spindle midzone assembly (GO:0051256),0.6724357921453836,1.0839060460448344,0.40816326530612246,0.8730312265404911,1.0,3/7,22.16%,MAP10;KIF4B;AURKC
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),-0.6170733485544804,-1.0837990951314311,0.3770491803278688,1.0,1.0,1/9,2.96%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),-0.6170733485544804,-1.0837990951314311,0.3770491803278688,1.0,1.0,1/9,2.96%,TERF2IP
prerank,GO_Biological_Process_2021__serotonin uptake (GO:0051610),-0.7285375748873586,-1.0837914179412003,0.38461538461538464,1.0,1.0,3/5,24.50%,SLC22A3;SLC6A4;SLC22A1
prerank,GO_Biological_Process_2021__serotonin transport (GO:0006837),-0.7285375748873586,-1.0837914179412003,0.38461538461538464,1.0,1.0,3/5,24.50%,SLC22A3;SLC6A4;SLC22A1
prerank,PanglaoDB_Augmented_2021__T Memory Cells,0.41050327222873667,1.0837834836738172,0.3,0.8726990122103644,1.0,9/72,5.09%,IL7R;SELPLG;SKAP1;CD247;TRAC;BCL2;GPR174;IL16;PYHIN1
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),-0.7074205947293007,-1.0835488777475701,0.4166666666666667,1.0,1.0,3/6,19.12%,CEACAM1;IL12A;CRTAM
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),0.6014442437301324,1.0834579986099968,0.42857142857142855,0.8729891738751653,1.0,5/12,21.12%,CD14;TICAM2;TICAM1;ITPK1;TRPM7
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),0.5862472405617922,1.0833704524062573,0.4222222222222222,0.8725309175182203,1.0,4/9,17.21%,TENM3;LRP6;NF1;SKI
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),-0.5737378843513673,-1.0833351300129157,0.3870967741935484,1.0,1.0,5/12,23.48%,CLDN1;DCTN1;F2RL1;CSF1R;PRTN3
prerank,PanglaoDB_Augmented_2021__Paneth Cells,-0.4909027924065913,-1.0832313260601536,0.34285714285714286,1.0,1.0,14/43,15.20%,ST6GALNAC1;CLCA1;ACSL5;GUCY2C;SLC5A1;CEACAM1;CFD;OLFM4;SPINK4;CYP4F12;GPX2;ADAMDEC1;MUC17;TMEM45B
prerank,GO_Biological_Process_2021__negative regulation of T cell differentiation (GO:0045581),-0.6649368574589338,-1.083206230902382,0.4107142857142857,1.0,1.0,2/6,15.95%,IRF1;GLI3
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),-0.6396896961403348,-1.0828702847604017,0.3225806451612903,1.0,1.0,3/10,19.66%,ATP1A4;ATP4A;ATP1A1
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),0.5424156224245551,1.0825235860286058,0.4166666666666667,0.8746605339200387,1.0,2/10,10.69%,NPL;NAGK
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.5165659483168179,1.082500590536268,0.34210526315789475,0.87408680506235,1.0,4/25,5.64%,KIT;PTPRO;CDH13;SRGAP2
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.5679641869356369,1.082298009738479,0.4222222222222222,0.8741339263631446,1.0,2/12,7.94%,MYORG;IGFBP4
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),-0.5845947146623738,-1.0822345823893404,0.3442622950819672,1.0,1.0,5/16,24.47%,SOX10;EIF2B2;PLP1;MYRF;ZNF488
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.5055897880657689,-1.0818646854144391,0.3037974683544304,1.0,1.0,1/36,0.29%,EPN1
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),-0.6563680871634756,-1.081766140094825,0.4262295081967213,1.0,1.0,2/8,8.28%,SLC7A7;SLC3A1
prerank,GO_Biological_Process_2021__regulation of flagellated sperm motility (GO:1901317),0.641841570180998,1.0816588125450939,0.5,0.8751675974494687,1.0,1/7,0.14%,TACR3
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.5021319289009998,1.0816140978648303,0.38235294117647056,0.874617717738912,1.0,7/23,20.40%,RIPK2;ALPK1;TAB3;TAB1;TAB2;MAP2K6;TRAF6
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),0.6503442549937958,1.0812179369726587,0.45,0.8744361595516378,1.0,2/7,3.01%,ADGRG6;PARD3
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),0.6503442549937958,1.0812179369726587,0.45,0.8744361595516378,1.0,2/7,3.01%,ADGRG6;PARD3
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),-0.6517242351628598,-1.081147210945043,0.4230769230769231,1.0,1.0,3/11,15.91%,SLCO2B1;SLCO2A1;SLCO1A2
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.4571315201550268,1.080899742542322,0.2894736842105263,0.8745743383175263,1.0,8/32,18.57%,CRK;ABL1;FLNA;CASS4;CSPG5;LIMS1;CRKL;DOCK1
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),-0.6253040080878741,-1.080860656105841,0.3870967741935484,1.0,1.0,4/10,21.55%,TERF2IP;DCLRE1C;DCLRE1A;TFIP11
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),-0.5301701967603969,-1.0808022693646062,0.3382352941176471,1.0,1.0,4/20,6.21%,TGFB1;NODAL;PBLD;DAB2
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),-0.42103967056308766,-1.0804926427296206,0.3108108108108108,1.0,1.0,19/126,17.19%,TRIP10;FOXM1;RASGRF2;ARHGAP9;TAGAP;OBSCN;VAV3;ARHGAP15;TGM2;RHOQ;ARHGAP12;ARAP3;ARHGAP28;ARHGDIG;A2M;AKAP13;RAC2;ECT2;RAC1
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.42670853672550985,1.080388651601352,0.26666666666666666,0.8752151803116599,1.0,14/45,16.47%,LAMB4;PARVA;ITGA8;ITGA4;USH2A;SRGAP2;NTN4;FER;NTNG2;TYRO3;PXN;ANTXR1;TMEFF2;SRCIN1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),-0.6370465499819423,-1.0802787574824746,0.4166666666666667,1.0,1.0,4/9,20.95%,RPL5;RPL23;RPS7;RPL11
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.3871506119290732,1.0800687286586952,0.24242424242424243,0.875341140484389,1.0,35/123,19.02%,SPHKAP;GRM3;LRRTM3;KCNC2;LRRC4C;PDE10A;ATXN1;ELAVL3;CADM2;NEGR1;PAK5;KCNIP1;ADGRA1;CELF4;CXCL14;BRINP1;GABRG1;RGS7BP;NXPH1;ELAVL4;RAB3C;DPF1;OLFM3;SNAP91;RBFOX1;SCRT1;VSTM2B;NRXN1;RIT2;PPFIA2;LSAMP;MMD2;ST8SIA3;ADGRB3;GRM5
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),0.5978437607593382,1.0800453328703121,0.40540540540540543,0.874759388460631,1.0,5/10,28.52%,MFSD2A;MTMR3;MTMR1;MTMR9;ABCA3
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.5314471797446568,-1.0800409806857032,0.31343283582089554,1.0,1.0,5/30,17.52%,RIN3;VAV3;NEB;RAC1;MSN
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),-0.5773016650175966,-1.0796730373773809,0.4305555555555556,1.0,1.0,3/18,10.71%,MCM3;MCMDC2;TERT
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.5052962184555598,1.079526336858398,0.3870967741935484,0.8756381021035802,1.0,8/22,22.29%,UBAP1L;MVB12A;UBAP1;PTPN23;SNF8;NEDD4;MVB12B;TSG101
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),-0.5479046923661129,-1.0793520067108882,0.3620689655172414,1.0,1.0,4/21,17.25%,AQP3;SFRP4;ABCA12;ZFP36L1
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),0.6202411268876777,1.079281086664725,0.4666666666666667,0.8758204299797155,1.0,8/9,34.83%,DRD4;HRH1;GABRB2;GABRB1;GABRB3;GABRG2;DIAPH1;DRD3
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3476491001687347,1.079160458886183,0.2222222222222222,0.8755128924441378,1.0,118/459,20.92%,CD38;FOXO1;PER2;GMNC;HDAC3;PRICKLE1;BCL6;HDAC10;TSHZ3;TWIST2;MTERF3;KLF10;CIART;SLFN11;PHC2;PRDM5;SAMD4A;HEXIM2;GATAD2A;TLE2;ATXN1;PPARG;WNT4;SIRT1;IFI16;RORB;SFMBT1;CRY1;HIC2;NRG1;HES1;PCIF1;PROX1;DHFR;ZBTB4;TRIM71;FOXP2;IKZF4;ZNF703;RIDA;KDM8;EIF2AK3;PML;PLCB1;WWP2;NANOS3;NKAP;CNOT9;FOXN3;ZEB1;MAP3K10;TWIST1;SPEN;CTBP2;TERF1;TIMELESS;DACH1;DPF1;RBFOX2;LIMS1;SMARCA2;MLXIPL;SMARCA4;SCMH1;MDFIC;KAT6A;DPF2;HDAC1;ASCL1;SMAD2;NR2F2;NR3C1;BCOR;MBTD1;MECP2;ZMYND11;HDAC4;PUS7;MALSU1;SPINDOC;MEN1;TP53;MPHOSPH8;MAGEL2;NOTCH1;ARID5B;ATF7IP;RAD17;PA2G4;SYNCRIP;THAP7;ZHX3;NIPBL;LSM14A;ZNF12;RBPJ;SP3;YAF2;ZNF706;ATR;SAMD4B;SOX13;DPF3;KAT6B;CDK5;KHDRBS1;EIF4A3;POU2F1;HDAC5;NANOS1;TRAF6;RSF1;PCGF6;RNF139;FXR2;HINFP;PRDM16;LARP1
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),0.6114074936482252,1.078872444872577,0.4186046511627907,0.8758088123116473,1.0,1/8,3.92%,RIPK2
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.6042415546193645,-1.0787541871614974,0.45,1.0,1.0,3/11,14.99%,USP50;NLRC3;DDX3X
prerank,GO_Biological_Process_2021__positive regulation of acrosome reaction (GO:2000344),-0.6637437513145521,-1.0786092986140758,0.43859649122807015,1.0,1.0,4/7,16.03%,PLA2G10;POMZP3;ZP3;IQCF1
prerank,PanglaoDB_Augmented_2021__Schwann Cells,-0.44126467333614183,-1.0782463956293347,0.34615384615384615,1.0,1.0,18/128,14.02%,GPR62;TRIL;LMOD1;PPP1R1B;SOX10;GFRA3;SHISA6;CTHRC1;DAAM2;LGI4;MPZ;ART3;AQP4;LRP4;APOD;EDNRB;NDRG1;RXRG
prerank,GO_Biological_Process_2021__regulation of T-helper 17 type immune response (GO:2000316),0.6741348061530202,1.0781193971008989,0.4864864864864865,0.8774798963251547,1.0,3/6,22.14%,CARD9;IL23A;SMAD7
prerank,GO_Biological_Process_2021__GDP-mannose metabolic process (GO:0019673),0.648987996623488,1.0780846214883053,0.375,0.8768764411806836,1.0,3/6,28.33%,GMDS;PMM2;GFUS
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),0.6128517695040998,1.0780426544283717,0.4146341463414634,0.8763533545500032,1.0,3/10,6.51%,BCL6;SOX12;HLA-DRA
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),-0.6443688497644839,-1.0777621455555122,0.375,1.0,1.0,6/12,16.51%,ALOX12;ALOX5;ALOX12B;ALOX15;HAO2;ALOX15B
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),-0.5240974878863742,-1.0774765173515024,0.3787878787878788,1.0,1.0,7/30,14.67%,PDCD1LG2;SFTPD;CEACAM1;VSIG4;HLA-DRB1;FGL1;CD80
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",0.3109816246647907,1.0773862137240462,0.0,0.877555197789109,1.0,215/966,19.37%,TEAD2;ERG;CD38;BAMBI;POU3F1;ESRRG;FOXO1;FANK1;ZNF496;SKAP1;TGFBR1;HDAC3;MED17;MAFB;MITF;NFATC3;RORA;APOE;RARB;POU3F2;GALR3;KLF10;CDH13;BCL11B;GABPB2;CCN1;AUTS2;ZNF263;RIPK2;PID1;SMARCD3;PPARG;CREB3L2;WNT4;FZD5;TET2;SIRT1;ELOF1;IFI16;ERBB2;MAML1;CREB3L4;PAX3;SNX5;RORB;ZEB2;PYHIN1;SOX12;LHX2;SSBP3;SERPINE1;JAG1;PKD2;SIRT7;HES1;PTOV1;PROX1;STAT5B;HMGB1;LBHD1;ATF3;DLX1;NCOA3;NCOA2;OSR1;SMARCB1;CDCA4;MED25;PCGF5;ETV1;GREM1;KDM8;SEC14L2;EIF2AK3;NRIP1;PML;ABL1;WWOX;NAT14;PLCB1;SP1;RBL1;FZD1;MYC;ZNF462;FSTL3;BCLAF3;TCF20;NR4A2;LRP6;SENP1;ZSCAN21;WNT3A;TWIST1;HIVEP3;HCLS1;TFE3;H1-10;WBP2NL;ATF1;CEP290;GRIN1;PLAGL1;ARID1A;CTBP2;RNF10;RPS6KA3;NPAS4;F2R;NAMPT;RRP1B;NPAS3;SP7;BPTF;TRIM44;PPM1A;CITED4;PIM2;DPF1;NSD1;SMARCA2;ZNF300;MLXIPL;SMARCA4;USP16;BCL9L;GDF6;RET;BICRAL;MDFIC;KAT6A;JUNB;NFIB;FADD;PLSCR1;DPF2;HDAC1;ASCL1;TESC;RYBP;ZXDC;MED16;FOXF2;ARRB1;CDK8;SMAD2;NR2F2;RPS6KA4;RLF;NR3C1;NFKB1;PPARGC1B;NFAT5;MLLT3;ASXL3;WWTR1;TFCP2;THRB;HDAC4;RFX6;NFIC;ETV5;MEN1;HSF1;NR1H3;SERTAD2;HJV;TP53;ZNF609;GABPA;RUNX1;ATAD2B;NR4A3;ZGLP1;NOTCH1;NCK1;ATM;PBX1;LPIN2;ATF7IP;NUFIP1;HIVEP1;GABPB1;BRD4;ICE1;SKI;FOXJ2;MAP2K7;PAX6;RFPL2;IL11;ELF2;ARID1B;TFEB;SATB2;RBPJ;SP3;YAF2;SUPT3H;ATF6;TNIP3;KLF6;NR4A1;RFX5;SPIN1;ACVR1;ASXL1;EP300;CXXC1;DPF3;TCF4;CREB1;KAT2B;QRICH1;KAT6B
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),0.6077567226271716,1.0772359107883738,0.4222222222222222,0.8773384194669855,1.0,2/10,7.94%,SPEF2;WWP2
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),-0.6670459561542696,-1.0772026259671936,0.3333333333333333,1.0,1.0,2/10,2.76%,CASQ2;CAV3
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),-0.5644734836709615,-1.0769191673853953,0.373134328358209,1.0,1.0,2/17,5.61%,HK2;PINK1
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),-0.5348601674340374,-1.076821556107063,0.32786885245901637,1.0,1.0,3/18,6.02%,TRIM62;TRIM5;TRIM25
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),-0.6780201643473825,-1.0766354023907774,0.41818181818181815,1.0,1.0,1/7,7.96%,RNF213
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by integrin (GO:0033631),0.6743615209681627,1.0764324052878993,0.43137254901960786,0.879115348185237,1.0,1/5,4.73%,ITGA4
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),0.6250383789983716,1.0763456526558826,0.42857142857142855,0.878614786774382,1.0,4/7,31.33%,VCL;IKBKB;ROCK1;ZDHHC21
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.4037564525692221,-1.0762210295986148,0.3253012048192771,1.0,1.0,31/175,15.41%,CLEC5A;APOL1;JCHAIN;TRIM58;TRIM62;HCK;BLK;SP100;TRIM77;TRIM5;CIITA;SFTPD;TRIM25;RNF39;MASP1;BPIFB1;PTX3;CFD;NLRP9;CYBA;SLC11A1;IFIT1;MASP2;OAS1;CXCL16;TLR2;COLEC12;NOS2;RNF187;DDX3X;IGLL1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),0.5543302849669849,1.0761126065637745,0.4318181818181818,0.8787030466517537,1.0,4/14,4.79%,TBC1D10A;PERP;RIPK2;IFI16
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),-0.6066983234426828,-1.0760997352792183,0.4426229508196721,1.0,1.0,4/10,14.65%,PLAAT4;ETV4;PRKCH;VDR
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),-0.6931941135122927,-1.0759108717868495,0.4084507042253521,1.0,1.0,1/6,13.49%,CD27
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),0.5071598217244926,1.0757840823388,0.32558139534883723,0.8790171864075222,1.0,3/13,7.07%,MSH4;TOP2A;HFM1
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.31246320728528215,1.0757765017519174,0.0,0.8783710236666525,1.0,407/1778,18.70%,TEAD2;ERG;CD38;BAMBI;POU3F1;ESRRG;FOXO1;PER2;FANK1;MLF1;ZNF496;ZNF607;ZSCAN4;ZNF808;SKAP1;TGFBR1;TSHZ2;KIT;ZNF408;POU6F2;HDAC3;PKNOX1;PRICKLE1;ZNF239;ZNF347;MKX;ZNF195;OR7D2;ZNF485;ZNF117;BCL6;ZNF212;ZBTB9;DMRT3;NEUROD2;ZNF623;MED17;MAFB;MITF;NFATC3;ZFPL1;RORA;APOE;ZNF518A;HDAC10;TSHZ3;POU3F2;ZNF692;CDK14;TWIST2;MTERF3;ZNF561;URI1;ZBTB7B;KLF10;SLC39A8;ARX;PCGF1;BCL11B;ZNF835;ZNF70;CIART;CBFB;PHC2;PRDM5;HEXIM2;APBB3;TGIF1;GATAD2A;ZNF263;ZNF99;TLE2;ZNF33B;E2F6;ZNF701;SMARCD3;ATXN1;PPARG;CREB3L2;WNT4;ATOH7;SIRT1;ZNF860;IFI16;ERBB2;ZFHX4;CREB3L4;PAX3;SNX5;TULP3;RORB;ZEB2;SFMBT1;BACH2;PYHIN1;SOX12;LHX2;ARID3B;ZNF641;ELP4;CRY1;GPBP1L1;ZBTB20;HIC2;NRG1;HES1;GFI1B;BCL11A;ZNF780B;ZNF534;TOX;ZFP3;PROX1;ZNF470;STAT5B;DHFR;ZBTB40;ZBTB4;CRK;HMGB1;BHLHA9;SMARCAL1;LBHD1;ATF3;TPRX1;DLX1;FOXP2;HIVEP2;NCOA2;SAFB2;OSR1;ZBTB1;HP1BP3;IKZF4;KDM7A;SMARCB1;ZNF703;PCGF5;ETV1;ZNF274;SPIN2B;KDM8;ZNF786;RGS14;SEC14L2;PML;ABL1;POFUT1;NAT14;PLCB1;SP1;FZD1;WWP2;MYC;MGA;NKAP;ZNF251;ZNF215;FSTL3;CTDSP1;TCF20;NR4A2;ZNF33A;TGFA;ZNF688;LRP6;ZSCAN12;FOXN3;SLTM;RFX1;ZEB1;FOXD4L5;HIF3A;ZNF202;ZSCAN21;WNT3A;HDX;RFX7;MAP3K10;TWIST1;SNAI2;HIVEP3;TENM1;SPEN;HCLS1;ZNF845;SRCAP;ZNF133;FADS1;LCORL;TFE3;WBP2NL;ATF1;ZNF2;CEP290;TESMIN;MAMLD1;PLAGL1;ZNF599;ZNF331;ARID1A;CTBP2;CREM;CDK18;ZNF519;RNF10;RPS6KA3;ZNF852;NPAS4;ZNF569;ELOA;ZNF514;F2R;EBF4;NPAS3;BATF2;MSC;KDM2A;ZNF777;ZNF652;SP7;BPTF;ZNF75A;TRIM44;HES6;TIMELESS;ZNF782;PPM1A;PIM2;DACH1;ZFP82;DPF1;RBFOX2;MYT1L;ZNF761;CCNH;NSD1;DMTF1;BRD3;LIMS1;SMARCA2;ZNF41;ZNF300;KDM3B;ZNF846;MLXIPL;SMARCA4;ZNF771;ZNF594;USP16;GDF6;TIAL1;RET;BICRAL;SCMH1;EPC2;ZNF337;MDFIC;KAT6A;ZNF155;JUNB;EFEMP1;ZNF704;NFIB;TEAD4;ZNF311;DPF2;ZNF276;NR3C2;MXI1;ZNF384;HDAC1;ASCL1;TESC;RYBP;CHD4;ZXDC;CDK11A;CARM1;MED16;FOXF2;ARRB1;TCIM;SMAD2;NR2F2;RPS6KA4;RLF;NFYC;ZNF774;NR3C1;NFKB1;PPARGC1B;NFAT5;MLLT3;BCOR;SOX5;ASCC2;ZNF611;MBTD1;CUX1;WWTR1;SCRT1;TFCP2;MECP2;ZMYND11;ZNF438;HDAC4;ZNF69;INSR;RFX6;ZFP62;NFIC;SPINDOC;CDK16;ETV5;MEN1;ZNF131;HSF1;MAGED1;ZNF48;NR1H3;ZNF586;TP53;ZNF165;ZNF609;BAZ1B;HSF4;GABPA;ZFY;RUNX1;NR6A1;ZNF549;BAZ2B;BAZ2A;NR4A3;FUS;TTC21B;ZFP28;MED13L;ZSCAN31;WWC1;SNF8;ZNF765;MPHOSPH8;GMEB1;ZNF708;ZGLP1;MAGEL2;NOTCH1;POLR3G;ZBTB2;CHD1;UBE2L3;ZNF283;PBX1;ZNF665;ARID5B;ATF7IP;ZNF292;KLF12;HIVEP1;ZNF273;BRD4;PA2G4;THAP7;SP2;ZFX;FOXJ2;NR2C1;MAP2K7;PAX6;RFPL2;ZHX3;ZNF646;ZNF675;ZNF322;ELF2;ZNF627;ZNF589;ARID1B;TFEB;NIPBL;ZBTB5;PRMT5;SATB2;ZNF12;ZBTB41;ZNF613;RBPJ;ZNF142;CAMTA1;SP3;NFX1;YAF2;UXT;ZNF706;SUPT3H;ATF6;KLF6;NR4A1;ZNF157;SOX13;RFX5;SPIN1;ZNF445;ERC1;ACVR1
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),0.5482407279997753,1.075357240256071,0.38461538461538464,0.8787413605470822,1.0,6/11,28.72%,PACSIN2;SNX9;BIN3;FNBP1L;SNX33;WHAMM
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.5904161031653451,1.0749816182464058,0.45454545454545453,0.87886069839463,1.0,5/10,31.49%,KLHL22;SESN2;RRAGD;SESN3;UBR2
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.5904161031653451,1.0749816182464058,0.45454545454545453,0.87886069839463,1.0,5/10,31.49%,KLHL22;SESN2;RRAGD;SESN3;UBR2
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),0.4786516700244462,1.074640993753718,0.4838709677419355,0.8791622908331826,1.0,8/27,17.08%,CDH5;SNCA;SLIT2;MAPRE1;KANK1;KANK4;SSH1;CLIP3
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),0.5866687746880669,1.0745748439494194,0.42424242424242425,0.878743428946688,1.0,5/15,15.63%,DSCAML1;BSG;DSCAM;EMB;CNTN6
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.51575753716229,1.0745519114854891,0.2903225806451613,0.8781340819463246,1.0,7/18,23.53%,RIDA;DXO;LIN28B;YTHDF1;METTL16;RBM24;MEX3D
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.46898946135029496,1.0745294901761684,0.24242424242424243,0.877548108381772,1.0,5/26,12.94%,CD14;TICAM2;TICAM1;TANK;FADD
prerank,GO_Biological_Process_2021__catecholamine uptake (GO:0090493),-0.6945353096760523,-1.0743249832551034,0.5,1.0,1.0,2/5,24.50%,SLC22A3;SLC22A1
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.5964379361323274,-1.0740548759624198,0.391304347826087,1.0,1.0,3/12,10.70%,HK2;PINK1;DNAJA1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),0.45541738605020016,1.0736473929050387,0.32432432432432434,0.8791518777991768,1.0,5/30,7.70%,ADAMTS1;FGF10;LSM10;CCND3;PLCB1
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.5140965791206378,1.072976616266693,0.3888888888888889,0.8804840647622085,1.0,6/17,19.24%,CRY1;ADCY2;PRKAR2A;ADCY3;ADCY6;CREB1
prerank,GO_Biological_Process_2021__regulation of leukocyte mediated cytotoxicity (GO:0001910),-0.6738093325015191,-1.0727009572817299,0.49122807017543857,1.0,1.0,2/6,20.84%,NOS2;AGER
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),-0.5478950829050928,-1.0726711888066656,0.390625,1.0,1.0,6/18,14.69%,TRIL;ITGB2;SCIMP;ITGAM;OAS1;NR1H4
prerank,GO_Biological_Process_2021__cobalamin transport (GO:0015889),-0.6584890867720581,-1.072589172766589,0.417910447761194,1.0,1.0,3/6,18.59%,TCN1;AMN;CBLIF
prerank,GO_Biological_Process_2021__regulation of defense response to bacterium (GO:1900424),-0.7043713378267109,-1.072555467796171,0.48,1.0,1.0,2/5,15.82%,CYBA;GRN
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),0.6825967207261772,1.0723147164095954,0.47368421052631576,0.8816909822416197,1.0,2/6,14.89%,PUS10;PUS7
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),0.6406575194346342,1.071895872969967,0.4897959183673469,0.8823473089744983,1.0,4/6,31.13%,CDK6;STAT3;DLL1;HES5
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.435384312823779,1.0717003331842754,0.3235294117647059,0.8822752022198553,1.0,12/38,23.49%,CCN4;CCN1;WNT4;SUCO;WWTR1;ZHX3;ACVR1;ACVR2A;BMPR2;BMP4;LRP3;BMPR1A
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.41981729136094853,1.0715668020852955,0.375,0.8819683507054729,1.0,27/110,18.88%,TBC1D10A;KLHL20;SNX5;STX5;RAB7A;STX6;WASHC2C;GBF1;RHOBTB3;STX8;UBE2O;GCC2;GGA1;DENND2A;VPS54;WASHC2A;VTI1A;PTPN23;SNX32;SNF8;MAGEL2;RAB5A;VPS50;MON2;ERC1;ARFRP1;DOP1B
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),0.6103565664583344,1.0714628303343472,0.42,0.881650778318525,1.0,4/7,29.63%,PRIMPOL;DNA2;LONP1;LIG3
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),-0.5826158881503767,-1.071380680180277,0.40298507462686567,1.0,1.0,3/13,18.02%,PHKG1;PYGL;CALM1
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.4746035811091011,1.071323264867604,0.35135135135135137,0.8814230106354907,1.0,6/26,11.59%,SLC38A5;SLC3A2;SLC6A20;SLC25A29;SLC7A8;SLC25A12
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),-0.6604718564973517,-1.0713169548365786,0.38596491228070173,1.0,1.0,3/8,14.82%,ZFPM1;HEY2;GATA4
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),0.5237215473085048,1.0705984275289773,0.4375,0.8827466266882655,1.0,2/22,0.91%,NGF;ADGRG6
prerank,GO_Biological_Process_2021__desmosome organization (GO:0002934),-0.6696428574043662,-1.0705434157413274,0.4642857142857143,1.0,1.0,1/6,1.00%,PKP2
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.632326439353372,-1.0705061646571084,0.40384615384615385,1.0,1.0,5/9,21.63%,SP100;IFIT1;TRIM56;MX1;ISG15
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.3902921840837422,-1.0702955934721368,0.27586206896551724,1.0,1.0,72/436,15.75%,CD44;DUOX1;CRLF1;PSMB9;TGFB1;TRIM62;IL21R;AIM2;ITGB2;HCK;IRF4;MMP9;CXCL13;CCND1;IFNK;SP100;ALOX5;RORC;CARD14;IRF1;TRIM5;TNFRSF1B;TEC;CLCF1;PTAFR;CIITA;TRIM25;STAT1;IL7;OAS2;IFIT3;CA1;INPP5D;HLA-A;CEACAM1;ALOX15;SOD2;HLA-DPB1;IL3RA;ANXA1;EDAR;OSMR;IL27;TXNDC17;GBP1;TRAF3IP2;HLA-DRB1;FPR1;SPI1;ITGAM;HSPA8;CDKN1A;IFIT1;OAS1;IL18BP;CFL1;F13A1;HLA-DPA1;CD300LF;OPRM1;CD27;PIK3CB;NOS2;IL12A;LCP1;CD80;IFNGR2;IL5RA;IL18;HLA-F;RBX1;CD4
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),0.4302292897796766,1.0702753284258801,0.34210526315789475,0.8828305964787955,1.0,4/53,5.65%,GCK;NUP210;NUP42;SLC25A33
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),-0.5006222242833223,-1.0702505007840688,0.36764705882352944,1.0,1.0,7/27,14.24%,NRAP;CAV3;NEB;ALPK2;ENG;HEY2;TTN
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),0.6253377953213966,1.0696920788440103,0.42857142857142855,0.8837723872316838,1.0,4/7,33.72%,LIN28B;LIN28A;TUT4;TENT4B
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),0.6098245191555098,1.0695542264259437,0.44,0.8834880571979826,1.0,3/8,21.96%,PDE3B;CDC34;PDE4D
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.3832003661996124,1.0694681960424415,0.35714285714285715,0.8831818947813322,1.0,33/111,19.41%,MEGF10;PCDH17;NOVA1;NLGN1;LRRC4C;PDGFD;SLC35F1;PTPRZ1;KCNIP1;SLIT2;EFS;DOK5;ADGRA1;SYNDIG1;GUCY1A2;PDZRN3;BRINP1;RGS7BP;NPAS3;SNAP91;MAP6;ASXL3;ANK2;PTPRD;CORO2B;MAGEL2;MARK1;CDH4;PAX6;PPFIA2;FAT3;ADGRB3;SLC1A3
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),-0.596206559084193,-1.0690889700268293,0.4098360655737705,1.0,1.0,1/12,1.18%,ELOVL2
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),0.618873479419087,1.069071058206656,0.42105263157894735,0.8836988802754451,1.0,2/8,5.38%,DRD5;SNCA
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.49235708245949855,-1.0689675753302519,0.31746031746031744,1.0,1.0,6/33,21.63%,UBE2L6;TRIM25;NLRC3;CACTIN;DHX58;ISG15
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),0.593713578932437,1.0689512772626164,0.43243243243243246,0.883337466565515,1.0,1/8,2.16%,GLA
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.3825881452043595,1.0687801503798677,0.2962962962962963,0.8830875961247512,1.0,27/97,15.15%,KIT;ADGRL2;PARVA;MID1;COL12A1;RAI14;SLIT2;EDNRA;TENM3;AADAT;SNAI2;KITLG;RND3;CAP2;CHST3;MPDZ;DDAH1;TSPAN6;RBFOX2;LRIG3;TEAD4;TSPAN12;NR2F2;MAGI1;WWTR1;ANTXR1;PTPRF
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),-0.6741299261699663,-1.0687039078643494,0.4444444444444444,1.0,1.0,1/5,1.88%,TIMP3
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.4280972118346362,1.068651284299344,0.3125,0.8829601161038203,1.0,7/47,9.71%,TSKU;APOE;PTPRO;DCC;PTPN9;WNT3A;KANK1
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),-0.5021676096357541,-1.0685645981135368,0.3424657534246575,1.0,1.0,2/40,1.19%,PKP2;SCN5A
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,-0.42983055096621076,-1.068443798762056,0.3888888888888889,1.0,1.0,22/102,16.78%,ANGPTL2;CFAP126;VWA3B;VWA3A;CCDC60;MAP3K19;BPIFB1;DRC1;MS4A8;AKAP14;AQP4;SNTN;CFAP77;FAM81B;APOBEC4;DRC3;CFAP61;DNAH2;CATIP;DNAI1;ADH7;ZBBX
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),-0.5968925397431982,-1.068261235203698,0.423728813559322,1.0,1.0,5/10,27.26%,B3GNT9;B4GAT1;B3GNT2;B3GALT2;B3GNT3
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),0.5965224957478633,1.0682496598380995,0.46808510638297873,0.8834314066120612,1.0,3/6,16.71%,SLC6A17;SLC6A20;SLC36A4
prerank,GO_Biological_Process_2021__isoleucine metabolic process (GO:0006549),-0.7080182110972795,-1.0682169494804663,0.45454545454545453,1.0,1.0,2/5,14.94%,SDS;SDSL
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),-0.5135424825988812,-1.068062196593058,0.3939393939393939,1.0,1.0,4/33,2.91%,TBX1;DNAH11;CCDC39;MMP21
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),-0.540194687297369,-1.0679645885935904,0.3783783783783784,1.0,1.0,3/17,18.26%,DEGS2;CALM1;GCHFR
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.4732103916349284,1.0678159745411564,0.3409090909090909,0.8839020055715004,1.0,3/26,2.88%,KIT;CLMP;RARB
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),0.63022868693528,1.0676015109839543,0.4634146341463415,0.8838959637112198,1.0,2/7,5.28%,TGFBR1;JAG1
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),-0.6335620931896501,-1.0674831904462085,0.44642857142857145,1.0,1.0,2/6,22.93%,TRNT1;PTCD1
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),-0.6444173481616524,-1.0674228470789597,0.390625,1.0,1.0,4/7,21.55%,TERF2IP;DCLRE1C;DCLRE1A;TFIP11
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.4981650699989334,-1.0674002906861826,0.4,1.0,1.0,8/32,25.72%,TERF2IP;ESR1;FAM47E;BOD1;RPA2;TPP1;SLF1;MRNIP
prerank,GO_Biological_Process_2021__regulation of inflammatory response to wounding (GO:0106014),-0.7481058737842493,-1.067306483052253,0.42857142857142855,1.0,1.0,2/5,15.82%,ALOX5;GRN
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),0.6350280918011668,1.0672341271792223,0.4186046511627907,0.8836628581852918,1.0,1/6,2.16%,GLA
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),0.6350280918011668,1.0672341271792223,0.4186046511627907,0.8836628581852918,1.0,1/6,2.16%,GLA
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),0.4098016831141315,1.067203065122749,0.3333333333333333,0.883104787926866,1.0,17/65,19.34%,FRMPD1;PARD3;ZDHHC11B;SYNE3;ZDHHC18;ZDHHC12;GOLGA7B;NECTIN3;RAB10;BID;MYO1C;ZDHHC14;ZDHHC3;RAB11B;BRAF;ZDHHC9;ZDHHC11
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.5129109440377767,1.0671232176232133,0.38095238095238093,0.8826799686647064,1.0,5/18,20.83%,TGFBR1;PTPRR;LIG4;ADAM10;HINFP
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.5805957633857604,1.0670960633188882,0.36363636363636365,0.8821234316641603,1.0,5/9,33.96%,PIH1D1;NUFIP1;ZNHIT6;NAF1;RUVBL2
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.4530817191909286,1.06699606158319,0.2926829268292683,0.8817330093365854,1.0,5/28,8.19%,SLC26A7;SLC39A8;CA3;CYB5R4;SLC4A7
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),-0.5080799707748302,-1.0669892889455295,0.3387096774193548,1.0,1.0,1/40,0.10%,CLIC1
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.48532795928263583,-1.0669525253925858,0.3220338983050847,1.0,1.0,11/33,19.10%,SLC51A;SLC16A8;SLCO2B1;CEACAM1;NR1H4;STARD5;SLC10A1;SLCO1A2;GHRL;ABCB11;SLC27A5
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),0.6456386601928085,1.0667372602647678,0.4146341463414634,0.8817175682694427,1.0,1/6,8.93%,GPHN
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),0.41458123970739624,1.0666607405286344,0.3076923076923077,0.8813060027234426,1.0,23/95,24.20%,CTDNEP1;PRICKLE1;TOR1B;RANBP17;PML;NOL8;NXT1;TAF3;BANP;GBP2;NUTF2;PPP1R10;ABCA7;MORC3;APPL2;IPO8;ZBTB7A;BMP4;NUP214;TPR;BCL3;PLK1;IPO7
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.6086307708562131,-1.0665832759908758,0.3870967741935484,1.0,1.0,5/9,27.26%,B3GNT9;B4GAT1;B3GNT2;B3GALT2;B3GNT3
prerank,GO_Biological_Process_2021__regulation of epithelial cell apoptotic process (GO:1904035),-0.6536512563608594,-1.0665486683954428,0.43859649122807015,1.0,1.0,3/8,17.25%,TEK;YAP1;ZFP36L1
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),0.6158711239071585,1.0664951377887177,0.4186046511627907,0.8812249187411941,1.0,1/6,3.31%,PARVA
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.4866247448937789,-1.0661949163221234,0.36231884057971014,1.0,1.0,10/38,25.97%,PINK1;ATG14;GABARAPL1;GABARAPL2;MAP1LC3B2;FIS1;FUNDC1;SPATA18;BNIP3;ULK1
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),0.4964215067337963,1.0658581965041902,0.4090909090909091,0.882308687717909,1.0,4/17,13.36%,DTX1;HES1;DLX1;ASCL1
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),0.5907340901736226,1.065793117566515,0.4,0.8818317097835464,1.0,2/10,10.73%,MED25;ZNF618
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),0.46117337950458825,1.0657688274266208,0.3409090909090909,0.88125667628166,1.0,9/38,8.91%,DGKD;ANGPT1;HIP1;SERPINE1;ARRB2;MAGI2;BICD1;GREM1;WNT3A
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.3961641352602846,1.0657253071589405,0.2916666666666667,0.8807921192399406,1.0,15/66,18.56%,HDAC3;PRICKLE1;ANGPT1;RIPK2;COMMD1;CRY1;DCUN1D1;TANK;HSPBP1;HDAC4;MALT1;FBXO4;UBE2L3;RASD2;SPRTN
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.38176021439315266,1.0656803623959041,0.2916666666666667,0.8802734555979023,1.0,27/118,22.28%,NOVA1;RNASET2;ATXN1;HNRNPF;BICD1;RBMS1;HNRNPH1;PCBP3;HNRNPL;ELAVL4;WDR74;RBFOX2;PNPT1;GTF2F2;CELF2;PTBP1;TBRG4;AGO3;NUFIP1;SYNCRIP;PAPOLA;XRN2;AGO2;RBM6;ADAR;LSM8;POLR2F
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.41566951106894123,-1.0656120283051467,0.3333333333333333,1.0,1.0,32/180,12.60%,CD44;ECM2;ITGB2;MMP9;MMP21;MMP19;TGFBI;COL18A1;NID1;COL1A1;COL5A1;COL27A1;LOX;VTN;DCN;ICAM3;COL4A4;ITGA9;COL4A3;THBS1;MATN4;VWF;ITGA2B;PXDN;MMP25;LAMC2;FBN2;ITGAM;ITGB6;MARCOL;COL23A1;VIT
prerank,GO_Biological_Process_2021__negative regulation of serine-type peptidase activity (GO:1902572),-0.6730172442554652,-1.0655421440157637,0.46296296296296297,1.0,1.0,4/5,32.18%,SPINK6;SPINK5;ANXA8;CR1
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.6418138448819201,1.065451470351081,0.44680851063829785,0.8801934731754936,1.0,1/7,1.01%,MEGF10
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),0.34385818364132464,1.0653656868143377,0.16666666666666666,0.8797963382246576,1.0,72/277,26.51%,CPSF1;SNRPN;NOVA1;PCF11;HNRNPF;TRA2A;RBM41;PUF60;PRPF40B;HNRNPH1;TXNL4A;SNRPB;SPEN;U2AF1;ERN1;SRRM1;HNRNPL;LSM2;ZMAT5;CCNH;GEMIN5;CWC27;SF3B1;CPSF7;SRSF4;GTF2F2;SRRM4;PTBP1;FUS;LSM7;TBRG4;SYNCRIP;AURKAIP1;PAPOLA;ERCC3;RNF113A;RPRD2;EIF4A3;U2AF2;SYMPK;SF3B4;RBM6;CPSF6;GPATCH1;LSM6;PPIH;CDC5L;LSM8;PDCD7;DDX46;DDX41;POLR2F;RALY;PRPF18;MAGOHB;TCERG1;SNRNP48;PSPC1;RBM10;YBX1;THOC1;SNRPF;WDR33;CWF19L1;PABPC1;CCAR1;SF1;SCAF11;SNRPA;RBM8A;SMU1;SON
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.5810842720710919,1.0652506138101419,0.3333333333333333,0.8794216431533517,1.0,3/10,11.69%,CSGALNACT1;B3GAT3;DSEL
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.4636301996109291,1.0652106421277956,0.29411764705882354,0.8788945479113061,1.0,10/36,16.80%,ATXN1;BACH2;RGS14;NXT1;ANP32A;SNRPB;AAAS;GEMIN5;MALT1;NUTF2
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.43735581434432985,-1.064816993670992,0.3787878787878788,1.0,1.0,17/60,27.50%,PSMB9;HLA-A;SNAP23;CYBA;HLA-F;PSMA3;ITGB5;PSMA7;PSMB6;PSMA5;HLA-C;PSMD6;NCF2;PSMC5;PSMB4;PSMB7;PSMD8
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.37502322966500745,1.0645523431083384,0.21739130434782608,0.8800166154111575,1.0,20/68,22.46%,TBC1D10A;IFT88;TBC1D16;TBC1D12;TRAPPC12;ALMS1;STX18;SDCCAG8;TBC1D22B;IFT140;MTMR3;RAB5A;TBC1D2;DCDC2;TBC1D8;USP6NL;TBC1D5;NPRL2;TSG101;RABEP2
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.5252034000786179,1.0645006204053578,0.391304347826087,0.8795553040053937,1.0,6/12,12.52%,NLGN1;LRRTM3;FZD1;WNT3A;NLGN4X;NLGN3
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),-0.5268628873133054,-1.0644459421893753,0.3888888888888889,1.0,1.0,4/14,10.60%,GPER1;CIITA;CEACAM1;SLC18A2
prerank,GO_Biological_Process_2021__negative regulation of response to food (GO:0032096),-0.652336076083095,-1.0643201729716227,0.4067796610169492,1.0,1.0,1/5,13.18%,CARTPT
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.5263769123128035,-1.064176533390226,0.4,1.0,1.0,5/23,13.21%,STAC;PDZK1;GLRX;ABCB1;COX17
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.5911918523557407,1.0640061523446254,0.41025641025641024,0.8803373494482796,1.0,2/8,5.50%,TGFBR1;NRG1
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.4810326319479959,1.0638011149541984,0.2857142857142857,0.8803993329763373,1.0,4/18,8.83%,BCL6;CBFB;SOX12;TNFRSF18
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.46465678760652496,1.0630842932403206,0.3939393939393939,0.8818654020656652,1.0,5/36,7.67%,IRGM;APOE;SNCAIP;RAPGEF1;LATS1
prerank,GO_Biological_Process_2021__positive regulation of flagellated sperm motility (GO:1902093),0.6557541214718442,1.063059087369058,0.4418604651162791,0.8800489881151042,1.0,1/6,0.14%,TACR3
prerank,GO_Biological_Process_2021__positive regulation of cilium movement (GO:0003353),0.6557541214718442,1.063059087369058,0.4418604651162791,0.8800489881151042,1.0,1/6,0.14%,TACR3
prerank,GO_Biological_Process_2021__positive regulation of cilium-dependent cell motility (GO:2000155),0.6557541214718442,1.063059087369058,0.4418604651162791,0.8800489881151042,1.0,1/6,0.14%,TACR3
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),-0.5311010101533238,-1.063027781275553,0.38461538461538464,1.0,1.0,3/20,9.78%,WNT5A;PLA2G10;THBS1
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.4681919340996377,1.0629464407016052,0.34210526315789475,0.8796333900196173,1.0,5/25,7.70%,ADAMTS1;FGF10;LSM10;CCND3;PLCB1
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.5770842785172093,-1.0628340216132897,0.4090909090909091,1.0,1.0,4/13,19.59%,ADSS1;RFK;PAICS;IMPDH2
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,0.36504303086173345,1.0627813213573043,0.17647058823529413,0.8794353086148511,1.0,21/115,10.72%,FIBIN;TPM2;FGF10;LAMA4;MXRA5;MRGPRF;CCN2;PARVA;CCN1;SLC8A1;COL12A1;PPARG;ADAMTS12;MMP2;TIMP1;PNPLA3;EDNRA;SNAI2;PDZRN3;COLEC11;COL16A1
prerank,GO_Biological_Process_2021__skin morphogenesis (GO:0043589),-0.6698776555597433,-1.0626033420976049,0.47619047619047616,1.0,1.0,2/5,14.91%,COL1A1;ABCA12
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.4894666572423983,1.0623905258732993,0.3333333333333333,0.8796927156818181,1.0,11/27,17.85%,SIRT7;SHLD2;SHLD1;SETMAR;KMT5C;SMCHD1;WRAP53;HSF1;KMT5B;USP51;PNKP
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),0.6509001721882015,1.0621250552907717,0.45,0.8797223146761228,1.0,2/6,10.74%,ABCA1;F2R
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.42982510338735064,-1.0620599875403223,0.3132530120481928,1.0,1.0,21/103,14.43%,F8;TGFB1;TIMP3;BLK;PSAP;SELP;CLU;PLG;CFD;THBS1;CD63;VWF;ITGA2B;ITIH3;TUBA4A;F13A1;ITIH4;A2M;F5;TTN;TGFB3
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),0.688412155258179,1.061829130021041,0.43902439024390244,0.8798168071565918,1.0,1/6,2.34%,NEUROD2
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),0.4836255606527017,1.061818319914174,0.3157894736842105,0.8791973807917696,1.0,6/16,18.84%,SMARCB1;SP1;RRP1B;SMARCA4;CHD1;EP300
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.319551802137803,1.0617670367460232,0.25,0.8787301414554616,1.0,79/604,11.92%,IL7R;ADRA1A;BAMBI;NGF;EGLN3;SMYD2;GRK5;ADAMTS1;FGF10;NOX4;TGFBR1;KIT;DUSP15;TCIRG1;BCL6;VEGFC;BCL2;FGFR1;KSR1;IRS1;POU3F2;KLF10;CDH13;FRK;FGF17;SIRT1;P3H3;AKR1C3;ERBB2;P3H2;JAG1;PKD2;KLHL41;PDGFD;NRG1;HES1;MAGI2;FKTN;SLC25A33;WNT9A;CHRNA10;PROX1;STAT5B;TRIM71;TIMP1;HP1BP3;ACER2;ZNF703;GREM1;CDK6;SGK1;FER;CDK4;PML;MYC;FGF18;TGFA;WNT3A;TENM1;HCLS1;AKT2;FGFR3;KITLG;PBRM1;CTBP2;ACER3;WNK2;ALDH1A2;IRS2;F2R;NAMPT;DDAH1;TIMELESS;PIM2;SGK2;RBFOX2;PPP1R9B;LIMS1;SMARCA2
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),-0.481010694307733,-1.0617410417330786,0.3698630136986301,1.0,1.0,9/44,20.23%,HK2;PINK1;TOMM20;TOMM7;PAM16;TIMM17A;ROMO1;FIS1;CHCHD4
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),0.5381796009113762,1.0616822532090333,0.45454545454545453,0.8783607654206229,1.0,6/12,23.88%,PGS1;CRLS1;LCLAT1;PLA2G5;HADHB;PLA2G6
prerank,GO_Biological_Process_2021__complement receptor mediated signaling pathway (GO:0002430),0.5870234488222169,1.0616327805397405,0.4473684210526316,0.8778192500878828,1.0,1/10,0.25%,GPR33
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),0.47402096189955933,1.0615332927818275,0.40540540540540543,0.8775696763844357,1.0,6/33,10.67%,GCK;CAPN10;DOC2B;GLUD1;MCU;IRS2
prerank,GO_Biological_Process_2021__cellular response to UV-B (GO:0071493),-0.6753766317788649,-1.061377042906406,0.47058823529411764,1.0,1.0,2/6,14.93%,CDKN1A;HYAL1
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.4387434863030094,1.061120481698745,0.42105263157894735,0.8781933395820896,1.0,8/30,15.02%,AUTS2;FER;SLIT2;ABI3;WASF2;AVIL;PIK3CA;FSCN1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),0.6531569432014395,1.0607580223632074,0.42857142857142855,0.8785576662810655,1.0,2/7,5.58%,JAG1;MAGI2
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),-0.6256161792458548,-1.060726779604191,0.40350877192982454,1.0,1.0,3/9,13.14%,SCIN;PITHD1;FAXDC2
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.33331521201412945,1.060466525426452,0.25,0.8788353860888688,1.0,83/384,18.34%,CD38;FOXO1;PER2;HDAC3;PRICKLE1;BCL6;HDAC10;TSHZ3;TWIST2;MTERF3;KLF10;CIART;PHC2;PRDM5;HEXIM2;GATAD2A;TLE2;ATXN1;PPARG;WNT4;SIRT1;IFI16;RORB;SFMBT1;CRY1;HIC2;NRG1;HES1;PROX1;ZBTB4;FOXP2;IKZF4;ZNF703;KDM8;PML;PLCB1;WWP2;NKAP;FOXN3;ZEB1;MAP3K10;TWIST1;SPEN;CTBP2;TIMELESS;DACH1;DPF1;RBFOX2;LIMS1;SMARCA2;MLXIPL;SMARCA4;SCMH1;MDFIC;KAT6A;DPF2;HDAC1;ASCL1;SMAD2;NR2F2;NR3C1;BCOR;MBTD1;MECP2;ZMYND11;HDAC4;SPINDOC;MEN1;TP53;MPHOSPH8;MAGEL2;NOTCH1;ARID5B;ATF7IP;PA2G4;THAP7;ZHX3;NIPBL;ZNF12;RBPJ;SP3;YAF2;ZNF706
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.4351702763314834,1.0604008946837102,0.2972972972972973,0.8784137472351217,1.0,8/35,12.34%,PRSS3;KIT;CDH13;ZEB2;ABL1;KANK1;PKN2;PXN
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),-0.6360086864358103,-1.0603121599674357,0.4074074074074074,1.0,1.0,1/8,10.71%,TERT
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),-0.5303562245245603,-1.0602978263001939,0.3333333333333333,1.0,1.0,6/19,20.44%,IL21R;IFNK;PTPRC;AXL;CASP8;PRDX1
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.40192058470229436,-1.060165038699202,0.3333333333333333,1.0,1.0,19/180,10.28%,CD44;TGFB1;NODAL;TIMP3;SCIMP;ROS1;GPER1;GPR183;ALKAL2;FLT4;CEACAM1;ALOX15;ATP6AP1;HTR2B;P2RY6;PRXL2C;GBP1;HLA-DRB1;PTPRC
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),-0.6214780694581542,-1.0600165222587972,0.4444444444444444,1.0,1.0,1/8,2.89%,CCDC39
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.43530867839704585,-1.0598771288340696,0.3333333333333333,1.0,1.0,17/62,27.50%,PSMB9;HLA-A;SNAP23;CYBA;HLA-F;PSMA3;ITGB5;PSMA7;PSMB6;PSMA5;HLA-C;PSMD6;NCF2;PSMC5;PSMB4;PSMB7;PSMD8
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),-0.5701438198556967,-1.0598765932572884,0.4166666666666667,1.0,1.0,1/14,0.34%,LILRB3
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),-0.6122047569186527,-1.059749797558226,0.4166666666666667,1.0,1.0,5/10,29.24%,PINK1;IL10RB;ISCU;PARK7;NUPR1
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),0.5671301491949318,1.0595184776835729,0.6111111111111112,0.8803782371298843,1.0,5/14,24.85%,ANP32B;TP53;RAPGEF3;TPR;GAS6
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),-0.6334001990386797,-1.0593855712034055,0.4067796610169492,1.0,1.0,1/8,4.67%,PLAAT4
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),0.4519969224347623,1.0593618327354701,0.32142857142857145,0.8801601223601304,1.0,15/37,31.27%,ITPKB;GPHN;FADS1;AGPAT5;IP6K1;IPPK;IP6K2;PNPO;CPS1;PCYT2;MOCS1;PPIP5K1;PIP5K1A;GK;G6PD
prerank,GO_Biological_Process_2021__skeletal muscle thin filament assembly (GO:0030240),-0.6651567736213441,-1.0593320443565761,0.43137254901960786,1.0,1.0,3/6,14.24%,ACTC1;LMOD3;TTN
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),0.5440685568434389,1.0592361304352118,0.42857142857142855,0.8798242837872697,1.0,3/16,8.09%,PNP;HLA-DRA;NKAP
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),-0.6303067608876166,-1.0591938268415937,0.46551724137931033,1.0,1.0,1/6,17.65%,CELSR1
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.4528717507346241,-1.0590693733187637,0.373134328358209,1.0,1.0,18/52,22.86%,CCNG2;CCND1;CDC25A;CCND2;CDKN2D;CDKN1A;CCNI2;CCNF;CCNE2;CDKN3;CDC37;CDK5R1;PKMYT1;CDC6;GTPBP4;CDKN1B;BLM;CCNI
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),-0.5792588054974219,-1.058888781634021,0.41818181818181815,1.0,1.0,7/14,29.44%,SFRP4;MESP1;BTG1;SOX9;TMEM100;FGF2;ATOH8
prerank,GO_Biological_Process_2021__terpenoid metabolic process (GO:0006721),0.6935623320248921,1.0588137848271504,0.4791666666666667,0.8802824041740174,1.0,1/5,0.59%,CYP1A2
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),-0.680950916049748,-1.0586238638841245,0.46,1.0,1.0,1/7,3.14%,ADAD2
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),0.3893624115150769,1.05860967009021,0.23809523809523808,0.8802469788357498,1.0,24/108,19.14%,ALCAM;TBC1D16;KCNIP3;TNFRSF19;SLC19A1;PLXNB1;FGFR3;CAP2;CHST3;MPDZ;SDC3;DDAH1;RBFOX2;FARP1;TYRO3;KIAA1549L;FOXF2;SRRM3;ANTXR1;PTPRF;ZNRF3;DOCK1;DZIP1;NAV2
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),0.6634626041054228,1.0585788526465352,0.5,0.8796976428316479,1.0,3/5,25.55%,HMGB1;SLC15A4;RSAD2
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),-0.47245300450162053,-1.0584198930742432,0.3880597014925373,1.0,1.0,6/38,7.40%,SIRPG;TGFB1;NODAL;RNASE10;ADA;CEACAM1
prerank,GO_Biological_Process_2021__regulation of superoxide metabolic process (GO:0090322),0.615689676181373,1.0583279432910822,0.4883720930232558,0.8797589815109568,1.0,1/6,6.34%,DHFR
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 cell differentiation (GO:2000321),0.6590876813911368,1.0581506592602619,0.4418604651162791,0.8795529244934,1.0,4/6,28.57%,IL23A;MALT1;NFKBID;NFKBIZ
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),0.6455431308580852,1.0578907505023953,0.5121951219512195,0.8795929092004869,1.0,3/6,27.85%,NTRK2;DOCK3;FYN
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.3494970564074088,1.057720419706727,0.2857142857142857,0.8796008056649939,1.0,67/354,15.01%,ATP6V0D2;EFNB1;NGF;FOXO1;SH2D6;SH2B2;FGF10;KIT;MAPKAPK2;TCIRG1;VEGFC;FGFR1;IRS1;ANGPT1;EPHA7;FRK;FGF17;SHC4;MMP2;ERBB2;PDGFD;HNRNPF;NRG1;CRK;TRIM71;EPHA3;RAPGEF1;RGS14;EIF2AK3;FER;PLCB1;CASP3;CD8A;EFS;HNRNPH1;ESRP1;EFNA5;FGF18;SPRED2;NUS1;CASS4;AKT2;FGFR3;GRIN1;MPZL1;IRS2;NAMPT;FLRT2;SPRED1;WASF2;RBFOX2;TYRO3;TIAL1;RET;PXN;GAB1;UBASH3B;IRS4;ARPC3;ANOS1;FLT3;GTF2F2;PTPRT;RYK;INSR;PIK3CA;VAV2
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),0.5427071317991362,1.057678319005519,0.32142857142857145,0.8790645371202956,1.0,4/14,13.71%,AASS;PIH1D1;NSD1;MTHFR
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.3712667237454605,1.057388866103664,0.25,0.879147430613195,1.0,28/215,12.52%,IL7R;RSPO3;TGFBR1;IRS1;NLGN1;KLK14;ZBTB7B;SIRT1;MAML1;SNX5;JAG1;PKD2;MYORG;SMARCB1;RSPO2;FLNA;PIH1D1;ERN1;KANK1;GRIN1;CTBP2;GKAP1;RIMS2;TRIM44;MACF1;LIMS1;SMARCA4;NLGN3
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.5295696126177867,-1.0573332851325148,0.3880597014925373,1.0,1.0,3/25,6.54%,CASQ2;CAV3;KCNS2
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.37726126760648676,1.057226062369732,0.23333333333333334,0.8788999137710277,1.0,25/111,16.94%,SLC17A6;LHFPL4;KCNB2;HRH3;ELAVL3;PAK5;KCNJ6;ERC2;ADGRA1;CASKIN1;NR4A2;CELF5;TENM1;ABCC8;CELF4;NXPH1;RIMS4;OLFM3;PRR36;SNAP91;MSI1;SCRT1;NRXN1;SRCIN1;GRIK3
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.5480974285513663,1.0566168133893,0.40476190476190477,0.8801114000946849,1.0,4/11,11.24%,APOE;KCNC2;DDAH2;DDAH1
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),0.4690926945671507,1.0565677825853432,0.3541666666666667,0.8796188418299076,1.0,7/26,26.76%,LSM10;SNRPB;ATM;TUT7;ERI1;SNRPF;XRN1
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),0.46493530500610336,1.0565051339634604,0.24324324324324326,0.8785401833811457,1.0,2/24,4.39%,CPSF1;PCF11
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),0.46493530500610336,1.0565051339634604,0.24324324324324326,0.8785401833811457,1.0,2/24,4.39%,CPSF1;PCF11
prerank,GO_Biological_Process_2021__adrenal gland development (GO:0030325),0.6700002119548754,1.0564116822833798,0.5,0.878155940805647,1.0,2/6,13.81%,WNT4;NF1
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.3544421062444037,1.0563526904283207,0.2727272727272727,0.8776449218863503,1.0,39/266,10.36%,GABRE;SLC17A6;CHRM2;GRID2;CEL;GABRA5;NOVA1;GABRR2;APOE;NLGN1;GRM3;HTR1F;GALR3;HTR2C;GABRG3;HRH3;DRD5;GRIK1;SNCA;CACNB4;CHRNA10;DTNA;DRD4;APBA3;PDZD11;PPFIA3;KCND2;ERC2;GRIK2;PDLIM4;SYT1;LRP6;GRM4;GRM7;GRIN1;PRKAR2A;AKAP9;GABRG1;RPS6KA3
prerank,GO_Biological_Process_2021__regulation of T-helper 1 type immune response (GO:0002825),-0.718343833914124,-1.0563293808977325,0.5263157894736842,1.0,1.0,2/5,10.72%,IL27;SLC11A1
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),-0.6313879884956943,-1.0562053814711656,0.453125,1.0,1.0,2/8,14.16%,TGFB1;HEY2
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),-0.42769891087083023,-1.0560963543061246,0.37662337662337664,1.0,1.0,20/123,18.80%,AMBP;APOL1;JCHAIN;ITGB2;SFTPD;DAB2;MASP1;PPT1;CAV2;LRP2;HPR;ITGAM;CXCL16;COLEC12;AMN;ASGR1;STAB2;LDLRAP1;HSPH1;CD81
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.41514122525314695,1.0556274128030616,0.34615384615384615,0.8792444681418431,1.0,12/46,15.83%,ST6GALNAC3;GLA;ESYT3;STS;SMPD4;SMPD3;ESYT2;NEU4;GLB1;PGAP1;ST3GAL6;NEU3
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),0.681259353373143,1.0553930293365763,0.4883720930232558,0.8791889793212704,1.0,2/5,13.71%,SIRT1;MTHFR
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.4815603008978188,1.0549679997266623,0.325,0.879811160554679,1.0,5/15,18.70%,DTNA;ERC2;CHRNA1;FCHSD2;ERC1
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),-0.4843657346425067,-1.0547231772218095,0.4264705882352941,1.0,1.0,4/38,9.57%,KCNJ15;STAC;KCNQ1;PDZK1
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.5136581314739616,1.0546790253160359,0.45454545454545453,0.8798294120973021,1.0,3/15,12.58%,INTS11;INTS14;INTS9
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),0.41040225286953425,1.0546634220559477,0.24,0.8792661478096452,1.0,23/86,19.85%,FOXO1;NOX4;HTRA2;PKD2;SNCA;VRK2;SLC25A24;ABL1;ADNP2;HSPA1A;PNPT1;GPX1;PIK3CA;ETV5;ATM;RAD52;SESN2;GSR;STOX1;ERMP1;PRKAA2;VKORC1L1;SLC4A11
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),0.4689213748236934,1.0545356218734818,0.3953488372093023,0.8789889309530032,1.0,4/18,12.82%,CTC1;TERF1;GNL3L;ACD
prerank,GO_Biological_Process_2021__lactation (GO:0007595),0.5975872180518785,1.054367065940259,0.4166666666666667,0.8788704682653701,1.0,1/7,3.16%,ZBTB7B
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.35718246370485784,1.0542389492489534,0.3333333333333333,0.8786255665162415,1.0,36/156,18.53%,TEAD2;ESRRG;HDAC3;MED17;RORA;TFB1M;HDAC10;RARB;CCN2;PPARG;MAML1;RORB;TAF1B;NAT14;TAF3;NR4A2;TAF12;CCNH;POLR1H;TEAD4;NR3C2;HDAC1;NR3C1;GTF2F2;WWTR1;THRB;NR1H3;NR6A1;NRBF2;NR4A3;NOTCH1;NR2C1;TAF4;ERCC3;RBPJ;NR4A1
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),0.5869395509566446,1.0541038091265922,0.4418604651162791,0.8783177487002903,1.0,4/9,21.65%,FGFR3;COL13A1;BMPR2;BMP4
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),-0.5694476699759912,-1.0538834636521404,0.40350877192982454,1.0,1.0,7/15,26.11%,PTPRC;TERT;YAP1;ZFP36L1;HMGA2;EPCAM;KDM1A
prerank,GO_Biological_Process_2021__pronephros development (GO:0048793),0.573045471626995,1.0534752423607208,0.44,0.8796328522540429,1.0,2/6,9.82%,OSR1;CEP290
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),0.3627013365285403,1.0532645247023127,0.3157894736842105,0.8794932143402734,1.0,20/106,14.06%,ARC;TDO2;VSTM5;KCNC2;TRPM2;CLYBL;PKD2;HCN1;ZBTB1;IKZF4;CARD9;ACACB;MICU1;SPAST;EHD4;ALDH1A2;USP16;TRMT61B;MPP2;PNPT1
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",0.5113764884128736,1.0531429912749997,0.4074074074074074,0.8791854354132588,1.0,5/25,12.88%,KHSRP;TXNL4A;SRRM1;SF3B1;SRSF4
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.43421242268333826,-1.0528680940133883,0.34782608695652173,1.0,1.0,25/85,18.13%,JCHAIN;GSDMA;CXCL13;HAMP;SFTPD;OAS2;HLA-A;SELP;LYG2;NLRC4;SLC11A1;OAS1;DEFB109B;TLR2;COLEC12;NOS2;IL12A;IGLL1;ELANE;NAIP;PGLYRP1;LYG1;GBP6;ROMO1;STAB2
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),0.65951229546263,1.0528278576631118,0.4423076923076923,0.8794668495658219,1.0,2/7,7.29%,CX3CR1;CARD9
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),-0.5468657653324221,-1.0527363998447188,0.4107142857142857,1.0,1.0,5/22,19.01%,BHMT;ETFBKMT;PCMT1;EEF1AKMT2;EEF2KMT
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),-0.6942890134774204,-1.0527319377343507,0.4909090909090909,1.0,1.0,3/5,10.21%,HLA-DMA;TAPBPL;HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.49882424485050225,-1.052549090302102,0.3972602739726027,1.0,1.0,6/30,14.93%,PLD4;ALOX5;APOD;NLRC3;NOS2;ADCY7
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,-0.45573902391097687,-1.0525206505757372,0.36231884057971014,1.0,1.0,15/58,10.28%,SIRPG;GMFG;ITGB2;CYTIP;TBC1D10C;ARHGAP9;TAGAP;TNFRSF1B;GPR183;PARVG;CD5;CD37;TRAF3IP3;MYO1F;PTPRC
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),-0.5263931011210499,-1.0522596136788513,0.4166666666666667,1.0,1.0,5/19,20.29%,SYNE2;MYO1F;MYO5B;MYO15A;MYO7B
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.3356813059807091,1.0520294435769328,0.15789473684210525,0.8809876194537513,1.0,58/234,26.04%,CPSF1;SNRPN;NOVA1;PCF11;HNRNPF;TRA2A;RBM41;PUF60;PRPF40B;HNRNPH1;TXNL4A;SNRPB;SPEN;U2AF1;SRRM1;HNRNPL;LSM2;ZMAT5;GEMIN5;CWC27;SF3B1;CPSF7;SRSF4;GTF2F2;PTBP1;FUS;LSM7;SYNCRIP;PAPOLA;RNF113A;EIF4A3;U2AF2;SYMPK;SF3B4;RBM6;GPATCH1;LSM6;PPIH;CDC5L;LSM8;PDCD7;DDX46;DDX41;POLR2F;RALY;MAGOHB;SNRNP48;PSPC1;RBM10;YBX1;SNRPF;WDR33;CWF19L1;PABPC1;CCAR1;SF1;SNRPA;RBM8A
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),-0.47462797258042017,-1.0519936688410654,0.3787878787878788,1.0,1.0,8/31,19.10%,ALOX12;ALOX5;PPT1;GGT5;ACSS3;AWAT1;ALOX5AP;SLC27A5
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),0.5897389588533829,1.0517661668417735,0.42105263157894735,0.8811099035365543,1.0,2/9,7.55%,PC;PDZD11
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.44600901705698415,1.0516007720136662,0.2692307692307692,0.8808228401274277,1.0,16/43,21.50%,LLGL1;RAB31;COMMD1;BLZF1;GOLGA4;GCC2;GGA1;MACF1;CCDC22;RAB10;ARL3;EXOC6B;ARFRP1;EXOC6;RAB26;EXOC4
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell differentiation (GO:2000727),-0.6012682426418398,-1.0509869884630785,0.4098360655737705,1.0,1.0,1/7,1.49%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),-0.6170315733358729,-1.0507334764794811,0.4426229508196721,1.0,1.0,2/7,17.55%,NLRC3;CACTIN
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),0.5836246013022638,1.0507303549358125,0.5,0.8825806423366497,1.0,4/10,25.52%,SMC5;NSMCE2;SMC6;TPRKB
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),0.5423468887380061,1.0502211467529161,0.40540540540540543,0.8835187855938522,1.0,4/13,20.51%,MGARP;SPAST;UXT;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),-0.4651541982649843,-1.0500827743842902,0.4722222222222222,1.0,1.0,10/33,20.84%,WNT5A;IL7;OAS1;TLR2;DDX3X;IL18;F2RL1;ALOX15B;CSF1R;AGER
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),0.6981658348532995,1.0498378973076379,0.6136363636363636,0.8840577713216718,1.0,1/5,7.51%,PML
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),0.6006667683409541,1.0498122027011718,0.5106382978723404,0.8834869692677126,1.0,4/8,34.38%,CHD1;ST3GAL2;ST3GAL4;SETD5
prerank,GO_Biological_Process_2021__isopentenyl diphosphate biosynthetic process (GO:0009240),0.6473209735731189,1.049646045195117,0.45652173913043476,0.8832410752898693,1.0,3/5,35.00%,MVK;PMVK;MVD
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.5034214455874999,-1.0496101079690585,0.3870967741935484,1.0,1.0,8/31,14.21%,C1QB;VTN;C3AR1;CPB2;CLU;C4BPA;C4BPB;C1S
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),0.6231382533091819,1.0491852416027763,0.39285714285714285,0.883852271374902,1.0,3/7,33.25%,NR1H3;ITGAV;NR1H2
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),-0.5820035247484662,-1.04909100460247,0.45,1.0,1.0,5/12,19.81%,WNT5A;CYBA;NOS2;RAC1;NOX1
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.4901380537039988,1.0490901107151356,0.25,0.8834602916845716,1.0,10/29,25.87%,CDK14;DHFR;CDK18;CDK16;BRD4;CDK5;HINFP;TFDP1;POLA1;RB1
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),0.6572218763286078,1.048761846508835,0.5116279069767442,0.8837053110772567,1.0,2/8,13.92%,SNCA;PLK3
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),-0.5151723606374069,-1.048710200432857,0.48484848484848486,1.0,1.0,5/25,24.07%,AIM2;USP50;VSIR;AGER;APH1A
prerank,GO_Biological_Process_2021__catecholamine catabolic process (GO:0042424),-0.7020699027478898,-1.0483683678420999,0.4918032786885246,1.0,1.0,1/6,0.42%,DBH
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.4504417407942097,1.0482784428233691,0.3225806451612903,0.884533877200352,1.0,5/25,8.20%,SCRIB;NLGN1;ITGA4;MAGI2;FLNA
prerank,GO_Biological_Process_2021__negative regulation of interleukin-17 production (GO:0032700),-0.6338936732989792,-1.0479274816471496,0.46774193548387094,1.0,1.0,3/7,24.92%,IL12A;VSIR;TNFSF4
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.4893908856923282,-1.0478930529505854,0.4482758620689655,1.0,1.0,8/28,23.17%,HLA-A;ERAP2;TAPBPL;HLA-F;ERAP1;SEC13;HLA-C;SEC24D
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),-0.5786659305174787,-1.04745346860854,0.4444444444444444,1.0,1.0,1/8,13.18%,CARTPT
prerank,GO_Biological_Process_2021__regulation of T-helper cell differentiation (GO:0045622),-0.6878681949897649,-1.04738504766695,0.5,1.0,1.0,3/6,10.21%,IRF4;IL27;HLA-DRB1
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.444133935374316,-1.0471886379365194,0.3382352941176471,1.0,1.0,12/64,17.19%,SIRPG;NODAL;ECM2;P2RY12;RNASE10;ALOX15;TGM2;VIT;IL12A;HYAL1;FBLN2;RAC1
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.38808699112597833,-1.04709670439712,0.3924050632911392,1.0,1.0,21/205,10.28%,CD44;TBX1;TGFB1;NODAL;LPAR1;SCIMP;GFRAL;TRIM5;GPER1;ALOX12B;GPR183;GSDME;ALKAL2;FLT4;ALOX15;ATP6AP1;HTR2B;P2RY6;PRXL2C;HLA-DRB1;PTPRC
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.5043744451936081,-1.0467287390236173,0.391304347826087,1.0,1.0,7/24,22.55%,ALOX5;CLU;WFS1;AQP11;CREB3;HERPUD1;UBXN1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.601284383392065,1.0464271039814421,0.4358974358974359,0.8890809986950332,1.0,2/9,10.45%,ACADS;ACADM
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.4073024970628039,1.0464216885223165,0.38461538461538464,0.8884886636640222,1.0,10/63,16.52%,MGAT4C;SLC39A8;DPM3;DERL3;UBE2J1;ALG12;ALG3;GAL3ST1;MGAT2;MOGS
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.5347187953070868,-1.0464076747531528,0.4,1.0,1.0,5/17,20.26%,PLAAT4;PLA2G10;PLA2G4A;MBOAT1;PLA2G4D
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),-0.5968382548883777,-1.0463166321774862,0.43859649122807015,1.0,1.0,6/12,18.49%,CYP26B1;CYP3A5;CYP3A4;ADH7;SCPEP1;ALDH1A3
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.522501315042369,-1.0462719693343283,0.44285714285714284,1.0,1.0,1/18,1.55%,RAB34
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.6661954287181825,-1.0462469944493735,0.5102040816326531,1.0,1.0,3/7,24.21%,STK17A;BTG1;SFRP1
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.4301940302556823,1.0457340255835783,0.3142857142857143,0.889530724334465,1.0,22/55,20.34%,ACADS;CYP4V2;ACAD10;PEX13;SLC27A2;ECHS1;ABCD3;ADIPOR1;ABCD2;ACADM;MECR;ADIPOR2;ADH4;ACSM1;BDH2;ECI1;ECHDC1;ACOX1;DECR1;HADHB;ECHDC2;ACADVL
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),-0.5829830061765775,-1.045359163894103,0.46774193548387094,1.0,1.0,2/11,5.18%,C1QTNF1;GPER1
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),0.42385593277332917,1.0450783831445416,0.3225806451612903,0.8906233386467689,1.0,16/54,19.29%,DTX1;MAML1;JAG1;HES1;POFUT1;GMDS;MYC;SNAI2;ASCL1;WWC1;NOTCH1;PBX1;RBPJ;ADAM10;EP300;KAT2B
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),-0.6782417893140243,-1.045013596956009,0.4117647058823529,1.0,1.0,2/5,18.12%,RAC1;AIF1L
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),0.4353496532574579,1.0448675241447547,0.35714285714285715,0.8906026503932504,1.0,8/27,16.13%,SHLD2;SHLD1;TIMELESS;KMT5C;ARID2;WRAP53;FUS;KMT5B
prerank,GO_Biological_Process_2021__positive regulation of sterol transport (GO:0032373),0.6670455977229702,1.0448251461271816,0.5434782608695652,0.8901458838028625,1.0,4/5,33.25%,NR1H3;ABCA13;LIPG;NR1H2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),0.5253914048563555,1.0446834408116836,0.3783783783783784,0.889897272243728,1.0,5/21,10.74%,TRPC3;SNCA;F2;GRIN1;F2R
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.49402704516903756,-1.0444547268415918,0.4166666666666667,1.0,1.0,7/25,25.62%,EIF6;LAS1L;RPL7A;WDR12;RPL35;DDX18;NSA2
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.4381180378982194,-1.043996334154623,0.33783783783783783,1.0,1.0,18/90,10.28%,GMFG;BLK;DOCK8;CYTIP;TBC1D10C;ARHGAP9;TAGAP;STAG3;TMC8;PARVG;WAS;LY86;P2RY14;CD37;TRAF3IP3;PSG2;MYO1F;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of membrane depolarization (GO:1904181),-0.6938373179971326,-1.0438391062697148,0.5,1.0,1.0,1/5,6.82%,DCN
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.4732237720824157,1.043720803827158,0.38235294117647056,0.8917643255221644,1.0,7/27,22.90%,SLC4A7;RHCG;WNK2;KLHL3;WNK3;SLC4A11;WNK1
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.5250842872885848,1.0436030513787071,0.39473684210526316,0.8915253065390516,1.0,7/10,29.44%,SEMA5A;ARHGAP35;EPHB2;NRCAM;EPHB3;CNTN4;EPHA4
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.4107924955118561,1.0432793570198138,0.3055555555555556,0.8919182709247377,1.0,11/47,17.53%,RAB27A;SNCA;RALA;SYT1;CHMP6;RAB27B;RIMS2;RAB3C;RAB10;RAB5A;RAB3D
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),-0.5694249720916525,-1.0432647252057778,0.3898305084745763,1.0,1.0,6/12,24.92%,ANXA1;NLRP3;CD80;IL18;CD86;TNFSF4
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.31546258083022455,1.0429821446397256,0.2222222222222222,0.8921968696152337,1.0,166/567,21.94%,SMYD2;PER2;HDAC3;ZNF239;BCL6;AASS;MITF;NFATC3;HDAC10;RARB;ZNF692;URI1;ZBTB7B;KLF10;PCGF1;CBFB;PRDM5;HEXIM2;TGIF1;GATAD2A;ZNF263;E2F6;FRK;ATXN1;PPARG;SIRT1;IFI16;ZEB2;CRY1;SNCA;PER3;SIRT7;HES1;GFI1B;KCNIP3;BCL11A;PROX1;ZBTB4;HMGB1;ATF3;DLX1;FOXP2;MIER2;OSR1;ZBTB1;MED25;ZNF274;NRIP1;WWOX;WWP2;MYC;NKAP;TAF3;NR4A2;ZNF688;ZEB1;ZNF202;TWIST1;SNAI2;SPEN;ZNF133;FHL2;ZNF599;CTBP2;CREM;BPTF;ZNF75A;PPM1A;DACH1;MYT1L;NSD1;SMARCA2;ZNF846;SMARCA4;SAP130;ZNF337;HSPA1A;NFIB;DPF2;MXI1;HDAC1;GATAD2B;ASCL1;SMAD2;NR2F2;PLK3;NR3C1;NFKB1;NCOA5;BCOR;CUX1;SCRT1;MECP2;OTUD7B;THRB;HDAC4;ZNF69;NFIC;CXXC5;ETV5;MEN1;HSF1;NR1H3;HJV;GADD45A;TP53;HSF4;RUNX1;NR6A1;NR4A3;WWC1;ZGLP1;NOTCH1;NEDD4;ZBTB2;ARID5B;ATN1;KLF12;HIVEP1;THAP7;SKI;SP2;ZMYM5;NR2C1;PAX6;ZNF675;ZNF589;NIPBL;ZBTB5;NOC2L;MACROH2A2;RBPJ;NFX1;UXT;IMPACT;SOX13;SIRT6;EP300;SLA2;AEBP1;PTCH1;ZNF79;SREBF2;RNF2;BRMS1L;ZNF596;HDAC5;IGBP1;TRAF6;JAZF1;TBL1X;ZNF764;ZNF778;PRDM16;ZNF785;ZBTB7A;MTDH;NFIX;DLG1;MDM4;BMP4;MLIP;ZNF25;SUV39H2;ZNF268;ZNF3
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),-0.44684509876335354,-1.0429212681927307,0.34782608695652173,1.0,1.0,7/49,13.88%,CASQ2;WAS;CHMP3;GAS7;VIL1;CATIP;PSTPIP1
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),0.650615103067722,1.0424579304513144,0.45454545454545453,0.8929714461770457,1.0,4/6,25.84%,ZDHHC12;NRXN1;PTEN;NLGN2
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.4719770129308243,1.0424182027482007,0.36363636363636365,0.8924739117310047,1.0,5/30,17.89%,PHLDB2;PLCB1;RPS6KA6;INSR;NIPBL
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),0.5627398636362461,1.0423920481918012,0.36363636363636365,0.8912848105567953,1.0,1/15,0.53%,PHLDB2
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),0.5627398636362461,1.0423920481918012,0.36363636363636365,0.8912848105567953,1.0,1/15,0.53%,PHLDB2
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),0.5329496331260702,1.0423793006713782,0.4,0.8907069471654273,1.0,3/12,4.75%,WNT4;SIRT1;AKR1C3
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.42967834523440007,1.0423521756055916,0.2916666666666667,0.8901607892569102,1.0,11/47,18.77%,SLC19A1;DHFR;ALDH18A1;AADAT;OGDH;IDH2;GLUD2;MTHFR;ME3;FPGS;SHMT2
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),0.5371707369064178,1.0423491096860555,0.40625,0.8889575009292693,1.0,3/12,15.73%,STAT5B;PLCB1;IL2RB
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),0.5371707369064178,1.0423491096860555,0.40625,0.8889575009292693,1.0,3/12,15.73%,STAT5B;PLCB1;IL2RB
prerank,GO_Biological_Process_2021__regulation of phospholipase A2 activity (GO:0032429),-0.6566874023902638,-1.0422257926995937,0.5454545454545454,1.0,1.0,1/5,8.67%,ANXA1
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),-0.4887643235929783,-1.0421892165706905,0.4084507042253521,1.0,1.0,5/32,14.29%,NOTUM;WNT5A;SMAD6;LRP4;SGMS2
prerank,GO_Biological_Process_2021__synapse pruning (GO:0098883),-0.6718999113592141,-1.0419193999997916,0.4807692307692308,1.0,1.0,2/5,11.77%,C1QB;ITGAM
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.46017265442161925,-1.041901021970472,0.391304347826087,1.0,1.0,22/64,21.24%,AQP3;PLEKHG6;TCN1;CYP24A1;RDH12;SERPINB5;ST6GALNAC2;SPINT1;CXCL16;TRIM29;VDR;IL18;TMEM45B;TJP3;PRRG4;F2RL1;SCNN1A;ANGPTL4;FAM3D;CBLC;COL17A1;CNR2
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.5861152297745236,-1.0415270254519888,0.40625,1.0,1.0,1/11,1.23%,ADSS1
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),-0.6238605560869965,-1.041391982320121,0.4915254237288136,1.0,1.0,3/9,15.82%,TAFA3;PTPRC;GRN
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),0.4984214860657569,1.0413634605046127,0.3684210526315789,0.8908305013028709,1.0,6/15,11.93%,GRIP1;MFSD2A;MOV10;NTNG2;MACF1;MAP3K13
prerank,GO_Biological_Process_2021__enzyme-directed rRNA pseudouridine synthesis (GO:0000455),0.6056898331286545,1.04122155190496,0.4772727272727273,0.8904296310074249,1.0,1/6,13.19%,RPUSD1
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),-0.6022245153481384,-1.041075026592463,0.40384615384615385,1.0,1.0,4/9,9.22%,RAB34;MAPKAPK3;DOCK2;PPT1
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),-0.5990994277092911,-1.0409839057986885,0.39285714285714285,1.0,1.0,3/10,17.62%,CHST9;XYLT2;B3GALT6
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),0.5354610851858598,1.0409654116013323,0.43243243243243246,0.8904914775993934,1.0,4/16,8.16%,CDH13;ERBB2;FER;MVB12A
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),0.630581551855499,1.0407427505262352,0.4722222222222222,0.8906661385539226,1.0,5/8,28.57%,CARD9;IL23A;MALT1;NFKBID;NFKBIZ
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),-0.5479575368910204,-1.0406645685049492,0.3968253968253968,1.0,1.0,4/14,20.26%,PLA2G10;PLA2G4A;MBOAT1;PLA2G4D
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),0.4123796990006465,1.0406491370894813,0.28125,0.8902969664780618,1.0,14/47,17.75%,PER2;PCM1;CX3CR1;HES1;RGS14;WNT3A;SPEN;NUMB;HES6;ASCL1;LIG4;NOTCH1;PAX6;FAIM
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,0.34181024214871575,1.0404898450984956,0.2,0.8900820390540143,1.0,17/93,12.06%,FIBIN;ADAMTS1;LAMA4;MXRA5;MRGPRF;ITGA11;ITGA8;COL12A1;SSC5D;MMP2;CNN1;SLIT2;EDNRA;COL16A1;RBMS3;MSRB3;PAMR1
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),0.6309192976083616,1.0404882096523513,0.45454545454545453,0.888875148153602,1.0,1/6,8.69%,NUS1
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),0.6309192976083616,1.0404882096523513,0.45454545454545453,0.888875148153602,1.0,1/6,8.69%,NUS1
prerank,GO_Biological_Process_2021__cGMP biosynthetic process (GO:0006182),-0.6440875408311252,-1.0403969874248862,0.48148148148148145,1.0,1.0,3/7,24.71%,GUCY2C;GUCY2F;NPR2
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),0.4631488710387708,1.0403360417491845,0.37777777777777777,0.8887127645032128,1.0,13/32,23.62%,KPTN;SIK3;TELO2;RNF152;PIH1D1;DYRK3;CLEC16A;KLHL22;ATM;SESN2;SZT2;RRAGD;SEH1L
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),-0.6165738480496764,-1.0402627498451815,0.42857142857142855,1.0,1.0,2/7,13.45%,OSMR;PTGER3
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),-0.6448191680839734,-1.0402425729826639,0.5,1.0,1.0,2/6,11.76%,SCIN;VIL1
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.47004112202789267,1.0402067261244596,0.30303030303030304,0.8884892699226361,1.0,6/26,13.21%,ADGRG6;FGF10;SLC8A3;PTPRZ1;NFIB;CDH2
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),0.6573227938511229,1.0401283092499116,0.47619047619047616,0.8881332842493131,1.0,4/5,29.31%,NFKB1;RC3H1;RC3H2;RELA
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),0.6595997461526449,1.0401234711215488,0.5365853658536586,0.8875634123908577,1.0,3/5,23.99%,SIRT7;PRIMPOL;SRPK2
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),-0.5485435409156347,-1.0398131489382583,0.453125,1.0,1.0,5/21,11.87%,ERN2;GPER1;H1-0;ENDOG;DNASE2
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),-0.6250890223307207,-1.039727939156656,0.423728813559322,1.0,1.0,1/8,5.16%,RAB11A
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),0.39732647065448684,1.0395438301270468,0.2413793103448276,0.8885958805570404,1.0,20/60,21.64%,MARCHF5;ERCC8;SH3RF1;TRIM71;SH3RF3;WWP2;RNF10;UBE3D;KLHL24;UBE2A;RNF146;CNOT4;RNF185;NFX1;LRSAM1;MARCHF7;RNF122;RNF19B;TRAF6;UBE2D2
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.5430046765134731,1.0394368353860675,0.4666666666666667,0.887641191409697,1.0,10/19,27.46%,BCKDK;BCAT1;ECHS1;HIBADH;HIBCH;BCKDHB;MCCC1;DBT;ACADSB;AUH
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.5430046765134731,1.0394368353860675,0.4666666666666667,0.887641191409697,1.0,10/19,27.46%,BCKDK;BCAT1;ECHS1;HIBADH;HIBCH;BCKDHB;MCCC1;DBT;ACADSB;AUH
prerank,GO_Biological_Process_2021__glyceraldehyde-3-phosphate metabolic process (GO:0019682),-0.6097255763448409,-1.0392995997289405,0.4745762711864407,1.0,1.0,2/7,5.00%,ALDOB;GLYCTK
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),-0.5386006543905402,-1.039236387726824,0.3793103448275862,1.0,1.0,5/14,18.44%,PINK1;ACTN3;COX7A1;COX7A2;NOP53
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),0.6036947370927204,1.0390975619680214,0.42424242424242425,0.8880301504046125,1.0,2/7,17.13%,PIH1D1;NUFIP1
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),0.4675446625257566,1.0388911339550582,0.4,0.887889558715599,1.0,3/20,10.27%,DAPK2;SLIT2;MCU
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),0.36568381566726865,1.0385855589674269,0.2631578947368421,0.8880439916982704,1.0,41/161,18.20%,TBC1D10A;SNX18;SCRIB;TBC1D16;RGS16;ERBB2;TBC1D12;ASAP3;SYDE2;SRGAP2;RAPGEF1;PLXNB1;SIPA1;SIPA1L2;RALGAPA2;ARHGAP42;TBC1D22B;F2R;EVI5L;LIMS1;TBC1D4;RAP1A;RGS7;SNX9;DOCK9;RAP1GDS1;NF1;RGS6;PKP4;SIPA1L3;BCR;DOCK11;RSU1;TBC1D8B;ARHGAP27;SLC27A4;CCDC125;TBC1D2;TBCK;ARHGEF16;RAPGEF3
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),0.6489340721971953,1.0385120919007405,0.5142857142857142,0.8876191028961173,1.0,3/8,10.36%,LAMB4;NTN4;NTNG2
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.5233943897098986,1.0381297142490236,0.4074074074074074,0.8881085610646577,1.0,10/20,29.31%,NOTCH1;RBPJ;SESN2;EP300;HIF1A;CARF;SMAD5;NFE2L2;BMP2;RELA
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),0.6799372764387824,1.038035335621903,0.5111111111111111,0.887765369858711,1.0,1/5,6.21%,DCC
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),-0.5281521947650176,-1.038003386769643,0.4576271186440678,1.0,1.0,4/17,9.49%,CASQ2;HTR1B;TGM2;CASP7
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.37240033402020695,1.037815020234172,0.125,0.8878687742635472,1.0,47/195,19.27%,PLEKHG2;PCM1;LLGL1;KPTN;CNTRL;FGD4;BIN1;MID1;LMNB1;PKD2;TOP2A;RASA2;PCGF5;CNTROB;ABL1;LATS1;ALMS1;FLNA;MYO9B;MAPRE1;EPB41;CEP250;WASF2;FARP1;SYNPO;CLIP2;RASAL2;PXN;CCDC88A;DST;SAC3D1;NF1;SEPTIN9;MARK4;BCR;FSCN1;FLNB;ESPL1;CLIP1;NCK1;ARHGAP27;ARHGAP10;KIF3B;UXT;ARHGAP5;ARFIP2;SOS1
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.44518210972075156,1.0376410869026444,0.4864864864864865,0.8877896527339046,1.0,2/19,4.33%,IRGM;PPARG
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.49581597968932933,1.0376383002008909,0.34375,0.8871942203712393,1.0,3/28,3.26%,KIT;PTPRO;CDH13
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,-0.47892829481298055,-1.0372958202327667,0.38028169014084506,1.0,1.0,8/36,10.28%,SIRPG;CYTIP;TBC1D10C;TAGAP;KLRB1;CD5;TRAF3IP3;PTPRC
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.45213311731496114,1.0372261747797042,0.3611111111111111,0.8877531562909423,1.0,7/22,21.29%,APOE;ABL1;GPX1;PIK3CA;GBA2;AEBP1;CAMSAP3
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),0.6390508943696286,1.0372004470626328,0.45454545454545453,0.8871989950392126,1.0,3/5,29.63%,PRIMPOL;DNA2;LIG3
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.3696231506021188,1.0370375159389338,0.2608695652173913,0.8868678964136713,1.0,28/107,20.53%,FOXO1;NOX4;HTRA2;AKR1C3;PKD2;SNCA;VRK2;SLC25A24;FER;ABL1;MAPK8;ADNP2;PXN;HSPA1A;PNPT1;GPX1;ETV5;TP53;RAD52;ERCC6L2;SESN2;GSR;ERMP1;PRKAA2;VKORC1L1;SLC4A11;HIF1A;FOS
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),-0.5263756137055241,-1.0369970176046777,0.36764705882352944,1.0,1.0,3/23,6.40%,CASQ2;MMP9;TRDN
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",0.5664937022817336,1.0369195995853007,0.4473684210526316,0.8865574381901236,1.0,2/7,2.69%,SCRIB;GRIP1
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),0.3928090372039106,1.0368933614079066,0.375,0.8860051875011319,1.0,15/57,19.85%,TRDMT1;TFB1M;METTL1;METTL8;PCIF1;MTO1;FBLL1;TRMT61B;ZC3H13;TRMT61A;FBL;ZCCHC4;BUD23;NSUN4;METTL16
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),-0.6298148166631397,-1.0368757551912209,0.49056603773584906,1.0,1.0,1/9,2.65%,BLK
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),0.6806173935302817,1.0366544110450202,0.475,0.8859075103494055,1.0,2/5,15.58%,NLGN1;NRXN1
prerank,GO_Biological_Process_2021__deoxyribonucleotide metabolic process (GO:0009262),0.6646753372346477,1.0366306171566175,0.4583333333333333,0.8853866663592207,1.0,2/5,21.59%,SAMHD1;RRM2B
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),-0.545068764272196,-1.0365245588886483,0.45454545454545453,1.0,1.0,3/13,12.51%,GPER1;CEACAM1;APOD
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 3 signaling pathway (GO:0034141),-0.6200903512289557,-1.0362614213071588,0.4418604651162791,1.0,1.0,2/5,24.64%,F2RL1;FLOT1
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),0.37342801504924367,1.0361237147716362,0.3333333333333333,0.8862060643543437,1.0,24/62,29.49%,TRDMT1;METTL1;PUS10;CTU1;TRMT9B;MTO1;TRMT61B;PUS7;CDKAL1;TRMT61A;ANKRD16;DTWD1;THUMPD1;THG1L;NSUN2;ADAT2;TRMT1;TPRKB;ELP5;ALKBH8;QTRT1;THADA;QTRT2;PUSL1
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),0.669739044919908,1.0356820489478025,0.5789473684210527,0.8869438492755285,1.0,4/6,33.00%,BNIP2;BNIPL;MINPP1;PRUNE2
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.39652956642726617,1.0355753686655171,0.4230769230769231,0.8865641729196869,1.0,10/47,12.59%,GABRE;GABRA5;GABRR2;SLC12A1;GABRG3;ANO5;SLC12A9;GABRG1;ANO7;ANO4
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.3860238557127266,1.035546921341576,0.39285714285714285,0.8861045887993944,1.0,11/112,10.02%,GCK;NUP210;HSPB1;CDH5;NUP42;SIRT1;DSCAM;FER;PML;BTBD10;AAAS
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),-0.6611143725109425,-1.0354636807157218,0.46938775510204084,1.0,1.0,4/8,19.69%,HCK;LCP1;IL5;KIF9
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),-0.6710423350366679,-1.0354338774623613,0.5,1.0,1.0,2/6,9.20%,TIMP3;TIMP4
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),0.5215594304543753,1.0353162784336127,0.3783783783783784,0.8860072354411558,1.0,4/15,14.43%,SMYD5;SIRT7;PIWIL1;TEX15
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.5132665128138181,-1.0351935150799543,0.4057971014492754,1.0,1.0,3/22,14.16%,TGFB1;ENG;HEY2
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),-0.633746223861167,-1.0351659373903714,0.4393939393939394,1.0,1.0,3/7,15.82%,TAFA3;PTPRC;GRN
prerank,GO_Biological_Process_2021__fibrinolysis (GO:0042730),-0.5939131634689367,-1.035137913509572,0.4576271186440678,1.0,1.0,5/9,13.43%,GP1BA;PLAU;CPB2;PLG;PLAT
prerank,GO_Biological_Process_2021__benzene-containing compound metabolic process (GO:0042537),0.5696171416871978,1.0351311096129512,0.4888888888888889,0.8858497817474975,1.0,4/8,20.00%,KYAT1;AADAT;ACSM1;KYAT3
prerank,GO_Biological_Process_2021__protein sulfation (GO:0006477),0.6198804093440793,1.0350925576068681,0.4375,0.8853614935328125,1.0,2/5,7.81%,HS3ST5;UST
prerank,GO_Biological_Process_2021__glycolipid transport (GO:0046836),-0.6830167154014248,-1.035075040171082,0.48333333333333334,1.0,1.0,1/6,8.35%,PSAP
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),-0.5083205478414143,-1.0346211860671983,0.37681159420289856,1.0,1.0,5/39,10.72%,TENT5B;BOLL;DAZL;MEIOC;SLC11A1
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.3849755904389957,-1.0344216929981036,0.45555555555555555,1.0,1.0,49/381,14.99%,CD44;TBX1;CRLF1;CLEC5A;FGF20;KIF14;PRAME;ALOX12;HCK;MMP9;WNT5A;CARD14;BCL2L2;CLCF1;PINK1;DAB2;IL7;IFIT3;FLT4;RNF213;SOD2;BEX3;ANXA1;CCND2;HTR2B;PTRH2;PPT1;THBS1;SMAD6;DNAJA1;COPS5;ATF5;LRP2;CDKN2D;PRKCH;WFS1;TAF9B;CFL1;NAA38;CD27;TEK;FOXB1;VDAC1;ITGA5;LEF1;TGFB3;NR1H4;GATA4;DDX3X
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),0.43323548210377455,1.0344035166453478,0.25806451612903225,0.886618198213795,1.0,9/42,11.59%,SLC38A5;SLC3A2;SLC7A9;SFXN2;SLC6A20;SLC7A11;SLC7A6;SLC7A8;SLC25A12
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),0.5249540749123243,1.0341583970923924,0.36585365853658536,0.8867111104424487,1.0,3/13,12.22%,GRM3;GRM2;ADGRV1
prerank,GO_Biological_Process_2021__hyperosmotic response (GO:0006972),0.6473132877718586,1.0340432973245772,0.5217391304347826,0.88644347924167,1.0,1/5,8.86%,ICOSLG
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.44019167843119045,1.0339555936666767,0.42105263157894735,0.8861161725281106,1.0,4/35,5.58%,THEM4;SIRT1;ARRB2;MAGI2
prerank,GO_Biological_Process_2021__negative regulation of hemostasis (GO:1900047),0.5948350659285457,1.0338293123291684,0.42424242424242425,0.8858492898043623,1.0,3/11,5.25%,APOH;APOE;SERPINE1
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),-0.5715027904242389,-1.0333885351355927,0.4838709677419355,1.0,1.0,1/12,1.00%,PKP2
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),-0.5924366578027194,-1.0333010930810953,0.4918032786885246,1.0,1.0,1/9,1.39%,AHR
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),-0.5924366578027194,-1.0333010930810953,0.4918032786885246,1.0,1.0,1/9,1.39%,AHR
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.5368589296616645,1.0332649739591813,0.4090909090909091,0.886741808524522,1.0,6/11,18.39%,SPRED3;PYHIN1;SPRED2;SPRED1;ATM;ATR
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),-0.6202572239045365,-1.033255396893947,0.4864864864864865,1.0,1.0,4/10,24.30%,COPS5;COPS4;TOR1A;COPS7A
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.3495298678327442,1.0330536714824325,0.45454545454545453,0.8866845539546152,1.0,24/122,15.10%,FIBIN;EDIL3;ADGRL2;GPC6;CBS;SLIT2;EDNRA;TENM3;SYNDIG1;ABCC8;GUCY1A2;PDZRN3;CAP2;COL16A1;CHST3;MPDZ;SDC3;RBFOX2;MAP6;MAGI1;ANK2;PRICKLE2;SRRM3;ANTXR1
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),0.3654016047103694,1.0327176767469763,0.38461538461538464,0.8870963686489368,1.0,26/216,13.66%,IL7R;CTDNEP1;CHRM2;TOR1B;APOB;PACSIN2;HIP1;KIAA0319;BIN1;ARRB2;UBXN2A;SYT1;TGFA;STX18;CHMP6;SPAST;LDLR;SH3KBP1;LPCAT2;SGIP1;FNBP1;CCDC88A;MOSPD3;SNX9;ARPC3;ARRB1
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),-0.5552912019302887,-1.032593460627733,0.417910447761194,1.0,1.0,3/14,8.55%,KIF14;CXCL13;SELP
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.5554408098159148,1.0325584046741618,0.36585365853658536,0.8870090395370364,1.0,2/11,3.01%,DGKD;PARD3
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.44094533388940593,1.0325397246798644,0.3103448275862069,0.8864335204362624,1.0,6/38,9.44%,BCL2;PID1;SLC25A33;OPRD1;ABL1;AKT2
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.5119782702261726,-1.0322893459778293,0.4153846153846154,1.0,1.0,5/17,19.11%,PSMB9;ENC1;PSMA3;PSMA7;PSMB6
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.438258463859995,-1.0319533370522709,0.35294117647058826,1.0,1.0,3/62,6.32%,ENPP2;PLAAT4;PLA2G10
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),-0.5010990949915662,-1.0318740851893298,0.43333333333333335,1.0,1.0,9/26,20.84%,WNT5A;IL7;TLR2;IL18;ELANE;F2RL1;ALOX15B;CSF1R;AGER
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),0.513806791281009,1.0318455152743171,0.42105263157894735,0.8874621338806122,1.0,5/17,12.14%,HYKK;AASS;ALDH7A1;AADAT;OGDH
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.44689839518682395,-1.031447474378533,0.4084507042253521,1.0,1.0,2/65,2.41%,SLC28A2;GAD1
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.45051132019995377,-1.031177018185709,0.4788732394366197,1.0,1.0,14/52,17.63%,FOXM1;CYP1B1;ALOX5;PINK1;EIF6;BRCA1;STK17A;THBS1;UCP1;CDKN1A;AGT;RAC2;RAC1;ROMO1
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),0.53711128774879,1.031039945325214,0.36363636363636365,0.8891163845633162,1.0,3/15,14.09%,TMEM106A;MAPK8;NFKB1
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),0.6334912016780909,1.0310205874729717,0.47619047619047616,0.8885605060527961,1.0,3/8,12.90%,ITGA8;ITGA3;ITGB4
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424),0.6153307335586206,1.0308200778378003,0.5111111111111111,0.8883929871405261,1.0,3/5,34.60%,SLC15A4;XIAP;SLC15A2
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.3861028324314532,-1.0307474143700037,0.3626373626373626,1.0,1.0,98/283,27.27%,TICRR;MCM2;RPL37A;DONSON;PCLAF;RPA3;MCM3;BRCA1;GRWD1;RPL38;RPL15;ALAS2;TERT;PIF1;COPS5;WARS1;RPS4X;RPL3;RPL35A;RAD1;RPS9;RPS27;EEF2;GCNT1;POLE2;RPS21;RPL13A;YARS2;RPL27A;RPS16;RPL36;RPS20;RPL7A;RPL9;ABCF1;RPL13;RPS8;RPS27A;RPL21;CDC6;RPL34;MRPL34;RPL4;RPL32;INHA;RPL5;RECQL4;RPL23;RPL41;RPS7;RPS11;SET;RPL27;RPL35;RPS14;RMI1;RPL11;ORC6;TOPBP1;POLE3;ASMT;DRG1;RPA2;RPS15;PTMS;RPLP1;BLM;RPS12;RPL24;RAD9B;POLR2B;RPL18A;RPS13;RPL29;RPLP2;PTMA;CDC7;RPL28;RPL12;IGF2BP3;CHEK1;GAL3ST4;RPL18;RPS3;RPL22;EEF1A1;RPSA;RMI2;RPS28;MCM5;RPS19;RPS24;RPS3A;RPL19;CREBL2;RPL8;RPS6;RPL10
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),0.5655813373678982,1.0305551216066517,0.3611111111111111,0.8884243413039908,1.0,2/7,6.20%,WNT4;H6PD
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),-0.49596053004951535,-1.0304923017473773,0.3870967741935484,1.0,1.0,1/25,1.19%,SCN5A
prerank,GO_Biological_Process_2021__regulation of osteoclast development (GO:2001204),-0.6774771727460223,-1.0302782636809922,0.5161290322580645,1.0,1.0,2/5,22.73%,ATP6AP1;SIGLEC15
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.4871722944415233,-1.0301556641829412,0.4782608695652174,1.0,1.0,6/34,10.22%,LMOD1;ACTC1;OBSCN;TMOD4;CSRP3;LMOD3
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),-0.5600375326358689,-1.0298749763011255,0.45901639344262296,1.0,1.0,1/10,0.55%,TBX1
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.5188753090981892,-1.0297712146148597,0.47761194029850745,1.0,1.0,7/15,21.70%,ANXA1;ZP3;RAC2;RAC1;CD81;BST1;TNFSF18
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),-0.44318720142015444,-1.0297635667717087,0.49230769230769234,1.0,1.0,1/49,0.37%,NEK2
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.4477688214105223,-1.0297253213154167,0.39705882352941174,1.0,1.0,10/63,14.41%,DISC1;LRPAP1;TMC8;DAB2;ZFPM1;CTSZ;CDKN1A;IFIT1;MITD1;EFHB
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.43821054734935416,-1.0294973943846841,0.4189189189189189,1.0,1.0,27/86,16.84%,GMFG;AIM2;BLK;CYTIP;TBC1D10C;ZBTB32;ARHGAP9;TAGAP;TMC8;ALOX5;IL7;PARVG;CLCA3P;WAS;LY86;CD37;TRAF3IP3;PTPRC;TMEM156;HVCN1;CXCR5;CD27;CD80;IKZF1;ADAM28;NAPSB;NT5E
prerank,GO_Biological_Process_2021__embryonic digestive tract morphogenesis (GO:0048557),0.6052579971014732,1.0291099245429298,0.5,0.8916220809286596,1.0,3/5,37.93%,NIPBL;PDGFRA;FGFR2
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.5560341052565988,-1.029038711066757,0.44776119402985076,1.0,1.0,2/12,7.50%,SEMA3F;SEMA3A
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),0.629704327882197,1.028541868747253,0.5428571428571428,0.892474597478885,1.0,2/6,22.74%,SREBF2;NFE2L2
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.6008679806865602,1.0284907920953694,0.46153846153846156,0.8919778173208436,1.0,4/8,25.84%,NLGN1;NRXN1;PTEN;NLGN2
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),0.5909958736576464,1.028460766149832,0.45454545454545453,0.8908773108148834,1.0,2/8,18.62%,SLC25A33;UQCC3
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),0.5909958736576464,1.028460766149832,0.45454545454545453,0.8908773108148834,1.0,2/8,18.62%,SLC25A33;UQCC3
prerank,GO_Biological_Process_2021__endochondral ossification (GO:0001958),0.6039834289205633,1.028093034182206,0.4883720930232558,0.8913125504487249,1.0,4/6,28.25%,FGFR3;COL13A1;BMP4;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.3760751952224851,1.0274985209134224,0.48148148148148145,0.8924689783319776,1.0,13/77,8.69%,FGFR1;HSPB1;ANGPT1;RIN2;SEMA5A;ANXA3;SIRT1;PROX1;HMGB1;ABL1;SP1;FGF18;NUS1
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)",0.6281635708052382,1.0274949560574151,0.5098039215686274,0.8918947824049701,1.0,2/5,26.76%,TOE1;XRN1
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),0.48673089644541456,1.0273730179495717,0.3877551020408163,0.8916570592413712,1.0,7/14,33.72%,ATM;TUT7;ERI1;XRN1;TUT4;EXOSC10;TENT4B
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),0.5578315017739579,1.0270728679928407,0.48484848484848486,0.8917847522315752,1.0,3/13,10.61%,MFSD2A;STAT5B;PPIB
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),-0.5606548656555008,-1.0270187006218772,0.463768115942029,1.0,1.0,3/12,18.26%,FTCD;CALM1;GCHFR
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.6566947876928722,1.0264103507762539,0.4473684210526316,0.8930068792002207,1.0,4/6,30.03%,ATP10A;ASAP1;SH3GLB1;DNM2
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.3509478516054263,1.0262566365059271,0.2608695652173913,0.892897008449765,1.0,56/210,21.78%,ATP6V0D2;IRGM;FOXO1;BCL2;HSPB1;DAPK2;HTRA2;FZD5;IFI16;SNX5;TRIM8;HMGB1;ACER2;ABL1;DHRSX;MAPK8;CASP3;MTMR8;OSBPL7;MLST8;RNF152;ABL2;LEPR;ERN1;TRIM65;PIM2;USP36;DAPL1;TICAM1;TAB3;KLHL22;IL10RA;EXOC7;SNX32;DEPP1;MTMR3;PIP4K2A;NEDD4;ATM;TFEB;ATF6;EP300;CDK5;PRKAA2;SREBF2;TAB2;PRKAG2;MID2;TRIM14;RASIP1;DRAM2;MTDH;RUBCN;EXOC4;NPRL2;EIF4E
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),-0.49977310728783375,-1.0261378120288946,0.5370370370370371,1.0,1.0,2/27,5.36%,ERN2;SLFN14
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),-0.5138947841638412,-1.02610331817289,0.4307692307692308,1.0,1.0,4/17,18.74%,GPR183;OSCAR;TNFRSF11A;CSF1R
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),0.5566406319831853,1.0260830773258915,0.41379310344827586,0.8927084938158026,1.0,3/11,10.78%,VCAN;ARSB;CSPG5
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),-0.641803413222781,-1.0260558793617731,0.5357142857142857,1.0,1.0,2/7,18.03%,TLR2;RPS27A
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),-0.641803413222781,-1.0260558793617731,0.5357142857142857,1.0,1.0,2/7,18.03%,TLR2;RPS27A
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.546288417728764,-1.0259942324288491,0.390625,1.0,1.0,1/15,2.96%,TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.4953584277166088,1.0258752899954924,0.3333333333333333,0.8926776966910331,1.0,2/19,3.49%,APOE;BIN1
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),0.6018513069361604,1.0258181668635602,0.5116279069767442,0.8923125302704018,1.0,4/6,13.66%,AUTS2;SMARCB1;PIH1D1;ARRB1
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.37164128121115375,1.025505791247931,0.2692307692307692,0.8925179310639567,1.0,23/118,16.01%,PHLDB2;MITF;SERPINE1;JAG1;MAGI2;SRGAP2;TIMP1;SLIT2;PTPRR;RAP2A;NAV3;KANK1;ADIPOR1;EVL;DACH1;ARID2;NF1;NEXMIF;ADAM15;PTPN23;PTPRT;TMEFF2;DLG5
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.454014545334544,-1.0254475836084258,0.4507042253521127,1.0,1.0,9/46,12.97%,HAMP;NUBP1;ATP6AP1;ABCG2;CP;ALAS2;SLC11A1;FTH1;FRRS1
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),0.6171603956657,1.0254336108842186,0.4807692307692308,0.8920256477104873,1.0,1/6,6.75%,TIMP1
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),0.4428186974895229,1.0253419003375908,0.4411764705882353,0.8916616175370877,1.0,6/33,8.06%,CYP1A2;CSGALNACT1;CARNMT1;CYP2S1;GSTO2;GLUD1
prerank,GO_Biological_Process_2021__mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),-0.6924487641491205,-1.0252156637950431,0.52,1.0,1.0,2/5,21.91%,ZNF473;CPSF2
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),0.6307088747919867,1.0251870515862376,0.47368421052631576,0.891494260591524,1.0,4/6,35.01%,AGO2;ACVR1B;APELA;SMURF2
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),-0.4849247211052579,-1.0251523506605025,0.47619047619047616,1.0,1.0,10/29,24.55%,HSPA1L;HSPA8;HSPE1;SDF2L1;DNAJB1;CHCHD4;HSPA5;ENTPD5;HSPA2;HSPA13
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),0.639218744505632,1.025137799722062,0.45098039215686275,0.891082030053282,1.0,5/7,33.36%,KMT2C;KMT2B;KMT2A;SETD4;KMT2D
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.3994613001033953,1.0250237102493676,0.42857142857142855,0.8907781045647398,1.0,22/81,16.63%,GRID2;EPHA7;IGDCC3;PLEKHG4B;IL17RD;UNC5D;CNTNAP2;BCL11A;TRIM71;GRM4;LIN28B;NLGN4X;RIMS4;ADAMTS19;CRABP1;MSI1;SYT6;ZNF663P;MYO3A;WNK3;FRAS1;MAGEL2
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.44644107760695384,1.0249606289564208,0.4358974358974359,0.8903179185192216,1.0,7/23,22.12%,AUTS2;WASF2;AVIL;PIK3CA;FSCN1;OCLN;CARMIL2
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.4513026687047961,-1.0248070536041596,0.4722222222222222,1.0,1.0,9/46,14.43%,TGFB1;NODAL;DAB2;TTK;SMAD6;GDF11;ENG;BMP3;TGFB3
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.558936619655727,1.0247427329381111,0.42857142857142855,0.8903084194846327,1.0,3/9,16.02%,SNCAIP;HSPA1A;SACS
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),-0.5629521000435356,-1.0244403415183085,0.48214285714285715,1.0,1.0,2/12,8.55%,WNT8B;GPC3
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),0.4726364937848867,1.0243896005627329,0.4,0.8900549324507019,1.0,11/33,27.98%,NUP210;NUP42;AAAS;RANBP2;NUP214;TPR;SEH1L;XPOT;NUP153;NUP98;NUP37
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.4726364937848867,1.0243896005627329,0.4,0.8900549324507019,1.0,11/33,27.98%,NUP210;NUP42;AAAS;RANBP2;NUP214;TPR;SEH1L;XPOT;NUP153;NUP98;NUP37
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),0.3690939830912654,1.0242690688841227,0.32,0.8898991381089998,1.0,3/45,4.24%,ATP6V0D2;TCIRG1;REP15
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.5801341865349884,1.0242599631285196,0.46,0.889353174093153,1.0,4/8,37.93%,NIPBL;EPHB3;PDGFRA;FGFR2
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.5507048220197117,1.024190537629053,0.55,0.8888859392394177,1.0,1/10,7.18%,GREM1
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),0.47051046131737734,1.024142920323095,0.38095238095238093,0.8883998143056168,1.0,9/26,29.44%,ITGA4;GRIN1;ABCC1;GRM5;CDK5;CACNA1A;FYN;CACNB1;EPHA4
prerank,MSigDB_Hallmark_2020__Apical Surface,0.43501394985886727,1.023924750996824,0.3333333333333333,0.8884208168213825,1.0,10/37,16.31%,SCUBE1;HSPB1;DCBLD2;EFNA5;CROCC;RHCG;AKAP7;ADIPOR2;IL2RB;MDGA1
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),-0.6384225496550952,-1.023874306841101,0.4838709677419355,1.0,1.0,2/7,11.77%,ITGB2;ITGAM
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.5960255210856207,-1.0237364387142671,0.48484848484848486,1.0,1.0,2/10,6.40%,CASQ2;TRDN
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.5960255210856207,-1.0237364387142671,0.48484848484848486,1.0,1.0,2/10,6.40%,CASQ2;TRDN
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.5015554205371296,1.0235628021086633,0.45454545454545453,0.8888116883673381,1.0,5/15,13.21%,TCOF1;NRG1;LRP6;SNAI2;CDH2
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.5908555549913694,1.0234424755895588,0.43902439024390244,0.888569746856404,1.0,7/11,27.83%,TP53;PTGIS;FAP;DFFA;BCL2L1;DLC1;FZD3
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),0.6344378372123259,1.0231989414338993,0.5531914893617021,0.8886878151020785,1.0,1/5,13.60%,LRP8
prerank,GO_Biological_Process_2021__skin development (GO:0043588),-0.44962179451340023,-1.022800257627773,0.3787878787878788,1.0,1.0,10/54,8.67%,FLG;ALOX12;WNT5A;FLG2;CLDN1;COL1A1;COL5A1;ALOX12B;HRNR;ANXA1
prerank,GO_Biological_Process_2021__regulation of blood-brain barrier permeability (GO:1905603),0.5737764269779444,1.0227045715489258,0.40476190476190477,0.8895732413984703,1.0,1/7,2.81%,ANGPT1
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.3395075074496974,1.0226160613972495,0.3125,0.8892438952925007,1.0,50/225,19.70%,VCAN;KLHL17;POU6F2;ROBO2;ADGRL2;EPHA7;MFSD2A;DSCAML1;DNAJC30;IL1RAPL2;PITPNM1;CX3CR1;ATXN1;CNTNAP2;SOX12;GRIK1;SLC8A3;PKD2;JHY;PROX1;PTPRZ1;MAST1;NR4A2;SLC6A17;SNTG2;GRIN1;RPS6KA3;BPTF;NFIB;CDH2;UTP3;CHST8;NF1;SMG9;RPS6KA6;CNTN6;AMIGO2;MDGA1;LIG4;PBX1;ATN1;PAX6;NIPBL;MACROH2A2;S100B;GBA2;PTCH1;CDK5;SH3GL1;NRCAM
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.44587979361549007,1.022494072288837,0.40625,0.8890702177739644,1.0,8/24,22.67%,CD14;MAP3K1;TAB3;IRAK4;TAB1;TAB2;TRAF6;TLR5
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",0.39437747850441573,1.0224878270386712,0.42424242424242425,0.8885185960565304,1.0,9/64,18.01%,ELOF1;IWS1;ELP4;ELOA;CCNH;MLLT3;GTF2F2;SETD2;ERCC3
prerank,PanglaoDB_Augmented_2021__Principal Cells,-0.4071307732365823,-1.0224269127547991,0.43283582089552236,1.0,1.0,22/95,19.93%,AQP3;SMIM22;TMC4;PTGES;SLC5A1;EPN3;SLCO2A1;MYO5B;AQP4;SOWAHB;ITGB6;TRIM29;TMEM45B;PROM2;SCNN1A;SCNN1G;CAPN13;ADGRG1;SLC44A3;FAM3D;ACE2;CBLC
prerank,GO_Biological_Process_2021__protein import (GO:0017038),0.39497909817331334,1.0224175732318692,0.3076923076923077,0.8881033476828318,1.0,8/80,10.37%,PRICKLE1;APOE;RANBP17;PEX13;GDAP1;NXT1;ABCD3;ABCD2
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.4735813105847848,1.022222596654583,0.34375,0.8881534715902428,1.0,6/22,11.24%,ADGRG6;KSR1;PDE7A;ADCY2;CAP2;RIMS2
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),0.5933130413762158,1.0222028501594567,0.5208333333333334,0.8876325321913536,1.0,1/7,1.32%,TSKU
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),-0.5147049077098023,-1.0221713664777945,0.4492753623188406,1.0,1.0,1/21,1.49%,TGFB1
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),-0.40070649507603484,-1.0216125752558076,0.4605263157894737,1.0,1.0,24/140,17.90%,NRAP;LMOD1;ACTC1;ELMO3;TMOD4;FHOD1;NLRP5;WAS;NEB;MYO1F;MYO5B;ARHGAP12;LMOD3;SVIL;SCIN;VIL1;BAIAP2L1;TTN;LCP1;RAC2;GHRL;RAC1;MYO15A;BAIAP2L2
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),0.5831119910694912,1.0215714134042952,0.44642857142857145,0.8886500684973166,1.0,1/8,1.53%,KIT
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),-0.575270969849117,-1.0209862962124698,0.5333333333333333,1.0,1.0,2/16,3.51%,HHIP;NLRP12
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),-0.6057684323346773,-1.0204521428590583,0.4666666666666667,1.0,1.0,2/8,17.52%,DAB2;MSN
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),-0.5824512025826263,-1.020421548492637,0.46551724137931033,1.0,1.0,5/11,19.41%,SCIMP;OAS1;COLEC12;SCARA3;CASP8
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),0.6127371253219952,1.0203900978860905,0.4772727272727273,0.8910098145257971,1.0,2/7,10.73%,MED25;ZNF618
prerank,GO_Biological_Process_2021__regulation of DNA methylation (GO:0044030),0.6290518038981272,1.0203743756806898,0.4897959183673469,0.8904687287875169,1.0,3/6,16.55%,MYC;MECP2;MPHOSPH8
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.4908146446273548,1.0203345590043524,0.4146341463414634,0.8900152137578418,1.0,3/16,15.03%,NUS1;ALG12;ALG3
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.488287487647187,1.0201661719065067,0.42424242424242425,0.8899288654380167,1.0,5/28,7.88%,TGFBR1;ROBO2;HES1;PROX1;SLIT2
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.44560291208864783,1.019968160682459,0.3793103448275862,0.8898811908755978,1.0,13/42,21.06%,NBDY;RIDA;DXO;ERN1;LSM2;HSPA1A;PNPT1;AGO3;RC3H1;XRN2;METTL16;TUT7;LSM6
prerank,GO_Biological_Process_2021__response to acetylcholine (GO:1905144),-0.6881275762986246,-1.01991411763592,0.5185185185185185,1.0,1.0,2/5,25.02%,CHRNA3;CHRNB2
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),-0.635037439152487,-1.0196392657671904,0.5,1.0,1.0,2/7,24.34%,BNIP3;ADCK1
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.37424549284631636,1.0196294406176585,0.35,0.8903731213250133,1.0,15/77,15.63%,BAMBI;TGFBR1;DUSP15;CDH5;PARD3;SIRT1;ARRB2;TWSG1;PXN;FNTA;SMAD2;LTBP2;SMURF1;FURIN;CGN
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),-0.5972474617001096,-1.0195772299874426,0.5737704918032787,1.0,1.0,2/14,3.51%,HHIP;NLRP12
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),0.4946841706162936,1.0194302139859264,0.425,0.8902674528098203,1.0,5/20,14.43%,SMYD5;SIRT7;MOV10;PIWIL1;TEX15
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),-0.7011188707022108,-1.0194096880662096,0.5217391304347826,1.0,1.0,1/5,8.37%,ATP6AP1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),0.5937818069940709,1.0192653959089366,0.5,0.890258143348596,1.0,2/7,4.97%,PPARG;DNMT1
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.4011984268223294,-1.0192206616875066,0.45569620253164556,1.0,1.0,21/128,19.37%,C1QTNF1;LMOD1;TIMP3;TMEM184A;DOCK6;ACOX2;COL18A1;SLCO2A1;CLU;SLC16A3;WNT6;GPX3;C1S;GATA4;AGT;YAP1;ITGB5;AARD;EPAS1;INHA;ANGPTL4
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.4780570881257491,-1.0188395646796213,0.44594594594594594,1.0,1.0,7/33,10.38%,DUOX1;CLDN1;VTN;ACTG1;ANXA1;THBS1;ENPP4
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.49839276669418203,-1.0187190008561704,0.3709677419354839,1.0,1.0,6/25,22.78%,ATP5F1E;ATP5MC3;ATP5PF;ATP5ME;ATP5PB;ATP5F1A
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.504749811134201,1.0186592727752772,0.4222222222222222,0.891239325359333,1.0,2/18,9.01%,FGF10;SNAI2
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),-0.6467048791331376,-1.0183751572505007,0.55,1.0,1.0,3/6,9.90%,HLA-A;ANXA1;STOML2
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.324735392828857,1.0182685824926894,0.3333333333333333,0.8918348508209889,1.0,69/421,14.23%,TEAD2;CD38;BAMBI;POU3F1;ESRRG;FOXO1;FANK1;ZNF496;SKAP1;TGFBR1;MED17;MAFB;MITF;RORA;APOE;SMARCD3;PPARG;CREB3L2;WNT4;PAX3;SNX5;RORB;PYHIN1;LHX2;HES1;LBHD1;KDM8;SEC14L2;PML;NAT14;PLCB1;SP1;FZD1;MYC;LRP6;WNT3A;HIVEP3;TFE3;WBP2NL;CEP290;ARID1A;RNF10;F2R;NPAS3;TRIM44;PPM1A;PIM2;NSD1;SMARCA2;MLXIPL;SMARCA4;USP16;GDF6;RET;BICRAL;MDFIC;KAT6A;NFIB;HDAC1;TESC;RYBP;ZXDC;MED16;FOXF2;SMAD2;NR2F2;RLF;NFKB1;MLLT3
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.517660645408638,-1.0180652507479953,0.4098360655737705,1.0,1.0,5/24,21.21%,KIF14;STMN4;KIF18A;STMN1;STMND1
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),0.5772125272272752,1.0178617238834926,0.4634146341463415,0.892343181964766,1.0,2/6,14.37%,SDF4;GPX1
prerank,GO_Biological_Process_2021__plasminogen activation (GO:0031639),0.6356936564860098,1.0177067642078275,0.5,0.8921022253731785,1.0,3/6,6.11%,APOH;KLKB1;F11
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),0.5503913164642437,1.0174594424129026,0.4358974358974359,0.8922452497140995,1.0,3/12,16.55%,TOP2A;RESF1;MPHOSPH8
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),0.6509140158357302,1.0174190440392268,0.45652173913043476,0.8917362594674161,1.0,1/6,6.26%,PROX1
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.3410610875310357,1.0172618549309682,0.4117647058823529,0.8916015233154118,1.0,38/151,20.19%,TGFBR1;MAPKAPK2;SBK1;VRK2;SGK1;EIF2AK3;LATS1;MAST1;MAST2;MAPK8;MAP3K10;AKT2;ERN1;DYRK3;PKN2;RPS6KA3;STK32C;SGK2;CAMK1G;MAP3K13;MARK3;RPS6KA4;RPS6KA2;RPS6KA6;CLSPN;MAPK12;SMG1;MARK1;ATM;CSNK1G1;MAST4;ATR;MORC3;PNCK;CDK5;PAK2;MARK2;PRKCE
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),0.6437231260386637,1.017069618596299,0.5555555555555556,0.8914861052839104,1.0,2/5,24.25%,TRIP11;C17ORF75
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.47299245527537415,-1.0170022943684154,0.47619047619047616,1.0,1.0,6/29,17.55%,ARG2;NLRC3;NR1H4;GHRL;VSIR;CACTIN
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),0.5038156215795491,1.0169208225627544,0.5,0.8913899686464472,1.0,6/12,30.26%,PKD2;CCDC22;FAF1;SUFU;PSMD10;PKD1
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.45090068479469286,1.016622428112709,0.3333333333333333,0.8915138681813471,1.0,9/35,19.70%,APOE;KIAA0319;GOLGA4;ABL1;MACF1;MAP3K13;DIP2B;LIMK1;NRCAM
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.48078461385654525,1.0166216095340381,0.45714285714285713,0.8909496188976881,1.0,7/24,16.58%,NGF;BCL2;FADD;CRADD;CASP8AP2;BID;ZDHHC3
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),0.5675233028370411,1.0165894108522955,0.5111111111111111,0.8904720280045091,1.0,6/9,36.03%,SREBF2;ARHGEF10L;ERLIN1;INSIG1;ERLIN2;SCAP
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.5563806887339474,1.01637888682679,0.45,0.8903958621809261,1.0,4/12,22.04%,SPTBN4;ARHGAP35;EPHB2;PTEN
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),0.6557836857343448,1.0162295314202103,0.46808510638297873,0.890167195221407,1.0,1/6,4.29%,CX3CR1
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.3395252800469234,1.016190005590317,0.3157894736842105,0.8896528775535419,1.0,37/211,12.71%,GABRE;CHRM2;CEL;GABRA5;NOVA1;GABRR2;NLGN1;GRM3;HTR1F;GALR3;HTR2C;GABRG3;HRH3;DRD5;GRIK1;SNCA;CACNB4;CHRNA10;DTNA;DRD4;APBA3;KCND2;GRIK2;SYT1;LRP6;GRM4;GRM7;GRIN1;PRKAR2A;AKAP9;GABRG1;RPS6KA3;NLGN4X;UNC13B;APBA1;NLGN3;CPNE6
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.42869237605167165,1.0161147251564082,0.3870967741935484,0.8893011389815977,1.0,8/37,10.74%,ITPR2;HTR2C;TRPM2;SLC8A1;SLC8A3;PKD2;GRIN1;F2R
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),0.5750254553424851,1.0157180011814126,0.4857142857142857,0.8897399454486878,1.0,5/11,30.06%,DDAH1;ACE;BMPR2;PLCB3;GPR37L1
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.44747602355802,1.0157091465659103,0.4634146341463415,0.8891888160576454,1.0,8/21,13.00%,NLGN1;DEF8;PLEKHM1;KANK1;ABI3;EVL;EPS8L2;EPS8
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),0.42966378119908144,1.0156657516104142,0.46153846153846156,0.8887334538438252,1.0,8/26,15.37%,CD14;TICAM2;SARM1;NLRP2B;TYRO3;TICAM1;GPR108;MFHAS1
prerank,GO_Biological_Process_2021__protein localization to microtubule end (GO:1905725),0.6524084413740892,1.0156039437345457,0.56,0.8878339431112459,1.0,5/5,34.77%,MAPRE1;MAPRE3;MAPRE2;GAS2L1;GAS2L2
prerank,GO_Biological_Process_2021__protein localization to microtubule plus-end (GO:1904825),0.6524084413740892,1.0156039437345457,0.56,0.8878339431112459,1.0,5/5,34.77%,MAPRE1;MAPRE3;MAPRE2;GAS2L1;GAS2L2
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),-0.4799245430367428,-1.0155905733563497,0.4852941176470588,1.0,1.0,4/21,21.25%,GPSM2;CHMP3;EML3;DRG1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.36921394384894585,1.0155219804437996,0.4444444444444444,0.8875036530431376,1.0,7/56,10.32%,NLGN1;CACNG4;DLGAP4;CNIH3;CACNG2;GRIN1;AKAP9
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),0.5023497558103039,1.015291041518536,0.4146341463414634,0.8874298302052314,1.0,5/18,19.39%,BCL2;BID;LIG4;ATN1;CDK5
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),0.5053344450950659,1.0152528583747948,0.36585365853658536,0.8869580465182109,1.0,6/17,22.98%,APOE;BIN1;RTN2;ABCA7;NTRK2;RTN1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.4663692913997222,-1.0150542887457101,0.4393939393939394,1.0,1.0,7/24,16.13%,WNT5A;SCIMP;CD160;HLA-A;LACC1;HLA-F;F2RL1
prerank,GO_Biological_Process_2021__multinuclear osteoclast differentiation (GO:0072674),-0.6705536429497917,-1.0150092036781453,0.49019607843137253,1.0,1.0,3/5,29.55%,TNFRSF11A;CD81;DCSTAMP
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),0.3637677410742078,1.0148571999205107,0.38095238095238093,0.8873392915232803,1.0,14/143,7.18%,ADRA1A;ADRA1B;FGF10;KIT;FGFR1;KSR1;EPHA7;CCN1;ERBB2;PAK5;VRK2;TMEM106A;HMGB1;GREM1
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),-0.5672002047743897,-1.0147947841979963,0.45614035087719296,1.0,1.0,3/9,18.95%,PPT1;PROM2;AXL
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),-0.4595441650089527,-1.0144966129103947,0.4625,1.0,1.0,12/43,21.55%,KIF14;TMC8;CLU;SMAD6;SVIP;NLRC3;DDX3X;RPL13A;THRA;NOP53;HSPA5;TFIP11
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),-0.644778227185941,-1.0144610450246372,0.4807692307692308,1.0,1.0,2/6,7.84%,BHMT;CHDH
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),0.5660890039318122,1.0143892578440614,0.45454545454545453,0.8880892161413342,1.0,6/12,31.83%,SLC25A33;LONP1;AKT3;MEF2A;MPV17;SLC25A36
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.44339039990093393,1.0143883072554531,0.3939393939393939,0.887551688564635,1.0,3/36,5.28%,ROBO2;MAML1;JAG1
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.41792372081393486,1.0141285999096188,0.34210526315789475,0.8876198726814172,1.0,8/30,13.97%,SLC26A3;PKD2;HCN1;RAPGEF1;AANAT;AKAP9;RAP1A;HCN3
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),0.3997710308375869,1.0141093927755727,0.34285714285714286,0.887149446238426,1.0,9/51,11.59%,PER2;FBP2;PC;ENO3;CRY1;G6PC3;SLC25A1;IRS2;SLC25A12
prerank,"GO_Biological_Process_2021__regulation of blood coagulation, intrinsic pathway (GO:2000266)",-0.6891806706568302,-1.013987485641097,0.5689655172413793,1.0,1.0,1/5,0.35%,F8
prerank,"GO_Biological_Process_2021__negative regulation of blood coagulation, intrinsic pathway (GO:2000267)",-0.6891806706568302,-1.013987485641097,0.5689655172413793,1.0,1.0,1/5,0.35%,F8
prerank,MSigDB_Hallmark_2020__Coagulation,-0.4236402136782698,-1.0138623822721793,0.41975308641975306,1.0,1.0,19/98,14.21%,F8;TIMP3;S100A13;MMP9;ACOX2;GP1BA;PLAU;PRSS23;ANXA1;CPB2;CLU;PLG;CFD;THBS1;VWF;MASP2;PLAT;A2M;C1S
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),-0.5143241740019531,-1.013703107415593,0.43636363636363634,1.0,1.0,7/21,17.21%,TGFB1;UBE3A;THBS1;TGFB3;YAP1;WBP2;HSD3B1
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),-0.5513355514328424,-1.0134944382547793,0.3898305084745763,1.0,1.0,2/13,12.51%,SP100;APOD
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),-0.48403267978299297,-1.013215098607861,0.38461538461538464,1.0,1.0,3/26,8.58%,MGST1;SLC13A4;ABCG2
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),0.638210075235973,1.0130335421422634,0.4878048780487805,0.8896160398284472,1.0,2/8,9.27%,MID1;MAPRE1
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.5331883404062712,1.01293072511127,0.45,0.8893053658338547,1.0,6/18,30.46%,LRP8;CUX1;PTPRD;CUL7;DBNL;IL1RAPL1
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5058417223926832,1.012904668860324,0.40540540540540543,0.8888441982216202,1.0,3/13,12.90%,NFATC3;PPARG;NFIB
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.38721914591939516,-1.0128675146121033,0.4444444444444444,1.0,1.0,35/139,15.90%,AMBP;AQP3;SLC28A1;AHR;F7;ITIH2;SMLR1;NR1I3;HAMP;ALDOB;SDC2;C3P1;OIT3;PON3;CYP2A6;GPC3;CPB2;CYP3A4;SLC22A7;CP;APOM;PON1;HPR;MASP2;FOXA3;HSD11B1;NOS2;FGL1;HAO2;VDR;NR1H4;CYP2E1;FGFR4;SLC10A1;PRRG4
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.4221979828740517,1.0127673459829722,0.3333333333333333,0.888713454080351,1.0,16/42,24.06%,SNCA;NRG1;RAB7A;EPHA3;WWP2;PXK;PLSCR1;NR1H3;LGALS3;ABCA7;LRSAM1;PIP4P2;RUBCN;PTEN;CTTNBP2NL;ERBB3
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",0.2979196703749508,1.0126472534318227,0.25,0.8884510162785564,1.0,216/787,21.94%,CD38;SMYD2;FOXO1;PER2;HDAC3;PRICKLE1;ZNF239;BCL6;AASS;MITF;HDAC10;TSHZ3;RARB;ZNF692;TWIST2;MTERF3;URI1;ZBTB7B;KLF10;PCGF1;CIART;CBFB;PHC2;PRDM5;HEXIM2;TGIF1;GATAD2A;ZNF263;TLE2;E2F6;FRK;ATXN1;PPARG;WNT4;SIRT1;IFI16;RORB;ZEB2;SFMBT1;CRY1;SNCA;PER3;SIRT7;HIC2;NRG1;HES1;GFI1B;KCNIP3;BCL11A;PROX1;ZBTB4;HMGB1;ATF3;DLX1;FOXP2;MIER2;OSR1;ZBTB1;IKZF4;ZNF703;MED25;ZNF274;KDM8;NRIP1;PML;WWOX;PLCB1;WWP2;MYC;NKAP;FLNA;TAF3;NR4A2;ZNF688;FOXN3;ZEB1;ZNF202;MAP3K10;TWIST1;SNAI2;SPEN;ZNF133;FHL2;ZNF599;CTBP2;CREM;KDM2A;BPTF;ZNF75A;TIMELESS;PPM1A;DACH1;DPF1;RBFOX2;MYT1L;NSD1;LIMS1;SMARCA2;ZNF846;MLXIPL;SMARCA4;SCMH1;SAP130;ZNF337;MDFIC;KAT6A;DPF2;MXI1;HDAC1;GATAD2B;ASCL1;SMAD2;NR2F2;PLK3;NR3C1;NFKB1;NCOA5;BCOR;MBTD1;CUX1;SCRT1;MECP2;OTUD7B;ZMYND11;THRB;HDAC4;ZNF69;NFIC;SPINDOC;CXXC5;ETV5;MEN1;HSF1;NR1H3;HJV;GADD45A;TP53;HSF4;RUNX1;NR6A1;NR4A3;WWC1;MPHOSPH8;ZGLP1;MAGEL2;NOTCH1;ZBTB2;ARID5B;ATN1;ATF7IP;KLF12;HIVEP1;PA2G4;THAP7;SKI;SP2;ZMYM5;NR2C1;PAX6;ZHX3;ZNF675;ZNF589;NIPBL;ZBTB5;NOC2L;MACROH2A2;ZNF12;RBPJ;SP3;NFX1;YAF2;UXT;ZNF706;IMPACT;SOX13;SIRT6;EP300;SLA2;AEBP1;DPF3;PTCH1;CREB1;KAT6B;CDK5;KHDRBS1;ZNF79;SREBF2;RNF2;BRMS1L;POU2F1;ZNF596;HDAC5;IGBP1;TRAF6;RSF1;JAZF1;PCGF6;TBL1X;ZNF764;ZNF778;HINFP;PRDM16;ZNF785;ZBTB7A;MTDH;NFIX;DLG1;MDM4;RCOR2;BAHD1;BMP4;MLIP;ZNF25;SUV39H2;ZNF268;ZNF3
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.4571009659653893,1.0118990440364537,0.2903225806451613,0.8896854884344179,1.0,10/36,20.81%,DCPS;TRIM71;RIDA;KHSRP;MOV10;YTHDF1;RC3H1;METTL16;RBM24;TUT7
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),-0.5337765194655617,-1.011565714354344,0.4461538461538462,1.0,1.0,1/17,1.49%,TGFB1
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.5156820919438584,-1.0111341795961524,0.463768115942029,1.0,1.0,1/20,2.96%,TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.5156820919438584,-1.0111341795961524,0.463768115942029,1.0,1.0,1/20,2.96%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),-0.6441027161113111,-1.0111145595462625,0.48,1.0,1.0,1/6,14.99%,DDX3X
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),-0.46530065462384473,-1.010625444442956,0.43283582089552236,1.0,1.0,11/40,17.92%,TIMP3;SERPIND1;VTN;SERPINB5;SERPINA10;TIMP4;SERPINE3;SPOCK3;AGT;SERPINB7;SERPINF1
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),0.5163613851500711,1.0105934635715832,0.42857142857142855,0.8922541602915042,1.0,2/12,4.97%,AASS;DNMT1
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,-0.3906386056345033,-1.0102655306106476,0.4520547945205479,1.0,1.0,8/122,10.63%,GPR62;TRIL;SOX10;LRRTM1;TMEM179;TCEAL5;MATN4;AQP4
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),-0.4643814708219514,-1.010241453079487,0.47297297297297297,1.0,1.0,8/49,9.35%,TBX1;SOX10;PDXDC1;SEMA3F;SEMA3A;GPC3;HTR2B;FAT2
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.44567469141360083,1.0101277474298516,0.46875,0.8929864873744203,1.0,17/34,24.78%,PI4KB;ITPKB;TMEM150A;PIK3C2B;PI4K2B;PIK3CA;SMG1;PIP4K2A;TTC7B;IP6K1;EFR3B;SLA2;SOCS7;SOCS4;IP6K2;EFR3A;PIK3CD
prerank,GO_Biological_Process_2021__cellular response to iron ion (GO:0071281),-0.6332277120375148,-1.0099976026369857,0.5254237288135594,1.0,1.0,3/5,35.86%,B2M;TFR2;BMP6
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),0.5070080396563345,1.0099054642254395,0.4,0.8929851009541583,1.0,3/14,13.17%,OSR1;TWIST1;HDAC1
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),0.41176937448591827,1.009871606437324,0.47368421052631576,0.8924673181845715,1.0,7/53,9.58%,BAMBI;APOE;RIPK2;RALB;ABL1;WNT3A;EPB41
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.6388628995978319,-1.0098691546452447,0.5,1.0,1.0,2/7,18.02%,TRDN;CALM1
prerank,GO_Biological_Process_2021__myeloid dendritic cell differentiation (GO:0043011),0.5877866217242437,1.0093579473434067,0.5675675675675675,0.8931793809151748,1.0,1/6,10.94%,BATF2
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),-0.40997706027956476,-1.0093091440862225,0.4864864864864865,1.0,1.0,8/109,7.51%,ENPP2;DUOX1;FGF20;KIF14;TGFB1;CAVIN1;CEACAM1;WAS
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.6371822586557709,1.0089429435749344,0.6,0.8938811817033396,1.0,2/5,7.70%,LHFPL2;PLCB1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),-0.5391188647765744,-1.0084981832121438,0.4714285714285714,1.0,1.0,4/15,9.78%,GPER1;CD160;SFRP4;THBS1
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),-0.49290608916624945,-1.0084578466280603,0.5,1.0,1.0,4/28,7.11%,P2RY12;CYP1B1;PLAU;ADA
prerank,GO_Biological_Process_2021__T-helper 1 type immune response (GO:0042088),-0.6167337824206998,-1.008346015679919,0.4807692307692308,1.0,1.0,4/7,15.16%,HLA-DRB1;IL18BP;LEF1;IL18
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),-0.6404715250796412,-1.0083238864352437,0.46774193548387094,1.0,1.0,3/9,19.94%,NLRP12;ENG;MVP
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),0.6301136814133991,1.0082979931036575,0.5348837209302325,0.8949288593800304,1.0,2/6,27.85%,FRRS1L;FYN
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),-0.5371881980431011,-1.0079935376361233,0.4714285714285714,1.0,1.0,3/15,16.00%,NODAL;ZP3;SPINK13
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),0.5342855453509536,1.0077164106681054,0.47058823529411764,0.8958253850807985,1.0,5/15,13.33%,SIK3;TELO2;PIH1D1;CLEC16A;KLHL22
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),0.3796756115715118,1.0077061252366695,0.3333333333333333,0.8953074464709893,1.0,11/58,9.00%,EGLN3;CPEB1;RORA;SIRT1;SLC8A3;HP1BP3;OPRD1;MGARP;KCND2;MYC;TWIST1
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),-0.5772234503759949,-1.0075754863486395,0.4461538461538462,1.0,1.0,2/13,9.32%,GAD1;ACOT4
prerank,GO_Biological_Process_2021__positive regulation of membrane invagination (GO:1905155),0.574929988591022,1.0074764853539895,0.46,0.8951736699142591,1.0,1/7,3.06%,RAB31
prerank,PanglaoDB_Augmented_2021__T Cells Naive,-0.4726492198641638,-1.007455287968645,0.43478260869565216,1.0,1.0,14/51,10.28%,SIRPG;GMFG;ITGB2;CYTIP;TBC1D10C;ARHGAP9;TAGAP;KLRB1;PARVG;CD5;WAS;CD37;TRAF3IP3;PTPRC
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),-0.6376956940363538,-1.0074279886567834,0.5964912280701754,1.0,1.0,2/6,15.72%,FBXL7;RBX1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),0.5732654952761039,1.0074073030871467,0.5454545454545454,0.8948063500178989,1.0,3/8,25.55%,HMGB1;SLC15A4;RSAD2
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),-0.4045192986559296,-1.007272966381839,0.4142857142857143,1.0,1.0,18/94,16.13%,TGFB1;WNT5A;P2RY12;NLRP12;SCIMP;IFNK;LY86;PLG;THBS1;CYBA;USP17L2;TLR2;SH2D1B;IL18;ZP3;AGT;GRN;F2RL1
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),0.5526342213492398,1.0070615212957497,0.5151515151515151,0.8952242610599188,1.0,3/11,14.61%,NR4A2;LRP6;RYK
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),-0.5800878037562689,-1.0070092952139,0.49122807017543857,1.0,1.0,4/9,22.14%,RPS21;ERI2;EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.3576110416261546,1.0061821055789104,0.42857142857142855,0.896743397332577,1.0,37/148,16.74%,PER2;NEUROD2;FGFR1;POU3F2;KIAA0319;AUTS2;CX3CR1;WNT4;PEX13;FZD5;ATOH7;ERBB2;LHX2;HES1;SH3RF1;WNT9A;CDK6;FZD1;CASP3;NR4A2;SDCCAG8;WNT3A;TAFA1;ADNP2;NLGN4X;HES6;MYT1L;ASCL1;FUT9;ANOS1;NAV1;SNPH;RYK;RUNX1;PTPRD;MDGA1;MARK1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.5292822286616496,1.0061742394506825,0.4375,0.8962078298458013,1.0,4/10,11.29%,KLRD1;CX3CR1;ARRB2;LGALS9
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),-0.5772044479000694,-1.0060873293590347,0.48214285714285715,1.0,1.0,1/10,1.49%,TGFB1
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),0.5682224426162015,1.0060468098096098,0.47058823529411764,0.8958687544986985,1.0,2/9,9.81%,KIT;KITLG
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),0.5202955208555544,1.0059931941996372,0.5161290322580645,0.8954089441679255,1.0,3/13,15.27%,ATF3;GSTO2;HSF1
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),-0.6228650391631765,-1.0058731169414845,0.5625,1.0,1.0,1/6,11.29%,USP17L2
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.3749911383718512,-1.0057118406078356,0.4945054945054945,1.0,1.0,105/355,26.43%,NOTUM;SFTPA1;APOL1;RPL37A;ITIH2;PIGH;SERPIND1;SDC2;LOX;UBE2L6;SFTPD;PAPPA2;PAPPA;PHEX;PRSS23;GPC3;RPL38;SERPINA10;PLG;RPL15;STOML2;USP6;CP;COPS5;WARS1;RPS4X;RPL3;RPL35A;WFS1;MFGE8;PLAT;RPS9;F5;RPS27;RPS21;PCMT1;RPL13A;YARS2;RPL27A;GNMT;RPS16;RPL36;PARP4;RPS20;RPL7A;RABGGTB;RABGGTA;RPL9;ABCF1;RPL13;RPS8;RPS27A;RPL21;RPL34;AMBN;MRPL34;RPL4;RPL32;CHGB;RPL5;RPL23;RPL41;RPS7;RPS11;GGCX;FN1;RPL27;RPL35;CSF2RA;RPS14;LAMB2;RPL11;ASMT;RPS15;ALB;IGFBP3;RPLP1;RPS12;RPL24;TGOLN2;RPL18A;RPS13;RPL29;RPLP2;APH1A;FBXO2;KNG1;RPL28;RPL12;IGF2BP3;RPL18;RPS3;FUCA2;RPL22;EEF1A1;RPSA;UBE2M;DENND3;RPS28;UBL5;SPCS2;RPS19;PROC;RPS24;SCG3
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),0.6355077160225427,1.0056222357713391,0.5116279069767442,0.8958531356888063,1.0,1/5,1.51%,TGFBR1
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),-0.6340098362444003,-1.0055087426438947,0.5098039215686274,1.0,1.0,3/7,16.69%,UBE3A;YAP1;WBP2
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),-0.6363167245396953,-1.005446263836844,0.5384615384615384,1.0,1.0,1/8,2.65%,BLK
prerank,GO_Biological_Process_2021__polyphosphate catabolic process (GO:0006798),0.6995322474331429,1.0053254222776433,0.6666666666666666,0.8962130073577612,1.0,2/5,22.25%,BNIP2;BNIPL
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),0.5724738927342671,1.0053203785762648,0.5333333333333333,0.8956794165976698,1.0,2/7,6.24%,RP1L1;NKD1
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),-0.5116796056167242,-1.005274531607422,0.453125,1.0,1.0,3/14,7.85%,SLC5A2;SLC5A1;SLC5A9
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),-0.4473685628483686,-1.005001340987993,0.4492753623188406,1.0,1.0,13/59,17.90%,LMOD1;HCK;CAV3;C15ORF62;PINK1;ALOX15;ANKRD53;DCTN1;BAIAP2L1;VASP;RAC1;CDK5R1;BAIAP2L2
prerank,MSigDB_Hallmark_2020__Adipogenesis,-0.39123935917938657,-1.0049490912564625,0.46153846153846156,1.0,1.0,5/183,1.55%,ENPP2;SQOR;COX6A1;CCNG2;RAB34
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,-0.4512592593933394,-1.004765811952704,0.4262295081967213,1.0,1.0,14/51,14.69%,AMBP;DBH;F7;ALDOB;C3P1;FTCD;DAO;SLC22A7;SHD;SLC18A2;UROC1;FGL1;HAO2;NR1H4
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),0.5171766938346145,1.004688743555028,0.4090909090909091,0.8966990072987321,1.0,5/16,15.70%,CSTA;ECM1;HDAC1;FURIN;MAPK12
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.390169253170383,1.0045868867830683,0.46153846153846156,0.8964073358186774,1.0,16/64,17.75%,NGF;ROBO2;SMARCD3;CX3CR1;RGS14;SLIT2;PLXNB1;DCT;SPEN;NUMB;MAP6;CUX1;PTPRD;LIG4;PLXNA4;FAIM
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.5087047801908644,1.0044300388150516,0.40425531914893614,0.8962088742781099,1.0,4/13,15.19%,FGFR1;CELF4;STOX2;RAI2
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),-0.5416706697455768,-1.0041872260542108,0.5,1.0,1.0,1/11,2.12%,ABCC6
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),0.3831726104015767,1.0041591359922994,0.5666666666666667,0.8963447154973507,1.0,5/54,4.79%,PNP;CD38;FGF10;BCL2;CCDC88B
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),0.6256390392102167,1.0039586951570627,0.56,0.8963783790120771,1.0,4/6,33.36%,KMT2B;KMT2A;SETD4;KMT2D
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.5187534582129396,-1.0039368444898271,0.47368421052631576,1.0,1.0,3/17,8.75%,SPDYA;CCND1;CCND2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.434373003685768,-1.0038632752268135,0.47761194029850745,1.0,1.0,18/51,29.05%,PSMB9;FBXL7;ATF5;RBX1;PSMA3;PSMA7;PSMB6;RFPL1;PSMA5;AURKA;PSMD6;SKP1;PSMC5;PSMB4;PSMB7;PSMD8;GPR132;PSMD3
prerank,GO_Biological_Process_2021__low-density lipoprotein particle remodeling (GO:0034374),0.55345517636096,1.0038608146180301,0.5526315789473685,0.8960598164998633,1.0,2/9,2.65%,LIPC;APOB
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.5037829751973824,1.003819788081704,0.45454545454545453,0.8950350839320629,1.0,8/14,29.72%,NANOS3;TNRC6C;AGO2;NANOS1;PABPC1;TNRC6B;TOB1;ZFP36L2
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.5037829751973824,1.003819788081704,0.45454545454545453,0.8950350839320629,1.0,8/14,29.72%,NANOS3;TNRC6C;AGO2;NANOS1;PABPC1;TNRC6B;TOB1;ZFP36L2
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),-0.546991980636586,-1.003810631968789,0.4107142857142857,1.0,1.0,2/14,6.95%,P2RY12;KCNJ11
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),-0.4952404086523491,-1.0037787714271325,0.5072463768115942,1.0,1.0,3/26,7.49%,PLAAT4;PLA2G10;ALOX15
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.4431662166423797,-1.0037486623498828,0.4411764705882353,1.0,1.0,7/43,19.11%,PSMB9;NQO1;AZIN1;OAZ2;PSMA3;PSMA7;PSMB6
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,0.3487274676838434,1.0037239402682334,0.3333333333333333,0.8947456830547821,1.0,16/165,9.44%,IL7R;NGF;EMP1;MAFB;DCBLD2;SPON1;TPH1;RGS16;ETV1;CFH;USP12;PTPRR;MAP3K1;TRIB2;SDCCAG8;AKT2
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.3655054445710209,1.0036333243256685,0.2857142857142857,0.8944196553522077,1.0,22/99,15.84%,BAMBI;TGFBR1;DUSP15;CDH5;PARD3;WNT4;SIRT1;ARRB2;DLX1;WWOX;TWSG1;LIMS1;PXN;FNTA;SMAD2;LTBP2;NR3C1;SMURF1;SOX5;FURIN;CGN;CRKL
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),0.5367731853318476,1.0036256321672918,0.3902439024390244,0.8933440320451893,1.0,3/11,12.22%,GRM3;GRM2;ADGRV1
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),0.5367731853318476,1.0036256321672918,0.3902439024390244,0.8933440320451893,1.0,3/11,12.22%,GRM3;GRM2;ADGRV1
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.4089837689047346,1.0035813510705516,0.5,0.8928994902288481,1.0,11/59,15.71%,DGKD;SLC30A10;NRG2;ERBB2;NRG1;PTPRR;TGFA;GAB1;EFEMP1;PIK3CA;MATK
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.42624848783896296,-1.0034333083065146,0.4393939393939394,1.0,1.0,8/52,12.20%,TRIM62;TRIM5;STAT1;OAS2;CHMP3;PTX3;IFIT1;OAS1
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),-0.4562456008768097,-1.0032438595367272,0.5373134328358209,1.0,1.0,7/52,12.92%,AMBP;HHIP;NLRP12;ALOX5;CLU;TERT;WFS1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast migration (GO:0010764),-0.6117942156408023,-1.0031903214052575,0.509090909090909,1.0,1.0,3/6,30.66%,RAC1;FGF2;HAS1
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.4644816814866907,1.0028751997007286,0.42857142857142855,0.8939219049061594,1.0,6/28,11.59%,SLC38A5;SLC3A2;SLC7A9;SLC6A20;SLC7A8;SLC25A12
prerank,GO_Biological_Process_2021__CRD-mediated mRNA stabilization (GO:0070934),0.6419414845949664,1.0028705274644396,0.5128205128205128,0.8933761650374744,1.0,3/5,31.79%,SYNCRIP;YBX1;HNRNPU
prerank,GO_Biological_Process_2021__regulation of phospholipid transport (GO:2001138),0.6180177954802568,1.0018149921795647,0.5128205128205128,0.8956313784613981,1.0,1/5,28.52%,ABCA3
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),0.33844242887505976,1.0015102429948384,0.3181818181818182,0.8958033184412639,1.0,24/182,11.55%,GCK;PLCH1;DUSP4;FBP2;DUSP15;EPHX2;PLPPR1;EPHA7;DUSP23;BCKDK;PFKP;ITPKB;G6PC3;PLCB1;ACYP2;INPP1;LPL;PLPP2;PSPH;PLCH2;GPD2;DUSP18;PPM1A;PTPRB
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),0.5613148667119499,1.001485626157163,0.5454545454545454,0.8952942307441385,1.0,3/8,14.49%,JMJD4;MTRF1;ETF1
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),0.5615177296730715,1.001467983137323,0.4666666666666667,0.8942687254194667,1.0,5/10,32.49%,ASCC2;MGMT;ALKBH3;ASCC3;FTO
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),0.5615177296730715,1.001467983137323,0.4666666666666667,0.8942687254194667,1.0,5/10,32.49%,ASCC2;MGMT;ALKBH3;ASCC3;FTO
prerank,GO_Biological_Process_2021__negative regulation of cytosolic calcium ion concentration (GO:0051481),0.6150063032530578,1.0014437711454705,0.5,0.8938166009019648,1.0,1/6,3.99%,SLC8A1
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.44433868411752475,-1.0013850367000114,0.463768115942029,1.0,1.0,25/61,25.59%,HCK;WNT5A;ALOX5;IRF1;PTGES;LRRC19;ALOX15;ANXA1;LACC1;GRN;SPATA2;ERAP1;CASP8;ACE2;DHX58;PIK3AP1;BST1;SEMA7A;TMSB4X;IL1R1;TKFC;TNFSF4;USP18;PARK7;UFL1
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),-0.6348606523571612,-1.001198214828399,0.5161290322580645,1.0,1.0,3/7,17.85%,COL1A1;COL4A6;OTOL1
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),-0.4446793767148085,-1.00105925944237,0.43661971830985913,1.0,1.0,5/43,9.40%,FOXM1;CYP1B1;PINK1;EIF6;STK17A
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.42031925254490105,1.0009619941039196,0.4166666666666667,0.894246101933423,1.0,6/31,15.02%,CD151;LAMA3;PLEC;ITGB4;DST;BCR
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.6242134860524734,1.000333958657109,0.5263157894736842,0.8953354865202828,1.0,3/5,37.05%,PGAP1;PIGU;PIGK
prerank,GO_Biological_Process_2021__protein localization to nucleolus (GO:1902570),0.656546214385281,1.000262361568335,0.5434782608695652,0.8949293714877686,1.0,1/6,7.64%,NOL8
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.5311862690373808,1.0001637644695813,0.4594594594594595,0.8945970386427438,1.0,1/12,2.88%,RARB
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.30443273921853836,1.0,1.0,0.8944573766921077,1.0,394/1744,18.84%,TEAD2;ERG;SMYD2;POU3F1;ESRRG;FOXO1;PER2;ZNF496;ZNF607;ZSCAN4;ZNF808;SKAP1;TSHZ2;KIT;ZNF408;POU6F2;HDAC3;PKNOX1;ZNF239;ZNF347;MKX;ZNF485;BCL6;ZNF212;ZBTB9;DMRT3;NEUROD2;AASS;ZNF623;MED17;MAFB;MITF;NFATC3;RORA;APOE;ZNF518A;HDAC10;TSHZ3;RARB;POU3F2;GALR3;ZNF692;TWIST2;ZNF561;URI1;ZBTB7B;KLF10;ARX;CDH13;PCGF1;BCL11B;ZNF835;ZNF70;GABPB2;CBFB;PRDM5;HEXIM2;CCN1;TGIF1;GATAD2A;AUTS2;ZNF263;ZNF99;RIPK2;PID1;ZNF33B;E2F6;ZNF701;SMARCD3;FRK;ATXN1;PPARG;CREB3L2;FZD5;TET2;ATOH7;SIRT1;ZNF860;IFI16;ERBB2;MAML1;ZFHX4;CREB3L4;PAX3;RORB;ZEB2;BACH2;SOX12;LHX2;SSBP3;ARID3B;SERPINE1;JAG1;ZNF641;ELP4;PKD2;CRY1;SNCA;ZBTB20;PER3;SIRT7;HIC2;HES1;GFI1B;PTOV1;KCNIP3;BCL11A;ZNF780B;ZNF534;TOX;ZFP3;PROX1;ZNF470;STAT5B;ZBTB40;ZBTB4;CRK;HMGB1;BHLHA9;SMARCAL1;ATF3;TPRX1;DLX1;FOXP2;NCOA3;MIER2;HIVEP2;NCOA2;SAFB2;OSR1;ZBTB1;IKZF4;KDM7A;SMARCB1;MED25;PCGF5;ETV1;ZNF274;GREM1;ZNF786;NRIP1;CDK4;ABL1;WWOX;SP1;RBL1;WWP2;MYC;MGA;NKAP;ZNF251;ZNF462;ZNF215;TAF3;FSTL3;BCLAF3;CTDSP1;TCF20;NR4A2;ZNF33A;TGFA;ZNF688;LRP6;ZSCAN12;SLTM;RFX1;ZEB1;FOXD4L5;HIF3A;SENP1;ZNF202;ZSCAN21;WNT3A;HDX;RFX7;TWIST1;SNAI2;HIVEP3;SPEN;HCLS1;MOV10;ZNF845;SRCAP;ZNF133;LCORL;TFE3;FHL2;ATF1;ZNF2;GRIN1;MAMLD1;PLAGL1;ZNF599;ARID1A;CTBP2;CREM;RNF10;RPS6KA3;ZNF852;NPAS4;ZNF569;ELOA;ZNF514;NAMPT;RRP1B;EBF4;NPAS3;BATF2;MSC;KDM2A;ZNF777;ZNF652;SP7;BPTF;ZNF75A;HES6;ZNF782;PPM1A;CITED4;DACH1;ZFP82;TNRC6C;DPF1;MYT1L;ZNF761;CCNH;NSD1;DMTF1;BRD3;SMARCA2;ZNF41;ZNF300;KDM3B;ZNF846;MLXIPL;SMARCA4;ZNF771;ZNF594;USP16;BCL9L;TIAL1;SAP130;EPC2;ZNF337;KAT6A;ZNF155;JUNB;ZNF704;NFIB;TEAD4;ZNF311;FADD;PLSCR1;DPF2;ZNF276;NR3C2;MXI1;ZNF384;HDAC1;GATAD2B;ASCL1;CHD4;ZXDC;MED16;FOXF2;ARRB1;CDK8;SMAD2;NR2F2;RPS6KA4;RLF;PLK3;NFYC;ZNF774;NR3C1;NFKB1;NCOA5;PPARGC1B;NFAT5;BCOR;SOX5;ASXL3;ZNF611;CUX1;WWTR1;SCRT1;TFCP2;MECP2;OTUD7B;THRB;ZNF438;HDAC4;ZNF69;RFX6;ZFP62;NFIC;CXXC5;ETV5;MEN1;ZNF131;HSF1;ZNF48;NR1H3;HJV;ZNF586;GADD45A;TP53;ZNF165;ZNF609;BAZ1B;HSF4;GABPA;ZFY;RUNX1;NR6A1;ZNF549;TNRC6A;ATAD2B;BAZ2B;NR4A3;FUS;TTC21B;ZFP28;MED13L;ZSCAN31;WWC1;SNF8;ZNF765;GMEB1;ZGLP1;NOTCH1;NCK1;ZBTB2;CHD1;ZNF283;ATM;PBX1;ZNF665;LPIN2;ARID5B;ATN1;ZNF292;KLF12;AGO3;NUFIP1;HIVEP1;GABPB1;BRD4;THAP7;SKI;SP2;ZMYM5;ZFX;FOXJ2;NR2C1;PAX6;IL11;ZHX3;ZNF675;ZNF322;ELF2;ZNF627;ZNF589;ARID1B;TFEB;NIPBL;ZBTB5;NOC2L;SATB2;MACROH2A2;ZNF12;ZBTB41;ZNF613;RBPJ;ZNF142;CAMTA1;SP3;NFX1;UXT;SUPT3H;ATF6;TNIP3;IMPACT;KLF6;NR4A1;ZNF157;SOX13;RFX5;ZNF445;ACVR1;DBX2;ASXL1;SIRT6;EP300
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),-0.4700689187099055,-0.999988095148051,0.4852941176470588,1.0,1.0,5/32,14.38%,TULP1;ROPN1B;ATP6V1D;TULP2;FSIP2
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),-0.5615570813887655,-0.9997247875341115,0.5245901639344263,1.0,1.0,5/12,17.19%,SEMA3A;LAMC2;NTN1;RAC2;RAC1
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.4563509994696352,-0.9993724896273681,0.4696969696969697,1.0,1.0,8/34,25.97%,PINK1;GABARAPL1;GABARAPL2;MAP1LC3B2;FIS1;FUNDC1;BNIP3;ULK1
prerank,GO_Biological_Process_2021__anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971),0.6169528049436839,0.9991947902012422,0.5581395348837209,0.8957331286773839,1.0,1/5,18.08%,KIF3B
prerank,GO_Biological_Process_2021__anterograde dendritic transport (GO:0098937),0.6169528049436839,0.9991947902012422,0.5581395348837209,0.8957331286773839,1.0,1/5,18.08%,KIF3B
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",0.4056514330351964,0.999120623242046,0.34615384615384615,0.8952914461663873,1.0,15/83,12.65%,TBC1D10A;SNX5;STX5;RAB7A;STX6;WASHC2C;GBF1;RHOBTB3;UBE2O;GCC2;GGA1;DENND2A;VPS54;WASHC2A;VTI1A
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.3645600382401707,0.9990153898649484,0.4090909090909091,0.8950238337101094,1.0,8/104,5.32%,SLC5A8;SLC17A6;SLC26A3;SLC26A7;CNGA3;SLC12A1;SLC8A1;SLC8A3
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.5503594395132176,0.99895797123902,0.5,0.8946835213807937,1.0,3/11,13.81%,SOX12;PKD2;NF1
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),-0.5973478936032357,-0.9989214001081425,0.4642857142857143,1.0,1.0,3/10,17.25%,HLA-DRB1;CD4;ZFP36L1
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),0.43044987264257933,0.9987561078180575,0.4666666666666667,0.8945443135020402,1.0,16/42,27.15%,TCOF1;PCIF1;TRIM71;NANOS3;GEMIN5;PUM3;RC3H1;GRM5;METTL16;NANOS1;LARP1;EIF4E;MEX3D;ZC3H7B;FOXO3;ATXN2
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),-0.5640412976725175,-0.9983379343127214,0.4444444444444444,1.0,1.0,2/8,19.05%,SMUG1;OGG1
prerank,GO_Biological_Process_2021__fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),-0.6297838092972285,-0.9982072760417086,0.5094339622641509,1.0,1.0,2/5,5.00%,ALDOB;GLYCTK
prerank,GO_Biological_Process_2021__fructose catabolic process (GO:0006001),-0.6297838092972285,-0.9982072760417086,0.5094339622641509,1.0,1.0,2/5,5.00%,ALDOB;GLYCTK
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB phosphorylation (GO:1903721),0.6562010874546834,0.9981959143507098,0.5555555555555556,0.8955448874160624,1.0,1/5,4.29%,CX3CR1
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),0.605836566538468,0.99760316763531,0.5405405405405406,0.8963711368984273,1.0,4/6,22.14%,KDM2A;DACH1;CREB1;SMAD7
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),-0.4354808311163606,-0.9975906069759066,0.5138888888888888,1.0,1.0,6/53,8.63%,TICRR;DTL;CCND1;DONSON;ABRAXAS1;BRCA1
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),0.5000097373126763,0.997584584002866,0.4358974358974359,0.8958851383907611,1.0,4/9,19.79%,BICD1;CEP250;MARK4;UBXN2B
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),0.464364331402003,0.99757350110571,0.4878048780487805,0.8954088261994783,1.0,6/12,27.39%,NAGK;UAP1;GNPNAT1;UAP1L1;NANP;GFPT2
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),-0.4494186386318485,-0.9966246129255173,0.47297297297297297,1.0,1.0,6/45,7.49%,MARVELD2;CTNNA1;CLDN1;CLDN6;CLDN5;CLDN2
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001268),-0.6463339551096935,-0.9965945823736758,0.5434782608695652,1.0,1.0,1/5,2.53%,MMP9
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.31596076550379476,0.9965883383762177,0.4166666666666667,0.897452386502705,1.0,88/362,20.31%,ERG;DGKD;GRK5;TGFBR1;MAPKAPK2;LMTK3;FGFR1;EPHA7;CDK14;DAPK2;CSK;FRK;BCKDK;ERBB2;MAML1;PAK5;CILK1;VRK2;CDK6;SGK1;EIF2AK3;FER;CDK4;ABL1;LATS1;MAST1;MAST2;MAPK8;MAP3K1;TRIB2;SIK3;TNIK;ERN1;MAP3K9;DYRK3;PKN2;CDK18;WNK2;MAP3K21;FASTK;PIM2;SGK2;MAP3K13;RET;PXK;FAM20B;MARK3;CDK11A;CDK8;RPS6KA4;MARK4;RYK;INSR;PIK3CA;BCR;CDK16;TSSK4;MAP4K2;MATK;WNK3;DGKH;NEK1;EPHB2;MARK1;ATM;BRAF;TBCK;PNKP;LIMK1;SIK2;MORC3;ADAM10;ACVR1;CLK2;PPP4R1;CREB1;CDK5;PDK1;DGKZ;PRKAA2;NIM1K;PAK3;XYLB;PRKAG2;PAK2;MARK2;PRKCE;ACVR2A
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.4136629841453515,-0.996586274241434,0.49295774647887325,1.0,1.0,12/67,16.67%,EOLA1;WNT5A;NLRP12;SCIMP;CYBA;TLR2;NLRC3;C1QTNF4;NOS2;AFAP1L2;F2RL1;GHRL
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.4674466490811446,-0.9965552608231695,0.49206349206349204,1.0,1.0,6/30,17.55%,ARG2;NLRC3;NR1H4;GHRL;VSIR;CACTIN
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.40704536961162574,0.996511903644156,0.40625,0.8971574935850904,1.0,10/35,15.67%,RAB27A;APOE;WNT4;ZBTB20;F2;GRIN1;F2R;MLXIPL;SUCO;RUNX1
prerank,GO_Biological_Process_2021__negative regulation of fibrinolysis (GO:0051918),0.6159804518672033,0.9964378670614928,0.4864864864864865,0.8968175355510573,1.0,3/7,7.30%,APOH;SERPINE1;F2
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.3968317237689294,0.9963839171960297,0.45161290322580644,0.896423515162773,1.0,13/47,13.81%,FGF10;TGFBR1;WNT4;PKD2;NRG1;HES1;PRKCSH;PROX1;ZBTB1;COBL;FADD;ARHGAP35;NF1
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),-0.5178943719178722,-0.996328554988089,0.4927536231884058,1.0,1.0,5/16,19.66%,ATP1A4;ATP6AP1;LACC1;ATP4A;ATP1A1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.3741019342655253,0.9961703906830849,0.47368421052631576,0.8963928914784319,1.0,17/80,16.19%,RASSF2;DUSP15;CCN2;MID1;TNFRSF19;SH3RF1;HMGB1;CARD9;SH3RF3;PLCB1;MAP3K10;GDF6;KLHDC10;MFHAS1;GADD45A;MAP4K2;RELL1
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),-0.4400875871410887,-0.9959778726866981,0.4266666666666667,1.0,1.0,10/40,19.50%,SCN5A;ACTC1;CSRP3;ZFPM1;HEY2;TTN;GATA4;AKAP13;MESP1;SGCG
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),-0.5555862147327124,-0.9956277765079259,0.5522388059701493,1.0,1.0,4/14,20.41%,IRF4;NLRP3;ZP3;CD86
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.5415805506154054,0.9954621881031519,0.5294117647058824,0.8977949899214067,1.0,4/12,23.79%,ADIPOR1;PIBF1;BCL3;NF2
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),0.3939285506038435,0.995395752927474,0.2413793103448276,0.8974645276482766,1.0,15/62,20.81%,CPSF1;PCF11;TENT4A;U2AF1;SRRM1;LIN28B;CPSF7;SRSF4;PNPT1;PAPOLA;RPRD2;EIF4A3;U2AF2;SYMPK;TUT7
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.5085216948480158,0.9952229052546541,0.47058823529411764,0.8974423913427191,1.0,4/13,10.67%,IRS1;SIRT1;AKT2;IRS2
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),0.44095049490275806,0.9951756744838317,0.3870967741935484,0.8970401261368598,1.0,7/19,22.04%,BRCC3;USP36;USP16;USP51;SUPT3H;USP15;ATXN7
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),0.46868213164124684,0.9950270166335283,0.5135135135135135,0.896864490395966,1.0,5/17,22.57%,DAPK2;MCU;MOSPD2;ADAM8;THBS4
prerank,GO_Biological_Process_2021__somite development (GO:0061053),-0.5788206665011152,-0.9949407316642095,0.5714285714285714,1.0,1.0,1/9,6.15%,PPP2R3A
prerank,GO_Biological_Process_2021__regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),-0.6458310808324729,-0.9946955719135914,0.4918032786885246,1.0,1.0,3/5,28.29%,CALM1;CALM3;RACK1
prerank,GO_Biological_Process_2021__alditol phosphate metabolic process (GO:0052646),0.6794214304151376,0.9945679727907373,0.5869565217391305,0.8975479106123311,1.0,1/5,12.29%,GPD1
prerank,GO_Biological_Process_2021__stress granule disassembly (GO:0035617),0.5900429784335202,0.9944217939892904,0.5151515151515151,0.8974625319065377,1.0,1/5,9.86%,DYRK3
prerank,MSigDB_Hallmark_2020__Angiogenesis,0.43991276613381464,0.9943793711226905,0.5,0.8969709203499686,1.0,6/27,9.91%,VCAN;APOH;FGFR1;JAG1;TIMP1;LPL
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.35012490003308644,0.9943250032628449,0.38095238095238093,0.8965972119896659,1.0,24/133,9.81%,FGF10;THEM4;TGFBR1;KIT;FGFR1;IRS1;ANGPT1;HIP1;NRG2;SEMA5A;CX3CR1;FGF17;AKR1C3;ERBB2;NRG1;HPSE;MYORG;FGF18;TGFA;CASS4;HCLS1;AKT2;FGFR3;KITLG
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),-0.5818509108253742,-0.994245694446302,0.5362318840579711,1.0,1.0,4/11,26.42%,IFIT1;OAS1;MX1;RNF135
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),-0.563764096785507,-0.9935626688309805,0.46808510638297873,1.0,1.0,5/9,16.86%,HLA-A;HLA-DRB1;NLRC4;NAIP;PGLYRP1
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),0.5180325783925156,0.993249221400025,0.4375,0.8985778772873021,1.0,2/16,2.31%,THEM4;BCL2
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.43824724707114976,0.9930980559684526,0.43902439024390244,0.8984920875654777,1.0,7/22,9.62%,TGFBR1;FGFR1;DSCAML1;SPEF2;WWOX;LRP6;FGFR3
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),0.570215251951818,0.9930177584193773,0.5714285714285714,0.8981541729792346,1.0,6/8,36.03%,SREBF2;ARHGEF10L;ERLIN1;INSIG1;ERLIN2;SCAP
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),0.5203888909229389,0.9927224511144846,0.48717948717948717,0.8982758013412733,1.0,4/12,11.91%,TIMP1;FLNA;PHACTR4;LIMS1
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.3982261625657584,0.9926939520778876,0.48148148148148145,0.8978124551038335,1.0,7/69,7.00%,HDAC3;PRICKLE1;ANGPT1;RIPK2;COMMD1;CRY1;DCUN1D1
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.5112180430304586,0.9926319675659093,0.4318181818181818,0.8973586528177571,1.0,4/15,10.25%,RORA;BCKDK;SIRT1;ADIPOR1
prerank,GO_Biological_Process_2021__L-ornithine transmembrane transport (GO:1903352),-0.6460998869351163,-0.9924734313656307,0.5833333333333334,1.0,1.0,1/5,5.15%,SLC7A3
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),-0.5658209293129897,-0.9917267883094013,0.5084745762711864,1.0,1.0,2/12,7.50%,SEMA3F;SEMA3A
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),0.5093903105391383,0.9916948863067088,0.4444444444444444,0.8991790177199688,1.0,3/16,7.93%,LRRTM3;SP1;CASP3
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),-0.5462511938881627,-0.9915313438543698,0.5806451612903226,1.0,1.0,3/14,14.16%,TBX1;ENG;HEY2
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),0.3763784437973054,0.9913866519139851,0.5,0.8993805788949718,1.0,7/68,8.73%,ATP6V0D2;TCIRG1;KPTN;EIF2AK3;MAPK8;MLST8;RNF152
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),-0.5676112530337287,-0.9912755457897817,0.5142857142857142,1.0,1.0,2/11,3.57%,P2RY12;CXCL13
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.30529382030582564,0.9911687181613793,0.5,0.8993126209390063,1.0,39/247,10.68%,IRGM;SLC26A3;FOXO1;CPEB1;RORA;IRS1;BRINP3;KCNC2;CD14;HTRA2;PID1;TICAM2;DRD5;CX3CR1;AKR1C3;RORB;SERPINE1;PKD2;CAPN2;WNT9A;HCN1;HMGB1;NCOA3;EPHA3;RAPGEF1;ZNF703;FER;NRIP1;MAPK8;SLIT2;ABL2;WNT3A;AANAT;LPL;BRINP1;MTR;PDE4B;AKAP9;ADNP2
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.34199629135083615,0.9908974984095775,0.38095238095238093,0.8995048925552251,1.0,21/112,16.01%,GPRIN3;TTC29;GPRIN1;APOE;NLGN1;CNTNAP2;PKD2;SAMD14;HMGB1;FAM161B;PTPRM;TTC17;RAB35;PPP1R9B;MNS1;MARK4;RYK;CDK16;PPP1R9A;BICDL1;FRY
prerank,GO_Biological_Process_2021__positive regulation of NK T cell activation (GO:0051135),-0.6207064084630802,-0.990855003687583,0.5294117647058824,1.0,1.0,3/5,18.62%,IL12A;IL18;HSPH1
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.4995688292658216,-0.9904385395844606,0.5230769230769231,1.0,1.0,7/26,22.47%,HMGB3;ANXA1;PIF1;DDX1;RECQL4;DDX11;BLM
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.4666557657692188,0.9904178067631524,0.4411764705882353,0.9003783002750542,1.0,7/13,24.81%,DRD4;WNK2;TESC;WNK3;DMD;WNK1;ANK3
prerank,GO_Biological_Process_2021__ventricular compact myocardium morphogenesis (GO:0003223),0.6593048586510951,0.9903213618529529,0.6086956521739131,0.9000948311664101,1.0,2/5,6.95%,TGFBR1;DSP
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.3902347907095123,0.9903144508773721,0.3793103448275862,0.89957887646449,1.0,5/42,11.72%,CTDNEP1;BIN1;CHMP6;IRAG2;USP36
prerank,GO_Biological_Process_2021__positive regulation of triglyceride lipase activity (GO:0061365),0.6592485666745929,0.990143220651979,0.54,0.899049669331166,1.0,1/5,1.08%,APOH
prerank,GO_Biological_Process_2021__positive regulation of lipoprotein lipase activity (GO:0051006),0.6592485666745929,0.990143220651979,0.54,0.899049669331166,1.0,1/5,1.08%,APOH
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),0.5577689232538594,0.9899063761753361,0.42857142857142855,0.8992682299512359,1.0,2/9,4.82%,EGLN3;P3H2
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),0.5629325804214429,0.9897032855748579,0.4857142857142857,0.8992899950906773,1.0,4/9,28.32%,PPCS;PDHA1;DLAT;MLYCD
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.6024323332199661,0.9893617345288686,0.4634146341463415,0.8997045756953846,1.0,1/6,8.52%,TGFA
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.4293109219891149,0.98934221694314,0.5555555555555556,0.899226372997685,1.0,2/27,4.97%,SMYD5;DNMT1
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.44680689495511683,0.9892546970910363,0.5777777777777777,0.8988289941760501,1.0,5/11,27.39%,NAGK;UAP1;GNPNAT1;UAP1L1;GFPT2
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell proliferation (GO:0061469),0.604348866788053,0.9892253031974478,0.5365853658536586,0.8983875225257963,1.0,3/6,23.83%,NR4A3;NR4A1;NR1D1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.380149141498466,-0.9890976162710584,0.475,1.0,1.0,22/117,22.47%,MCM2;PSMB9;RPA3;MCM3;CDK2AP1;MCMDC2;POLE2;PSMA3;POLD4;RPS27A;CDC6;PSMA7;PSMB6;RECQL4;HMGA1;ORC6;TOPBP1;POLE3;RPA2;PSMA5;BAZ1A;BLM
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.5227365581420191,-0.9887288496192648,0.5151515151515151,1.0,1.0,7/23,14.43%,OGN;GPER1;SOD2;CDKN1A;APOD;IL12A;TGFB3
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),-0.4779778974684765,-0.9884612545235847,0.4264705882352941,1.0,1.0,2/30,12.07%,KIF14;CDKN1A
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.3677932722652247,0.9882341163529368,0.4482758620689655,0.9004049423551529,1.0,18/85,13.33%,CCN4;CCN2;SLFN11;CCN1;RIPK2;AKR1C3;SNCA;SRGAP2;RRAS2;SARM1;DCC;ACER2;SLC25A24;ACER3;ADNP2;NOA1;HSPA1A;RILPL1
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),-0.4756145632277498,-0.9881620315516515,0.5,1.0,1.0,4/26,19.39%,ALOX5;CYP21A2;HSD3B1;CYP17A1
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),-0.6679806016215499,-0.9881589529321988,0.5614035087719298,1.0,1.0,2/5,18.76%,ATG14;GPS2
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.4147785292542412,0.988158727448491,0.5,0.9000787866361265,1.0,7/34,7.93%,CSTA;AKR1C3;JAG1;USH2A;DSP;LORICRIN;CASP3
prerank,GO_Biological_Process_2021__negative regulation of B cell differentiation (GO:0045578),-0.6707449090563896,-0.9880400376642522,0.5490196078431373,1.0,1.0,4/5,32.18%,INHA;SFRP1;INHBA;CR1
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),0.5355164217135162,0.9880049309440082,0.47368421052631576,0.9000110179327233,1.0,3/10,9.70%,KIT;MITF;LRMDA
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.5201867745519617,-0.9880039132871994,0.5238095238095238,1.0,1.0,5/18,9.30%,PSMB9;AIM2;NLRP12;BEX3;USP50
prerank,GO_Biological_Process_2021__positive regulation of macrophage proliferation (GO:0120041),-0.671637543582969,-0.9878445735066227,0.6226415094339622,1.0,1.0,2/5,30.71%,CSF1R;MAPK3
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),0.560996509627478,0.987826470345613,0.5,0.8998455236208961,1.0,5/12,25.76%,PKD2;MYC;BMP4;BMP2;SHH
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.5753722829992121,-0.9877818753369325,0.5362318840579711,1.0,1.0,4/14,26.06%,COPS5;HSPA5;UFL1;DDRGK1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),0.38246456027388354,0.9877413031975615,0.36363636363636365,0.8995025007342194,1.0,16/67,15.21%,GMNC;SCRIB;BRINP3;HTRA2;HEXIM2;TRIM35;PPP1R13B;CDK6;LATS1;SIPA1;BRINP1;NLRP2B;HECA;NR2F2;RPS6KA2;MEN1
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.3864400064484195,0.9873587582746551,0.4117647058823529,0.900065737515758,1.0,16/78,15.72%,ELOVL6;HDAC3;RORA;SMARCD3;PPARG;NCOA2;ACACB;SP1;ADIPOR1;IRS2;SC5D;CHD9;CARM1;NFYC;TM7SF2;OPA3
prerank,PanglaoDB_Augmented_2021__Pericytes,-0.3903777929156519,-0.9873172759049867,0.5128205128205128,1.0,1.0,24/124,14.86%,C1QTNF1;LMOD1;TIMP3;ECM2;ANGPTL2;ANGPT2;COL1A1;PDE5A;VTN;ADAM33;DAAM2;DCN;ASPN;P2RY14;GPIHBP1;ATP13A5;STEAP4;HSD11B1;MFGE8;COX7A1;TEK;C1S;ACTA2;ADGRF5
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),-0.4606506549662593,-0.9872988587082097,0.4461538461538462,1.0,1.0,6/31,13.30%,RIN3;LRPAP1;PINK1;BRCA1;PTX3;EDNRB
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.3618143216203525,0.9871516260770172,0.43478260869565216,0.9000513901733906,1.0,21/96,14.12%,NGF;EGLN3;CFLAR;HIP1;HTRA2;PPARG;SIRT1;SNCA;HMGB1;ACER2;CARD9;EIF2AK3;MYC;SENP1;ANP32B;F2R;LGALS9;FADD;CRADD;CASP8AP2;BID
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.42011845713558776,-0.9871241084200749,0.46153846153846156,1.0,1.0,19/56,29.05%,PSMB9;FBXL7;RBX1;PSMA3;PSMA7;PSMB6;RFPL1;PSMA5;AURKA;PSMD6;CHEK1;SKP1;PSMC5;PSMB4;PSMB7;PSMD8;GPR132;VPS4A;PSMD3
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.6160899364642909,0.9870368334158273,0.5116279069767442,0.8996911099414603,1.0,3/6,31.78%,ARFIP1;ATP9A;EIPR1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.4561472572898326,-0.9869692430926903,0.4857142857142857,1.0,1.0,6/26,24.92%,RPA3;RBX1;RPS27A;RPA2;DDB1;CDK7
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle recycling (GO:1903421),0.6705787880468782,0.9866665574434673,0.5806451612903226,0.9000050154418703,1.0,3/5,27.48%,SNCA;CDK5;ROCK1
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.4257640450089226,-0.9866629812444201,0.4931506849315068,1.0,1.0,15/52,18.85%,ITGB2;IFNK;GPR151;CYBA;HLA-DRB1;PTPRC;ITGAM;NLRP3;SH2D1B;ZP3;GRN;F2RL1;IFI35;CD81;SASH3
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),-0.5528968619195198,-0.98643711519428,0.5423728813559322,1.0,1.0,1/10,2.49%,RIN3
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.47076101354651767,-0.9863873746938332,0.5068493150684932,1.0,1.0,2/32,6.25%,TGFB1;BACE2
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.4641160520833013,-0.9862264853966063,0.56,1.0,1.0,4/29,12.99%,CD160;CEACAM1;GBP1;TESPA1
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),0.443016871846697,0.9862240091971354,0.45652173913043476,0.90063751592827,1.0,3/22,11.41%,PHLDB2;CGNL1;WASF2
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.4889367797894796,0.9861641042582449,0.4,0.9002332513594586,1.0,6/24,19.29%,FGF10;GREM1;RSPO2;ZNRF3;PTCH1;KAT2B
prerank,GO_Biological_Process_2021__regulation of dopamine metabolic process (GO:0042053),-0.5993931542413975,-0.9859569862887841,0.5084745762711864,1.0,1.0,2/6,11.77%,ITGB2;ITGAM
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),-0.44167913421296506,-0.9858272708815125,0.4927536231884058,1.0,1.0,6/33,6.30%,AHR;BLK;VAV3;CLCF1;GPR183;IL7
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.5128698893149912,0.9856007938160859,0.5151515151515151,0.9014401075810933,1.0,2/18,4.88%,PLD6;GDAP1
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.5480313613764553,-0.9855051432640173,0.5074626865671642,1.0,1.0,1/10,5.54%,CNMD
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.5076677568046973,0.9852273102914532,0.5714285714285714,0.9017434083823203,1.0,3/13,14.95%,SLC8A1;GSTM2;PIK3CA
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),0.610080921212053,0.9851007888382477,0.5555555555555556,0.9016220654533921,1.0,3/7,15.23%,SLC30A10;NFKB1;CA2
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),-0.6049643779898145,-0.9845182830698201,0.47692307692307695,1.0,1.0,2/6,7.99%,WAS;NEB
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),-0.615857363656498,-0.9844676332851827,0.5818181818181818,1.0,1.0,2/9,15.16%,IRF4;IL18
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.4213999301777541,0.9842934618929793,0.5161290322580645,0.9031970257683887,1.0,10/24,24.95%,NLGN1;RALA;TENM1;FSCN1;MIEN1;DOCK11;PLPPR5;PALM;GPM6A;TENM2
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),0.5730369707565811,0.9841763461589438,0.4418604651162791,0.9031102907201216,1.0,3/8,22.36%,LGALS9;TP53;ADAM8
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),-0.5417701974700788,-0.9835597783713982,0.532258064516129,1.0,1.0,4/15,17.87%,F7;ZNF580;F2RL1;MTUS1
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.3532356882138436,0.9831882237548522,0.41379310344827586,0.9050443179729051,1.0,9/82,10.27%,MCOLN3;TRPC3;TRPM2;SLC8A1;SLC8A3;PKD2;MICU1;GRIN1;MCU
prerank,GO_Biological_Process_2021__depurination (GO:0045007),-0.5838189047366734,-0.9830731335368578,0.4642857142857143,1.0,1.0,1/8,2.96%,TERF2IP
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),-0.5785254414851042,-0.9826653392996609,0.5245901639344263,1.0,1.0,5/7,27.75%,ZFPM1;GATA4;HEY1;DCHS1;OLFM1
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),-0.6271715963802528,-0.9822218206996647,0.475,1.0,1.0,2/6,16.96%,RNF26;HOOK2
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),0.5086126121452703,0.9822203383228291,0.5,0.9071524597016154,1.0,4/13,6.16%,APOH;APOE;SERPINE1;HS3ST5
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.5099989133789611,-0.9822096338532649,0.546875,1.0,1.0,5/16,18.22%,HCK;BAIAP2L1;TEK;BAIAP2L2;NTRK3
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle cell differentiation (GO:2000726),0.6468250461592895,0.9821327608624257,0.6326530612244898,0.9068344153262795,1.0,4/5,34.50%,FZD7;BMP2;FRS2;SMAD4
prerank,GO_Biological_Process_2021__monoacylglycerol biosynthetic process (GO:0006640),-0.6135416438276188,-0.9819584304106443,0.4838709677419355,1.0,1.0,2/6,17.74%,DGAT2L6;PLA2G4A
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),-0.4488066320022993,-0.9819383549315196,0.42857142857142855,1.0,1.0,10/57,15.12%,AQP3;ZACN;TRPV6;HAMP;THBS1;HVCN1;HAAO;NDRG1;TTN;ITPR3
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),-0.48851100816270676,-0.981783416519995,0.53125,1.0,1.0,3/22,4.08%,MYBPH;NMUR2;MYBPC3
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),-0.5960483077899994,-0.9816770183784769,0.6037735849056604,1.0,1.0,1/8,4.80%,DYDC2
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.5334191364340661,-0.9814163864631072,0.48484848484848486,1.0,1.0,2/14,3.57%,P2RY12;CXCL13
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),-0.4790388171227387,-0.9813520760353223,0.49230769230769234,1.0,1.0,8/24,24.55%,HSPA1L;HSPA8;HSPE1;SDF2L1;DNAJB1;HSPA5;HSPA2;HSPA13
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),0.42788459245484106,0.9812014556227854,0.45161290322580644,0.9088157351139656,1.0,14/25,35.89%,ESPL1;NSMCE2;ANAPC7;CDK5RAP2;USP44;PLK1;ANAPC4;RB1;HECW2;DLGAP5;CDC16;ANAPC15;ANAPC11;CENPE
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.46854210611339986,-0.9811388756665638,0.5,1.0,1.0,8/21,23.57%,PDE6B;GRK7;PDE6A;CALM1;GUCY2F;NMT1;PDE6G;CNGB1
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),0.4544787596197922,0.9808769008230486,0.475,0.9090781073779323,1.0,4/16,13.08%,SRR;CBS;PSPH;THNSL2
prerank,GO_Biological_Process_2021__heart development (GO:0007507),-0.3916313884579959,-0.9807926178459194,0.5066666666666667,1.0,1.0,25/120,19.91%,TBX1;PKP2;TGFB1;MYH7;MMP21;MYBPC3;CSRP3;ZFPM1;GPC3;HTR2B;HEG1;POPDC2;ALPK2;CDKN1A;TEK;GATA4;AKAP13;MESP1;NTRK3;LDB3;MESP2;CASP8;DAND5;SGCG;FN1
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),-0.5332011791111002,-0.9807023966446392,0.46875,1.0,1.0,4/14,14.82%,SCN5A;ENG;HEY2;GATA4
prerank,GO_Biological_Process_2021__antifungal innate immune response (GO:0061760),0.6622040530520268,0.9806843097838599,0.5660377358490566,0.9089882483953295,1.0,2/5,7.29%,CX3CR1;CARD9
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.36879734384063,-0.9799451756167076,0.5393258426966292,1.0,1.0,38/251,12.60%,CD44;TGFB1;ECM2;ITGB2;MMP9;MMP21;CYP1B1;MMP19;SCUBE3;TGFBI;COL18A1;NID1;COL1A1;COL5A1;P4HA3;COL27A1;LOX;VTN;DCN;ICAM3;COL4A4;ITGA9;COL4A3;PLG;LOXL4;THBS1;MATN4;VWF;ITGA2B;PXDN;MMP25;LAMC2;FBN2;ITGAM;ITGB6;MARCOL;COL23A1;VIT
prerank,GO_Biological_Process_2021__regulation of glomerular filtration (GO:0003093),0.6247669431141043,0.9799375947839584,0.5454545454545454,0.9100943437351235,1.0,2/6,10.74%,PTPRO;F2R
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),0.37621000487318923,0.9797807201817016,0.4666666666666667,0.9099161188985987,1.0,15/71,22.28%,AUP1;DERL3;UBE2J1;MAN1A1;FBXO27;RHBDD2;TMUB2;RNF185;UBE4B;EDEM1;TMEM67;UBXN4;UBE2J2;BAG6;FBXO17
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.5683210015062068,0.9797183796824885,0.4782608695652174,0.9094921835312205,1.0,2/7,2.68%,RORA;NLGN1
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.43440262161706256,-0.9794544126704025,0.4153846153846154,1.0,1.0,9/32,18.30%,LRPAP1;VTN;CLU;PPT1;PIK3CB;RSPO1;PROM2;RAC1;LDLRAP1
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),0.4319133662384605,0.9792299391402068,0.53125,0.910016730066235,1.0,6/27,9.97%,LHFPL2;KIT;WNT4;AKR1C3;KITLG;MAMLD1
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),0.4869971538659386,0.9789793076642189,0.5121951219512195,0.9101809914359269,1.0,4/15,8.91%,WNT4;OSR1;PLCB1;WNT3A
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),-0.5053265198709047,-0.9786890804973176,0.5,1.0,1.0,3/18,7.85%,SLC5A2;SLC5A1;SLC5A9
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3511654599609189,0.9783916929710859,0.3611111111111111,0.911072762928746,1.0,19/76,16.30%,NLGN1;AUTS2;DEF8;CEP120;PLEKHM1;RALA;TENM1;CROCC;WASF2;AVIL;EPS8L2;EPS8;CCDC88A;ARHGAP35;MARK4;PIK3CA;FSCN1;MIEN1;DOCK11
prerank,MSigDB_Hallmark_2020__Allograft Rejection,-0.3943039569142194,-0.9783257135628436,0.525,1.0,1.0,29/137,15.83%,TGFB1;ITGB2;IRF4;MMP9;CXCL13;HLA-DMA;STAT1;IL7;HLA-A;WAS;LY86;BRCA1;CCND2;IGSF6;PTPRC;SPI1;WARS1;TLR2;CARTPT;NLRP3;RPS9;NOS2;IL12A;GCNT1;CD80;IFNGR2;IL18;CD4;ELANE
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.44065437942626706,0.9780394644452783,0.43333333333333335,0.9113588942174762,1.0,7/25,11.28%,GPC4;SDC4;GPC6;HPSE;GPC5;SDC3;GLB1
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.45137945015050995,0.9779545395042614,0.5142857142857142,0.9111104976777145,1.0,13/34,26.35%,NOX4;TGFA;CASS4;LRP8;SRCIN1;GRM5;NTRK2;ACE;ERBB3;GAS6;DLG3;BTC;DOCK3
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),0.3789256277646506,0.9779539334172306,0.42424242424242425,0.9105823176790607,1.0,12/67,13.07%,PHLDB2;TGFBR1;CCN2;SORBS3;ASAP3;CGNL1;ABL1;ALMS1;WASF2;EVL;PXN;CCDC88A
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.5886286273824944,-0.9777373597795178,0.56,1.0,1.0,3/8,24.21%,STK17A;BTG1;SFRP1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),-0.5949829700656819,-0.9776505851395249,0.5357142857142857,1.0,1.0,2/10,6.40%,CASQ2;TRDN
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),-0.5579501368595257,-0.9776169975803395,0.4642857142857143,1.0,1.0,2/11,17.52%,DAB2;MSN
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),0.41369525895539067,0.9775765690928894,0.4473684210526316,0.9108682357878275,1.0,7/24,10.85%,APOH;APOE;SERPINE1;HPSE;F2;F2R;F12
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.33113150078677644,0.9775384140176339,0.47058823529411764,0.9104282287136287,1.0,46/317,14.00%,ATP6V0D2;TBC1D10A;TCIRG1;APOB;APOE;RAB31;TBC1D16;TICAM2;REP15;PPARG;STX5;BLZF1;TBC1D12;RAB28;RAB20;SCFD2;RAB7A;STX6;TOM1;GOLGA4;OLFM2;SCAMP4;STX8;ABCA1;SYNDIG1;GCC2;GGA1;CEP290;TMED3;RPGR;TBC1D22B;EVI5L;RAB3C;TVP23B;MACF1;TBC1D4;ACD;ARL5A;PREB;SNX9;COG7;IL10RA;RAB10;LTBP2;LRP1B;WLS
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.3251627908727784,0.9769038033761922,0.47619047619047616,0.9114565533103827,1.0,28/129,16.89%,GPRIN3;RP1L1;GPRIN1;APOE;NLGN1;POU3F2;CNTNAP2;SAMD14;HMGB1;ETV1;TENM3;TENM1;PTPRM;RAB35;UGDH;MYT1L;PPP1R9B;ASCL1;RYK;CDK16;SRRM4;PPP1R9A;RUNX1;BICDL1;FRY;ARL3;NEDD4;PBX1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),0.49327287066627834,0.9768967828470049,0.5714285714285714,0.9109555910502807,1.0,5/12,11.02%,SPRED3;OSR1;ZEB1;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.45133073917414435,0.9765854626703069,0.46153846153846156,0.9111708168118088,1.0,4/18,19.00%,CDH13;FARP2;EPS8;ELMO1
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.29518828934965524,0.9764225745685445,0.5555555555555556,0.9110630837515491,1.0,115/446,20.31%,ERG;GRK5;TGFBR1;KIT;MAPKAPK2;LMTK3;FGFR1;SBK1;CDK14;DAPK2;CSK;FRK;BCKDK;ERBB2;MAML1;CRY1;PAK5;CILK1;VRK2;EPHA3;CDK6;SGK1;EIF2AK3;FER;CDK4;ABL1;LATS1;MAST1;MAST2;MAPK8;MAP3K1;TRIB2;SIK3;ABL2;MAP3K10;TNIK;AKT2;ERN1;FGFR3;MAP3K9;DYRK3;PKN2;CDK18;RPS6KA3;STK32C;WNK2;ABI3;MAP3K21;FASTK;PIM2;SGK2;CCNH;CAMK1G;MAP3K13;TYRO3;GDF6;RET;PXK;EFEMP1;FAM20B;MARK3;CDK11A;CDK8;SMAD2;RPS6KA4;FLT3;EEF2K;RPS6KA2;MARK4;RYK;RPS6KA6;INSR;BCR;CDK16;TSSK4;MYO3A;BAZ1B;CLSPN;MAP4K2;MAPK12;MATK;WNK3;SLK;NEK1;SMG1;EPHB2;MARK1;ATM;CSNK1G1;BRAF;MAST4;TBCK;LIMK1;SIK2;ATR;MORC3;ADAM10;ERC1;ACVR1;CLK2;PPP4R1;PNCK;CREB1;CDK5;PDK1;PRKAA2;NIM1K;MAP2K6;PAK3;USP15;PRKAG2;PAK2;MARK2;PRKCE;ACVR2A
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.46020534671703284,-0.9763968538240834,0.484375,1.0,1.0,2/24,14.50%,B3GNT5;GCNT1
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),0.38336907324617375,0.9763654578445358,0.4230769230769231,0.910693969288392,1.0,12/60,14.18%,SKAP1;UTRN;CDH13;JAG1;EPHA3;ACER2;CDK6;EFNA5;MACF1;NF1;NEXMIF;ADAM15
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.33703589545811835,0.9762933274518526,0.5789473684210527,0.91035141629928,1.0,28/173,9.81%,FGF10;THEM4;TGFBR1;KIT;FGFR1;IRS1;ANGPT1;HIP1;NRG2;SEMA5A;CX3CR1;FGF17;SIRT1;AKR1C3;ERBB2;ARRB2;NRG1;MAGI2;HPSE;MYORG;FGF18;TGFA;CASS4;HCLS1;GRM2;AKT2;FGFR3;KITLG
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),-0.5873173935102014,-0.9761248605320603,0.4897959183673469,1.0,1.0,2/8,20.84%,GRN;AGER
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),0.42400355713896054,0.975943024072772,0.40625,0.9108538186082346,1.0,7/40,9.91%,APOH;LIPC;APOB;APOE;SIRT1;PNPLA3;LPL
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.40442742250049657,-0.9758166227309051,0.5,1.0,1.0,15/67,14.90%,AMBP;PKP2;FOXM1;SMLR1;CLDN1;CLDN2;MYO5B;HNF1A;SOWAHB;FOXA3;BAIAP2L1;FGL1;NR1H4;TOM1L1;FGFR4
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.4260390405573174,0.9755878174874836,0.45714285714285713,0.9110945881445339,1.0,4/23,12.82%,CTC1;TERF1;GNL3L;ACD
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.5020087520903258,-0.9754790389501958,0.4857142857142857,1.0,1.0,3/18,10.00%,CD160;CEACAM1;GBP1
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.4199812307670103,-0.9754431195131075,0.5138888888888888,1.0,1.0,11/49,15.80%,SIRPG;DOCK8;PDCD1LG2;IL7;HLA-A;HLA-DPB1;ANXA1;PTPRC;HLA-DPA1;CD80;ZP3
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),0.46623019429928086,0.9753154749389016,0.525,0.9112481125438987,1.0,5/20,15.27%,MT1G;AKR1C3;MAPK8;MT4;HSF1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),0.4674042253959127,0.9752595450105683,0.42424242424242425,0.9108451869903931,1.0,6/18,18.88%,DDAH2;PKD2;TMEM106A;DDAH1;INSR;AGXT2
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),0.5918768260357359,0.9752202386682287,0.6341463414634146,0.9104253515677148,1.0,2/6,25.82%,MYO1C;JCAD
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),0.4036323425972058,0.975040538270911,0.41379310344827586,0.9104574511466501,1.0,6/29,8.63%,CYP7B1;OSBPL3;OSBPL6;AKR1C1;SLC27A2;OSBPL7
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),0.43735130896480595,0.9748650208698644,0.5,0.910437453133433,1.0,7/24,12.05%,MEGF10;XKR7;RHOBTB1;HMGB1;XKR6;XKR4;TYRO3
prerank,MSigDB_Hallmark_2020__DNA Repair,0.3255059578891291,0.9747477560339322,0.4375,0.9102180267188027,1.0,32/140,22.29%,PNP;AK3;ERCC8;POLD3;DUT;RALA;HCLS1;TAF12;AAAS;PDE4B;ELOA;REV3L;NT5C3A;DGCR8;SAC3D1;BCAM;TP53;HPRT1;RAD52;GTF3C5;ERCC3;ADCY6;NFX1;APRT;TARBP2;NME3;SEC61A1;RRM2B;SMAD5;POLB;POLR2F;TSG101
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),-0.46891899088290123,-0.9745495793882101,0.5138888888888888,1.0,1.0,6/29,21.60%,RAB6D;RAB6B;GABARAPL2;RAB6C;TRAPPC3L;COG8
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.5700035536041541,-0.9743476910350344,0.5245901639344263,1.0,1.0,3/8,21.61%,SLIRP;PHAX;ZCCHC17
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.3464127385685575,0.9739153365313568,0.5142857142857142,0.9117235495716186,1.0,16/76,13.10%,MRAP2;GRK5;FRMPD1;KLK14;RGS16;TULP3;CRY1;KCTD8;RGS11;RGS14;PLCB1;RPGRIP1L;CAMKMT;PPP1R9B;FNTA;SAG
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.39365966240684747,-0.9738859524852006,0.4810126582278481,1.0,1.0,13/68,14.77%,SLC22A24;AMACR;CYP26B1;CYP1B1;CYP3A5;CYP24A1;CYP2A6;CYP3A4;CYP21A2;LRP2;HSD11B1;VDR;CYP2E1
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),-0.47544723449260984,-0.9738210982065434,0.578125,1.0,1.0,3/24,6.27%,FGF20;SYT10;SYT2
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.5628598351998502,0.9737385481924159,0.5217391304347826,0.9116335648003392,1.0,4/7,27.01%,TP53;PTGIS;FAP;DLC1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),-0.5069174519049365,-0.9733338812765657,0.4393939393939394,1.0,1.0,3/16,12.51%,CTNNA1;LATS2;APOD
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),0.426324414614118,0.9731790801166171,0.30434782608695654,0.9126950485024191,1.0,8/39,12.82%,SLC38A5;SLC19A1;SLC7A9;SLC16A7;SLC7A11;SLC7A6;SLC7A8;ABCC1
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.5331261377939585,0.9730529873981281,0.5135135135135135,0.9119954574242866,1.0,2/9,14.18%,NFATC3;NFAT5
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.5331261377939585,0.9730529873981281,0.5135135135135135,0.9119954574242866,1.0,2/9,14.18%,NFATC3;NFAT5
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),-0.6042221691015183,-0.9730210859316929,0.5970149253731343,1.0,1.0,3/8,23.39%,SCIN;TMSB10;TMSB4X
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),-0.5038066600409568,-0.9729763096491423,0.582089552238806,1.0,1.0,1/22,0.34%,LILRB3
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.5077832179793192,0.9728948951761248,0.5428571428571428,0.9119228070748514,1.0,3/12,14.95%,SLC8A1;GSTM2;PIK3CA
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),0.4889758321563203,0.9728202757202997,0.42857142857142855,0.9116084018332474,1.0,1/10,5.26%,TIMM29
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.34431324573471334,0.9726687371640245,0.4482758620689655,0.9116051129310432,1.0,27/109,15.10%,SLITRK6;EDIL3;ADGRL2;PARVA;ALDH7A1;IL17RD;GPC6;PCDH7;ASAP3;SLIT2;EDNRA;TENM3;EFS;PDZRN3;DENND2A;CAP2;COL16A1;CHST3;MPDZ;SDC3;RBFOX2;FARP1;MAGI1;ANK2;PRICKLE2;CDH11;ANTXR1
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.5128234547568427,-0.9726199208502223,0.4915254237288136,1.0,1.0,4/17,20.83%,USP17L2;NOP53;DHX58;DDX60
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),0.4635325707091551,0.9725437763266966,0.5,0.9114034021630775,1.0,8/24,19.93%,PLEKHG2;LATS1;HCLS1;COTL1;ARHGAP35;FCHSD2;GBA2;PAK3
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),-0.6298713435317389,-0.9725338469394728,0.5357142857142857,1.0,1.0,1/7,7.99%,SLC24A1
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.31748160512938606,0.9724783905124623,0.3333333333333333,0.9110294763090145,1.0,39/171,15.67%,RSPO3;GRK5;FRMPD1;LLGL1;RORA;RFNG;CBFB;CSK;SEMA5A;SIRT1;DTX1;RGS16;AKR1C3;TULP3;SLC8A3;CRK;KCTD8;RGS11;TIMP1;RGS14;POFUT1;PLCB1;IGFBP4;DOK5;ITGA3;VWA2;SHARPIN;PXN;MDFIC;UBASH3B;PLSCR1;TSPAN12;FRRS1L;ANKRD54;RGS6;WWTR1;NCAM1;BRAP;RUNX1
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),0.5569405890911215,0.9723678711310845,0.5106382978723404,0.9107766202482238,1.0,1/10,2.38%,EIF2S3B
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.3683593003749478,0.9723186797680321,0.5,0.9104293158654767,1.0,17/91,15.97%,GPR3;ESRRG;PER2;ELOVL6;HDAC3;ZBTB7B;ACACB;ALMS1;LEPR;ADIPOR1;ACSL1;ADIPOR2;PPARGC1B;INSR;HSF1;ACHE;PIGA
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),0.5340491688993141,0.9721822326157755,0.40476190476190477,0.910271773084661,1.0,1/10,1.73%,RNLS
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),0.3371965931267417,0.972150684626115,0.4117647058823529,0.9098219206868448,1.0,62/202,21.50%,PCM1;TTC29;IFT88;DZIP1L;PARVA;SCLT1;PKD2;FHDC1;GBF1;CILK1;BBS9;SPAG16;FLNA;CNGA4;FAM161B;TTC17;CEP290;EHD4;RPGR;CEP250;RAB11FIP3;AVIL;MKS1;MNS1;CFAP410;CEP20;TTC36;RILPL1;PIBF1;ARL13B;EXOC7;KIAA0586;RP2;PTPN23;MARK4;CEP41;CEP162;CDC14B;IFT140;NEK1;ARL3;NOTCH1;CFAP70;DCDC2;KIF3B;BBIP1;CFAP221;PDE6D;DZIP1;UNC119B;CFAP43;TMEM67;PTPDC1;EXOC6;TMEM138;WDR19;TTC39C;IQCB1;POC1B;FBF1;KIF27;EXOC4
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.35116862779974145,0.9720424359544068,0.4782608695652174,0.9096735009599042,1.0,24/81,21.10%,TBC1D10A;SCRIB;TBC1D16;TBC1D12;SYDE2;SIPA1;SIPA1L2;RALGAPA2;ARHGAP42;TBC1D22B;EVI5L;TBC1D4;SIPA1L3;BCR;TBC1D8B;SLC27A4;CCDC125;TBC1D2;TBCK;ARHGEF16;TBC1D8;TBC1D26;USP6NL;TBC1D5
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.36345964614915305,0.9719093820223194,0.5142857142857142,0.909499471690482,1.0,24/64,27.57%,HDAC3;EPM2A;SIRT1;DEPTOR;MLST8;TELO2;PIH1D1;DYRK3;PIK3CA;MINAR1;TBCK;PRKAA2;GNA12;NPRL2;RRAGD;SEH1L;PKHD1;HTR6;LAMTOR4;GAS6;LIN28A;GPAT3;TMEM127;C9ORF72
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),-0.5519374321006857,-0.9718306922628015,0.5362318840579711,1.0,1.0,5/13,19.41%,MMP9;HLA-DRB1;CD4;CSF1R;CASP8
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),0.5616893735090157,0.9717379410273266,0.5434782608695652,0.9092998765808694,1.0,4/7,24.85%,PYHIN1;RO60;TPR;GAS6
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.4971971280342154,0.9710761755679934,0.5,0.9102506384013762,1.0,1/15,1.54%,INTS11
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),0.5734144580567605,0.9709498691653031,0.5,0.9101280469510191,1.0,5/11,25.76%,PKD2;MYC;BMP4;BMP2;SHH
prerank,PanglaoDB_Augmented_2021__Thymocytes,-0.431065286436258,-0.9709253305098927,0.5428571428571428,1.0,1.0,16/60,10.28%,SIRPG;GMFG;ITGB2;CYTIP;TBC1D10C;ARHGAP9;TAGAP;TMC8;TSHR;PARVG;CD5;WAS;CD37;TRAF3IP3;MYO1F;PTPRC
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.4942258070460486,0.9706260210495352,0.4666666666666667,0.9105199934306896,1.0,6/14,22.22%,SIRT1;HP1BP3;SMCHD1;PRDM16;BAHD1;SETD7
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.48352591154478475,0.9706131064811345,0.48717948717948717,0.9100118081914355,1.0,5/12,9.94%,CDH13;PPARG;ABCA1;LPL;LDLR
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.4704755188840936,-0.9704247845002065,0.5072463768115942,1.0,1.0,10/26,26.77%,TERF2IP;H1-0;CDKN1A;H1-3;MSH6;BLM;H1-2;RPS3;ZNF93;ZRANB3
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),-0.47670229391488184,-0.9702350025833355,0.5384615384615384,1.0,1.0,6/20,19.28%,PDCD1LG2;HLA-DRB1;NR1H4;VSIR;AXL;INHA
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),0.5325491518259166,0.9702257605941865,0.5526315789473685,0.9105489569272031,1.0,4/9,21.69%,DHFR;MTR;NREP;RTN4RL2
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.4473727016506566,0.970167598330308,0.45161290322580644,0.910221064798005,1.0,14/31,25.86%,SMYD2;PRDM5;SMYD1;SETMAR;DPY30;MEN1;CXXC1;SUV39H2;DYDC1;KMT2B;WDR5B;EZH2;KMT2A;SMYD3
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.4166757334952156,0.9698790247091666,0.5526315789473685,0.9104238849066912,1.0,11/33,22.88%,IFT88;RALB;TBC1D12;SEC22B;MTMR3;PIP4K2A;RAB5A;LRSAM1;MTM1;NPRL2;ELAPOR1
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.5175486523685592,-0.9698014965845467,0.4461538461538462,1.0,1.0,8/17,26.26%,PWP2;RPS27;RPS14;RPS15;RPSA;RPS28;RPS19;ABT1
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),-0.5358141976434662,-0.9694993563421206,0.5362318840579711,1.0,1.0,5/12,17.19%,FHOD1;ACTG1;WAS;AKAP13;RAC1
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.36755675297340706,0.9689763801205049,0.5217391304347826,0.9121225570460079,1.0,21/101,20.93%,RHEBL1;KSR1;RIN2;RALB;DNMT1;RRAS2;RALA;CCDC88A;NF1;BCR;TP53;BRAP;CRKL;ARL3;RIT2;ARHGAP33;RASSF1;ARFIP2;SOS1;PLD2;SHOC2
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.4827937103343687,-0.968962889132092,0.4927536231884058,1.0,1.0,10/26,19.90%,HLA-A;LYG2;TLR2;IL12A;PGLYRP1;LYG1;GBP6;ROMO1;STAB2;DEFB119
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.46285547586229503,0.9688862486091335,0.5128205128205128,0.9118028752609715,1.0,4/19,11.29%,KLRD1;ARRB2;CADM1;LGALS9
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),0.48486485259180057,0.9687920490574939,0.47368421052631576,0.9115347913123364,1.0,3/17,7.75%,AUP1;PLIN5;PNPLA3
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),0.47253085959595476,0.9687632819294965,0.47619047619047616,0.9110792505671359,1.0,1/14,0.67%,DGKD
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),-0.5534458463830094,-0.9686048010622916,0.48148148148148145,1.0,1.0,4/12,15.61%,ALOX5;CLU;WFS1;AQP11
prerank,"GO_Biological_Process_2021__fructose 1,6-bisphosphate metabolic process (GO:0030388)",0.6005336114513793,0.9685862780469912,0.5555555555555556,0.9109910024556469,1.0,2/6,5.03%,FBP2;PFKP
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),-0.5277078461996232,-0.9683236662773287,0.4861111111111111,1.0,1.0,5/13,18.26%,CYP1B1;NQO1;ARG2;NOS2;GCHFR
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.39889130382578686,-0.9681671544486855,0.47435897435897434,1.0,1.0,5/76,5.72%,TBX1;SCN5A;TGFB1;NODAL;FUT2
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),0.5392500105400411,0.9680613239478244,0.4857142857142857,0.9116956699114273,1.0,3/11,10.61%,PC;APOE;PPIB
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.355290925883554,0.9680370837346058,0.42424242424242425,0.9112493296998052,1.0,20/99,14.40%,TGFBR1;ROBO2;URI1;HTRA2;PID1;ERBB2;DCPS;STAT5B;NCOA3;NCOA2;MAPK8;SLIT2;KHSRP;PTPN9;HCLS1;PTPN20;NDOR1;FLT3;NFAT5;PTPN23
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),-0.4421258092726633,-0.9679691871534758,0.4264705882352941,1.0,1.0,8/35,17.67%,ITGB2;WNT5A;CLU;REST;ITGAM;GRN;DDIT4;CDK5R1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.5181684428245346,0.9677111973911493,0.4883720930232558,0.9115954145608473,1.0,5/11,28.03%,ATF3;TP53;ATF6;CREB3L1;CREB3L3
prerank,GO_Biological_Process_2021__adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191),0.572113666328048,0.9674616143415019,0.52,0.91173685758735,1.0,1/7,4.25%,DRD5
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),-0.5614046676955367,-0.9673465761944742,0.5636363636363636,1.0,1.0,1/10,0.22%,NOTUM
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",-0.5992980584290638,-0.9673273506248224,0.5714285714285714,1.0,1.0,2/8,7.32%,IRF1;HLA-A
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.5583080724621042,-0.9673017664637036,0.5909090909090909,1.0,1.0,3/11,22.57%,RAC1;STMN1;MST1
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),0.30699266147635335,0.967218350064363,0.6363636363636364,0.9117845786383239,1.0,48/366,10.78%,IL7R;BAMBI;MEGF10;CCN4;GRK5;FGF10;TGFBR1;TCIRG1;VEGFC;BCL2;FGFR1;IRS1;POU3F2;CDH13;CCN1;PID1;FGF17;SIRT1;AKR1C3;ERBB2;PDGFD;NRG1;HES1;SLC25A33;HPSE;TOX;PROX1;TIMP1;OSR1;ACER2;ZNF703;GREM1;CDK6;FER;CDK4;MYC;FGF18;TGFA;WNT3A;HCLS1;AKT2;FGFR3;KITLG;SAAL1;ACER3;IRS2;F2R;NAMPT
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.4010285426109428,0.9672012038297771,0.4444444444444444,0.911322191832327,1.0,19/66,22.33%,GCK;NUP210;NUP42;ZBTB20;AAAS;MLXIPL;HDAC4;INSR;RANBP2;EP300;PFKFB4;PRKAA2;PRKAG2;HIF1A;PFKFB3;ZBTB7A;GIT1;NUP214;TPR
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),-0.5488516892444164,-0.9671970094335868,0.6,1.0,1.0,4/11,29.23%,CCT6A;CCT8;CCT7;CCT2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),-0.5488516892444164,-0.9671970094335868,0.6,1.0,1.0,4/11,29.23%,CCT6A;CCT8;CCT7;CCT2
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),-0.5544777034109581,-0.9669527919237579,0.5614035087719298,1.0,1.0,2/9,9.05%,CYP26B1;SFRP4
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),-0.6365232023011247,-0.9668655233912457,0.53125,1.0,1.0,2/6,11.92%,DCTN1;HSPA8
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),0.38796917782676843,0.9663224538349444,0.40540540540540543,0.9130098433186001,1.0,5/39,10.09%,LLGL1;NLGN1;RHOBTB3;RHOBTB1;RND3
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),-0.5501349504146162,-0.9661540969765745,0.5606060606060606,1.0,1.0,2/9,9.85%,ZFPM1;SMAD6
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.5497291328639221,0.9660216779693314,0.5531914893617021,0.9132690513761722,1.0,2/9,5.56%,SNCA;RAB7A
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),0.4328472879339392,0.965629044152816,0.4146341463414634,0.9136552665230383,1.0,6/16,21.72%,TGFBR1;SNAI2;NOTCH1;RBPJ;BMP4;SPRY1
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),-0.43621360431152867,-0.9655479203074165,0.5753424657534246,1.0,1.0,6/41,7.49%,MARVELD2;CLDN1;CLDN6;CLDN5;ACTG1;CLDN2
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.311473299626307,0.9655164318765731,0.5555555555555556,0.9134473218042763,1.0,48/246,18.01%,NGF;PLEKHG2;RASSF2;FOXO1;FANK1;BCL6;SCRIB;FGD4;BIN1;DAPK2;HTRA2;SIRT1;SNCA;TRIM35;TOP2A;HMGB1;ABL1;LATS1;MAPK8;SLIT2;CASP3;FGD1;MAP3K10;RRP1B;CALHM2;NLRP2B;UNC13B;FADD;RYBP;CRADD;NF1;BID;AIFM2;RPS6KA2;MARK4;VAV2;GADD45A;TP53;UBE2Z;ATM;GPLD1;CLIP3;IAPP;PAWR;SLC27A4;ARHGEF16;FAF1;ERCC3
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),0.46461489812820705,0.9653778903256159,0.39473684210526316,0.9134854446562679,1.0,8/18,25.60%,SMYD2;SETMAR;SETD2;ASH1L;SUV39H2;SETD7;KMT2B;KMT2A
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),0.411943434809392,0.9653439929937545,0.42105263157894735,0.9130999107524032,1.0,12/34,21.89%,DNAJC30;CAPN10;REEP6;AAAS;ATPSCKMT;TTC21B;WWC1;RAB11B;MLC1;RNF139;GAS1;NUP214
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.5539160367778606,-0.9652746412961051,0.5079365079365079,1.0,1.0,2/9,14.26%,THBS1;IL12A
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),0.37244281448273986,0.9651422577738836,0.5384615384615384,0.9131043155774119,1.0,7/69,8.73%,ATP6V0D2;TCIRG1;KPTN;EIF2AK3;MAPK8;MLST8;RNF152
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),-0.40964630010849684,-0.965123662231008,0.4788732394366197,1.0,1.0,3/59,6.32%,ENPP2;PLAAT4;PLA2G10
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),0.4402735511181065,0.9648506148304635,0.4772727272727273,0.9132102688400466,1.0,5/20,8.37%,SMARCD3;CX3CR1;TOX;PROX1;DCT
prerank,GO_Biological_Process_2021__omega-hydroxylase P450 pathway (GO:0097267),0.6389566352832211,0.964815450821097,0.625,0.912766330770622,1.0,2/6,4.45%,CYP1A2;CYP2U1
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),0.3799758210208005,0.9643077533971746,0.4666666666666667,0.9134725392463984,1.0,23/79,21.75%,IRGM;FOXO1;EPM2A;SIRT1;TRIM8;HMGB1;DHRSX;RNF152;TRIM65;GPSM1;PIM2;TICAM1;PLK3;TFEB;ATF6;SESN2;PRKAA2;MID2;TRIM14;LARP1;BNIP3L;MTDH;NPRL2
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),-0.610382985797847,-0.9642504371750088,0.5172413793103449,1.0,1.0,2/6,31.08%,DHX58;SEC14L1
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),0.47327425765604686,0.9641942917614846,0.48717948717948717,0.9132486141899636,1.0,4/10,9.99%,PCM1;CEP120;WNT3A;NUMB
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),-0.5108099632458019,-0.964160543532255,0.5517241379310345,1.0,1.0,9/18,26.84%,ABCG2;ABCB1;SLC22A3;SLC22A4;SLC47A1;ABCC11;SLC22A1;ABCC2;ABCC3
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.5798275557567996,-0.9638295263982601,0.5357142857142857,1.0,1.0,3/9,18.31%,GABARAPL1;GABARAPL2;MAP1LC3B2
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.5798275557567996,-0.9638295263982601,0.5357142857142857,1.0,1.0,3/9,18.31%,GABARAPL1;GABARAPL2;MAP1LC3B2
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.32887860204728403,0.9637545410729874,0.45,0.9137595544648129,1.0,31/113,22.14%,BAMBI;TGFBR1;DUSP15;CDH5;PARD3;SIRT1;ARRB2;ZFYVE16;AMH;TWSG1;GDF6;PXN;FNTA;SMAD2;LTBP2;SMURF1;FURIN;HJV;CGN;HIVEP1;SKI;ACVR1;USP15;APPL2;ACVR2A;ZFYVE9;FOS;BMPR2;BMP4;SMAD5;SMAD7
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),-0.5216645157683623,-0.9634203805165223,0.5517241379310345,1.0,1.0,5/16,12.91%,ESR1;GPER1;FAM210B;H2AZ1;SSTR1
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),0.3529401438639329,0.9634017872769575,0.46875,0.9141686539890054,1.0,24/74,24.77%,PRR16;LRRTM3;SAMD4A;ERBB2;PCIF1;SP1;CASP3;NSMAF;SMPD3;EIF3E;YTHDF1;ZCCHC4;GSAP;EIF4A3;PIWIL2;FXR2;NIBAN1;LARP4B;BCL3;ABCA2;PLA2G6;PRKCD;SLC2A13;UPF3A
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),-0.5360513778806554,-0.9632525962029428,0.5087719298245614,1.0,1.0,2/8,18.98%,CAV2;RGS8
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.5183376623272803,0.9632022017017751,0.4523809523809524,0.9142230510118775,1.0,1/12,5.39%,RNF168
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),-0.4533285785876547,-0.9631809524070478,0.5616438356164384,1.0,1.0,3/33,2.75%,TGFB1;F7;P2RY12
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.416226042958245,0.9628908166746107,0.5333333333333333,0.9143532546359424,1.0,7/25,15.44%,CTC1;TERF1;GNL3L;DACH1;ACD;MEN1;TP53
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),0.3782264355162439,0.9627300683618634,0.45454545454545453,0.9141800129060036,1.0,17/61,12.24%,CYP1A2;GPC4;CYP4V2;APOB;APOE;SDC4;ALDH1A1;GPC6;AKR1C3;CYP2S1;AKR1C1;GPC5;LPL;ALDH1A2;AWAT2;SDC3;ADH4
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),0.5727528834627174,0.9627081110121725,0.5365853658536586,0.9136785726321377,1.0,2/8,11.29%,HTRA2;LGALS9
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.41049260573670915,0.9625604411693212,0.42424242424242425,0.9134554064619959,1.0,14/49,22.88%,IRGM;EPM2A;SIRT1;RALB;GPSM1;PIP4K2A;LRSAM1;SESN2;CALCOCO2;PRKAA2;LARP1;BNIP3L;STING1;ELAPOR1
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),-0.45407598800901794,-0.9624562518465023,0.578125,1.0,1.0,3/32,10.70%,AMBP;PINK1;DNAJA1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion-dependent exocytosis (GO:0045955),-0.5977255369894057,-0.9624055616293045,0.5666666666666667,1.0,1.0,1/5,9.69%,REST
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.4731869573927749,0.962373925846925,0.5151515151515151,0.9133670636691099,1.0,6/21,20.40%,RIPK2;TAB3;TAB1;TAB2;MAP2K6;TRAF6
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),0.4337945796952967,0.9622370050319905,0.45454545454545453,0.9131611319338411,1.0,3/25,11.41%,PHLDB2;CGNL1;WASF2
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.5054442608777094,0.9622037337299634,0.5128205128205128,0.9127117841770902,1.0,5/13,25.01%,ARHGAP35;GBA2;NTRK2;PTEN;MAP2
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.4967278437391527,0.9619819578647124,0.4594594594594595,0.9128255276441679,1.0,2/11,5.56%,JAG1;HES1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),0.3568742237730711,0.9619473927551465,0.45161290322580644,0.9124020426475045,1.0,10/61,11.91%,SKAP1;UTRN;CDH13;CRK;CDK6;ABL1;FLNA;CASS4;CSPG5;LIMS1
prerank,GO_Biological_Process_2021__lung development (GO:0030324),0.42077769312247904,0.9618629863916626,0.5,0.9121719419913294,1.0,3/25,9.59%,FGF10;PROX1;ITGA3
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),0.5969672781991608,0.961725225760371,0.6304347826086957,0.9119923942571426,1.0,2/6,31.40%,RAB11B;RAB11FIP2
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.4513921612727042,-0.9613866243733915,0.5373134328358209,1.0,1.0,8/34,19.73%,WNT5A;ACOX2;GPR151;ARG2;CD80;IER5;HMGA2;HMGA1
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),-0.4977375793347477,-0.9610433275039414,0.45161290322580644,1.0,1.0,2/23,2.76%,SCN5A;CAV3
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.3933380081304117,0.9608987578349139,0.44,0.9134300475525575,1.0,4/34,8.46%,RASSF2;EPHA7;PDGFD;RAP2A
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,0.3580252154678803,0.9606826173678903,0.5333333333333333,0.9134928356164747,1.0,15/51,17.21%,TGFBR1;RAB31;KLF10;TGIF1;SERPINE1;PPM1A;JUNB;FNTA;HDAC1;LTBP2;SMURF1;WWTR1;FURIN;PMEPA1;SKI
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.501827209716402,0.9606017146917448,0.5263157894736842,0.9132040577965544,1.0,8/15,26.50%,SEMA5A;ERN1;BMPER;DLG1;BMPR2;BMP4;THAP1;CD34
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",0.3157287512761535,0.9605797628595741,0.5625,0.9127817707942552,1.0,65/257,26.04%,CPSF1;SNRPN;NOVA1;PCF11;HNRNPF;TRA2A;DCPS;RBM41;PUF60;PRPF40B;HNRNPH1;TXNL4A;SNRPB;SPEN;CELF4;U2AF1;SRRM1;HNRNPL;LSM2;ZMAT5;GEMIN5;CWC27;SF3B1;CPSF7;SRSF4;GTF2F2;PTBP1;FUS;LSM7;SYNCRIP;PAPOLA;PRMT5;RNF113A;EIF4A3;U2AF2;SYMPK;SF3B4;RBM6;GPATCH1;LSM6;PPIH;CDC5L;LSM8;PDCD7;DDX46;DDX41;POLR2F;RALY;MAGOHB;SNRNP48;SRPK2;CLNS1A;PSPC1;RBM10;YBX1;CDK13;SNRPF;WDR33;CWF19L1;PABPC1;CCAR1;SF1;SCAF11;SNRPA;RBM8A
prerank,GO_Biological_Process_2021__positive regulation of epidermis development (GO:0045684),-0.5844806440997196,-0.9602005594634769,0.5555555555555556,1.0,1.0,2/7,13.52%,SFRP4;TMEM79
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.4368268344514974,0.9601635646458168,0.4642857142857143,0.9134299918831394,1.0,10/32,13.66%,RAB31;BLZF1;RAB7A;GOLGA4;GCC2;GGA1;MACF1;RILPL1;NECTIN3;RAB10
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.45581379589662224,-0.9600439203581055,0.5254237288135594,1.0,1.0,9/23,19.10%,SLC51A;SLCO2B1;CEACAM1;NR1H4;STARD5;SLC10A1;SLCO1A2;ABCB11;SLC27A5
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.39436435436690886,0.9598547998597938,0.4594594594594595,0.9136430321534633,1.0,13/55,14.99%,GCK;IRS1;PPARG;CRY1;CYB5R4;LEPR;ADIPOR1;MCU;MLXIPL;ADIPOR2;ACSM2A;INSR;RFX6
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.430647856375395,0.9596088573632465,0.5454545454545454,0.9137138792201148,1.0,13/31,20.96%,ZDHHC11B;ZDHHC16;ZDHHC18;ZDHHC12;GOLGA7B;ZDHHC14;ZDHHC3;ZDHHC13;CLIP3;ZDHHC9;ZDHHC11;ZDHHC5;ZDHHC23
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.42282430499380325,-0.9595313994958513,0.5128205128205128,1.0,1.0,13/65,13.55%,EPN1;ALOX5;CNMD;STAT1;CD160;DCN;CLDN5;COL4A3;ISM1;THBS1;FOXO4;PIK3CB;TEK
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.4475319153935314,-0.9593988162413183,0.5555555555555556,1.0,1.0,3/28,10.90%,TERF2IP;TERT;PIF1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.4856976868240048,-0.959248896866627,0.5806451612903226,1.0,1.0,3/20,8.75%,SPDYA;CCND1;CCND2
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,-0.43331061714617913,-0.9591938871602813,0.463768115942029,1.0,1.0,9/47,10.72%,GMFG;SLFN14;GYPB;ICAM3;FRAT1;FAM110A;MFSD2B;ALAS2;ITGA2B
prerank,GO_Biological_Process_2021__cellular triglyceride homeostasis (GO:0035356),0.5941804705241261,0.9590813546348019,0.6285714285714286,0.9145691557401342,1.0,1/5,4.59%,SIRT1
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.42439896407463734,-0.9590765500868941,0.5507246376811594,1.0,1.0,9/49,12.97%,HAMP;NUBP1;ATP6AP1;ABCG2;CP;ALAS2;SLC11A1;FTH1;FRRS1
prerank,GO_Biological_Process_2021__positive regulation of vesicle fusion (GO:0031340),0.615822635576978,0.9586860503406434,0.525,0.9149814027287362,1.0,3/6,9.44%,DOC2B;SNCA;AKT2
prerank,GO_Biological_Process_2021__catecholamine biosynthetic process (GO:0042423),-0.5837501620314498,-0.9586693049428308,0.5333333333333333,1.0,1.0,2/9,8.03%,DBH;DAO
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),-0.46187247189091934,-0.9584533255417254,0.5161290322580645,1.0,1.0,4/27,11.77%,ITGB2;CLU;SLC11A1;ITGAM
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),-0.3811838319465558,-0.9577608384007323,0.5063291139240507,1.0,1.0,29/153,14.21%,SQOR;C1QTNF1;LMOD1;TIMP3;ANGPTL2;CYP1B1;PROCR;COL1A1;COL5A1;LOX;BACE2;UACA;DCN;SLCO2A1;COL4A4;ITGA9;COL4A3;ITGBL1;SMAD6;ENPP4;AFAP1L1;PPIC;COX7A1;TEK;PKN3;NTN1;ITGA5;HEY2;C1S
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",-0.5088922424620557,-0.9575942968198573,0.55,1.0,1.0,3/15,19.05%,TERF2IP;SMUG1;OGG1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),0.5157223145032999,0.9574927115811134,0.5,0.917318951504612,1.0,7/16,28.81%,TRPC3;PDE9A;NR4A3;AKAP6;EDN1;ROCK1;MEF2A
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),0.4936183642806821,0.9572565989889442,0.5128205128205128,0.9174042775426275,1.0,3/13,4.19%,VEGFC;CDH13;IL16
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),-0.6478486146456116,-0.9570062086787855,0.6545454545454545,1.0,1.0,2/5,9.78%,TIMP3;THBS1
prerank,GO_Biological_Process_2021__action potential (GO:0001508),-0.4486083497324138,-0.9569822193514013,0.45161290322580644,1.0,1.0,3/41,8.12%,SCN5A;GPER1;KCNQ1
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.3296988076300088,0.9569623294055839,0.5833333333333334,0.9175561287669868,1.0,52/164,23.90%,DGKD;PLD6;SLC44A5;MFSD2A;PITPNM1;PI4KB;CPNE7;PIK3C2B;PNPLA3;ABHD3;MTMR8;CHPT1;PGS1;CEPT1;PI4K2B;CRLS1;LPCAT2;CHKA;GPD1;CPNE6;PLSCR1;PLA2G4C;AGPAT5;PIK3CA;ACHE;DGKH;MTMR3;PIP4K2A;AGPAT2;RAB5A;LPIN2;LCLAT1;ABHD4;PIK3R5;HDHD5;PLA2G5;MTMR14;CPNE1;DGKZ;MTMR1;MTM1;PLD2;PLCG2;PIK3R4;ETNPPL;PTEN;CDS1;SLC44A2;PTDSS2;VAC14;PEMT;PCTP
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.4582175895762447,0.9566403074373695,0.6,0.9178825918638426,1.0,5/27,4.59%,EPHX2;RORA;APOE;BCKDK;SIRT1
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.46758264351927087,0.9566066123426679,0.45652173913043476,0.9174101443793217,1.0,5/13,20.02%,SFSWAP;SRSF4;PTBP1;PCBP4;U2AF2
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),0.5724963856305443,0.9565221115123883,0.5263157894736842,0.9171044903597028,1.0,1/6,12.54%,UBASH3B
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.34511140051493705,0.9564013678071313,0.42857142857142855,0.9168407181878342,1.0,21/111,13.85%,ARC;PHLDB2;BCL6;LRRC4C;PID1;MARCHF5;ERBB2;LZTS3;SARM1;VASH1;EFNA5;RAP2A;TNIK;ABI3;PDZD8;BCL9L;CDH2;ARHGAP35;TSPAN12;NF1;BMPER
prerank,GO_Biological_Process_2021__fructose metabolic process (GO:0006000),0.5836462856437997,0.9563421664439831,0.5652173913043478,0.916452668522222,1.0,1/6,1.09%,FBP2
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.4487306019792471,0.9561817670151511,0.4878048780487805,0.9163389437388879,1.0,5/17,14.09%,APOB;PLIN5;LPL;OSBPL11;NFKB1
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),0.5242095442373005,0.9561810875148279,0.42857142857142855,0.9158354608027677,1.0,2/7,13.81%,DRD5;NF1
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),-0.4602942856322364,-0.9561302994207512,0.5645161290322581,1.0,1.0,5/21,18.49%,TBX1;FBN2;MFAP5;MESP1;ALDH1A3
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.35453242782028405,0.9555035641404122,0.47058823529411764,0.9169243702465933,1.0,15/63,12.71%,NEUROD2;NLGN1;CPNE4;TRPM2;AKR1C3;CPNE7;ITPKB;SYT3;PKD2;SYT17;SLC25A24;SYT1;SYT12;ADGRV1;CPNE6
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.5096733866049781,0.9554602422839042,0.5121951219512195,0.9165039814696447,1.0,1/13,5.39%,RNF168
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell proliferation (GO:1902033),0.6094584824801632,0.9552750652041421,0.6046511627906976,0.9164484502130462,1.0,4/6,37.42%,ACE;PDCD2;N4BP2L2;EIF2AK2
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),-0.5757592680343906,-0.9551524971420455,0.6,1.0,1.0,2/7,13.13%,HAT1;CHAF1A
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),-0.5757592680343906,-0.9551524971420455,0.6,1.0,1.0,2/7,13.13%,HAT1;CHAF1A
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),0.35648125780438783,0.9550790187447797,0.42857142857142855,0.9164674745920257,1.0,18/90,14.82%,PCM1;CEP152;CEP135;CNTRL;SCLT1;ALMS1;DYNC1I2;SDCCAG8;C2CD3;MAPRE1;RPGRIP1L;CEP290;AKAP9;CEP250;MKS1;MARK4;CEP41;CEP162
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.3562249795515243,-0.9549214041784274,0.6292134831460674,1.0,1.0,31/304,13.80%,CD44;CLEC5A;KIF14;PRAME;HCK;MMP9;WNT5A;CARD14;BCL2L2;DAB2;IL7;IFIT3;FLT4;ANXA1;CCND2;HTR2B;PPT1;THBS1;SMAD6;DNAJA1;COPS5;ATF5;LRP2;WFS1;TAF9B;CFL1;NAA38;CD27;TEK;VDAC1;LEF1
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),0.6114916693929957,0.9546472908783974,0.625,0.9166294827594568,1.0,1/5,16.45%,DHRS7B
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),0.6114916693929957,0.9546472908783974,0.625,0.9166294827594568,1.0,1/5,16.45%,DHRS7B
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),-0.5852207053269324,-0.9542216254098754,0.546875,1.0,1.0,1/9,2.76%,CAV3
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),0.5775085228020874,0.9542083199313847,0.5434782608695652,0.9173342558243046,1.0,3/6,17.93%,BCL6;IRS2;NOC2L
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),-0.5283663452150975,-0.9540964586093188,0.5454545454545454,1.0,1.0,3/16,5.44%,TGFB1;TNFRSF1B;CLCF1
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),0.46801489579431566,0.9538275222983226,0.53125,0.9177657080972144,1.0,5/25,18.79%,GBF1;GCC2;ARL5A;COG7;ARFRP1
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),-0.5655465807467233,-0.9538221172157588,0.6,1.0,1.0,1/6,12.73%,ABCB1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),-0.4931368366989838,-0.953809618639232,0.5344827586206896,1.0,1.0,4/13,19.74%,TEC;TXK;BMX;NTRK1
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.4607175215690999,0.9538074208053965,0.525,0.9173217045460691,1.0,12/24,28.52%,PITPNM1;LDLR;PITPNC1;PRELID2;OSBPL8;NPC2;SCARB1;PCTP;PITPNB;PRELID3A;PRELID3B;ABCA3
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),0.4559394070472412,0.9534606410839622,0.5,0.9175629408647965,1.0,7/22,18.39%,MYC;MEN1;HSF1;TP53;LIG4;ATM;ATR
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),-0.48811806025550386,-0.9534406160601786,0.5285714285714286,1.0,1.0,4/16,18.85%,CEP55;CHMP3;MITD1;KLHDC8B
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),0.41877756180448544,0.9534178711961875,0.42105263157894735,0.9171525152392617,1.0,3/26,13.73%,IFT88;DYNC1I2;ARL13B
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.4476933624712335,0.9530046389955162,0.4166666666666667,0.9176160888762284,1.0,7/23,18.06%,DRD5;SNCA;ABL1;PDE4B;GABPA;NR4A3;ADCY6
prerank,GO_Biological_Process_2021__response to cGMP (GO:0070305),0.5850715598142417,0.9530033748138437,0.5454545454545454,0.9166318811477533,1.0,4/5,40.85%,HCN2;RAPGEF2;PDE3A;PDE2A
prerank,GO_Biological_Process_2021__cellular response to cGMP (GO:0071321),0.5850715598142417,0.9530033748138437,0.5454545454545454,0.9166318811477533,1.0,4/5,40.85%,HCN2;RAPGEF2;PDE3A;PDE2A
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),-0.5772761384415218,-0.9529420341849247,0.5614035087719298,1.0,1.0,1/8,3.57%,CXCL13
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),-0.41407465848503033,-0.9529161371600043,0.48484848484848486,1.0,1.0,13/50,15.91%,SLC51A;SLC16A8;SLCO2B1;SLCO2A1;CEACAM1;SLC6A12;ABCG2;SLC16A3;SLC16A4;NR1H4;STARD5;SLC10A1;SLCO1A2
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.44416908738097116,-0.9527555252294037,0.5522388059701493,1.0,1.0,13/39,26.42%,IRF1;OAS2;OAS1;TLR2;NLRC3;DDX3X;CACTIN;DHX58;TRIM56;ISG15;FLOT1;PTPN11;RNF135
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),0.30999659230718235,0.9525124616470348,0.6,0.9172759872938221,1.0,39/170,22.51%,PRR16;HSPB1;TCOF1;SAMD4A;ERBB2;PCIF1;DHFR;TRIM71;RIDA;EIF2AK3;NANOS3;CNOT9;RPS6KA3;GEMIN5;EIF3H;MTRF1;EIF3E;PUM3;ETF1;YTHDF1;PUS7;MALSU1;ZCCHC4;SYNCRIP;LSM14A;IMPACT;SAMD4B;SHMT2;GRM5;EIF4A3;NANOS1;RNF139;PIWIL2;FXR2;LARP1;EIF4E;NIBAN1;LARP4B;NEMF
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.4734997662575677,0.9524989327659514,0.5116279069767442,0.9167928278256496,1.0,3/11,27.38%,UQCC3;UQCRC2;UQCRHL
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),0.5884187366103423,0.9524637990291709,0.5111111111111111,0.9163512874801009,1.0,1/5,6.04%,SLC19A1
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),-0.5264444789959469,-0.9524163906051534,0.48333333333333334,1.0,1.0,3/13,6.21%,TGFB1;NODAL;DAB2
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),-0.5607066290183079,-0.9524005967664483,0.5833333333333334,1.0,1.0,2/12,6.21%,NODAL;DAB2
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.3510761147645668,0.9521374955741077,0.36363636363636365,0.9166248583657348,1.0,30/95,22.08%,SMARCD3;SIRT1;ZBTB1;SMARCB1;MYC;PIH1D1;SRCAP;PBRM1;ARID1A;BPTF;SMARCA2;SMARCA4;HDAC1;GATAD2B;CHD4;HDAC4;BAZ1B;BAZ2B;BAZ2A;NUDT5;ARID1B;SATB2;KAT2B;HDAC5;RSF1;ZBTB7A;RBBP4;BAHD1;SUV39H2;SMARCAD1
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.4328244750756491,-0.9520909377613359,0.515625,1.0,1.0,4/35,8.12%,DUOX1;AHR;STAT1;KCNQ1
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),-0.5770529311610567,-0.9520189883571444,0.5862068965517241,1.0,1.0,1/7,1.74%,CASQ2
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),-0.5770529311610567,-0.9520189883571444,0.5862068965517241,1.0,1.0,1/7,1.74%,CASQ2
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),-0.6582221090392797,-0.9519443219626331,0.6363636363636364,1.0,1.0,2/5,14.16%,ZFPM1;HEY2
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.4172989881384957,0.9517569439285833,0.4411764705882353,0.9170294866130128,1.0,12/37,20.33%,RP1L1;JHY;SPAG16;SPAST;AAAS;NAV1;TPPP3;MARK4;CLIP1;NCKAP5L;CFAP46;CDK5RAP2
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),-0.43417149814272843,-0.9517245924104498,0.5068493150684932,1.0,1.0,3/48,4.10%,NOTUM;TGFB1;ALOX5
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),-0.552426004744473,-0.951617022572385,0.5757575757575758,1.0,1.0,1/10,2.44%,CYP26B1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),0.4477344493198286,0.9516084783007602,0.4857142857142857,0.9169085410690779,1.0,10/21,36.49%,TENM1;POLR3G;ICE1;ICE2;CEBPA;NAB2;ZNF345;CHD8;BRF2;ZC3H8
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),0.5211419093424419,0.951605654817601,0.6,0.9164104918887036,1.0,3/8,21.99%,SNAPC3;ICE1;ICE2
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),0.43197769139789943,0.9515069087407781,0.5483870967741935,0.9161916579970144,1.0,11/37,27.98%,NUP210;NUP42;AAAS;RANBP2;NUP214;TPR;SEH1L;XPOT;NUP153;NUP98;NUP37
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),0.33524339079129484,0.9513308322181542,0.5789473684210527,0.916104131374787,1.0,7/67,4.79%,AOAH;RORA;APOE;CDH5;METRNL;PPARG;IFI16
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",-0.5935334389068266,-0.9511250165530432,0.5932203389830508,1.0,1.0,3/7,17.08%,IRF1;HLA-A;VSIR
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),0.4641366174069971,0.9511049525221389,0.5370370370370371,0.916074011621484,1.0,2/15,2.85%,IRS1;MIDN
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),0.41286990939604756,0.9509105631581548,0.4857142857142857,0.9161257543387247,1.0,7/25,17.42%,TRPC3;GRIN1;F2R;ANK2;WNK3;STIM2;LGALS3
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.618274179935605,-0.9505016918154217,0.65625,1.0,1.0,5/9,31.28%,AGT;SIX4;SOX9;PAX2;PAX8
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),-0.562392622707762,-0.9504722175064693,0.5645161290322581,1.0,1.0,4/12,22.40%,CASQ2;CASR;CALM1;KCNMB2
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),0.3636534429661916,0.9503685500789387,0.6,0.9168807962298134,1.0,3/29,4.59%,APOE;PPARG;SIRT1
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.3164928688119548,0.9503378114429589,0.6,0.9164170764741171,1.0,22/118,16.85%,MGAT4C;GALNT7;SLC39A8;DPM3;TET2;FKTN;ST8SIA4;GALNT1;ST3GAL3;PLOD3;POFUT1;NUS1;ALG12;COG7;FUT9;ALG3;GAL3ST1;MGAT2;ST3GAL6;B3GALNT2;MOGS;POMT2
prerank,GO_Biological_Process_2021__regulation of hormone secretion (GO:0046883),-0.5603799701936841,-0.9503267456217591,0.5740740740740741,1.0,1.0,1/8,8.67%,ANXA1
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.36897972678511326,-0.9503221961572078,0.5333333333333333,1.0,1.0,58/165,27.27%,RPL37A;EIF6;SENP3;RPL38;PWP2;EMG1;RPL15;NOB1;RPL3;RPL35A;RPS9;RPS27;RPL13A;RPL27A;RPS16;RPL36;LAS1L;RPL7A;RPL9;RPL13;RPL21;WDR12;NOP53;EXOSC8;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPL27;RPL35;RPS14;RPL11;RPS15;EXOSC2;RPLP1;RPL24;SBDS;RPL18A;RPL29;RPLP2;PDCD11;RPL28;RPL12;RPL18;EBNA1BP2;RPL22;IMP3;NSA2;RPS28;RPS19;RPS24;RPL19;RPL8;RPS6;RPL10
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.3718811972497352,0.9502925510052708,0.5263157894736842,0.915986537371543,1.0,29/106,22.16%,EYA4;HDAC10;PRDM5;SIRT1;SIRT7;MIER2;USP36;NSD1;USP16;KAT6A;UBE2A;HDAC1;CARM1;RPS6KA4;HDAC4;EYA3;BAZ1B;HDAC11;BAZ2A;USP51;SUPT3H;EP300;KAT6B;BRMS1L;HDAC5;TBL1X;RCOR2;ATXN7;AURKC
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),-0.5498133928677933,-0.9501352382659869,0.6166666666666667,1.0,1.0,3/10,14.16%,TMEM204;EDNRB;HEY2
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.32518684142372234,0.949806599843476,0.5806451612903226,0.9164301488788773,1.0,37/139,19.46%,SLC17A6;SPHKAP;NOVA1;LRRTM3;ELAVL3;NKAIN2;GDAP1;CADM2;MAGI2;PAK5;LRFN5;ERC2;ADGRA1;PARM1;BRINP1;RGS7BP;ELAVL4;RAB3C;AVIL;OLFM3;SCN7A;SNAP91;MAP6;RBFOX1;ASXL3;ANK2;NRXN1;PTPRD;DGKH;DLG2;PPFIA2;LSAMP;MMD2;ST8SIA3;ADGRB3;GRM5;DGKZ
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),0.49117019498176623,0.9497691318422589,0.43243243243243246,0.9160408724871808,1.0,5/9,40.37%,POGZ;DLGAP5;CENPE;CENPT;CENPC
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),0.592336525490395,0.9496445613111922,0.5641025641025641,0.9158722410458506,1.0,1/8,5.36%,KLHL41
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),0.5540402469765238,0.9496035670434984,0.6170212765957447,0.915475534232314,1.0,3/6,21.51%,EIF2AK3;SULF2;BMPR2
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),-0.5006904768120954,-0.9492873299186235,0.5636363636363636,1.0,1.0,2/13,8.70%,ACSL5;AZIN1
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),0.37776603810560466,0.949209337055584,0.6153846153846154,0.9160325310516908,1.0,7/50,11.91%,PHLDB2;EPHA3;ABL1;EFNA5;COL16A1;MACF1;LIMS1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),-0.49898635297464317,-0.9487155741665521,0.5633802816901409,1.0,1.0,4/23,16.13%,F7;ZNF580;ZP3;F2RL1
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.3826924890768399,0.9485392720021016,0.5365853658536586,0.9170449495057926,1.0,7/31,14.95%,NYAP2;IRS1;ERBB2;PIK3C2B;TYRO3;NF1;PIK3CA
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),-0.5068395428432008,-0.9485134779089981,0.4714285714285714,1.0,1.0,2/18,8.41%,MCM3;MCMDC2
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),-0.530684025656631,-0.9482247032178633,0.5714285714285714,1.0,1.0,1/10,1.41%,FOXM1
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),0.46702352237263334,0.9479575847786094,0.5454545454545454,0.918031859796821,1.0,4/14,10.95%,LAMB4;NTN4;NTNG2;FLRT2
prerank,GO_Biological_Process_2021__negative regulation of anion transmembrane transport (GO:1903960),-0.5609161457024724,-0.9479373435283273,0.5660377358490566,1.0,1.0,4/5,39.62%,TCAF2;ARL6IP5;GOPC;SLC43A1
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",0.5739654962877992,0.9476539181037009,0.5434782608695652,0.9183100065195275,1.0,2/7,6.51%,ZBTB7B;HLA-DRA
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.4850167980460416,-0.9476143521604786,0.5774647887323944,1.0,1.0,3/22,21.44%,RPA3;RPS27A;RPA2
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.39355229210529485,-0.9472910850294453,0.625,1.0,1.0,15/82,16.55%,CRLF1;FGF20;KIF14;TNFRSF1B;CLCF1;PINK1;SOD2;PPT1;REST;WFS1;FOXB1;TGFB3;HLA-F;GRN;NAIP
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),0.4538410319719157,0.9472315434147239,0.5652173913043478,0.9187992363628776,1.0,5/14,20.02%,SFSWAP;SRSF4;PTBP1;PCBP4;U2AF2
prerank,GO_Biological_Process_2021__L-arginine transmembrane transport (GO:1903400),-0.5749716209986222,-0.9471963434521014,0.5686274509803921,1.0,1.0,1/6,5.15%,SLC7A3
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.5091318781231353,-0.947193234239457,0.5409836065573771,1.0,1.0,1/17,0.77%,POLQ
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),0.5374098564677686,0.9469142361084449,0.5208333333333334,0.9191823051276877,1.0,3/5,43.94%,CLUH;LRRK2;MAPT
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.5925118316534592,-0.9468876321067864,0.6349206349206349,1.0,1.0,1/5,10.04%,PDHX
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.41229623029370177,0.9468482748280804,0.5128205128205128,0.9188908891736739,1.0,5/27,10.67%,NGF;FGF10;RAPGEF1;EPOR;IRS2
prerank,GO_Biological_Process_2021__negative regulation of intracellular transport (GO:0032387),-0.6108652928095262,-0.9466195578658313,0.6271186440677966,1.0,1.0,2/5,20.55%,PLN;MRLN
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),0.4172493327947061,0.9466044649866587,0.41935483870967744,0.918981285111889,1.0,5/34,7.30%,CSTA;ECM1;TIMP1;CHAC1;F2
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),0.5729321382212447,0.9463646006192651,0.5454545454545454,0.9190634712737789,1.0,3/6,9.20%,DNMT1;SMARCB1;PIH1D1
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),0.5022231079801671,0.9462358825690234,0.5428571428571428,0.9189023210080303,1.0,4/12,9.46%,APOE;HTR2C;KCNC2;PDE9A
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.38332469962543303,0.9459058082010453,0.48,0.9192113710690021,1.0,8/34,15.56%,RIPK2;IL16;HMGB1;PLCB1;MAST2;LGALS9;PIBF1;IL23A
prerank,GO_Biological_Process_2021__regulation of glial cell migration (GO:1903975),-0.6451335066051086,-0.9458437365925507,0.6666666666666666,1.0,1.0,2/5,6.26%,P2RY12;GPR183
prerank,GO_Biological_Process_2021__negative regulation of posttranscriptional gene silencing (GO:0060149),-0.6266182099112568,-0.9456622865992097,0.6111111111111112,1.0,1.0,1/5,1.49%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by RNA (GO:0060967),-0.6266182099112568,-0.9456622865992097,0.6111111111111112,1.0,1.0,1/5,1.49%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),-0.38475225841710015,-0.9456216059016596,0.5797101449275363,1.0,1.0,17/116,15.79%,AMBP;HCK;SCTR;TSHR;GPHB5;FCGR3A;ALOX15;GPR27;CGA;HLA-DRB1;SPI1;GPR39;PTGDR;NLRC3;GGT5;ADCY7;RNF26
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),-0.4179968277101897,-0.9453850262492414,0.5394736842105263,1.0,1.0,7/59,14.75%,NEK2;GPER1;BRCA1;MAX;FOXO4;RBBP7;TOM1L1
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),-0.4595266424793076,-0.945183654778007,0.515625,1.0,1.0,3/21,8.01%,CASQ2;CAV3;HTR1B
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),0.5246304993937501,0.9450364712258725,0.5128205128205128,0.9208889171680645,1.0,2/7,24.00%,PDSS2;MVK
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.42893707849788043,-0.9448720090210474,0.5753424657534246,1.0,1.0,4/42,10.71%,TERF2IP;SP100;RPA3;TERT
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.536478403142984,-0.9448459511734059,0.5423728813559322,1.0,1.0,2/10,21.14%,NUF2;BOD1
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),-0.5271597648110128,-0.9446399623744582,0.5873015873015873,1.0,1.0,3/18,14.99%,BOLL;DAZL;DDX3X
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.42174025284539296,0.9446081424406677,0.5135135135135135,0.9213260942711557,1.0,3/23,9.76%,SNCA;DSCAM;BTBD10
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),0.5439176849903984,0.9445922348080165,0.5161290322580645,0.9208808957271665,1.0,2/10,6.40%,IMMP2L;IMMP1L
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),-0.44351934766233725,-0.9445282772763041,0.5230769230769231,1.0,1.0,3/33,10.72%,TENT5B;MEIOC;SLC11A1
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.33976776999446645,0.9443819986267461,0.42105263157894735,0.920880934729853,1.0,25/104,21.50%,ATP6V0D2;EPM2A;SIRT1;SNX5;MAPK8;CASP3;MTMR8;MLST8;ERN1;GPSM1;USP36;CLEC16A;QSOX1;EXOC7;PIK3CA;SNX32;SMG1;NEDD4;SESN2;CDK5;PRKAA2;PRKAG2;LARP1;BNIP3L;EXOC4
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",0.5741272348418764,0.9442101791657722,0.5263157894736842,0.920711246903223,1.0,2/6,2.69%,SCRIB;GRIP1
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),0.36349493973821984,0.9439745284369766,0.5,0.920767921959345,1.0,13/75,9.08%,APOH;TGFBR1;VEGFC;APOE;ANGPT1;CDH13;SEMA5A;SIRT1;PROX1;ECM1;VASH1;FGF18;PTPRM
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),0.40829706776223895,0.943824780833984,0.43333333333333335,0.9207115062260459,1.0,8/17,22.36%,KLKB1;RHBDD1;F12;ASTL;NKD2;PLGRKT;ENO1;ADAM8
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),0.5863399879637864,0.9437166407578588,0.631578947368421,0.920485696154056,1.0,1/5,3.69%,CD14
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),0.4829699175054201,0.9435763031073803,0.5116279069767442,0.9204052965808414,1.0,1/12,0.75%,MT1G
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),0.38317397414780396,0.9435736252949669,0.48148148148148145,0.9199219502408968,1.0,10/45,11.22%,SLC38A5;SLC3A2;SLC7A9;SLC16A10;SLC6A17;SLC6A20;SLC7A11;SLC7A6;SLC25A29;SLC7A8
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),-0.6420314533965112,-0.9433249551272437,0.6666666666666666,1.0,1.0,1/5,2.76%,CAV3
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),0.5386173142154138,0.9432120334374303,0.6046511627906976,0.9201883603929963,1.0,2/9,7.63%,APOE;ABCA1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),-0.4754942083640907,-0.9431183505654998,0.46774193548387094,1.0,1.0,5/21,18.68%,NLRP12;CEACAM1;NLRP3;GHRL;CARD8
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),-0.4847824192835458,-0.9430356133009747,0.578125,1.0,1.0,5/14,21.32%,CEACAM1;APOLD1;ALOX15B;CD24;SOX9
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.3709597026481227,-0.9427722065160695,0.6024096385542169,1.0,1.0,8/136,5.75%,NEK2;PSMB9;KIF14;DTL;CCND1;CDC25A;RAB11A;FBXL7
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),-0.607642437516935,-0.9427024422379869,0.6326530612244898,1.0,1.0,1/5,2.41%,GAD1
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.4998806995424924,-0.9426873245423899,0.5217391304347826,1.0,1.0,4/15,24.21%,CD27;ZFP36L1;INHA;SFRP1
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.43876238698973774,-0.9426466888896458,0.6065573770491803,1.0,1.0,3/29,10.90%,TERF2IP;TERT;PIF1
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),0.6134824147975213,0.9426391828950764,0.6428571428571429,0.9209698178512467,1.0,2/5,30.67%,NTRK2;TMEM108
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.33769626781315737,0.9423804604787674,0.5652173913043478,0.9211549077972901,1.0,26/101,21.15%,RASSF2;KIT;FGFR1;EPHA7;CCN1;ERBB2;EPHA3;DRD4;F2;FGFR3;TYRO3;RET;RAP1A;SNX9;FLT3;RYK;INSR;EPHB2;ROR1;EPHA6;DUSP19;MMD2;TAB2;PRKAG2;NTRK2;CACUL1
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",0.5336549112279845,0.942212176130235,0.46938775510204084,0.9211306701842646,1.0,3/8,20.03%,RAB31;ABCA7;APPL2
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),0.500548993816605,0.9420747087138531,0.53125,0.9210823408085302,1.0,4/11,10.74%,CX3CR1;CARD9;OCIAD2;F2R
prerank,GO_Biological_Process_2021__regulation of translational elongation (GO:0006448),0.5737629311563748,0.9419631388673181,0.5681818181818182,0.9209296090030519,1.0,2/6,19.02%,USP16;GRM5
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),0.526792927498295,0.9419613019146471,0.5227272727272727,0.9204477834673399,1.0,2/8,23.39%,SHMT2;METTL4
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),0.5692091809069609,0.9416030907280614,0.5652173913043478,0.9209135818928711,1.0,2/6,15.15%,ADAM15;PTPRF
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.42352859785758873,-0.9415489096921762,0.5606060606060606,1.0,1.0,3/68,4.03%,GML;FOXM1;SP100
prerank,MSigDB_Hallmark_2020__Complement,-0.3717412545356083,-0.941547191274192,0.611764705882353,1.0,1.0,25/158,18.04%,F8;PSMB9;F7;S100A13;CPM;IRF1;GP1BA;WAS;PHEX;CLU;ERAP2;CASP7;PLG;CP;ITGAM;PLAT;F5;C4BPB;C1S;ATOX1;PIK3CG;CDK5R1;PLA2G4A;CALM1;CPQ
prerank,GO_Biological_Process_2021__metanephric mesenchyme development (GO:0072075),0.4872940582964658,0.9412128989698314,0.4444444444444444,0.9212906421582734,1.0,3/8,6.85%,WNT4;PKD2;OSR1
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.46624286465752346,0.9410968318599462,0.5263157894736842,0.9206091294112856,1.0,5/21,15.44%,BCL2;PPP1R13B;MAPK8;BID;TP53
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.46624286465752346,0.9410968318599462,0.5263157894736842,0.9206091294112856,1.0,5/21,15.44%,BCL2;PPP1R13B;MAPK8;BID;TP53
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),-0.529524783277977,-0.9410747489510316,0.5833333333333334,1.0,1.0,1/11,4.19%,CLDN1
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),0.5995271086074382,0.9409753093245715,0.6444444444444445,0.9203369947274309,1.0,1/6,0.67%,EGLN3
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),-0.5371723932421579,-0.9408281176044467,0.5471698113207547,1.0,1.0,1/12,2.65%,BLK
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),-0.406447344667206,-0.940816388047936,0.5915492957746479,1.0,1.0,7/54,17.20%,TGFB1;NODAL;SMAD6;ENG;TGFB3;SMAD3;GDF15
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),-0.47421412460688744,-0.9406160259044862,0.5161290322580645,1.0,1.0,4/22,9.69%,AIM2;HTR1B;KCNQ1;REST
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),-0.5133494850739984,-0.9402736982957399,0.5833333333333334,1.0,1.0,4/12,17.77%,GAD1;DAO;NOS2;PRODH2
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),0.5149745072458142,0.9399924806222854,0.5945945945945946,0.9222905639607212,1.0,2/9,2.69%,SCRIB;GRIP1
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),-0.509723367754186,-0.9399298865637531,0.527027027027027,1.0,1.0,5/14,18.26%,CYP1B1;NQO1;ARG2;NOS2;GCHFR
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),0.6036180481603753,0.9397271696606015,0.6341463414634146,0.922385865694774,1.0,2/6,23.80%,PIBF1;PRLR
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.47524278404665604,-0.9395589191342959,0.5757575757575758,1.0,1.0,3/21,8.28%,LILRB3;CEACAM1;ZFPM1
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),-0.47465054588213806,-0.9394105100030492,0.546875,1.0,1.0,3/11,17.79%,ALOX5;PLA2G4A;ALOX5AP
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),-0.6149113362996111,-0.9391601195729423,0.5319148936170213,1.0,1.0,1/5,8.95%,CLU
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.31397576668112726,0.939123940112454,0.5882352941176471,0.9233287072562539,1.0,50/264,18.01%,NGF;PLEKHG2;RASSF2;FOXO1;FANK1;TGFBR1;BCL6;SCRIB;EPHA7;FGD4;BIN1;DAPK2;HTRA2;SIRT1;SNCA;TRIM35;TOP2A;HMGB1;ABL1;LATS1;MAPK8;SLIT2;CASP3;FGD1;MAP3K10;RRP1B;CALHM2;NLRP2B;UNC13B;FADD;RYBP;CRADD;NF1;BID;AIFM2;RPS6KA2;VAV2;GADD45A;TP53;PTGIS;UBE2Z;ATM;GPLD1;CLIP3;IAPP;PAWR;SLC27A4;ARHGEF16;FAF1;ERCC3
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),-0.5386884090342339,-0.9389852391368126,0.6363636363636364,1.0,1.0,2/11,17.74%,DGAT2L6;PLA2G4A
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),-0.5651126099896078,-0.938827640562745,0.5178571428571429,1.0,1.0,3/8,22.42%,AGBL5;FOLH1B;FOLH1
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.4523002280791123,-0.9386608592982942,0.6301369863013698,1.0,1.0,1/39,0.29%,EPN1
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),-0.4418227768740038,-0.9386336295481851,0.5645161290322581,1.0,1.0,3/36,5.61%,AMBP;FOXM1;PINK1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.44119797976111297,0.938543990379001,0.5897435897435898,0.9241986191724695,1.0,5/29,15.44%,BCL2;PPP1R13B;MAPK8;BID;TP53
prerank,GO_Biological_Process_2021__phospholipase C-activating dopamine receptor signaling pathway (GO:0060158),0.5563791170692395,0.9385121499995931,0.5434782608695652,0.9237815185362839,1.0,1/7,4.25%,DRD5
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),0.45521479732938275,0.9381259268094849,0.4878048780487805,0.9240913962030883,1.0,8/20,32.71%,TRA2A;CELF4;SF3B4;NUP98;LEO1;DAZAP1;CDC73;TRA2B
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.35387139341261314,-0.9380464896663167,0.5555555555555556,1.0,1.0,59/184,27.27%,RPL37A;EIF6;SENP3;RPL38;PWP2;EMG1;RPL15;NOB1;RPL3;RPL35A;RPS9;RPS27;RPL13A;RPL27A;RPS16;RPL36;LAS1L;RPL7A;RPL9;RPL13;RPL21;WDR12;NOP53;EXOSC8;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPL27;RPL35;RPS14;RPL11;RPS15;EXOSC2;RPLP1;SURF6;RPL24;SBDS;RPL18A;RPL29;RPLP2;PDCD11;RPL28;RPL12;RPL18;EBNA1BP2;RPL22;IMP3;RPS28;RPS19;RPS24;RPL26L1;RPL19;RPL8;RPS6;RPL10
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),-0.45819295817125566,-0.937879367180183,0.5441176470588235,1.0,1.0,4/29,13.80%,TCF7;TCF7L1;TERT;LEF1
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),0.554193143580316,0.9376751369978747,0.575,0.924672256273732,1.0,2/6,16.35%,RNF168;LIG4
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),0.3371570516847968,0.9375492069509133,0.3157894736842105,0.9245586350541671,1.0,26/125,16.34%,CTDNEP1;AUP1;TOR1B;PACSIN2;FAM83H;CNTLN;MARCHF5;STX5;TULP3;WASHC2C;GBF1;BBS9;BICD1;GCC2;CROCC;TSPAN17;CEP250;RAB35;BANP;WASHC2A;COG7;ANK2;GBP2;IFT140;TTC21B;ARL3
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),-0.6467228440597244,-0.9374480387651658,0.6037735849056604,1.0,1.0,1/5,12.51%,APOD
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.33545203685853237,0.9370689456008185,0.5,0.9253458883082787,1.0,13/103,7.93%,ADRA1A;GPR33;ADRA1B;TRPC3;GPR174;HTR2C;SLC8A1;CX3CR1;JPH1;CHRNA10;HMGB1;ABL1;EDNRA
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),0.5552423510605625,0.9370024416374864,0.5652173913043478,0.9250328547213201,1.0,5/8,35.79%,DPYSL2;DPYSL5;DPYS;ALDH6A1;DPYSL4
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),-0.3847304694382022,-0.9369788815566182,0.582089552238806,1.0,1.0,3/39,2.81%,TBX1;WNT5A;WNT8B
prerank,GO_Biological_Process_2021__cannabinoid signaling pathway (GO:0038171),-0.6174097444928552,-0.9369612938746994,0.6181818181818182,1.0,1.0,3/5,28.32%,ALOX15B;CNR2;CNR1
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.46200211938719926,-0.9369422273306506,0.5238095238095238,1.0,1.0,11/29,26.42%,IRF1;OAS2;OAS1;TLR2;DDX3X;DHX58;TRIM56;ISG15;FLOT1;PTPN11;RNF135
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),0.3553907933785856,0.9368584104208023,0.6153846153846154,0.9248634830018392,1.0,30/92,26.93%,SNRPN;NOVA1;KHSRP;TXNL4A;SNRPB;U2AF1;SRRM1;ZMAT5;PPP1R9B;SF3B1;SRSF4;PTBP1;FUS;SYNCRIP;RNF113A;SF3B4;LSM6;YJU2;NRDE2;PDCD7;PRPF18;MAGOHB;TCERG1;SNRNP48;SRPK2;SNRPF;SCAF11;RBM8A;SMU1;RP9
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),0.4121184941497097,0.9367769746959655,0.5454545454545454,0.9245589924166441,1.0,4/27,9.31%,GPC4;GPC6;STX8;GPC5
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.38489031199311563,-0.9365208444544909,0.5714285714285714,1.0,1.0,15/85,18.03%,TCF7;WNT5A;WNT8B;FZD8;TCF7L1;FRAT1;SFRP4;WNT8A;WNT6;LEF1;DDX3X;RBX1;WNT10A;CD24;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.46750621190216185,0.9364874041057208,0.53125,0.9247718638453432,1.0,3/20,7.93%,LRRTM3;SP1;CASP3
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,0.3633896953837426,0.9363992032586425,0.5,0.9245631456786327,1.0,17/99,13.08%,CYP7B1;ABCA9;EPHX2;ALDH1A1;ATXN1;PEX13;ABCA6;SLC27A2;SOAT2;ABCA1;ABCD3;FADS1;ABCD2;ISOC1;ACSL1;IDH2;NR3C2
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),0.4916194524527173,0.9360680045199189,0.4358974358974359,0.9248790902273956,1.0,4/15,8.00%,BTN3A2;JAG1;CADM1;CD8A
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.44202584554023194,-0.9359150282179932,0.6285714285714286,1.0,1.0,7/35,8.97%,HK2;ENO4;ALDOB;PKLR;ENOSF1;ENO2;GAPDHS
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),-0.4884369796387142,-0.9358419684838518,0.5614035087719298,1.0,1.0,4/19,11.81%,TBX1;SMAD6;LRP2;ENG
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.487558244478736,-0.9357753811382966,0.6351351351351351,1.0,1.0,4/26,8.63%,NODAL;DAB2;ZNF366;BRCA1
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.41045613074393156,0.9357160447933317,0.45161290322580644,0.9250835154099286,1.0,11/21,28.69%,EPHA3;EFNA5;MACF1;SLK;VCL;CAMSAP3;PTPRA;PEAK1;ROCK1;GPM6B;CORO1C
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.548886296643215,0.9354915903537112,0.6097560975609756,0.9251130951185463,1.0,2/8,2.68%,GRID2;NLGN1
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),0.5038778305031161,0.9353490786393184,0.5121951219512195,0.9248887691944341,1.0,1/13,1.67%,SLC26A7
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),0.36016185317207566,0.9353422357890182,0.5454545454545454,0.9244109376989877,1.0,17/61,24.67%,ADAMTS12;CAPN2;RHBDD1;CTSV;RSPRY1;NGLY1;OTUD7B;MALT1;CTSC;HM13;FAP;ZER1;OTUD7A;BAG6;LONP1;NR1D1;FBXL17
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.34685092604193135,0.9351862130888474,0.5483870967741935,0.9243219451297137,1.0,16/91,9.20%,IRGM;KIT;FGFR1;SIRT1;ERBB2;RALB;DIPK2A;PKD2;SNCA;PDGFD;PROX1;CCND3;FGF18;TELO2;TENM1;PIH1D1
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),-0.5346614242430499,-0.9351771239025857,0.5535714285714286,1.0,1.0,1/11,0.55%,TBX1
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),0.39819475582152414,0.9351254780631745,0.6086956521739131,0.9240350186352153,1.0,16/70,15.44%,APOE;HEXIM2;PKIA;SLC8A1;SIRT1;SLC8A3;RGS14;ABL1;LATS1;LRP6;PRKAR2A;NF1;NR2F2;MEN1;SPRY4;GADD45A
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),0.4495406116156786,0.9350321735123354,0.46875,0.9238433963228693,1.0,4/18,14.25%,AUTS2;DNMT1;PIH1D1;BCOR
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.47647753865222725,-0.934747370371428,0.5857142857142857,1.0,1.0,3/27,11.86%,PINK1;CLU;ACAA2
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.4962622158424932,-0.9347324506713769,0.5230769230769231,1.0,1.0,4/15,18.76%,TRAIP;F2RL1;CARD8;GPS2
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),0.35191912672820097,0.9343261287016695,0.7272727272727273,0.9248784572042564,1.0,10/57,11.29%,MT1G;KIT;PPARG;SIRT1;IFI16;CDK4;PML;FARP2;BATF2;LGALS9
prerank,GO_Biological_Process_2021__coronary artery morphogenesis (GO:0060982),-0.5849686358998426,-0.934239185762918,0.5833333333333334,1.0,1.0,1/5,0.55%,TBX1
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),-0.5762299066289118,-0.9338179736190705,0.559322033898305,1.0,1.0,2/10,8.63%,ZNF366;BRCA1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),-0.5604171882360514,-0.933600440633736,0.5106382978723404,1.0,1.0,2/6,24.64%,F2RL1;FLOT1
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),0.5390676759113792,0.9335876214048782,0.5945945945945946,0.9262762313198031,1.0,2/10,4.75%,PTGS1;AKR1C3
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),0.3042033261779246,0.9331563717678792,0.7,0.926668669841088,1.0,50/302,14.07%,COL22A1;COL8A1;TPM2;PCM1;TGFBR1;CD151;LAMA3;LOXL1;HIP1;SNCAIP;COL9A2;COL12A1;CCDC88B;P3H2;KLHL41;SNCA;RHOBTB3;SAMD14;RHOBTB1;COLGALT1;CGNL1;DSP;GREM1;PLOD3;MAP10;COLGALT2;SPAST;TPM4;GGA1;P3H4;RND3;PPIB;COL16A1;PLEC;TLL1;EVL;AVIL;PPP1R9B;KLHL24;CLIP2;COL13A1;COL5A3;ITGB4;CCDC88A;DST;NF1;LTBP2;PLK3;TPPP3;MAP7D3
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.5378792157141982,-0.9329115563940127,0.543859649122807,1.0,1.0,3/7,24.74%,CYBA;F2RL1;PJA2
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),0.4713518419509678,0.9325741719642586,0.4594594594594595,0.9272549094999009,1.0,5/16,15.10%,EYA4;BCL2;SNAI2;HSPA1A;EYA3
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.4713518419509678,0.9325741719642586,0.4594594594594595,0.9272549094999009,1.0,5/16,15.10%,EYA4;BCL2;SNAI2;HSPA1A;EYA3
prerank,GO_Biological_Process_2021__regulation of microglial cell migration (GO:1904139),-0.6089833096547702,-0.9323295471194429,0.5606060606060606,1.0,1.0,1/5,2.75%,P2RY12
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),0.4039327469285344,0.9320086387011124,0.5675675675675675,0.9281749922089467,1.0,10/36,16.67%,PTPRO;JAG1;ACER2;EFNA5;KANK1;NEXMIF;ADAM15;SPRY4;CORO2B;NOTCH1
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",0.45892391264186944,0.9319958405010782,0.6206896551724138,0.9277137162493778,1.0,3/15,12.12%,DCPS;PRPF39;SFSWAP
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),-0.4859319824420411,-0.9319100372744116,0.5970149253731343,1.0,1.0,9/19,32.18%,CLCF1;PTPRC;SASH3;CD86;TNFSF4;TNFRSF4;SUPT6H;PHB2;CR1
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.4605940990570856,0.9318369503655265,0.5116279069767442,0.9275840443787037,1.0,5/13,24.57%,RAD17;RAD9A;MDC1;EME2;MUS81
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.3482406812187381,-0.9313034700701428,0.6551724137931034,1.0,1.0,46/250,16.51%,TGFB1;NODAL;S100A13;IRF4;WNT5A;CYP1B1;SCIMP;IRF1;IL7;NFKB2;POLR1C;HLA-A;FLT4;NFAM1;ZFPM1;HLA-DPB1;BRCA1;ANXA1;HTR2B;IL27;NLRP9;STOML2;CYBA;PTPRC;SLC11A1;LACC1;TLR2;TXK;HLA-DPA1;C1QTNF4;NLRP3;ZNF580;POLR3H;NOS2;IL12A;CD80;NR1H4;GATA4;AFAP1L2;IL18;CD4;ZP3;AGT;ELANE;F2RL1;ALOX15B
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),0.41561998135256095,0.9311812583457131,0.5,0.928612831181225,1.0,5/22,5.81%,CYP1A2;LIPC;GLYATL2;CEL;STS
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),0.502984424377445,0.9310307926893531,0.6,0.9284434473749674,1.0,4/10,18.15%,JAG1;SNAI2;NOTCH1;RBPJ
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.32913734418158913,0.9309718306309365,0.5806451612903226,0.9280380941795927,1.0,8/82,7.29%,LETM2;CDH5;RGN;HTR2C;SLC8A1;DRD5;SLC8A3;DRD4
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),0.3941699886004161,0.9304708226615819,0.6363636363636364,0.9286480621655251,1.0,3/26,2.31%,CD38;SH2B2;BCL2
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),0.4679106912997793,0.9302262121004398,0.6190476190476191,0.9287541413726511,1.0,3/19,11.29%,FGF10;MYC;LGALS9
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),-0.425620360744114,-0.930216830002445,0.5735294117647058,1.0,1.0,5/40,8.81%,TBX1;SOX10;SEMA3F;SEMA3A;HTR2B
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.3455898017178878,-0.9300882760432804,0.6627906976744186,1.0,1.0,53/341,15.16%,DUOX1;CRLF1;TCF7;TGFB1;AIM2;ITGB2;HCK;IRF4;MMP9;WNT5A;DOCK8;NLRP12;CCND1;IFNK;ALOX5;RORC;IRF1;TNFRSF1B;TEC;GPER1;CLCF1;PTAFR;STAT1;IL7;GSDME;INPP5D;ALOX15;IL3RA;BRCA1;ANXA1;OSMR;GBP1;FPR1;AQP4;ITGAM;HSPA8;CDKN1A;IFIT1;OAS1;IL18BP;TLR2;F13A1;HLA-DPA1;OPRM1;PIK3CB;LEF1;NOS2;IL12A;CD80;IFNGR2;HYAL1;IL5RA;IL18
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.516405467440832,0.9297511916821048,0.475,0.9292530721856164,1.0,3/12,7.88%,ROBO2;JAG1;SLIT2
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),-0.38399162535652936,-0.929720053092864,0.5694444444444444,1.0,1.0,14/75,17.66%,SCN5A;SLC5A2;SLC5A1;ATP1A4;ASIC5;SLC24A1;SLC6A12;SLC9A2;SLC9C1;SLC6A4;ATP4A;SCNN1A;SCNN1G;SLC6A7
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.4585383001992559,0.9296848444633299,0.525,0.9289816789380408,1.0,3/20,8.23%,PPP1R14D;BOD1L1;STYXL1
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.45209071976924303,0.9291096337080766,0.5,0.929848972667515,1.0,7/23,14.40%,NMU;GRIK2;SYT1;RIMS2;CLSTN2;WLS;PTPN23
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),-0.43822315108282983,-0.929048199015141,0.5540540540540541,1.0,1.0,7/40,12.97%,LMOD1;HCK;C15ORF62;ALOX15;LMOD3;SCIN;BAIAP2L1
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),-0.5616433091985064,-0.9288496937612056,0.6271186440677966,1.0,1.0,1/10,1.65%,MSMP
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),-0.4494928349811361,-0.9288141589832845,0.5522388059701493,1.0,1.0,3/24,7.72%,LIPI;LIPH;PNPLA4
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),0.4045351111675349,0.9287543767686134,0.4444444444444444,0.9302366986728717,1.0,8/28,17.93%,CLC;SCRIB;HMGB1;ICOSLG;LGALS9;FADD;IL23A;RC3H1
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.4589289963332577,-0.9286539351082951,0.5740740740740741,1.0,1.0,3/17,18.37%,EIF6;LAS1L;WDR12
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.4441298593514102,-0.9286378692117776,0.5833333333333334,1.0,1.0,4/28,11.77%,ITGB2;PDZK1;USP17L2;ITGAM
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),-0.39312919926580536,-0.9283212883986739,0.527027027027027,1.0,1.0,5/71,8.63%,POLQ;MEIOB;RPA3;RAD51AP2;BRCA1
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),-0.5566469500066848,-0.9283105579221117,0.603448275862069,1.0,1.0,1/12,2.65%,BLK
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),0.5574863777880615,0.9278021777913446,0.6,0.9319730023762579,1.0,4/6,39.02%,KIF3B;FYCO1;KIF13A;KIFAP3
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),0.5379698077248574,0.9276798535594647,0.574468085106383,0.931739954742453,1.0,2/11,6.42%,SERPINE1;HMGB1
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),0.4659440208676455,0.9274969013878016,0.475,0.931687348695651,1.0,2/15,5.94%,ST6GALNAC3;ST8SIA4
prerank,GO_Biological_Process_2021__positive regulation of blood-brain barrier permeability (GO:1905605),0.5753599104770747,0.9274159888985913,0.5813953488372093,0.931376383909513,1.0,1/5,2.81%,ANGPT1
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),0.585329418687864,0.927324086930527,0.6585365853658537,0.9310970481213175,1.0,4/5,35.74%,PNPT1;TST;TSC1;MRPL18
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,0.349268127584771,0.9271842421819877,0.6060606060606061,0.9309275180832162,1.0,25/97,19.12%,HRH3;ELAVL3;NGB;PPFIA3;ADGRA1;CASKIN1;GRIN1;BRINP1;B4GALNT4;NXPH1;CSPG5;RIMS4;PRR36;FBLL1;SNAP91;MAP6;MPP2;SCRT1;VSTM2B;SRRM3;CLIP3;SYN1;MMD2;GRM5;PNCK
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),-0.4284378918671642,-0.9271392895620469,0.5694444444444444,1.0,1.0,8/38,17.06%,MARVELD2;CLDN1;CLDN6;CLDN5;CLDN2;CLDN18;CLDN20;ECT2
prerank,PanglaoDB_Augmented_2021__Chondrocytes,0.3057382883926551,0.9271373038491124,0.75,0.9305627001183722,1.0,19/124,11.20%,FIBIN;EMP1;LAMA4;MXRA5;MATN1;MRGPRF;COL12A1;SEMA5A;CREB3L2;ADAMTS12;MMP2;OLFML2B;EDNRA;EFS;FGF18;SNAI2;PDZRN3;COL16A1;SDC3
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),0.33270497281261213,0.9269565460852158,0.5161290322580645,0.930417065636002,1.0,10/83,9.05%,KIT;FGFR1;KSR1;APOE;ERBB2;PDGFD;RGS14;TRIB2;FGF18;TENM1
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),-0.4174554643964122,-0.9267885147069334,0.5492957746478874,1.0,1.0,5/44,18.33%,NEK2;CAV2;TOM1L1;BORA;PKMYT1
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),-0.4399299336053814,-0.9266387982042998,0.5846153846153846,1.0,1.0,5/44,8.63%,TBX1;TGFB1;WNT5A;COL1A1;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),-0.5820893723199231,-0.9263147740276352,0.6833333333333333,1.0,1.0,2/7,18.95%,PPT1;AXL
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),-0.44163041098315836,-0.9261929559459273,0.5211267605633803,1.0,1.0,8/24,20.21%,KIF14;TNFRSF1B;LGI4;JAM2;EGR2;MYRF;ITGAX;NCMAP
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),0.47694094092790557,0.9260176629124913,0.4878048780487805,0.9320289333204747,1.0,5/13,17.84%,ELOF1;CDCA4;ARID1A;SERTAD2;ARID1B
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),-0.39979210243516444,-0.9258694845506761,0.5161290322580645,1.0,1.0,1/43,0.37%,NEK2
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.2968370122583271,0.9258133394175757,0.7692307692307693,0.9320544323834947,1.0,98/396,19.38%,TEAD2;ESRRG;MLF1;TGFBR1;POU6F2;ZNF195;OR7D2;ZNF117;ZNF212;MAFB;TCOF1;MITF;ZFPL1;RORA;HDAC10;SLC39A8;PCGF1;APBB3;ZNF263;ATXN1;TULP3;RORB;SOX12;GPBP1L1;PCIF1;ZBTB4;NCOA2;HP1BP3;ZNF703;ZNF274;SPIN2B;PML;ABL1;POFUT1;SP1;RBBP6;NANOS3;ZNF33A;FOXN3;ZSCAN21;SNAI2;HCLS1;FADS1;ZNF2;TESMIN;ZNF331;CREM;ZNF519;MSC;HES6;NSD1;DMTF1;SMARCA2;GEMIN5;MLXIPL;EFEMP1;CCDC88A;RYBP;CDK11A;CARM1;RPS6KA4;NFYC;PUM3;NR3C1;PPARGC1B;ASCC2;WWTR1;SCRT1;ESCO1;INSR;MAGED1;TP53;DSCC1;BAZ2A;FUS;WWC1;ZNF708;NOTCH1;UBE2L3;ZNF273;THAP7;ZNF646;ZNF675;TFEB;PRMT5;SP3;NFX1;YAF2;SUPT3H;SOX13;SPIN1;ERC1;EP300;GRM5;CXXC1;ZNF280B;KAT6B;ZNF66
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.4410194696555809,0.9256029498257422,0.5609756097560976,0.9320096836868722,1.0,4/11,18.92%,NOVA1;PCBP3;ZNF445;PCBP4
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.4676277074684191,0.9255999404558336,0.575,0.9315438704224313,1.0,8/19,25.18%,SIRT1;IFI16;PML;TP53;EP300;BAG6;BCL3;DYRK2
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),0.5807257799983799,0.9254980080698073,0.6,0.9312967791397863,1.0,4/6,36.70%,NR4A3;HAVCR1;NECTIN2;CRLF2
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),0.5418348849890646,0.9250458086377273,0.5434782608695652,0.9317822310758412,1.0,3/9,18.26%,PPP1R15B;NCK1;ABCA7
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),0.4187956771836665,0.9249293335556416,0.5428571428571428,0.9315742031409193,1.0,7/17,20.13%,TCOF1;SIRT7;TAF1B;GTF3C4;GTF3C5;SPIN1;MARS1
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),0.4702370685436675,0.9248365258980107,0.625,0.9313196960537717,1.0,1/12,4.57%,TET2
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),0.5551076077715198,0.9247342700086979,0.625,0.9311121207674288,1.0,2/6,17.58%,PPARG;FAM120B
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.5077835981801286,-0.9246681523696564,0.6031746031746031,1.0,1.0,2/15,8.12%,KCNA5;KCNQ1
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),0.5784949212937845,0.9246103568295952,0.625,0.9308814364929183,1.0,4/5,39.02%,KIF3B;FYCO1;KIF13A;KIFAP3
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),-0.34997025320061437,-0.9245952029400665,0.575,1.0,1.0,30/188,17.08%,DUOX1;TGFB1;F7;MMP9;SMIM22;CLDN1;COL1A1;SEMA3F;GPER1;DAB2;SYNE2;CAVIN1;PLAU;ACTG1;SEMA3A;PIK3R3;SOD2;CGA;THBS1;LAMC2;VIL1;CXCL16;NTN1;LEF1;EPHA1;GRN;PLET1;F2RL1;ANGPTL3;VSIR
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),0.342869511779987,0.9243560167344227,0.5428571428571428,0.9309384890364937,1.0,16/62,17.67%,APOE;GPR174;ABL1;ABCA1;MYO9B;ABL2;ITGA3;KANK1;F2R;EPS8L2;EPS8;ARHGAP35;ARRB1;BCR;RIT2;CCDC125
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.48488972125327257,0.9242595847299862,0.6190476190476191,0.9305916375666696,1.0,2/9,6.24%,RSPO3;NKD1
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),-0.39936576575969157,-0.9241908888883844,0.6301369863013698,1.0,1.0,5/64,6.81%,CLIC1;APOL1;ANO2;SLC5A1;GLRA2
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell migration (GO:0090521),0.6142859740405571,0.9240334011748554,0.6744186046511628,0.9307962634414878,1.0,3/5,30.72%,KANK1;ROCK1;TESK1
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",0.4241577554283169,0.923838951623157,0.5833333333333334,0.9307291394103387,1.0,5/23,20.56%,MAN1A2;MAN1A1;RNF185;EDEM1;RNF139
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.4560167797951614,0.9236595899452469,0.6052631578947368,0.9306931014888562,1.0,3/17,4.59%,HSPB1;HTRA2;SIRT1
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.42409001817558273,0.923216093489617,0.6153846153846154,0.9311918718859069,1.0,6/26,7.93%,CSTA;AKR1C3;JAG1;DSP;LORICRIN;CASP3
prerank,GO_Biological_Process_2021__diphosphoinositol polyphosphate metabolic process (GO:0071543),0.5429455646630184,0.9231638750469711,0.5384615384615384,0.9279966870932532,1.0,1/5,5.02%,NUDT4B
prerank,GO_Biological_Process_2021__adenosine 5'-(hexahydrogen pentaphosphate) catabolic process (GO:1901911),0.5429455646630184,0.9231638750469711,0.5384615384615384,0.9279966870932532,1.0,1/5,5.02%,NUDT4B
prerank,GO_Biological_Process_2021__diadenosine pentaphosphate metabolic process (GO:1901906),0.5429455646630184,0.9231638750469711,0.5384615384615384,0.9279966870932532,1.0,1/5,5.02%,NUDT4B
prerank,GO_Biological_Process_2021__diadenosine hexaphosphate metabolic process (GO:1901908),0.5429455646630184,0.9231638750469711,0.5384615384615384,0.9279966870932532,1.0,1/5,5.02%,NUDT4B
prerank,GO_Biological_Process_2021__adenosine 5'-(hexahydrogen pentaphosphate) metabolic process (GO:1901910),0.5429455646630184,0.9231638750469711,0.5384615384615384,0.9279966870932532,1.0,1/5,5.02%,NUDT4B
prerank,GO_Biological_Process_2021__diadenosine pentaphosphate catabolic process (GO:1901907),0.5429455646630184,0.9231638750469711,0.5384615384615384,0.9279966870932532,1.0,1/5,5.02%,NUDT4B
prerank,GO_Biological_Process_2021__diadenosine hexaphosphate catabolic process (GO:1901909),0.5429455646630184,0.9231638750469711,0.5384615384615384,0.9279966870932532,1.0,1/5,5.02%,NUDT4B
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),-0.5488065193678402,-0.9230398655931125,0.5692307692307692,1.0,1.0,1/10,0.55%,TBX1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),-0.5134806675670592,-0.9227230518971229,0.6290322580645161,1.0,1.0,3/11,9.78%,GPER1;CD160;THBS1
prerank,GO_Biological_Process_2021__negative regulation of systemic arterial blood pressure (GO:0003085),-0.5804803865209435,-0.9224709316846287,0.6101694915254238,1.0,1.0,1/6,8.33%,SOD2
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.3647619890251693,0.9224093517162016,0.6071428571428571,0.9292435012694904,1.0,12/55,15.91%,GCK;CAPN10;APBB3;DOC2B;GLUD1;MCU;IRS2;UNC13B;WLS;PTPN23;ACHE;FRMD4A
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),0.4798121710373103,0.9223605199995011,0.5384615384615384,0.928876675988364,1.0,1/16,1.53%,KIT
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),0.45189723745390326,0.922304216750597,0.5555555555555556,0.9285025146749072,1.0,3/19,7.88%,CCN4;SERPINE1;SLIT2
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),-0.40314956161840165,-0.9219018718413375,0.5285714285714286,1.0,1.0,17/54,27.50%,PSMB9;NQO1;AZIN1;OAZ2;NR1H4;FGFR4;PSMA3;PSMA7;PSMB6;PANK2;PSMA5;PSMD6;PDK4;PSMC5;PSMB4;PSMB7;PSMD8
prerank,GO_Biological_Process_2021__RNA localization to Cajal body (GO:0090670),0.6197007189069103,0.9217731418839281,0.5957446808510638,0.9288106289986751,1.0,1/5,14.52%,WRAP53
prerank,GO_Biological_Process_2021__scaRNA localization to Cajal body (GO:0090666),0.6197007189069103,0.9217731418839281,0.5957446808510638,0.9288106289986751,1.0,1/5,14.52%,WRAP53
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),-0.5917331007192784,-0.9213455255281134,0.6666666666666666,1.0,1.0,3/6,23.97%,TRDN;PLN;ATP2A2
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.3623413576001681,-0.9212612441776326,0.6493506493506493,1.0,1.0,30/141,19.37%,PLAG1;MYH7;ACTC1;STAG3;MYOT;PDE6B;NRIP2;ZC2HC1C;SOX10;SNN;TCF7L1;ALOX12B;GP1BA;HTR1B;EDAR;SERPINA10;HNF1A;ITIH3;ARHGDIG;CD80;FGF22;TG;ATP4A;CHRNG;MYO15A;EFHD1;ABCB11;AMBN;IL5;NUDT11
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,-0.4083626943421012,-0.920724824242748,0.5555555555555556,1.0,1.0,7/38,14.16%,TCF7;FZD8;FRAT1;CCND2;WNT6;LEF1;HEY2
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.4335019756353128,0.9206770451823192,0.4878048780487805,0.9310008174821858,1.0,6/27,15.98%,MEGF10;ABL1;BNIP2;CDH2;MAPK12;PTBP1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),-0.49989027044512807,-0.9206344732265399,0.6071428571428571,1.0,1.0,4/11,22.60%,ERH;SLC25A19;SLC19A3;DCK
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.520026235129312,-0.9204530034267434,0.6440677966101694,1.0,1.0,3/11,15.29%,ITM2A;BACE2;ITM2C
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.45898882006825104,-0.9204183284968476,0.5344827586206896,1.0,1.0,2/16,10.63%,CCDC39;AQP4
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),-0.5157216555320188,-0.9201039542571513,0.6140350877192983,1.0,1.0,1/12,1.49%,TGFB1
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.356412489236035,0.9194643074337236,0.6296296296296297,0.9332349433939434,1.0,21/46,23.59%,FGFR1;KIAA0319;AUTS2;PEX13;SH3RF1;NR4A2;SDCCAG8;NAV1;MDGA1;MARK1;DCDC2;CEP85L;ASTN2;CDK5;NRCAM;MARK2;NTRK2;ELP3;ADGRL3;GPM6A;TUBB2B
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.3646749578754131,0.9192993128986348,0.5172413793103449,0.9331440850902439,1.0,17/69,25.97%,PRICKLE1;RANBP17;NXT1;CBLB;KPNA6;NUTF2;PPP1R10;RANBP2;RGPD5;APPL2;IPO8;NUP214;TPR;IPO7;RGPD8;FAM53A;NUP153
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),-0.3415240892937309,-0.9191778912909639,0.5833333333333334,1.0,1.0,32/237,16.59%,ENPP2;TGFB1;F7;MMP9;SMIM22;CLDN1;COL1A1;RAB11A;SEMA3F;GPER1;VTN;DAB2;SYNE2;PLAU;ACTG1;SEMA3A;PIK3R3;SOD2;CGA;THBS1;PTPRC;LAMC2;VIL1;CXCL16;LEF1;HYAL1;EPHA1;ZP3;GRN;PLET1;F2RL1;ANGPTL3
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),-0.5611233165680152,-0.9190331474153591,0.6101694915254238,1.0,1.0,4/9,19.47%,ZFPM1;HEY2;GATA4;DAND5
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),0.5393993450749808,0.9189020296604651,0.5957446808510638,0.9335145495098055,1.0,1/5,11.79%,UNC13B
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),-0.3827663592992506,-0.9186757426915385,0.581081081081081,1.0,1.0,16/101,16.91%,ENPP2;ELOVL2;DEGS2;PDXDC1;ALOX12B;PRKD3;PSAP;PPT1;ORMDL3;SGMS2;HACD4;ABCA12;CERS3;GBA3;SERINC1;SUMF1
prerank,GO_Biological_Process_2021__regulation of epinephrine secretion (GO:0014060),-0.6173061904217563,-0.9183604944204162,0.6470588235294118,1.0,1.0,1/5,13.18%,CARTPT
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,-0.3874738860115021,-0.9179191266213096,0.6621621621621622,1.0,1.0,10/96,6.82%,C1QTNF1;LMOD1;TGFB1;TIMP3;ANGPTL2;COL1A1;COL5A1;LOX;FBXL7;DCN
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),-0.5481690672506322,-0.917911130891371,0.6833333333333333,1.0,1.0,2/9,5.93%,TAF7;CIITA
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.5036690998827338,0.9177998399449715,0.6052631578947368,0.9356056866463336,1.0,2/8,5.17%,SIRT1;ERCC8
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.4146830177905396,-0.9177842768864272,0.6197183098591549,1.0,1.0,6/38,19.01%,BHMT;ETFBKMT;CTCFL;PCMT1;EEF1AKMT2;EEF2KMT
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),-0.43894900182325153,-0.9176868688508383,0.5507246376811594,1.0,1.0,1/23,0.65%,BHMT
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),0.4636609022757392,0.9176490132318034,0.5666666666666667,0.9353832121676391,1.0,6/15,9.00%,SLC30A10;SIRT1;MARCHF5;CDK6;RBL1;TWIST1
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),0.6164442530453627,0.91750034510417,0.6666666666666666,0.9352607446910787,1.0,2/6,7.63%,APOE;ABCA1
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),-0.513724134961784,-0.9173627013799517,0.582089552238806,1.0,1.0,1/13,4.10%,ALOX5
prerank,GO_Biological_Process_2021__sphingosine-1-phosphate receptor signaling pathway (GO:0003376),-0.5851930422433198,-0.916982805672291,0.6451612903225806,1.0,1.0,3/6,17.46%,PIK3CB;RAC1;PIK3CG
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immune response to tumor cell (GO:0002842),-0.6074571686962114,-0.9166811476018644,0.6349206349206349,1.0,1.0,1/5,10.21%,HLA-DRB1
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.34669433641535863,0.9165717637040066,0.52,0.9370486165434037,1.0,7/62,9.86%,TGFBR1;SBK1;GALNT1;MAPK8;MAP3K10;GALNT13;DYRK3
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),0.45556531658461125,0.9163485146870392,0.45161290322580644,0.9369944364956694,1.0,3/12,17.03%,H6PD;PGLS;RPIA
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),-0.4064616616658581,-0.9162944018467443,0.5633802816901409,1.0,1.0,7/51,11.77%,ITGB2;WNT5A;CIDEB;ACOX2;CLU;HPR;ITGAM
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.5269579268873559,0.9162838710646818,0.6571428571428571,0.9367027349770173,1.0,3/9,14.76%,HDAC3;HDAC1;HDAC4
prerank,GO_Biological_Process_2021__response to morphine (GO:0043278),0.6290987145354668,0.9162019556088208,0.68,0.9364419689279216,1.0,1/5,11.85%,PPP1R9B
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),-0.5051331709596948,-0.9161285196987203,0.5964912280701754,1.0,1.0,3/13,13.74%,SP100;WAS;SPOCK3
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.4837509047021123,0.9160848600469869,0.6382978723404256,0.9361814673474359,1.0,3/10,11.29%,ZBTB7B;HLA-DRA;LGALS9
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.37066760884499383,0.9158364046186178,0.5714285714285714,0.936280878737451,1.0,6/32,9.68%,SEMA6C;SEMA5A;FLNA;PLXNB1;FARP2;SEMA4A
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),0.4616841322835922,0.915111765933671,0.6410256410256411,0.9375656647304237,1.0,5/16,29.77%,ATG2A;ATG2B;ATG12;ATG7;ATG3
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),-0.5232585661576572,-0.9150426389397053,0.6721311475409836,1.0,1.0,4/10,15.53%,AHR;CEACAM1;PTPRC;HLA-F
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),-0.4463014933112154,-0.9144096305000551,0.5507246376811594,1.0,1.0,2/30,2.14%,CASQ2;KCNA5
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),-0.5613608515388171,-0.9143884119037393,0.631578947368421,1.0,1.0,2/9,7.49%,ALOX12;ALOX15
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.5172214737831409,-0.9141800712232568,0.6666666666666666,1.0,1.0,1/13,5.36%,SLFN14
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),0.4518157696076155,0.9141306340592235,0.47058823529411764,0.9395830077902414,1.0,4/15,22.57%,DAPK2;MCU;MOSPD2;THBS4
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),0.5302326180209269,0.9141204512486729,0.5757575757575758,0.9391457127505314,1.0,2/7,16.35%,RNF168;LIG4
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),0.5179561981242746,0.9136700860057272,0.5777777777777777,0.939625254743616,1.0,4/7,27.83%,PAK2;DFFA;BCL2L1;FZD3
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),-0.577759675713544,-0.9134057552397568,0.5925925925925926,1.0,1.0,3/5,35.38%,PANK2;C3;FITM2
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),-0.47136287641906793,-0.9130713523544943,0.5671641791044776,1.0,1.0,4/16,15.82%,ITGB2;CLU;ITGAM;GRN
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),-0.42693847349218056,-0.9129843904882883,0.6447368421052632,1.0,1.0,9/31,13.81%,SLC22A25;SLC22A24;SLC22A6;SLCO2B1;SLC13A4;ABCG2;SLC17A8;VDAC1;SLC22A3
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),-0.43050096384547665,-0.9129612862360499,0.6323529411764706,1.0,1.0,5/32,11.97%,CASQ2;GRK7;TRDN;ANXA1;MTCH1
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),-0.38090639061254367,-0.912948436783247,0.5714285714285714,1.0,1.0,9/71,11.21%,KCNJ15;TRPV6;SLC5A2;SLC5A1;ATP1A4;KCNJ11;SLC24A1;SLC9A2;SLC9C1
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),0.5203810998110915,0.9126256689902069,0.5434782608695652,0.9415698020319603,1.0,2/12,5.34%,TGFBR1;PKD2
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),0.5013886684435301,0.9125345052387075,0.6,0.9413610330896814,1.0,2/9,18.06%,AKR1C3;ADCY6
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),0.5028316545650616,0.9122215393481664,0.4888888888888889,0.9416176031633762,1.0,3/8,17.52%,SLC27A2;ACSL1;SLC27A4
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),-0.40848789781560413,-0.9121714572105108,0.6176470588235294,1.0,1.0,3/34,4.10%,TGFB1;WNT5A;ALOX5
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),-0.47863538059794125,-0.9120042241954317,0.6268656716417911,1.0,1.0,4/18,14.82%,ZFPM1;SMAD6;HEY2;GATA4
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),-0.3375152845418835,-0.9117963418758549,0.625,1.0,1.0,19/127,15.16%,AHR;TGFB1;P2RY12;CTNNA1;CYP1B1;RORC;ESR1;GPER1;KCNQ1;TGM2;BRCA1;P2RY6;CASP7;FAM210B;H2AZ1;SSTR1;TFPI;NR1H4;IL18
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),-0.3710566791447172,-0.91178104105798,0.5692307692307692,1.0,1.0,14/94,14.06%,NOTUM;DISC1;ESR1;HIC1;TCF7L1;SOX30;DAAM2;ATP6V1C2;GPC3;SFRP4;TERT;TLR2;RSPO1;ATP6AP2
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),0.44318614294958447,0.9114456074366732,0.5609756097560976,0.9428037008934753,1.0,4/12,13.82%,FZD5;CXXC4;COBL;SMAD2
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),0.35039704042362224,0.9114070859756619,0.4838709677419355,0.9423889567532246,1.0,24/82,20.34%,HSPB1;PTPRO;SLC8A1;CEP85;SLC8A3;SNCA;DEPTOR;ABL1;TRIB2;LRP6;SPRED1;PTPRB;UBASH3B;NF1;PTPRT;WWTR1;GADD45A;SRCIN1;DUSP19;TAB1;TARBP2;PRKAG2;PAK2;GNAQ
prerank,GO_Biological_Process_2021__positive regulation of T-helper 1 type immune response (GO:0002827),-0.5580824275794034,-0.9113924523473269,0.6730769230769231,1.0,1.0,3/7,24.13%,SLC11A1;IL18;IL1R1
prerank,GO_Biological_Process_2021__glial cell-derived neurotrophic factor receptor signaling pathway (GO:0035860),-0.6090590097866646,-0.9113382024706624,0.6333333333333333,1.0,1.0,2/5,17.20%,GFRAL;GDF15
prerank,GO_Biological_Process_2021__CD40 signaling pathway (GO:0023035),-0.5440655032714934,-0.9113150009148493,0.5932203389830508,1.0,1.0,4/6,31.80%,ITGA5;CD86;TNIP2;PHB2
prerank,GO_Biological_Process_2021__tubulin complex assembly (GO:0007021),-0.5748304714578175,-0.9112704404072006,0.6610169491525424,1.0,1.0,3/6,30.54%,TBCC;VBP1;TBCE
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),-0.409403710870367,-0.911207777579307,0.5694444444444444,1.0,1.0,13/69,19.87%,CASQ2;CAV3;TRDN;ATP1A4;KCNJ11;KCNQ1;CYP2J2;ITPR3;AGT;PLN;CALM1;ATP1A1;ACE2
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),-0.5124869906179047,-0.9107944530204573,0.6190476190476191,1.0,1.0,2/12,18.67%,DOCK2;IFI35
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,-0.3705487001001694,-0.9106901291646672,0.6538461538461539,1.0,1.0,15/97,13.87%,ENPP2;C1QB;GALNT15;LYVE1;P2RY12;SHISA6;SLCO2B1;FCGR3A;VSIG4;VWF;AQP4;GAS7;SSTR1;EDNRB;A2M
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),0.5395885683186015,0.9106307709400103,0.5909090909090909,0.9437105125188827,1.0,2/6,26.74%,HIF1A;EGR1
prerank,GO_Biological_Process_2021__mature ribosome assembly (GO:0042256),-0.5937295877463442,-0.9105824578000238,0.6415094339622641,1.0,1.0,2/5,14.99%,EIF6;DDX3X
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),0.4585333099497769,0.9102586446519078,0.5588235294117647,0.94416323273812,1.0,3/13,17.11%,APOE;LDLR;IAPP
prerank,PanglaoDB_Augmented_2021__Myoblasts,-0.3676410067067602,-0.9102220417493139,0.684931506849315,1.0,1.0,11/101,6.32%,C1QTNF1;LMOD1;ACTC1;TIMP3;ANGPTL2;ANGPT2;SYNC;COL1A1;COL5A1;FBXL7;UACA
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.508258645844047,-0.9101786192744653,0.5862068965517241,1.0,1.0,1/10,15.82%,GRN
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),0.324820966560984,0.9099348771573231,0.7241379310344828,0.9443188688701231,1.0,14/64,18.77%,PRSS3;PC;SLC19A1;DHFR;PDZD11;GSTO2;MTR;ABCC1;MTHFR;TCN2;PCCA;CD320;FPGS;SHMT2
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),-0.4550159172920034,-0.9098298285322788,0.65,1.0,1.0,5/24,18.74%,TGFB1;PPT1;SIAH1;ELANE;CLN8
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,-0.3503338791465384,-0.9096726448684178,0.6904761904761905,1.0,1.0,29/182,20.05%,COX6A1;ATP6V1D;ATP6AP1;ATP5F1E;CASP7;NDUFS2;COX6C;PDHX;ATP5MC3;ACAA2;ATP5PF;COX17;VDAC1;NDUFA2;NDUFB4;NDUFC1;COX7C;ETFB;ATP6V1E1;NDUFA1;TIMM17A;ATP5ME;COX7A2;IDH3G;COX4I1;NNT;MRPL34;LDHB;MRPS22
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),0.4151017305784128,0.9094312048535607,0.5853658536585366,0.9449988873064544,1.0,7/20,21.19%,TFB1M;FBLL1;FBL;ZCCHC4;BUD23;NSUN4;THUMPD1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),-0.4510446780708222,-0.909411341764541,0.6,1.0,1.0,6/24,12.29%,TGFB1;DAB2;RHOQ;GBP1;USP17L2;MRAP
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.4849169011851172,0.9093836362078842,0.5277777777777778,0.9445916802251637,1.0,4/15,13.82%,ITGA8;ITGA3;ITGB4;SMAD2
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),0.3843705760618909,0.9091838610613173,0.4722222222222222,0.9445266293300253,1.0,8/38,15.64%,KIT;FLVCR1;CASP3;HCLS1;DYRK3;ABCB10;MFHAS1;ACIN1
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),0.36650945796543516,0.9091151865285589,0.4857142857142857,0.9442718801217521,1.0,11/53,17.08%,PCM1;CCDC88B;MAP10;SPAST;CLIP2;CCDC88A;DST;PLK3;CLIP1;SLK;CLIP3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),-0.5915060241074971,-0.9088897193207879,0.6607142857142857,1.0,1.0,1/5,5.55%,GPSM2
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),0.5491482775967346,0.9088819452501999,0.5777777777777777,0.9442601624502048,1.0,2/5,32.49%,ALKBH3;FTO
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),0.40130454219267175,0.9084802694257743,0.6285714285714286,0.9447640953874662,1.0,6/33,11.66%,IRS1;APOE;MIDN;DRD4;F2R;RAB11FIP3
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.345972429032892,0.9083711469126228,0.5,0.9445778226843881,1.0,33/106,19.68%,ZSWIM5;PLPPR1;DSCAML1;ZDHHC11B;ASAP3;PPP1R13B;USP54;PIK3C2B;PLXNB1;KIAA1671;PDE9A;FGFR3;WNK2;HID1;COBL;EBF4;SGK2;ZNF704;NEO1;PTPRT;TMPRSS2;RAI2;RALGPS1;PPP1R9A;CGN;SRCIN1;MYRIP;EPB41L4B;PTCH1;TMEM125;NDRG2;PCDH1;HDC
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),0.49777478329444946,0.9082380945208517,0.6,0.9444826406826556,1.0,5/6,38.45%,NUTF2;PLK1;TOR1AIP2;NUP54;INTS13
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),0.3308568753296131,0.9080200397546544,0.75,0.944538984458905,1.0,27/113,18.20%,SNX18;PLIN5;RGS16;ERBB2;ASAP3;SRGAP2;RAPGEF1;MAPK8;PLXNB1;F2R;EVI5L;LIMS1;RAP1A;RGS7;FNTA;SNX9;DOCK9;RAP1GDS1;NF1;RGS6;PKP4;MAPK12;DOCK11;RSU1;ARHGAP27;TBC1D2;RAPGEF3
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.43143586080791724,0.9079980599132399,0.6470588235294118,0.9441109376552604,1.0,5/24,12.52%,ALCAM;AUTS2;SEMA5A;SLIT2;NLGN3
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),-0.4589394827207961,-0.9078430040871155,0.603448275862069,1.0,1.0,6/16,26.68%,STAT1;SPI1;YAP1;PTPN11;IL6R;ST18
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.2861948783040243,0.9077659321149183,0.6666666666666666,0.9441598472699921,1.0,45/264,15.73%,FGF10;KIT;MAPKAPK2;FGFR1;KSR1;IRS1;ANGPT1;SPTBN4;NRG2;ABHD17A;IL17RD;FGF17;PSME4;ERBB2;NRG1;RASA2;PPP5C;PSMA1;MAPK8;MYC;FGF18;TGFA;ABHD17C;TNIK;FGFR3;KITLG;GRIN1;IRS2;SPRED1;LGALS9;RASAL2;RET;FNTA;ABHD17B;MARK3;NF1;FLT3;NFKB1;PIK3CA;MEN1;HSF1;NCAM1;BRAP;MAPK12;IL2RB
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),0.5205766084000255,0.907670660676857,0.5882352941176471,0.943891181973585,1.0,1/8,2.55%,NFATC3
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),-0.5567458102959515,-0.9076476751804532,0.6166666666666667,1.0,1.0,2/6,12.73%,PDZK1;ABCB1
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.38929670314253484,0.9075606007595219,0.5833333333333334,0.9436756801124359,1.0,8/26,23.81%,SLC8A1;MICU1;MCU;SLC25A23;TRPC4;CACNA1I;CACNA1A;CACNA1B
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.4558576814694283,-0.9074511569771746,0.5909090909090909,1.0,1.0,3/18,9.20%,TIMP3;TNFRSF1B;TIMP4
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),0.5055391358178425,0.9073767995788782,0.6,0.9436643134459177,1.0,1/8,0.97%,AUP1
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.4945754920153191,0.9073244402818176,0.5454545454545454,0.9433283597059764,1.0,2/9,10.37%,SLC30A10;ABCD2
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),0.4528764254915252,0.9071678346466208,0.6382978723404256,0.9432266376328435,1.0,2/16,2.85%,IRS1;MIDN
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),-0.37740832565830285,-0.9068126954556829,0.7162162162162162,1.0,1.0,19/111,15.91%,SLC22A25;SLC22A24;TCN1;SLC22A6;SLCO2B1;SLCO2A1;CHMP3;ABCG2;PPT1;MFSD2B;SLC18A2;LRP2;SLC22A3;SLC6A4;SLC22A4;ABCA12;TXNIP;AMN;SLCO1A2
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),0.4975278937673787,0.9067290081989736,0.5869565217391305,0.9436001165395399,1.0,2/8,9.44%,DOC2B;AKT2
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),0.31174409140014175,0.9064769185169212,0.72,0.943656647749717,1.0,15/111,8.41%,MT1G;NEUROD2;NLGN1;CPNE4;TRPM2;AKR1C3;CPNE7;ITPKB;SYT3;PKD2;SNCA;SYT17;SLC25A24;MAPK8;SYT1
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),-0.49481833752348064,-0.9063874735828104,0.6376811594202898,1.0,1.0,4/14,13.40%,CYP1B1;RDH13;DHRS13;BCO1
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),-0.5373129331321431,-0.9062754161376615,0.6714285714285714,1.0,1.0,2/10,18.18%,ADA;PRPS1
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),0.5561771629829559,0.9062258774564547,0.6976744186046512,0.9437733924092437,1.0,4/7,18.55%,ZC4H2;MDGA2;MDGA1;SOX13
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),-0.5368543102656017,-0.9060954847630609,0.6491228070175439,1.0,1.0,1/8,0.55%,TBX1
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),0.43792017551138185,0.9060516064348754,0.6341463414634146,0.943671651311467,1.0,6/15,28.25%,MAGI2;PPP1R15B;GPLD1;BMP2;MTMR9;MEF2C
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),-0.43113504687116744,-0.9060499111324726,0.6323529411764706,1.0,1.0,3/35,9.20%,TIMP3;AZIN1;TIMP4
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),-0.6063781887830721,-0.9059904300677876,0.6885245901639344,1.0,1.0,1/6,6.40%,TRDN
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),0.36147918107361277,0.9059802823372011,0.5263157894736842,0.9433893823161053,1.0,15/65,22.28%,HNRNPF;DXO;HNRNPH1;HNRNPL;WDR74;SETMAR;RBFOX2;POLG;ANKLE1;GTF2F2;PTBP1;XRN2;DNA2;LSM8;POLR2F
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.3903392032494247,-0.9059507652590951,0.6363636363636364,1.0,1.0,21/46,28.06%,EIF6;MPV17L2;PWP2;RPL3;RPS27;DDX3X;BRIX1;NOP53;MRPL20;RPL5;RPS14;RPL11;RPS15;RPL24;SBDS;RPSA;RPS28;RPS19;MRPS2;RPL10;DHX37
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),0.47328281391115035,0.9057355074185005,0.5405405405405406,0.9432728889953885,1.0,1/8,12.44%,AK9
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),-0.48547176946199677,-0.9056474937349015,0.6060606060606061,1.0,1.0,3/15,7.72%,LIPI;LIPH;PNPLA4
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.44284198900914035,-0.9055986637442413,0.5357142857142857,1.0,1.0,1/17,1.47%,MGST1
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.44284198900914035,-0.9055986637442413,0.5357142857142857,1.0,1.0,1/17,1.47%,MGST1
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.3377243483180748,0.9052530130626418,0.5909090909090909,0.9439685341149218,1.0,7/75,9.93%,EFNB1;EPHA7;MMP2;CRK;EPHA3;EFNA5;GRIN1
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),-0.42911458640130395,-0.9052307481202638,0.6133333333333333,1.0,1.0,5/29,17.81%,CCDC39;TBX6;ENG;GATA4;MESP1
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.4589133274183366,-0.905050090908001,0.6811594202898551,1.0,1.0,5/17,26.06%,PINK1;GRN;VSIR;APH1A;DDRGK1
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.40948291030119877,-0.905040371123268,0.6428571428571429,1.0,1.0,12/64,10.28%,SIRPG;ITGB2;CYTIP;TAGAP;KLRB1;TNFRSF1B;GPR183;PARVG;CD5;HLA-DPB1;TRAF3IP3;PTPRC
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),-0.4815865511945969,-0.9049937427656989,0.5918367346938775,1.0,1.0,3/10,9.84%,MGST1;CYP3A5;CYP3A4
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),-0.4815865511945969,-0.9049937427656989,0.5918367346938775,1.0,1.0,3/10,9.84%,MGST1;CYP3A5;CYP3A4
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),-0.4815865511945969,-0.9049937427656989,0.5918367346938775,1.0,1.0,3/10,9.84%,MGST1;CYP3A5;CYP3A4
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),0.5534936048767243,0.9049616254821766,0.575,0.9442351326458422,1.0,3/7,17.93%,BCL6;IRS2;NOC2L
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.44714969205158506,0.9047478432403987,0.6428571428571429,0.9442761285633294,1.0,3/14,12.30%,AK3;IMPDH1;EFL1
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222),0.560265991239637,0.9046708482986532,0.65,0.9435325825351752,1.0,2/5,22.16%,GSTZ1;IL4I1
prerank,GO_Biological_Process_2021__L-phenylalanine catabolic process (GO:0006559),0.560265991239637,0.9046708482986532,0.65,0.9435325825351752,1.0,2/5,22.16%,GSTZ1;IL4I1
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),0.41138678040565113,0.9046537196987996,0.5714285714285714,0.9430938631238107,1.0,2/28,5.55%,CPEB1;CAPN2
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),0.37866315348319574,0.9046224501213399,0.5806451612903226,0.9426930610153985,1.0,12/41,17.37%,HRH3;PCLO;SNCA;PDZD11;PPFIA3;SYT1;GRM4;RIMS2;SNPH;SYN2;NRXN1;SYN1
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.5107991453729129,0.9045836709366781,0.5531914893617021,0.9423151345446097,1.0,5/10,6.51%,ZBTB7B;CBFB;SH3RF1;HMGB1;HLA-DRA
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),0.5322528709263803,0.9045638758838603,0.625,0.9418926496619922,1.0,2/7,32.87%,RNF122;HEBP2
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.446723852552252,-0.9043946354341428,0.5942028985507246,1.0,1.0,1/38,1.82%,TRIM62
prerank,GO_Biological_Process_2021__positive regulation of lipoprotein particle clearance (GO:0010986),-0.5629529328303846,-0.9043508387322274,0.5849056603773585,1.0,1.0,2/5,18.30%,GPIHBP1;LDLRAP1
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.39606967556595923,0.904345167762986,0.46153846153846156,0.941859812903681,1.0,11/31,30.73%,BICD1;TRAK2;ARHGAP21;BICDL1;UXT;PEX14;LRPPRC;TRAK1;RAB6A;NDE1;BICDL2
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.5232212171836031,-0.904059118198355,0.6612903225806451,1.0,1.0,2/12,14.99%,TERF2IP;DDX3X
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),0.3298973212857029,0.9038525600377644,0.6111111111111112,0.942522785187455,1.0,22/51,28.52%,APOE;MFSD2A;PITPNM1;ABCA1;LDLR;ABCC1;PITPNC1;PRELID2;ABCA7;ATP8A2;ATP10A;OSBPL8;NPC2;SCARB1;PCTP;ATP11B;PITPNB;PRELID3A;ABCG1;ATP8B1;PRELID3B;ABCA3
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),-0.40958346493767817,-0.9036627760239111,0.64,1.0,1.0,3/43,7.51%,POLQ;TERF2IP;WAS
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),-0.5005700961824557,-0.9035262644468063,0.5818181818181818,1.0,1.0,2/11,3.67%,MMP9;CCND1
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),-0.38480215063999534,-0.9034259259489316,0.6557377049180327,1.0,1.0,11/75,11.61%,SIRPG;TULP1;DOCK2;SFTPD;DAB2;GPC3;ANXA1;CYBA;SLC11A1;SCIN;PON1
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),-0.43601774197456195,-0.9034166770226717,0.6666666666666666,1.0,1.0,2/27,6.30%,TCF7;IL7
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),0.4051888550722343,0.9033423948605616,0.5757575757575758,0.9433122226951671,1.0,4/17,18.00%,APOE;RNF128;CTSC;FAF1
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.5104768715607457,-0.9032073070001412,0.6271186440677966,1.0,1.0,4/11,26.68%,SEC62;HSPA5;SGTB;CHMP4B
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),-0.44215987396068085,-0.9027878948191475,0.5972222222222222,1.0,1.0,2/31,1.19%,PKP2;SCN5A
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081),-0.571151704262016,-0.9027850568166903,0.6,1.0,1.0,2/5,19.87%,AGT;ACE2
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),-0.5534439844049961,-0.9024060246161506,0.6181818181818182,1.0,1.0,1/9,1.81%,ACTC1
prerank,GO_Biological_Process_2021__regulation of bile acid biosynthetic process (GO:0070857),0.5074848676160431,0.9023612462853995,0.5319148936170213,0.9451173507863322,1.0,3/7,13.68%,SIRT1;PROX1;STARD4
prerank,PanglaoDB_Augmented_2021__Neurons,0.32733858660650694,0.9023233136622979,0.5555555555555556,0.9447766985750073,1.0,74/267,20.45%,SLC17A6;LHFPL4;RORA;GRM3;LRRTM3;RESP18;ELAVL3;CNTNAP2;CADM2;PCLO;CACNB4;RIN1;PAK5;PROX1;SAFB2;NCALD;PDE1A;LUZP2;ERC2;ADGRA1;CACNG2;CELF5;CELF4;SLC6A17;PNISR;BRINP1;RGS7BP;NXPH1;GPATCH8;CTTNBP2;ELAVL4;GNL3L;RAB3C;OLFM3;SGIP1;SFSWAP;CPNE6;TESC;SNAP91;RBFOX1;FRRS1L;NWD2;RHBDD2;SCRT1;CSPP1;MECP2;ZMYND11;VSTM2B;SRRM4;NRXN1;HDAC11;PPP1R9A;MATK;SACS;SLC36A4;RIT2;DZANK1;SYN1;PPFIA2;MYO5A;ZNF445;MMD2;ST8SIA3;ADGRB3;CHODL;GRM5;PNCK;ZCCHC7;CDK5;CTNNA2;UNC79;KMT2C;HPCA;TRIP11
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),-0.5050720008722416,-0.9019941876470463,0.6119402985074627,1.0,1.0,1/13,0.42%,DBH
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),-0.4768774830951362,-0.9015187414026317,0.5964912280701754,1.0,1.0,1/11,7.26%,BTBD18
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),0.33272639713919544,0.9012500597335144,0.5151515151515151,0.9467659835972076,1.0,8/89,8.03%,RFWD3;HDAC3;HDAC10;SIRT1;TOP2A;ABL1;LATS1;MYC
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.4856877316807098,0.9009208149163512,0.5416666666666666,0.9471189100537141,1.0,4/11,22.88%,RALB;PIP4K2A;LRSAM1;ELAPOR1
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),-0.4749340482492122,-0.9008675952970658,0.6031746031746031,1.0,1.0,7/24,22.95%,TCN1;ABCG2;AMN;CBLIF;SLC23A1;SLC52A2;GC
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.32713554217579643,0.9006924716304596,0.6,0.94729992411111,1.0,27/123,16.92%,IRGM;APOE;PACSIN2;HIP1;SNCAIP;URI1;CDH13;PAK5;RAPGEF1;SGK1;NRG3;ABL1;LATS1;ABL2;WNT3A;ZFYVE16;CHPT1;SGK2;RAP1A;CD22;CDK11A;MLLT3;MARK4;PTCH2;NEDD4;RAB5A;RIT2
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),-0.3604941268877948,-0.9005872121041193,0.6447368421052632,1.0,1.0,7/72,9.57%,FGF20;KCNJ15;KCNA5;SYT10;SYT2;KCNJ11;PDZK1
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),0.45702814727734536,0.9005659728019635,0.5641025641025641,0.9471676239431086,1.0,5/14,11.49%,PTGS1;AKR1C3;CYP2S1;AKR1C1;CES2
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),0.3826858827410562,0.9005286553790096,0.5675675675675675,0.9467969927487835,1.0,5/39,4.97%,CCN4;ADAMTS1;CDH13;MMP2;DNMT1
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),0.28064361353788486,0.900387299193306,1.0,0.9466799677339285,1.0,56/486,10.78%,IL7R;BAMBI;RAB27A;GRK5;FGF10;TGFBR1;TCIRG1;VEGFC;BCL2;FGFR1;IRS1;POU3F2;MFSD2A;PARD3;TRPC3;CCN2;SLFN11;CAPN10;RIPK2;FGF17;SIRT1;AKR1C3;ERBB2;PDGFD;NRG1;HES1;SLC25A33;PROX1;DLX1;TIMP1;ACER2;ZNF703;GREM1;ACACB;FER;CDK4;MAPK8;MYC;FGF18;TGFA;LRP6;TNFRSF18;WNT3A;HCLS1;TFE3;AKT2;FGFR3;KITLG;GRIN1;RNF10;RPS6KA3;ACER3;IRS2;ADNP2;F2R;NAMPT
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.38165337944095373,-0.9003678894355539,0.6428571428571429,1.0,1.0,4/68,5.16%,NEK2;MISP;ABRAXAS1;RAB11A
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.5024191833192735,0.9002795848680715,0.5853658536585366,0.9459923683874842,1.0,3/7,28.09%,ATG2A;ATG2B;ATG7
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.5024191833192735,0.9002795848680715,0.5853658536585366,0.9459923683874842,1.0,3/7,28.09%,ATG2A;ATG2B;ATG7
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),0.479809801383154,0.9001094103197312,0.5833333333333334,0.9459725968325535,1.0,1/9,0.53%,PHLDB2
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.4176225113929336,0.9000273442938557,0.5777777777777777,0.9456109000473603,1.0,2/25,4.06%,SMYD2;SMYD1
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.3607584439534115,0.8999433926048698,0.4827586206896552,0.945286708873827,1.0,14/47,17.39%,TBC1D10A;APOE;PERP;RHBDD1;ASTL;TANK;FADD;SNX9;NKD2;FURIN;MAPK12;CTSC;GPLD1;AURKAIP1
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.3691958504949425,-0.8993854754404275,0.6714285714285714,1.0,1.0,12/85,14.93%,HCK;SCTR;TSHR;GPHB5;FCGR3A;GPR27;CGA;HLA-DRB1;GPR39;PTGDR;GGT5;ADCY7
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),-0.49339063819413803,-0.8990694676933269,0.6,1.0,1.0,3/10,23.60%,MOAP1;BLOC1S2;BNIP3
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.43187581386242896,-0.8988858681208226,0.5921052631578947,1.0,1.0,2/23,6.40%,CASQ2;TRDN
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),-0.5150979973835408,-0.8984949428429488,0.625,1.0,1.0,4/11,22.55%,USP13;AQP11;HERPUD1;UBXN1
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),0.5029512551267958,0.8979961271478869,0.6410256410256411,0.9492552192546985,1.0,4/8,21.69%,DHFR;MTR;NREP;RTN4RL2
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),0.4202258736690636,0.8979773470364475,0.5428571428571428,0.9488033706728277,1.0,5/19,19.41%,SFXN2;SLC6A20;SLC7A8;SLC16A2;SLC1A3
prerank,GO_Biological_Process_2021__elastic fiber assembly (GO:0048251),-0.59412767008234,-0.8978829899916871,0.6909090909090909,1.0,1.0,2/6,21.40%,TNXB;MYH11
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),0.4245842196286724,0.8978017330417278,0.6470588235294118,0.9488341991515784,1.0,4/26,7.30%,IRGM;SERPINE1;GALP;F2
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),0.40597816548508264,0.897797319430536,0.5581395348837209,0.9483830012166952,1.0,6/24,9.00%,NGF;PPARG;PYHIN1;HES1;HMGB1;TWIST1
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.5007587527938722,-0.8977386215594941,0.6153846153846154,1.0,1.0,5/15,29.23%,NOP10;CCT6A;CCT8;CCT7;CCT2
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.3985758445240147,-0.8975773097847332,0.6911764705882353,1.0,1.0,12/59,16.55%,CRLF1;FGF20;KIF14;CLCF1;PINK1;SOD2;PPT1;WFS1;FOXB1;TGFB3;GRN;NAIP
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.42139936265763384,-0.8975753300440945,0.6575342465753424,1.0,1.0,11/62,10.28%,SIRPG;AHR;GMFG;IRF4;CYTIP;TAGAP;KLRB1;RORC;CD5;TRAF3IP3;PTPRC
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.3667088643600054,-0.8974990768316616,0.5735294117647058,1.0,1.0,22/79,22.88%,CCNG2;SPDYA;CCND1;CDC25A;LATS2;CCND2;CDKN2D;CDKN1A;CCNI2;CCNF;CCNE2;CDKN3;CDC37;CDK5R1;PKMYT1;CDC6;INCA1;GTPBP4;CDKN1B;BLM;CCNI;PSRC1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.40523393895686366,-0.8971631632371286,0.625,1.0,1.0,6/28,16.76%,TGFB1;P2RY12;PIK3R3;ATG14;TEK;TNFAIP8L3
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.3991233733944947,0.8968780095717273,0.5483870967741935,0.9499408128552951,1.0,9/24,19.40%,ABHD17A;ABL1;ABHD17C;WNT3A;ABHD17B;MDGA1;NEDD4;SLITRK2;CTNNA2
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 2 signaling pathway (GO:0034137),-0.5537911745876319,-0.8968577293655741,0.6440677966101694,1.0,1.0,3/6,24.74%,CYBA;F2RL1;PJA2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.39990189794747555,0.8966185039561756,0.6111111111111112,0.9500377102688655,1.0,1/21,0.17%,PNP
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.37434973335931543,-0.8965535429985005,0.6571428571428571,1.0,1.0,12/59,16.67%,TGFB1;ALOX5;CNMD;STAT1;CEACAM1;THBS1;CAV2;NLRC3;ATP5IF1;VDR;AQP11;GHRL
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.30749222616948013,0.8964778569182386,0.782608695652174,0.9499123801930953,1.0,48/137,25.25%,ELOVL6;SLC44A5;APOE;MFSD2A;GSTM5;ACER2;ABHD3;GSTO2;HACD1;GPHN;ELOVL4;GSTM2;CHPT1;PLPP2;ACER3;CEPT1;LPCAT2;CHKA;PLA2G4C;GSTA4;GSTZ1;FURIN;PPM1L;ACHE;ELOVL1;CERS4;LPIN2;SAMD8;PAM;FA2H;ST3GAL2;ELOVL5;ASL;PLPP3;DMD;CPS1;ESD;CERS5;SLC44A2;LARGE1;PEMT;PCTP;CSNK1G2;ELOVL7;PAH;GSTT2B;NANP;LPCAT3
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),0.5310139843313314,0.8964291491795567,0.675,0.9495503478626597,1.0,3/7,27.18%,ATM;SMG6;NBN
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.44259067748625824,0.8963785409176557,0.55,0.9491812731328104,1.0,4/16,8.00%,BTN3A2;BACH2;JAG1;CD8A
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),-0.42345600238677017,-0.8959763343022412,0.6153846153846154,1.0,1.0,3/28,6.27%,FGF20;SYT10;SYT2
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),0.38958885215383054,0.8959396655011437,0.6296296296296297,0.949670210139375,1.0,1/26,5.00%,STX5
prerank,GO_Biological_Process_2021__lens fiber cell differentiation (GO:0070306),-0.6213472567405462,-0.8959143949746263,0.6296296296296297,1.0,1.0,3/5,28.07%,MAF;WNT5B;BFSP1
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.4060382567851929,-0.8958836295212488,0.7213114754098361,1.0,1.0,1/57,0.37%,NEK2
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),0.48762472016577835,0.8957097879354051,0.6382978723404256,0.9496635440138086,1.0,2/12,5.81%,CYP1A2;STS
prerank,PanglaoDB_Augmented_2021__Pinealocytes,0.3245558970568319,0.8953906351147858,0.7741935483870968,0.9501074488500787,1.0,29/87,17.09%,ADRA1B;MGAT4C;RP1L1;SLC2A11;CDH7;SV2C;GABRG3;PDE10A;TPH1;HCN1;KCNJ6;OPRD1;DRD4;CATSPER2;CATSPERG;AANAT;CREM;RGR;MYT1L;XKR4;SAG;FRRS1L;ZNF774;PDZD7;SRRM4;AP3B2;SLC7A14;PMEPA1;UNC13C
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),-0.5161079729359496,-0.8953032345747347,0.6140350877192983,1.0,1.0,3/10,15.82%,GPER1;CD300LF;GRN
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.4419988275573197,-0.8951009558734663,0.5972222222222222,1.0,1.0,11/29,23.97%,CHMP3;ATG14;GABARAPL1;GABARAPL2;CALM1;MAP1LC3B2;RUBCNL;LIX1;VAMP7;LAMP2;ATP2A2
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),0.49099159628668476,0.8950655378317356,0.5476190476190477,0.9503368215280372,1.0,7/13,22.91%,STX6;FHDC1;GCC2;VTI1A;PRMT5;TRIP11;MYO18A
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),-0.4165117878292503,-0.8950210224145041,0.6216216216216216,1.0,1.0,9/37,21.27%,LPAR1;PRDM12;ANXA1;NDUFS2;METTL14;ROGDI;MESP1;GCM2;SIX4
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.3330255096353384,0.8949666383424261,0.7083333333333334,0.9500863296573366,1.0,14/91,7.66%,GALNT7;GALNT12;DPM3;TMTC2;TET2;POGLUT3;FKTN;GALNT1;ST3GAL3;MUC13;POGLUT2;PLOD3;FKRP;POFUT1
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.37386653972384704,0.8942435056330016,0.5882352941176471,0.951030909836373,1.0,6/28,18.80%,RAB27A;MVB12A;CHMP6;VTA1;SNF8;STAM2
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),0.49637717532592324,0.8942410196108974,0.6111111111111112,0.9505665392749294,1.0,3/13,12.78%,CPSF1;ERN1;CPSF7
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),0.4421511294868883,0.893988521308499,0.5,0.9506331380035673,1.0,5/10,24.22%,HDAC10;ODC1;SAT1;SMS;SRM
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),0.45499885505343085,0.8937626270888254,0.5945945945945946,0.9507070364416719,1.0,1/13,3.16%,ZBTB7B
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.42258458901975976,-0.8937497882292295,0.640625,1.0,1.0,7/29,21.63%,IRF4;PDCD1LG2;HLA-DRB1;F2RL1;VSIR;AGER;ISG15
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.375841140035576,0.8937326798386466,0.5142857142857142,0.9503023917700363,1.0,7/25,13.66%,RAB31;BLZF1;GOLGA4;GCC2;GGA1;MACF1;RAB10
prerank,GO_Biological_Process_2021__regulation of leukocyte tethering or rolling (GO:1903236),-0.5324235450161624,-0.8936436769881682,0.6,1.0,1.0,1/7,8.55%,SELP
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),-0.4083150382615274,-0.893454263994078,0.6285714285714286,1.0,1.0,10/47,17.19%,WAS;SVIL;SCIN;GAS7;VIL1;CFL1;CATIP;PSTPIP1;GHRL;RAC1
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.3833888453561177,0.8933898546011787,0.7027027027027027,0.9506633220902451,1.0,7/31,14.65%,ARC;PKD2;GSTM2;ATPSCKMT;NLGN3;STAC2;ANK2
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),-0.5443597325613021,-0.8933815131865347,0.6428571428571429,1.0,1.0,2/8,9.78%,SLFN14;THBS1
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),0.33068441325954445,0.8932720211763276,0.6129032258064516,0.9504870644919161,1.0,9/75,5.33%,PCDH15;LHFPL3;KIT;LHFPL4;SPTBN4;ALDH7A1;PAX3;WHRN;USH2A
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),0.4223600675266307,0.8930575292154106,0.7142857142857143,0.9505167880851187,1.0,5/21,15.27%,MT1G;AKR1C3;MAPK8;MT4;HSF1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.41307074894736273,0.8929084016519314,0.5833333333333334,0.9504509748065813,1.0,2/21,3.92%,IRGM;RIPK2
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.32990856228909987,0.892867845249798,0.6785714285714286,0.9500768115028696,1.0,13/90,8.99%,RASSF2;HDAC3;DUSP15;CCN2;FKTN;TNFRSF19;SH3RF1;HMGB1;CARD9;SH3RF3;PLCB1;RAP2A;MAP3K10
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),-0.45908832406998523,-0.8927122520835178,0.6086956521739131,1.0,1.0,4/15,16.73%,PINK1;ACTN3;COX7A1;COX7A2
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.3812670732626967,-0.892616392449928,0.7183098591549296,1.0,1.0,11/64,10.54%,ELOVL2;ALOX12;LIPI;ACSM6;ALOX5;TECRL;LIPH;ALOX15;CYP3A4;OLAH;ACSM3
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.3795630608603532,-0.8925632869921097,0.6212121212121212,1.0,1.0,9/69,13.30%,NMUR2;XCR1;P2RY12;ACKR4;SELP;HTR2B;PTPRC;CXCR5;EDNRB
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.28770025822484274,0.89251701726796,0.7857142857142857,0.9504883515176428,1.0,88/359,19.38%,TEAD2;ESRRG;MLF1;TGFBR1;POU6F2;ZNF195;OR7D2;ZNF117;ZNF212;MAFB;MITF;ZFPL1;RORA;HDAC10;SLC39A8;PCGF1;APBB3;ZNF263;ATXN1;TULP3;RORB;SOX12;GPBP1L1;ZBTB4;NCOA2;HP1BP3;ZNF703;ZNF274;SPIN2B;PML;ABL1;POFUT1;SP1;ZNF33A;FOXN3;ZSCAN21;SNAI2;HCLS1;FADS1;ZNF2;TESMIN;ZNF331;CREM;ZNF519;MSC;HES6;NSD1;DMTF1;SMARCA2;MLXIPL;EFEMP1;RYBP;CDK11A;CARM1;RPS6KA4;NFYC;NR3C1;PPARGC1B;ASCC2;WWTR1;SCRT1;INSR;MAGED1;TP53;BAZ2A;FUS;WWC1;ZNF708;NOTCH1;UBE2L3;ZNF273;THAP7;ZNF646;ZNF675;TFEB;PRMT5;SP3;NFX1;YAF2;SUPT3H;SOX13;SPIN1;ERC1;EP300;CXXC1;ZNF280B;KAT6B;ZNF66
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),0.3542673606622283,0.8920719953582887,0.6,0.9509508439780054,1.0,19/78,14.94%,HYKK;AASS;TDO2;HNMT;ALDH7A1;CARNMT1;BCKDK;CBS;KYAT1;BCAT1;ECHS1;GLUD1;AADAT;SARDH;DDAH1;OGDH;GLUD2;GSTZ1;HIBADH
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),-0.4535801909522606,-0.8920426259102697,0.5862068965517241,1.0,1.0,1/12,0.55%,TBX1
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),-0.4325438383457082,-0.8919979499732174,0.6229508196721312,1.0,1.0,4/32,8.63%,CAV3;PINK1;TCHP;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),0.4521130636573901,0.8919663897223569,0.5142857142857142,0.9507822928515397,1.0,4/14,22.57%,DAPK2;MCU;MOSPD2;THBS4
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),-0.4362159014481273,-0.8917971066284545,0.6774193548387096,1.0,1.0,5/30,10.70%,RAB11A;PINK1;ACTG1;USP6;DNAJA1
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),0.5296770963797871,0.8916007935253212,0.6571428571428571,0.9510536413435843,1.0,4/7,25.37%,DENND4A;DENND4B;DENND1A;SGSM3
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),-0.534782162288704,-0.8915493248469097,0.6451612903225806,1.0,1.0,1/8,9.78%,THBS1
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.36695688903868046,-0.8911550249908743,0.6575342465753424,1.0,1.0,11/76,14.69%,SFTPA1;TRIL;ITGB2;SCIMP;MAPKAPK3;SFTPD;ITGAM;OAS1;TLR2;COLEC12;NR1H4
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.3286974782000828,0.8911486140562116,0.5666666666666667,0.9516177415957459,1.0,11/65,9.01%,ANGPT1;PTPRO;CDH13;SEMA5A;SERPINE1;JAG1;ACER2;DSCAM;PLXNB1;SIPA1;SNAI2
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),-0.4714926270935653,-0.8908818681748168,0.6557377049180327,1.0,1.0,1/12,1.82%,NODAL
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),0.3410044013988444,0.8908700789980221,0.6176470588235294,0.9517273415976107,1.0,15/53,26.43%,IRGM;RAB7A;UBXN2A;SMURF1;ATG2A;ATG16L2;UBXN2B;ATG2B;STING1;ELAPOR1;ATG12;VMP1;TP53INP1;TRAPPC8;AMBRA1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),-0.48679950468426175,-0.890826716604087,0.6065573770491803,1.0,1.0,2/9,14.06%,THBS1;ATP6AP2
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),-0.4922220308006383,-0.8907730435414933,0.6557377049180327,1.0,1.0,1/12,1.47%,MGST1
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.44087963135628727,-0.8907140100949205,0.6212121212121212,1.0,1.0,2/16,4.18%,ELOVL2;ACSL5
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),0.49650097015207506,0.8906420836010653,0.6052631578947368,0.9512220647677119,1.0,3/8,12.91%,ABHD17A;ABHD17C;ABHD17B
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),0.49650097015207506,0.8906420836010653,0.6052631578947368,0.9512220647677119,1.0,3/8,12.91%,ABHD17A;ABHD17C;ABHD17B
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.40915329293739855,0.890364525318921,0.6666666666666666,0.951295141218729,1.0,3/24,4.97%,AUTS2;SIRT1;DNMT1
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),0.33648408354265114,0.8902136007144168,0.52,0.9511635327689179,1.0,15/99,9.20%,IRGM;CCNG1;KSR1;SLC8A1;CNPPD1;SIRT1;RALB;SLC8A3;SNCA;ABL1;CCND3;TRIB2;LRP6;TELO2;PIH1D1
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.2592687688540427,0.8901511140603809,1.0,0.9508567529461739,1.0,161/908,16.83%,ERG;CSTA;EGLN3;CTDNEP1;DUSP4;VCAN;GRK5;DUSP2;ASB18;TGFBR1;CD247;MAPKAPK2;KLHL20;CEL;LMTK3;FGFR1;APOB;LOXL1;APOE;PTPRO;CDK14;PTAR1;DAPK2;CCN1;CSK;FRK;JMJD4;COMMD1;BCKDK;SIRT1;PSME4;ERBB2;MAML1;ERCC8;KLHL41;SIRT7;PRKCSH;PDIA6;PAK5;ST8SIA4;HS3ST5;CILK1;LGALS1;VRK2;ST3GAL3;FBXO15;PTPRZ1;TIMP1;DSP;DCUN1D1;PPP5C;CDK6;SGK1;PSMA1;EIF2AK3;FER;CDK4;LORICRIN;LTBP1;ABL1;LATS1;MAST1;MAST2;UST;MAPK8;WWP2;IGFBP4;PTPRR;METAP1D;CTDSP2;MAP3K1;FSTL3;TRIB2;SIK3;CTDSP1;MAN2A1;HIF3A;NUS1;ABL2;PTPN9;PTPRM;TNIK;RHBDD1;KTN1;AKT2;ERN1;ANO8;DCAF13;MAP3K9;UBE2E1;DYRK3;WDTC1;PKN2;CDK18;WNK2;PGGT1B;GAN;MAP3K21;PPP2R1B;UBE2E2;FASTK;FBXL14;PPM1A;PTPRB;PIM2;SGK2;MAP3K13;KLHL3;RET;NGLY1;PXK;QSOX1;KLHL42;CCDC22;FBXL20;FAM20B;MARK3;CDH2;KLHL22;COG7;FUT9;CDK11A;ASB7;FBXO27;CDK8;RPS6KA4;SENP8;NTAQ1;PGAP1;PTPRT;MARK4;RYK;DCAF5;INSR;BCR;ALG3;CDK16;TSSK4;PTPRF;SSH1;MEN1;ST3GAL6;PPM1L;CDC14B;B3GALNT2;KLHL5;MAP4K2;MATK;WNK3;PTPRD;PTPRE;MTMR3;NEK1;FBXO4;DNAJC3;ASB6;MARK1;RAB5A;UBE2L3;RAB11B;ATM
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.5452257180773727,0.8900460647536849,0.5526315789473685,0.9505575703968875,1.0,1/6,4.59%,SIRT1
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),-0.5165452555429286,-0.8896411826331501,0.6229508196721312,1.0,1.0,1/11,0.55%,TBX1
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,0.2830777274708247,0.8895397952964478,0.8571428571428571,0.9512364821032605,1.0,45/201,19.11%,MLF1;PCOLCE2;SPTBN4;CNPPD1;PCLO;NRG1;SPEF2;H2BC21;LRRC73;NAT14;ABHD3;FSTL5;IMPDH1;MORN4;CASKIN1;EFNA5;CNGA4;CAP2;FGF12;RNF128;CSPG5;PRR36;GOLGA7B;CLSTN2;TESC;MAP6;OSCP1;MPP2;SRRM3;FAM81A;PTPRF;IFT140;KLHL5;LRRC45;ARL3;SRCIN1;MARK1;LRRIQ1;TTC21A;FAIM;DCDC2;RIC8B;TRIM66;CFAP43;EPB41L4B
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),0.4114051887849944,0.8893478493482013,0.6829268292682927,0.951207265691623,1.0,4/27,11.29%,IRGM;GBF1;RRP1B;LGALS9
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),0.3403512952697952,0.8893037794005253,0.6333333333333333,0.9508791872598855,1.0,13/57,18.13%,APOE;PPARG;SIRT1;ZBTB20;ABCA1;PNPLA3;IRS2;TLCD3B;MLXIPL;NR1H3;TLCD3A;ABHD4;ACOX1
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),-0.533419061503482,-0.8890866909385517,0.6065573770491803,1.0,1.0,3/9,17.49%,IRF4;SLC11A1;GBP6
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),0.46618317678614807,0.8889402230116842,0.5675675675675675,0.9513675120934484,1.0,2/16,4.75%,PTGS1;AKR1C3
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),0.5213637996913755,0.8888778771967302,0.6086956521739131,0.9510615218025964,1.0,2/7,13.68%,APOE;STARD4
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.4679728231850502,-0.8888673398828381,0.6764705882352942,1.0,1.0,2/21,6.09%,CLCF1;STAT1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),-0.5292389844795092,-0.8887419786494241,0.660377358490566,1.0,1.0,3/10,13.53%,BLK;ANXA1;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),0.48520990987427126,0.8887198798524794,0.6388888888888888,0.9510178871760204,1.0,4/9,14.09%,APOB;PLIN5;LPL;NFKB1
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.44182229422643454,0.8887073385538194,0.5588235294117647,0.9505741172080941,1.0,3/9,21.29%,RAP2A;MYO9A;CAMSAP3
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),-0.5984202743458354,-0.8886025761237527,0.7272727272727273,1.0,1.0,3/5,26.06%,HSPA5;UFL1;DDRGK1
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.318043038375385,0.8884801876094998,0.7777777777777778,0.9505743940868341,1.0,25/98,16.89%,LGR5;FREM1;GPC4;TMEM132C;SPON1;TNFRSF19;PARM1;PDZRN3;PDE9A;VWA2;WNK2;HID1;COBL;LRRN1;ZNF704;NEO1;TPPP3;MSI1;ASXL3;PTPRT;RAI2;RALGPS1;PPP1R9A;EPHB2;PBX1
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.3209529762185571,0.8881297201137608,0.75,0.9510398832744706,1.0,65/298,21.29%,TBC1D10A;PRICKLE1;NLGN1;RAB31;TBC1D16;TICAM2;NUP42;RANBP17;STX5;TBC1D12;RAB28;RAB20;SCFD2;RAB7A;STX6;STX8;NXT1;SYNDIG1;AKT2;GGA1;TMED3;RPGR;TRAK2;TBC1D22B;EVI5L;TBC1D4;ACD;XPO7;ARL5A;PREB;ANKLE1;SNX9;COG7;LTBP2;WLS;SMURF1;RTN2;MYO1C;XPO5;HERC2;RASSF9;SNF8;RAB5A;NUTF2;CLIP3;TBC1D8B;ARFIP1;VPS26C;AP4S1;TBC1D2;TBCK;TECPR2;PPP1R10;AP4B1;ARFRP1;ARFIP2;TBC1D8;TBC1D26;APPL2;USP6NL;IPO8;LAPTM5;XPO1;TBC1D5;CAMSAP3
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.3644113941710224,-0.8881127910918182,0.6666666666666666,1.0,1.0,14/75,14.23%,AMBP;SERINC2;TMEM184A;MISP;CLDN1;CLDN2;SLC3A1;MYO5B;GPR39;LAMC2;SOWAHB;ITGB6;TRIM29;GPX2
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,-0.35968131897949057,-0.8879828648286682,0.6811594202898551,1.0,1.0,26/112,18.18%,SLC22A8;IYD;MACC1;SLC22A6;TMEM213;CYP3A5;SLC5A1;SLC3A1;MYO5B;ATP10B;SCIN;ITGB6;ATP5MK;UROC1;MUC4;SGMS2;VDR;PIK3C2G;NPHS2;ADGRF5;PROM2;PGAM2;SCNN1A;SCNN1G;COL28A1;MUC15
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),0.46079313287151646,0.887892588624734,0.6052631578947368,0.9511925101625144,1.0,3/10,17.11%,APOE;LDLR;IAPP
prerank,GO_Biological_Process_2021__DNA protection (GO:0042262),0.5313407241723058,0.8878229126660415,0.6170212765957447,0.95087296322902,1.0,1/5,5.66%,CBS
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),-0.5075123807679984,-0.8877931279297782,0.6296296296296297,1.0,1.0,1/13,6.25%,BACE2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),-0.5650573504023028,-0.8877590579013782,0.6666666666666666,1.0,1.0,2/6,17.25%,ATF5;ZFP36L1
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),0.48003714560064115,0.8877048701401606,0.6,0.9506843758760214,1.0,3/14,12.94%,COMMD1;COX19;CCDC22
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.4014951413885161,0.8876541548029776,0.5675675675675675,0.9503145954082172,1.0,7/22,13.71%,KIT;HES1;F2;OCIAD2;F2R;IL10RA;PIBF1
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.3507244161900415,0.887630654501413,0.6285714285714286,0.9498944097280612,1.0,16/53,21.78%,BCL2;SNCA;MTMR8;LEPR;USP36;DAPL1;QSOX1;TAB3;KLHL22;IL10RA;PIK3CA;SMG1;TAB2;RASIP1;RUBCN;EIF4E
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),0.5472675835579915,0.8876239063536338,0.6363636363636364,0.9494456354564033,1.0,4/5,33.25%,NR1H3;ITGAV;PTPN2;NR1H2
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),0.47397306018481483,0.887477442218684,0.5625,0.949308806687971,1.0,3/14,12.32%,DNAJC30;PID1;ATPSCKMT
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.44412763816901923,-0.8873843459628499,0.6617647058823529,1.0,1.0,4/22,17.52%,ITGB2;SELP;NT5E;MSN
prerank,GO_Biological_Process_2021__regulation of nephron tubule epithelial cell differentiation (GO:0072182),0.4967626067429184,0.8873786216505162,0.6428571428571429,0.9490707343854535,1.0,1/6,6.85%,OSR1
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),-0.4787607102579066,-0.8870884070408445,0.6417910447761194,1.0,1.0,1/13,11.55%,AHNAK2
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.36209689929358535,-0.886855969313829,0.676056338028169,1.0,1.0,12/86,14.93%,HCK;SCTR;TSHR;GPHB5;FCGR3A;GPR27;CGA;HLA-DRB1;GPR39;PTGDR;GGT5;ADCY7
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),-0.4798088639871554,-0.8865916228098281,0.6557377049180327,1.0,1.0,2/16,3.26%,DISC1;TAFA3
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.47149235392822786,-0.886513476687466,0.6521739130434783,1.0,1.0,1/15,1.23%,ADSS1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.4326712377303591,-0.8863621301557247,0.6619718309859155,1.0,1.0,1/22,2.76%,CAV3
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.36089027924232797,-0.8861714649262197,0.6666666666666666,1.0,1.0,7/96,9.33%,PSMB9;AIM2;CARD14;TNFRSF1B;STAT1;EDAR;TXNDC17
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),0.2946941951726535,0.8861458956658849,0.7857142857142857,0.9518292504417869,1.0,72/283,21.22%,PCM1;RP1L1;IFT88;CEP152;CEP135;CNTRL;DZIP1L;PARVA;SCLT1;FHDC1;GBF1;JHY;CILK1;BBS9;ALMS1;SPAG16;FLNA;DYNC1I2;CNGA4;SDCCAG8;C2CD3;MAPRE1;RPGRIP1L;CEP290;EHD4;RPGR;AKAP9;CEP250;RAB11FIP3;AVIL;MKS1;CFAP410;CEP20;TTC36;RILPL1;PIBF1;ARL13B;EXOC7;KIAA0586;RP2;PTPN23;MARK4;CEP41;CEP162;CDC14B;IFT140;TTC21B;NEK1;ARL3;NOTCH1;CFAP70;DCDC2;KIF3B;BBIP1;CFAP221;PDE6D;DZIP1;UNC119B;CFAP43;TMEM67;PTPDC1;CFAP46;EXOC6;CDK5RAP2;TMEM138;TRIP11;WDR19;TTC39C;IQCB1;POC1B;FBF1;KIF27
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),0.4964667748286845,0.8857063507121229,0.5833333333333334,0.9522919079340564,1.0,2/7,6.37%,SIRT1;TMEM106A
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),0.5606818044989338,0.8855654569830853,0.6521739130434783,0.952211823350257,1.0,3/6,19.15%,MYC;SETD2;TCF4
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),0.256363245028963,0.8854961896062534,1.0,0.9519872716203949,1.0,142/735,17.52%,ERG;FOXO1;SKAP1;HDAC3;MED17;MITF;NFATC3;RORA;RARB;POU3F2;GALR3;KLF10;CDH13;BCL11B;GABPB2;CCN1;AUTS2;ZNF263;RIPK2;PID1;SMARCD3;PPARG;FZD5;TET2;SIRT1;IFI16;MAML1;CREB3L4;PAX3;RORB;ZEB2;SOX12;SSBP3;SERPINE1;JAG1;PKD2;SIRT7;HES1;PTOV1;PROX1;STAT5B;HMGB1;ATF3;DLX1;NCOA3;NCOA2;OSR1;SMARCB1;MED25;PCGF5;ETV1;GREM1;NRIP1;ABL1;WWOX;SP1;RBL1;MYC;ZNF462;FSTL3;BCLAF3;TCF20;NR4A2;LRP6;SENP1;ZSCAN21;WNT3A;TWIST1;HCLS1;TFE3;ATF1;GRIN1;PLAGL1;CTBP2;RNF10;RPS6KA3;NPAS4;NAMPT;RRP1B;SP7;BPTF;CITED4;DPF1;SMARCA2;ZNF300;MLXIPL;SMARCA4;USP16;BCL9L;KAT6A;JUNB;NFIB;FADD;PLSCR1;DPF2;HDAC1;ASCL1;MED16;FOXF2;ARRB1;CDK8;SMAD2;NR2F2;RPS6KA4;RLF;NR3C1;NFKB1;PPARGC1B;NFAT5;ASXL3;WWTR1;TFCP2;THRB;HDAC4;RFX6;NFIC;ETV5;MEN1;HSF1;NR1H3;HJV;TP53;ZNF609;GABPA;RUNX1;ATAD2B;NR4A3;WWC1;ZGLP1;NOTCH1;NCK1;ATM;PBX1;LPIN2;NUFIP1;HIVEP1;GABPB1;BRD4;SKI;FOXJ2;PAX6;IL11
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),0.5572475187913449,0.8854271861567804,0.6727272727272727,0.9516979211760246,1.0,4/5,43.65%,VPS13A;SORL1;VPS13C;VPS13D
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),0.43873946898316735,0.8853381542541447,0.5952380952380952,0.9514666097157796,1.0,1/14,2.99%,SNCAIP
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.35435167899194764,0.8849199108706464,0.6333333333333333,0.9518489496806848,1.0,13/70,12.69%,GCK;FOXO1;IRS1;PPARG;SIRT1;CRY1;CYB5R4;LEPR;ADIPOR1;MCU;MLXIPL;ADIPOR2;ACSM2A
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),0.3224228672597852,0.8848952812002864,0.6071428571428571,0.9514085991092794,1.0,7/75,7.57%,SMYD5;CBFB;PSME4;JAG1;HES1;PSMA1;ABL1
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),0.5314449333709047,0.8848862527961566,0.6744186046511628,0.950961459187004,1.0,2/9,18.97%,FARP2;ADGRB3
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),0.4904180354051313,0.8848646131997217,0.5869565217391305,0.9505363656062267,1.0,3/12,6.53%,CYP1A2;CYP2U1;CYP2S1
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),-0.4194371515934623,-0.884713240624276,0.6229508196721312,1.0,1.0,6/31,18.65%,KIF14;HTR2B;SVIL;CXCR5;ECT2;CDC6
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C activity (GO:1900020),-0.565856005046708,-0.8845249771424323,0.6595744680851063,1.0,1.0,1/5,2.54%,WNT5A
prerank,GO_Biological_Process_2021__regulation of protein kinase C activity (GO:1900019),-0.565856005046708,-0.8845249771424323,0.6595744680851063,1.0,1.0,1/5,2.54%,WNT5A
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),0.2745027949566799,0.884342642223876,0.9166666666666666,0.951156120526181,1.0,58/464,12.09%,ADRA1A;NGF;SMYD2;CCN4;ADAMTS1;NOX4;SMYD5;GMNC;BCL6;BCL2;ANGPT1;CCN2;KLF10;CDH13;DCBLD2;HTRA2;CCN1;FRK;SEMA5A;SIRT1;P3H3;MARCHF5;P3H2;PKD2;SIRT7;MAGI2;FKTN;DACT3;SRGAP2;WNT9A;PROX1;PPP1R13B;ST7L;CDK6;DSCAM;EIF2AK3;PML;SLIT2;MYC;PLXNB1;SIPA1;TENM1;ANP32B;PIWIL1;PBRM1;BRINP1;CTBP2;WNK2;ALDH1A2;ADNP2;F2R;ASTL;DDAH1;NLRP2B;PIM2;PPP1R9B;SMARCA2;SMARCA4
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),-0.5574662577771156,-0.8843099795368697,0.6666666666666666,1.0,1.0,1/6,8.36%,BPIFB1
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.35578952701932476,0.884096997980637,0.5405405405405406,0.9512713110015171,1.0,4/29,9.68%,KIAA0319;SEMA6C;SEMA5A;SEMA4A
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),0.3810231021970127,0.883982050474532,0.6129032258064516,0.9509546204030548,1.0,10/30,21.64%,TRIM71;MOV10;TNRC6C;XPO5;TNRC6A;AGO3;TARBP2;AGO2;CNOT6;ADAR
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),0.5039993848462694,0.8835573391897745,0.5813953488372093,0.9514653988830252,1.0,2/7,14.19%,ZBTB7B;SMURF1
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),0.5464859664437431,0.8835190544541723,0.6739130434782609,0.9510410774585373,1.0,5/7,40.71%,DPYSL2;DPYSL5;DPYS;DPYSL4;CRMP1
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),0.501268260147063,0.8834927812642139,0.625,0.9506890190809297,1.0,3/7,19.09%,B4GALT3;GAL3ST1;FA2H
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.37584836756950785,-0.8834703667912535,0.6521739130434783,1.0,1.0,8/67,10.54%,LIPI;ACSM6;ALOX5;ACSL5;LIPH;OLAH;CYP21A2;ACSM3
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),-0.40072530851460897,-0.8834671783547315,0.640625,1.0,1.0,10/49,18.94%,C15ORF62;ROPN1B;WAS;ARHGDIG;CFL1;NTN1;PLEKHG7;CELSR1;RTKN;ADGRG1
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),-0.46642035187239117,-0.8834479229507486,0.5892857142857143,1.0,1.0,3/16,21.27%,ERVW-1;JAM2;SIX4
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),-0.43541327150294645,-0.8834251149900156,0.6615384615384615,1.0,1.0,6/24,13.43%,GPER1;ATP6AP1;TGM2;LMOD3;LRP2;OPRM1
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),0.4844769233698777,0.8833405194989015,0.625,0.9505455879967709,1.0,6/10,27.00%,SMPD4;SMPD3;SAMD8;ABCA2;SMPDL3A;ABCA8
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),-0.39816177485421933,-0.883178080494201,0.6,1.0,1.0,8/31,14.71%,ELOVL2;ACOX2;TECRL;ACOT4;ACOT1;CYP4F12;ACOT2;HACD4
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),0.5015865623153688,0.8828731722582163,0.6538461538461539,0.9511417383934612,1.0,2/9,13.88%,TWIST1;RPS6KA4
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),-0.32876781633236124,-0.8825294583506977,0.7236842105263158,1.0,1.0,13/162,11.14%,NOTUM;PSMB9;WNT5A;SHISA6;HIC1;DAB2;SOX30;LATS2;RNF213;SFRP4;ALPK2;DRAXIN;LRP4
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),-0.44526875085229456,-0.8825067771862954,0.5901639344262295,1.0,1.0,4/17,20.29%,MYO1F;MYO5B;MYO15A;MYO7B
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),-0.5852748856199498,-0.8825049607463672,0.6153846153846154,1.0,1.0,1/5,4.10%,ALOX5
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),0.40292879988046143,0.8824995663140456,0.6222222222222222,0.9516296871129828,1.0,3/23,9.53%,PCF11;POP1;ERN1
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),0.34267453199516257,0.8820607898031354,0.7272727272727273,0.9519952438471657,1.0,4/45,8.86%,PNP;CCDC88B;HMGB1;ICOSLG
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),-0.5409277804561563,-0.8820064018303773,0.6481481481481481,1.0,1.0,1/7,2.54%,WNT5A
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.395054119516865,0.8817691417721657,0.6923076923076923,0.9522027386846297,1.0,3/15,10.94%,CHST6;NAGK;CHST3
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.3439583732995492,-0.881701217898223,0.6470588235294118,1.0,1.0,26/153,14.91%,F8;TGFB1;TIMP3;BLK;SYT10;SYT2;PSAP;SELP;CLU;PLG;CFD;THBS1;CD63;VWF;ITGA2B;SCIN;ITIH3;TUBA4A;F13A1;TMEM79;ITIH4;A2M;F5;TTN;TGFB3;ABCA12
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.3405302130974057,-0.8816012539412165,0.7307692307692307,1.0,1.0,58/160,27.27%,RPL37A;RPL38;RPL15;RPS4X;RPL3;RPL35A;RPS9;RPS27;RPS21;RPL13A;RPL27A;RPS16;RPL36;RPS20;RPL7A;ZFP36L1;RPL9;RPL13;RPS8;RPS27A;RPL21;EXOSC8;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;RPL27;RPL35;RPS14;RPL11;RPS15;RPLP1;PNLDC1;RPS12;RPL24;RPL18A;RPS13;RPL29;RPLP2;RPL28;RPL12;RPL18;RPS3;RPL22;RPSA;RPS28;CNOT11;RPS19;RPS24;RPS3A;RPL19;RPL8;RPS6;RPL10
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),0.42817814807029986,0.8815863509467514,0.6571428571428571,0.9522523966779091,1.0,3/16,18.66%,APOE;ACHE;ADAM10
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),0.42780831769752925,0.8815496732740039,0.6046511627906976,0.9519080947952201,1.0,4/12,21.96%,FER;LGALS3;RC3H1;CD55
prerank,GO_Biological_Process_2021__metanephric collecting duct development (GO:0072205),0.5708297671468563,0.8815110225516154,0.6808510638297872,0.95111314116412,1.0,4/5,30.26%,PTCH1;BMP4;SHH;PKD1
prerank,GO_Biological_Process_2021__collecting duct development (GO:0072044),0.5708297671468563,0.8815110225516154,0.6808510638297872,0.95111314116412,1.0,4/5,30.26%,PTCH1;BMP4;SHH;PKD1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.49904677737926495,0.8814734469175878,0.5833333333333334,0.9507412607658949,1.0,3/10,22.98%,AKAP9;ANK2;GAL
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.34254268830750756,0.8814022803655267,0.5833333333333334,0.9504984052703025,1.0,27/90,22.47%,MITF;SERPINE1;JAG1;MAGI2;SRGAP2;CRK;SLIT2;RAP2A;NAV3;KANK1;DACH1;FRMD5;ARID2;NF1;ADAM15;PTPRT;TMEFF2;DLG5;CCDC125;MIA3;RECK;VCL;SRGAP2B;PTPRJ;PTEN;SMAD7;SCAI
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",0.506960090338715,0.8812643199238854,0.6666666666666666,0.9504058267979698,1.0,3/7,11.12%,SH3RF1;HLA-DRA;TWSG1
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.5189859017857912,-0.8810965545484765,0.559322033898305,1.0,1.0,1/8,13.40%,ATG14
prerank,MSigDB_Hallmark_2020__Inflammatory Response,0.3192700167796793,0.8810677507875695,0.7083333333333334,0.9504490286436943,1.0,9/147,5.25%,IL7R;TACR3;DCBLD2;CD14;RIPK2;FZD5;RGS16;PCDH7;SERPINE1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.4687119741583165,-0.8807129038273603,0.6619718309859155,1.0,1.0,2/18,10.00%,MISP;GBP1
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.4048711834250886,0.8804269234616897,0.625,0.9514630046974087,1.0,4/18,16.67%,BCL2;SNAI2;PIK3CA;NOTCH1
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.3044676497284502,0.880359839941603,0.6956521739130435,0.9511417824993303,1.0,44/140,22.14%,RASSF2;SAMSN1;SPRED3;HSPB1;PARD3;PID1;CEP85;SNCA;DEPTOR;GREM1;SLIT2;TRIB2;LRP6;SPRED2;TWIST1;SPRED1;NLRP2B;MLXIPL;UBASH3B;PPP1R15B;NF1;WWTR1;MEN1;CRKL;DNAJC3;EPHB2;NCK1;PMEPA1;DUSP19;TAB1;IMPACT;TARBP2;PRKAG2;PAK2;GNAQ;PLPP3;EMILIN1;OCLN;DMD;NIBAN1;PDE4D;NCK2;PTEN;SMAD7
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),-0.3525535213753564,-0.8802567892182808,0.6533333333333333,1.0,1.0,28/111,17.21%,CHRNA9;C1QTNF1;NMUR2;XCR1;WNT5A;CAV3;CXCL13;LPAR1;ESR1;TAC4;ACKR4;GPER1;C3AR1;TRPC7;FPR1;CAV2;PTGDR;CALB2;FPR3;CXCR5;PTGER3;ITPR3;ACKR2;F2RL1;SMAD3;GHRL;PLN;CD24
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,-0.35082029644921336,-0.8801805542693922,0.6867469879518072,1.0,1.0,44/155,21.14%,PSMB9;IRF4;IRF1;UBE2L6;HLA-DMA;CIITA;TRIM25;STAT1;IL7;OAS2;IFIT3;HLA-A;LATS2;P2RY14;RNF213;SOD2;SELP;CASP7;HLA-DRB1;FPR1;ARL4A;WARS1;CDKN1A;IFIT1;SP110;IL18BP;APOL6;C1S;TXNIP;PSMA3;GBP6;PLA2G4A;IFIT2;IFI35;CASP8;NUP93;GPR18;MVP;DHX58;IFI27;CD86;DDX60;BTG1;MX1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.4065917051803814,-0.880174350725478,0.6470588235294118,1.0,1.0,7/36,23.78%,RPA3;RBX1;POLD4;RPS27A;OGG1;RPA2;DDB1
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.2659358960182589,0.8797383308462653,1.0,0.952104552167114,1.0,138/857,14.76%,TEAD2;NGF;POU3F1;ESRRG;RAB27A;CCN4;MLF1;FGF10;TSKU;TGFBR1;POU6F2;ZNF804A;PC;BTN3A2;ZNF195;OR7D2;ZNF117;BCL6;ZNF212;NOVA1;EPHX2;MAFB;MITF;ZFPL1;RORA;APOE;HDAC10;ANGPT1;CDH5;ZBTB7B;SLC39A8;PCGF1;PRDM5;APBB3;ZNF263;PID1;SLC8A1;ATXN1;WNT4;FGF17;CIAO3;SIRT1;IFI16;DNMT1;TULP3;RBM20;RORB;SOX12;GPBP1L1;HNRNPF;UBAP2;PROX1;ZBTB4;TRIM71;NCOA2;OSR1;HP1BP3;ZNF703;ZNF274;OPRD1;SPIN2B;CDK6;EIF2AK3;CDK4;PML;ABL1;POFUT1;SP1;RBL1;MAPK8;WWP2;MYC;NKAP;ZNF462;HNRNPH1;ESRP1;ZNF33A;FGF18;FOXN3;KHSRP;ZSCAN21;ICOSLG;FEZF2;WNT3A;PCBP3;TWIST1;SNAI2;HCLS1;MOV10;FADS1;ZNF2;TESMIN;HNRNPL;ZNF331;CREM;ZNF519;ADNP2;RRP1B;AMH;RBMS3;MSC;RIMS2;LGALS9;TRIM44;FASTK;HES6;TNRC6C;USP36;NSD1;DMTF1;LIMS1;SMARCA2;TOB2;MLXIPL;TICAM1;HSPA1A;EFEMP1;RNF207;PLSCR1;HDAC1;ASCL1;TESC;RYBP;CDK11A;CARM1;RPS6KA4;NFYC;NR3C1;NFKB1;PPARGC1B;ASCC2;GPX1;WWTR1;SCRT1;TRIM4;MECP2;ANK2;HDAC4
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),0.37950528720141896,0.8796639462721452,0.5757575757575758,0.9518047150977043,1.0,7/38,7.84%,NGF;PPARG;IFI16;PYHIN1;HES1;HMGB1;MAPK8
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),-0.452673678767858,-0.8795681093251828,0.6333333333333333,1.0,1.0,6/18,20.09%,BLK;NFAM1;PRKCH;GPS2;CD81;PAX5
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),-0.4409546362142509,-0.8793201301627632,0.6857142857142857,1.0,1.0,3/21,19.05%,TERF2IP;SMUG1;OGG1
prerank,GO_Biological_Process_2021__xenobiotic transport across blood-brain barrier (GO:1990962),-0.5849193508138583,-0.8791471530986064,0.6470588235294118,1.0,1.0,4/6,24.67%,ABCG2;ABCB1;SLC22A1;ABCC2
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),0.48007082546304336,0.8790938488682181,0.7222222222222222,0.9524456440123769,1.0,5/12,32.02%,PATL1;RC3H1;LSM14A;ATXN2;LIMD1
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.4404567638263294,0.8788024735970421,0.625,0.9525304904726763,1.0,3/10,18.47%,HSPA1A;NCK1;IMPACT
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.31588750937135407,0.8787347464833626,0.85,0.9522095222233085,1.0,39/127,21.42%,MRAP2;KCNB2;SPTBN4;BSG;TMEM150A;KCNIP3;PDZD11;FLNA;RAP2A;LRP6;TNIK;DPP10;KCNIP4;TSPAN17;EHD4;RAB3C;RAP1A;TESC;RAB10;SMURF1;NKD2;ANK2;DPP6;WNK3;ARL3;ZDHHC3;TTC7B;RAB3D;EFR3B;MYO5A;SLMAP;RAB40A;PTCH1;PACS1;WDR19;LIN7A;JUP;ZDHHC23;DLG1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.5203422268537576,-0.8783770144367579,0.6923076923076923,1.0,1.0,3/10,14.26%,DCN;PIK3CB;IL12A
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),-0.5785889066709528,-0.8783078614594121,0.6909090909090909,1.0,1.0,2/5,21.60%,MSN;AR
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),-0.5785889066709528,-0.8783078614594121,0.6909090909090909,1.0,1.0,2/5,21.60%,MSN;AR
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),0.4668126111452425,0.8783031066993293,0.5853658536585366,0.9527284026810683,1.0,1/12,1.41%,CPSF1
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),0.4108902915750233,0.8782876641591446,0.6,0.9523080833239217,1.0,3/20,7.37%,EPHX2;APOE;SEC14L2
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),0.5113524426676138,0.878216087847456,0.6590909090909091,0.9520232136250341,1.0,2/9,18.70%,HES1;ACVR1
prerank,GO_Biological_Process_2021__negative regulation of neuron migration (GO:2001223),0.5835350285867158,0.8781714586395472,0.6956521739130435,0.9516462502391617,1.0,3/5,22.41%,SRGAP2;NEXMIF;TNN
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),-0.36219242980801886,-0.8781245112668614,0.7213114754098361,1.0,1.0,7/52,13.03%,MMP9;CIDEB;GPER1;PINK1;DCN;BIK;MOAP1
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),0.3720392445559901,0.8781133389837054,0.6521739130434783,0.9512980471233883,1.0,8/45,8.63%,PER2;CYP7B1;OSBPL3;OSBPL6;PSAT1;AKR1C3;SLC27A2;OSBPL7
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.4127173074569451,0.8778483991573608,0.5897435897435898,0.9514896249892527,1.0,4/12,22.35%,SPEF2;CTNNA2;PTEN;VPS51
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),-0.4975507618601739,-0.8775806499683255,0.5892857142857143,1.0,1.0,2/12,8.67%,MSMP;ANXA1
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),-0.554637608288912,-0.8774289686650516,0.6779661016949152,1.0,1.0,1/6,4.89%,TNFRSF1B
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),-0.5447098779199793,-0.8773398238266056,0.6515151515151515,1.0,1.0,3/7,21.48%,GPS2;OTUB1;PARP10
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),-0.5545835865866329,-0.8772818121768116,0.6376811594202898,1.0,1.0,2/5,30.48%,HDAC6;BAG3
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),-0.45352329470694364,-0.8772152428895301,0.6,1.0,1.0,1/17,2.54%,WNT5A
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,0.3135629797253617,0.8770750409048722,0.875,0.952511107113778,1.0,30/106,24.65%,PSAT1;PDIA6;EXOSC1;ATF3;CHAC1;EIF2AK3;ALDH18A1;KHSRP;ERN1;PREB;H2AX;YIF1A;CNOT4;FUS;DNAJC3;EIF4EBP1;ATF6;NOP14;CXXC1;EDEM1;EIF4A3;CNOT6;EXOSC5;SLC30A5;EIF4E;SEC31A;DCP1A;XPOT;DDX10;SLC7A5
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.39397533754670255,-0.8765590796305402,0.7272727272727273,1.0,1.0,8/40,17.19%,ECM2;ALOX15;PLG;VIT;PIK3CB;FBLN2;RAC2;RAC1
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),0.4416682790527421,0.8764314530622179,0.6521739130434783,0.9534110757596992,1.0,4/10,24.06%,NRG1;NR1H3;VAMP8;ERBB3
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),0.40132127367862896,0.8763854471196301,0.6578947368421053,0.9531406668258289,1.0,8/24,14.25%,DOC2B;SDF4;SYT3;SYT17;SYT1;SYT12;RIMS2;SYT6
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.3104701595165693,0.8763392590721807,0.7391304347826086,0.9528209184291783,1.0,34/123,19.26%,MRAP2;KCNB2;SPTBN4;BSG;TMEM150A;KCNIP3;FLNA;RAP2A;LRP6;TNIK;DPP10;KCNIP4;TSPAN17;EHD4;RAB3C;RAP1A;CCDC88A;TESC;NECTIN3;RAB10;SMURF1;NKD2;ANK2;DPP6;WNK3;ZDHHC3;TTC7B;RAB3D;EFR3B;MYO5A;SLMAP;RAB40A;PTCH1;PACS1
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),0.45430021334843557,0.8755477445425515,0.6222222222222222,0.9541372795670133,1.0,7/12,35.79%,CTPS2;CDA;DPYSL2;DPYSL5;DPYS;ALDH6A1;DPYSL4
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),-0.5174537202328906,-0.8752505217620535,0.6333333333333333,1.0,1.0,1/10,1.55%,RAB34
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.3303807887930802,0.8752062327003244,0.7,0.9545251744289259,1.0,14/59,17.12%,MED17;CBFB;MED25;CDK4;MOV10;TNRC6C;MED16;CDK8;NFKB1;MECP2;TP53;TNRC6A;ATF7IP;AGO3
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),-0.5769957029310012,-0.8752047161024382,0.6851851851851852,1.0,1.0,2/5,40.04%,TMEM33;RAB3GAP2
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),0.3810927852304832,0.8751277063476078,0.5952380952380952,0.9542688998628135,1.0,2/24,4.79%,PER2;IFI16
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),0.2812873645568174,0.8750162289816682,0.8333333333333334,0.9540552942242515,1.0,30/303,10.74%,ADRA1A;NGF;SMYD2;PER2;ADAMTS1;NOX4;KLF10;CDH13;FRK;PPARG;P3H3;P3H2;PKD2;HES1;MAGI2;FKTN;WNT9A;PROX1;MED25;GREM1;CDK6;PML;MYC;PLXNB1;TENM1;PBRM1;CTBP2;WNK2;ALDH1A2;F2R
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),-0.34766130229902065,-0.8746836854426001,0.6388888888888888,1.0,1.0,11/71,17.62%,ST6GALNAC1;CHST9;B3GNT5;FUT2;B3GNT9;ST6GALNAC2;GALNTL5;GCNT1;ALG1L2;CHST10;B3GALT6
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),0.5375171079513881,0.8744060188420932,0.627906976744186,0.9544482062274872,1.0,2/6,36.83%,ENPP1;GSK3B
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),0.5375171079513881,0.8744060188420932,0.627906976744186,0.9544482062274872,1.0,2/6,36.83%,ENPP1;GSK3B
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.3751564458044701,0.8743788375904988,0.59375,0.9540512160529432,1.0,12/24,27.93%,RHEX;STAT5B;HSPA1A;ANKRD54;ABCB10;ACVR2A;HIF1A;ACVR1B;ZNF16;FOXO3;ETS1;STAT3
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),0.4463722820303231,0.8743248699466385,0.6578947368421053,0.9538169368757042,1.0,5/17,10.74%,CHRM2;KCNB2;CNN1;NMU;F2R
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),0.5119791063040431,0.8739054741864221,0.6888888888888889,0.9541825477530674,1.0,2/7,17.07%,GTF3C4;GTF3C5
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.31133861756105424,0.8735497035935781,0.7333333333333333,0.9544067839181245,1.0,7/57,7.59%,TGFBR1;CFLAR;FGFR1;SH3RF1;DEPTOR;PML;WWOX
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.428037375536844,-0.8731223333841571,0.6461538461538462,1.0,1.0,8/25,22.21%,LPAR1;LPAR6;AKAP13;F2RL1;RAC1;ADGRG1;GPR18;SYNPO2L
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.4220234073601933,-0.8731000238163201,0.6323529411764706,1.0,1.0,6/32,14.99%,TMC8;SP100;BRCA1;THBS1;TNFRSF10A;DDX3X
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.4046637182270786,0.8726891365884352,0.6052631578947368,0.9554886854366782,1.0,10/23,20.96%,ZDHHC11B;ZDHHC18;ZDHHC12;GOLGA7B;ZDHHC14;ZDHHC3;CLIP3;ZDHHC9;ZDHHC11;ZDHHC23
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.4046637182270786,0.8726891365884352,0.6052631578947368,0.9554886854366782,1.0,10/23,20.96%,ZDHHC11B;ZDHHC18;ZDHHC12;GOLGA7B;ZDHHC14;ZDHHC3;CLIP3;ZDHHC9;ZDHHC11;ZDHHC23
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.3399018108722163,-0.8726781223973332,0.6521739130434783,1.0,1.0,13/105,14.41%,DISC1;LRPAP1;TMC8;VTN;DAB2;CLDN5;ZFPM1;TERT;CTSZ;CDKN1A;IFIT1;MITD1;EFHB
prerank,GO_Biological_Process_2021__positive regulation of defense response to bacterium (GO:1900426),-0.5740343060864124,-0.8725816208872215,0.711864406779661,1.0,1.0,3/5,15.82%,PGC;CYBA;GRN
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.3839389578812217,0.8724355867398139,0.6875,0.9555429956264881,1.0,6/33,15.67%,SLC26A3;SLC4A7;GPR89A;SLC9C2;CA2;GPR89B
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),-0.4250555142721574,-0.8723206073318719,0.734375,1.0,1.0,2/20,15.75%,MPV17L2;RCC1L
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),0.5213163552598146,0.8722415879945137,0.6739130434782609,0.9550745753658287,1.0,3/6,32.28%,IQSEC1;MAP4K4;MAPRE2
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),0.5213163552598146,0.8722415879945137,0.6739130434782609,0.9550745753658287,1.0,3/6,32.28%,IQSEC1;MAP4K4;MAPRE2
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),-0.4118127945974384,-0.8721664491920141,0.6666666666666666,1.0,1.0,5/31,17.48%,MAB21L1;FREM2;ITGAM;HIPK1;SALL2
prerank,GO_Biological_Process_2021__adult heart development (GO:0007512),-0.5364915189155715,-0.8721642364968301,0.7083333333333334,1.0,1.0,1/5,1.51%,MYH7
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.5154947042599868,-0.8721003241249288,0.6481481481481481,1.0,1.0,3/9,27.87%,SVIP;HERPUD1;USP14
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.4146092052301616,0.8720747821677456,0.6486486486486487,0.954903980068835,1.0,4/14,16.67%,BCL2;SNAI2;PIK3CA;NOTCH1
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),-0.3592231324895439,-0.8719031767959603,0.7222222222222222,1.0,1.0,12/77,16.07%,ARIH2;RASGRP4;TGFB1;WNT5A;PLD4;FLT4;ZFPM1;PTPRC;MFAP5;TEK;RRAS;HIPK1
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.3425905663308791,-0.8716124196452597,0.6805555555555556,1.0,1.0,23/84,21.63%,IRF1;TRIM5;AGBL5;STAT1;PLA2G10;OAS2;IFIT3;NLRP9;PTPRC;IFIT1;OAS1;TLR2;F2RL1;DDIT4;IFIT2;SERINC3;IFI27;IFIT1B;TRIM56;MLKL;MX1;IFI6;ISG15
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),0.4862855373274368,0.8714771296630203,0.6,0.9557808167403817,1.0,1/11,0.86%,FOXO1
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),0.38216192242666336,0.8712885850247643,0.6129032258064516,0.9557716359580954,1.0,6/23,17.57%,RHEBL1;MLST8;CCDC88A;SMG1;EIF4EBP1;SYAP1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857),-0.6051125191739922,-0.8712833226653075,0.6949152542372882,1.0,1.0,2/5,19.12%,IL12A;CRTAM
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860),-0.6051125191739922,-0.8712833226653075,0.6949152542372882,1.0,1.0,2/5,19.12%,IL12A;CRTAM
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),0.550940034767954,0.8710658121606685,0.6590909090909091,0.9558397072604955,1.0,2/6,11.98%,GALE;GALT
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),-0.5481176701130795,-0.8710441519828129,0.6727272727272727,1.0,1.0,1/6,8.60%,ST6GALNAC2
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),-0.4247696140719468,-0.8707504348966204,0.71875,1.0,1.0,6/36,14.30%,PIGH;B3GNT5;MPPE1;A4GALT;PIGC;PIGL
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.46842811459937134,0.8707431576770857,0.6888888888888889,0.9561463570476899,1.0,5/11,17.09%,DOC2B;SYT1;RIMS2;UNC13B;UNC13C
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.3080489128539394,0.8706998192886128,0.5416666666666666,0.955800269719185,1.0,23/125,15.15%,NGF;SH2D6;KIT;FGFR1;EPHA7;FRK;SHC4;ERBB2;EPHA3;RAPGEF1;FER;CD8A;EFS;CASS4;FGFR3;MPZL1;TYRO3;RET;FLT3;PTPRT;RYK;INSR;PTPRF
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.39808603993895564,0.8706993521033661,0.7,0.9553563309037093,1.0,5/22,11.29%,RIPK2;IL16;HMGB1;PLCB1;LGALS9
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),-0.5140546673141609,-0.8704550802047375,0.6296296296296297,1.0,1.0,1/8,8.63%,BRCA1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",0.3239441914188588,0.8704254548305316,0.6774193548387096,0.9554945596055946,1.0,14/67,20.71%,CPSF1;LSM10;PCF11;TAF1B;SNRPB;CCNH;POLR1H;CPSF7;PAPOLA;PRMT5;ERCC3;POLR3K;SYMPK;MTERF2
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),-0.43033802368688,-0.8701385213924574,0.6714285714285714,1.0,1.0,2/28,11.86%,PLPP6;ACAA2
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.44127920923473174,-0.870101288746859,0.671875,1.0,1.0,5/16,25.47%,HPR;ITIH4;ELANE;TNFSF4;IL6R
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),-0.5525109441442448,-0.8700832306952158,0.6875,1.0,1.0,1/6,8.63%,BRCA1
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",-0.5050062525842669,-0.8699631967125342,0.6779661016949152,1.0,1.0,3/8,22.14%,ERI2;EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),-0.5050062525842669,-0.8699631967125342,0.6779661016949152,1.0,1.0,3/8,22.14%,ERI2;EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.27534132457958743,0.8697881165314179,0.8666666666666667,0.9565224026830735,1.0,24/234,10.28%,KCNK6;MCOLN3;SLC12A1;KCNB2;SLC30A10;TRPC3;SLC39A8;KCNC2;TRPM2;SLC8A1;KCNH8;SLC39A11;SLC8A3;PKD2;HCN1;KCNH7;KCNG1;TMEM175;KCND2;KCNK2;ABCC8;SLC6A17;SLC6A20;RHCG
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),-0.5558693546015687,-0.869328225002429,0.6481481481481481,1.0,1.0,3/7,25.54%,NOS2;CHCHD4;PARK7
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),0.38470516191191284,0.8692667163935451,0.6296296296296297,0.9572061649732045,1.0,5/25,8.63%,CYP7B1;OSBPL3;OSBPL6;SLC27A2;OSBPL7
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),-0.37027647281579745,-0.8691860143643061,0.6575342465753424,1.0,1.0,10/65,14.71%,ADSS1;ACSM6;ACOT6;RHOQ;HINT1;ACOT4;ACSM3;ACOT1;ABHD14B;ACOT2
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.42862885009204077,0.8689403225076029,0.6052631578947368,0.957525326975185,1.0,11/18,37.01%,TGFA;INSR;DMRT1;EDN1;BTC;PHIP;EDN3;DRD3;SIRT2;NPM2;IGF1
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),0.49690042321237704,0.8688459287445761,0.6590909090909091,0.9573124889467131,1.0,1/7,5.59%,FKTN
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.4057524743327854,0.8688278478040653,0.6,0.9568970549117487,1.0,5/23,8.40%,CHST6;PRELP;ST3GAL3;B4GALT2;B4GALT3
prerank,GO_Biological_Process_2021__alkaloid metabolic process (GO:0009820),0.5539079296923332,0.8684408729524327,0.6610169491525424,0.9572508648921452,1.0,1/5,0.59%,CYP1A2
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.35375604764263946,-0.8681105003326376,0.7464788732394366,1.0,1.0,15/91,16.86%,APOL1;AHR;LRP10;DTX2;CYBA;CTSZ;SPINT1;OAS1;CXCL16;MFGE8;FOSL2;VDR;GRN;RAC2;PGLYRP1
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.3480361287177982,-0.8680887615588448,0.7051282051282052,1.0,1.0,10/169,7.08%,CD44;TRIP10;CCND1;IRF1;SNN;DRAM1;CLCF1;GPR183;NFKB2;PLAU
prerank,GO_Biological_Process_2021__maintenance of DNA repeat elements (GO:0043570),-0.554409883719656,-0.8679822113372689,0.6862745098039216,1.0,1.0,3/6,31.99%,MSH6;RMI2;TCF7L2
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.4139161520287633,0.8678871584066242,0.7096774193548387,0.9580305175813718,1.0,7/16,19.29%,MAML1;WWC1;NOTCH1;PBX1;RBPJ;EP300;KAT2B
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),-0.31969087345593344,-0.8676121972702553,0.76,1.0,1.0,25/182,15.75%,TBX1;FGF20;TGFB1;MMP9;TERF2IP;CCND1;CARD14;GPER1;PINK1;DAB2;FLT4;CDK2AP1;PIK3R3;CCND2;HLA-DRB1;SVIP;ENG;FAXDC2;ATG14;TEK;RSPO1;DDX3X;FGF22;PROM2;CD4
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.30859332957998453,0.8675358026887096,0.7222222222222222,0.9582717453635885,1.0,30/153,16.13%,PHLDB2;PLD6;NEUROD2;FGFR1;APOE;NLGN1;GRIP1;CCN2;SIRT1;MARCHF5;DLX1;NCOA3;ZNF703;PLCB1;RALA;SHLD2;SHLD1;MCU;RPS6KA3;COBL;MAP3K13;KMT5C;MIEF2;LRP8;SOX5;INSR;NRXN1;ELAPOR2;DLG5;KMT5B
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.4386007726179191,0.8672342992326897,0.7142857142857143,0.9584080510544812,1.0,2/18,3.96%,URI1;PPP1R35
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.3641711586598258,-0.8669670303591036,0.6753246753246753,1.0,1.0,18/60,19.28%,PDCD1LG2;HLA-A;ZFPM1;HLA-DPB1;IL27;HLA-DRB1;SLC11A1;TXK;HLA-DPA1;IL12A;NR1H4;IL18;ZP3;F2RL1;VSIR;AXL;CRTAM;INHA
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,-0.36097009913285083,-0.8669019300230566,0.6515151515151515,1.0,1.0,15/102,10.05%,AMBP;SLC28A1;BHMT;ELOVL2;F7;SMLR1;ACOX2;ALDOB;VTN;OIT3;MASP1;CLDN2;PON3;CYP3A4;HNF1A
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),-0.5111575977578159,-0.8667147458655504,0.7164179104477612,1.0,1.0,1/8,2.96%,TERF2IP
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),-0.4507239995250854,-0.8663169558966687,0.6515151515151515,1.0,1.0,2/16,5.00%,WNT5A;COL1A1
prerank,GO_Biological_Process_2021__renal filtration cell differentiation (GO:0061318),0.5409791310719726,0.8660657337454019,0.6326530612244898,0.9602353725432725,1.0,1/5,2.84%,PTPRO
prerank,GO_Biological_Process_2021__glomerular epithelial cell differentiation (GO:0072311),0.5409791310719726,0.8660657337454019,0.6326530612244898,0.9602353725432725,1.0,1/5,2.84%,PTPRO
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),-0.37506676866985206,-0.8658576642456649,0.7,1.0,1.0,6/67,10.22%,LMOD1;ACTC1;OBSCN;TMOD4;CSRP3;LMOD3
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),-0.3950790300528744,-0.8658239511567364,0.6615384615384615,1.0,1.0,7/41,9.84%,ALOX12;CYP3A5;ALOX5;ALOX12B;ALOX15;PLPP6;CYP3A4
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),0.5050930030637079,0.8657982595320364,0.6,0.9598995348885515,1.0,3/6,19.09%,B4GALT3;GAL3ST1;FA2H
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),0.5050930030637079,0.8657982595320364,0.6,0.9598995348885515,1.0,3/6,19.09%,B4GALT3;GAL3ST1;FA2H
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),0.36023645383267444,0.8657810518668738,0.5588235294117647,0.959484632154497,1.0,8/37,15.48%,CD14;SERPINE1;HMGB1;F2R;LGALS9;HSPA1A;FADD;LBP
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.4471167772951013,0.8656537554962689,0.6410256410256411,0.9593206945991399,1.0,3/12,13.81%,DRD5;MAPK8;NF1
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.320958596317907,0.865628723828645,0.7666666666666667,0.9589273132712383,1.0,9/74,7.29%,CDH5;RGN;HTR2C;TMTC2;SLC8A1;DRD5;SLC8A3;SNCA;DRD4
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.27444789064159686,0.8656260347805677,1.0,0.9584925690467304,1.0,65/272,21.65%,SMYD5;PC;APOE;SAMD4A;WNT4;SIRT1;DNMT1;PCIF1;DHFR;TRIM71;OPRD1;RIDA;EIF2AK3;RBL1;WWP2;NANOS3;DXO;CNOT9;MOV10;ERN1;LSM2;RBMS3;TWSG1;N4BP1;LGALS9;TNRC6C;HSPA1A;HDAC1;RPS6KA4;PNPT1;NFKB1;MECP2;PUS7;MALSU1;RUNX1;TNRC6A;CRKL;PTBP1;MPHOSPH8;NOTCH1;AGO3;SYNCRIP;MACROH2A2;LSM14A;SAMD4B;CPNE1;ADAM10;STOX1;KAT2B;EIF4A3;PRKAA2;METTL16;AGO2;NANOS1;HIF1A;RNF139;EMILIN1;FXR2;HINFP;LARP1;LSM6;RBBP4;PHF1;OCLN;BMP4
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,0.31808629967251173,0.8655359486598952,0.7741935483870968,0.9582737065654328,1.0,18/89,16.63%,CACNG4;POU3F2;KCNB2;IGDCC3;GRM8;CASKIN1;LIN28B;CSPG5;RIMS4;RHBDL3;CRABP1;FBLL1;SNAP91;MPP2;MSI1;ACHE;EFNA2;MAGEL2
prerank,PanglaoDB_Augmented_2021__Spermatozoa,-0.3833797391438292,-0.8654016189561282,0.7272727272727273,1.0,1.0,19/82,15.45%,C1QB;ANKUB1;FMO5;CPM;SLCO2B1;MAP3K19;VSIG4;SOD2;HLA-DPB1;CP;GAS7;APOBEC4;HVCN1;FPR3;HLA-DPA1;APOL6;OMG;KCNE3;ADAM28
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.45043356050547356,-0.8653147192798363,0.7192982456140351,1.0,1.0,5/13,26.56%,ABHD14B;SULT4A1;SULT1C3;SULT1C2;BPNT2
prerank,GO_Biological_Process_2021__positive regulation of dopamine receptor signaling pathway (GO:0060161),-0.5608803232438908,-0.8652764651296331,0.6730769230769231,1.0,1.0,1/5,11.01%,CAV2
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),-0.46363154370006265,-0.865178448760499,0.6060606060606061,1.0,1.0,2/13,8.63%,CEACAM1;BRCA1
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.29465511600611705,0.864803651790316,0.8333333333333334,0.9594862953998632,1.0,21/109,15.15%,ADGRL2;APOE;HTR2C;GPC6;CGNL1;PLXNB1;EFS;PDZRN3;FGFR3;RNF128;COBL;MPDZ;DDAH1;UNC13B;FARP1;NEO1;MAP6;MAGI1;BCAM;PRICKLE2;PTPRF
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),-0.5467744175042544,-0.8646558367745388,0.6774193548387096,1.0,1.0,3/7,18.02%,TRDN;JPH2;CALM1
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),0.3537297806776195,0.8644497875922623,0.6388888888888888,0.9598227466939934,1.0,5/41,6.32%,IRS1;ZBTB7B;SIRT1;CRY1;STAT5B
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),-0.3977735189677789,-0.8644042171702142,0.6923076923076923,1.0,1.0,12/41,29.49%,TOMM20;SEC62;PAM16;TIMM17A;ROMO1;CHCHD4;HSPA5;DNAJC19;TIMM21;PEX1;SRP54;GRPEL1
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.4256976161268774,-0.8642917554090693,0.6231884057971014,1.0,1.0,4/21,21.44%,RPA3;POLE2;RPS27A;RPA2
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.42049927122169906,0.8642378128740279,0.6857142857142857,0.9599089972664155,1.0,4/15,18.06%,ADCY2;PRKAR2A;ADCY3;ADCY6
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.47746263992863175,-0.8642069890860986,0.6666666666666666,1.0,1.0,1/17,1.65%,GMFG
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.362987083388235,-0.8640275770737647,0.6911764705882353,1.0,1.0,3/63,7.07%,PSMB9;CARD14;NFKB2
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.3860563870361517,0.8639608403529702,0.6590909090909091,0.9601131185789817,1.0,7/22,14.12%,HTRA2;PML;WWOX;PPP2R1B;RET;FADD;BID
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.3898882529563261,-0.8638847399261542,0.7246376811594203,1.0,1.0,14/50,27.00%,NDUFS2;TMEM126A;NDUFA2;NDUFB4;NDUFC1;NDUFA1;NDUFB9;NDUFB10;NDUFS5;NDUFB11;NDUFAF5;NDUFB2;TIMM21;NDUFS6
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.3898882529563261,-0.8638847399261542,0.7246376811594203,1.0,1.0,14/50,27.00%,NDUFS2;TMEM126A;NDUFA2;NDUFB4;NDUFC1;NDUFA1;NDUFB9;NDUFB10;NDUFS5;NDUFB11;NDUFAF5;NDUFB2;TIMM21;NDUFS6
prerank,GO_Biological_Process_2021__glycerol-3-phosphate metabolic process (GO:0006072),0.5697858746893135,0.8638702680218943,0.7111111111111111,0.959880144273681,1.0,4/5,35.48%,GPD1;GK;GK5;GPAM
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.43760772062162284,-0.8631715934818168,0.7,1.0,1.0,6/25,8.97%,HK2;ENO4;ALDOB;PKLR;ENO2;GAPDHS
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),-0.4981623997998236,-0.8630301033354354,0.65,1.0,1.0,3/12,9.69%,GPER1;ANXA1;REST
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),0.508835697477829,0.8628211505182659,0.6521739130434783,0.9616298972787087,1.0,2/9,11.98%,GALE;GALT
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),0.40250932129013206,0.8626262629480212,0.5806451612903226,0.9616666593858132,1.0,6/28,16.47%,SMYD5;TET2;KMT5C;ATPSCKMT;KMT5B;SETD2
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),0.32741185431260245,0.8625581532241412,0.6785714285714286,0.9614125165376293,1.0,19/66,21.57%,NAALADL1;CPN1;CARNMT1;GSTM5;TRHDE;GSTM2;GSTA4;GPX1;GSTZ1;THOP1;FURIN;ETHE1;ADAMTS13;GSR;AEBP1;HM13;GSTT2;ACE;DMD
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.36812944106461776,-0.8625296807969455,0.726027397260274,1.0,1.0,20/81,13.88%,SIRPG;AHR;TGFB1;GMFG;CYTIP;ARHGAP9;TAGAP;KLRB1;DOCK2;PARVG;FCGR3A;CD5;TRAF3IP3;MYO1F;PTPRC;ITGAM;HSD11B1;TXK;CD27;PSTPIP1
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),0.42123074563614027,0.8624728768207184,0.6888888888888889,0.9611793737313025,1.0,3/14,11.15%,SCD5;SLC25A1;PPCS
prerank,GO_Biological_Process_2021__positive regulation of Golgi to plasma membrane protein transport (GO:0042998),-0.5578902769257043,-0.862064866239866,0.7321428571428571,1.0,1.0,3/5,28.29%,ACSL3;CNST;RACK1
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),-0.5046359761856558,-0.8618138239307352,0.6885245901639344,1.0,1.0,3/9,20.83%,USP17L2;DHX58;DDX60
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,-0.34909611842575133,-0.8617788845956499,0.7272727272727273,1.0,1.0,27/90,18.18%,SLC22A8;SLC22A6;TMEM213;VWA3B;WDR93;CCDC60;P2RY14;ATP6V1C2;BPIFB1;RP1;NEK5;SCIN;ZNF750;SNTN;ATP13A5;CFAP61;DNAH2;RERG;NPHS2;ADGRF5;PROM2;RHBG;SCNN1G;SLC4A1;CYP4B1;COL28A1;MUC15
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.4919049131716287,0.8617445217222893,0.6578947368421053,0.9624824976067179,1.0,3/7,31.55%,PIBF1;NF2;PTPN2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),-0.5371105802721821,-0.8615973282486482,0.6923076923076923,1.0,1.0,3/9,18.38%,ENG;GATA4;CAMK2A
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.4797600174118952,-0.8613295851682935,0.6229508196721312,1.0,1.0,4/12,20.83%,USP17L2;TLR2;DHX58;DDX60
prerank,GO_Biological_Process_2021__aromatic compound catabolic process (GO:0019439),0.5403475059385499,0.86122153553738,0.6458333333333334,0.9632518965204622,1.0,2/6,4.57%,EPHX2;TET2
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),-0.368508329216979,-0.8611849259448273,0.7105263157894737,1.0,1.0,12/67,16.59%,ITGB2;HCK;TEC;DAB2;CEACAM1;ITGBL1;ITGA2B;ITGB6;TXK;ITGA5;ITGB5;ANGPTL3
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),0.35937073838242545,0.8608232714600605,0.5806451612903226,0.9637440780017832,1.0,1/39,0.42%,SYPL2
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.4676927052084203,-0.8607095690298823,0.7272727272727273,1.0,1.0,1/13,7.50%,SEMA3A
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),-0.45650362354935464,-0.8606665017154108,0.6290322580645161,1.0,1.0,3/12,20.04%,PINK1;PHF23;FEZ1
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),0.38296746671027215,0.8605233062482543,0.6363636363636364,0.9639110550663534,1.0,4/25,22.28%,MDFIC;GTF2F2;RSF1;POLR2F
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),0.30693249766610226,0.8604958715550637,0.8823529411764706,0.9635322661192881,1.0,33/150,18.20%,SNX18;FGD4;RGS16;ERBB2;ASAP3;SRGAP2;CRK;EPHA3;RAPGEF1;FGD5;PLXNB1;EFNA5;FGD1;F2R;RRP1B;EVI5L;GPSM1;LIMS1;RAP1A;RGS7;SNX9;DOCK9;RAP1GDS1;NF1;RGS6;PKP4;VAV2;DOCK11;RSU1;ARHGAP27;PLXNA4;TBC1D2;RAPGEF3
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),-0.47763013872790294,-0.8602249525559487,0.6956521739130435,1.0,1.0,1/11,3.04%,PDCD1LG2
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",-0.5124492402737011,-0.8601515546817013,0.6935483870967742,1.0,1.0,2/7,21.19%,SEC62;HSPA5
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),0.5547245161598867,0.8597471551636451,0.6923076923076923,0.9642316657055598,1.0,1/5,3.19%,SLC39A8
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),0.5547245161598867,0.8597471551636451,0.6923076923076923,0.9642316657055598,1.0,1/5,3.19%,SLC39A8
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),-0.47141621970471714,-0.8597200079605193,0.7049180327868853,1.0,1.0,3/14,14.24%,CAV3;CSRP3;TTN
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),-0.535714328212735,-0.8596803697943595,0.7230769230769231,1.0,1.0,1/7,6.30%,IL7
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),0.40578861830117907,0.8595603941606322,0.7352941176470589,0.9641705128672086,1.0,8/19,19.85%,TFB1M;METTL15;FBLL1;FBL;ZCCHC4;BUD23;NSUN4;METTL16
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),0.3631003114478276,0.8592469937096989,0.6060606060606061,0.9643438078686174,1.0,13/40,20.61%,HRH3;PCLO;SNCA;PDZD11;PPFIA3;SYT1;GRM4;SNPH;SYN2;NRXN1;SYN1;CDK5;LIN7A
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.4196987153103154,0.8591847837866613,0.7105263157894737,0.9640277024490348,1.0,6/21,8.91%,SMYD1;MAML1;NRG1;PROX1;GREM1;WNT3A
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.3702917593078401,-0.859160668902181,0.7391304347826086,1.0,1.0,18/74,16.51%,ELOVL2;ALOX12;CYP1B1;ALOX5;ACSL5;ALOX12B;PLA2G10;ALOX15;CYP2J2;ACOT4;CYP3A4;ACOT1;CYP4F12;ACOT2;CYP2E1;AWAT1;ACSL3;ALOX15B
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.3184610181768882,0.8586275198625348,0.5555555555555556,0.9647036987079862,1.0,36/122,22.22%,HDAC3;HDAC10;SMARCD3;SIRT1;HIRIP3;ZBTB1;HP1BP3;SMARCB1;MYC;PIH1D1;PBRM1;ARID1A;BPTF;SMARCA2;SMARCA4;HDAC1;HDAC4;BAZ1B;HDAC11;BAZ2B;BAZ2A;SETD2;CHD1;NUDT5;SATB2;KAT2B;HDAC5;RSF1;PRDM16;ZBTB7A;RBBP4;PHF1;BRWD1;SUV39H2;SMARCAD1;SETD7
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.33852545022813296,0.8584940211065296,0.6388888888888888,0.9646217888120687,1.0,6/47,11.09%,PLCH1;NUDT4B;ITPKB;PLCB1;INPP1;PLCH2
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),0.4131947455971152,0.8584552788031369,0.7222222222222222,0.964257819728978,1.0,8/27,13.73%,PCM1;IFT88;C2CD3;RPGRIP1L;CEP290;CEP250;PIBF1;ARL13B
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.40636396953235016,0.8583649882348535,0.5609756097560976,0.9640455022081597,1.0,6/17,26.74%,PDZD11;ADAM10;TPR;NUP153;AFDN;NUP98
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.38595487502929043,-0.8580970192863159,0.6231884057971014,1.0,1.0,3/40,7.40%,ITGB2;CAV3;CEACAM1
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,-0.34667708241009654,-0.8578675189772355,0.7228915662650602,1.0,1.0,10/105,7.34%,C1QTNF1;LMOD1;TIMP3;ANGPTL2;CYP1B1;COL1A1;UACA;ADAM33;DCN;ASPN
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.47225076861667703,0.8578610448760685,0.6363636363636364,0.9645965082037421,1.0,2/8,17.65%,PLXNB1;PLXNA4
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),-0.48521638295593533,-0.8577942190662939,0.7169811320754716,1.0,1.0,1/11,2.54%,WNT5A
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),-0.5008748087462552,-0.8574277064958272,0.6785714285714286,1.0,1.0,2/9,7.50%,SEMA3F;SEMA3A
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.5038760553915637,0.8572299476129299,0.6829268292682927,0.9655180961240851,1.0,1/5,31.69%,NAA16
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.4294070536679237,-0.8571807222678847,0.65625,1.0,1.0,4/24,11.76%,FHOD1;ACTG1;WAS;VIL1
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.38040681556764877,-0.8571195582848344,0.7323943661971831,1.0,1.0,6/69,4.89%,TGFB1;HCK;WNT5A;PDCD1LG2;CXCL13;TNFRSF1B
prerank,GO_Biological_Process_2021__protein sialylation (GO:1990743),-0.5485934888575816,-0.8570984261280449,0.6833333333333333,1.0,1.0,1/5,8.60%,ST6GALNAC2
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),-0.37010199373465563,-0.8568974036681614,0.6811594202898551,1.0,1.0,20/72,19.32%,CRYBB1;TULP1;ROM1;COL18A1;COL1A1;CABP4;RDH12;SLC24A1;GPR179;CRYBA4;TULP2;FSCN2;WFS1;PDE6C;RABGGTB;RABGGTA;CRYBG3;GUCY2F;TYR;PRPH2
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.2907188092449903,0.8564773291178396,0.9523809523809523,0.9665693524973795,1.0,23/115,15.67%,SCRIB;PARVA;COL12A1;ERBB2;PAX3;NTN4;EDNRA;SNAI2;KITLG;RND3;CDCP1;CAP2;COL16A1;CHST3;DDAH1;RBFOX2;LRIG3;EFEMP1;NR2F2;WWTR1;ANTXR1;NCAM1;RUNX1
prerank,MSigDB_Hallmark_2020__p53 Pathway,-0.32484605900115326,-0.8564418389830862,0.6829268292682927,1.0,1.0,25/174,18.02%,CLCA2;TGFB1;PROCR;MAPKAPK3;DRAM1;ADA;SERPINB5;CCND2;HINT1;DEF6;TPD52L1;CDKN1A;NDRG1;GPX2;VDR;TXNIP;EI24;NUDT15;DDIT4;ALOX15B;RPL36;ZFP36L1;RRAD;CDK5R1;IER5
prerank,GO_Biological_Process_2021__regulation of sarcomere organization (GO:0060297),-0.5722132158690192,-0.8564065882215525,0.7592592592592593,1.0,1.0,1/5,2.76%,CAV3
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),-0.38165935796349204,-0.8563496677022637,0.7076923076923077,1.0,1.0,4/52,6.68%,ELOVL2;DEGS2;B3GNT5;PRKD3
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),0.474355193297361,0.8563477951544087,0.7027027027027027,0.966335773008267,1.0,5/14,20.80%,TRIM71;KHSRP;MOV10;RC3H1;RBM24
prerank,GO_Biological_Process_2021__membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915),-0.566653186918454,-0.8559654887614855,0.7307692307692307,1.0,1.0,1/5,8.12%,KCNQ1
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.41823475226849605,-0.8558580936542718,0.7384615384615385,1.0,1.0,10/30,23.44%,TAF7;TERT;TBPL1;TAF10;TCEA2;TAF6;SMARCA5;TAF13;TBP;TAF5
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.48039169424651995,-0.8556963687703226,0.6571428571428571,1.0,1.0,5/10,29.66%,PARP10;PARP15;PARP14;PARP9;PARP2
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),0.32480607320969007,0.8556838148847227,0.7368421052631579,0.9673445267448257,1.0,18/87,17.66%,KIT;FGFR1;EPHA7;ERBB2;EPHA3;DRD4;RBL1;FGFR3;IRS2;TYRO3;RET;FLT3;ANKRD54;RYK;INSR;EPHB2;ROR1;EPHA6
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),0.47081766095898975,0.8555640470687547,0.7352941176470589,0.9671656827394242,1.0,4/10,6.88%,FGF10;TGFBR1;HES1;ZBTB1
prerank,GO_Biological_Process_2021__caveola assembly (GO:0070836),-0.5366193400241572,-0.8555253305439545,0.72,1.0,1.0,2/5,11.01%,CAV3;CAV2
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),-0.5142353347659507,-0.8554608247746109,0.7142857142857143,1.0,1.0,1/6,2.65%,LRPAP1
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),-0.4759300855765454,-0.8554474869179209,0.6417910447761194,1.0,1.0,3/12,15.82%,TAFA3;PTPRC;GRN
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.4423106318754428,0.8554468343180671,0.6842105263157895,0.9669252943522013,1.0,3/10,16.39%,WWP2;TERF1;CORO2B
prerank,GO_Biological_Process_2021__endothelin receptor signaling pathway (GO:0086100),-0.5678188154324082,-0.8554377150548421,0.7021276595744681,1.0,1.0,1/5,13.30%,EDNRB
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),0.3117574951961448,0.8553641083048961,0.6923076923076923,0.9666371517950834,1.0,22/93,18.20%,TGFBR1;CD151;NEUROD2;APOE;CDH5;SNCA;NRG1;PIH1D1;GNL3L;FRMPD4;BID;GPX1;PTPN23;SPIDR;INSR;NRXN1;RUNX1;CLIP3;ICE1;LGALS3;FAF1;RAPGEF3
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),-0.3882821229657162,-0.8551933277372897,0.7058823529411765,1.0,1.0,3/29,10.93%,CAVIN1;POLR1C;POLR1G
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),0.4758754339128362,0.8551814360997134,0.7105263157894737,0.9666232743739456,1.0,2/10,13.60%,COBL;LRP8
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),0.4951688757921359,0.8546473098812489,0.675,0.9672256381875738,1.0,2/8,16.53%,PLEKHM1;PIP4K2A
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),0.37570258781761523,0.85457871503761,0.68,0.9669514390971674,1.0,6/33,11.28%,VCAN;PRELP;CHAC1;ARSB;CSPG5;GLB1
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),0.5192706249773418,0.8545505014937319,0.627906976744186,0.966533832104189,1.0,2/5,17.99%,FLNA;MACROH2A2
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),-0.4816473994332387,-0.8545194974903981,0.65,1.0,1.0,1/12,1.55%,RAB34
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.532722290467583,-0.854388165666614,0.6935483870967742,1.0,1.0,2/8,16.15%,DARS2;YARS2
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),0.4859270505207919,0.8541569491694888,0.7894736842105263,0.9670533658129502,1.0,2/8,17.07%,GTF3C4;GTF3C5
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),0.2907783812055612,0.8540692267388664,0.8214285714285714,0.9668479629598875,1.0,14/111,9.00%,EGLN3;CPEB1;RORA;SIRT1;PSME4;SLC8A3;HP1BP3;OPRD1;PSMA1;MGARP;KCND2;MYC;HIF3A;TWIST1
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),0.33875842797123046,0.8540401060500854,0.6388888888888888,0.9664719586403498,1.0,3/51,6.64%,IRGM;RAB7A;UBXN2A
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),-0.38747042664635567,-0.8539289702441759,0.7164179104477612,1.0,1.0,4/43,8.63%,AHR;CTNNA1;GLRA2;BRCA1
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),0.4978210384224767,0.8538586092541209,0.6176470588235294,0.9664104010392257,1.0,3/10,7.30%,BIN1;HES1;F2
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.3923803364340663,0.8538019053236447,0.6829268292682927,0.9660758864040224,1.0,3/13,10.94%,CHST6;NAGK;CHST3
prerank,GO_Biological_Process_2021__regulation of intestinal cholesterol absorption (GO:0030300),0.535430095501816,0.8535737303954771,0.6346153846153846,0.9661510080729983,1.0,2/5,25.25%,ABCG8;LPCAT3
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),0.468017327155357,0.8535550206227408,0.6190476190476191,0.9657759978691628,1.0,3/7,28.09%,ATG2A;ATG2B;ATG7
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.3649658974193439,0.853468690425354,0.65625,0.9655717281019071,1.0,8/36,14.49%,BAMBI;TGFBR1;JAG1;ZNF703;TWIST1;BCL9L;SMAD2;WWTR1
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),0.4323652146815047,0.8533096369969589,0.6363636363636364,0.9655924716022809,1.0,3/11,20.74%,FBLL1;FBL;EXOSC5
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),-0.46992510614896943,-0.8533042193727784,0.6,1.0,1.0,1/16,1.49%,TGFB1
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),0.5360860177773675,0.8530882873413588,0.6875,0.9655859566928852,1.0,1/5,3.45%,BCL11B
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),-0.49346834956668345,-0.8530490336821255,0.7213114754098361,1.0,1.0,5/12,17.81%,ZFPM1;ENG;HEY2;GATA4;MESP1
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.42408581617681335,0.852712604310742,0.631578947368421,0.9658585286663878,1.0,2/12,15.03%,ALG12;ALG3
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.386082380750432,0.852674632502513,0.71875,0.9654912990539407,1.0,3/32,4.26%,ALCAM;AUTS2;SEMA5A
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.4233772618767435,-0.8521700214572188,0.75,1.0,1.0,3/20,11.99%,CXCL13;SP100;WARS1
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.3629772346518765,0.851733216004611,0.7142857142857143,0.9669333922141139,1.0,7/37,7.29%,CHRM2;HTR1F;GALR3;HTR2C;HRH3;OPRD1;DRD4
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.3342413485197908,-0.8516564815237572,0.7468354430379747,1.0,1.0,23/91,21.63%,IRF1;TRIM5;AGBL5;STAT1;PLA2G10;OAS2;IFIT3;NLRP9;PTPRC;IFIT1;OAS1;TLR2;F2RL1;DDIT4;IFIT2;SERINC3;IFI27;IFIT1B;TRIM56;MLKL;MX1;IFI6;ISG15
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),-0.501846182500167,-0.8513994599822763,0.6507936507936508,1.0,1.0,1/7,7.97%,CHMP3
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),0.44548662812888423,0.8511727686747321,0.6458333333333334,0.9676536348637194,1.0,5/12,20.11%,KPTN;RNF152;ATM;SESN2;SZT2
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.42643413132146873,-0.8511649467408017,0.7,1.0,1.0,2/25,4.81%,IRF1;TRIM5
prerank,"GO_Biological_Process_2021__regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",0.5185499418582954,0.8511641403276458,0.7317073170731707,0.9672249417795613,1.0,2/7,6.24%,RSPO3;NKD1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.411439062321842,-0.8508534891083822,0.7014925373134329,1.0,1.0,8/20,33.37%,RBX1;RPS27A;DDB1;UBB;CETN2;UBC;GTF2H5;RAD23B
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.4024848676091889,0.8506312648198658,0.7096774193548387,0.9678085744102026,1.0,4/26,9.53%,BCL2;TMEM117;CHAC1;ERN1
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),0.33409265940894534,0.8502146200267277,0.631578947368421,0.9682355469202737,1.0,4/51,4.79%,PNP;CLC;SDC4;CCDC88B
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.33634994579930066,0.8501873292117628,0.6666666666666666,0.9678343120719154,1.0,17/61,18.92%,NOVA1;MITF;RBM20;HNRNPF;HNRNPH1;ESRP1;PCBP3;HNRNPL;RRP1B;FASTK;USP36;SRRM4;PTBP1;FUS;RC3H1;CLK2;PCBP4
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.29698911299864134,0.8500709003513719,0.7368421052631579,0.9675690855375684,1.0,31/112,23.29%,SDC4;PERP;ERBB2;TMEM117;DSP;PTGFRN;PLXNB1;PARM1;RNF128;HID1;COBL;UNC13B;OGDH;BCAM;PTPRF;HDAC11;TMEM63B;ARHGEF16;ADCY6;DOCK1;EPB41L4B;TMEM125;PCDH1;JUP;CAMSAP3;ARHGEF10L;GNA11;SYT7;ST14;CDS1;PTPN21
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),-0.4948592533642894,-0.8498610017032618,0.6610169491525424,1.0,1.0,3/13,17.25%,ANXA1;REST;ZFP36L1
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),-0.5072586929067241,-0.8497044546279958,0.703125,1.0,1.0,2/10,11.15%,SYNE2;DCTN1
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),0.39837343828313165,0.8496683402074651,0.625,0.9681447360055938,1.0,5/18,20.02%,SFSWAP;SRSF4;PTBP1;PCBP4;U2AF2
prerank,GO_Biological_Process_2021__adenosine metabolic process (GO:0046085),-0.5118130228106641,-0.8495481924397755,0.7142857142857143,1.0,1.0,2/6,11.90%,ADA;ACP3
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),-0.3521627215081211,-0.8494402952024653,0.7215189873417721,1.0,1.0,15/104,8.67%,LMOD1;MYH4;MYH7;CASQ2;ACTC1;MYH8;CAV3;MYOT;TMOD4;MYBPC3;TRDN;LTB4R;CHRNE;NEB;ACTN3
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.4990129808305275,0.8493925199500338,0.6111111111111112,0.968374278306639,1.0,3/7,15.56%,ZBTB1;CARD9;IL23A
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),-0.48378867333114967,-0.8492061305869247,0.6666666666666666,1.0,1.0,2/11,13.00%,VIL1;CFL1
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),0.35128272819046424,0.8491210361026154,0.7333333333333333,0.9684816959247924,1.0,8/28,19.88%,MFSD2A;ABCA1;ABCC1;PLSCR1;PLSCR4;ABCA7;ATP8A2;ATP10A
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.40351951662482943,0.8490554018237059,0.76,0.9681624930260363,1.0,4/17,5.56%,TGFBR1;ROBO2;PKD2;HES1
prerank,GO_Biological_Process_2021__positive regulation of osteoclast differentiation (GO:0045672),-0.5359494366552198,-0.8487115017767778,0.75,1.0,1.0,1/5,8.37%,ATP6AP1
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),-0.5469926512547107,-0.8486261481201042,0.7735849056603774,1.0,1.0,1/7,7.60%,HAT1
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.317513267043419,-0.8483226798459588,0.8157894736842105,1.0,1.0,27/252,19.40%,TICRR;MCM2;POLQ;HMGB3;TERF2IP;SP100;RPA3;MCM3;UBE2U;BRCA1;ENDOG;TERT;DNASE2;REXO4;RAD1;POLE2;NUDT15;PARP4;NT5E;POLD4;SMUG1;RPS27A;NOP53;CDC6;RAD54L;OGG1;RECQL4
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),0.3196914257234717,0.8481323246669619,0.7037037037037037,0.9696368817453552,1.0,6/50,14.37%,APOE;COMMD1;OSBPL7;TMTC3;FOXF2;GPX1
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.5078746175192372,-0.8479433521459244,0.711864406779661,1.0,1.0,5/10,31.83%,TLR2;RPS27A;UBB;PGK1;UBC
prerank,GO_Biological_Process_2021__epoxygenase P450 pathway (GO:0019373),0.45803160063476644,0.8478494771854929,0.7027027027027027,0.9697706459366114,1.0,3/10,6.53%,CYP1A2;EPHX2;CYP2S1
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.41917459522971706,-0.8478424161741014,0.703125,1.0,1.0,3/23,11.77%,ITGB2;PDZK1;ITGAM
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),-0.41158834645915726,-0.8476559886703922,0.7213114754098361,1.0,1.0,6/27,17.19%,WAS;GAS7;VIL1;CATIP;PSTPIP1;RAC1
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),0.41336200138434,0.847589589619407,0.6222222222222222,0.9695174411370627,1.0,3/14,5.32%,TRPM2;SLC8A1;SLC8A3
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),0.41336200138434,0.847589589619407,0.6222222222222222,0.9695174411370627,1.0,3/14,5.32%,TRPM2;SLC8A1;SLC8A3
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),-0.3708337857582745,-0.8475703796211532,0.6944444444444444,1.0,1.0,3/42,6.24%,BUB1;TGFB1;ZWILCH
prerank,GO_Biological_Process_2021__regulation of apoptotic cell clearance (GO:2000425),-0.5162705248215609,-0.8475125278104783,0.7555555555555555,1.0,1.0,2/5,13.42%,TGM2;CD300LF
prerank,GO_Biological_Process_2021__phenol-containing compound biosynthetic process (GO:0046189),-0.5481245695116151,-0.8473108053164002,0.72,1.0,1.0,1/7,0.42%,DBH
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),0.40114792308674413,0.8472127286621671,0.7045454545454546,0.9698672417523471,1.0,5/14,11.12%,SLIT2;FSTL3;DOK5;ITGA3;TWSG1
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),0.48563118337002875,0.8470845503241962,0.6326530612244898,0.9697845977698822,1.0,4/8,21.17%,SP7;MLLT3;TP53;ACE
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),-0.35093459451581716,-0.8468833567363959,0.7215189873417721,1.0,1.0,8/95,7.49%,AQP3;SCN5A;CASQ2;WNT5A;TRPV6;SYT10;SYT2;ALOX15
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),-0.40150274968104904,-0.8468253118715715,0.7361111111111112,1.0,1.0,6/28,14.71%,ACSM6;ACOT6;ACOT4;ACSM3;ACOT1;ACOT2
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),-0.40150274968104904,-0.8468253118715715,0.7361111111111112,1.0,1.0,6/28,14.71%,ACSM6;ACOT6;ACOT4;ACSM3;ACOT1;ACOT2
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),-0.5241607403502805,-0.8466886808262487,0.7241379310344828,1.0,1.0,3/6,19.41%,SPI1;TNFRSF10A;CASP8
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),0.4154181949545054,0.8464599631254411,0.6818181818181818,0.9706468932371328,1.0,3/15,12.76%,NT5C1A;UPP2;NT5C3A
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.48032908941200586,0.8461580022832619,0.7209302325581395,0.9709282600398199,1.0,3/8,15.48%,TICAM2;NR1H3;LBP
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.34522580683762777,-0.8459687203162969,0.8,1.0,1.0,25/120,22.02%,TRIM62;AIM2;WNT5A;TERF2IP;CARD14;TRIM5;TRIM25;NFKB2;CLU;NLRC4;TLR2;PRKCH;NLRP3;IL18;AGT;TNFRSF11A;RPS27A;CAMK2A;NTRK1;TRIM68;ALK;AGER;AR;TNFSF18;TRIM22
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),0.4515599549960088,0.8459436961949998,0.5277777777777778,0.9709194260324202,1.0,1/11,3.16%,ZBTB7B
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),0.5328903961056822,0.845914865044655,0.7804878048780488,0.970560119869241,1.0,3/7,8.53%,APOH;DIPK2A;LRP6
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.43572701097685435,-0.8457658833785034,0.6507936507936508,1.0,1.0,6/19,14.99%,NLRP12;UACA;SPI1;NLRC3;NLRP3;DDX3X
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),-0.47673245520230106,-0.8457469561482499,0.676923076923077,1.0,1.0,1/11,1.49%,TGFB1
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.29154300681971523,0.8456940934662436,0.8636363636363636,0.9705851429870124,1.0,36/225,14.49%,LGR5;BAMBI;FGF10;PRICKLE1;APOE;PTPRO;CDK14;TLE2;SEMA5A;PSME4;ZEB2;DACT3;NKD1;ZNF703;GREM1;PSMA1;LATS1;IGFBP4;LRP6;WNT3A;SNAI2;LZTS2;GPC5;KANK1;WNK2;RBMS3;PPM1A;HDAC1;TMEM131L;RNF146;TPBGL;WLS;NFKB1;MLLT3;NKD2;WWTR1
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),0.33176348741260103,0.8455204318973271,0.7272727272727273,0.9705226019341882,1.0,7/58,9.05%,KIT;FGFR1;ERBB2;PDGFD;FGF18;MAP3K10;TENM1
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.44566049279128245,-0.845413880855476,0.6774193548387096,1.0,1.0,3/16,14.99%,STAT1;NLRC3;DDX3X
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.27122802171964167,0.8452734090067037,0.9333333333333333,0.9706149293276376,1.0,86/441,15.06%,ADRA1A;ADRA1B;FGF10;THEM4;TGFBR1;KIT;HDAC3;BCL2;CFLAR;NEUROD2;FGFR1;KSR1;IRS1;NLGN1;ANGPT1;MAP3K14;HIP1;CDH13;NRG2;CD14;RIPK2;TICAM2;SEMA5A;CX3CR1;FGF17;SIRT1;AKR1C3;ERBB2;TNFSF14;PDGFD;NRG1;TNFRSF19;HPSE;TRIM8;LGALS1;TMEM106A;HMGB1;ECM1;MYORG;PPP5C;CARD9;FLNA;STYXL1;PLXNB1;FGF18;TGFA;EPOR;MLST8;GRM4;ALPK1;CASS4;HCLS1;AKT2;APOL3;FGFR3;KITLG;IRS2;SHARPIN;F2R;LGALS9;TRIM44;PPM1A;PIM2;TSPAN6;GPR89A;LIMS1;ADGRV1;RET;TICAM1;GAB1;FADD;CCDC22;NR3C2;TAB3;PELI1;TCIM;FLT3;WLS;BID;NFAT5;RYK;PELI2;INSR;PIK3CA;IRAK4;CXXC5
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),-0.49160030350991846,-0.845200909467819,0.7384615384615385,1.0,1.0,3/7,14.43%,TGFB1;ENG;TGFB3
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),-0.3846413116045664,-0.8446936758791435,0.7428571428571429,1.0,1.0,3/31,10.93%,CAVIN1;POLR1C;POLR1G
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),-0.3885781462553498,-0.8443343216134662,0.7301587301587301,1.0,1.0,5/35,16.68%,DTL;TRIM25;ATXN7L3;RBX1;RNF20
prerank,GO_Biological_Process_2021__positive regulation of inositol phosphate biosynthetic process (GO:0060732),-0.5531357340093315,-0.8442903837913679,0.7,1.0,1.0,2/6,9.43%,GPER1;P2RY6
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.4024704553210331,0.8442688561193591,0.7,0.9722344273844046,1.0,2/14,3.01%,VEGFC;ITGA11
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),-0.5742232820437712,-0.8440291581029818,0.7735849056603774,1.0,1.0,1/5,12.91%,PRKCH
prerank,MSigDB_Hallmark_2020__UV Response Up,0.2932897874391422,0.8439498912338121,0.8928571428571429,0.972446959835015,1.0,21/142,15.23%,TACR3;PDLIM3;RAB27A;BSG;LHX2;ARRB2;ATF3;CCND3;CASP3;FGF18;NXF1;CTSV;CHKA;TYRO3;RET;JUNB;H2AX;BID;CYB5B;FURIN;CA2
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.3510155900115851,-0.8438631134521136,0.725,1.0,1.0,15/79,17.90%,LMOD1;HCK;CAV3;C15ORF62;ALOX15;ANKRD53;CLU;DCTN1;VIL1;BAIAP2L1;F2RL1;VASP;RAC1;CDK5R1;BAIAP2L2
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),0.31618297858606825,0.8437956466915731,0.7692307692307693,0.9722895932796343,1.0,48/290,17.92%,TBC1D10A;FGF10;GRID2;SEPTIN10;ANGPT1;RAB31;TBC1D16;CNTLN;ABHD17A;TICAM2;CNTNAP2;STX5;TBC1D12;RAB28;RAB20;SCFD2;STX6;BICD1;STX8;FLNA;RAP2A;SYNDIG1;GGA1;TMED3;CROCC;RPGR;TBC1D22B;CEP250;EVI5L;TBC1D4;ACD;ARL5A;SNX9;COG7;WLS;SMURF1;SEPTIN9;SEPTIN8;ANK2;HERC2;RAB5A;TBC1D8B;ARFIP1;VPS26C;TBC1D2;TBCK;NIPBL;CEP68
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),0.4030584688868728,0.8435196976763941,0.6388888888888888,0.9723809699383622,1.0,3/18,13.71%,NAALAD2;SLC25A12;MTHFR
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),-0.41705941587973183,-0.8434663258345607,0.7,1.0,1.0,4/24,10.18%,FLG2;SOX10;ACTG1;ARHGAP12
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.41923335780972454,-0.843327381112993,0.765625,1.0,1.0,2/22,4.18%,ELOVL2;ACSL5
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),0.4817126352874588,0.8433046648756727,0.5813953488372093,0.9723715250751656,1.0,2/7,7.93%,SLC8A1;EDNRA
prerank,GO_Biological_Process_2021__positive regulation of neutrophil extravasation (GO:2000391),0.5405557934829489,0.8430907843752753,0.7291666666666666,0.9723553755822939,1.0,1/5,22.36%,ADAM8
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),0.4315182637418512,0.8430632227667835,0.6829268292682927,0.9719836080450491,1.0,2/11,14.09%,APOE;NFKB1
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.388908141845131,-0.8428732700237095,0.7763157894736842,1.0,1.0,14/47,16.64%,HK2;ENO4;SLC16A8;ALDOB;PKLR;ENO2;GAPDHS;PDHX;SLC16A3;PGAM1;VDAC1;SDS;HK3;PGAM2
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.4963466463862032,0.8426005832134932,0.5897435897435898,0.9725846951526051,1.0,3/9,19.55%,SIRT1;DIP2B;PRKAA2
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.294350652822226,0.8424307325213491,0.7727272727272727,0.972461207137783,1.0,41/179,25.99%,CTDNEP1;TOR1B;TICAM2;BLZF1;GBF1;UBXN2A;REEP6;SMPD4;EIF2AK3;TRAPPC12;TMED3;PI4K2B;ARHGAP21;COG7;FAM174B;GOLGB1;MIA3;DOP1B;TMCC1;COG4;UBXN2B;TRIP11;USP6NL;SEC61A1;TRAPPC11;COG2;VPS51;SEC31A;MYO18A;COG3;VMP1;BNIP1;ANK3;HOOK3;ZNF501;GOLGA8H;CUL7;SYNE1;TRAPPC8;DNAJC28;SEC23IP
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),0.3233349768681938,0.8423604443769116,0.9333333333333333,0.9721635998719841,1.0,18/84,22.28%,AUP1;DERL3;UBE2J1;RHBDD1;MAN1A1;FBXO27;RHBDD2;TMUB2;POMT2;RNF185;UBE4B;EDEM1;TMEM67;UBXN4;UBE2J2;RNF139;BAG6;FBXO17
prerank,GO_Biological_Process_2021__regulation of striated muscle cell differentiation (GO:0051153),0.5326679897783368,0.8422967593235366,0.6037735849056604,0.9718662566765185,1.0,3/6,20.80%,NRG1;HDAC5;RBM24
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),-0.48009287528899647,-0.8422429275083392,0.6842105263157895,1.0,1.0,3/10,20.42%,ANGPTL3;ABCB11;ALK
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),0.3344648791157606,0.8420650322200155,0.8285714285714286,0.9720445340658777,1.0,14/51,27.98%,NUP210;NUP42;BCL11A;AAAS;RNF212;NSMCE2;RANBP2;NUP214;TPR;SEH1L;NUP153;NUP98;SAE1;NUP37
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.32833331448486175,0.8420166588840414,0.8947368421052632,0.9716939696546675,1.0,29/120,15.95%,TGFBR1;NEUROD2;POU3F2;WNT4;FZD5;ATOH7;ERBB2;RORB;LHX2;USH2A;WNT9A;FZD1;CASP3;TENM3;NR4A2;LRP6;WNT3A;TENM1;ADNP2;NLGN4X;UGDH;MYT1L;ASCL1;FUT9;ANOS1;SNPH;RYK;RUNX1;PTPRD
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.42877850164881726,-0.8420019751084653,0.7538461538461538,1.0,1.0,5/25,16.15%,TGFB1;TERT;SPI1;GNL3;SMAD3
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.3786291244653443,0.8418680083582644,0.6666666666666666,0.9715644606224361,1.0,8/23,13.70%,CSGALNACT1;ADAMTS12;CHST12;HPSE;CHST11;HS3ST4;FAM20B;CHST8
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),0.3887543356614901,0.8416087646802117,0.6571428571428571,0.971555419195,1.0,8/24,18.13%,PTGS1;AKR1C3;CYP2S1;AKR1C1;CES2;PTGR2;PTGIS;ACOX1
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.36400799647724813,0.8416004923787563,0.7058823529411765,0.9711453870508651,1.0,4/23,9.68%,SEMA6C;SEMA5A;DSCAM;SEMA4A
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.4614328935012282,-0.8413382054328082,0.7627118644067796,1.0,1.0,5/20,18.02%,STAC;TRDN;P2RY6;JPH2;CALM1
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.36108261898583216,0.8412495506184701,0.6944444444444444,0.9714371550218073,1.0,7/43,11.02%,DUSP4;SPRED3;RGS14;PTPRR;SPRED2;WNK2;SPRED1
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),-0.46851514661112836,-0.8412047402630364,0.7333333333333333,1.0,1.0,5/15,16.70%,AHR;TNFRSF1B;IL27;IL12A;TNFSF8
prerank,GO_Biological_Process_2021__parallel actin filament bundle assembly (GO:0030046),0.48774464720603594,0.8406190349674062,0.6829268292682927,0.9722428247210266,1.0,3/6,15.74%,SPIRE2;FSCN1;ESPN
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.32819846187730833,0.8401579495763793,0.7894736842105263,0.9728208508292665,1.0,7/77,3.00%,NGF;EGLN3;GRID2;BCL2;APOE;EPHA7;SLC30A10
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),0.4712968522712102,0.8398737524897558,0.6842105263157895,0.9729847331602974,1.0,2/9,2.66%,PC;APOE
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),-0.519699030816152,-0.8397925557817556,0.7068965517241379,1.0,1.0,2/5,22.14%,EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),-0.519699030816152,-0.8397925557817556,0.7068965517241379,1.0,1.0,2/5,22.14%,EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),-0.519699030816152,-0.8397925557817556,0.7068965517241379,1.0,1.0,2/5,22.14%,EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),-0.519699030816152,-0.8397925557817556,0.7068965517241379,1.0,1.0,2/5,22.14%,EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),0.34514132474340786,0.8395294331233579,0.8,0.9733618643848824,1.0,12/49,16.50%,MAPKAPK2;CD14;FZD5;SRR;SNCA;FER;RPS6KA3;F2R;LGALS9;PELI1;LBP;OTUD5
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.2927149372576727,0.8393542524221924,0.9375,0.9733920509916262,1.0,16/120,9.13%,KCNK6;SLC12A1;KCNB2;KCNC2;KCNH8;PKD2;HCN1;KCNH7;KCNJ3;KCNG1;SLC12A9;KCNJ6;TMEM175;KCND2;KCNK2;ABCC8
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.4694171391902707,-0.8391460051420881,0.6176470588235294,1.0,1.0,2/12,8.95%,LRPAP1;CLU
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),-0.426156683133179,-0.8390885487601888,0.6666666666666666,1.0,1.0,5/19,12.29%,TGFB1;DAB2;RHOQ;GBP1;MRAP
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.44448412189344494,-0.8390884141046316,0.7301587301587301,1.0,1.0,2/21,6.86%,DUOX1;CAVIN1
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.3623497257420861,0.8387838067834442,0.6923076923076923,0.974061826921314,1.0,2/33,5.55%,CPEB1;CAPN2
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),-0.37100044158048023,-0.8386295737273908,0.7419354838709677,1.0,1.0,3/37,7.54%,TGFB1;CTNNA1;LATS2
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,0.29816173363552734,0.8381753300200367,0.7894736842105263,0.9747776300504696,1.0,33/142,20.35%,ACADS;CEL;TDO2;ALDH1A1;ENO3;BPHL;LGALS1;REEP6;SLC22A5;ECHS1;AADAT;ACADM;ACSL1;UGDH;GPD2;ODC1;ADIPOR2;GPD1;CPT1A;RAP1GDS1;GSTZ1;CA2;ECI1;LTC4S;ACOX1;DECR1;HIBCH;BCKDHB;ELOVL5;HADHB;CRYZ;ACADVL;NSDHL
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),-0.46708310508960293,-0.8380937078867279,0.6935483870967742,1.0,1.0,2/8,11.01%,LMOD3;CAV2
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),0.5357747342335196,0.8379503698593239,0.7058823529411765,0.9748470932382107,1.0,2/5,21.34%,DSCAM;SDK2
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),0.4199793203088261,0.8378462909596137,0.5555555555555556,0.9745838023406249,1.0,7/23,19.89%,PCGF1;RNF168;UBE2E1;RYBP;BCOR;RNF40;RNF2
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),-0.43119852967145444,-0.8371605078890874,0.6774193548387096,1.0,1.0,4/19,18.89%,NODAL;REST;HMGA2;TAF6L
prerank,GO_Biological_Process_2021__acylglycerol acyl-chain remodeling (GO:0036155),-0.5271424627480394,-0.8371468812313695,0.7384615384615385,1.0,1.0,1/7,4.57%,DGAT2L6
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),0.4818874044871232,0.8371172906431903,0.6744186046511628,0.9755711174925308,1.0,1/7,14.89%,PUS7
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.3810152080969535,0.8370846891188715,0.7368421052631579,0.9752146676920104,1.0,4/19,19.62%,CBLB;KPNA6;RANBP2;RGPD5
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),-0.4459833151184091,-0.8369051299313619,0.696969696969697,1.0,1.0,3/18,14.16%,TGFB1;ASPN;HEY2
prerank,GO_Biological_Process_2021__regulation of t-circle formation (GO:1904429),-0.5637300262183939,-0.8368700276469693,0.75,1.0,1.0,2/5,40.35%,ERCC1;SLX4
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.46266797506870583,-0.8368531234006431,0.7428571428571429,1.0,1.0,1/15,1.74%,CASQ2
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),0.4549337385868565,0.836542701965192,0.6578947368421053,0.9759483233516135,1.0,3/8,21.91%,OTUD3;OTUD7B;OTUD7A
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),0.34624449438981714,0.8364992038161553,0.84375,0.9755787369430918,1.0,7/29,13.92%,PCM1;SIRT7;TENM1;GCC2;CEP290;B3GAT3;PLK3
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),-0.4938165203937498,-0.8364703320477078,0.6935483870967742,1.0,1.0,1/6,7.50%,SEMA3A
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.32240159659857026,0.8364562812341859,0.8181818181818182,0.9752426717228464,1.0,16/62,18.04%,KIT;FGFR1;SIRT1;PDGFD;PLXNB1;EPOR;HCLS1;IRS2;F2R;GAB1;FLT3;INSR;PIK3CA;NEDD4;ROR1;PIK3R5
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,-0.3283552241178566,-0.8363316209708559,0.75,1.0,1.0,26/147,15.89%,LMOD1;ACTC1;TIMP3;ANGPTL2;HHIP;IRAG1;OBSCN;OGN;COL1A1;COL5A1;LOX;FBXL7;ADAM33;DAAM2;DCN;ITGA9;PRXL2C;COX7A1;MFAP5;NEXN;TEK;C1S;ADAMDEC1;ACTA2;JPH2;FBLN2
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),-0.497159118447178,-0.8362709895295365,0.7368421052631579,1.0,1.0,1/9,4.38%,GUCY2C
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.3747587831108836,0.8362172244098763,0.7560975609756098,0.9752586262956849,1.0,2/25,7.51%,QRICH2;PML
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.4202164834081307,0.8358770009483483,0.6571428571428571,0.9751844057280237,1.0,3/12,15.43%,EFNA5;KANK1;SPRY4
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.4202164834081307,0.8358770009483483,0.6571428571428571,0.9751844057280237,1.0,3/12,15.43%,EFNA5;KANK1;SPRY4
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.30460017274705375,0.8357570884050132,0.8518518518518519,0.9750081653703099,1.0,7/78,5.87%,CCN4;CCN2;HTRA2;CCN1;SNCA;SRGAP2;DCPS
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.35617502737619455,-0.8354692702281342,0.6933333333333334,1.0,1.0,8/63,19.05%,IHO1;RPA3;REXO4;RBX1;POLD4;RPS27A;DDX1;OGG1
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),0.3691612127014764,0.8353485974742055,0.6410256410256411,0.9753090552517225,1.0,4/24,8.23%,URI1;PPP1R35;BOD1L1;STYXL1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),0.4132613239901975,0.8349246629818998,0.65625,0.9757090075226993,1.0,5/17,18.88%,DDAH2;PKD2;DDAH1;INSR;AGXT2
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),-0.42145642449385196,-0.8347283766147845,0.65,1.0,1.0,8/28,16.69%,TGFB1;SOX30;UBE3A;THBS1;TGFB3;TFPI;YAP1;WBP2
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.31470522660205097,0.8346913768384052,0.8095238095238095,0.9757114779802524,1.0,19/75,22.28%,SMYD5;IFI16;DNMT1;TAF1B;SF3B1;POLR1H;GPX1;MECP2;HDAC4;MYO1C;BAZ1B;MPHOSPH8;MACROH2A2;EP300;KAT2B;HDAC5;RBBP4;PHF1;POLR2F
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),-0.3132000780928406,-0.8346863377554082,0.8378378378378378,1.0,1.0,23/146,16.67%,HCK;NLRP12;SCTR;ALOX5;TNFRSF1B;TSHR;GPER1;GPHB5;FCGR3A;GPR27;CGA;HLA-DRB1;GPR39;PTGDR;NLRC3;NLRP3;TEK;NR1H4;GGT5;ADCY7;GRN;ELANE;GHRL
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.3632190569477504,-0.8346466996490054,0.7721518987341772,1.0,1.0,5/61,7.40%,EPN1;MMP9;GPER1;PDE6H;CEACAM1
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.41876582773732446,0.8345004758293011,0.7391304347826086,0.9756808665139499,1.0,3/18,12.47%,TGFBR1;DCUN1D1;HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),-0.3750864667007142,-0.8344729752888604,0.7285714285714285,1.0,1.0,3/37,14.00%,KCNJ15;KCNQ1;KCNJ4
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.3525952243181447,-0.8343804356315202,0.7397260273972602,1.0,1.0,9/56,10.54%,AMACR;LIPI;ACMSD;ACSM6;ALOX5;ACOX2;LIPH;HSD3B7;ACSM3
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),0.29999026901996967,0.8343503500122876,0.8148148148148148,0.9755047946805474,1.0,14/97,12.00%,SLC10A3;ABCA9;APOE;MFSD2A;PITPNM1;ABCA6;NCOA2;AKR1C1;ABCA1;ABCD3;LDLR;ABCD2;ACSL1;CHKA
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.38253953927775464,0.8343332029055083,0.8,0.9750843011635527,1.0,6/23,15.67%,CBFB;RAPGEF1;SNAI2;RAP1A;MYO1C;RUNX1
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),0.33305053076137014,0.8341768301519172,0.7142857142857143,0.974981324441541,1.0,8/54,10.74%,NGF;FGF10;GPR174;AUTS2;RAPGEF1;EPOR;IRS2;F2R
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),0.45617719936354617,0.833661242392138,0.5454545454545454,0.9755718972161306,1.0,5/12,10.84%,RP1L1;MFSD2A;RORB;CEP290;CDHR1
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),0.3421753465081273,0.8333327610058762,0.7105263157894737,0.9757328568439122,1.0,7/39,13.07%,TGFBR1;CCN2;SORBS3;ABL1;EVL;PXN;CCDC88A
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.35694949010039667,0.8331636171797016,0.6486486486486487,0.9756759218996706,1.0,9/46,15.44%,TGFBR1;BCL2;PML;WWOX;STYXL1;FADD;CRADD;BID;TP53
prerank,"GO_Biological_Process_2021__positive regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000096)",0.5206976391953091,0.8331342419307639,0.7142857142857143,0.975328825045357,1.0,2/5,6.24%,RSPO3;NKD1
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),0.2862640729995303,0.832970886056909,0.75,0.9751138881172446,1.0,41/238,16.07%,TEAD2;LLGL1;CD247;RP1L1;QRICH2;MATN1;MITF;NLGN1;PARD3;LRRTM3;PARVA;FSCN3;PCLO;HES1;JHY;SLC7A9;PML;FZD1;SPAG16;FLNA;WNT3A;WASF3;CEP290;P3H4;NLGN4X;LIMS1;GEMIN5;NLGN3;QSOX1;ACD;EPS8;SNX9;TRIP13;MAGI1;YTHDF1;FSCN1;TP53;IL2RB;ESPN;PARD6B;CALD1
prerank,GO_Biological_Process_2021__heart process (GO:0003015),-0.4307536959205409,-0.8329536345335243,0.676923076923077,1.0,1.0,2/12,6.40%,ACTC1;TRDN
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.4248826740385994,-0.8327929953285278,0.6461538461538462,1.0,1.0,2/22,4.02%,CAV3;VAV3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.39029352730833883,-0.8325303852354166,0.746268656716418,1.0,1.0,6/34,23.78%,RPA3;RBX1;POLD4;RPS27A;RPA2;DDB1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),0.474878164680651,0.8323976809954877,0.7441860465116279,0.9758217334392,1.0,2/11,14.52%,TERF1;WRAP53
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.4431309431559471,-0.8323380099263451,0.7230769230769231,1.0,1.0,4/21,18.02%,CASQ2;TRDN;DHRS7C;CALM1
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.5107058447895794,0.8321247377000879,0.7567567567567568,0.9758768395485713,1.0,1/5,12.57%,TANK
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),0.4315442161655098,0.8319203735668113,0.6521739130434783,0.97585947124332,1.0,3/11,11.29%,KLRD1;ARRB2;LGALS9
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),0.2885794294841868,0.8314073462493111,0.8666666666666667,0.9764146949602279,1.0,32/194,14.28%,ADRA1A;EGLN3;FOXO1;BCL2;CFLAR;HIP1;DAPK2;CD14;TNFSF14;PAX3;TNFRSF19;PAK5;TP53AIP1;DCC;CASP3;MYC;EFNA5;RNF152;MAP3K10;BNIP2;PLAGL1;DPF1;GDF6;FADD;PLSCR1;DPF2;CDK11A;PLK3;BID;MAGI3;ADAM15;AIFM2
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),0.32911914681343873,0.8310024485569579,0.6842105263157895,0.9767589235977886,1.0,8/45,13.07%,TGFBR1;CCN2;SORBS3;ABL1;EVL;SYNPO;PXN;CCDC88A
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),-0.47030339934648546,-0.8309146947323337,0.7419354838709677,1.0,1.0,3/15,9.71%,TULP1;PDE6B;RP1
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.45658888908377426,0.8308463134660591,0.6153846153846154,0.9766096815920031,1.0,2/9,4.59%,PLIN5;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),0.4445905097449131,0.83046563664067,0.675,0.9770126803527136,1.0,5/11,13.00%,NLGN1;DEF8;PLEKHM1;EPS8L2;EPS8
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.4880723611348199,-0.8304058714286598,0.7142857142857143,1.0,1.0,2/10,12.51%,F7;APOD
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.436134912242911,0.8303565916550236,0.6041666666666666,0.9767846191584517,1.0,2/13,6.23%,DERL3;UBE2J1
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),0.27203576892935843,0.8303140263616643,1.0,0.9764319827954036,1.0,16/153,10.30%,CD38;SH2B2;SKAP1;CD247;BTN3A2;BCL2;HLA-DQB1;CSK;RIPK2;PSME4;HLA-DRA;PSMA1;ICOSLG;PAG1;DENND1B;PDE4B
prerank,GO_Biological_Process_2021__positive regulation of unsaturated fatty acid biosynthetic process (GO:2001280),-0.5458596058330709,-0.830266443381738,0.75,1.0,1.0,1/5,8.67%,ANXA1
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),0.49708704051441494,0.8302109475457394,0.6818181818181818,0.9761649873440801,1.0,1/5,3.75%,PDE10A
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),0.5531688098293411,0.8301918984075646,0.7441860465116279,0.9758063654541635,1.0,1/6,25.92%,LIN28A
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.4254820633119723,-0.8299133000948951,0.7384615384615385,1.0,1.0,3/25,8.67%,ITGB2;CXCL13;ANXA1
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.3562473851399022,0.8298595535788837,0.6296296296296297,0.9760120837050545,1.0,13/45,19.16%,SIRT1;IFI16;TANK;SPIDR;HSF1;GADD45A;TP53;LIG4;ATM;NIPBL;RAD9A;ATR;EEF1D
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),-0.4839997773965353,-0.8297672920659067,0.7037037037037037,1.0,1.0,2/10,15.21%,BRCA1;CCNF
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),-0.45486489425598475,-0.8296553161844874,0.7741935483870968,1.0,1.0,3/11,21.02%,TCHP;YAP1;TBC1D7
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),0.2824858688286728,0.8295798904981686,0.8823529411764706,0.9762110676796246,1.0,50/256,16.83%,PER2;GRK5;MLF1;FGF10;TGFBR1;GMNC;BIN1;HTRA2;SIRT1;PKD2;MAGI2;GBF1;PROX1;PPP1R13B;ZNF703;MED25;CDK6;CDK4;PML;ABL1;NANOS3;MYC;SIPA1;LRP6;MAEA;PHACTR4;AKT2;ERN1;LIN52;BRINP1;PLAGL1;SETMAR;NLRP2B;PIM2;PPP1R9B;MLXIPL;JUNB;CDK11A;PNPT1;RPS6KA2;CDC26;MEN1;GADD45A;TP53;CDC14B;MAPK12;USP51;TBRG4;NOTCH1;ATM
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),-0.4580139345181397,-0.8293723667038201,0.6911764705882353,1.0,1.0,3/13,16.36%,TULP1;RP1;USH1C
prerank,GO_Biological_Process_2021__tyrosine catabolic process (GO:0006572),0.5305294652823881,0.8293149930734318,0.7,0.9763050344676569,1.0,2/5,22.16%,GSTZ1;IL4I1
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),-0.4622908821972039,-0.8292962227697246,0.7313432835820896,1.0,1.0,4/14,22.70%,KCNQ1;KCNE3;ATP1A1;KCNE4
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),-0.4101366748699639,-0.829183333675958,0.71875,1.0,1.0,2/32,1.95%,RAB34;S100A13
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.37143970456549236,-0.8290480164904465,0.7746478873239436,1.0,1.0,15/44,17.74%,ALOX12;CYP1B1;ALOX5;ALOX12B;PTGES;PLA2G10;ALOX15;CYP2A6;CYP2J2;CYP4F12;CYP2E1;AWAT1;ALOX15B;TBXAS1;PLA2G4A
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.4050577509098724,-0.8289940677981492,0.7575757575757576,1.0,1.0,10/24,34.67%,RBX1;RPS27A;DDB1;UBB;CETN2;ERCC4;UBC;GTF2H5;RAD23B;RNF111
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.42333320232103977,-0.8288489546365466,0.6875,1.0,1.0,4/18,15.53%,HLA-A;HLA-DRB1;IL12A;HLA-F
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),-0.5047741405922459,-0.8285697704336183,0.6721311475409836,1.0,1.0,2/8,11.31%,STOML2;GLRX
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),0.415543044581578,0.8285064810503577,0.7560975609756098,0.9777416565479554,1.0,5/13,24.44%,NSMAF;SMPD3;SAMD8;PLA2G6;PRKCD
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),-0.4658345688800296,-0.828384882705328,0.6885245901639344,1.0,1.0,3/12,18.80%,ERVW-1;JAM2;CD81
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol biosynthetic process (GO:0010511),0.4998683793103091,0.8283569459640193,0.6538461538461539,0.9776515594267708,1.0,1/5,3.39%,HTR2C
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.3748387710659127,0.8281969031583312,0.5666666666666667,0.9775549961557715,1.0,7/29,19.18%,KIAA0319;DCC;NKD1;FGFR3;DIP2B;WWC1;PTCH1
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),-0.4428443957511145,-0.8281169862027701,0.765625,1.0,1.0,4/13,28.45%,TESPA1;CD81;RPS3;PRKD2
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.2697598891449231,0.8280726545614207,0.9230769230769231,0.9773603952325074,1.0,31/230,9.44%,IRGM;FGF10;HDAC3;VEGFC;HSPB1;ANGPT1;CDH5;EPHA7;SPTBN4;CCN1;PID1;FGF17;SIRT1;ERBB2;RALB;ATF3;F2;EIF2AK3;FER;PML;ABL1;CCND3;SLIT2;EFNA5;RAP2A;FGF18;LRP6;WNT3A;LEPR;TNIK;AKT2
prerank,PanglaoDB_Augmented_2021__Merkel Cells,-0.3404916857161199,-0.8280080393714314,0.7428571428571429,1.0,1.0,15/55,19.93%,CLCA1;MISP;PIEZO2;VIL1;FOXA3;BCO1;NOS2;GPX2;NR1H4;USH1C;LGALS4;ADGRG7;SLC44A3;ACE2;CBLC
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.3906468235559127,-0.8278643434072129,0.7205882352941176,1.0,1.0,4/25,11.81%,TGFB1;LATS2;SFRP4;ENG
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),-0.3536758476763954,-0.8275354353713062,0.8266666666666667,1.0,1.0,10/68,17.12%,TGFB1;MARVELD2;MYOT;CLDN1;ACTG1;LRP4;TGFB3;TJP3;SMAD3;VASP
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.28039913606484274,0.8272555859614843,0.9285714285714286,0.9784540648892256,1.0,94/372,23.26%,IRGM;AUP1;PCM1;HDAC3;IFT88;DZIP1L;PARVA;SCLT1;KLHL41;RAB7A;FHDC1;GBF1;STARD9;CILK1;BBS9;BICD1;UBXN2A;PRRC2C;MVB12A;SPAG16;FLNA;CNGA4;CHMP6;FARP2;MAPRE1;CEP290;EHD4;RPGR;CEP250;RAB11FIP3;AVIL;MKS1;SYNPO;CFAP410;CEP20;TTC36;SAC3D1;PLA2G4C;RILPL1;PIBF1;ARL13B;EXOC7;VTA1;KIAA0586;RP2;PTPN23;YTHDF1;CEP41;CEP162;CDC14B;IFT140;ATG2A;PATL1;NEK1;ARL3;SNF8;ATG16L2;NOTCH1;CFAP70;DCDC2;RC3H1;LSM14A;KIF3B;BBIP1;CFAP221;PDE6D;DZIP1;STAM2;UNC119B;CFAP43;TMEM67;PTPDC1;UBXN2B;EXOC6;TMEM138;WDR19;TTC39C;IQCB1;POC1B;FBF1;KIF27;EXOC4;ATG2B;TSG101;STING1;CDS1;SSTR3;ELAPOR1;ASAP1;ATG12;CORO1A;FAM161A;POGZ;WDR35
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),-0.44949639048002143,-0.8272043050415582,0.7333333333333333,1.0,1.0,2/16,8.03%,DBH;DAO
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),0.3092853337254577,0.8267091790560793,0.7741935483870968,0.9791611779012135,1.0,17/61,20.63%,TDO2;TRPM2;PKD2;SNCA;HCN1;ACACB;GRIN1;ALDH1A2;USP16;CPSF7;HPRT1;SAMHD1;SHMT2;KCNC3;APPL2;CRYZ;CPSF6
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),-0.4021318050810567,-0.8266867066626203,0.71875,1.0,1.0,4/28,15.88%,MISP;GPSM2;DCTN1;NDEL1
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),-0.4180618276841796,-0.8266328609043367,0.7323943661971831,1.0,1.0,5/19,17.08%,TGFB1;IL12A;NR1H4;IL18;VSIR
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",0.2838922202399087,0.8263268761244128,1.0,0.9794561043517581,1.0,36/198,18.26%,MLF1;PKNOX1;ZBTB7B;CBFB;TEFM;DTX1;IWS1;ARRB2;SLC25A33;PPP5C;TAF1B;NAT14;TAF3;NR4A2;TAF12;ELOA;CCNH;MED16;TRIP13;NFKB1;MLLT3;GTF2F2;SOX5;THRB;SNAPC3;GTF3C4;NFIC;HSF1;TP53;BAZ2A;POLR3G;GTF3C5;TAF4;PRMT5;ERCC3;NFX1
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.35311264225683525,0.8263194237388459,0.71875,0.9790455243774404,1.0,11/40,22.39%,DGKD;SLC30A10;TGFA;GAB1;EFEMP1;PIK3CA;BRAF;SOS1;KIF16B;NCK2;SHC3
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),0.3342958078744473,0.826290423956277,0.7037037037037037,0.9786875176737088,1.0,14/37,17.85%,SHLD2;SHLD1;SETMAR;TIMELESS;KMT5C;SPIRE2;ARID2;SMCHD1;WRAP53;SPIDR;MGMT;FUS;KMT5B;PNKP
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),0.37403859725714955,0.8261928849675697,0.6451612903225806,0.9784603096090007,1.0,3/23,5.03%,GCK;ENO3;PFKP
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),0.37506094370424,0.8260297805898105,0.6756756756756757,0.9783832956086622,1.0,6/20,18.53%,CDH5;GREM1;SLIT2;GPLD1;MIA3;NR4A1
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),-0.43140345697870824,-0.8259567869395344,0.6833333333333333,1.0,1.0,2/12,5.09%,ELOVL2;TECRL
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.2705630740292936,0.8259504552564838,1.0,0.9780716703651778,1.0,35/168,18.34%,LAMA4;TNNT1;SPRED3;NOVA1;PTPRO;ALDH1A1;IL17RD;SFMBT1;CHSY1;HS3ST5;DLX1;TIMP1;PLCL2;PTPRR;SPRED2;TFE3;ADIPOR1;F2R;SPRED1;TWSG1;N4BP1;EVL;RAB11FIP3;NFIB;RPS6KA4;PTPN23;RPS6KA6;NR1H3;ELAPOR2;WWC1;NOTCH1;RAB11FIP1;IP6K1;RBPJ;ZNF706
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),-0.5401619506404826,-0.8259329854542389,0.746268656716418,1.0,1.0,1/6,2.76%,CAV3
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),0.3294422761514449,0.8259054135959234,0.8,0.977760314111977,1.0,21/78,24.64%,PARD3;ZDHHC11B;PEX13;GDAP1;ABCD3;ZDHHC18;ABCD2;ZDHHC12;GOLGA7B;MYO1C;ZDHHC14;ZDHHC3;SSR2;ZDHHC9;ZDHHC11;ZDHHC23;SEC61A1;SLC25A17;ZDHHC20;PEX3;PEX14
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),-0.43356937447322397,-0.8258053689070773,0.7205882352941176,1.0,1.0,1/16,2.44%,CYP26B1
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),-0.370825274535519,-0.8251721212695091,0.7972972972972973,1.0,1.0,10/60,15.48%,SPDYA;CCND1;CRLF3;CDC25A;LATS2;CDKN2D;CDKN1A;MAX;CCNE2;CDKN3
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),0.28678793670492575,0.8251606880990394,0.9047619047619048,0.9787062744560067,1.0,19/139,14.09%,LGR5;BAMBI;RSPO3;FGF10;SEMA5A;PSME4;ZEB2;PSMA1;RSPO2;WNT3A;GPC5;KANK1;WNK2;PPM1A;MACF1;SMARCA4;RNF146;WLS;NFKB1
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.2968252559015924,-0.8251509980698566,0.9325842696629213,1.0,1.0,78/602,17.35%,CD44;CLEC5A;KIF14;RASGRF2;PRAME;HCK;MMP9;WNT5A;CIDEB;CYP1B1;OBSCN;VAV3;CARD14;BCL2L2;GPER1;BCL2L14;PINK1;ITGB3BP;STAT1;DAB2;IL7;IFIT3;FLT4;LATS2;TGM2;ACTN3;ANXA1;CCND2;HTR2B;CLU;SFRP4;PPT1;STK17A;REST;THBS1;SMAD6;OLFM4;ALPK2;NLRC4;PXT1;DNAJA1;TFPT;SCIN;USP17L2;COPS5;ATF5;LRP2;DDX20;MTCH1;TNFRSF10A;WFS1;TAF9B;CFL1;MOAP1;NAA38;NDRG1;CD27;TEK;VDAC1;LEF1;TGFB3;BEX2;NR1H4;DDX3X;TP53I3;ANP32E;SIAH1;AGT;PNMA1;AKAP13;NAIP;GHRL;ECT2;RABGGTB;RABGGTA;PNMA2;EGR3;PAX7
prerank,GO_Biological_Process_2021__peptidyl-lysine oxidation (GO:0018057),-0.5109840085212811,-0.8250964136009139,0.7551020408163265,1.0,1.0,2/5,9.75%,LOX;LOXL4
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),0.4361229103341441,0.8250391191497597,0.7608695652173914,0.9784795481867021,1.0,6/10,27.79%,CDC14B;FZR1;PTEN;PLK1;BTRC;GORASP1
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),0.4047694774067039,0.8245806969729932,0.6875,0.9789883747032778,1.0,3/20,2.66%,EPHX2;RORA;APOE
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),0.3718898035730161,0.8245645874079972,0.7714285714285715,0.9785991026802792,1.0,3/12,12.21%,AKR1C3;SGK1;KLHL3
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),0.4339529210674446,0.8242577664498765,0.7333333333333333,0.9787563324232903,1.0,5/11,21.85%,HIRIP3;TP53;NOC2L;RBBP4;SUV39H2
prerank,GO_Biological_Process_2021__response to macrophage colony-stimulating factor (GO:0036005),0.4587733701193578,0.8239584891099598,0.6585365853658537,0.9784272437324382,1.0,1/5,7.46%,FER
prerank,GO_Biological_Process_2021__cellular response to macrophage colony-stimulating factor stimulus (GO:0036006),0.4587733701193578,0.8239584891099598,0.6585365853658537,0.9784272437324382,1.0,1/5,7.46%,FER
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),0.496899960327436,0.8238576399191242,0.7142857142857143,0.978155767430999,1.0,3/6,21.53%,SIRT1;SMCHD1;BAHD1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),0.37841146547012455,0.8238320805813072,0.7073170731707317,0.9778131257521275,1.0,6/17,18.46%,MED25;MYC;NF1;TP53;SKI;MORC3
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),-0.4059252960136517,-0.8237247099620865,0.7058823529411765,1.0,1.0,3/19,11.84%,WNT8B;FRAT1;WNT8A
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),0.31985007585990655,0.8237056413699393,0.8260869565217391,0.9776200028211047,1.0,13/69,17.11%,APOE;CDH5;SNCA;SLIT2;MAPRE1;NAV3;KANK1;LDLR;KANK4;PIK3CA;SSH1;CLIP3;IAPP
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.3870631967354481,0.823602765658212,0.75,0.9773686787857351,1.0,3/32,9.93%,CPEB1;CAPN2;GRIN1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),0.3417700588200159,0.8234222722850496,0.8787878787878788,0.9773898330356316,1.0,16/50,20.34%,ACADS;ACAD10;SLC27A2;ECHS1;ABCD3;ABCD2;ACADM;MECR;BDH2;ECI1;ECHDC1;ACOX1;DECR1;HADHB;ECHDC2;ACADVL
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),-0.5044874565899216,-0.8234042045648832,0.6666666666666666,1.0,1.0,3/7,23.97%,ATG14;CALM1;ATP2A2
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),0.533678064923382,0.8233053949316211,0.7391304347826086,0.9772424980336055,1.0,2/5,21.56%,RAB11B;TRAPPC11
prerank,GO_Biological_Process_2021__cellular response to gonadotropin stimulus (GO:0071371),0.5342690918416215,0.8229239539907728,0.7027027027027027,0.9775486708825136,1.0,2/5,30.19%,NOTCH1;FSHR
prerank,GO_Biological_Process_2021__brown fat cell differentiation (GO:0050873),0.5124891938055832,0.8228634231258145,0.6888888888888889,0.9773042826232781,1.0,1/6,3.38%,METRNL
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471),-0.5463282623828543,-0.8224138094646599,0.7377049180327869,1.0,1.0,2/5,18.81%,TGM2;FIS1
prerank,GO_Biological_Process_2021__establishment of centrosome localization (GO:0051660),-0.5099079830883564,-0.8222631656209819,0.8035714285714286,1.0,1.0,1/7,2.29%,MISP
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),0.5441776283958644,0.8221485630318834,0.8367346938775511,0.9774387886417047,1.0,2/5,17.60%,SMC5;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),0.5441776283958644,0.8221485630318834,0.8367346938775511,0.9774387886417047,1.0,2/5,17.60%,SMC5;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),0.5441776283958644,0.8221485630318834,0.8367346938775511,0.9774387886417047,1.0,2/5,17.60%,SMC5;NSMCE2
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),-0.5155975514718175,-0.8220145093001406,0.7704918032786885,1.0,1.0,2/10,14.57%,TTN;LCP1
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),0.5136744423986905,0.8218756198013312,0.7083333333333334,0.977582646763957,1.0,2/6,17.07%,GTF3C4;GTF3C5
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),-0.5051914457674582,-0.8217294250759097,0.6885245901639344,1.0,1.0,1/6,6.09%,STAT1
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),-0.5051914457674582,-0.8217294250759097,0.6885245901639344,1.0,1.0,1/6,6.09%,STAT1
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),0.3571853436258901,0.8216830943408175,0.6666666666666666,0.9774679718135392,1.0,7/33,14.74%,RHEX;MAFB;STAT5B;CDK6;HSPA1A;ANKRD54;ABCB10
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),-0.33404957981261396,-0.8213513171322762,0.7567567567567568,1.0,1.0,14/94,15.80%,TGFB1;DTL;WNT5A;PLA2G10;GPC3;CLU;C4BPA;WFS1;ASB5;OAZ2;C4BPB;CD80;IL18;AGT
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.38781084204621996,0.8212358804700014,0.5769230769230769,0.9779474836558706,1.0,6/27,11.28%,CHST6;PRELP;ST3GAL3;B4GALT2;B4GALT3;GLB1
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.2781883453835555,0.821167465597023,0.8695652173913043,0.9776197448540103,1.0,14/109,9.13%,KCNK6;KCNB2;KCNC2;KCNH8;PKD2;HCN1;KCNH7;KCNJ3;KCNG1;KCNJ6;TMEM175;KCND2;KCNK2;ABCC8
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.44225450083457546,0.8211667050856101,0.7586206896551724,0.9772019586382608,1.0,1/17,0.97%,RAB27A
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),0.3454463949517913,0.8211210908179465,0.8108108108108109,0.9769135135629317,1.0,10/34,18.58%,RFWD3;SMARCAL1;BOD1L1;SETMAR;MMS22L;PRIMPOL;SAMHD1;FBH1;ATR;EME2
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),0.41294075331666463,0.8210893162042289,0.7297297297297297,0.9765544037863383,1.0,1/11,0.99%,RFWD3
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.4249796164880617,0.8210477237302098,0.7142857142857143,0.9761956005481801,1.0,2/13,5.92%,KLRD1;CADM1
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,-0.3368359356275664,-0.8210324907475968,0.7611940298507462,1.0,1.0,20/80,19.93%,PLEKHG3;PPP1R1B;TMC4;GPRIN2;SLCO2A1;SLC5A9;KCNQ1;SPINT1;SOWAHB;CYP4F12;TMEM45B;TJP3;CD24;SCNN1A;ANPEP;CAPN13;SLC44A3;FAM3D;ACE2;CBLC
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),-0.320915901628056,-0.8206842903258069,0.8571428571428571,1.0,1.0,9/94,9.43%,AHR;P2RY12;CTNNA1;TSHR;GLRA2;HTR1B;KCNQ1;BRCA1;P2RY6
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.3216892933590385,-0.8206671921884753,0.813953488372093,1.0,1.0,28/157,16.67%,HK2;NODAL;WNT5A;CXCL13;CYP1B1;SP100;ALOX5;CNMD;STAT1;CD160;DCN;CLDN5;CEACAM1;BRCA1;COL4A3;ISM1;THBS1;WARS1;FOXO4;TEK;GATA4;HYAL1;RRAS;EPHA1;GRN;HIPK1;ANGPTL3;GHRL
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),-0.4742653263824704,-0.8205350211312109,0.7301587301587301,1.0,1.0,2/7,11.01%,LMOD3;CAV2
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),-0.3890151083498602,-0.8204259666972016,0.7464788732394366,1.0,1.0,7/29,24.55%,HSPA1L;HSPA8;STUB1;HSPA5;OPTN;HSPA2;HSPA13
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),-0.46542804328211285,-0.8204078452257114,0.7586206896551724,1.0,1.0,5/14,28.50%,WBP2;AR;SFRP1;SRA1;RARA
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.3371199269646339,0.8201005480908424,0.7916666666666666,0.9776920989070741,1.0,13/40,22.08%,SMARCB1;SRCAP;PBRM1;ARID1A;SMARCA2;SMARCA4;HDAC1;GATAD2B;CHD4;ARID1B;NASP;RBBP4;SMARCAD1
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.4259423434323697,-0.820086398975643,0.7058823529411765,1.0,1.0,4/13,9.05%,DAAM2;RNF213;GPC3;SFRP4
prerank,GO_Biological_Process_2021__regulation of mast cell chemotaxis (GO:0060753),-0.5405934092989546,-0.8199832774938886,0.7758620689655172,1.0,1.0,1/5,2.49%,RIN3
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),0.48596201477241774,0.8198839184373379,0.75,0.9777516001604114,1.0,1/7,3.81%,CSK
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),-0.5115770888267707,-0.8198699067419701,0.76,1.0,1.0,2/6,11.01%,CAV3;CAV2
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),0.37230111343816097,0.8198487983977697,0.7777777777777778,0.9774249227631159,1.0,3/27,2.43%,CYP1A2;ELOVL6;EPHX2
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.4183325466914621,-0.8196495824663652,0.8,1.0,1.0,7/25,22.88%,CAV3;ANKRD53;DCTN1;RAC1;CDK5R1;DRG1;PSRC1
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.4240479208741685,-0.8189789779350515,0.6984126984126984,1.0,1.0,4/16,25.13%,OAS1;CACTIN;ISG15;USP18
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.42938208864228766,0.8188416553007553,0.7352941176470589,0.9788868208550245,1.0,2/13,10.42%,DUT;UPP2
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),-0.5029259794815809,-0.8187458880036032,0.75,1.0,1.0,3/5,26.11%,RNF20;CDK9;KDM1A
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),0.48611826147467513,0.818602204669496,0.6666666666666666,0.9789264473079776,1.0,2/6,35.49%,EPHA4;PTPRS
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),-0.29798116052856083,-0.8185798663507042,0.9560439560439561,1.0,1.0,50/348,18.74%,ENPP2;FGF20;KIF14;TGFB1;F7;MMP9;CYP1B1;SMIM22;CLDN1;COL1A1;SEMA3F;GPER1;DAB2;SYNE2;CLDN5;PLAU;ACTG1;CEACAM1;SEMA3A;PIK3R3;SOD2;ANXA1;CGA;IGSF10;THBS1;USP17L2;LAMC2;VIL1;ENG;CXCL16;NEXN;LEF1;TMSB10;FGF22;EPHA1;GRN;PLET1;F2RL1;DUSP22;ALOX15B;ANGPTL3;RNF20;VSIR;RAC1;BEX4;ARHGEF39;NTRK3;CAMK2A;PLXNA3;CSF1R
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),0.37690615726937376,0.8185412197276964,0.6388888888888888,0.9786639594397116,1.0,11/32,21.33%,PRSS3;CDH5;CDH13;ABL1;PXN;PIK3CA;NR4A1;CORO1B;FAP;LGALS8;FSTL1
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),-0.5088390050176234,-0.8183802641690506,0.7586206896551724,1.0,1.0,2/6,9.78%,ACSL5;THBS1
prerank,GO_Biological_Process_2021__innate immune response in mucosa (GO:0002227),-0.5198126222407878,-0.8183515393035816,0.7096774193548387,1.0,1.0,2/5,14.17%,BPIFB1;NOS2
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),0.2859436569052884,0.8181236227745388,0.9230769230769231,0.9789670519713709,1.0,20/100,15.48%,IRGM;MAPKAPK2;CD14;TICAM2;CX3CR1;SERPINE1;SRR;SNCA;HMGB1;FER;MAPK8;PDE4B;RPS6KA3;F2R;LGALS9;TICAM1;PELI1;NFKB1;NR1H3;LBP
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.381377968754786,-0.8180327042170985,0.75,1.0,1.0,4/36,16.15%,NARS1;DARS2;WARS1;YARS2
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),0.47480256977801094,0.8179141419112018,0.6739130434782609,0.9789873283962215,1.0,3/7,30.14%,BRPF1;BRPF3;ING5
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.3287375299962961,-0.8175846925040109,0.8289473684210527,1.0,1.0,20/138,19.11%,PSMB9;AIM2;CARD14;TNFRSF1B;GPER1;STAT1;GSDME;BRCA1;EDAR;TXNDC17;GBP1;CD27;HYAL1;PSMA3;TNFSF8;ZFP36L1;CACTIN;TNFRSF11A;PSMA7;PSMB6
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.41249133171543684,0.8174733886644866,0.6388888888888888,0.9794761781132779,1.0,9/13,26.64%,RORA;LRP6;OSBPL7;GPLD1;PTCH1;MLC1;GRAMD1B;GRAMD1A;INSIG1
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),0.35223014712134976,0.8174274802529541,0.71875,0.9791689885907898,1.0,3/28,2.94%,GJB6;CDH5;MFSD2A
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.4381415886197988,-0.817232303596477,0.7419354838709677,1.0,1.0,2/22,3.57%,ITGB2;CXCL13
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta1 production (GO:0032908),0.5159968147183988,0.8168568591884319,0.675,0.9798818216152521,1.0,1/5,1.32%,TSKU
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),-0.487525134996417,-0.8167894013210888,0.6666666666666666,1.0,1.0,1/5,1.49%,TGFB1
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.3092626026920294,0.816670178302787,0.7857142857142857,0.9797991012226177,1.0,15/41,23.61%,QRICH2;COMMD1;PYHIN1;PML;LATS1;CCDC22;FOXF2;SMURF1;RNF139;LAPTM5;XPO1;GNA12;PTEN;AXIN1;PDCL3
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),-0.4721190038996117,-0.8163643884097433,0.7288135593220338,1.0,1.0,3/11,13.31%,PTGES;OSMR;NLRP3
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),0.459405098175649,0.8162311876772932,0.6818181818181818,0.9803764905213423,1.0,4/8,16.67%,HES1;F2;NF1;NOTCH1
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),0.4573654074727943,0.8161337338049492,0.7435897435897436,0.9801783326820875,1.0,1/8,2.31%,BCL2
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,-0.32870740541522075,-0.8159581526926307,0.7922077922077922,1.0,1.0,17/102,15.22%,TRIL;TSPAN11;PPP1R1B;SOX10;GFRA3;SHISA6;DAAM2;LGI4;MPZ;TCEAL5;SLC18A2;AQP4;APOD;EDNRB;RXRG;NOS2;TSPAN7
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.36019714678878084,0.8159296812573545,0.6857142857142857,0.9801660216493435,1.0,8/27,22.14%,ABL1;TERF1;IRS2;MEN1;TP53;LIMK1;NPRL2;SMAD7
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.36395589771902326,-0.8155857033209307,0.765625,1.0,1.0,9/67,14.99%,IRF1;STAT1;OAS2;NFKB2;POLR1C;OAS1;TLR2;POLR3H;DDX3X
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.4308830204099085,-0.8154990998770021,0.7254901960784313,1.0,1.0,5/18,29.23%,NOP10;CCT6A;CCT8;CCT7;CCT2
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.26693800160931125,0.8152700777346686,0.8695652173913043,0.9810241211615998,1.0,29/220,9.76%,IRGM;FGF10;KIT;HDAC3;VEGFC;FGFR1;ANGPT1;EPHA7;CCN1;FGF17;SIRT1;ERBB2;RALB;ZBTB20;EPHA3;DRD4;F2;DSCAM;ABL1;CCND3;EFNA5;RAP2A;FGF18;WNT3A;LEPR;TNIK;AKT2;FGFR3;BTBD10
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),0.3725847561957025,0.8151820276776404,0.6875,0.9807491733310322,1.0,3/15,8.69%,APOE;DHFR;NUS1
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.3226114156560711,0.8148191471581717,0.7666666666666667,0.9810052084951386,1.0,8/49,8.37%,EMP1;LAMA3;KLK14;CCN2;STS;KLK7;DSP;DCT
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.38078464620027064,-0.814815430673905,0.7424242424242424,1.0,1.0,12/41,18.22%,TIMP3;SERPIND1;VTN;SERPINB5;SERPINA10;TIMP4;SERPINE3;SPOCK3;AGT;SERPINB7;SERPINF1;SPINK6
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),-0.34941150172350965,-0.8147427725935219,0.7142857142857143,1.0,1.0,8/58,17.20%,TGFB1;NODAL;SMAD6;ENG;VSTM2A;TGFB3;SMAD3;GDF15
prerank,GO_Biological_Process_2021__ornithine transport (GO:0015822),-0.5159378261988702,-0.8143743240717646,0.7213114754098361,1.0,1.0,1/5,5.15%,SLC7A3
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),-0.35038507088383714,-0.8141023699825983,0.7721518987341772,1.0,1.0,10/70,17.11%,PIGH;LOX;UBE2L6;PHEX;USP6;PLAT;GNMT;PARP4;RABGGTB;RABGGTA
prerank,GO_Biological_Process_2021__flavin-containing compound metabolic process (GO:0042726),-0.5375459281273088,-0.8140187278208207,0.7627118644067796,1.0,1.0,2/5,22.38%,RFK;SLC52A2
prerank,GO_Biological_Process_2021__riboflavin metabolic process (GO:0006771),-0.5375459281273088,-0.8140187278208207,0.7627118644067796,1.0,1.0,2/5,22.38%,RFK;SLC52A2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.31706953501891877,0.8139674041728608,0.7407407407407407,0.9822645507813531,1.0,12/53,14.95%,KIT;FGFR1;ERBB2;EPHA3;FER;ABL1;ABL2;FGFR3;ABI3;EFEMP1;FLT3;INSR
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),0.4634938971353359,0.8138035528518368,0.8085106382978723,0.9822066587600404,1.0,2/6,9.51%,RORB;RPGRIP1L
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),-0.468132607411054,-0.8135981361466945,0.7627118644067796,1.0,1.0,2/11,14.57%,FHOD1;LCP1
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),-0.44568941224666925,-0.8134962460702886,0.7205882352941176,1.0,1.0,3/14,11.87%,H1-0;ENDOG;DNASE2
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),0.45103902052025724,0.8133094178029132,0.6888888888888889,0.9828193944797722,1.0,2/9,3.39%,HTR1F;HTR2C
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.4835776741605289,-0.813180398596422,0.7377049180327869,1.0,1.0,2/9,7.11%,CXCL13;ADA
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),-0.4368702295904777,-0.8130592546323238,0.7761194029850746,1.0,1.0,4/19,24.07%,BACE2;ERAP1;PRTN3;APH1A
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.4817633783336736,-0.812920570435787,0.8367346938775511,1.0,1.0,2/10,7.84%,BHMT;CHDH
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),-0.35454445357674835,-0.8128058000999527,0.7894736842105263,1.0,1.0,12/49,20.22%,WNT8B;CHMP3;FRAT1;WNT8A;HSPA8;GABARAPL1;GABARAPL2;MAP1LC3B2;RUBCNL;LIX1;RPL23;VAMP7
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),0.46918138954554717,0.8124900988990534,0.6458333333333334,0.9840508371379519,1.0,3/6,35.06%,MAP2;CFAP100;FBXW11
prerank,GO_Biological_Process_2021__nose development (GO:0043584),0.4714746645764671,0.8124433961453652,0.7631578947368421,0.9836987345096799,1.0,3/6,17.21%,PROX1;SMCHD1;SKI
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),0.34112428526249905,0.8120233954409044,0.7941176470588235,0.9840931986847111,1.0,5/32,9.91%,APOE;HRH3;SNCA;DRD4;GRM7
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.34457343809581564,0.8118742151007006,0.8333333333333334,0.9840155296391624,1.0,11/38,18.58%,RFWD3;SLFN11;SMARCAL1;BOD1L1;SETMAR;TIMELESS;MMS22L;PRIMPOL;FBH1;ATR;EME2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),-0.3572181465155913,-0.8115313918804993,0.7910447761194029,1.0,1.0,6/36,10.45%,S100A13;AIM2;WNT5A;NLRP12;USP50;NLRC4
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.3149496825635634,0.8110826035278541,0.6896551724137931,0.9852443881243613,1.0,11/50,15.48%,CD14;SSC5D;SERPINE1;HMGB1;F2R;LGALS9;HSPA1A;FADD;ARRB1;OTUD7B;LBP
prerank,GO_Biological_Process_2021__arginine catabolic process (GO:0006527),-0.5242800417607677,-0.8110689902306543,0.7719298245614035,1.0,1.0,2/6,14.17%,ARG2;NOS2
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,0.2907463778404342,0.8110475107988556,0.8148148148148148,0.9848923761541174,1.0,26/123,15.58%,SLC17A6;CNGA3;ALCAM;LHFPL4;PLPPR1;KCNB2;ARX;UNC5D;ELAVL3;PAK5;KCNIP1;ADGRA1;INSL5;ABCC8;CELF4;ELAVL4;RAB3C;OLFM3;VWA5B2;SNAP91;ASXL3;PTPRT;SCRT1;RFX6;CFC1;NRXN1
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),0.3875099498160448,0.8110393430044294,0.6585365853658537,0.9844833526305874,1.0,1/10,4.26%,SEMA5A
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.4173329348251375,0.8109793108429802,0.6909090909090909,0.9841446881574615,1.0,2/14,5.50%,JAG1;NRG1
prerank,GO_Biological_Process_2021__negative regulation of lipase activity (GO:0060192),0.5100363444311201,0.8107927705359724,0.6744186046511628,0.9841371457348651,1.0,1/6,4.35%,PLIN5
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.3074913945810444,0.8107450808458386,0.9047619047619048,0.9838052719684395,1.0,10/74,9.08%,APOH;APOE;ANGPT1;RIN2;ANXA3;PROX1;VASH1;ABL1;SLIT2;PTPRM
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),0.3780251592428183,0.810634160891149,0.8372093023255814,0.983721596189489,1.0,4/16,15.56%,HMGB1;ICOSLG;FADD;IL23A
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),-0.41528514048318615,-0.8105274570072951,0.734375,1.0,1.0,1/17,2.76%,CAV3
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.41795652323949856,0.8105126223158764,0.6111111111111112,0.9834854898157601,1.0,5/11,15.58%,CEL;NLGN1;NLGN4X;NLGN3;NRXN1
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),-0.4817982614398779,-0.8103360713976409,0.7222222222222222,1.0,1.0,1/6,2.41%,GAD1
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),0.42483859228973775,0.8098151037509843,0.8,0.9842594763781792,1.0,2/10,5.03%,FBP2;PFKP
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),-0.4691287691160145,-0.8097555442316873,0.7368421052631579,1.0,1.0,4/9,35.21%,FIS1;BNIP3;VPS35;CCAR2
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),-0.5549384371397427,-0.8095340192270865,0.7241379310344828,1.0,1.0,1/5,10.28%,PTPRC
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),-0.37502543508612085,-0.8089744785512124,0.7391304347826086,1.0,1.0,4/43,6.95%,CASQ2;TRDN;ATP1A4;KCNJ11
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),-0.4690841766091999,-0.8086628472539007,0.75,1.0,1.0,4/12,22.70%,KCNQ1;KCNE3;ATP1A1;KCNE4
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.4812446916169427,-0.8081730160851028,0.734375,1.0,1.0,3/10,20.26%,PLA2G10;PLA2G4A;PLA2G4D
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),0.5008103523805725,0.8080396282188276,0.7567567567567568,0.9869414666591315,1.0,2/6,15.48%,CD14;LBP
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),0.5008103523805725,0.8080396282188276,0.7567567567567568,0.9869414666591315,1.0,2/6,15.48%,CD14;LBP
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),-0.4030627193083133,-0.8077815164426094,0.75,1.0,1.0,1/23,1.49%,TGFB1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.2859825753873949,0.8077433079868244,0.8857142857142857,0.9870786724976037,1.0,19/88,18.04%,KIT;FGFR1;SIRT1;DIPK2A;PDGFD;PLXNB1;EPOR;TWIST1;HCLS1;IRS2;F2R;GAB1;FLT3;INSR;PIK3CA;PIP4K2A;NEDD4;ROR1;PIK3R5
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),-0.45121246242897584,-0.8076634825689581,0.75,1.0,1.0,3/10,15.51%,PBLD;MUC4;STRAP
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),0.3789190832297442,0.8072713231964087,0.7096774193548387,0.9873210475480352,1.0,3/22,5.03%,GCK;ENO3;PFKP
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),0.3789190832297442,0.8072713231964087,0.7096774193548387,0.9873210475480352,1.0,3/22,5.03%,GCK;ENO3;PFKP
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),-0.34594389587828905,-0.8066774921788339,0.8227848101265823,1.0,1.0,12/67,18.22%,LMOD1;HCK;C15ORF62;GPSM2;ALOX15;VIL1;BAIAP2L1;TEK;F2RL1;VASP;BAIAP2L2;NTRK3
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.36201902495175553,0.8066258256724654,0.7027027027027027,0.9879774359943528,1.0,2/22,3.31%,QRICH2;PARVA
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.37708585146192336,-0.8065719009275181,0.7419354838709677,1.0,1.0,5/34,16.69%,ESR1;GPER1;UBE3A;YAP1;WBP2
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),0.44347650061675314,0.8064770312305997,0.6590909090909091,0.9879176575834573,1.0,4/12,31.32%,ATM;PIK3R4;TRAPPC8;PIK3C3
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.3295882008377543,0.8064646574242166,0.8,0.9875160968061599,1.0,10/51,11.15%,CHRM2;HTR1F;HRH3;GRM8;DRD4;ADCY2;FLNA;GRM4;GRM7;ADCY3
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.3506708833933588,-0.8063913906099875,0.8115942028985508,1.0,1.0,6/62,7.51%,HCK;BLK;VAV3;FCGR3A;ACTG1;WAS
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),-0.5038715937574952,-0.806234503325482,0.75,1.0,1.0,1/7,4.73%,IRF1
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.32249395469622194,0.8061438121132343,0.7586206896551724,0.9878109062412114,1.0,5/54,9.82%,TRIM67;DZIP1L;STX6;MAPK8;CEP290
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.37004913523457394,-0.8055201308617175,0.7391304347826086,1.0,1.0,14/39,27.12%,PWP2;EMG1;NOB1;RPS27;RPS16;RPS7;RPS14;RPS15;SURF6;RPSA;RPS28;RPS19;RPS24;RPS6
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid segregation (GO:0033047),0.4799880293335728,0.8054929246050775,0.7209302325581395,0.9882227605766325,1.0,2/6,23.38%,CDK5RAP2;USP44
prerank,GO_Biological_Process_2021__regulation of mitotic spindle checkpoint (GO:1903504),0.4799880293335728,0.8054929246050775,0.7209302325581395,0.9882227605766325,1.0,2/6,23.38%,CDK5RAP2;USP44
prerank,GO_Biological_Process_2021__piRNA biosynthetic process (GO:1990511),-0.5121738126809526,-0.8052610912621481,0.7538461538461538,1.0,1.0,1/6,7.26%,BTBD18
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),-0.5389334557831033,-0.805255900085935,0.7692307692307693,1.0,1.0,2/6,14.42%,CAV3;C12ORF57
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),0.4230321528652785,0.8052265146434209,0.7878787878787878,0.9882388401773935,1.0,6/12,33.04%,ABCA7;ADAM10;DYRK1A;ABCG1;NCSTN;CLN3
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.3271166100906693,-0.8050554594049238,0.8356164383561644,1.0,1.0,26/111,18.26%,ALOX12;LIPI;ACSM6;ALOX5;ACOX2;ACSL5;ACOT6;ALOX12B;LIPH;ALOX15;PON3;CYP2J2;ACOT4;ACSM3;PON1;ACOT1;CYP4F12;HAO2;ACOT2;GGT5;ACSL3;ALOX15B;ANGPTL3;ALOX5AP;CYP4B1;ABCB11
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),-0.486108020154683,-0.805000863441297,0.71875,1.0,1.0,2/8,8.82%,GPR183;C17ORF99
prerank,"GO_Biological_Process_2021__CD4-positive, alpha-beta T cell activation (GO:0035710)",0.5185536849601668,0.8048915989259916,0.782608695652174,0.9884254650045746,1.0,2/5,6.42%,CDH26;HMGB1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.4375031385687503,-0.8048382348072869,0.7536231884057971,1.0,1.0,1/18,1.74%,CASQ2
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),0.4035010422843353,0.804805667750205,0.6595744680851063,0.9881951868736963,1.0,1/18,2.38%,EIF2S3B
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.4411686097698455,0.8046151538031616,0.6829268292682927,0.9877288989223952,1.0,2/8,10.30%,SNCA;PDE4B
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.4411686097698455,0.8046151538031616,0.6829268292682927,0.9877288989223952,1.0,2/8,10.30%,SNCA;PDE4B
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),0.4741268717683612,0.8038734397785621,0.6444444444444445,0.9884830039541558,1.0,2/5,16.67%,HES1;NOTCH1
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),-0.3321177250518184,-0.8036045130836605,0.8157894736842105,1.0,1.0,10/85,8.58%,SLC51A;SLC22A6;SLC16A8;SLC7A7;SLC7A3;SLCO2B1;CEACAM1;SLC6A12;SLC3A1;ABCG2
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.3041999193664967,0.8033394904162702,0.7837837837837838,0.9891230108466148,1.0,7/63,8.76%,HSPB1;DAPK2;IFI16;ACER2;ABL1;OSBPL7;ABL2
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.30910353628980874,-0.80332141595131,0.8591549295774648,1.0,1.0,9/143,11.14%,NOTUM;PSMB9;WNT5A;SHISA6;DAB2;LATS2;SFRP4;DRAXIN;LRP4
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.33125820134870715,0.8032927120921001,0.8421052631578947,0.9887668987455861,1.0,5/31,9.68%,EPHA7;SEMA6C;UNC5C;SLIT2;SEMA4A
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),0.4055211713413945,0.8030659496903859,0.7222222222222222,0.9887134137257857,1.0,1/17,4.88%,GDAP1
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.36781624427167126,0.802807821664194,0.813953488372093,0.9887418201965107,1.0,6/24,13.81%,WNT4;PKD2;PRKCSH;PROX1;COBL;NF1
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),-0.3911214495446899,-0.8027626576458591,0.75,1.0,1.0,9/23,26.85%,DAO;ABHD14B;GNMT;SULT4A1;SULT1C3;PPA1;SULT1C2;BPNT2;LIAS
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),0.48879950792775706,0.8025626430940752,0.775,0.9887072700888331,1.0,4/7,34.77%,FSCN1;CARMIL2;CLASP2;CLASP1
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),0.43594913225831633,0.8025329299766237,0.7346938775510204,0.9883456340658447,1.0,1/9,1.76%,GLYATL2
prerank,GO_Biological_Process_2021__regulation of growth hormone secretion (GO:0060123),-0.5148659458346769,-0.8023299640377535,0.7884615384615384,1.0,1.0,1/5,16.67%,GHRL
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.3684282617760752,0.8022708106961666,0.7428571428571429,0.988493631122024,1.0,7/22,18.24%,APOB;PPARG;ABCA1;LPL;NFKB1;NR1H3;PLA2G5
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),0.5259160121095625,0.8019166696046502,0.725,0.9887860698304825,1.0,3/5,38.81%,CAMSAP3;TJP1;KIFC3
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),0.31542751431094695,0.8018927081888505,0.8518518518518519,0.988406004054158,1.0,8/70,9.20%,TGFBR1;BCL2;CFLAR;URI1;CX3CR1;SH3RF1;NR4A2;PIH1D1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.34190919131571706,0.8016481196374865,0.7142857142857143,0.9885035497059805,1.0,17/83,16.39%,TRPM2;RHOBTB3;RHOBTB1;CRK;EPHA3;ABL1;EFNA5;MLST8;ABL2;RND3;ABI3;EPS8;CCDC88A;ARHGAP35;PIK3CA;FSCN1;CORO2B
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.3413048976908963,-0.801553343520709,0.796875,1.0,1.0,17/53,27.27%,EIF6;RPL3;RPL35A;BRIX1;LAS1L;RPL7A;WDR12;NOP53;MRPL20;RPL5;RPL11;SURF6;RPL24;EBNA1BP2;NSA2;RPL26L1;RPL10
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.3887406943005486,-0.8015172853443405,0.782608695652174,1.0,1.0,4/21,16.15%,TGFB1;LATS2;ENG;SMAD3
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.39330897383989755,-0.8014865464519032,0.7205882352941176,1.0,1.0,2/25,6.09%,CLCF1;STAT1
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),0.373876780869137,0.8014549451086338,0.7027027027027027,0.9883938537973719,1.0,5/18,18.77%,SLC19A1;DHFR;MTHFR;FPGS;SHMT2
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),-0.36982447307848887,-0.8014019179626752,0.7671232876712328,1.0,1.0,8/47,13.14%,EIF6;GP1BA;ZFPM1;THBS1;ITGA2B;SCIN;PITHD1;FAXDC2
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.28786847901991663,0.8013282528425149,0.92,0.9882152242941276,1.0,20/89,17.37%,GPC4;DUSP15;FGFR1;SPTBN4;DNAJB5;KCNIP1;SPRED2;ABCC8;PDZRN3;NPAS4;SLC7A8;CAMK1G;PRR36;ANK2;RFX6;CFC1;WWC1;MAGEL2;ATN1;SYN1
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,0.27235143497092384,0.8012524131486722,1.0,0.9879238405014953,1.0,14/169,7.94%,CYP1A2;HGFAC;PC;PAPSS2;APOE;TDO2;DDAH2;AKR1C3;SERPINE1;BPHL;F11;CYP2S1;BCAT1;IGFBP4
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.39723631995542813,0.801182960020925,0.6216216216216216,0.9876326987219797,1.0,6/19,27.28%,EIF2AK3;HSPA1A;NCK1;CREB3L1;BCL2L1;TXNDC12
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),0.4413218886716126,0.8011753699400249,0.7291666666666666,0.9872352568394588,1.0,5/10,26.76%,DXO;EXOSC5;PCID2;EXOSC9;XRN1
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),-0.39993786908758877,-0.8010172297677324,0.6935483870967742,1.0,1.0,9/23,22.96%,CAV3;KCNQ1;CYP2J2;AGT;PLN;ACE2;AGER;KCNMB2;KCNG2
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.28957994851737284,0.8009564433634767,1.0,0.9872328123848372,1.0,31/161,22.14%,RASSF2;IRGM;HIP1;PARVA;PYHIN1;PER3;FLNA;TELO2;PPIB;TRIM44;PIM2;USP36;CCNH;HSPA1A;TESC;COG7;OTUD3;ANK2;ATF7IP;MORC3;EP300;CREB1;MARCHF7;SWSAP1;GNAQ;PLPP3;TBL1X;MDM4;BAG6;PTEN;SMAD7
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.35209870843443286,-0.8009224288125159,0.8115942028985508,1.0,1.0,16/52,26.42%,IFNK;IRF1;NLRC3;SH2D1B;CDC37;CACTIN;ERAP1;IFI35;CASP8;DHX58;HSP90AB1;TKFC;USP18;PTPN11;CCL5;RNF135
prerank,GO_Biological_Process_2021__insulin metabolic process (GO:1901142),-0.5307225202827334,-0.8000835141231352,0.7868852459016393,1.0,1.0,1/5,7.40%,CEACAM1
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,0.2732239078911394,0.7999885002724336,0.95,0.9886205265792647,1.0,25/117,15.45%,FIBIN;MXRA5;LAMA3;MRGPRF;SDC4;PARVA;COL12A1;NTN4;OSR1;DSP;FZD1;EDNRA;SNAI2;MIR22HG;RND3;COL16A1;CRLS1;TWSG1;LRIG3;EFEMP1;WWTR1;PRICKLE2;CDH11;PLSCR4;GBP2
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.28485116370169106,0.7997563225480295,0.8888888888888888,0.9886300285686307,1.0,21/85,17.21%,BAMBI;TGFBR1;SPRED3;IL17RD;SIRT1;ZEB2;ZNF703;LATS1;SPRED2;ITGA3;SPRED1;PPM1A;BCL9L;HSPA1A;SMAD2;SMURF1;FAM89B;MEN1;NREP;PMEPA1;SKI
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),0.4511546537971396,0.7997226781392117,0.6666666666666666,0.9882828864178133,1.0,7/12,32.82%,MARK3;DLG5;WWC1;WWC2;WWC3;LIMD1;VGLL4
prerank,GO_Biological_Process_2021__auditory receptor cell stereocilium organization (GO:0060088),0.5368059231020165,0.7997106326627278,0.7777777777777778,0.9874706842766245,1.0,2/5,14.36%,WHRN;PDZD7
prerank,GO_Biological_Process_2021__auditory receptor cell morphogenesis (GO:0002093),0.5368059231020165,0.7997106326627278,0.7777777777777778,0.9874706842766245,1.0,2/5,14.36%,WHRN;PDZD7
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),-0.4733619607731624,-0.7996680494658593,0.7627118644067796,1.0,1.0,2/9,4.14%,TGFB1;RORC
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),-0.3477686417485932,-0.7989202824252613,0.7746478873239436,1.0,1.0,10/54,17.08%,DTL;WNT5A;GPC3;ACTN3;C4BPA;ASB5;OAZ2;C4BPB;ANGPTL3;VSIR
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),0.28824871244931854,0.7988315849007196,0.9130434782608695,0.9886929538968201,1.0,15/119,14.09%,LGR5;BAMBI;FGF10;SEMA5A;PSME4;ZEB2;PSMA1;WNT3A;GPC5;KANK1;WNK2;PPM1A;RNF146;WLS;NFKB1
prerank,PanglaoDB_Augmented_2021__Stromal Cells,-0.3164196781575965,-0.7986149369001341,0.8823529411764706,1.0,1.0,16/104,14.70%,LMOD1;TIMP3;ANGPTL2;MMP9;COL1A1;COL5A1;DAB2;ADAM33;DCN;ICAM3;LAMC2;CALB2;TLR2;TEK;C1S;ACTA2
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),0.38715847703496725,0.7984769165932162,0.7058823529411765,0.988927277454189,1.0,6/33,19.66%,RNASET2;NUDT18;PNPT1;NUDT5;XRN2;ENTPD2
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.4145336640342413,0.7983437816541376,0.7142857142857143,0.9888367275855546,1.0,2/10,9.91%,HMGB1;LPL
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),-0.44897152942638835,-0.7982290623282634,0.7755102040816326,1.0,1.0,2/8,6.26%,ALOX5;GPR183
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.3473671145040258,0.7980114106449829,0.7419354838709677,0.9889397315646014,1.0,5/22,11.56%,SLIT2;KANK1;ABI3;EVI5L;EVL
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.3348560732875354,-0.7979085518249363,0.8028169014084507,1.0,1.0,21/62,24.91%,CCND1;SEMA3F;PTGES;SH2D4A;EPN3;BAIAP2L1;TRIM29;PPIC;TOM1L1;ABCA12;YAP1;CELSR1;ALDH1A3;SIX4;KLRG2;C6ORF132;GNG12;LYPD6;TPBG;GRHL2;TMEM54
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),0.39714816048052476,0.7977920388200742,0.6666666666666666,0.9889553089180024,1.0,4/14,16.13%,SHLD2;SHLD1;KMT5C;KMT5B
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),-0.48636323686495586,-0.797784320155513,0.7846153846153846,1.0,1.0,1/8,8.44%,DRC1
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.33011585702247304,0.7972503069157114,0.875,0.9895445947459344,1.0,6/33,13.71%,PRICKLE1;SCRIB;LRP6;PHACTR4;COBL;MTHFR
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.4177189701538848,-0.7969777690818418,0.8095238095238095,1.0,1.0,5/18,12.70%,MICB;BLK;C3AR1;FPR1;FPR3
prerank,GO_Biological_Process_2021__negative regulation of nervous system process (GO:0031645),0.47255415951912044,0.7969218771161571,0.74,0.9896471788739912,1.0,1/6,7.38%,EIF2AK3
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),0.39639752029927006,0.7969131047994381,0.7272727272727273,0.989244971041961,1.0,4/13,14.36%,KIT;WHRN;ADGRV1;PDZD7
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),0.3688741515864671,0.7968420583766421,0.78125,0.9889614343531204,1.0,9/28,29.79%,AKAP9;TPPP3;MAP7D3;TPPP;CCDC57;ZNF207;NDE1;FGF13;CLASP2
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),-0.358686209452109,-0.7968197822327131,0.7671232876712328,1.0,1.0,6/38,16.95%,KCNJ15;ATP1A4;KCNJ11;KCNJ4;ATP4A;KCNJ13
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),0.4204559693635425,0.7968128251675116,0.6571428571428571,0.9886096475417508,1.0,6/11,29.74%,EIF2AK3;IMPACT;QRICH1;NFE2L2;EIF2S1;EIF2AK4
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.30658298461300393,0.7967216101325375,0.8,0.9883452762290322,1.0,13/57,20.06%,MAPKAPK2;VEGFC;HSPB1;CRK;WASF2;PXN;PIK3CA;VAV2;CLEC14A;NCK1;DOCK1;ELMO1;PAK2
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.49554221331132897,-0.7965569299830848,0.7424242424242424,1.0,1.0,5/10,31.28%,AGT;SIX4;SOX9;PAX2;PAX8
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),-0.3883073466222995,-0.7965379517233838,0.7971014492753623,1.0,1.0,7/35,17.25%,TCF7;ANXA1;PTPRC;SPI1;CD4;GLI3;ZFP36L1
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),-0.5238457809428017,-0.7965064289176388,0.7962962962962963,1.0,1.0,1/6,2.54%,WNT5A
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),-0.4539346915918514,-0.796288321080778,0.7692307692307693,1.0,1.0,2/9,9.43%,CASQ2;P2RY6
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.33193630659559276,0.7962716400930593,0.7941176470588235,0.9887218533030804,1.0,1/38,0.97%,RAB27A
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),-0.3923248521888978,-0.7962085671535549,0.7540983606557377,1.0,1.0,5/26,18.65%,KIF14;SVIL;CXCR5;ECT2;CDC6
prerank,GO_Biological_Process_2021__histidine metabolic process (GO:0006547),0.5068087910459762,0.7961100326400049,0.78125,0.9881750246384337,1.0,2/7,3.54%,HNMT;CARNMT1
prerank,GO_Biological_Process_2021__histidine catabolic process (GO:0006548),0.5068087910459762,0.7961100326400049,0.78125,0.9881750246384337,1.0,2/7,3.54%,HNMT;CARNMT1
prerank,GO_Biological_Process_2021__aromatic compound biosynthetic process (GO:0019438),-0.5075776154789122,-0.7957695851469008,0.7407407407407407,1.0,1.0,1/7,2.55%,ACMSD
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),-0.37589707434246233,-0.7955947907169217,0.8095238095238095,1.0,1.0,3/29,8.67%,MMP9;STAT1;ANXA1
prerank,GO_Biological_Process_2021__extracellular exosome biogenesis (GO:0097734),0.49846263151163267,0.7954459739954715,0.7,0.9889177741529681,1.0,1/5,0.97%,RAB27A
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),-0.3838345551730825,-0.7953115520735518,0.7205882352941176,1.0,1.0,3/32,13.14%,PLPP6;ACAA2;FAXDC2
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.42722456144470355,0.7952483765943864,0.8055555555555556,0.9887966601717341,1.0,2/11,16.94%,ARID1A;PMEPA1
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.28912136624463236,0.7952250010275059,0.9565217391304348,0.9884149141796645,1.0,16/67,18.48%,PIGQ;CPNE7;SMPD4;PLCB1;PNPLA3;ABHD3;CRLS1;CPNE6;PLA2G4C;PLA2G15;PIGA;DGKH;SERINC5;GPLD1;HDHD5;CPNE1
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,-0.3248780673965205,-0.7952164630753783,0.7631578947368421,1.0,1.0,8/81,7.34%,LMOD1;TIMP3;ANGPTL2;COL1A1;ADAM33;DCN;SLCO2A1;ASPN
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,-0.322160178713832,-0.7952019231045993,0.8902439024390244,1.0,1.0,22/117,19.16%,AQP3;CRLF1;CLDN1;COL1A1;SEMA3F;SLCO2A1;A4GALT;COL4A4;OSMR;COL4A3;LAMC2;ITGB6;TRIM29;PPIC;CLDN18;YAP1;SCARA3;SCNN1A;SCNN1G;CYP4B1;EPAS1;SLC44A3
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),0.38876767149236896,0.7950353487665803,0.8108108108108109,0.9882444636891904,1.0,6/16,13.07%,SMARCD3;SMARCB1;MYC;ARID1A;SMARCA4;ARID2
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,-0.33248886196572197,-0.7950146603018037,0.8481012658227848,1.0,1.0,9/86,6.82%,LMOD1;GALNT15;ANGPTL2;COL1A1;COL5A1;DAB2;ADAM33;DAAM2;DCN
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),-0.43162905594782136,-0.7949276964095565,0.7627118644067796,1.0,1.0,2/12,9.14%,TAF7;TAF7L
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),0.49749605338446856,0.7946759358673275,0.7083333333333334,0.9877215564715266,1.0,3/5,28.07%,MAN1A1;EDEM1;EDEM3
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),0.49749605338446856,0.7946759358673275,0.7083333333333334,0.9877215564715266,1.0,3/5,28.07%,MAN1A1;EDEM1;EDEM3
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),0.49749605338446856,0.7946759358673275,0.7083333333333334,0.9877215564715266,1.0,3/5,28.07%,MAN1A1;EDEM1;EDEM3
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),-0.44430704570146845,-0.7946680178129183,0.6779661016949152,1.0,1.0,2/7,23.62%,HAAO;QPRT
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),0.3684485230797145,0.794616288158311,0.7352941176470589,0.9874153767724551,1.0,7/25,14.77%,TDO2;CBS;KYAT1;AADAT;SARDH;THNSL2;GSTZ1
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),0.2603187727464473,0.7942674612661786,1.0,0.9877534804832768,1.0,55/290,17.45%,NGF;POU3F1;RAB27A;FGF10;TGFBR1;ZNF804A;SCRIB;EPHX2;MITF;ANGPT1;CDH5;ZBTB7B;PID1;FGF17;DNMT1;SNCA;ARRB2;MAGI2;OSR1;GREM1;EIF2AK3;SP1;MAPK8;MYC;FGF18;WNT3A;TWIST1;MOV10;AMH;RBMS3;RIMS2;LGALS9;TNRC6C;LIMS1;TICAM1;HSPA1A;RESF1;RNF207;PLSCR1;TESC;ARRB1;ANK2;INSR;TP53;GABPA;TNRC6A;SNF8;MPHOSPH8;EPHB2;NOTCH1;ATM;ATF7IP;AGO3;BRAF;PAX6
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),0.4239765414877446,0.7942493465369784,0.7045454545454546,0.9873608776637794,1.0,3/8,10.93%,SLC22A5;SLC6A20;SLC25A29
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),-0.47752581327492627,-0.793854042016783,0.7333333333333333,1.0,1.0,1/8,1.49%,TGFB1
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.41461114858470866,0.7936747759728797,0.7045454545454546,0.9879214780790331,1.0,2/12,12.30%,AK3;EFL1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.4233383756087422,-0.7935731907036929,0.7538461538461538,1.0,1.0,3/12,18.80%,HLA-A;IL18;CD81
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),0.37302763953680673,0.7935107445752968,0.7674418604651163,0.9878507484692877,1.0,4/17,7.52%,CSTA;CD247;DSP;LORICRIN
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.36372678311389306,0.7934582166532718,0.6551724137931034,0.9875327778213087,1.0,8/30,20.65%,CBFB;NCOA2;SAFB2;LATS1;CARM1;RUNX1;EP300;KCTD6
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),-0.4513242269448529,-0.7934484592808937,0.7540983606557377,1.0,1.0,1/11,7.60%,HAT1
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,-0.3156283678092676,-0.7930804176360122,0.9125,1.0,1.0,14/137,7.54%,LMOD1;TIMP3;ANGPTL2;ANGPT2;NOSTRIN;FILIP1L;COL1A1;COL5A1;FBXL7;DAB2;ADAM33;DCN;PLAU;LATS2
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.299076872411737,0.7930318975500238,0.7391304347826086,0.9878392417740764,1.0,25/95,20.34%,RASSF2;HSPB1;CCN1;CEP85;SIRT1;SNCA;DEPTOR;TRIB2;LRP6;SPRED1;RAP1A;UBASH3B;SNX9;NF1;ANKRD54;WWTR1;DUSP19;TAB1;TARBP2;MMD2;C5AR1;TAB2;PRKAG2;PAK2;GNAQ
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),-0.4138108700154929,-0.7930010833852291,0.7727272727272727,1.0,1.0,3/17,18.95%,IL7;CD27;AXL
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.37381546732734067,0.792994140567879,0.8,0.9875030037948362,1.0,6/19,21.39%,EPHA3;NR1H3;LGALS3;ABCA7;LRSAM1;RUBCN
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.29249311735092237,0.7929940010468767,0.9310344827586207,0.9870991170857177,1.0,5/56,9.86%,TGFBR1;SBK1;MAPK8;MAP3K10;DYRK3
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.3209992171055186,-0.7925180370835618,0.8181818181818182,1.0,1.0,28/116,18.49%,AMACR;ALOX12;CYP26B1;SLC16A8;CYP3A5;PTGR1;ACOT6;CYP2J2;ACOT4;CYP3A4;CKB;PDHX;CKMT2;SLC16A3;ACOT1;CYP4F12;VDAC1;ACOT2;GGT5;ACSL3;ADH7;ANGPTL3;SCPEP1;PRODH2;MCCC2;CYP4B1;ABCB11;ALDH1A3
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),0.3165261198295321,0.792496193764571,0.9024390243902439,0.9875843810069856,1.0,16/41,25.94%,HDAC3;FLNA;HCLS1;ANP32B;TP53;NEDD4;RAPGEF3;KHDRBS1;CPSF6;JUP;NRDE2;TPR;UBR5;PRKCD;GAS6;DMAP1
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),0.33146311340348994,0.7921810772966984,0.8648648648648649,0.9878162848120735,1.0,3/33,3.19%,SLC30A10;TRPC3;SLC39A8
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),0.30497935098426776,0.7921751030724568,0.9354838709677419,0.9874189324089087,1.0,16/58,18.33%,BRCC3;ERCC8;RNF168;HMGB1;SMARCAL1;POLM;SETMAR;KDM2A;SMC5;H2AX;PAXX;HERC2;LIG4;ATM;NSMCE2;MDC1
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),0.4795850123565754,0.7918127730264288,0.7333333333333333,0.9877431864259023,1.0,1/6,4.59%,SIRT1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.2916918182287434,0.791793791232583,0.9545454545454546,0.9873585128010731,1.0,13/64,14.95%,KIT;FGFR1;ERBB2;EPHA3;FER;ABL1;ABL2;FGFR3;ABI3;EFEMP1;PIBF1;FLT3;INSR
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",0.47367336019516715,0.7915731554476974,0.7659574468085106,0.9873745382657789,1.0,2/9,6.23%,DERL3;UBE2J1
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.32645691216233247,0.7915485339913154,0.7380952380952381,0.9870149577905696,1.0,11/50,11.44%,HSPB1;RIPK2;CX3CR1;FZD5;IFI16;PYHIN1;TMEM106A;LPL;F2R;LGALS9;NLRP2B
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),0.35740874488682706,0.7914742751459776,0.71875,0.986766455992292,1.0,11/24,37.32%,ABCD3;ABCD2;PEX3;PEX14;ACOT8;MFF;PEX16;LONP2;PEX12;ABCD4;PEX7
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.3683665262254438,0.791307748784835,0.75,0.9866904194979291,1.0,7/16,22.47%,ABL2;ITGA3;KANK1;ARHGAP35;CCDC125;RASIP1;SCAI
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.464117831454787,-0.79118407004351,0.7692307692307693,1.0,1.0,6/10,27.21%,H1-0;H1-3;SMARCA5;PAF1;H1-2;LIN54
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.2996679750499781,-0.7910429361335196,0.8875,1.0,1.0,58/192,27.27%,RPL37A;INTS5;SENP3;RPL38;PWP2;EMG1;RPL15;NOB1;RPL3;RPL35A;RPS9;RPS27;RPL13A;SMAD3;RPL27A;RPS16;RPL36;LAS1L;RPL7A;RPL9;RPL13;RPL21;WDR12;NOP53;EXOSC8;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPL27;RPL35;RPS14;RPL11;RPS15;EXOSC2;RPLP1;RPL24;SBDS;RPL18A;RPL29;RPLP2;PDCD11;RPL28;RPL12;RPL18;EBNA1BP2;RPL22;IMP3;RPS28;RPS19;RPS24;RPL19;RPL8;RPS6;RPL10
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.3568368327428736,-0.7910163066110101,0.7536231884057971,1.0,1.0,5/47,7.34%,CLCA2;AQP3;FLG;DUOXA1;SERPINB5
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),0.43529052595016104,0.7909717500521408,0.6956521739130435,0.9868112364995567,1.0,2/7,14.66%,METAP1D;FKBP7
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.31800505786415545,0.7908784385162746,0.8275862068965517,0.9865569739621998,1.0,10/43,15.44%,RBM20;SIRT7;RIOK1;DXO;ERN1;LIN28B;HSPA1A;PNPT1;NFKB1;TP53
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),-0.5192382202958374,-0.7908752273972957,0.7543859649122807,1.0,1.0,2/6,18.78%,DDX3X;DDX1
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),0.30745971873092925,0.7906139415070847,0.896551724137931,0.9866900363912845,1.0,7/34,14.19%,DOC2B;PCLO;SNCA;SYT1;RIMS2;UNC13B;SNPH
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),-0.34496891612039987,-0.7904572491540096,0.8051948051948052,1.0,1.0,10/50,15.93%,GALNT15;B3GNT5;MUCL1;MUC5B;ST6GALNAC2;CHST4;MUC4;MUC17;GCNT1;GALNT6
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.3089627377240932,0.7901688746827654,0.8846153846153846,0.9870379686089792,1.0,10/58,13.52%,BCL2;MFSD2A;PLIN5;TIMP1;MTMR8;LEPR;DAPL1;TAB3;KLHL22;IL10RA
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),0.32861106671405904,0.789953878651815,0.7619047619047619,0.9870540722926662,1.0,5/82,4.29%,HGFAC;PRSS3;CPN1;HTRA2;KLKB1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),-0.4603834598965812,-0.789772594029255,0.8307692307692308,1.0,1.0,2/13,6.10%,BOLL;DAZL
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),0.45237539839883817,0.7897528779701667,0.717948717948718,0.9870026532820935,1.0,2/7,35.49%,EPHA4;PTPRS
prerank,GO_Biological_Process_2021__dehydroascorbic acid transport (GO:0070837),-0.5122413511461087,-0.7895715077252319,0.7407407407407407,1.0,1.0,2/5,30.03%,SLC23A1;SLC2A2
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),-0.3534081416622528,-0.7894372999008444,0.7972972972972973,1.0,1.0,3/40,7.51%,FOXM1;TERF2IP;WAS
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.349086983120166,-0.7892443800392352,0.8055555555555556,1.0,1.0,3/50,7.35%,POLQ;TERF2IP;H1-0
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),-0.398133056189342,-0.7891313081308016,0.8194444444444444,1.0,1.0,3/18,8.63%,GPER1;CEACAM1;BRCA1
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,-0.3083029189659562,-0.7890529364540358,0.8571428571428571,1.0,1.0,19/121,14.86%,C1QTNF1;CYYR1;LMOD1;TIMP3;ANGPTL2;PPP1R1B;DRAM1;DCN;SLCO2A1;ENC1;THBS1;VWF;GPX3;SLC14A2;EDNRB;TEK;HEY2;C1S;ADGRF5
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),-0.3808606514505703,-0.7888802911121912,0.765625,1.0,1.0,2/26,5.61%,WNT5A;PINK1
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.30536378244421314,0.7887570319137189,0.8928571428571429,0.9883929406007406,1.0,14/59,15.05%,BAMBI;TGFBR1;SPRED3;IL17RD;SIRT1;LTBP1;SPRED2;SPRED1;PPM1A;BCL9L;HSPA1A;SMAD2;SMURF1;FAM89B
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),0.45846282732768096,0.7886337730525717,0.775,0.987847797846828,1.0,1/9,14.10%,VTA1
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),0.45846282732768096,0.7886337730525717,0.775,0.987847797846828,1.0,1/9,14.10%,VTA1
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),-0.466295176850877,-0.7885249667555818,0.7058823529411765,1.0,1.0,3/9,21.09%,CEACAM1;APOLD1;BTG1
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),-0.48752536457445944,-0.7882799386998905,0.7419354838709677,1.0,1.0,1/6,10.17%,CYBA
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.33470949610844425,0.7880699021774222,0.8333333333333334,0.988044639026642,1.0,6/30,13.71%,PRICKLE1;SCRIB;LRP6;PHACTR4;COBL;MTHFR
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.33470949610844425,0.7880699021774222,0.8333333333333334,0.988044639026642,1.0,6/30,13.71%,PRICKLE1;SCRIB;LRP6;PHACTR4;COBL;MTHFR
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),-0.3375671489469644,-0.7879525211538249,0.8055555555555556,1.0,1.0,5/68,8.09%,ELOVL2;DEGS2;ALOX12B;PRKD3;A4GALT
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),0.4516247085361602,0.7877756766181796,0.7,0.9880847779946984,1.0,2/14,7.70%,SMYD1;PLCB1
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),-0.4066681508200165,-0.7876157062014625,0.7777777777777778,1.0,1.0,2/17,5.93%,TGFB1;CIITA
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),-0.32725479801241336,-0.7875957455433018,0.8767123287671232,1.0,1.0,21/73,19.32%,CRYBB1;TULP1;ROM1;COL18A1;COL1A1;CABP4;RDH12;SLC24A1;GPR179;CRYBA4;TULP2;FSCN2;WFS1;PDE6C;USH1C;RABGGTB;RABGGTA;CRYBG3;GUCY2F;TYR;PRPH2
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated cytotoxicity (GO:0001915),0.48852689766922475,0.7874796320650309,0.7111111111111111,0.9882350412252708,1.0,1/5,1.42%,KLRD1
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.3511246451862263,0.7873367502664892,0.8444444444444444,0.9880793155499711,1.0,3/30,6.23%,DPM3;DERL3;UBE2J1
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),0.30693495814682664,0.7871344235536882,0.8571428571428571,0.9879787498050608,1.0,8/42,12.12%,CD38;BCL2;SHLD2;SHLD1;SH3KBP1;IRS2;TNFSF13B;KMT5C
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),-0.5004351564714327,-0.7870509380942359,0.7857142857142857,1.0,1.0,3/7,35.87%,MSN;EGF;EZR
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),-0.5004351564714327,-0.7870509380942359,0.7857142857142857,1.0,1.0,3/7,35.87%,MSN;EGF;EZR
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),-0.5004351564714327,-0.7870509380942359,0.7857142857142857,1.0,1.0,3/7,35.87%,MSN;EGF;EZR
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.36220338586303386,0.786944627873075,0.7575757575757576,0.9878843778793225,1.0,2/22,6.91%,SLC12A1;SLC12A9
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),0.4857149917804183,0.7868859300728039,0.76,0.9875701253694988,1.0,3/5,32.66%,DOCK11;DLL1;DOCK10
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),-0.33577227089088557,-0.7864818787391393,0.8311688311688312,1.0,1.0,6/66,8.28%,TGFB1;WNT5A;ALOX5;RORC;GPER1;ZFPM1
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.30323058049697693,0.7864803298466382,0.8,0.9878485491889183,1.0,8/75,7.87%,PRICKLE1;FZD5;PSME4;VANGL1;ARRB2;MAGI2;PSMA1;FZD1
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.3933204029942788,0.7863748976036847,0.8292682926829268,0.9876627697777065,1.0,1/11,2.83%,CDH5
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),0.43500318538388005,0.7862422587166998,0.725,0.9874527305246855,1.0,1/9,3.49%,BIN1
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.34793800207084125,-0.7861178860265705,0.8181818181818182,1.0,1.0,5/37,15.16%,CRLF1;CLCF1;STAP2;IL12A;IL18
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.3979026619804976,-0.7860880615375048,0.7962962962962963,1.0,1.0,5/22,16.76%,TGFB1;P2RY12;ATG14;TEK;TNFAIP8L3
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.384473631398886,0.785723023874186,0.75,0.9879626658569302,1.0,5/19,9.20%,TOX;PROX1;TRIM71;PTPRZ1;TAFA1
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.39370586119652873,-0.7854686357460104,0.7580645161290323,1.0,1.0,6/19,15.53%,HLA-A;CEACAM1;HLA-DRB1;PTPRC;IL12A;HLA-F
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.3317795310737867,0.7854464799001724,0.9411764705882353,0.9880026758199335,1.0,10/29,28.25%,NLGN1;GRIN1;EPHB2;DLG2;DLG1;GRIA4;LRRC7;DLG3;GRIA1;MEF2C
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.3230131958254205,-0.7853016281857459,0.7922077922077922,1.0,1.0,13/114,13.31%,AIM2;NLRP12;CYP1B1;SP100;ESR1;TBX6;PLA2G10;SFRP4;ID1;SPI1;WFS1;NLRC3;NLRP3
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),0.4277818025816094,0.7851848067555252,0.7142857142857143,0.9879999876670799,1.0,1/12,1.16%,PTGS1
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.38933112883727533,-0.784912997631826,0.7868852459016393,1.0,1.0,2/24,9.78%,ANXA1;THBS1
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.38829036819637397,-0.7847999002804107,0.7681159420289855,1.0,1.0,3/21,7.64%,LPAR1;C3AR1;LPAR6
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),-0.30747354964161006,-0.7847324054938649,0.926829268292683,1.0,1.0,27/197,16.36%,NEK2;CCNG2;FOXM1;SPDYA;CCND1;CRLF3;CDC25A;FBXL7;LATS2;CCND2;DCTN1;TPD52L1;CDKN2D;CDKN1A;MAX;ABCB1;TUBA4A;CEP72;DYNLL1;CCNI2;CCNF;CCNE2;CDKN3;BORA;TUBB;CEP76;USH1C
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),-0.4368871727547473,-0.7847234266570492,0.7540983606557377,1.0,1.0,9/14,27.40%,DOCK8;SLC11A1;PIK3CG;MSN;CRTAM;TNFSF18;RASGRP1;CTPS1;TNFRSF4
prerank,GO_Biological_Process_2021__succinyl-CoA metabolic process (GO:0006104),-0.508755978964214,-0.7842436069389079,0.803921568627451,1.0,1.0,1/5,9.32%,ACOT4
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.39339009774811123,0.7840551798163682,0.7297297297297297,0.9894229832158523,1.0,6/16,27.48%,PAG1;MIA3;LAPTM5;IL4I1;WNK1;AKT1
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),-0.334206764744212,-0.7839752196501578,0.8607594936708861,1.0,1.0,5/62,6.81%,APOL1;SLC37A2;ANO2;SLC5A1;GLRA2
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),-0.4953631750812215,-0.7834252223988302,0.75,1.0,1.0,1/6,9.85%,SMAD6
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.37646821157880084,-0.7834104638965088,0.75,1.0,1.0,3/26,10.72%,TMC8;CP;SLC11A1
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.32973723789346754,-0.7832289606069254,0.8450704225352113,1.0,1.0,8/67,18.65%,KIF14;RAB11A;ANKRD53;SVIL;CXCR5;ECT2;CALM1;CDC6
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),0.42488322366147213,0.7832023612917784,0.6388888888888888,0.9903637050500609,1.0,4/10,16.94%,SLC8A1;JAG1;NOTCH1;ALPK3
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.25184702596727204,0.7831110226136175,1.0,0.9901226461562829,1.0,111/461,20.98%,RFWD3;RNF182;LZTR1;KLHL20;BCL2;NEUROD2;UBE2E3;CBFB;COMMD1;ZNRF1;PEX13;SIRT1;DTX1;MARCHF5;PSME4;ERCC8;KLHL41;RNF168;ARRB2;TRIM69;SH3RF1;UBE2J1;TRIM35;TRIM71;FANCL;FBXO15;PSMA1;SH3RF3;RBBP6;WWP2;UBE2O;HIF3A;RNF152;PDZRN3;UBE2E1;UBE2D4;TSPAN17;RNF10;KLHL18;ANAPC16;MSL2;GAN;RNF166;UBE2E2;TRIM44;FBXL14;MARCHF8;UBE3D;RNF38;RNF217;KLHL24;KLHL3;FBXO28;UBE2A;KLHL42;CCDC22;FBXL20;KLHL22;RNF146;PELI1;ARRB1;FBXO27;SMURF1;TRIM4;PELI2;HERC2;THOP1;SHPRH;CNOT4;UBE2QL1;BRAP;UBE2Z;MARCHF3;ZNRF3;FBXO4;NEDD4;ARIH1;UBE2L3;SPOP;RNF185;LONRF1;FBH1;HERC5;RC3H1;RNF113A;UBE4B;NFX1;LRSAM1;TRIM47;MIB2;ANAPC7;FBXO11;FBXL22;FBXO31;RNF40;MARCHF7;RNF122;RNF19B;CDC34;UBE2J2;TRPC4AP;TRIM14;FBXO30;TRAF6;HLTF;RNF19A;HIF1A;RNF139;FBXO41;PSMD4;TRIM26
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),0.3312172652205534,0.7830483917991895,0.7741935483870968,0.9898391845638895,1.0,7/46,11.29%,FOXO1;MID1;GREM1;CARD9;MYC;RAP2A;LGALS9
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),-0.39997649311629335,-0.7829657128618981,0.765625,1.0,1.0,2/16,6.70%,TNFRSF1B;DAAM2
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),-0.39840388877143285,-0.7828078294159799,0.7580645161290323,1.0,1.0,3/16,21.25%,CHMP3;EML3;DRG1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.3707624573680327,-0.782750164302609,0.734375,1.0,1.0,1/22,7.26%,BTBD18
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.337208157893367,-0.7826543203637214,0.8157894736842105,1.0,1.0,8/89,8.63%,TBX1;TGFB1;SOX10;UPK1B;STAT1;PPP2R3A;UPK1A;UPK3A
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),-0.4265971914059413,-0.782363631465861,0.7796610169491526,1.0,1.0,2/16,11.97%,LGI4;MTCH1
prerank,MSigDB_Hallmark_2020__Myc Targets V2,0.32011553937909204,0.7822850430580456,0.9090909090909091,0.9907299389598354,1.0,6/54,10.96%,DUSP2;TCOF1;SLC19A1;CDK4;MYC;WDR74
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),-0.4681993411509737,-0.7821302696495336,0.7666666666666667,1.0,1.0,2/7,13.40%,RBP2;BCO1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),0.34022885769908395,0.7814628618216454,0.7837837837837838,0.9917719855578854,1.0,8/28,21.99%,SNAPC3;GTF3C4;POLR3G;GTF3C5;ICE1;RO60;POLR3K;ICE2
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.35828291424254316,0.7811795131330616,0.75,0.991901502215158,1.0,12/37,19.16%,SIRT1;OPN5;IFI16;RGR;TANK;SPIDR;GADD45A;TP53;LIG4;OPN3;RAD9A;EEF1D
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),-0.45614255253620983,-0.7811535179994384,0.7659574468085106,1.0,1.0,4/10,20.23%,LOX;LOXL4;SUMF1;CHCHD4
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.4334846051136411,-0.7810337106555767,0.7936507936507936,1.0,1.0,1/11,1.49%,TGFB1
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),0.4330918452812408,0.7809875886492715,0.7,0.9919094047595103,1.0,2/7,18.01%,USH2A;ERCC3
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),0.47540560473462695,0.7806554262807375,0.8125,0.9921541498893942,1.0,3/8,23.14%,ZNF703;GPX1;DEAF1
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.4437367113330242,-0.7804927867308695,0.8103448275862069,1.0,1.0,1/13,1.49%,TGFB1
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),0.2716371365178457,0.7802310895029038,1.0,0.9923804863759916,1.0,38/112,28.15%,MAPKAPK2;HSPB1;SAMD4A;PSME4;EXOSC1;PSMA1;ANP32A;KHSRP;CSDC2;MOV10;HSPA1A;PNPT1;YTHDF1;ZC3H14;DIS3;RC3H1;SAMD4B;PCBP4;FXR2;EXOSC5;RBM24;PSMD4;XPO1;NUP214;DCP1A;PCID2;PRKCD;PSMB2;PABPC1;EXOSC9;PSMD5;PSMF1;XRN1;RC3H2;YWHAZ;AKT1;PSMD10;PSMD13
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),0.48312701552454207,0.7799859365841135,0.75,0.9924549367212752,1.0,3/6,32.65%,SLC4A11;STK39;SLC12A5
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),-0.37429331853205655,-0.7799500065186223,0.803030303030303,1.0,1.0,4/29,9.69%,TRPV6;SYT10;SYT2;REST
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),-0.486279996135229,-0.7799278446778697,0.8360655737704918,1.0,1.0,1/6,9.57%,PDZK1
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),0.3161485048625052,0.7795264245768989,0.8,0.9927476935215351,1.0,16/67,25.97%,PRICKLE1;RANBP17;BACH2;NXT1;SNRPB;GEMIN5;NUTF2;PPP1R10;APPL2;IPO8;NUP214;TPR;IPO7;SNRPF;FAM53A;NUP153
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),-0.3215543585498519,-0.7795208598406331,0.8656716417910447,1.0,1.0,8/72,11.77%,KIF14;ITGB2;WNT5A;TNFRSF1B;CLU;REST;CTSZ;ITGAM
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),0.3539222145629767,0.7793063273268191,0.7741935483870968,0.9927188605979291,1.0,12/35,27.98%,NUP210;NUP42;AAAS;RANBP2;NUP214;TPR;SEH1L;XPOT;YBX1;NUP153;NUP98;NUP37
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.3535710886000191,0.7791982102713411,0.7631578947368421,0.9924657990098733,1.0,6/26,12.11%,MITF;CX3CR1;SIRT1;ADIPOR1;AVIL;ADIPOR2
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.45618106907854544,0.7789632414821918,0.7608695652173914,0.9924310439187289,1.0,2/10,6.23%,DERL3;UBE2J1
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,-0.32075195085109254,-0.7789313170290237,0.8194444444444444,1.0,1.0,9/87,6.32%,LMOD1;TIMP3;CYP26B1;PDGFRL;COL1A1;COL5A1;TCF7L1;LOX;UACA
prerank,PanglaoDB_Augmented_2021__Decidual Cells,-0.37809981249543395,-0.7788218903159505,0.7704918032786885,1.0,1.0,4/28,7.00%,SIRPG;CYTIP;KLRB1;CD5
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),-0.39632566790756907,-0.7788170834102102,0.71875,1.0,1.0,1/25,0.82%,CLEC5A
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,-0.31968521205672545,-0.7787223506796458,0.8831168831168831,1.0,1.0,9/89,6.82%,LMOD1;TIMP3;ANGPTL2;COL1A1;COL5A1;FBXL7;ADAM33;DAAM2;DCN
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),-0.3327323743743833,-0.7786004893252975,0.8701298701298701,1.0,1.0,3/76,1.41%,RASGRP4;KIF14;FOXM1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),-0.4544197831493841,-0.7783389289823233,0.7368421052631579,1.0,1.0,3/11,25.49%,TMEM35A;HSP90AB1;GPD1L
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.4386336771174857,-0.7782444200452039,0.7307692307692307,1.0,1.0,1/12,8.67%,ANXA1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),-0.3513377481457786,-0.7782313974129015,0.7368421052631579,1.0,1.0,3/48,5.55%,STAC;GPER1;GPSM2
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),-0.3284503355643297,-0.777624631866685,0.7945205479452054,1.0,1.0,5/64,5.61%,TBX1;FOXM1;TGFB1;PRAME;PINK1
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),0.44399721000254255,0.777620302815479,0.6666666666666666,0.9943584599123511,1.0,3/11,12.79%,CPT1C;ACADM;CPT1A
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),0.34674628350418546,0.7774466409684833,0.8387096774193549,0.9942382238361125,1.0,5/22,16.67%,SIRT1;TIMP1;APBA3;TP53;NOTCH1
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.29726452254409275,-0.7771531180974871,0.8888888888888888,1.0,1.0,22/141,15.83%,HCK;MMP9;WNT5A;NLRP12;ALOX5;TNFRSF1B;GPER1;PTGES;LRRC19;ALOX15;ANXA1;LACC1;TLR2;NLRC3;NLRP3;TEK;NR1H4;IL18;ZP3;AGT;GRN;ELANE
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),-0.377264287860358,-0.7767297715868319,0.8676470588235294,1.0,1.0,3/23,8.55%,HHIP;RFX4;GPC3
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),0.4737790831979322,0.7766442193874074,0.8205128205128205,0.9951225738847961,1.0,3/7,6.88%,CLC;HMGB1;ZBTB1
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),0.3661323901180247,0.7766108655960468,0.7419354838709677,0.9947722767057225,1.0,2/17,6.48%,SIRT1;POLD3
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.3019045087956752,0.7765495139361603,0.9166666666666666,0.9944524915825886,1.0,6/58,5.52%,BCL2;HSPB1;URI1;HTRA2;SIRT1;ARMC10
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.3684225758597997,0.7762553825264147,0.7837837837837838,0.9945560338016366,1.0,4/20,9.53%,ADAMTS1;MMP2;DNMT1;ERN1
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),-0.46168766164837516,-0.7760709229968875,0.7551020408163265,1.0,1.0,1/12,0.55%,TBX1
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),-0.31238654007220856,-0.775927708577306,0.8732394366197183,1.0,1.0,5/93,7.97%,KIF14;CEP55;RAB11A;ANKRD53;CHMP3
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),0.3942171571950526,0.7758352133713748,0.7142857142857143,0.9948709441602701,1.0,3/11,34.42%,TRAPPC8;PACS2;ATG9B
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),-0.4289853613229275,-0.7756523366344561,0.8235294117647058,1.0,1.0,4/15,20.24%,HVCN1;GPR68;HYAL1;PKD1L3
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.3867475527448814,0.7752468414797657,0.8372093023255814,0.9954392423019426,1.0,8/15,33.39%,DSCC1;MAU2;NIPBL;POGZ;RB1;PDS5A;NAA50;RAD21L1
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),0.4404644052226881,0.7752096623203091,0.75,0.9951197019508582,1.0,2/9,16.83%,REP15;RAB11B
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.30042451457431224,0.7750933538785436,0.7894736842105263,0.9948486907347138,1.0,5/45,11.09%,PLCH1;ITPKB;PLCB1;INPP1;PLCH2
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.43287560058674374,0.7747839517104999,0.675,0.9948734543942382,1.0,2/9,14.26%,GDF6;SOX5
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.2821808740453613,0.774740309733828,0.9523809523809523,0.9945183464703796,1.0,38/117,25.35%,PCDH17;DOC2B;UNC5D;PCLO;SERPINE1;KCNIP1;ERC2;ADGRA1;GUCY1A2;BRINP1;RGS7BP;ELAVL4;RAB3C;DST;SNAP91;MAP6;RBFOX1;ASXL3;ANK2;NRXN1;PTPRD;LSAMP;ST8SIA3;ADGRB3;AKAP12;CNTN1;PLD2;TMEM196;GRIA4;SHC3;RAPGEF4;PLPPR4;CACNA1B;CDC42BPA;CADPS;MAP2;TAGLN3;NCS1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.3657609646329556,-0.7746419310200929,0.8615384615384616,1.0,1.0,1/51,0.47%,GML
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),-0.31553390789546126,-0.7742216726437028,0.8513513513513513,1.0,1.0,10/94,14.16%,TBX1;PKP2;TGFB1;FLT4;ZFPM1;HEG1;POPDC2;CDKN1A;TEK;HEY2
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.33845033593087304,-0.7741954213230766,0.8289473684210527,1.0,1.0,5/43,15.16%,CRLF1;CLCF1;STAP2;IL12A;IL18
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.45125409611797723,0.7741039087754576,0.7,0.9950615430948955,1.0,2/6,15.44%,SIRT1;TP53
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),0.3289512594897992,0.7740932696760475,0.84375,0.9946644714496061,1.0,7/35,16.47%,KIT;OSR1;LRP6;SP7;MLLT3;TP53;SETD2
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),-0.3773924068915926,-0.7740881615233143,0.847457627118644,1.0,1.0,3/23,8.63%,EIF6;CEACAM1;BRCA1
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),-0.4090237934311384,-0.7736832868177832,0.7313432835820896,1.0,1.0,4/16,21.55%,TERF2IP;DCLRE1C;DCLRE1A;TFIP11
prerank,GO_Biological_Process_2021__regulation of catecholamine uptake involved in synaptic transmission (GO:0051940),-0.49573062108958016,-0.7736768926269975,0.7321428571428571,1.0,1.0,2/5,32.79%,TOR1A;DRD2
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.33567584590497934,-0.7736395421677109,0.8615384615384616,1.0,1.0,9/50,13.20%,WNT5A;OAS2;CLU;THBS1;CYBA;PTPRC;OAS1;TLR2;C1QTNF4
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),-0.3768565490812344,-0.7735582543455237,0.8153846153846154,1.0,1.0,4/29,5.82%,NODAL;ITGB2;MMP9;VTN
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.3851689514508132,-0.7734231210599676,0.796875,1.0,1.0,8/28,15.53%,CD160;HLA-A;HLA-DRB1;SPI1;ITGAM;NOS2;IL12A;HLA-F
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),-0.36978096487176454,-0.7733360602032165,0.7903225806451613,1.0,1.0,3/25,9.22%,ELOVL2;ACSL5;PPT1
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),-0.2945213406184864,-0.7731302593059945,0.9512195121951219,1.0,1.0,11/154,5.18%,TBX1;AHR;MGST1;WNT5A;WNT8B;PDCD1LG2;CXCL13;RORC;ESR1;TNFRSF1B;GPER1
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.4313520357766054,-0.7730001496219757,0.7936507936507936,1.0,1.0,1/13,4.94%,SHISA6
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.38361059899811806,-0.7729108076103846,0.8333333333333334,1.0,1.0,5/23,15.41%,SIRPG;HLA-DPB1;HLA-DPA1;IL12A;IGLL1
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.3529048004976766,-0.7728773388573474,0.8243243243243243,1.0,1.0,10/40,20.84%,TERF2IP;NLRP12;LRRC19;TLR2;C1QTNF4;CD27;DDX3X;IFI35;CD86;AGER
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),0.4637806337896512,0.7727482897519486,0.7142857142857143,0.9964718339589822,1.0,3/5,15.67%,HCLS1;TESC;RUNX1
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),-0.3902172570817305,-0.7723593352464561,0.8214285714285714,1.0,1.0,1/14,5.77%,PPP1R17
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),-0.3880511897443346,-0.7717190582960777,0.7631578947368421,1.0,1.0,5/19,12.29%,TGFB1;DAB2;RHOQ;GBP1;MRAP
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.3966041244323299,0.7716811295981107,0.6666666666666666,0.997916568542961,1.0,4/15,14.95%,CLEC16A;MTRF1;ETF1;INSR
prerank,GO_Biological_Process_2021__immunoglobulin mediated immune response (GO:0016064),-0.4790334192620838,-0.7716598731561168,0.7761194029850746,1.0,1.0,3/5,18.80%,CD27;ZP3;CD81
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),-0.4431620796411381,-0.7716169695411982,0.7681159420289855,1.0,1.0,3/12,10.89%,TAF7;BRCA1;SPI1
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),-0.45472876864462064,-0.7714856467087763,0.7846153846153846,1.0,1.0,1/8,8.67%,ANXA1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.35944194748934133,0.7711023370625807,0.8823529411764706,0.9984214404884182,1.0,3/25,4.59%,HSPB1;HTRA2;SIRT1
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),-0.4579616321957934,-0.7710811918140619,0.782608695652174,1.0,1.0,2/8,24.56%,NUGGC;CDC7
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.4602334064306241,0.7709963980129327,0.6595744680851063,0.9982341873508779,1.0,2/5,24.74%,ATP8A2;ATP11B
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),0.3193529547960793,0.7709854877431949,0.8297872340425532,0.9978667057984971,1.0,7/27,27.53%,MAPK8;NFKB1;MAP2K7;CUL1;IKBKB;TAOK2;BTRC
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),-0.3979883654095995,-0.7708622036732825,0.8135593220338984,1.0,1.0,4/14,17.79%,THBS1;CTSZ;USP17L2;ACP4
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.30955705614618134,-0.7708573669712309,0.8955223880597015,1.0,1.0,10/86,13.03%,ERN2;CIDEB;CYP1B1;BCL2L2;TNFRSF1B;HIC1;BRCA1;HINT1;CDKN1A;MOAP1
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),-0.4774759460982595,-0.77085669559226,0.7540983606557377,1.0,1.0,2/8,25.20%,FLOT1;EHD2
prerank,GO_Biological_Process_2021__negative regulation of cellular respiration (GO:1901856),-0.516107763903858,-0.7708222577002721,0.7543859649122807,1.0,1.0,1/5,8.67%,ACTN3
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),0.4615504480996564,0.7708049280481725,0.6904761904761905,0.997860128336476,1.0,2/5,9.20%,SMARCB1;PIH1D1
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),-0.3435854568650662,-0.7706719918889454,0.8133333333333334,1.0,1.0,6/34,16.65%,TGFB1;ALOX5;FBN2;WNT6;TGFB3;ODAPH
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),0.3954993560725024,0.7705828810301315,0.7560975609756098,0.9978235171082792,1.0,1/15,0.59%,CYP1A2
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),0.38085959790255586,0.7705695823623478,0.6944444444444444,0.99749266989404,1.0,4/15,23.42%,GBF1;ANK2;MIA3;UBAC2
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),0.26692793914008744,0.7703843703310211,1.0,0.9973902006381645,1.0,21/97,19.05%,THEM4;PC;CPN1;SLC19A1;DHFR;PDZD11;ACOT9;NSMAF;SMPD3;PLPP2;ACSM2A;ACSM1;MTHFR;THOP1;OXSM;PLA2G15;PCCA;ABHD4;FPGS;SHMT2;AEBP1
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by integrin (GO:0033634),0.4827048346024579,0.7703171005403178,0.8048780487804879,0.9970777905528968,1.0,1/5,1.48%,SKAP1
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.32877487035873315,-0.770130101347562,0.8636363636363636,1.0,1.0,13/47,26.21%,TRAIP;PTPRC;OAS1;PALM3;F2RL1;CACTIN;CARD8;GPS2;ISG15;OTUD4;PELI3;USP18;RFFL
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),-0.4734530033027191,-0.7699797793407646,0.7833333333333333,1.0,1.0,2/7,11.93%,CKB;CKMT2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.38594182150461165,-0.7696623136885454,0.7746478873239436,1.0,1.0,6/21,24.93%,IRF1;TLR2;CACTIN;GPS2;FLOT1;OTUD4
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.45474933147826546,0.7695977164435904,0.7692307692307693,0.9977493421386543,1.0,3/6,29.95%,ADAR;CORO1C;PPM1F
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),0.3055097973591947,0.7692205403737852,0.8888888888888888,0.997982661778705,1.0,13/65,15.48%,IRGM;CD14;TICAM2;CX3CR1;FZD5;SERPINE1;HMGB1;MAPK8;PDE4B;TICAM1;NFKB1;NR1H3;LBP
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.3512154903066795,0.7691109095974649,0.8837209302325582,0.9977602909141936,1.0,3/29,6.23%,DPM3;DERL3;UBE2J1
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.32726129355296124,0.7689765787024142,0.8529411764705882,0.9976099898767078,1.0,5/29,11.80%,MEGF10;XKR7;RHOBTB1;XKR6;XKR4
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),-0.3649053325143379,-0.7689181857674865,0.7971014492753623,1.0,1.0,2/27,7.97%,RAB11A;CHMP3
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.37505356267438106,0.7687198915284826,0.8,0.9976993574931927,1.0,6/22,15.70%,NRG1;OLFM2;ABL1;BNIP2;CDH2;MAPK12
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),0.46300151203189777,0.7686493616063156,0.8181818181818182,0.997411513510667,1.0,1/6,19.95%,USP15
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),0.29956067463664887,0.7685681169227405,0.875,0.9971418496682758,1.0,20/114,15.72%,ELOVL6;HDAC3;APOE;SMARCD3;PPARG;PSME4;NCOA2;PSMA1;ACACB;SP1;LDLR;ADIPOR1;IRS2;ODC1;SC5D;CHD9;CARM1;NFYC;TM7SF2;OPA3
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),0.4292555568054798,0.7685525536089801,0.7692307692307693,0.9967467855440015,1.0,2/8,15.44%,EIF2AK3;TP53
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),-0.4237256735698617,-0.7685354473330572,0.803921568627451,1.0,1.0,5/15,20.20%,ANXA1;NDUFS2;METRN;METTL14;GCM2
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),0.35545297392610103,0.7683224675981689,0.8809523809523809,0.9968124364580739,1.0,5/24,14.70%,P3H2;PPIB;CWC27;FKBP7;NKTR
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),-0.5009438606625802,-0.7682752248351067,0.8095238095238095,1.0,1.0,4/7,41.28%,BAK1;TMEM33;BCL2L11;AGR2
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),0.4347116035430514,0.7681693542043654,0.7843137254901961,0.9966748214318353,1.0,1/11,2.66%,APOE
prerank,GO_Biological_Process_2021__inner ear auditory receptor cell differentiation (GO:0042491),0.44733001161134783,0.7680036867985278,0.7857142857142857,0.9965014682254876,1.0,3/6,21.76%,SLC4A7;PDZD7;JAG2
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.3615084639020202,-0.7680024589462295,0.8857142857142857,1.0,1.0,9/38,17.63%,TGFB1;ITGB2;THBS1;CYBA;ITGAM;CDKN1A;AGT;F2RL1;ROMO1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),0.29922569918866043,0.7676663909554995,0.9333333333333333,0.9965372775079352,1.0,4/34,13.41%,FHIT;N4BP1;EIF3H;RYBP
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),0.3236996990502319,0.7675954944651981,0.7575757575757576,0.9962506897483684,1.0,7/21,27.48%,ABL1;COL16A1;LIMS1;IQSEC1;PTPRJ;MAP4K4;ROCK1
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.36439345840573445,-0.7675286205908809,0.7746478873239436,1.0,1.0,9/30,21.33%,HK2;SOD2;CLU;BIK;IFIT2;CAMK2A;FIS1;BBC3;IFI6
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),0.43736016821404894,0.7674277234692997,0.8108108108108109,0.9961433514874016,1.0,3/8,16.67%,LRP6;PHACTR4;NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.394012560230075,-0.7673653755694335,0.7213114754098361,1.0,1.0,2/18,9.78%,DAB2;THBS1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.394012560230075,-0.7673653755694335,0.7213114754098361,1.0,1.0,2/18,9.78%,DAB2;THBS1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),0.2615321962787368,0.7672084951574725,1.0,0.9960957487835934,1.0,45/215,16.76%,TSKU;BCL2;IRS1;KLK14;KCTD21;PID1;CX3CR1;PLIN5;ADAMTS12;ERBB2;TULP3;CXXC4;CRY1;SNCA;DACT3;DCC;NKD1;CHAC1;RGS14;WWOX;WWP2;FSTL3;NR4A2;BEND6;SNAI2;PHACTR4;RPGRIP1L;KANK1;NLGN4X;DLK2;NLRP2B;TYRO3;UBASH3B;ARRB1;TCIM;NKD2;PTPRT;GPR108;SPRY4;BRAP;PTPRE;PTCH2;PIP4K2A;NEDD4;NCK1
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.36496684453215,0.7671868320235152,0.696969696969697,0.9957440850649003,1.0,6/19,18.15%,CHSY1;ECM1;GREM1;BCOR;NOTCH1;RBPJ
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.37194233678167965,-0.7670953645745789,0.8769230769230769,1.0,1.0,3/26,9.78%,TGFB1;ANGPT2;THBS1
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),0.4080338022474316,0.7670797960290106,0.75,0.9955238270187137,1.0,2/8,9.51%,RORB;RPGRIP1L
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),-0.47865317848574185,-0.7669631780682737,0.7166666666666667,1.0,1.0,1/5,6.09%,STAT1
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.27434717241582596,0.7667724564193014,0.9545454545454546,0.9955956853922032,1.0,15/114,11.41%,BCL2;CDH5;RGN;TRPC3;HTR2C;SLC8A1;DRD5;SLC8A3;DRD4;F2;PML;MICU1;WBP2NL;MCU;PDZD8
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),0.4592250792182515,0.7667517810720053,0.7714285714285715,0.9952327237842865,1.0,2/8,5.56%,BIN1;HES1
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",-0.39570599480963986,-0.7666501067099921,0.7571428571428571,1.0,1.0,4/21,12.35%,H1-0;ENDOG;DNASE2;REXO4
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),0.46465958321247636,0.7666156125799128,0.7631578947368421,0.9946088254014629,1.0,3/7,22.58%,ZEB2;OPN3;TYRP1
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),0.46465958321247636,0.7666156125799128,0.7631578947368421,0.9946088254014629,1.0,3/7,22.58%,ZEB2;OPN3;TYRP1
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),-0.39260989260998536,-0.7661432708904302,0.8275862068965517,1.0,1.0,2/29,6.64%,CAV3;KANK3
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.3414606473799186,0.7661363594857361,0.75,0.9949307731549517,1.0,5/50,7.64%,GDAP1;TIMM29;IMMP2L;IMMP1L;MGARP
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),0.31637557127954147,0.7661258833646175,0.9,0.9945626989660205,1.0,12/64,16.39%,RHOBTB3;RHOBTB1;CRK;EPHA3;ABL1;EFNA5;MLST8;RND3;CCDC88A;ARHGAP35;FSCN1;CORO2B
prerank,GO_Biological_Process_2021__response to fructose (GO:0009750),-0.4917235656317417,-0.7659018910997986,0.7857142857142857,1.0,1.0,2/5,31.93%,GCKR;SLC26A6
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),0.40792322704916856,0.765850841448761,0.8409090909090909,0.9945931584279978,1.0,1/11,1.79%,PC
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.36962530815678196,0.7658079160386729,0.8,0.994284922799378,1.0,1/25,1.76%,SAMSN1
prerank,PanglaoDB_Augmented_2021__Plasma Cells,0.30741739796492223,0.7656992317523569,0.9032258064516129,0.9940541400800804,1.0,5/57,4.74%,IGLL3P;CD38;HTRA2;IL16;AMPD1
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),0.332839559479544,0.7656332532040087,0.9090909090909091,0.9937582326832083,1.0,11/34,17.53%,RAB27A;SYT3;SYT17;SYT1;SYT12;RIMS2;RIMS4;SYT6;RAB5A;SYN1;RAB3D
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),0.3812190861988656,0.7654784400821893,0.75,0.9936109227161355,1.0,4/18,14.65%,SNCA;F2;F2R;ANK2
prerank,PanglaoDB_Augmented_2021__Leydig Cells,-0.3083077181777334,-0.7649626817699634,0.926829268292683,1.0,1.0,18/119,14.86%,C1QTNF1;LMOD1;TIMP3;ANGPTL2;CYP26B1;COL1A1;DCN;SLCO2A1;ADAM21;CFD;CALB2;VIT;TEK;SLC22A3;C1S;GATA4;MLANA;ADGRF5
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),0.39220957036106185,0.7649340466400792,0.6923076923076923,0.9941874642411724,1.0,1/9,11.15%,ADCY3
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.2612670282702125,0.7649156082637957,0.9130434782608695,0.9938266239210946,1.0,48/172,22.11%,DGKD;THEM4;BCL2;RORA;URI1;EPM2A;ADGRG3;PDE10A;SIRT1;ARRB2;MAGI2;DEPTOR;CGNL1;SLIT2;TWIST1;ADIPOR1;SPRED1;PPM1A;TSPAN6;TANK;CCDC22;CD22;MARK3;NF1;OTUD3;OTUD7B;ZMYND11;BANK1;DLG5;WWC1;MINAR1;NOC2L;ABCA7;TNIP3;CPNE1;PDE3B;SLA2;STAMBP;PRKAA2;CDC34;PHLPP2;HDAC7;PTPRJ;NPRL2;OTUD7A;PDE4D;PTEN;ARHGAP25
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.4412081545407655,-0.764873026441546,0.8269230769230769,1.0,1.0,1/9,2.54%,WNT5A
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),0.41492079653548236,0.7646958716354054,0.7872340425531915,0.9937683746397826,1.0,1/10,1.19%,FGF10
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),-0.3731099892224253,-0.7645206861149586,0.8260869565217391,1.0,1.0,4/26,9.71%,CCDC39;CFAP74;DRC1;RP1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),-0.3692842426531664,-0.7642592057335065,0.8648648648648649,1.0,1.0,5/28,9.78%,TGFB1;ANGPT2;SP100;DCN;THBS1
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.34390065518133417,0.7642106458111209,0.7857142857142857,0.9942967733502922,1.0,2/25,6.21%,KIAA0319;DCC
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),0.4096471527016279,0.7639060968900412,0.7631578947368421,0.9944338427079233,1.0,2/17,2.75%,CYP1A2;UGT2B15
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.3074222355032084,-0.7636976276242947,0.9154929577464789,1.0,1.0,16/72,17.28%,TBX1;PIEZO2;MARVELD2;COL1A1;EYA1;GSDME;GRXCR2;KCNQ1;COL4A3;LRP2;MYO3B;WFS1;NDUFB9;USH1C;GRXCR1;SLC26A5
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),-0.38744938897335635,-0.7636805254269625,0.7796610169491526,1.0,1.0,2/17,8.19%,TGFB1;PIK3R3
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.32254415265911396,0.7635975486203607,0.9090909090909091,0.9945589633038118,1.0,4/28,13.41%,FHIT;N4BP1;EIF3H;RYBP
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.3843399997558419,-0.7635695130739965,0.7391304347826086,1.0,1.0,2/16,11.88%,CLU;CDKN2D
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.5209125594700892,0.7634997221488944,0.8372093023255814,0.9943584789041112,1.0,3/6,29.59%,IKBKB;ROCK1;NUAK1
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),-0.37075518341042235,-0.7629747571618769,0.8285714285714286,1.0,1.0,3/27,10.40%,SCN5A;PDZK1;CD63
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),-0.4371558248477241,-0.7628380119806698,0.8208955223880597,1.0,1.0,6/12,34.07%,ENG;DLL4;COL4A1;SFRP2;NRP1;TGFBR2
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),0.40197684245287263,0.7626518346088506,0.8333333333333334,0.9953827611794808,1.0,1/14,1.59%,LLGL1
prerank,GO_Biological_Process_2021__negative regulation of cardiocyte differentiation (GO:1905208),-0.4604586115387893,-0.7625614001336587,0.7142857142857143,1.0,1.0,1/6,14.16%,HEY2
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),0.34486643314265886,0.762410770945252,0.8333333333333334,0.9953536076160507,1.0,12/30,27.48%,TCOF1;PCIF1;NANOS3;GEMIN5;PUM3;SAMD8;GRM5;EIF4E;PRKCD;FOXO3;ATXN2;ROCK1
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",-0.4750132754898711,-0.7622164531519321,0.8333333333333334,1.0,1.0,2/7,14.17%,C4BPA;C4BPB
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),-0.4750132754898711,-0.7622164531519321,0.8333333333333334,1.0,1.0,2/7,14.17%,C4BPA;C4BPB
prerank,"GO_Biological_Process_2021__negative regulation of complement activation, classical pathway (GO:0045959)",-0.4750132754898711,-0.7622164531519321,0.8333333333333334,1.0,1.0,2/7,14.17%,C4BPA;C4BPB
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),0.44856534464115433,0.7618218045833789,0.717948717948718,0.9959156124291243,1.0,5/10,28.15%,PSMG2;PSMD4;PSMD5;PSMD10;PSMD13
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),-0.31904286443450486,-0.7617561099557931,0.8961038961038961,1.0,1.0,15/96,18.22%,KIF14;WNT5A;CARD14;PINK1;SLC11A1;STRADB;TNFRSF10A;STRADA;TOM1L1;ADCY7;IL18;BORA;ECT2;PRRC1;NTRK3
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.3628975196570383,-0.761691552531754,0.8059701492537313,1.0,1.0,5/40,16.58%,NARS1;DARS2;WARS1;YARS2;TARS3
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.4375703770574878,0.761357164738412,0.76,0.9962585427691577,1.0,2/8,9.93%,RAB27A;GRIN1
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),0.45739656901965553,0.7606752188073712,0.825,0.9968492874353393,1.0,1/9,13.60%,LRP8
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.33721669684600336,0.7604382499434075,0.7407407407407407,0.9968786501435729,1.0,11/23,35.47%,TRAK2;BICDL1;KIF3B;TRAK1;NDE1;BICDL2;CLN3;FYCO1;KIF13A;FBXW11;KIF1C
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.4501535134465645,0.7602722501554805,0.7272727272727273,0.9967368286534131,1.0,1/5,4.33%,PPARG
prerank,GO_Biological_Process_2021__urea cycle (GO:0000050),-0.48398777365217904,-0.7601075114188194,0.8135593220338984,1.0,1.0,1/7,11.64%,ARG2
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.33431734506642075,-0.7596848253314487,0.8227848101265823,1.0,1.0,2/49,2.28%,TGFB1;ITGB2
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),-0.48348175583650266,-0.7595828179439441,0.8070175438596491,1.0,1.0,1/6,15.72%,RBX1
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),-0.40565123605254755,-0.7595739059392749,0.7164179104477612,1.0,1.0,1/13,5.98%,EIF6
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.4214635961136118,-0.759572748529042,0.8064516129032258,1.0,1.0,4/14,14.43%,GPER1;SOD2;CDKN1A;TGFB3
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),-0.4001718856103249,-0.7595065426161667,0.8028169014084507,1.0,1.0,1/16,4.98%,ACTL6A
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),0.4628781307652464,0.7594636719385548,0.7321428571428571,0.9969253181254807,1.0,1/7,11.03%,EEFSEC
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),0.4628781307652464,0.7594636719385548,0.7321428571428571,0.9969253181254807,1.0,1/7,11.03%,EEFSEC
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),0.46356000991302776,0.7594150038716256,0.7317073170731707,0.9966185790032548,1.0,1/7,10.72%,COL16A1
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.3913067722439536,0.7591137601558481,0.8529411764705882,0.9966833318387636,1.0,5/17,16.80%,URI1;AKR1C3;MGARP;NR3C1;UBE2L3
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),-0.3792723962572788,-0.7590796152453576,0.8088235294117647,1.0,1.0,1/23,0.22%,NOTUM
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),-0.405510330749287,-0.7585700925450654,0.8181818181818182,1.0,1.0,4/18,17.25%,ANXA1;REST;HSD3B1;ZFP36L1
prerank,MSigDB_Hallmark_2020__Protein Secretion,0.28188109663661454,0.758459663900728,1.0,0.9974254528790173,1.0,21/91,23.02%,GLA;GBF1;GOLGA4;ABCA1;RPS6KA3;BET1;DST;SEC22B;CTSC;DOP1A;RAB5A;ARFIP1;MON2;PAM;ADAM10;SSPN;GNAS;COG2;TSG101;SEC31A;VPS45
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),0.3932979170772809,0.7584494656428655,0.7674418604651163,0.9970599945929718,1.0,2/7,27.54%,XPO1;RRS1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),-0.4039282519041742,-0.7584063706730991,0.8,1.0,1.0,4/18,7.95%,PKD2L2;CAV3;PIEZO2;CSRP3
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.4400327446017358,-0.7582268838084605,0.7678571428571429,1.0,1.0,3/12,20.26%,PLA2G10;PLA2G4A;PLA2G4D
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.5101589142316769,-0.758107576267051,0.8,1.0,1.0,2/5,26.06%,UFL1;DDRGK1
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.5101589142316769,-0.758107576267051,0.8,1.0,1.0,2/5,26.06%,UFL1;DDRGK1
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.5101589142316769,-0.758107576267051,0.8,1.0,1.0,2/5,26.06%,UFL1;DDRGK1
prerank,GO_Biological_Process_2021__telencephalon cell migration (GO:0022029),0.45267544925964964,0.7580596530143761,0.7818181818181819,0.9972716497179619,1.0,1/6,4.55%,PEX13
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),-0.346588629733584,-0.7580059372974821,0.8208955223880597,1.0,1.0,3/44,7.99%,TBX1;CAV3;NEB
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),0.4684470243859561,0.757926024108296,0.7804878048780488,0.997059512697783,1.0,3/5,40.91%,DCAF1;PKN1;PRKCA
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.3461226360727989,0.7577262200212014,0.7428571428571429,0.9970181021007108,1.0,12/33,22.90%,UTRN;OSR1;WNK2;FGF12;FGF14;WNK3;NEDD4;NETO1;SLMAP;PRKCE;DMD;WNK1
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.4006255901626576,0.7575635189658343,0.7755102040816326,0.9969179324703628,1.0,1/11,1.19%,FGF10
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),0.28592775506078966,0.7574684155322191,0.8620689655172413,0.9967473187438237,1.0,6/32,22.95%,STX5;EMC2;EMC4;UBE2J2;BAG6;EMC8
prerank,MSigDB_Hallmark_2020__Apical Junction,-0.2961891734195974,-0.7571744978112986,0.9651162790697675,1.0,1.0,26/180,18.30%,NRAP;ACTC1;MMP9;CTNNA1;TGFBI;CLDN6;TSPAN4;CLDN5;ACTG1;PIK3R3;ITGA9;ACTN3;PTPRC;VWF;LAMC2;CALB2;NEXN;PIK3CB;CLDN18;RRAS;ALOX15B;RAC2;VASP;MSN;MYL9;LDLRAP1
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),-0.36805237288207204,-0.7571399495803743,0.7941176470588235,1.0,1.0,1/23,2.89%,CCDC39
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),0.34796054845694346,0.7567927854144637,0.8571428571428571,0.9973875261397641,1.0,3/16,11.91%,ABL1;COL16A1;LIMS1
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.3616047369412318,0.7566296319311085,0.7857142857142857,0.9972638406313117,1.0,10/15,25.35%,TGFBR1;LRP6;OSBPL7;SMAD2;GPLD1;PTCH1;MLC1;ABCA2;GRAMD1B;GRAMD1A
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.33100722952476697,-0.7564185116862217,0.8701298701298701,1.0,1.0,19/70,30.31%,RPA3;UVSSA;COPS5;RBX1;POLD4;COPS4;RPS27A;RPA2;XRCC1;POLR2B;DDB1;COPS7A;CDK7;PRPF19;PCNA;TCEA1;UBB;COPS7B;ERCC4
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),-0.3209584987500555,-0.7563418066396419,0.8831168831168831,1.0,1.0,4/67,8.88%,HK2;RAB11A;PINK1;RANBP6
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),-0.429620991988671,-0.7562229700041825,0.7910447761194029,1.0,1.0,3/12,17.25%,PTPRC;GLI3;ZFP36L1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),-0.28865825832475095,-0.7561297603100974,0.9186046511627907,1.0,1.0,3/150,1.49%,NEK2;PSMB9;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.299912004124492,0.7560445434791072,0.8846153846153846,0.9977272498186136,1.0,10/55,17.20%,PCM1;APBB3;TENM1;CEP290;B3GAT3;UNC13B;PLK3;ACHE;FRMD4A;ICE1
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.33997799241401394,0.7559506196203618,0.7941176470588235,0.9974627035260908,1.0,11/27,25.60%,TET2;SETMAR;DPY30;MEN1;CXXC1;KMT2C;DYDC1;TET3;KMT2B;WDR5B;KMT2A
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),-0.35767934148760194,-0.755581796114625,0.8363636363636363,1.0,1.0,4/17,15.08%,PDZK1;SLC22A3;SLC22A4;SLC25A19
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.3174847100184467,-0.7555103714070771,0.8421052631578947,1.0,1.0,7/95,8.81%,TBX1;SCN5A;NODAL;WNT5A;CLDN1;FLT4;HTR2B
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),-0.42061527338237137,-0.7554004523166682,0.7692307692307693,1.0,1.0,1/10,10.62%,ALAS2
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.3414723618292147,-0.75536294431974,0.835820895522388,1.0,1.0,3/48,5.61%,ARIH2;HSPA1L;PINK1
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.43869602832802823,-0.7551892481312558,0.8245614035087719,1.0,1.0,2/10,10.28%,BLK;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of fibroblast growth factor receptor signaling pathway (GO:0045743),-0.5016594000253889,-0.7551568908773967,0.8076923076923077,1.0,1.0,3/5,35.10%,PRKD2;SMOC2;NPTN
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),0.29723163522200946,0.7550882479375051,0.9736842105263158,0.9982834662613621,1.0,8/44,19.39%,RIPK2;ITGA4;GRIN1;TIMELESS;ABCC1;TP53;GRM5;CDK5
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.3730707625284201,-0.7549298184087149,0.7746478873239436,1.0,1.0,5/24,22.81%,RPA3;POLD4;RPS27A;RPA2;XRCC1
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),0.339558557299525,0.7548367439069101,0.9142857142857143,0.9983003404603515,1.0,4/20,13.88%,SMARCB1;PIH1D1;ARRB1;RPS6KA4
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.3226156180861627,-0.754712625100117,0.8611111111111112,1.0,1.0,7/46,16.13%,WNT5A;SCIMP;CYBA;TLR2;C1QTNF4;NOS2;F2RL1
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),0.31583557641469606,0.7543398044157719,0.896551724137931,0.9986336885538645,1.0,9/51,14.37%,APOE;SIRT1;AKR1C3;PKD2;FER;MAPK8;PXN;PLK3;GPX1
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),-0.3922321762622376,-0.7542009207423737,0.7936507936507936,1.0,1.0,3/18,11.76%,SVIL;SCIN;VIL1
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),-0.3922321762622376,-0.7542009207423737,0.7936507936507936,1.0,1.0,3/18,11.76%,SVIL;SCIN;VIL1
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),0.40905752485002367,0.7540915493962094,0.7272727272727273,0.9985683934098991,1.0,4/17,5.09%,IRGM;HTRA2;IFI16;PYHIN1
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),0.31660059435499194,0.7540278191270768,0.8888888888888888,0.9982688959834287,1.0,6/33,11.24%,GLA;APOE;DDAH2;DHFR;NUS1;DDAH1
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.3791543709336709,-0.7537311130071781,0.8472222222222222,1.0,1.0,5/28,21.48%,ART1;ART3;PARP4;ART4;PARP10
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),0.33654419533582236,0.7537074076055815,0.8378378378378378,0.9983559982924834,1.0,3/26,9.01%,ERBB2;STAT5B;SNAI2
prerank,GO_Biological_Process_2021__dorsal aorta development (GO:0035907),-0.5104673596892794,-0.7534442176877991,0.8,1.0,1.0,2/6,14.16%,ENG;HEY2
prerank,GO_Biological_Process_2021__dorsal aorta morphogenesis (GO:0035912),-0.5104673596892794,-0.7534442176877991,0.8,1.0,1.0,2/6,14.16%,ENG;HEY2
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),-0.36808458155456053,-0.7531311806961944,0.8484848484848485,1.0,1.0,1/21,2.13%,STAC
prerank,GO_Biological_Process_2021__negative regulation of cholesterol transport (GO:0032375),-0.4768166552528313,-0.7530922546769944,0.7796610169491526,1.0,1.0,1/7,6.32%,PLA2G10
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),0.2907174176161887,0.7530728167488515,0.9655172413793104,0.998934582908519,1.0,12/51,20.51%,ADAMTS12;SNCA;LGALS9;TANK;NFKB1;HDAC4;GBP2;PTGIS;RC3H1;IGBP1;TRAF6;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.32121425403909165,-0.7529552776323472,0.8787878787878788,1.0,1.0,9/53,13.20%,WNT5A;OAS2;CLU;THBS1;CYBA;PTPRC;OAS1;TLR2;C1QTNF4
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.39629666632891647,0.7529197992833506,0.7567567567567568,0.9987464325328852,1.0,4/13,17.89%,BRCC3;LIG4;ATM;NIPBL
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.35756040137253775,0.752594408559136,0.8461538461538461,0.9989092629522278,1.0,4/20,18.00%,BICD1;PRRC2C;YTHDF1;LSM14A
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.2932859076965965,0.7522592407796075,0.9615384615384616,0.9990661223058703,1.0,21/114,19.34%,NLGN1;PARD3;ZDHHC11B;GDAP1;MGARP;ZDHHC18;TRAK2;ZDHHC12;MAN1A1;GOLGA7B;LTBP2;MYO1C;ZDHHC14;RASSF9;ZDHHC3;AP4S1;ZFAND6;AP4B1;ZDHHC9;EDEM1;ZDHHC11
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),-0.43622236341282683,-0.7522367083139585,0.8059701492537313,1.0,1.0,4/9,21.32%,PBLD;MUC4;STRAP;SOX9
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),-0.4352092501668161,-0.7517899815619258,0.8412698412698413,1.0,1.0,1/11,2.96%,TERF2IP
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.4137909796004752,0.7516973645022623,0.6756756756756757,0.9994565692585368,1.0,2/9,11.53%,HNMT;ODC1
prerank,GO_Biological_Process_2021__negative regulation of plasminogen activation (GO:0010757),-0.4961054583079283,-0.7516361176671719,0.8431372549019608,1.0,1.0,2/5,10.87%,THBS1;CTSZ
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.36234610781688426,-0.7515369352376537,0.7941176470588235,1.0,1.0,3/25,13.35%,TERF2IP;PIF1;GNL3
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),0.404798461517526,0.7515117905092341,0.7941176470588235,0.9992860294905418,1.0,5/9,25.76%,PROX1;NF1;PTCH1;BMP4;SHH
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),-0.3388352232810603,-0.7512730401985677,0.8787878787878788,1.0,1.0,10/32,20.84%,AIM2;WNT5A;NLRP12;USP50;NLRC4;NLRP3;F2RL1;CARD8;CASP8;AGER
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),-0.371927524767928,-0.7512184600895973,0.8194444444444444,1.0,1.0,3/26,10.28%,CLCF1;C17ORF99;PTPRC
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),0.421874294297026,0.7511045759945866,0.8372093023255814,0.9994834286231684,1.0,4/10,17.33%,NT5C1A;UPP2;NT5C3A;MACROD2
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.3388665751567837,0.7507341083014845,0.8888888888888888,0.9997740503424086,1.0,5/25,17.75%,CFLAR;SERPINE1;FADD;GPX1;FAIM
prerank,GO_Biological_Process_2021__epithelial tube formation (GO:0072175),0.4886932728300599,0.7506906295306722,0.8222222222222222,0.9994635769165576,1.0,1/5,9.82%,CEP290
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544),0.4357008425418506,0.7506726990269355,0.8695652173913043,0.9991066917996811,1.0,2/5,8.49%,FGFR1;FGF18
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),0.4237366949833302,0.7505178700667221,0.8297872340425532,0.9989424455367685,1.0,4/11,13.00%,FLNA;GAS2L3;GAS2;EPS8
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.33297495267399524,-0.750275798166356,0.8787878787878788,1.0,1.0,8/50,10.45%,NODAL;AIM2;CIDEB;GPER1;UACA;USP50;REST;NLRC4
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),0.3926427242681055,0.7494579092925399,0.6923076923076923,1.0,1.0,3/9,15.56%,TICAM1;PIBF1;IL23A
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.3118821974492152,0.749407086860317,0.8571428571428571,0.9997617975498747,1.0,15/65,18.84%,SIRT1;MMP2;OPN5;TIMP1;ZBTB1;MYC;RHBDD1;N4BP1;TP53;NEDD4;OPN3;NOC2L;ATR;IMPACT;EP300
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),-0.320039235012466,-0.7493684560140884,0.8961038961038961,1.0,1.0,1/58,0.35%,F8
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),-0.320039235012466,-0.7493684560140884,0.8961038961038961,1.0,1.0,1/58,0.35%,F8
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.320039235012466,-0.7493684560140884,0.8961038961038961,1.0,1.0,1/58,0.35%,F8
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),-0.3340890178933057,-0.7491635619490362,0.8918918918918919,1.0,1.0,10/66,18.53%,ARHGAP9;VAV3;ARHGAP15;PPP1R17;ARHGAP12;ATP5IF1;PROM2;EPHA1;CAMK2A;PLXNA3
prerank,GO_Biological_Process_2021__translocation of molecules into host (GO:0044417),0.42843578380768166,0.7487246698558058,0.8571428571428571,0.9999513043781572,1.0,2/7,33.91%,THOC1;ALYREF
prerank,GO_Biological_Process_2021__viral mRNA export from host cell nucleus (GO:0046784),0.42843578380768166,0.7487246698558058,0.8571428571428571,0.9999513043781572,1.0,2/7,33.91%,THOC1;ALYREF
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),-0.33064205593023394,-0.7485464995624365,0.9014084507042254,1.0,1.0,8/50,16.30%,DTL;PCLAF;UVSSA;GPR88;SLC24A1;CDKN2D;ELANE;RRH
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),0.3784602841409794,0.748484084531948,0.775,0.9998626825634049,1.0,2/9,10.79%,SIRT1;ABI3
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.26619707618104826,0.7484203849822119,1.0,0.9996054732253691,1.0,21/112,18.84%,MAPKAPK2;NUP210;NUP42;SIRT1;ATF3;VASH1;ABL1;MLST8;DYRK3;AAAS;HSPA1A;PNPT1;AIFM2;HSF1;USP51;CORO2B;SMG1;ATM;RANBP2;ATR;EP300
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),-0.36823989526034995,-0.7480848665375559,0.8088235294117647,1.0,1.0,2/29,11.86%,PLPP6;ACAA2
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated protein folding (GO:1903644),-0.4819891439031054,-0.7478574123901254,0.7894736842105263,1.0,1.0,2/5,22.91%,SGTB;PDCD5
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),0.3652900565335323,0.7477404761010051,0.8571428571428571,0.9999749570664072,1.0,5/14,13.07%,SMARCD3;SMARCB1;ARID1A;SMARCA4;ARID2
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),0.3652900565335323,0.7477404761010051,0.8571428571428571,0.9999749570664072,1.0,5/14,13.07%,SMARCD3;SMARCB1;ARID1A;SMARCA4;ARID2
prerank,GO_Biological_Process_2021__cellular response to UV-A (GO:0071492),0.43435825048637944,0.74738743161769,0.7346938775510204,1.0,1.0,3/8,6.75%,MMP2;OPN5;TIMP1
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),-0.38437846636908257,-0.7473225923935741,0.8208955223880597,1.0,1.0,6/19,21.90%,ABCG2;ALAS2;ATP5IF1;UROS;PGRMC1;ALB
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),0.331890056045254,0.7472375907371961,0.9032258064516129,0.9999141714946196,1.0,5/52,7.64%,BCL2;GDAP1;FLVCR1;SLC25A24;MGARP
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.393513657645818,-0.7471953262837668,0.8307692307692308,1.0,1.0,3/20,16.68%,ATXN7L3;UBE2U;RNF20
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.36827720568297956,0.7470695057328186,0.8461538461538461,0.9997909411649055,1.0,8/19,24.20%,HEXIM2;LATS1;NR2F2;MEN1;PTEN;TFAP4;PLK1;IPO7
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),-0.5051651468570136,-0.746788906171706,0.7868852459016393,1.0,1.0,2/5,10.89%,TAF7;SPI1
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.3536932396214123,0.7466812287592751,0.9117647058823529,0.9999927347264594,1.0,2/19,3.99%,SLC12A1;SLC8A1
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),-0.4966381177443569,-0.7466455506606454,0.7547169811320755,1.0,1.0,2/6,17.64%,SLC25A18;SLC25A22
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),-0.3226659600611411,-0.746491983202482,0.8641975308641975,1.0,1.0,3/46,8.55%,RAB34;HHIP;GPC3
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.28030927742315237,0.7463548749305122,0.9230769230769231,1.0,1.0,10/63,14.12%,NGF;BCL2;BCL2A1;DCC;CASP3;FGFR3;FADD;CRADD;CASP8AP2;BID
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),0.4027840888851164,0.7463176064812292,0.7777777777777778,0.999740699817281,1.0,1/7,12.15%,MRRF
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),-0.4050627990322852,-0.7461496351155316,0.7377049180327869,1.0,1.0,2/11,7.97%,TRIM5;CHMP3
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),-0.3754052087133787,-0.7453668986137187,0.828125,1.0,1.0,6/21,21.90%,ABCG2;ALAS2;ATP5IF1;UROS;PGRMC1;ALB
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),-0.5085434842772447,-0.7453395221244711,0.8545454545454545,1.0,1.0,2/6,6.09%,TGFB1;STAT1
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),-0.5085434842772447,-0.7453395221244711,0.8545454545454545,1.0,1.0,2/6,6.09%,TGFB1;STAT1
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),0.3544994931866355,0.7452557905424104,0.8421052631578947,1.0,1.0,1/24,0.59%,CYP1A2
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),0.3454994844173314,0.7452418052670378,0.8484848484848485,1.0,1.0,3/19,10.27%,SLC8A3;MICU1;MCU
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),-0.3634821366759047,-0.7451653371607596,0.8133333333333334,1.0,1.0,6/19,21.27%,CSRP3;POPDC2;SVIL;MYL6;BASP1;SIX4
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),0.3942759198764293,0.7450627323770292,0.7560975609756098,1.0,1.0,3/13,7.31%,FGF10;NRG1;SGK1
prerank,PanglaoDB_Augmented_2021__Melanocytes,-0.3066917640553055,-0.7448402825744249,0.9305555555555556,1.0,1.0,10/121,6.32%,AHR;TIMP3;FLG;ANGPTL2;CCND1;SYNC;FILIP1L;COL1A1;LOX;UACA
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.30385088257015624,0.7447259134732956,0.8823529411764706,1.0,1.0,7/34,19.41%,SLC19A1;SLC6A20;SLC7A8;IL10RA;LRSAM1;SLC16A2;SLC1A3
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.39086403723196017,-0.7446645416466219,0.7741935483870968,1.0,1.0,2/10,16.77%,ESR1;THRA
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),0.4115726586480835,0.7446338204575297,0.7333333333333333,1.0,1.0,4/9,26.76%,DXO;EXOSC5;EXOSC9;XRN1
prerank,GO_Biological_Process_2021__positive regulation of protein maturation (GO:1903319),-0.42645474570252606,-0.744622651545143,0.765625,1.0,1.0,2/10,10.45%,TNP1;NLRC4
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.31932905158065666,0.7444650989101325,0.8666666666666667,1.0,1.0,12/41,20.45%,DGKD;PLD6;PNPLA3;GPD1;AGPAT5;DGKH;AGPAT2;LCLAT1;ABHD4;PLA2G5;DGKZ;PLD2
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),-0.34195081412958417,-0.7444397523804319,0.8571428571428571,1.0,1.0,2/35,9.60%,TGFB1;PLG
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),-0.45566636564325785,-0.7442797951408227,0.8846153846153846,1.0,1.0,6/11,28.50%,NLRP3;IL18;CD81;CD86;TNFSF4;RARA
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),0.45502952266360264,0.7442491809854992,0.8974358974358975,0.9999920591610755,1.0,2/6,5.38%,GLA;SNCA
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),-0.2936003064574981,-0.7442425796468628,0.9753086419753086,1.0,1.0,11/152,7.85%,PANX3;KCNJ15;SCN5A;KCNA5;PIEZO2;TAF7;SLC5A2;SLC5A1;KCNS2;ATP1A4;SLC5A9
prerank,GO_Biological_Process_2021__ethanolamine-containing compound metabolic process (GO:0042439),0.49734016308868423,0.7442383699277803,0.8695652173913043,0.9992497730107259,1.0,1/5,24.65%,NAPEPLD
prerank,GO_Biological_Process_2021__N-acylethanolamine metabolic process (GO:0070291),0.49734016308868423,0.7442383699277803,0.8695652173913043,0.9992497730107259,1.0,1/5,24.65%,NAPEPLD
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),0.43299194254252404,0.744206328512167,0.7272727272727273,0.9989137099051049,1.0,2/7,20.98%,NOP9;XPO1
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),-0.3997505286261718,-0.7438426514561329,0.7931034482758621,1.0,1.0,2/14,15.79%,USP17L2;RNF26
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.32501627289510704,0.7435132934791439,0.9487179487179487,0.9996171268996157,1.0,10/35,25.20%,NOX4;CASS4;LRP8;SRCIN1;GRM5;ACE;NCK2;ERBB3;GAS6;DLG3
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.38164966387881516,0.7433704169565074,0.8484848484848485,0.9994716316968443,1.0,5/15,14.45%,GALP;H2BC21;F2;CXCL14;MUC7
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.3518194993792273,0.7432428161539462,0.7894736842105263,0.999262788144778,1.0,7/31,13.52%,KIT;HES1;F2;OCIAD2;ADIPOR1;F2R;IL10RA
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",0.2857541929294891,0.7426921573167545,0.88,0.9997230582303744,1.0,14/53,19.29%,ELOF1;CDCA4;TAF1B;H1-10;ARID1A;SF3B1;POLR1H;MYO1C;SERTAD2;BAZ1B;ATAD2B;ARID1B;EP300;KAT2B
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",0.36725098180118754,0.7426866934574916,0.7692307692307693,0.9989656733011393,1.0,5/11,20.09%,TRIM71;TNRC6C;TNRC6A;AGO3;AGO2
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),0.36725098180118754,0.7426866934574916,0.7692307692307693,0.9989656733011393,1.0,5/11,20.09%,TRIM71;TNRC6C;TNRC6A;AGO3;AGO2
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),0.40351494088357803,0.7424956465210497,0.7777777777777778,0.9988149439616826,1.0,3/13,6.53%,CYP1A2;CYP2U1;CYP2S1
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.3329550813375825,-0.7423856543458269,0.8405797101449275,1.0,1.0,7/44,22.78%,ATP5F1E;ATP5MC3;ATP5PF;ATP5ME;ROMO1;ATP5PB;ATP5F1A
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),-0.32543609875728513,-0.7422832416339886,0.926829268292683,1.0,1.0,8/72,12.91%,TGFB1;STAC;GPER1;DAB2;RHOQ;GBP1;MRAP;PRKCH
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.2695445489818858,0.742270634693683,1.0,0.9987910066510973,1.0,28/151,16.10%,FANK1;BCL6;HIP1;PERP;DAPK2;SIRT1;DCPS;TP53AIP1;LGALS1;PPP1R13B;ACER2;SGK1;ABL1;ANP32A;ANP32B;ACER3;USP36;CRADD;LRP8;FLT3;BID;AIFM2;MARK4;MAGED1;TP53;SLK;MALT1;AMIGO2
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),0.37599739994199144,0.7422034089035975,0.8285714285714286,0.9985080742168799,1.0,2/15,5.92%,KLRD1;CADM1
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),0.4292849877990079,0.7420755679476079,0.7857142857142857,0.9983116623210916,1.0,2/7,8.03%,FOXO1;MYC
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",-0.46619873971351256,-0.7419921214197676,0.8135593220338984,1.0,1.0,1/6,1.18%,ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",-0.46619873971351256,-0.7419921214197676,0.8135593220338984,1.0,1.0,1/6,1.18%,ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",-0.46619873971351256,-0.7419921214197676,0.8135593220338984,1.0,1.0,1/6,1.18%,ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",-0.46619873971351256,-0.7419921214197676,0.8135593220338984,1.0,1.0,1/6,1.18%,ELOVL2
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),0.28395840257747107,0.741980958524611,0.9259259259259259,0.9980751398008229,1.0,12/71,20.63%,CPSF1;PCF11;U2AF1;SRRM1;CPSF7;SRSF4;PAPOLA;RPRD2;EIF4A3;U2AF2;SYMPK;CPSF6
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),-0.35783019640148234,-0.7414491258695921,0.7936507936507936,1.0,1.0,4/22,12.80%,ZACN;GLRA2;HVCN1;HAAO
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),0.24192607460535998,0.7414046203432044,1.0,0.9985344599578814,1.0,37/243,16.20%,TEAD2;LLGL1;CD247;MATN1;MITF;PARD3;TLE2;STX5;HES1;SLC7A9;TRAPPC1;SEC24C;PML;PDZD11;MYC;CNIH3;TGFA;FARP2;WASF3;MCU;BET1;COL16A1;GEMIN5;SMARCA4;BCL9L;FADD;HDAC1;PREB;SNX9;MAGI1;MEN1;HSF1;TP53;SEC22B;IL2RB;PARD6B;CTSC
prerank,GO_Biological_Process_2021__negative regulation of T cell apoptotic process (GO:0070233),0.46317103148870975,0.7413383336054551,0.7659574468085106,0.9982290676336646,1.0,2/5,21.65%,FADD;BMP4
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.3095992095166926,-0.7412667101543321,0.8271604938271605,1.0,1.0,8/82,13.40%,TGFB1;TERF2IP;ACTN3;CDKN2D;WARS1;CDKN1A;DYNLL1;ATG14
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",0.3953523154964066,0.7410873886703327,0.8444444444444444,0.998262856928421,1.0,2/14,9.29%,PUF60;CELF4
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),-0.30570468209718094,-0.7410274590446104,0.8974358974358975,1.0,1.0,5/85,6.08%,DTL;CCND1;PCLAF;CDC25A;UVSSA
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),0.26559714711012045,0.7409894459357893,1.0,0.9980152274061532,1.0,23/108,23.08%,TCIRG1;HDAC10;MTERF3;VPS16;TMEM74;PLEKHM1;MVB12A;CHMP6;KLHL3;VTA1;MTMR3;SNF8;PIP4K2A;MTMR14;STAM2;VAMP8;PRKAA2;PRKAG2;TBC1D5;PIK3R4;TSG101;LIX1L;ATG12
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.43729738912907135,-0.7408147402437595,0.875,1.0,1.0,1/9,8.67%,ACTN3
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),-0.43729738912907135,-0.7408147402437595,0.875,1.0,1.0,1/9,8.67%,ACTN3
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),-0.45902401097449136,-0.7407330804522658,0.8983050847457628,1.0,1.0,1/8,2.54%,WNT5A
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),0.4446792771852154,0.7405939724462933,0.7592592592592593,0.99829591523392,1.0,2/6,6.42%,TRPM2;HMGB1
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),0.3927983776187094,0.7405149363612508,0.8611111111111112,0.9980771531423107,1.0,2/14,10.59%,KPTN;RNF128
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),0.39582445982079695,0.7404408956465554,0.775,0.9978298764286877,1.0,2/8,18.84%,NSD1;EP300
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),0.2845325570697165,0.7401490941121884,0.975609756097561,0.9978236152227523,1.0,6/58,9.14%,HDAC3;PYHIN1;F2;EIF2AK3;FLNA;HCLS1
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.43067101591204576,0.7400626588816639,0.717948717948718,0.9971693873681481,1.0,3/7,28.89%,AGO2;STAT3;TNRC6B
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),0.43067101591204576,0.7400626588816639,0.717948717948718,0.9971693873681481,1.0,3/7,28.89%,AGO2;STAT3;TNRC6B
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),-0.4584553730487215,-0.7398990590477159,0.8059701492537313,1.0,1.0,2/8,10.43%,OGN;OMD
prerank,GO_Biological_Process_2021__skeletal myofibril assembly (GO:0014866),-0.4437922554361252,-0.7398718018131263,0.8,1.0,1.0,3/8,14.24%,ACTC1;LMOD3;TTN
prerank,GO_Biological_Process_2021__purine ribonucleoside metabolic process (GO:0046128),-0.49262085728870814,-0.7396933816685495,0.875,1.0,1.0,3/5,16.50%,ENPP4;ACP3;GNMT
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.3253947857850023,0.7396158552393558,0.9444444444444444,0.9974153923817585,1.0,11/29,21.65%,CREB3L2;OSR1;EIF2AK3;FGFR3;NFIB;SOX5;RUNX1;GPLD1;SULF2;BMPR2;BMP4
prerank,GO_Biological_Process_2021__serine family amino acid catabolic process (GO:0009071),-0.45193880589110214,-0.7396060038035549,0.8666666666666667,1.0,1.0,3/8,14.01%,DAO;GLDC;SDS
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),-0.38201664625157605,-0.739507344256474,0.7666666666666667,1.0,1.0,4/18,15.68%,FHOD1;RHOQ;LCP1;FMNL1
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),-0.4748184928411772,-0.7393482432836203,0.9019607843137255,1.0,1.0,1/7,14.99%,DDX3X
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),-0.44652656248206024,-0.7393279736567888,0.84375,1.0,1.0,1/12,4.14%,RORC
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),-0.3486670713894681,-0.7393230867331951,0.835820895522388,1.0,1.0,6/30,17.19%,P2RY12;PARVG;RHOQ;SCIN;RAC2;RAC1
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),-0.4303318862261316,-0.7390078188215241,0.8208955223880597,1.0,1.0,3/10,14.94%,GLDC;SDS;SDSL
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.43174936926435276,-0.7388929899503922,0.8275862068965517,1.0,1.0,1/14,8.95%,CLU
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),0.3206491119752117,0.7388491879267751,0.926829268292683,0.9980677067326315,1.0,9/26,15.44%,MLF1;KIT;PRRC2C;FSTL3;ARMC6;SP7;FLT3;MLLT3;TP53
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),0.37305286911463936,0.7385177115255592,0.7804878048780488,0.9981243216056336,1.0,6/14,31.42%,PDE9A;NR4A3;EDN1;ROCK1;MEF2A;SLC9A1
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),-0.42693643341949417,-0.73846646308648,0.8070175438596491,1.0,1.0,2/9,27.25%,CELSR1;SHROOM3
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.3290673611094529,-0.7384561852891065,0.8450704225352113,1.0,1.0,2/59,3.67%,GML;CCND1
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),-0.35106595943657704,-0.7381432487801788,0.875,1.0,1.0,4/30,9.50%,PINK1;ACTN3;GAPDHS;PRXL2C
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),0.470926940724893,0.7380436392932257,0.7894736842105263,0.9983410803295124,1.0,2/6,27.08%,SLC4A11;STK39
prerank,GO_Biological_Process_2021__cell differentiation involved in metanephros development (GO:0072202),0.44003080296487024,0.7380418595273497,0.7804878048780488,0.9979686396179727,1.0,2/7,6.85%,WNT4;OSR1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.3775438403319542,-0.7377595094783411,0.84375,1.0,1.0,1/31,0.77%,POLQ
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),0.31987905158151403,0.7376885472867242,0.8181818181818182,0.9981452767786131,1.0,3/38,4.33%,CCN4;CDH13;PPARG
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),0.4073150933934799,0.7375414771993105,0.8409090909090909,0.9979046246847344,1.0,4/11,17.99%,PIH1D1;ACD;NIPBL;MACROH2A2
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),0.43413175313917635,0.7375045931111234,0.8125,0.9975784702360386,1.0,3/11,7.10%,SIRT1;DNMT1;ZNF274
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),-0.3057131730383248,-0.7371661321666003,0.9285714285714286,1.0,1.0,9/77,9.89%,SCN5A;SLC5A2;SLC5A1;ATP1A4;ASIC5;SLC5A9;SLC24A1;SLC6A12;SLC5A4
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),-0.42770252398157416,-0.7370465550883333,0.7678571428571429,1.0,1.0,1/6,15.75%,CD4
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),-0.42770252398157416,-0.7370465550883333,0.7678571428571429,1.0,1.0,1/6,15.75%,CD4
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),-0.4839565487799995,-0.736824393641899,0.8235294117647058,1.0,1.0,2/5,24.71%,CD4;NPR2
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),-0.4839565487799995,-0.736824393641899,0.8235294117647058,1.0,1.0,2/5,24.71%,CD4;NPR2
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.4082589298395004,-0.7366589275635054,0.8305084745762712,1.0,1.0,4/9,31.83%,RPS27A;ISG15;UBB;UBC
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.32659722797191504,-0.7365384647511326,0.8615384615384616,1.0,1.0,4/42,6.85%,MMP9;BCL2L2;PINK1;GSDME
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.44726261469198497,-0.7364124996855318,0.7755102040816326,1.0,1.0,1/8,8.95%,CLU
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),-0.3989962251674889,-0.7362371416432117,0.8148148148148148,1.0,1.0,1/15,2.12%,ABCC6
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),0.4274496765973468,0.7361563940519337,0.8421052631578947,0.9990798062962609,1.0,4/12,5.09%,IRGM;HTRA2;IFI16;PYHIN1
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.36378267685125826,0.7358756500657018,0.7906976744186046,0.9990673929552554,1.0,7/16,32.18%,GDF6;SOX5;BMPR2;BMP4;BMP2;ZBTB16;BMPR1B
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),-0.3112436619587137,-0.7356975334775834,0.9041095890410958,1.0,1.0,1/65,0.35%,F8
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),0.39486803181539976,0.7356774550097672,0.8372093023255814,0.9989522842223822,1.0,3/9,15.44%,TERF1;MEN1;TP53
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),-0.344704163619793,-0.7354665284172992,0.8205128205128205,1.0,1.0,6/23,21.27%,CSRP3;POPDC2;SVIL;MYL6;SGCG;SIX4
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),0.4905104074296658,0.7354080148892489,0.84,0.9989570394323212,1.0,3/5,28.70%,PLSCR1;TPR;NUMA1
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),-0.40780218974931604,-0.7352284248700601,0.8490566037735849,1.0,1.0,4/16,19.81%,WNT5A;CYBA;RAC1;NOX1
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.3209527675667336,-0.735174011995314,0.9154929577464789,1.0,1.0,3/49,4.30%,TERF2IP;SP100;RPA3
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),0.3200433296932569,0.7351465880319739,0.8275862068965517,0.9988591638477043,1.0,3/27,8.10%,SIRT1;CEP120;ALMS1
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),0.343088073265546,0.7348359746172692,0.8571428571428571,0.9988981467741938,1.0,3/19,11.72%,HTRA2;FZD5;USP36
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),0.30329504746687785,0.7346996889892602,0.9285714285714286,0.9987263035743268,1.0,14/59,25.46%,RAB7A;KPNA6;PKN2;TYRO3;MDFIC;GTF2F2;TARBP2;RSF1;LARP1;PPIH;ADAR;POLR2F;SRPK2;PABPC1
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),0.3461175781388712,0.7345395666224497,0.8604651162790697,0.9986115406102374,1.0,4/17,24.64%,SMPD4;PLA2G4C;ABHD12;PNPLA6
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),-0.38937943836660205,-0.7343908613677852,0.875,1.0,1.0,1/17,2.41%,GAD1
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),-0.4305693543148844,-0.7342817123898632,0.8,1.0,1.0,2/11,11.76%,SCIN;VIL1
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),-0.48080555272786807,-0.7342343337250656,0.8301886792452831,1.0,1.0,1/6,12.91%,PRKCH
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),-0.401808559069992,-0.7340531881176576,0.8421052631578947,1.0,1.0,1/14,2.12%,ABCC6
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),0.42462372129772746,0.7340382262087484,0.8604651162790697,0.9988839821909152,1.0,5/9,29.73%,FURIN;HM13;PCSK5;SPPL3;SEC11A
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.3706457953904791,-0.7339024021144082,0.8378378378378378,1.0,1.0,6/22,15.61%,SLC14A1;ABCG2;UPK3A;SLC14A2;ABCA12;AQP11
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.43655841645427634,0.7338007749520292,0.7837837837837838,0.998843226264727,1.0,1/7,12.46%,ARHGAP21
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.355502757109941,0.7336957095849723,0.7878787878787878,0.9986147765368505,1.0,5/20,13.74%,SLC8A3;MICU1;MCU;PDZD8;RAP1GDS1
prerank,MSigDB_Hallmark_2020__Notch Signaling,-0.34624568587054355,-0.7335303772772171,0.8405797101449275,1.0,1.0,4/28,11.59%,WNT5A;CCND1;DTX2;SAP30
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),-0.3020348699108625,-0.7334503964576996,0.8961038961038961,1.0,1.0,14/83,16.59%,HK2;NODAL;WNT5A;CYP1B1;BRCA1;THBS1;TEK;GATA4;HYAL1;RRAS;EPHA1;GRN;HIPK1;ANGPTL3
prerank,GO_Biological_Process_2021__establishment of protein localization to telomere (GO:0070200),-0.4689312986407871,-0.7334213304552085,0.7692307692307693,1.0,1.0,1/5,10.71%,TERT
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),-0.4017909818378195,-0.7333970484290658,0.8591549295774648,1.0,1.0,9/18,31.28%,AGT;ITGAX;SIX4;SOX9;WNT5B;FGF2;PAX2;EGF;PAX8
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),-0.4049020036651124,-0.733211276584509,0.8701298701298701,1.0,1.0,3/15,14.30%,PIGH;PIGC;PIGL
prerank,GO_Biological_Process_2021__regulation of prostaglandin biosynthetic process (GO:0031392),0.43188846569206363,0.7331882569754249,0.7804878048780488,0.9990461304683913,1.0,2/5,13.71%,SIRT1;PIBF1
prerank,GO_Biological_Process_2021__dopamine uptake (GO:0090494),0.47132842784899415,0.7328323919112546,0.8205128205128205,0.9991019932738293,1.0,1/6,5.38%,SNCA
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),0.27255658955631995,0.7324217760717863,0.9333333333333333,0.9993169155924774,1.0,11/50,20.34%,EXTL1;PDIA6;CTDSP2;ERN1;PREB;YIF1A;DNAJC3;CXXC1;EDEM1;ADD1;ACADVL
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),-0.3380895094625901,-0.7322724561741139,0.8703703703703703,1.0,1.0,6/27,18.70%,TGFB1;DUSP16;STRADB;STRADA;EGR2;RANBP3L
prerank,GO_Biological_Process_2021__regulation of macrophage proliferation (GO:0120040),-0.4671344963154713,-0.7322381439734723,0.7884615384615384,1.0,1.0,2/6,30.71%,CSF1R;MAPK3
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle contraction (GO:0045987),-0.4633088216175503,-0.7319445086878933,0.8135593220338984,1.0,1.0,1/7,5.18%,GPER1
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,-0.2984085967944976,-0.7319069680994642,0.9459459459459459,1.0,1.0,7/103,6.82%,LMOD1;TIMP3;ANGPTL2;TSPAN11;FBXL7;VTN;DCN
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.32486319162196564,-0.7318170807692563,0.9428571428571428,1.0,1.0,8/43,17.24%,XCR1;LPAR1;ACKR4;DEFB109B;CXCR5;LEF1;ACKR2;EGR3
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.4101408609332612,-0.7316905927164896,0.8448275862068966,1.0,1.0,3/14,18.74%,RAC1;AIF1L;CSF1R
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),0.38386851415488255,0.7316762601623858,0.8571428571428571,0.9998667997867372,1.0,3/10,17.52%,SLC27A2;ACSL1;SLC27A4
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001270),-0.4839844988113453,-0.7316129484482273,0.8392857142857143,1.0,1.0,3/5,26.21%,RFPL1;RPS3;RFFL
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),-0.3796867038427366,-0.731356076472088,0.7931034482758621,1.0,1.0,9/16,28.07%,ROS1;TMEM79;ACTA2;GRHL2;WNT5B;POF1B;EXPH5;LRTOMT;BFSP1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),0.4515666158722895,0.7313025725280874,0.723404255319149,1.0,1.0,1/6,9.14%,HCLS1
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),-0.3553599657164074,-0.7312642788768674,0.8783783783783784,1.0,1.0,6/25,24.55%,HSPA1L;HSPA8;HSPA5;OPTN;HSPA2;HSPA13
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),0.4804078657959774,0.7310961339625216,0.8125,1.0,1.0,1/5,21.97%,ABHD12
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),0.3964460149854962,0.7310255219157291,0.6739130434782609,0.9997154232821738,1.0,4/8,27.89%,EIF2AK3;QRICH1;NFE2L2;EIF2S1
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",0.321992779141572,0.7309691598421627,0.7666666666666667,0.9993909165178987,1.0,2/16,6.18%,APOE;CHRNA10
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),-0.4313729037646261,-0.7308787616299484,0.8103448275862069,1.0,1.0,2/8,17.52%,JAM2;MSN
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),-0.4314755175666862,-0.7307032897628242,0.8059701492537313,1.0,1.0,3/9,23.25%,CLU;MYRF;PRX
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.3052405196318112,-0.7305943027254133,0.9104477611940298,1.0,1.0,1/57,0.62%,PSMB9
prerank,GO_Biological_Process_2021__regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547),0.4574029419831281,0.73059330149116,0.7428571428571429,0.9993614620669881,1.0,2/5,13.75%,ADAMTS12;TSPAN12
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.34746285812492145,0.7304910575506335,0.8709677419354839,0.9991166735462745,1.0,4/14,16.05%,TIMELESS;ARID2;WRAP53;FUS
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),-0.42135402689536267,-0.7299010403218894,0.7868852459016393,1.0,1.0,2/9,10.28%,IFNK;PTPRC
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),-0.3824024124936663,-0.7294667317480817,0.8709677419354839,1.0,1.0,2/14,7.60%,HMGB3;HAT1
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),-0.4440272812491474,-0.7288538380957039,0.8,1.0,1.0,1/8,3.82%,DONSON
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.37563977292118356,-0.7288214577442084,0.8571428571428571,1.0,1.0,1/19,1.23%,ADSS1
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),0.4001755821793962,0.7287582683903904,0.7948717948717948,1.0,1.0,4/10,30.73%,RPUSD1;GAR1;NAF1;RPUSD4
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),-0.34158476159390294,-0.7283482362291409,0.9152542372881356,1.0,1.0,6/31,16.67%,ALDOB;KCNJ11;OAS1;APOD;GALM;GHRL
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),-0.3712394304167255,-0.7282812817704069,0.8688524590163934,1.0,1.0,5/26,14.67%,PDCD1LG2;SFTPD;VSIG4;HLA-DRB1;CD80
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),-0.3582324380666545,-0.7279924354863823,0.8615384615384616,1.0,1.0,4/27,17.52%,MARVELD2;TJP3;F2RL1;MSN
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),0.41805750395025787,0.7277472240889695,0.825,1.0,1.0,1/6,5.65%,SLC25A33
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),-0.4419886950321174,-0.7277430237256168,0.85,1.0,1.0,4/10,22.57%,P2RY12;MTUS1;CD81;MST1
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),0.27355537218773013,0.7276433486723811,1.0,1.0,1.0,21/100,16.67%,MT1G;BCL6;DCBLD2;SIRT1;DACT3;ST7L;PML;SLIT2;SIPA1;FGFR3;PPP1R9B;SMARCA2;SMARCA4;HSPA1A;PNPT1;ADAM15;CGRRF1;SERTAD2;TP53;MINAR1;NOTCH1
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),-0.43655177520474614,-0.7275756504108128,0.7333333333333333,1.0,1.0,1/8,5.61%,PINK1
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.4272327390090468,-0.7275151343850264,0.8269230769230769,1.0,1.0,2/8,11.64%,AZIN1;ARG2
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.3227471083331694,-0.7274558711202416,0.8904109589041096,1.0,1.0,6/63,13.31%,AIM2;NLRP12;CYP1B1;SPI1;NLRC3;NLRP3
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),-0.4171003705117411,-0.7273901435433933,0.7894736842105263,1.0,1.0,1/8,11.75%,CAMLG
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),-0.30589337908516595,-0.7272408487083932,0.9428571428571428,1.0,1.0,10/65,15.82%,WNT5A;NLRP12;IFNK;CYBA;TLR2;SH2D1B;IL18;ZP3;AGT;GRN
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.3835197819429917,-0.7271842473674832,0.8103448275862069,1.0,1.0,1/11,2.53%,MMP9
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),-0.4390098813313381,-0.7269680183908339,0.8095238095238095,1.0,1.0,1/7,7.51%,WAS
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.3375747092692106,0.7268568880920064,0.9642857142857143,1.0,1.0,4/27,8.56%,DGKD;HIP1;TGFA;CNOT9
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.3105659575357605,0.7268424995431527,0.8857142857142857,1.0,1.0,9/37,15.44%,MAP3K14;TNFSF14;MAPK8;MAP3K1;FADD;CRADD;CASP8AP2;NFKB1;GADD45A
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.365589601662665,-0.7268285615624681,0.8227848101265823,1.0,1.0,5/26,18.26%,CYP1B1;NQO1;ARG2;NOS2;GCHFR
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.3881882114777938,-0.726623399849218,0.8461538461538461,1.0,1.0,2/22,6.40%,CASQ2;TRDN
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),-0.3526232960588538,-0.7265665746754975,0.8933333333333333,1.0,1.0,10/35,24.32%,ATP10B;ACP3;GRN;HOOK2;SNAPIN;ACP4;TPP1;HPS4;VPS18;ACP2
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),-0.32867913491780804,-0.7265533536446999,0.8636363636363636,1.0,1.0,4/36,15.51%,SNRPD2;DDX20;GEMIN4;STRAP
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),0.4396091123429398,0.7264015884988559,0.7551020408163265,1.0,1.0,3/7,31.80%,RAP1A;FMR1;RAP1B
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),0.3243867199172505,0.726391358852497,0.8484848484848485,1.0,1.0,5/18,18.39%,SPRED3;SPRED2;SPRED1;ATM;ATR
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),-0.4702120758900317,-0.7263707291916613,0.8245614035087719,1.0,1.0,3/7,11.81%,GPER1;SOD2;ENG
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.27289144117733366,0.7262149859607727,1.0,1.0,1.0,14/88,16.75%,FOXO1;STX5;RAB7A;NKD1;WWP2;FLNA;CHMP6;ODC1;BANP;SMURF1;FURIN;SEC22B;SNF8;NEDD4
prerank,GO_Biological_Process_2021__cellular response to monoamine stimulus (GO:0071868),0.4259555149468494,0.726034825912591,0.782608695652174,1.0,1.0,3/7,18.06%,DRD5;NR4A3;ADCY6
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),0.4385325377448356,0.7260274576511762,0.7916666666666666,1.0,1.0,5/7,29.51%,FNTA;EP300;PRKAA2;TPPP;PRKAA1
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),0.33137414203792237,0.7260232565812194,0.8387096774193549,1.0,1.0,5/17,18.17%,PRSS3;MTR;ABCC1;TCN2;CD320
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),0.33137414203792237,0.7260232565812194,0.8387096774193549,1.0,1.0,5/17,18.17%,PRSS3;MTR;ABCC1;TCN2;CD320
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),-0.41798213193472733,-0.726010210398128,0.8225806451612904,1.0,1.0,1/9,10.71%,TERT
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.3504139592161917,-0.7259538358800331,0.8243243243243243,1.0,1.0,8/33,19.41%,NLRP12;ESR1;STAT1;NLRC3;NR1H4;CACTIN;CARD8;CASP8
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),-0.36768786630095684,-0.7259500431802746,0.8472222222222222,1.0,1.0,4/23,19.63%,SOX10;TLR2;EIF2B2;MYRF
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.3473898995796546,0.7258617925111429,0.7894736842105263,1.0,1.0,5/16,18.53%,GREM1;SLIT2;GPLD1;MIA3;NR4A1
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),-0.4390001559378881,-0.7255837092941042,0.8688524590163934,1.0,1.0,1/9,8.67%,ACTN3
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),-0.4390001559378881,-0.7255837092941042,0.8688524590163934,1.0,1.0,1/9,8.67%,ACTN3
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.28061758600141545,0.7254559334196482,0.875,1.0,1.0,16/86,17.53%,PACSIN2;HIP1;CDH13;ABL1;RALA;SYT1;ABL2;ZFYVE16;RIMS2;RAB3C;CD22;RAB10;RAB5A;RAB11B;RIT2;RAB3D
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),-0.40249362318112636,-0.724956130153793,0.8260869565217391,1.0,1.0,3/13,23.32%,SLC25A18;SLC25A22;SLC25A11
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),-0.29325301724594666,-0.7248451295249411,0.948051948051948,1.0,1.0,5/92,7.28%,PSMB9;CLEC4C;MUCL1;ICAM3;MUC5B
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.29325301724594666,-0.7248451295249411,0.948051948051948,1.0,1.0,5/92,7.28%,PSMB9;CLEC4C;MUCL1;ICAM3;MUC5B
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.29325301724594666,-0.7248451295249411,0.948051948051948,1.0,1.0,5/92,7.28%,PSMB9;CLEC4C;MUCL1;ICAM3;MUC5B
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.37421518648923885,0.7247915792313944,0.8571428571428571,1.0,1.0,6/12,23.34%,APOE;SNX9;FURIN;GPLD1;ADAM8;SH3D19
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.31423087223320706,0.7247730795614173,0.8928571428571429,1.0,1.0,12/42,20.45%,DGKD;PLD6;PNPLA3;GPD1;AGPAT5;DGKH;AGPAT2;LCLAT1;ABHD4;PLA2G5;DGKZ;PLD2
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),-0.38662475067391633,-0.7247179147427452,0.7407407407407407,1.0,1.0,1/9,8.48%,TGM2
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),-0.38662475067391633,-0.7247179147427452,0.7407407407407407,1.0,1.0,1/9,8.48%,TGM2
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),-0.44202226567039804,-0.7245573594155189,0.7857142857142857,1.0,1.0,3/7,15.67%,HTR2B;NR1H4;ACSL3
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.40363775951802083,0.7244011039105991,0.8604651162790697,1.0,1.0,6/13,20.89%,KIT;SIRT1;TICAM1;NR4A3;LAPTM5;PLCG2
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.3765400855273967,-0.7243606486986743,0.8260869565217391,1.0,1.0,4/23,14.59%,KANK3;SCIN;VIL1;TMSB10
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),-0.36273925274969326,-0.7240731720341801,0.8448275862068966,1.0,1.0,7/20,30.71%,THBS1;MSN;CSF1R;CXCL17;CCL5;CSF1;MAPK3
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),0.28325987627684346,0.7234523842352976,0.9545454545454546,1.0,1.0,16/74,18.22%,CDH5;SDC4;NRG1;RAB7A;STX18;SMPD3;PIH1D1;GNL3L;SYNPO;BID;SPIDR;SNF8;ICE1;LGALS3;FAF1;LIMK1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),-0.3551734332137949,-0.723430379130045,0.8382352941176471,1.0,1.0,9/29,16.67%,ALOX5;CNMD;STAT1;COL4A3;THBS1;CAV2;ATP5IF1;IL12A;GHRL
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),-0.28270985808322,-0.7233889599483664,0.963855421686747,1.0,1.0,17/119,15.86%,TCN1;SLC7A7;SLC7A3;CHMP3;SLC6A12;SLC3A1;ABCG2;PPT1;SLC18A2;SLC11A1;LRP2;SLC22A3;SLC6A4;SLC22A4;TXNIP;AMN;RHBG
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),-0.2961719028582331,-0.7233742329775872,0.925,1.0,1.0,15/95,16.59%,HK2;NODAL;WNT5A;CYP1B1;BRCA1;THBS1;TEK;ITGA5;GATA4;HYAL1;RRAS;EPHA1;GRN;HIPK1;ANGPTL3
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.4185080642169785,-0.723220054818617,0.8088235294117647,1.0,1.0,4/11,24.41%,H1-0;H1-3;HMGA1;H1-2
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),0.4215308984703758,0.7230580781503504,0.8,1.0,1.0,4/7,23.88%,LCLAT1;PLA2G5;HADHB;PLA2G6
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.2892688437519049,-0.7228994015085545,0.958904109589041,1.0,1.0,16/123,14.75%,TIMP3;NLRP12;SP100;MAPKAPK3;CIITA;STAT1;SELP;ANXA1;OSMR;TIMP4;SLC11A1;CXCL16;IL18BP;ITIH4;LEF1;GGT5
prerank,GO_Biological_Process_2021__gas homeostasis (GO:0033483),-0.4790451220571086,-0.7224093654715935,0.7959183673469388,1.0,1.0,2/5,10.62%,SOD2;ALAS2
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),0.3527342500050013,0.7223411579087858,0.9375,1.0,1.0,3/19,9.13%,TOR1B;UBXN2A;SPAST
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),-0.429834668806202,-0.722310386573568,0.8813559322033898,1.0,1.0,1/11,13.81%,SLC22A3
prerank,MSigDB_Hallmark_2020__Hypoxia,-0.27975895842709175,-0.7220830916294484,0.9759036144578314,1.0,1.0,24/174,14.43%,CCNG2;HK2;PHKG1;TGFBI;ALDOB;PKLR;SDC2;COL5A1;LOX;DCN;ENO2;CAVIN1;TGM2;GPC3;GAPDHS;CP;LXN;GLRX;SAP30;CDKN1A;NDRG1;PNRC1;FOSL2;TGFB3
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),0.39480876171836615,0.7220627771471555,0.9142857142857143,1.0,1.0,2/16,16.93%,PNPLA3;LPIN2
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.310500259373447,-0.7219855024179441,0.927536231884058,1.0,1.0,4/72,8.95%,ARIH2;CAV3;DAB2;CLU
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),0.3832722210074515,0.7218634427112466,0.8461538461538461,1.0,1.0,4/8,44.06%,CBL;MET;GRB2;SRC
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),-0.3451231506049421,-0.7216933894687093,0.8484848484848485,1.0,1.0,4/23,15.41%,ITGB2;ARHGAP12;ITGAM;IGLL1
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.31878081709782446,0.7216868896760112,0.90625,1.0,1.0,3/23,11.59%,SLC26A7;SLC19A1;SLC25A12
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.38344391845717063,-0.7214814720028504,0.7846153846153846,1.0,1.0,3/15,14.93%,APOD;NLRC3;ADCY7
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.2599002820060465,0.7213060538830324,0.9090909090909091,1.0,1.0,6/94,6.22%,TBC1D10A;PRR16;PERP;SAMD4A;ERBB2;PCIF1
prerank,GO_Biological_Process_2021__sulfation (GO:0051923),0.3792208889437402,0.7211533712694627,0.8333333333333334,1.0,1.0,3/10,15.36%,HS3ST5;UST;SULT2A1
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),-0.34351528044366597,-0.7209418901918156,0.9420289855072463,1.0,1.0,4/27,8.28%,TGFB1;WNT5A;GPER1;ZFPM1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.2655799074345471,0.7206590430336368,1.0,1.0,1.0,32/130,21.17%,RASSF2;IRGM;NOX4;CCN1;RALB;SNCA;PAK5;TELO2;CASS4;PIH1D1;TNIK;RAP1A;CCDC88A;SNX9;LRP8;INSR;CLSPN;IL23A;SRCIN1;SYAP1;DUSP19;MMD2;STOX1;GRM5;TAB2;PAK3;PRKAG2;PAK2;MARK2;TRAF6;CACUL1;ACE
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.32426762171957235,-0.7206445360382049,0.9135802469135802,1.0,1.0,11/58,13.55%,ALOX5;CNMD;STAT1;CD160;DCN;CLDN5;COL4A3;ISM1;THBS1;FOXO4;TEK
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.3144741862298611,0.7206242803098211,0.8571428571428571,1.0,1.0,4/37,9.36%,TRPM2;DHFR;DRD4;RHBDD1
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),0.27707432251005804,0.7205825330703992,0.9666666666666667,1.0,1.0,12/46,20.35%,ST6GALNAC3;ACER2;SMPD4;NSMAF;PLPP2;ACER3;TLCD3B;PLA2G15;CERS4;SAMD8;FA2H;PLPP3
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),-0.40561384621447605,-0.7204123793620668,0.8064516129032258,1.0,1.0,1/13,3.12%,RPP38
prerank,GO_Biological_Process_2021__regulation of aldosterone biosynthetic process (GO:0032347),0.4159159115376447,0.7203965239322206,0.8378378378378378,1.0,1.0,1/7,4.40%,WNT4
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),0.3802124330947433,0.7203467132907649,0.8,1.0,1.0,2/9,9.13%,PKD2;ABCC8
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.342297325628998,-0.7202462751233896,0.8840579710144928,1.0,1.0,6/33,14.71%,ACSM6;ACOT6;ACOT4;ACSM3;ACOT1;ACOT2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.3703077879107277,-0.720187728687445,0.8870967741935484,1.0,1.0,1/18,2.33%,IRF4
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.28463661098689197,-0.720178147335108,0.961038961038961,1.0,1.0,15/151,14.65%,TGFB1;RIN3;LRPAP1;ESR1;GPER1;PINK1;CLDN5;PTRH2;REST;TERT;SPI1;ENG;HEY2;NOS2;VDR
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.34509816118491293,0.7200245186727321,0.8461538461538461,1.0,1.0,7/31,18.97%,SARM1;RAP2A;TNIK;CUX1;PTPRD;NEDD4;ADGRB3
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.359987998518101,0.7200113595280029,0.8064516129032258,1.0,1.0,3/13,32.15%,RAB10;REEP2;REEP1
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),-0.3307940997814922,-0.7193654702047976,0.9206349206349206,1.0,1.0,3/40,5.16%,MISP;ABRAXAS1;RAB11A
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),-0.4085271401372377,-0.7193530524610189,0.7666666666666667,1.0,1.0,1/9,11.23%,PYGL
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.2826017648066968,0.7192999013336464,0.972972972972973,1.0,1.0,8/45,17.24%,TRIM67;REEP6;FER;EFNA5;CDK16;PARD6B;WWC1;ADGRE2
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),0.32416682626268095,0.7192414967492458,0.8648648648648649,1.0,1.0,6/18,27.08%,PKD2;WNK3;SLC4A11;SERPINB6;AQP1;STK39
prerank,GO_Biological_Process_2021__protein localization to site of double-strand break (GO:1990166),-0.4919371488643006,-0.7192274343607717,0.8181818181818182,1.0,1.0,1/5,23.63%,SLF1
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),-0.3387663770397509,-0.7189457402687772,0.8571428571428571,1.0,1.0,7/35,21.32%,HAT1;NAP1L2;GRWD1;CHAF1A;SMARCA5;H2BC18;SOX9
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),0.3715037401369896,0.7188493263757438,0.8235294117647058,1.0,1.0,1/10,6.34%,DHFR
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),0.2749821331201586,0.7188030178379102,0.9583333333333334,1.0,1.0,5/76,5.23%,MT1G;ACO1;SLC30A10;SLC39A8;FLVCR1
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.40477909561493874,0.7186568136705455,0.9375,1.0,1.0,6/12,36.38%,MLLT3;METTL4;SSRP1;HNRNPU;SETD5;TLK2
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),0.4136040048051556,0.7184007111057745,0.8717948717948718,1.0,1.0,3/11,8.37%,SMARCD3;CX3CR1;DCT
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),-0.35009930217130547,-0.7183008095788158,0.859375,1.0,1.0,7/26,22.88%,CAV3;ANKRD53;DCTN1;RAC1;CDK5R1;DRG1;PSRC1
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.24735081899227546,0.7182727299407549,1.0,1.0,1.0,33/115,23.27%,PIGQ;DPM3;PITPNM1;PI4KB;ITPKB;TMEM150A;PIK3C2B;MTMR8;PI4K2B;PIK3CA;PIGA;MTMR3;SMG1;PIP4K2A;RAB5A;TTC7B;IP6K1;PIK3R5;EFR3B;MTMR14;SLA2;MTMR1;MTM1;SOCS7;PIGF;SOCS4;PLCG2;PIK3R4;PTEN;IP6K2;PIGZ;CDS1;VAC14
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.28399268997132626,0.7181176062957751,0.9428571428571428,1.0,1.0,17/57,21.76%,KIT;ADGRG3;ITGA4;TOX;LEPR;GPR89A;FLT3;HDAC4;GPR89B;PBX1;IL11;KLF6;HDAC5;PLCG2;ZBTB7A;PTPRJ;JAG2
prerank,GO_Biological_Process_2021__positive regulation of establishment of endothelial barrier (GO:1903142),0.44082719265928516,0.7181071230908179,0.8333333333333334,0.9999343685821103,1.0,1/5,2.83%,CDH5
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell development (GO:1901552),0.44082719265928516,0.7181071230908179,0.8333333333333334,0.9999343685821103,1.0,1/5,2.83%,CDH5
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),0.24718833488944023,0.7180544098110595,1.0,0.9996095981522377,1.0,31/150,18.58%,RFWD3;BRCC3;TENT4A;SEM1;RNF168;HMGB1;SMARCAL1;PPP5C;MAPK8;POLM;SETMAR;KDM2A;REV3L;SMC5;MMS22L;TRIP13;H2AX;PAXX;AP5Z1;SPIDR;HERC2;EYA3;BAZ1B;LIG4;ATM;RAD52;SAMHD1;NSMCE2;FBH1;MDC1;EME2
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),0.3247474950506064,0.7177953224885806,0.8611111111111112,0.999535950922058,1.0,6/34,14.52%,ZSCAN4;TELO2;CTC1;TERF1;ACD;WRAP53
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),0.28276483668612656,0.7177564562531434,0.9310344827586207,0.9992282867174028,1.0,16/42,23.80%,PAPSS2;AMPD1;PANK1;ADCY2;IMPDH1;ADCY3;PPCS;GMPS;SLC25A16;ADCY6;SLC35B2;GUCY1A1;AMPD3;SLC26A2;ACOT7;PANK3
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),-0.35214585392282305,-0.7177179653172505,0.8545454545454545,1.0,1.0,2/24,2.75%,TGFB1;P2RY12
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.34134738446430246,-0.7176194544087487,0.9027777777777778,1.0,1.0,6/35,16.15%,TGFB1;REST;TERT;SPI1;GNL3;SMAD3
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.3380170394908178,-0.7174938891860103,0.9076923076923077,1.0,1.0,5/31,13.58%,RIN3;LRPAP1;SFRP4;CD63;RSPO1
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),0.29689894421132834,0.7174563145897602,0.9130434782608695,0.9992551138191267,1.0,6/52,8.63%,CYP7B1;OSBPL3;OSBPL6;AKR1C3;SLC27A2;OSBPL7
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),0.4706538105164624,0.7170185791949891,0.8837209302325582,0.9989691239678719,1.0,1/5,6.12%,TOX
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),0.4706538105164624,0.7170185791949891,0.8837209302325582,0.9989691239678719,1.0,1/5,6.12%,TOX
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),0.414476095657333,0.7168546572696473,0.851063829787234,0.9987734205155444,1.0,2/7,12.54%,GREM1;UBASH3B
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.3466968783485397,-0.7167784665161288,0.90625,1.0,1.0,6/33,22.81%,RPA3;POLD4;SMUG1;OGG1;RPA2;XRCC1
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),-0.3048468097611358,-0.7164146251048309,0.9130434782608695,1.0,1.0,6/59,14.43%,TGFB1;GPER1;PLA2G10;ATP6AP1;TTN;TGFB3
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),-0.39464055184462554,-0.7163447780929024,0.819672131147541,1.0,1.0,5/15,19.91%,SOX10;SEMA3A;EDNRB;NTRK1;FN1
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),0.3649764087781846,0.716201989675009,0.8095238095238095,0.9991563987142216,1.0,4/10,25.76%,TOX;BMP4;ADAM8;SHH
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),0.37047678850778964,0.7161699434662383,0.8095238095238095,0.9988328717956959,1.0,2/10,10.79%,SIRT1;ABI3
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",0.3997289201134327,0.7161552589152793,0.7678571428571429,0.9984762305335212,1.0,1/6,3.64%,CBFB
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),-0.3648261149424801,-0.7160296391500091,0.8035714285714286,1.0,1.0,4/22,23.62%,ASIP;SNAPIN;BLOC1S2;HPS4
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),0.2438256128695559,0.7157980935487827,1.0,0.9984754817269449,1.0,61/353,18.43%,RFWD3;RNF182;LZTR1;KLHL20;NUP210;NEUROD2;UBE2E3;NUP42;COMMD1;PEX13;SIRT1;DTX1;KLHL41;RNF168;ARRB2;BCL11A;TRIM69;TRIM35;DCUN1D1;WWP2;HIF3A;RNF152;PDZRN3;UBE2E1;UBE2D4;AAAS;TSPAN17;KLHL18;ANAPC16;MSL2;GAN;TRIM44;RNF38;KLHL24;KLHL3;UBE2A;CCDC22;RNF212;ARRB1;SMURF1;TRIM4;HERC2;SHPRH;CNOT4;BRAP;UBE2Z;MARCHF3;ZNRF3;FBXO4;NEDD4;ARIH1;UBE2L3;NSMCE2;FBH1;HERC5;RNF113A;NFX1;RANBP2;TRIM47;MIB2;ANAPC7
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),0.4107756989008643,0.715797429628797,0.7727272727272727,0.9981081250375677,1.0,2/9,14.75%,TIMELESS;SPIDR
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),0.22645096551779056,0.71576514874159,1.0,0.9977688017143923,1.0,26/327,11.04%,MLF1;NOX4;CPSF1;NUP210;NOVA1;RPL3L;NXF5;NUP42;ATXN1;DTX1;HNRNPF;BICD1;RBMS1;PPP5C;TAF1B;NXT1;HNRNPH1;NR4A2;NXF1;U2AF1;SRRM1;HNRNPL;AAAS;TSPAN17;ELAVL4;MRPL41
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),-0.37546040630787625,-0.7152328207698363,0.7931034482758621,1.0,1.0,1/12,1.18%,ELOVL2
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.26304821103555537,0.7151044855041283,1.0,0.9981346526866044,1.0,12/76,18.84%,MAPKAPK2;NUP210;NUP42;SIRT1;MLST8;AAAS;HSPA1A;HSF1;ATM;RANBP2;ATR;EP300
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),-0.3675327179497375,-0.714885689527764,0.8260869565217391,1.0,1.0,5/26,14.82%,TBX1;WNT8A;ATP6AP2;HEY2;GATA4
prerank,GO_Biological_Process_2021__beta-catenin destruction complex assembly (GO:1904885),0.4714173818585124,0.714630258182987,0.8918918918918919,0.99840590941639,1.0,3/5,37.09%,AXIN1;GSK3B;APC
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.38229516017636656,-0.714418555010693,0.8507462686567164,1.0,1.0,2/13,14.99%,STAT1;DDX3X
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),0.3995983115075452,0.7143928550582941,0.8636363636363636,0.9983552692242031,1.0,3/9,18.06%,ADCY2;ADCY3;ADCY6
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),0.3041605480892695,0.7142801489671416,0.8918918918918919,0.998127243068269,1.0,5/27,9.97%,KIT;WNT4;AKR1C3;KITLG;MAMLD1
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),0.2821414426615895,0.7141043488041442,0.96,0.9979658935917358,1.0,17/58,20.34%,HSPB1;CEP85;SNCA;DEPTOR;TRIB2;LRP6;IRS2;SPRED1;UBASH3B;NF1;WWTR1;DUSP19;TAB1;TARBP2;PRKAG2;PAK2;GNAQ
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),0.3420356562851739,0.7138616787189267,0.9,0.9979265514326245,1.0,1/20,2.32%,CFLAR
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),0.2917742312741477,0.7137723222048572,0.90625,0.9976601648890187,1.0,12/45,20.31%,TDO2;TRPM2;PKD2;HCN1;ACACB;ALDH1A2;USP16;HPRT1;SAMHD1;SHMT2;APPL2;CRYZ
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),-0.30784694573968474,-0.7130613552421764,0.9240506329113924,1.0,1.0,8/63,12.97%,LMOD1;HCK;C15ORF62;KANK3;ALOX15;VIL1;ARHGAP28;BAIAP2L1
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),-0.4331903775519025,-0.7128492273229402,0.8620689655172413,1.0,1.0,1/8,5.45%,DOCK2
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),0.3883417904101794,0.7127011773390364,0.8648648648648649,0.9985344599578814,1.0,3/11,11.24%,ANGPT1;SLIT2;DDAH1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),0.4147381489178784,0.712569412940756,0.8478260869565217,0.9983621291680369,1.0,1/5,21.53%,PHF1
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),0.3248542980456057,0.7124813787205534,0.8387096774193549,0.9980903435698437,1.0,7/30,22.04%,PCM1;WNT3A;NF1;NOTCH1;PAX6;APPL2;PTEN
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),-0.4477927681651333,-0.7123757321626099,0.7454545454545455,1.0,1.0,1/7,4.00%,IFNK
prerank,GO_Biological_Process_2021__regulation of cellular response to osmotic stress (GO:0106049),0.4606699799455862,0.7122140047878708,0.8484848484848485,0.9981505725075752,1.0,2/5,19.44%,MICU1;SLC25A23
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),0.35102277313453917,0.7116653958721814,0.8823529411764706,0.9984318866216925,1.0,4/15,10.21%,SARM1;DHFR;MORN4;MTR
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.41209700241070535,0.7114599548764262,0.75,0.99832063398595,1.0,1/8,7.00%,DCUN1D1
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),-0.3703127274483098,-0.7113562467562237,0.9,1.0,1.0,2/14,10.05%,SLC5A1;HNF1A
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),-0.38032526343672535,-0.7113370030234576,0.828125,1.0,1.0,3/14,7.49%,AHR;IRF1;ALOX15
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),0.3776995705910975,0.711282568162932,0.8108108108108109,0.9981707934585935,1.0,4/13,22.73%,ATG2A;ATG2B;RETREG1;STING1
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),-0.36299515546644506,-0.711210300981262,0.8615384615384616,1.0,1.0,5/16,24.67%,ABCG2;ABCB1;RHBG;SLC23A1;ABCC2
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),-0.463703656995038,-0.7110775106721194,0.8367346938775511,1.0,1.0,2/5,22.60%,PRPS1;DCK
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),0.42462532410228226,0.7110433780136651,0.782608695652174,0.9981259836980558,1.0,3/7,23.72%,BCAT1;MCCC1;HMGCLL1
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.3144189038020634,0.7109619568853898,0.9090909090909091,0.9978769612686078,1.0,2/25,7.94%,LLGL1;WWP2
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),0.25394208362790294,0.7105491403658182,1.0,0.9979647267626249,1.0,17/58,23.87%,PIGQ;DPM3;ZDHHC16;ZDHHC18;ZDHHC12;ZDHHC14;PIGA;ZDHHC3;ZDHHC13;GPLD1;ZDHHC9;PIGF;ZDHHC5;ZDHHC23;PIGZ;ATG12;ZDHHC20
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),-0.300424976809524,-0.7104321394144306,0.95,1.0,1.0,11/79,16.30%,NEK2;KIF14;DCTN1;USP17L2;ATF5;TUBA4A;CEP72;DYNLL1;ATAD5;TUBB;CEP76
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),0.30141629534987513,0.7099524706910659,0.9259259259259259,0.9982620404261225,1.0,5/62,10.02%,NUP210;NUP42;PPARG;TRIM71;AAAS
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.4121592217183727,-0.7096859519098454,0.8387096774193549,1.0,1.0,1/15,1.49%,TGFB1
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",0.45312909089979625,0.7093633868908886,0.8148148148148148,0.9986363342937029,1.0,2/5,27.81%,SEC61A1;SEC61A2
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.34057518423183314,-0.7093176517870615,0.8888888888888888,1.0,1.0,9/31,19.93%,SIRPG;KLRB1;ICAM3;H2AZ1;TUBB;CD8B;ADGRG1;STMN1;SPON2
prerank,GO_Biological_Process_2021__detection of light stimulus involved in visual perception (GO:0050908),-0.41158401097641956,-0.709308133579375,0.8253968253968254,1.0,1.0,1/10,1.75%,TULP1
prerank,GO_Biological_Process_2021__detection of light stimulus involved in sensory perception (GO:0050962),-0.41158401097641956,-0.709308133579375,0.8253968253968254,1.0,1.0,1/10,1.75%,TULP1
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.37696534235786927,-0.7090191982576858,0.8571428571428571,1.0,1.0,3/14,17.66%,BRCA1;CEP76;C10ORF90
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),0.40079826655306267,0.7089188709055712,0.7555555555555555,0.998773335182855,1.0,1/9,1.25%,GREM2
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.36476250743309546,0.7089105798495251,0.925,0.9984253495881146,1.0,1/18,2.21%,PAPSS2
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),-0.35445141430860994,-0.7087858030631168,0.8524590163934426,1.0,1.0,2/21,6.83%,ENO4;ENO2
prerank,GO_Biological_Process_2021__regulation of immunoglobulin mediated immune response (GO:0002889),-0.45603553846549405,-0.7084722336607975,0.82,1.0,1.0,3/5,38.15%,TNFSF4;SUPT6H;CD226
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),0.3822625147206935,0.7084318290772421,0.8421052631578947,0.9986559645650545,1.0,3/10,22.58%,ZEB2;OPN3;TYRP1
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),-0.45859497867981425,-0.7083789172169688,0.864406779661017,1.0,1.0,2/8,18.14%,CLU;STUB1
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.4359822161897585,-0.7083113982474263,0.8666666666666667,1.0,1.0,1/7,22.25%,MSH6
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.38957505940210035,-0.7082676545742336,0.873015873015873,1.0,1.0,5/12,31.63%,THBS1;MMRN2;DLL4;TBXA2R;PDCD10
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.3865160994952581,-0.708232846637767,0.9193548387096774,1.0,1.0,5/13,16.51%,PLA2G10;PRKCH;IL18;AGT;ALOX15B
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),-0.2791132599050394,-0.7081621817201513,0.9743589743589743,1.0,1.0,6/133,7.35%,NEK2;TGFB1;ROS1;PLAAT4;PINK1;FLT4
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),0.33775667298893725,0.7078344780968591,0.8421052631578947,0.9991507019561258,1.0,3/15,14.76%,PID1;MLXIPL;HDAC4
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.42185415208719335,-0.7078188313002851,0.8676470588235294,1.0,1.0,4/9,24.41%,H1-0;H1-3;HMGA1;H1-2
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.42185415208719335,-0.7078188313002851,0.8676470588235294,1.0,1.0,4/9,24.41%,H1-0;H1-3;HMGA1;H1-2
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.42185415208719335,-0.7078188313002851,0.8676470588235294,1.0,1.0,4/9,24.41%,H1-0;H1-3;HMGA1;H1-2
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),0.4201620428516212,0.7077585960132976,0.8181818181818182,0.9988910241338408,1.0,3/7,18.77%,GMPS;CTPS2;SHMT2
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.2700859494946175,-0.7075677139288515,0.9615384615384616,1.0,1.0,15/182,10.21%,TRIM62;S100A13;WNT5A;TERF2IP;NLRP12;LPAR1;ESR1;TRIM5;PINK1;TRIM25;STAT1;HTR2B;EDAR;TRAF3IP2;HLA-DRB1
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),0.39162613105751326,0.7074726292931183,0.8108108108108109,0.9988956335729064,1.0,4/12,28.72%,ARPC3;MAGEL2;JMY;WHAMM
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.24786098796871073,0.7073721795733582,1.0,0.9987242384660537,1.0,20/103,16.51%,BCL6;KIAA0319;DCBLD2;SIRT1;DACT3;DCC;ST7L;PML;SLIT2;SIPA1;PPP1R9B;SMARCA2;SMARCA4;HSPA1A;ADAM15;CGRRF1;SERTAD2;TP53;DIP2B;MINAR1
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),0.41137845958496877,0.7073087698972903,0.8529411764705882,0.9984814937473924,1.0,2/9,15.44%,SIRT1;TP53
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.34870514711875883,0.7072524830643296,0.926829268292683,0.9981949575014359,1.0,4/16,15.67%,CBFB;SNAI2;MYO1C;RUNX1
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),0.30951873093480403,0.7072375583224335,0.8888888888888888,0.9978372073720193,1.0,5/21,13.81%,TSKU;TENM3;CEP290;EFEMP1;NF1
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.25288010295840946,0.707003454994958,1.0,0.9978037475337166,1.0,42/160,24.87%,GOLT1A;SPTBN4;TICAM2;STX5;GBF1;TRAPPC1;SEC24C;F2;TRAPPC12;CNIH3;DYNC1I2;TGFA;SPAST;TMED3;BET1;VTI1A;PREB;COG7;PGAP1;ANK2;YIF1A;SEC22B;CTSC;GOLGB1;MIA3;COG5;COG4;TMEM115;TRIP11;TFG;CAPZA1;TRAPPC11;CD55;COG2;SEC31A;ANK1;COG3;CNIH2;SPTB;ANK3;GAS6;CAPZB
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),0.3608911040845068,0.7067154820440366,0.8222222222222222,0.9977812921039251,1.0,4/13,25.57%,YAE1;ISCA2;CIAO2A;LTO1
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),-0.34891401784760556,-0.7063976049237681,0.8852459016393442,1.0,1.0,5/23,20.26%,PLA2G10;SERINC1;PLA2G4A;MBOAT1;PLA2G4D
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),-0.3134010481567723,-0.7062573000155825,0.927536231884058,1.0,1.0,5/43,12.50%,SFTPA1;MAPKAPK3;SFTPD;LACC1;TLR2
prerank,GO_Biological_Process_2021__fatty acid omega-oxidation (GO:0010430),0.45009672713251037,0.7060221887557385,0.8095238095238095,0.9981759441450794,1.0,1/5,1.24%,CYP4V2
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),-0.40167331506738524,-0.7057643448707591,0.921875,1.0,1.0,2/14,13.35%,SHCBP1L;GNL3
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.35645767717517884,-0.7057600542211869,0.8518518518518519,1.0,1.0,3/18,10.60%,PINK1;BRCA1;SLC18A2
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),0.362334599727996,0.705556469250159,0.926829268292683,0.9983508674875899,1.0,5/16,19.29%,SIRT7;RIOK1;USP36;BUD23;KAT2B
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),0.40116228086265243,0.7053489670056632,0.813953488372093,0.9981911364311075,1.0,5/9,14.61%,FZD1;NR4A2;LRP6;WNT3A;RYK
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),0.3710365344317709,0.7049818224695225,0.8444444444444444,0.9979213428492208,1.0,4/8,29.56%,GSTZ1;PDK1;PDP2;PDPR
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),0.3710365344317709,0.7049818224695225,0.8444444444444444,0.9979213428492208,1.0,4/8,29.56%,GSTZ1;PDK1;PDP2;PDPR
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.2879789435058132,-0.7048673616415227,0.9230769230769231,1.0,1.0,15/81,17.55%,WNT5A;OAS2;CLU;THBS1;CYBA;PTPRC;ARG2;OAS1;TLR2;NLRC3;C1QTNF4;NR1H4;GHRL;VSIR;CACTIN
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.3086016239443756,0.7045576170537645,0.9,0.9979974991650123,1.0,18/47,23.22%,ACER2;ABL1;H2AX;BID;GADD45A;TP53;CLSPN;ATM;RAD17;RAD9A;ATR;SESN2;HINFP;MDM4;CDC5L;ATRIP;BRIP1;BCL3
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 7 signaling pathway (GO:0034157),-0.46305169394674084,-0.7044524077880515,0.8596491228070176,1.0,1.0,1/5,14.99%,DDX3X
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 7 signaling pathway (GO:0034155),-0.46305169394674084,-0.7044524077880515,0.8596491228070176,1.0,1.0,1/5,14.99%,DDX3X
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.300385004391364,-0.7042844921059475,0.96,1.0,1.0,8/71,11.95%,TGFB1;NODAL;DAB2;TTK;THBS1;GDF11;ENG;BMP3
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),-0.4198829109169392,-0.7042520148339971,0.8666666666666667,1.0,1.0,2/10,11.75%,ALOX5;UCP1
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),-0.36245965311035877,-0.7039615189175193,0.8769230769230769,1.0,1.0,3/21,11.05%,TGFB1;TNXB;PXDN
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),0.28285430618881696,0.7038526706648895,0.8333333333333334,0.9984404987932082,1.0,10/52,13.55%,UBE2E3;ZNRF1;RNF152;UBE2E1;UBE2D4;UBE2E2;KLHL3;UBE2A;RNF146;PELI1
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),-0.4560051287506296,-0.7033860694763039,0.8666666666666667,1.0,1.0,2/5,24.17%,RTF1;PAF1
prerank,GO_Biological_Process_2021__sterol import (GO:0035376),0.43545201151911206,0.7032317466483023,0.8695652173913043,0.9984171613669982,1.0,3/6,22.82%,LDLR;STARD4;SCARB1
prerank,GO_Biological_Process_2021__cholesterol import (GO:0070508),0.43545201151911206,0.7032317466483023,0.8695652173913043,0.9984171613669982,1.0,3/6,22.82%,LDLR;STARD4;SCARB1
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),0.41198613936784073,0.7029624231474607,0.8717948717948718,0.9983398635900395,1.0,2/8,14.59%,PCGF5;MECP2
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),-0.2705113154940969,-0.7029556339772846,0.9875,1.0,1.0,8/149,7.35%,NEK2;HCK;MAK;MAPKAPK3;GRK7;TEC;PINK1;FLT4
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),-0.3210566651275239,-0.702875015884561,0.9180327868852459,1.0,1.0,1/35,1.49%,TGFB1
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.43672711333749725,-0.7027301316775594,0.8833333333333333,1.0,1.0,1/10,8.63%,BRCA1
prerank,GO_Biological_Process_2021__regulation of coagulation (GO:0050818),-0.42151233424408624,-0.7025554774368403,0.8727272727272727,1.0,1.0,2/9,6.69%,PROCR;GP1BA
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.25329799000600145,0.7025515328321392,1.0,0.9985250936961145,1.0,27/109,19.69%,ANGPT1;EPHA7;CDH13;SEMA5A;ERBB2;DSCAM;ABL1;PLXNB1;EFNA5;SIPA1;ABL2;TNFRSF18;TFE3;RET;FRMD5;TESC;PKP4;EPHB2;ATM;RSU1;PLXNA4;MIA3;PPP1CB;ADAM10;PDE3B;EPB41L4B;CYTH1
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.3406168223099303,-0.7020811763455963,0.9142857142857143,1.0,1.0,3/39,6.40%,CASQ2;GPER1;TRDN
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),0.37776674921765196,0.7020390634208057,0.875,0.9983651236652296,1.0,1/8,15.95%,DSCC1
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),0.37776674921765196,0.7020390634208057,0.875,0.9983651236652296,1.0,1/8,15.95%,DSCC1
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),0.36904413194939145,0.7014282556030241,0.8108108108108109,0.9987522460718105,1.0,4/12,18.59%,UPP2;UCK2;HPRT1;PUDP
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),-0.42628673739971207,-0.7012176151146178,0.8484848484848485,1.0,1.0,2/8,21.56%,OLFM4;BST1
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),0.4117479486524044,0.7010265829013631,0.7906976744186046,0.9989425193239825,1.0,2/8,14.75%,TIMELESS;SPIDR
prerank,GO_Biological_Process_2021__drug transport (GO:0015893),0.4558169387461348,0.7010025171957377,0.8536585365853658,0.9986195766969863,1.0,1/5,6.04%,SLC19A1
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell differentiation (GO:0035886),-0.4659711550899957,-0.700969371830562,0.7843137254901961,1.0,1.0,3/5,17.81%,ENG;HEY2;MESP1
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),-0.35883276927697416,-0.7007593724263914,0.8852459016393442,1.0,1.0,5/19,18.49%,COL5A1;FBN2;MFAP5;C12ORF57;ALDH1A3
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),-0.32246273611513926,-0.7007568834104669,0.890625,1.0,1.0,3/39,10.18%,ARIH2;TRIM5;TRAF3IP2
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),0.34275794522893616,0.7007103447468368,0.8571428571428571,0.998651527458662,1.0,1/14,2.83%,CDH5
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.32616618059193914,-0.7005630663940698,0.921875,1.0,1.0,8/34,21.63%,VSIG4;OAS1;NLRC3;A2M;GRN;CACTIN;DHX58;ISG15
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.2796304995341335,0.7004010747271312,1.0,0.9986507291189247,1.0,7/56,7.84%,TRPM2;SIRT1;AKR1C3;PKD2;FER;ABL1;MAPK8
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),-0.40089764680988715,-0.7003822208707434,0.84375,1.0,1.0,1/12,1.23%,ADSS1
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),0.43538593000645043,0.7003565302215448,0.9166666666666666,0.9979896360367128,1.0,3/7,38.13%,APPL2;SIRT2;APPL1
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),0.43538593000645043,0.7003565302215448,0.9166666666666666,0.9979896360367128,1.0,3/7,38.13%,APPL2;SIRT2;APPL1
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),0.3513812089142307,0.7002536195943423,0.9210526315789473,0.9977438980371173,1.0,2/11,17.38%,RAB5A;NETO1
prerank,GO_Biological_Process_2021__regulation of monocyte chemotactic protein-1 production (GO:0071637),-0.42409963002526807,-0.7002157117806396,0.8833333333333333,1.0,1.0,2/7,12.51%,OAS1;APOD
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),0.3354244046332286,0.7001962956053525,0.8823529411764706,0.9974329797538359,1.0,1/19,2.32%,CFLAR
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),-0.41901398583450095,-0.7000455372317945,0.8461538461538461,1.0,1.0,1/11,1.75%,TULP1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),-0.40653626850432606,-0.7000069952751004,0.890625,1.0,1.0,3/12,15.16%,TGFB1;NR1H4;IL18
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.29821831605117816,0.6997892181570317,0.9375,0.997470733795078,1.0,5/31,7.94%,BCL2;SNCA;KCNJ3;KCNJ6;WWP2
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.25758615094178405,-0.6997701087550386,1.0,1.0,1.0,39/299,19.91%,NOTUM;PSMB9;APOL1;DTL;ITIH2;SERPIND1;RAB11A;SDC2;FBXL7;FBXL13;ASB14;PRSS23;GPC3;SERPINA10;CP;COPS5;WFS1;MFGE8;ASB5;F5;RBBP7;FBXO40;CCNF;KLHL2;RAB8A;RBX1;PSMA3;SUMF1;RABGGTB;RABGGTA;COPS4;FBXL18;AMBN;PSMA7;EPAS1;PSMB6;CHGB;FEM1C;FN1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),-0.397988750783417,-0.6997632679801927,0.828125,1.0,1.0,1/10,12.51%,APOD
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),0.2915570775981743,0.6994137335402616,0.9428571428571428,0.9975520009245807,1.0,10/80,11.02%,FOXO1;DUSP4;SPRED3;APOE;RGS14;PTPRR;MYC;SPRED2;WNK2;SPRED1
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),-0.27843711547554356,-0.6990140051088328,0.9743589743589743,1.0,1.0,22/143,21.26%,TGFB1;CASQ2;CCDC39;CHMP3;DRC1;HIGD1C;RPL38;CLU;CYBA;TMEM35A;TESPA1;COX7A1;SMAD3;USH1C;COX7A2;NUP93;SRP19;HSPA4;CHCHD4;ANKS4B;NSG1;CHRNA3
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),0.3570987478980309,0.6988399627524663,0.9166666666666666,0.997948762963593,1.0,2/16,4.56%,CLC;FZD5
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.3970854648319439,0.6988036641772186,0.7674418604651163,0.9976164644212154,1.0,1/8,5.38%,SNCA
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),0.3215607285389595,0.6987736451064811,0.84375,0.99729527851867,1.0,3/21,8.69%,APOE;DHFR;NUS1
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),0.3102124176999097,0.6987364880715752,0.95,0.9969797585533705,1.0,6/32,20.51%,MGARP;SPAST;DST;AP3B2;KIF3B;HIF1A
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.3381184864057205,-0.6984134585547564,0.8545454545454545,1.0,1.0,5/27,16.69%,ESR1;ZNF366;BRCA1;YAP1;WBP2
prerank,MSigDB_Hallmark_2020__Androgen Response,0.2485823736511798,0.6982728508708897,1.0,0.9970393251546744,1.0,32/96,27.89%,ADAMTS1;UBE2J1;CDK6;SGK1;CCND3;FADS1;RPS6KA3;UAP1;NGLY1;TMPRSS2;CDC14B;PMEPA1;ARID5B;PA2G4;GSR;AKAP12;ANKH;ELOVL5;SAT1;GUCY1A1;SMS;SLC26A2;PTPN21;HPGD;APPBP2;AZGP1;B4GALT1;INSIG1;STK39;NCOA4;AKT1;SRF
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.3740192370764443,0.6979955990546746,0.8285714285714286,0.9970010946456308,1.0,3/15,7.88%,ROBO2;JAG1;SLIT2
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),-0.29152269411825027,-0.6976352314085801,0.9878048780487805,1.0,1.0,11/79,15.48%,SPDYA;CCND1;CRLF3;CDC25A;LATS2;CDKN2D;CDKN1A;MAX;CDK15;CCNE2;CDKN3
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.3398398511850188,0.697223905336216,0.9444444444444444,0.9974732025171313,1.0,2/20,6.91%,SLC12A1;SLC12A9
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),-0.3919114631625464,-0.697204146462286,0.8484848484848485,1.0,1.0,1/15,1.49%,TGFB1
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),0.39385095860430613,0.6967378981629183,0.85,0.9976139308309449,1.0,5/10,33.10%,RAB11B;ATP9A;EHD1;EIPR1;SORL1
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.33492849720189555,-0.6962890275257665,0.9242424242424242,1.0,1.0,7/37,10.28%,IRF4;SFTPD;VSIG4;ANXA1;STOML2;GBP1;PTPRC
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),0.3828393776927149,0.6957820490372523,0.8,0.998335026353845,1.0,2/10,16.55%,RESF1;MPHOSPH8
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),-0.42557870985031265,-0.6954910639041061,0.8387096774193549,1.0,1.0,2/8,7.50%,SEMA3F;SEMA3A
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),-0.42557870985031265,-0.6954910639041061,0.8387096774193549,1.0,1.0,2/8,7.50%,SEMA3F;SEMA3A
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),0.3540123894082957,0.6950236016824087,0.9148936170212766,0.998675994606066,1.0,4/11,20.08%,SMARCB1;PIH1D1;RAPGEF3;HDAC5
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,0.2885151219130767,0.694659449718064,0.9444444444444444,0.9987077186059394,1.0,12/34,28.10%,UNC5C;CDK6;PML;NF1;ACHE;PTCH1;NRCAM;RTN1;TLE3;SHH;DPYSL2;SLIT1
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.3687023260147302,-0.6946164408631252,0.847457627118644,1.0,1.0,3/14,25.29%,WDR12;RPL35;DDX18
prerank,GO_Biological_Process_2021__venous blood vessel morphogenesis (GO:0048845),0.43485232030396676,0.6945854071185543,0.8108108108108109,0.9984142740631433,1.0,2/5,16.67%,PROX1;NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotactic protein-1 production (GO:0071639),0.47162714125401806,0.6943695184114381,0.8108108108108109,0.9982673031979324,1.0,2/5,11.29%,TWIST1;LGALS9
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),-0.38956319758214797,-0.6943127352667177,0.8688524590163934,1.0,1.0,3/12,19.66%,ATP1A4;ATP4A;ATP1A1
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),-0.4383482586195886,-0.69428098017406,0.8813559322033898,1.0,1.0,2/7,22.47%,DDX11;BLM
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.3535978517512214,0.694213402304204,0.8571428571428571,0.9980554552593196,1.0,4/15,18.06%,ADCY2;PRKAR2A;ADCY3;ADCY6
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),-0.3544972976762757,-0.6940056265250221,0.8414634146341463,1.0,1.0,2/28,6.21%,NODAL;DAB2
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),-0.2556121429573821,-0.6940024156811859,1.0,1.0,1.0,17/317,8.63%,TICRR;POLQ;DTL;BLK;TRAIP;SPDYA;CIDEB;CCND1;PCLAF;VAV3;BCL2L2;TNFRSF1B;HIC1;FANCF;SUV39H1;UBE2U;BRCA1
prerank,GO_Biological_Process_2021__metanephric nephron tubule morphogenesis (GO:0072282),-0.4615293698153119,-0.6938629981307695,0.8461538461538461,1.0,1.0,3/5,31.28%,SOX9;PAX2;PAX8
prerank,MSigDB_Hallmark_2020__Myc Targets V1,-0.2696349481148461,-0.6938491237988499,0.9876543209876543,1.0,1.0,39/188,29.23%,MCM2;PRDX4;SNRPD2;ERH;COPS5;H2AZ1;GNL3;IFRD1;VDAC1;HSPE1;EIF2S2;RPL34;PSMA7;IMPDH2;SET;POLE3;SRPK1;HSP90AB1;DEK;EIF1AX;RPL18;RPS3;DDX18;RPL22;MCM5;XRCC6;VDAC3;CTPS1;RPS6;PCNA;PSMD8;SF3A1;MCM6;CCT7;RACK1;RAN;COX5A;PSMD3;CCT2
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),-0.40190041713118174,-0.6938409360024976,0.9152542372881356,1.0,1.0,3/11,15.83%,WAS;SPOCK3;ELANE
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),-0.33382273889206915,-0.6935916099805864,0.8970588235294118,1.0,1.0,1/28,1.49%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),0.29158397522656637,0.6931429053558215,0.868421052631579,0.9987586013726966,1.0,8/22,23.99%,CBLB;CHMP6;GPRC5A;SRCIN1;ZFYVE28;SOCS4;TSG101;CBL
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.31217826547869826,-0.6931126954820773,0.9166666666666666,1.0,1.0,11/40,16.13%,HLA-A;ZFPM1;HLA-DPB1;IL27;SLC11A1;TXK;HLA-DPA1;IL12A;IL18;ZP3;F2RL1
prerank,GO_Biological_Process_2021__sensory perception of sour taste (GO:0050915),-0.4528416697786063,-0.6930534551505996,0.796875,1.0,1.0,1/5,20.24%,PKD1L3
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),0.3144469344416693,0.6930459168092112,0.972972972972973,0.9984709706282048,1.0,3/21,11.24%,DDAH2;SNCA;DDAH1
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.29169947185433365,0.6930109341555758,0.96,0.9981456802808596,1.0,6/34,16.75%,UTRN;WWP2;FGF12;ANK2;WNK3;NEDD4
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),0.4086053841066632,0.6926824789123427,0.8695652173913043,0.9981721072336204,1.0,1/6,2.68%,NLGN1
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),-0.32354537259628413,-0.692605360799755,0.9130434782608695,1.0,1.0,4/30,14.43%,TGFB1;ALOX5;FBN2;TGFB3
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),0.29872773391472,0.6925927402119231,0.9354838709677419,0.9979012119678132,1.0,11/42,15.67%,KIT;TET2;IFI16;FLVCR1;CASP3;HCLS1;DYRK3;KAT6A;MFHAS1;ACIN1;RUNX1
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),0.40122730726123285,0.6925555480652366,0.8421052631578947,0.9975602640771997,1.0,5/9,31.44%,PPP1R3E;PPP1R3D;AKT1;PPP1R3C;PPP1R3G
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),-0.3235670486453118,-0.6925025761517773,0.921875,1.0,1.0,1/24,1.49%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),-0.3659685478446948,-0.6923742003421031,0.8245614035087719,1.0,1.0,1/16,4.10%,ALOX5
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),-0.3247603224101961,-0.6922514665666066,0.8787878787878788,1.0,1.0,1/30,1.19%,SCN5A
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.37860738934467864,0.6920315718743728,0.8222222222222222,0.997792134681553,1.0,3/12,14.52%,PML;DYRK3;WRAP53
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.3061702795391148,0.6914436966848949,0.9428571428571428,0.9981156345743506,1.0,2/18,4.84%,BCL2;TNFSF14
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),0.3922222031609183,0.6914253973702583,0.8292682926829268,0.9977695779312169,1.0,3/9,12.75%,PTAR1;PGGT1B;FNTA
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),-0.39884841096616513,-0.6914056199752675,0.8548387096774194,1.0,1.0,2/13,10.93%,CAVIN1;POLR1G
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),0.350785593475853,0.6913487866092025,0.9565217391304348,0.9975101023256531,1.0,5/20,18.25%,SERPINE1;HMGB1;LGALS9;LGALS3;MOSPD2
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),-0.34441399958192676,-0.6911803436796061,0.8709677419354839,1.0,1.0,7/30,18.41%,POU2F3;LRRC19;REST;SAP30;LEF1;NUCKS1;HMGA2
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),0.42951762952366934,0.6911415173353997,0.8378378378378378,0.9970078831356778,1.0,1/6,18.43%,ANAPC7
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),0.42951762952366934,0.6911415173353997,0.8378378378378378,0.9970078831356778,1.0,1/6,18.43%,ANAPC7
prerank,GO_Biological_Process_2021__regulation of growth rate (GO:0040009),0.4564349624446852,0.691106976247943,0.9024390243902439,0.996673496318228,1.0,2/5,22.25%,NOTCH1;BNIPL
prerank,GO_Biological_Process_2021__positive regulation of epithelial tube formation (GO:1905278),-0.4484467776659062,-0.6908447572297315,0.8225806451612904,1.0,1.0,3/5,30.74%,SIX4;FGF2;EGF
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.33192667139191656,-0.69082683593026,0.9,1.0,1.0,7/25,18.15%,CSRP3;POPDC2;LMOD3;SVIL;CAV2;MYL6;EGR2
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),0.40692792649777365,0.6904303927393449,0.9428571428571428,0.996883551528602,1.0,2/8,13.11%,GLUD1;GLUD2
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),0.38535271093541407,0.690388911920508,0.8,0.9965817650380981,1.0,1/9,5.50%,NRG1
prerank,GO_Biological_Process_2021__proline metabolic process (GO:0006560),-0.45597865191931786,-0.6903432894494571,0.8979591836734694,1.0,1.0,2/5,17.77%,DAO;PRODH2
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.35453082329511765,0.690325862878421,0.84375,0.9963124996546445,1.0,1/14,3.86%,AUTS2
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.41154782052463035,-0.6902399950288541,0.8181818181818182,1.0,1.0,2/11,21.19%,KDELR3;HSPA5
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),-0.3975755531586476,-0.6902373225135775,0.8392857142857143,1.0,1.0,3/8,18.49%,FBN2;MFAP5;ALDH1A3
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.3170186025038389,-0.6901779116959389,0.9298245614035088,1.0,1.0,7/22,22.81%,RPL3;BRIX1;NOP53;MRPL20;RPL5;RPL11;RPL24
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),0.327915584151077,0.6900479629093591,0.8275862068965517,0.9963071633343403,1.0,4/16,18.39%,HSF1;TP53;ATM;ATR
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.36599647473841374,0.6899224580933685,0.8918918918918919,0.9960274267922058,1.0,3/11,15.99%,WASF3;WASF2;FCHSD2
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.32221585538177394,-0.6898635478323518,0.9305555555555556,1.0,1.0,6/46,18.74%,DEGS2;ALOX12B;ARG2;SGMS2;CERS3;CLN8
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),-0.36632643162375644,-0.6895153565287284,0.8636363636363636,1.0,1.0,1/15,1.49%,TGFB1
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),-0.350755164115783,-0.6894938110411774,0.9230769230769231,1.0,1.0,5/22,16.59%,TBX1;LRP2;ENG;HEY2;ANGPTL3
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),-0.3144389180384852,-0.6893974323391997,0.927536231884058,1.0,1.0,2/43,8.12%,KCNJ15;KCNQ1
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),0.4156305722805846,0.6893829377278928,0.9,0.9962803664373467,1.0,2/8,15.83%,NEU4;NEU3
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.2695447041241921,0.6893089127665489,1.0,0.9959793321254555,1.0,44/139,21.34%,CFLAR;MAP3K14;RIPK2;TICAM2;TNFRSF19;TRIM8;LGALS1;TMEM106A;ECM1;PPP5C;CARD9;FLNA;ALPK1;APOL3;SHARPIN;F2R;LGALS9;PPM1A;PIM2;TSPAN6;GPR89A;TICAM1;FADD;CCDC22;TAB3;PELI1;WLS;PELI2;IRAK4;CXXC5;MALT1;ZDHHC13;BRD4;ROR1;S100B;MIB2;EEF1D;TAB2;MID2;TRIM14;TRAF6;SLC35B2;MTDH;TFG
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.2621139184581749,0.6892969935304012,1.0,0.9956301396262527,1.0,21/74,22.86%,NUP42;RANBP17;ATXN1;NXF1;U2AF1;SRRM1;SRSF4;XPO7;ANKLE1;SMURF1;XPO5;MALT1;NUTF2;EIF4A3;U2AF2;XPO1;EIF4E;NUP214;TPR;NEMF;MAGOHB
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),-0.4027546601331854,-0.6892778413113816,0.9152542372881356,1.0,1.0,4/16,18.44%,ACTN3;NOS2;IL10RB;NOP53
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),0.25361499379438274,0.6890830230404446,1.0,0.9955605818893128,1.0,20/94,28.79%,LARS2;MRPL4;MRPL41;NOA1;MRRF;MTRF1;EARS2;DAP3;MRPL2;AURKAIP1;QRSL1;MRPS7;MRPL55;MRPL43;MRPL58;ERAL1;MRPL3;MRPL1;MRPS16;MRPS18A
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.2641985472268688,-0.6888078831992723,1.0,1.0,1.0,3/170,1.34%,NEK2;PSMB9;KIF14
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),-0.3615145573313612,-0.6884578703163694,0.8840579710144928,1.0,1.0,3/14,18.02%,PHKG1;PYGL;CALM1
prerank,GO_Biological_Process_2021__regulation of guanyl-nucleotide exchange factor activity (GO:1905097),0.4324681888481233,0.6882927732072562,0.7894736842105263,0.9960818727189272,1.0,1/5,11.34%,GPSM1
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.32956393944106943,0.687970929918369,0.9166666666666666,0.9960873696791731,1.0,2/21,3.96%,URI1;PPP1R35
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell differentiation (GO:0051150),0.400389759695151,0.6878780405643642,0.8,0.9958298757097043,1.0,1/6,6.59%,OLFM2
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.2861584223611149,-0.6876865187657087,0.9868421052631579,1.0,1.0,2/77,2.54%,PSMB9;WNT5A
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.3836961475730727,0.6876546565073479,0.825,0.9956959637696688,1.0,2/10,7.77%,F2;RBL1
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),-0.356204190017112,-0.6876453556295783,0.847457627118644,1.0,1.0,1/17,1.39%,AHR
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.30971449933082645,0.6874941232287509,0.9142857142857143,0.9955299673581209,1.0,7/44,7.57%,BCL2;BCL2A1;HTRA2;SIRT1;IFI16;PML;ABL1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),0.26529209234101647,0.6873030044156417,0.9428571428571428,0.9954230638490353,1.0,11/59,14.59%,PYHIN1;BICD1;F2;EIF2AK3;TRAPPC12;CROCC;CEP250;GNL3L;CCDC88A;WWTR1;MARK4
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),-0.4202308011815681,-0.6872203975538008,0.9215686274509803,1.0,1.0,2/7,21.32%,REST;SOX9
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),-0.3043242217804055,-0.6868817902175675,0.9264705882352942,1.0,1.0,4/53,10.40%,KCNJ15;CAV3;KCNQ1;CD63
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),-0.31315248451034705,-0.6864199938168866,0.9310344827586207,1.0,1.0,5/36,12.62%,IFNK;CLCF1;NFAM1;PTPRC;BLNK
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),-0.424257047676395,-0.6861065916584271,0.8695652173913043,1.0,1.0,1/8,1.95%,S100A13
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),0.30156018132587825,0.6855409962456799,0.9166666666666666,0.9971062962397741,1.0,3/21,14.10%,MVB12A;CHMP6;VTA1
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),0.3731238776483412,0.6852276917980455,0.8888888888888888,0.9970685574937748,1.0,3/13,11.45%,SLFN11;SMARCAL1;TIMELESS
prerank,GO_Biological_Process_2021__positive regulation of podosome assembly (GO:0071803),-0.4438936988331511,-0.6850945026625616,0.8269230769230769,1.0,1.0,2/5,19.23%,LCP1;IL5
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),-0.30693368355734796,-0.6849168022446431,0.9,1.0,1.0,3/57,8.75%,SPDYA;CCND1;CCND2
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.35170776401060133,0.6848992334904858,0.8181818181818182,0.9970254898636416,1.0,6/15,22.35%,PPARG;ADIPOR1;ADIPOR2;PRKAA2;PRKAG2;SLC22A13
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),0.4005904275408807,0.684850699238834,0.8333333333333334,0.9967147648016038,1.0,2/10,7.32%,DEF8;PLEKHM1
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),0.42765252454262737,0.6847763788388643,0.8297872340425532,0.9957357778138478,1.0,1/5,19.97%,XYLB
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),0.42765252454262737,0.6847763788388643,0.8297872340425532,0.9957357778138478,1.0,1/5,19.97%,XYLB
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),0.42765252454262737,0.6847763788388643,0.8297872340425532,0.9957357778138478,1.0,1/5,19.97%,XYLB
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),0.24442565727473436,0.6842699092910951,1.0,0.9959124516122843,1.0,8/79,7.77%,SLFN11;PSME4;PKD2;GFI1B;CDK6;PSMA1;CDK4;RBL1
prerank,GO_Biological_Process_2021__cranial nerve development (GO:0021545),0.42709538194916746,0.6840564861608807,0.875,0.9958004090042475,1.0,1/7,4.58%,ATOH7
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.3446483675784936,-0.6838273494987337,0.9166666666666666,1.0,1.0,9/33,23.73%,WNT5A;PDE6B;LEF1;PDE6A;CALM1;CAMK2A;PDE6G;GNAT2;PLCB2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),0.2529601807827666,0.6833462457680166,1.0,0.9960463860034813,1.0,20/90,17.94%,BCL2;ERBB2;PPP1R13B;EPHA3;MAPK8;PTPN9;AKT2;ITGA3;DPP10;MIEF2;STAC2;BID;NKD2;MYO1C;TP53;WNK3;EPHB2;CLIP3;LGALS3;ARHGEF16
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),-0.249514274647756,-0.6831314385144357,1.0,1.0,1.0,44/378,16.15%,RHOXF2;C1QTNF1;FGF20;TGFB1;ACTC1;S100A13;WNT5A;GPER1;ALOX12B;EIF6;CLDN5;POLR1C;ACTG1;NFAM1;PIK3R3;BRCA1;HTR2B;CLU;SFRP4;THBS1;SLC11A1;POLR1G;WARS1;RPS4X;VSTM2A;WNT6;TLR2;TXK;PIK3CB;ZNF580;LEF1;HEY2;TTN;EEF2;CTCFL;VDR;ACTA2;FGFR4;DDX3X;METTL14;FGF22;AGT;YAP1;SMAD3
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),0.290296619749893,0.6826769651366766,0.9375,0.9964257015568776,1.0,7/35,14.18%,AKR1C3;DCPS;ADCY2;ADCY3;NDOR1;NR3C1;ADAM15
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),0.2827724860958762,0.6822383693746992,0.92,0.9965004478254822,1.0,16/55,20.28%,MAFB;CBFB;CDK6;MOV10;TNRC6C;DPY30;HDAC1;CNOT4;RUNX1;TNRC6A;NR4A3;AGO3;LGALS3;EP300;KAT2B;KMT2C
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),-0.42854053650135093,-0.6820548385161996,0.8478260869565217,1.0,1.0,1/7,1.95%,S100A13
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),-0.42854053650135093,-0.6820548385161996,0.8478260869565217,1.0,1.0,1/7,1.95%,S100A13
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),-0.4290984053252245,-0.6820291117499979,0.85,1.0,1.0,1/6,6.43%,SOX30
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),0.3280483608713712,0.6819076064013646,0.8888888888888888,0.9964470597931718,1.0,2/24,8.39%,PER2;GYS1
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),0.3847581163712319,0.6818096190037655,0.925,0.9962283293998229,1.0,3/11,8.21%,TDO2;KYAT1;AADAT
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),-0.30338878717573364,-0.6817239522454864,0.9032258064516129,1.0,1.0,6/44,14.16%,TGFB1;WNT5A;HTR2B;ENG;LEF1;HEY2
prerank,GO_Biological_Process_2021__amino-acid betaine biosynthetic process (GO:0006578),-0.442263545378216,-0.6809718503330694,0.7843137254901961,1.0,1.0,2/5,20.62%,TMLHE;BBOX1
prerank,GO_Biological_Process_2021__carnitine biosynthetic process (GO:0045329),-0.442263545378216,-0.6809718503330694,0.7843137254901961,1.0,1.0,2/5,20.62%,TMLHE;BBOX1
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.327017107620528,0.6809668529953835,0.9512195121951219,0.9967617004984202,1.0,2/14,14.95%,ABCD2;INSR
prerank,GO_Biological_Process_2021__mitochondrial ribosome assembly (GO:0061668),0.41304139008222174,0.6807434739669735,0.9230769230769231,0.9965803309924773,1.0,1/6,3.07%,MTERF3
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.2589845786940369,0.6802377161692542,1.0,0.9966708783358491,1.0,12/67,18.08%,KIFC1;KIFC2;FLNA;SPAST;AAAS;SGO2;EPS8;KLHL22;PIBF1;ESPL1;LSM14A;KIF3B
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),0.31378007371515676,0.6801746588090444,0.875,0.9963671406994503,1.0,5/12,27.39%,NAGK;UAP1;GNPNAT1;UAP1L1;GFPT2
prerank,GO_Biological_Process_2021__regulation of glucagon secretion (GO:0070092),0.4348825591743458,0.6800351412857925,0.8461538461538461,0.9961381733986345,1.0,2/5,30.89%,SYT7;CRH
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),0.3686901392005937,0.6799437021980032,0.9285714285714286,0.9958667791301474,1.0,1/7,9.00%,TWIST1
prerank,GO_Biological_Process_2021__negative regulation of delayed rectifier potassium channel activity (GO:1902260),-0.41830646338680316,-0.6799120480935749,0.9076923076923077,1.0,1.0,4/7,29.76%,KCNE3;KCNE4;KCNAB1;KCNE2
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),0.3998581638528156,0.6796726369357315,0.85,0.9958084433259264,1.0,4/8,13.98%,SERPINE1;ACER2;SNAI2;NEXMIF
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),-0.3477810012322948,-0.6796445976231864,0.9365079365079365,1.0,1.0,2/18,6.82%,PINK1;DCN
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),0.3798451661824139,0.6796149048565002,0.8064516129032258,0.9955160772854701,1.0,1/7,3.65%,CAPN10
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.3720334034881331,0.679490781872029,0.8780487804878049,0.9952770965041638,1.0,6/11,29.07%,ADCY2;ADCY3;ADCY6;PDE4D;ADCY9;ADCY5
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),-0.40654516146868575,-0.6793242476949752,0.8620689655172413,1.0,1.0,1/11,3.12%,RPP38
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),-0.2709868876483254,-0.6792697494075182,0.9868421052631579,1.0,1.0,15/122,16.36%,NEK2;FOXM1;CDC25A;FBXL7;DCTN1;TPD52L1;CDKN1A;ABCB1;TUBA4A;CEP72;DYNLL1;BORA;TUBB;CEP76;USH1C
prerank,GO_Biological_Process_2021__B cell chemotaxis (GO:0035754),-0.42052836473667776,-0.6790665948980031,0.8627450980392157,1.0,1.0,2/6,8.93%,CXCL13;HSD3B7
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),0.40080617405205154,0.6788887367070374,0.8529411764705882,0.9955433094336686,1.0,3/10,20.89%,CX3CR1;LBP;PLCG2
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),0.31271028369485426,0.6787847687189655,0.9428571428571428,0.9952672880034227,1.0,3/19,9.68%,SEMA6C;SEMA5A;SEMA4A
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),-0.26201258527364435,-0.6785901031760524,0.9883720930232558,1.0,1.0,22/178,16.15%,KIF14;TGFB1;TMC8;TP53TG5;ROS1;CRLF3;TCHP;NUBP1;PAPPA2;CEACAM1;PPT1;CDKN2D;CDKN1A;CXCL16;TAF9B;RBBP7;RERG;HYAL1;DDX3X;AGT;EI24;SMAD3
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),0.43499979931463834,0.678567349737422,0.7555555555555555,0.9951773918751198,1.0,3/5,14.40%,PTPRR;TENM3;PTPN23
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),0.3808365880903697,0.6782090551479506,0.7857142857142857,0.9951619052502858,1.0,2/7,11.91%,FLNA;LIMS1
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.34425205342683995,0.6781135775186143,0.851063829787234,0.9948863090902487,1.0,5/14,28.22%,SEC24C;MIA3;SEC31A;SEC24B;SAR1A
prerank,GO_Biological_Process_2021__positive regulation of activation of Janus kinase activity (GO:0010536),-0.4401159351787107,-0.6781047225061143,0.8113207547169812,1.0,1.0,3/5,25.89%,AGT;IL6R;CCL5
prerank,GO_Biological_Process_2021__regulation of activation of Janus kinase activity (GO:0010533),-0.4401159351787107,-0.6781047225061143,0.8113207547169812,1.0,1.0,3/5,25.89%,AGT;IL6R;CCL5
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),-0.43793986808853985,-0.6778852021238702,0.9615384615384616,1.0,1.0,3/8,25.25%,EFHB;SARAF;CASQ1
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),-0.4540093656866777,-0.677704168374716,0.8813559322033898,1.0,1.0,1/7,18.16%,KDELR3
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 methylation (GO:0051574),-0.4705827942159384,-0.6774749216384992,0.890625,1.0,1.0,1/6,5.91%,PRDM12
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),-0.25747484324172193,-0.6772644169688652,1.0,1.0,1.0,15/154,14.49%,EOLA1;AHR;TRIM58;TRIM77;TRIM5;PRDM12;RNF39;IGF2BP2;REST;PTPRC;ALPK2;TXK;RSPO1;RNF187;CGGBP1
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.2594482162348996,-0.6768262270226778,1.0,1.0,1.0,18/198,13.31%,TRIM62;NODAL;AIM2;WNT5A;TERF2IP;BEX1;CARD14;ESR1;TRIM5;TRIM25;NFKB2;NFAM1;CLU;NLRC4;COPS5;TLR2;PRKCH;NLRP3
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),0.41465787619855526,0.6761726409252014,0.9285714285714286,0.9962719082117406,1.0,1/6,3.71%,PRDM5
prerank,GO_Biological_Process_2021__eye development (GO:0001654),-0.30933450019606884,-0.6760959459462741,0.9393939393939394,1.0,1.0,7/45,17.48%,MAB21L1;COL5A1;FREM2;FBN2;CRYBA4;HIPK1;SALL2
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.4282053206669874,0.6759316321955984,0.8636363636363636,0.9961340417909302,1.0,1/6,2.54%,MITF
prerank,GO_Biological_Process_2021__T cell mediated cytotoxicity (GO:0001913),-0.41748157793398855,-0.6752885216961277,0.8653846153846154,1.0,1.0,2/6,19.12%,HLA-A;CRTAM
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),-0.3704266422560415,-0.6751972927849206,0.8333333333333334,1.0,1.0,4/12,17.95%,PON3;ACOT4;PON1;RENBP
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),-0.3715703302570105,-0.6751884780071928,0.9056603773584906,1.0,1.0,2/15,16.15%,DARS2;YARS2
prerank,GO_Biological_Process_2021__negative regulation of phospholipase activity (GO:0010519),0.38359574198779345,0.6751093732596328,0.8205128205128205,0.9964894499420386,1.0,2/7,7.57%,BICD1;ABL1
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.28171275375675076,-0.6750529570510732,0.9864864864864865,1.0,1.0,1/73,0.62%,PSMB9
prerank,GO_Biological_Process_2021__amino-acid betaine transport (GO:0015838),0.43597765311216763,0.6750321096046485,0.9333333333333333,0.9961978713502438,1.0,3/5,10.93%,SLC22A5;SLC6A20;SLC25A29
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),-0.3172102103434384,-0.6746806182863402,0.9076923076923077,1.0,1.0,7/38,19.83%,F7;THBS1;ZNF580;IL12A;F2RL1;CSF1R;CREB3
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),-0.2545378855476153,-0.6742532148613749,1.0,1.0,1.0,17/229,13.31%,PSMB9;ESR1;ACTL6A;ABRAXAS1;CDC25A;TOMM20;ATXN7L3;BRCA1;USP13;USP50;USP6;TFPT;USP17L2;COPS5;FOXO4;TAF9B;NLRP3
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),0.4203601116411448,0.6742035904302736,0.8787878787878788,0.9966801899256729,1.0,1/7,9.86%,DYRK3
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),0.3892639895302722,0.6740435306094905,0.8571428571428571,0.9961663546697664,1.0,3/9,14.60%,LGALS1;LGALS9;TMPRSS2
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),0.3892639895302722,0.6740435306094905,0.8571428571428571,0.9961663546697664,1.0,3/9,14.60%,LGALS1;LGALS9;TMPRSS2
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),-0.3594100829847383,-0.6739168463026255,0.8545454545454545,1.0,1.0,1/18,4.03%,SP100
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),-0.3303858009140277,-0.6739106233836074,0.9402985074626866,1.0,1.0,5/24,10.28%,VAV3;CLCF1;GPR183;IL7;PTPRC
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),-0.29564645349631946,-0.6734700528204433,0.958904109589041,1.0,1.0,5/41,14.16%,TGFB1;WNT5A;ENG;LEF1;HEY2
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),-0.2964692729806054,-0.6734251094645383,0.9705882352941176,1.0,1.0,5/60,7.51%,HCK;VAV3;FCGR3A;ACTG1;WAS
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.2964692729806054,-0.6734251094645383,0.9705882352941176,1.0,1.0,5/60,7.51%,HCK;VAV3;FCGR3A;ACTG1;WAS
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),0.3594775146760008,0.6731104855662938,0.8536585365853658,0.9966270021910214,1.0,3/10,21.62%,IRAK4;TRAF6;PIK3R4
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.321154011587216,0.6727317659485126,0.9705882352941176,0.9966004780801035,1.0,8/17,33.61%,MAP3K10;DUSP19;TRAF6;EDN1;TAOK3;DVL2;MAP3K4;MAP3K7
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.31365967957067054,0.6726668320915145,0.9411764705882353,0.9963041835953684,1.0,6/29,19.55%,ZBTB20;ERN1;UNC13B;MLXIPL;RAB11B;PRKAA2
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),-0.3472891235638515,-0.6723150323766784,0.9180327868852459,1.0,1.0,1/18,4.81%,ESR1
prerank,GO_Biological_Process_2021__tryptophan metabolic process (GO:0006568),0.39376206694933336,0.6722669336539817,0.926829268292683,0.9959553857507869,1.0,3/10,8.21%,TDO2;KYAT1;AADAT
prerank,GO_Biological_Process_2021__indolalkylamine catabolic process (GO:0046218),0.39376206694933336,0.6722669336539817,0.926829268292683,0.9959553857507869,1.0,3/10,8.21%,TDO2;KYAT1;AADAT
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.3236809049651418,0.6722073629466064,0.9444444444444444,0.9956543437595482,1.0,2/12,8.41%,DOC2B;SYT1
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),-0.3575302625501159,-0.6721907026020304,0.9166666666666666,1.0,1.0,1/19,1.19%,SCN5A
prerank,GO_Biological_Process_2021__negative regulation of catecholamine secretion (GO:0033604),-0.4275111251324748,-0.6720551304161293,0.85,1.0,1.0,3/6,32.45%,SYT11;SYT4;ADRA2A
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),0.3304002214870881,0.67164914299971,0.8888888888888888,0.9958342268395705,1.0,8/19,28.83%,PPIB;CWC27;NKTR;PPIH;PPIL2;PPIL6;PPIA;PPIF
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),-0.25745585453176734,-0.6715853243078442,1.0,1.0,1.0,7/182,7.96%,ARIH2;DTL;PINK1;UBE2L6;FBXL7;TRIM25;RNF213
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),-0.27296946490412927,-0.6709894368506453,0.9866666666666667,1.0,1.0,15/121,16.36%,NEK2;FOXM1;CDC25A;FBXL7;DCTN1;TPD52L1;CDKN1A;ABCB1;TUBA4A;CEP72;DYNLL1;BORA;TUBB;CEP76;USH1C
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),-0.37487759077819893,-0.6709115491893551,0.8412698412698413,1.0,1.0,3/13,17.64%,SLC25A18;ETFB;SLC25A22
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),0.30755742198962216,0.670720196534588,0.9393939393939394,0.9963572314148852,1.0,1/24,4.88%,GDAP1
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.3168894267573432,0.6707192753866786,0.9666666666666667,0.9960088547605443,1.0,2/23,2.90%,DGKD;HIP1
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),-0.4802119550622962,-0.6701833118493323,0.8888888888888888,1.0,1.0,2/5,26.89%,ALG10B;GOLGA2
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),-0.2892923841339854,-0.6699778402455621,0.9736842105263158,1.0,1.0,4/56,11.55%,CAV3;COL5A1;A4GALT;AHNAK2
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),0.3987548709632017,0.6696735216572435,0.9069767441860465,0.9965314326888575,1.0,2/10,7.20%,SIRT7;RIOK1
prerank,GO_Biological_Process_2021__melanosome assembly (GO:1903232),-0.43369648944426864,-0.6693914414724913,0.8793103448275862,1.0,1.0,1/5,23.62%,HPS4
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),0.3382976887661883,0.6689312488577009,0.8333333333333334,0.9968953896486886,1.0,5/11,23.04%,SERPINE1;TP53;ATM;ATR;PLA2R1
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),-0.3309743639022025,-0.6686060882704408,0.9375,1.0,1.0,5/30,14.82%,TGFB1;TNFRSF1B;SMAD6;HEY2;GATA4
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),0.35535490460592845,0.6685129116963379,0.90625,0.996921597941647,1.0,3/15,8.21%,TDO2;KYAT1;AADAT
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),-0.4083142288582462,-0.6684913515792357,0.9137931034482759,1.0,1.0,2/8,13.30%,SOX10;EDNRB
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),0.4387283549227991,0.6683105272095919,0.8695652173913043,0.9967421990805182,1.0,1/5,7.87%,BDP1
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),-0.3136320028697919,-0.6681619660405784,0.8695652173913043,1.0,1.0,2/25,11.31%,NUDT13;GLRX
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.3980090890797896,-0.6681243801175916,0.8387096774193549,1.0,1.0,5/8,32.97%,KCNE3;KCNE4;KCNAB1;KCNE2;CAV1
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),0.280209435781909,0.6680094580740193,0.9375,0.9966577794973247,1.0,7/42,15.37%,PUF60;TXNL4A;CELF5;CELF4;SF3B1;CELF2;LUC7L
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),0.37682028540539514,0.6678745120579039,0.9090909090909091,0.9964206517442402,1.0,2/9,16.71%,SLC6A17;SLC36A4
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.27544654860951695,-0.6678412683164819,0.9705882352941176,1.0,1.0,8/61,20.68%,PSMB9;SPI1;METTL14;YAP1;PSMA3;PSMA7;PSMB6;LMO2
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),-0.2856611051777474,-0.667364730776355,0.9833333333333333,1.0,1.0,7/69,13.23%,TICRR;ABRAXAS1;EYA1;BRCA1;ANXA1;CDKN1A;RAD1
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),-0.33769130267255265,-0.666484505257155,0.9154929577464789,1.0,1.0,4/28,14.30%,PIGH;MPPE1;PIGC;PIGL
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),-0.36328827734483243,-0.666250378627995,0.9272727272727272,1.0,1.0,1/14,4.81%,ESR1
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),-0.3179222672659061,-0.6661196650573858,0.9538461538461539,1.0,1.0,4/29,9.78%,ANGPT2;SEMA3F;SEMA3A;THBS1
prerank,GO_Biological_Process_2021__determination of left/right asymmetry in lateral mesoderm (GO:0003140),-0.4408792585492763,-0.6657781234855644,0.8709677419354839,1.0,1.0,1/5,19.47%,DAND5
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.2830677236178981,-0.6657220257987609,0.9868421052631579,1.0,1.0,12/50,22.72%,RPA3;FANCF;RAD51AP2;DCLRE1C;NUCKS1;RPS27A;DCLRE1A;FAAP20;RPA2;FANCC;MSH6;FANCI
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.31763130802541334,-0.6657181480340657,0.9552238805970149,1.0,1.0,7/34,14.43%,MMP9;GPER1;HTR1B;SOD2;P2RY6;CDKN1A;TGFB3
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.27072796028352436,-0.6655475098001795,0.9873417721518988,1.0,1.0,10/98,11.99%,TGFB1;HCK;TMC8;PINK1;SELP;CLU;BIK;SVIP;HSPA8;WARS1
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),-0.34195715927242365,-0.6649835636563808,0.8666666666666667,1.0,1.0,2/17,7.35%,TGFB1;H1-0
prerank,GO_Biological_Process_2021__p38MAPK cascade (GO:0038066),0.416171716284075,0.6648481287142536,0.8333333333333334,0.9988114199053372,1.0,1/5,11.29%,LGALS9
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),0.31216648168245986,0.6648479643737922,0.8846153846153846,0.9984631592986756,1.0,6/36,12.99%,FGF10;RGN;DNAJC24;SETMAR;PLSCR1;MYL3
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),-0.38259483030425856,-0.6647567713807978,0.8703703703703703,1.0,1.0,1/8,9.69%,REST
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),-0.4032341512829007,-0.664703545284681,0.8833333333333333,1.0,1.0,1/8,5.61%,PINK1
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.27996817157304904,-0.6643893868924385,0.9620253164556962,1.0,1.0,16/75,20.16%,TBX1;UPK1B;DAB2;UPK1A;UPK3A;ANXA1;VIL1;VDAC1;PTER;DEUP1;MESP1;OVOL3;BASP1;CASP6;ACTL8;MAF
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),0.32217956053136854,0.6640331024296411,0.925,0.9987887186850034,1.0,2/18,11.44%,CX3CR1;NLRP2B
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),-0.36002222368448067,-0.6640073485274164,0.9230769230769231,1.0,1.0,3/14,22.93%,INTS5;TRNT1;PTCD1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.3487251741129176,-0.6639361209350705,0.9523809523809523,1.0,1.0,1/16,3.74%,SCIMP
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),0.2448688643371922,0.6637162115696087,1.0,0.9986511282166759,1.0,13/60,18.13%,PPARG;ZBTB20;PNPLA3;SLC4A7;WNK2;IRS2;TLCD3B;KLHL3;NR1H3;WNK3;TLCD3A;ABHD4;ACOX1
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.3383275525461425,-0.6635020351112049,0.9310344827586207,1.0,1.0,4/22,20.26%,PLA2G10;PLB1;PLA2G4A;PLA2G4D
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),0.3287503814211374,0.6634601769265474,0.9411764705882353,0.9985609615023431,1.0,3/19,14.43%,PLD6;PIWIL1;TEX15
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),0.317461026854476,0.6634545075822437,0.9473684210526315,0.9982237867955975,1.0,3/23,7.33%,NAALADL1;CHAC1;TRHDE
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.3757134776528731,-0.6633501819167651,0.8852459016393442,1.0,1.0,5/12,24.09%,GNAT3;RTP5;PKD1L3;GNAT2;RTP1
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),-0.3148506113785722,-0.6632675974886695,0.967741935483871,1.0,1.0,1/25,1.49%,TGFB1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),0.3361095018027646,0.6631980736671421,0.8918918918918919,0.998076026643861,1.0,6/11,27.80%,WNK2;WNK3;DMD;WNK1;ANK3;NOS1
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.2955169565623176,0.6625400485949238,1.0,0.9982645720034812,1.0,5/23,17.60%,SIRT1;PML;KAT6A;SMC5;NSMCE2
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),-0.4124280647662477,-0.6620255618670692,0.8392857142857143,1.0,1.0,1/7,7.96%,RNF213
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.3391354864287706,0.6618143364736139,0.9,0.9985842696955872,1.0,7/18,30.61%,TRIM71;AGO3;TARBP2;AGO2;ZC3H7B;DROSHA;PRKRA
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.3264349729379318,-0.6617185019493504,0.921875,1.0,1.0,1/31,2.67%,SLC25A31
prerank,GO_Biological_Process_2021__negative regulation of adaptive immune response (GO:0002820),-0.4608959522594815,-0.6614325351262382,0.8888888888888888,1.0,1.0,2/5,7.49%,CD160;ALOX15
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.29871161786177536,-0.6611422370634226,0.9552238805970149,1.0,1.0,10/43,28.14%,USP50;CAV2;RNF26;HOOK2;PHETA1;VPS18;ALS2CL;LAMTOR1;LAPTM4B;ANXA8
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.27979141394531437,-0.661138977818534,0.9594594594594594,1.0,1.0,4/78,9.25%,ARIH2;DAB2;CLU;USP13
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),-0.37498264620840893,-0.661114145586036,0.9090909090909091,1.0,1.0,2/10,14.15%,LATS2;SLC6A4
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.30306757596168915,-0.6608133172530702,0.9868421052631579,1.0,1.0,6/37,17.52%,CA1;SOD2;CFL1;IL12A;LCP1;MSN
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),-0.33151763907526,-0.6607863368543958,0.8852459016393442,1.0,1.0,4/20,21.14%,PPP1R1B;TIPRL;ARPP19;BOD1
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),-0.34095186526616694,-0.6607758235031833,0.9,1.0,1.0,3/18,22.14%,INTS5;EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.2590999739099752,-0.6607367544879017,1.0,1.0,1.0,32/125,26.27%,EIF6;SNRPD2;RPL38;PWP2;DDX20;RPL3;RPS27;GEMIN4;STRAP;BRIX1;EIF2S3;EIF2S2;SRSF9;SRSF5;NOP53;DDX1;MRPL20;RPL5;RPS14;SRPK3;RPL11;RPS15;SRPK1;DENR;RPL24;CRNKL1;HSP90AB1;RPSA;RPS28;RPS19;ABT1;PRPF19
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),-0.3791868561360059,-0.6606466565142608,0.8870967741935484,1.0,1.0,1/10,3.04%,PDCD1LG2
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),0.3401431115145929,0.6605299722047467,0.9142857142857143,0.9992974586062132,1.0,2/13,12.96%,NDOR1;ENOX2
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),0.356070038289434,0.6601149666606643,0.8863636363636364,0.9993331998218932,1.0,3/8,19.09%,B4GALT3;GAL3ST1;FA2H
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),0.3691050476392577,0.6599299240925578,0.9090909090909091,0.9991800650300828,1.0,2/10,14.95%,SEMA5A;PIK3CA
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.3874598470810085,-0.6598820043073589,0.9193548387096774,1.0,1.0,2/10,14.17%,PINK1;NOS2
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),0.4258832575671681,0.6597500662995285,0.88,0.9989693521379156,1.0,1/6,1.53%,KIT
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),0.2993994635924064,0.6592941569991598,0.9375,0.9989212944831052,1.0,7/27,19.40%,SRGAP2;PHACTR1;NTNG2;NEXMIF;ZNF609;NIPBL;CTNNA2
prerank,MSigDB_Hallmark_2020__heme Metabolism,-0.2514591863693414,-0.6589424119425811,1.0,1.0,1.0,9/171,8.58%,AQP3;TRIM58;GYPE;LRP10;GYPB;FTCD;CA1;H1-0;ABCG2
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),-0.3236287005234195,-0.6582577511150695,0.8970588235294118,1.0,1.0,2/20,3.64%,TRPV6;TMC8
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),-0.3670468556181103,-0.6579292841478389,0.9230769230769231,1.0,1.0,1/11,15.75%,CD4
prerank,GO_Biological_Process_2021__regulation of gap junction assembly (GO:1903596),0.4483636529179448,0.6578767285063255,0.9259259259259259,0.999858466007698,1.0,1/5,4.67%,CNTNAP2
prerank,GO_Biological_Process_2021__glutathione catabolic process (GO:0006751),0.43167771950207023,0.6573566728576078,0.8490566037735849,0.9998363261220629,1.0,1/5,6.86%,CHAC1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.2760716613263188,-0.6569880949111345,1.0,1.0,1.0,11/96,15.72%,TGFB1;CXCL13;RPA3;ESR1;CLU;USP50;BIK;WARS1;LCP1;DDX3X;RBX1
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),0.2847551813500735,0.6569781427624827,0.9705882352941176,0.999788017755834,1.0,7/19,24.31%,NAGK;UAP1;UGDH;SLC35D1;GNPNAT1;PMM2;UAP1L1
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),0.30331497644075656,0.6566001335792221,0.9183673469387755,0.9997868574594783,1.0,2/20,8.91%,PCM1;WNT3A
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),-0.4343590491446475,-0.6562255974786853,0.9259259259259259,1.0,1.0,1/7,4.94%,SHISA6
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.2855176497032359,0.6557906028826168,0.9722222222222222,1.0,1.0,7/24,15.67%,HCLS1;FADD;TESC;HSF1;IL23A;ACIN1;RUNX1
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.25117727033102283,-0.6557032091441801,0.9759036144578314,1.0,1.0,18/131,19.58%,ARIH2;TGFB1;HSPA1L;ITGB2;PINK1;PDZK1;ITGAM;TOMM7;OAZ2;SMAD3;RAC2;ECT2;CD81;FIS1;NMT1;YWHAG;CASP8;BBC3
prerank,GO_Biological_Process_2021__alpha-beta T cell differentiation (GO:0046632),0.41513279945758913,0.6555917780642728,0.8125,0.9999153223859607,1.0,1/5,3.16%,ZBTB7B
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),-0.3252076882962193,-0.6554219658043106,0.9682539682539683,1.0,1.0,2/24,6.82%,PINK1;DCN
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.30293177184942477,-0.655309374984004,1.0,1.0,1.0,6/39,17.52%,CA1;SOD2;CFL1;IL12A;LCP1;MSN
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),-0.4309331590617743,-0.6549404333269235,0.9047619047619048,1.0,1.0,2/7,14.26%,SOD2;IL12A
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.22077784337441922,0.6548113519479202,1.0,1.0,1.0,36/191,20.85%,KLHL20;ZNRF1;SIRT1;SPOPL;PSME4;ERCC8;ARRB2;TRIM71;UBXN2A;PSMA1;PML;WWP2;MAEA;RHBDD1;SHARPIN;UBE3D;UBE2A;KLHL42;KLHL22;PELI1;ARRB1;SMURF1;NEDD4;SPOP;RNF185;FAF1;UBE4B;FBXL22;RNF122;UBXN2B;CDC34;RNF139;TBL1X;HECTD3;TRIM9;PSMD4
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.21943725422440336,0.6545237125893649,1.0,1.0,1.0,85/302,26.63%,AUP1;KLHL20;DERL3;ZNRF1;SIRT1;SPOPL;PSME4;ERCC8;ARRB2;UBE2J1;TRIM71;UBXN2A;PSMA1;PML;WWP2;MAEA;UBE2E1;SHARPIN;ANAPC16;CDC20B;DMAC2;FBXL14;UBE3D;MAN1A1;UBE2A;KLHL42;FBXL20;KLHL22;PELI1;ARRB1;FBXO27;SMURF1;RHBDD2;CDC26;TMUB2;FBXO4;NEDD4;SPOP;RNF185;FAF1;UBE4B;ANAPC7;FBXL6;EDEM1;FBXL22;FBXO31;TMEM67;RNF122;UBXN4;UBXN2B;CDC34;UBE2J2;TBL1X;HECTD3;TRIM9;PSMD4;FZR1;RNF216;CUL1;BAG6;FBXO17;AMN1;NEMF;NFE2L2;USP44;PLK1;TRIM3;APPBP2;AGAP3;UBE4A;FBXL17;FBXL2;PSMB2;ANAPC4;SIAH2;UBE2D3;ANAPC2;RB1;DNAJB14;NHLRC3;UBE2G1;PSMD5;ERLIN1;KCTD5;PSMF1
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),0.39882620319671913,0.6545220034875027,0.9230769230769231,0.9997340349988515,1.0,1/7,17.54%,CTPS2
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),-0.3778966470908819,-0.6544401008094766,0.9090909090909091,1.0,1.0,2/10,8.63%,CEACAM1;BRCA1
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.32844319749407835,0.6540022913120405,0.9024390243902439,0.9998791701338954,1.0,3/11,20.11%,PID1;PNPT1;MTM1
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),0.358735513459849,0.6535997530365164,0.8888888888888888,0.9999145370539867,1.0,2/11,12.94%,COX19;CCDC22
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.3057094904502976,-0.6532328499751873,0.9577464788732394,1.0,1.0,4/32,11.54%,TRMO;WDR6;TRMT10A;DALRD3
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",0.3663124530458799,0.6531429830906709,0.8108108108108109,0.9999603204574423,1.0,2/7,11.29%,TWSG1;LGALS9
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),0.3015380691696173,0.6531177555836051,0.8888888888888888,0.9996355468960878,1.0,9/30,19.27%,FSCN3;EPS8;FSCN1;ESPN;CALD1;MICAL1;PAWR;CORO1B;ADD1
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),0.404205552121129,0.6530540920890744,0.8604651162790697,0.9993318652333445,1.0,3/5,29.63%,LIG4;POLB;LIG3
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),0.35443683844721285,0.6530101670289258,0.8974358974358975,0.999017963245764,1.0,5/10,35.11%,XPO5;STAT3;FMR1;LIMD1;PUM2
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),0.3450962867932109,0.652870963874144,0.9523809523809523,0.9987616239047602,1.0,4/12,28.09%,AGBL4;GPLD1;ATG12;ATG7
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),0.29589335025874663,0.652637636247723,1.0,0.9986044792873013,1.0,3/23,11.79%,ZBTB20;ERN1;UNC13B
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),0.4279322282903787,0.6523644673669997,0.9069767441860465,0.9985464267073385,1.0,1/5,17.54%,CTPS2
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.3047687947550807,-0.652145484926362,0.9571428571428572,1.0,1.0,6/55,8.75%,DTL;CCND1;CDC25A;RAB11A;ANXA1;CCND2
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.24672312163262541,0.6521369368699207,1.0,0.9984102961960857,1.0,5/74,8.65%,EGLN3;PSME4;ATF3;PSMA1;HIF3A
prerank,GO_Biological_Process_2021__nodal signaling pathway (GO:0038092),0.4088132453247928,0.651469631255088,0.9459459459459459,0.9986126540924961,1.0,3/5,24.13%,SMAD2;CFC1;ACVR1B
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),0.3854584850813308,0.6512154950766216,0.8888888888888888,0.9985078202530202,1.0,5/8,40.03%,ZFAND6;PEX16;LONP2;PEX12;HACL1
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),0.3595535661499567,0.6502929447369125,0.9130434782608695,0.9988244596798139,1.0,2/11,9.08%,CHAC1;SARDH
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.36002705455542894,0.6501009018835245,0.8863636363636364,0.9986416147601184,1.0,2/8,16.02%,HSPA1A;SACS
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),0.3707331319434358,0.6500794484439708,0.8913043478260869,0.9983185255014058,1.0,2/8,10.67%,AKT2;IRS2
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),-0.3457237070814906,-0.6500346617363905,0.9375,1.0,1.0,1/16,1.49%,TGFB1
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),-0.3481263062751273,-0.6500273201923588,0.921875,1.0,1.0,5/17,24.71%,GUCY2C;ADCY7;GUCY2F;ADCY1;NPR2
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),-0.3688838728532882,-0.6497744809756023,0.9090909090909091,1.0,1.0,3/9,14.70%,HTR2B;EDNRB;ACTA2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),0.31626667191598723,0.6497437053420028,0.8947368421052632,0.9982295285877623,1.0,5/14,25.91%,DYRK3;KLHL18;PLCG2;EZH2;ZNF16
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),-0.3977744333214689,-0.6496229907219432,0.9,1.0,1.0,2/7,23.11%,SPI1;VCPIP1
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),-0.2461071500283719,-0.649315556031402,1.0,1.0,1.0,17/238,13.31%,PSMB9;ESR1;ACTL6A;ABRAXAS1;CDC25A;TOMM20;BRCA1;SENP3;USP13;USP50;USP6;TFPT;USP17L2;COPS5;FOXO4;TAF9B;NLRP3
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),0.3529625243468414,0.6491590727219346,1.0,0.9983068431859892,1.0,3/8,29.68%,ITPK1;IPPK;POMK
prerank,GO_Biological_Process_2021__venous blood vessel development (GO:0060841),0.4058014123227841,0.6488839251301124,0.7435897435897436,0.9981867503194578,1.0,1/5,6.26%,PROX1
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),-0.3646734041081997,-0.6487071264608006,0.9464285714285714,1.0,1.0,2/13,20.12%,USP13;HERPUD1
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),-0.3560227292370333,-0.648327928788386,0.8615384615384616,1.0,1.0,5/10,20.21%,TNFRSF1B;EGR2;MYRF;ITGAX;NCMAP
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),-0.2878580062687203,-0.6481614994187034,0.9571428571428572,1.0,1.0,3/33,10.93%,CAVIN1;POLR1C;POLR1G
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.271032501264049,0.6480737585536045,0.9767441860465116,0.9985132303367268,1.0,8/38,19.37%,JADE3;TAF12;KAT6A;SUPT3H;JADE2;KAT14;KAT2B;KAT6B
prerank,GO_Biological_Process_2021__cellular ion homeostasis (GO:0006873),0.3885827979617683,0.6478673339489576,0.8125,0.998341249460548,1.0,2/5,19.85%,RHCG;SLC4A11
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),0.2536614691649904,0.6474764290770736,1.0,0.9982575858329781,1.0,16/57,21.61%,KIT;BCL2;ADGRG3;ITGA4;CD22;FLT3;HDAC4;BANK1;MALT1;EPHB2;IL11;KLF6;HDAC5;PLCG2;ZBTB7A;PTPRJ
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.3221581206264061,0.6473550374288283,0.9393939393939394,0.9979717102007822,1.0,3/19,13.74%,BCL2;PML;RAP1GDS1
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),-0.37586467287339514,-0.6471214933689996,0.8421052631578947,1.0,1.0,4/8,22.47%,TXNIP;RFPL1;ORC6;BLM
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),-0.2729651349987242,-0.646122877698808,1.0,1.0,1.0,8/74,14.17%,DTL;WNT5A;TNFRSF1B;GPC3;C4BPA;ASB5;OAZ2;C4BPB
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),0.3409758317163284,0.6460273697440874,0.9393939393939394,0.998697031036604,1.0,3/15,7.51%,JAGN1;CDK4;PML
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),0.313918667624967,0.6460155039589487,0.9032258064516129,0.9983801038063558,1.0,5/17,12.32%,PARD3;RNF10;RIMS2;UNC13B;ATPSCKMT
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),0.24700114805258747,0.6457599491561228,1.0,0.9981618341910313,1.0,35/142,23.33%,SMYD2;CCNG1;PPP1R13B;SGK1;PML;TAF3;MLST8;TAF12;BANP;KAT6A;HDAC1;CHD4;PLK3;TP53;EXO1;PIP4K2A;ATM;RAD17;TAF4;PRMT5;NOC2L;RAD9A;ATR;EP300;CDK5;PRKAA2;MAP2K6;PRKAG2;DNA2;RBBP4;MDM4;ATRIP;TTC5;BRIP1;JMY
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.3306622637644427,-0.6454133308831191,0.8939393939393939,1.0,1.0,5/24,18.02%,GPER1;TRDN;P2RY6;JPH2;CALM1
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),0.2812069657121601,0.6453050875938523,0.95,0.9981198098596274,1.0,4/32,12.82%,ITGA4;MMP2;GRIN1;ABCC1
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),0.42283558180296743,0.6451959544954142,0.8636363636363636,0.9978603591806063,1.0,2/5,24.57%,FBH1;MUS81
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.2685950352782283,0.6451054415528307,0.9285714285714286,0.99758555920291,1.0,6/45,12.47%,HSPB1;TOR1B;DNAJB5;RHBDD1;ERN1;HSPA1A
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.3252038639815291,-0.6442821670790352,0.9482758620689655,1.0,1.0,4/23,16.35%,PINK1;UBE3A;ATP5IF1;NUDT15
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.3225726888920049,-0.6441794403039831,0.921875,1.0,1.0,5/23,20.07%,NLRC3;RNF26;CACTIN;CARD8;DHX58
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),-0.36158038771909884,-0.6440371348271277,0.9538461538461539,1.0,1.0,1/11,6.40%,TRDN
prerank,"GO_Biological_Process_2021__regulation of phagocytosis, engulfment (GO:0060099)",0.3699803424393471,0.6430133253087431,0.9069767441860465,0.9989459174805869,1.0,1/8,3.06%,RAB31
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.35089091345831636,0.6428261543486934,0.8780487804878049,0.9987381722702409,1.0,4/8,19.44%,MICU1;MCU;RAP1GDS1;SLC25A23
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.280929750721354,-0.6423668742836277,0.96,1.0,1.0,11/60,14.99%,TERF2IP;NLRP12;UACA;LRRC19;SPI1;TLR2;NLRC3;C1QTNF4;NLRP3;CD27;DDX3X
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.30607155608958,0.642024525315735,1.0,0.9989959063949077,1.0,6/33,17.62%,BCL2;STYXL1;BID;TP53;NCK1;FBH1
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),0.3604047190981177,0.6416576634519772,0.8235294117647058,0.9989019964267829,1.0,1/7,10.31%,TERF1
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),0.27321987119737645,0.6411300511505044,1.0,0.998916655062044,1.0,4/38,16.04%,SDHAF4;COX10;ME3;NR4A3
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),-0.39109880915040157,-0.6411286692312691,0.9047619047619048,1.0,1.0,1/8,18.81%,FIS1
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),-0.4141306204646176,-0.641055099728603,0.8771929824561403,1.0,1.0,2/6,13.53%,ANXA1;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),0.3829710589387355,0.6404596312112216,0.8888888888888888,0.9990397708720867,1.0,1/5,13.88%,RPS6KA4
prerank,GO_Biological_Process_2021__protein geranylgeranylation (GO:0018344),0.3896884058714797,0.6403692740089155,0.825,0.9987807154202952,1.0,2/5,12.75%,PGGT1B;FNTA
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.30826951347025056,0.6402847864566976,1.0,0.9984908676607145,1.0,2/18,11.34%,RRP1B;GPSM1
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),-0.376452350085894,-0.64002058451478,0.9193548387096774,1.0,1.0,3/8,26.49%,TXN;PARK7;PDE8A
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),0.35827712341550166,0.6399656650185703,0.88,0.9984230898176403,1.0,2/7,11.01%,ABI3;RBMS3
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.30537115703603646,-0.6396207767229564,0.9857142857142858,1.0,1.0,6/22,20.83%,HLA-DRB1;PTPRC;USP17L2;CD81;DHX58;DDX60
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.2375014428817434,0.6391480025692483,1.0,0.9987215795823812,1.0,8/84,12.84%,HLA-DQB1;RAB7A;HLA-DRA;SEC24C;DYNC1I2;CTSV;MARCHF8;KIF4B
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.2586449246284988,-0.6390404500415725,1.0,1.0,1.0,4/111,4.31%,PSMB9;WNT5A;PDE6B;FZD8
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),-0.2515071247578674,-0.6389495072894696,1.0,1.0,1.0,2/138,0.62%,TENT5B;PSMB9
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),0.38532587086181214,0.6388989728982342,0.918918918918919,0.9985712686839554,1.0,2/7,18.00%,CCDC22;FAF1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),-0.3831766734712148,-0.6385285245644022,0.9166666666666666,1.0,1.0,1/5,18.30%,LDLRAP1
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),-0.3226495728548533,-0.6383810941413417,0.9076923076923077,1.0,1.0,1/20,8.67%,ACTN3
prerank,GO_Biological_Process_2021__regulation of glycogen (starch) synthase activity (GO:2000465),0.38421500899025257,0.6383755023040429,0.847457627118644,0.9986994047375565,1.0,5/5,61.59%,EPM2AIP1;GSK3B;INPP5K;GSK3A;PPP1R3F
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),-0.34305612276820874,-0.6382104920351069,0.9841269841269841,1.0,1.0,1/14,2.81%,WNT8B
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),-0.370115546978796,-0.6379721305472109,0.8676470588235294,1.0,1.0,1/11,10.70%,DNAJA1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.3080409366347992,0.6379066770472925,0.9444444444444444,0.9987089397280198,1.0,7/17,23.83%,TICAM2;MFHAS1;NR1H3;LBP;APPL2;NINJ1;NR1D1
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),-0.3206689483674665,-0.6378990080389924,0.9841269841269841,1.0,1.0,2/20,11.55%,CHMP3;ATF5
prerank,GO_Biological_Process_2021__negative regulation of skeletal muscle cell differentiation (GO:2001015),-0.4068783003631832,-0.6376700366888849,0.8888888888888888,1.0,1.0,2/5,32.58%,SIX4;EPHB1
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),-0.31775904991854786,-0.6373220159819453,0.9117647058823529,1.0,1.0,5/21,22.07%,CDKN2D;CDKN1A;DYNLL1;INHA;CDKN1B
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,0.24571196374532261,0.637129108327255,1.0,0.9989039044684475,1.0,2/84,3.08%,TEAD2;FAM83H
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),-0.3755835918646333,-0.6369980111358574,0.8450704225352113,1.0,1.0,1/7,8.69%,SENP3
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),0.2918913861799216,0.6368916383299715,0.8918918918918919,0.9987794826996366,1.0,9/31,19.27%,FSCN3;EPS8;FSCN1;ESPN;CALD1;MICAL1;PAWR;CORO1B;ADD1
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),-0.38444207275209225,-0.6368131101504327,0.9137931034482759,1.0,1.0,2/8,13.27%,BLK;ORMDL3
prerank,GO_Biological_Process_2021__succinate transmembrane transport (GO:0071422),-0.4235827734952584,-0.6368105662563716,0.8253968253968254,1.0,1.0,1/5,23.32%,SLC25A11
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),-0.36911942379957213,-0.6366259812625681,0.9402985074626866,1.0,1.0,2/10,17.64%,SLC25A18;SLC25A22
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.31040369412311103,0.6365877538669577,0.918918918918919,0.9986397032894835,1.0,2/17,5.50%,SLC8A1;NRG1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.3859527797192314,-0.6365273488292562,0.9090909090909091,1.0,1.0,2/10,8.63%,TAF7;BRCA1
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),-0.29632496127905433,-0.6364176692775312,0.9696969696969697,1.0,1.0,10/32,21.60%,WNT5A;ADAM21;BIK;LRP2;GATA4;MEA1;BASP1;SIX4;SOX9;AR
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),0.3059806402100653,0.6363739285404073,0.9743589743589743,0.9984588532398972,1.0,1/18,2.88%,EPHA7
prerank,GO_Biological_Process_2021__alpha-amino acid biosynthetic process (GO:1901607),-0.3803610501750711,-0.6362738492948469,0.9245283018867925,1.0,1.0,2/7,14.94%,SDS;SDSL
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,-0.24686457841275167,-0.635780829190301,1.0,1.0,1.0,19/187,16.42%,BUB1;MCM2;HK2;ITGB2;CDC25A;ATP6V1D;PIK3R3;PDAP1;GLRX;COPS5;WARS1;CDKN1A;TUBA4A;IFRD1;CCNF;ACSL3;HSPE1;PSMA3;DDIT4
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),0.38973985788011,0.6355181672223656,0.851063829787234,0.9987719491797842,1.0,4/5,31.37%,CLEC16A;RUBCN;TMEM39A;UBQLN4
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),-0.29516909348664067,-0.6349983037912775,1.0,1.0,1.0,1/26,2.89%,CCDC39
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.23719977397391562,0.6349811164834767,1.0,0.998863715735455,1.0,13/94,14.39%,FHIT;PRICKLE1;COMMD1;TRIB2;N4BP1;RNF217;EIF3H;HSPA1A;RNF180;RYBP;FOXF2;NKD2;HSPBP1
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.2473845367675094,-0.6348051995348674,1.0,1.0,1.0,12/162,13.22%,HK2;PINK1;TOMM20;HIGD1C;SLIRP;STOML2;TERT;CAV2;BIK;CHCHD2;TOMM7;COX7A1
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),0.26744748832090437,0.6344164095371776,1.0,0.998965700769375,1.0,8/25,21.39%,USP36;CLEC16A;QSOX1;PIK3CA;SEC22B;SMG1;MTM1;RUBCN
prerank,GO_Biological_Process_2021__hyaluronan biosynthetic process (GO:0030213),-0.3949122763677548,-0.6341900499634823,0.8703703703703703,1.0,1.0,1/6,14.93%,HYAL1
prerank,"GO_Biological_Process_2021__pentose-phosphate shunt, non-oxidative branch (GO:0009052)",-0.4102462837512733,-0.6334286876842229,0.9354838709677419,1.0,1.0,2/5,21.68%,TALDO1;RPEL1
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),-0.3035701394615773,-0.6334272897662762,1.0,1.0,1.0,3/33,7.24%,KIF14;TNFRSF1B;LGI4
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),-0.33920246875975263,-0.6331623092321734,0.9666666666666667,1.0,1.0,4/12,18.95%,IL12A;IL18;HLA-F;AXL
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting serotonin receptor signaling pathway (GO:0007198),0.40814831078813707,0.6330557674320697,0.9090909090909091,0.9996688483111554,1.0,1/6,2.78%,HTR1F
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),-0.38122842339293583,-0.6328379989685277,0.8833333333333333,1.0,1.0,1/6,15.61%,POLR2M
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),-0.29306062768743696,-0.6323052928338562,0.9523809523809523,1.0,1.0,3/29,7.40%,GPER1;EIF6;CEACAM1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.25754604487161953,-0.6322093942910091,0.9868421052631579,1.0,1.0,8/86,15.53%,HLA-DMA;HLA-A;HLA-DPB1;HLA-DRB1;DCTN1;HLA-DPA1;DYNLL1;HLA-F
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.29336623662933137,0.6319944379138378,0.926829268292683,1.0,1.0,7/24,23.71%,DCUN1D1;ABL1;UBE2L3;LIMK1;SMAD7;AXIN1;PLK1
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),-0.38456956077409343,-0.6318108311290128,0.9387755102040817,1.0,1.0,1/6,11.56%,LRP2
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),-0.2757895128083626,-0.6312184678867346,0.9875,1.0,1.0,13/68,21.60%,TMC8;CLU;APOM;PON1;SVIP;HSPA8;NR1H4;DDX3X;DNAJB1;NOP53;HSPA5;TFIP11;AR
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),-0.35003670096376327,-0.631180210331372,0.9393939393939394,1.0,1.0,3/16,11.29%,TAF7;BRCA1;USP17L2
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),-0.31998065160578787,-0.6308021427942453,0.958904109589041,1.0,1.0,7/23,27.53%,USP50;USP17L2;OTUB1;VCPIP1;OTUD4;YOD1;USP5
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),0.38558992726791674,0.6307827168021632,0.8918918918918919,1.0,1.0,5/7,40.03%,ZFAND6;PEX16;LONP2;PEX12;HACL1
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),0.36742606709330583,0.6306331537128042,0.825,1.0,1.0,1/8,13.55%,PELI1
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.25339748936994133,-0.6303865137358378,1.0,1.0,1.0,3/98,5.08%,PSMB9;VAV3;TEC
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),-0.33842109073763993,-0.6299170012893494,0.9384615384615385,1.0,1.0,4/23,19.91%,WNT5A;CDKN1A;AGT;FN1
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),-0.32706105011969694,-0.6295758507434855,0.971830985915493,1.0,1.0,4/25,14.30%,PIGH;MPPE1;PIGC;PIGL
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),-0.39348118792897424,-0.6293527616247419,0.864406779661017,1.0,1.0,1/6,21.48%,PARP10
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.31310878954658466,-0.629186379277882,0.9545454545454546,1.0,1.0,3/27,13.34%,CAV3;CLU;ATP5IF1
prerank,GO_Biological_Process_2021__regulation of cellular response to hypoxia (GO:1900037),-0.4107670281575604,-0.6290976909619703,0.8936170212765957,1.0,1.0,1/5,12.00%,CHCHD2
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.23749199723203893,-0.6288210053908024,1.0,1.0,1.0,41/269,23.15%,TICRR;POLQ;TRAIP;RPA3;ABRAXAS1;FANCF;EYA1;RAD51AP2;TNP1;UBE2U;BRCA1;CDKN2D;REXO4;DCLRE1C;RAD1;POLE2;NUCKS1;PARP4;POLD4;SMUG1;RPS27A;HMGA2;NOP53;RAD54L;DDX1;OGG1;RECQL4;DCLRE1A;SMARCA5;FAAP20;TOPBP1;RPA2;FANCC;APTX;MSH6;BLM;UBXN1;FANCI;XRCC1;VCPIP1;RAD9B
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),-0.3881586678159114,-0.6285250576264312,0.9795918367346939,1.0,1.0,2/5,25.58%,RNF20;CDK9
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),-0.379745356480157,-0.6279593798297223,0.9473684210526315,1.0,1.0,3/8,17.46%,PIK3CB;PIK3C2G;PIK3CG
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.3293795146515861,0.6278185182286105,0.9166666666666666,1.0,1.0,3/11,20.80%,SP7;SOX5;RBM24
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),0.35828205386823486,0.6276944116542228,0.9117647058823529,1.0,1.0,3/10,19.44%,MICU1;MCU;SLC25A23
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.3267882184342437,-0.6274804451587261,0.9285714285714286,1.0,1.0,2/12,21.05%,HLA-DRB1;BAIAP3
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),0.4035462803235139,0.6272416751743697,0.9090909090909091,1.0,1.0,2/5,21.96%,PDE4B;PDE4D
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),0.2586457379655927,0.626839525995187,1.0,1.0,1.0,6/39,10.32%,CDH5;SNCA;ABL1;MAPRE1;NAV3;AKAP9
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),-0.28404859297845725,-0.6267248456383614,0.9487179487179487,1.0,1.0,5/36,20.29%,MYO1F;MYO5B;NDEL1;MYO15A;MYO7B
prerank,GO_Biological_Process_2021__negative regulation of NLRP3 inflammasome complex assembly (GO:1900226),-0.4230618995004822,-0.6265084391977795,0.9245283018867925,1.0,1.0,1/5,13.04%,NLRC3
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),0.35884534839745275,0.6265034494123298,0.9090909090909091,1.0,1.0,1/9,10.31%,TERF1
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.34038258744277894,-0.6263453967591174,0.9607843137254902,1.0,1.0,5/16,21.33%,SOD2;CLU;FIS1;BBC3;IFI6
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),-0.3289524385880662,-0.6262804387504749,0.9464285714285714,1.0,1.0,1/16,2.65%,BLK
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),0.3076296526170322,0.6259703263376097,0.9473684210526315,1.0,1.0,4/14,24.51%,UPP2;UCK2;PUDP;CDA
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),-0.29440948031061637,-0.6258773335701758,0.9701492537313433,1.0,1.0,5/32,13.14%,STAT1;FAM210B;SCIN;PITHD1;FAXDC2
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),-0.3634584674547485,-0.6258652392909614,0.9333333333333333,1.0,1.0,4/12,16.97%,IFIT1;ATP5IF1;PAM16;PLN
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.3382182207992315,-0.625773668830693,0.896551724137931,1.0,1.0,2/16,10.28%,SELP;PTPRC
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.27413631930760624,0.6256152596059553,0.9375,1.0,1.0,13/27,34.77%,ABL1;MAPRE1;SKA1;GBA2;CAMSAP3;MAP2;MAPRE3;CLASP2;SKA3;MAPRE2;GAS2L1;CLASP1;GAS2L2
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),-0.417435435773016,-0.6252648041521757,0.9310344827586207,1.0,1.0,1/5,5.67%,UBE2L6
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.39867922382021626,-0.623754029635132,0.8947368421052632,1.0,1.0,2/6,24.17%,RTF1;PAF1
prerank,GO_Biological_Process_2021__glomerulus vasculature development (GO:0072012),-0.3942165056417857,-0.6237091933700323,0.8653846153846154,1.0,1.0,2/6,13.55%,ANGPT2;TEK
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),-0.37906095099114523,-0.6233489514941861,0.8478260869565217,1.0,1.0,1/7,20.84%,AGER
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.39308023439658535,0.623340766914554,0.9285714285714286,1.0,1.0,3/5,31.33%,CHRM3;DOCK4;ZDHHC21
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.27403569736471267,-0.6231103265285571,1.0,1.0,1.0,11/68,19.41%,GPER1;GSDME;BRCA1;GBP1;CXCL16;GGT5;HYAL1;ZFP36L1;CACTIN;TNFRSF11A;CASP8
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.3038774314664512,-0.6229791177037449,1.0,1.0,1.0,1/25,2.00%,DISC1
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),-0.3085483051439148,-0.6222514026600309,0.9726027397260274,1.0,1.0,9/31,24.32%,ACP3;GRN;HOOK2;SNAPIN;ACP4;TPP1;HPS4;VPS18;ACP2
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),-0.3951929818279092,-0.6211991363965627,0.9375,1.0,1.0,2/5,14.51%,PDZK1;SLC22A4
prerank,GO_Biological_Process_2021__nephron tubule development (GO:0072080),0.39400591671291507,0.6209120520532952,0.8444444444444444,1.0,1.0,1/5,6.85%,OSR1
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),-0.2979108463384174,-0.620360012746332,0.9454545454545454,1.0,1.0,7/26,19.87%,GPER1;HTR2B;EDNRB;AGT;F2RL1;SCPEP1;ACE2
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),0.2788171965809664,0.6202018527319256,1.0,1.0,1.0,6/26,16.08%,FZD5;HLA-DRA;ZBTB1;FADD;IL23A;MALT1
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.231830304650017,0.6201402825493337,1.0,1.0,1.0,13/67,18.96%,SNX18;SEPTIN10;SPAST;RAB35;KIF4B;SPIRE2;SNX9;SEPTIN9;SEPTIN8;ESPL1;ARL3;BIN3;STAMBP
prerank,GO_Biological_Process_2021__retinal cone cell development (GO:0046549),-0.4167420380370501,-0.6196787832254692,0.9047619047619048,1.0,1.0,2/5,16.36%,RP1;USH1C
prerank,GO_Biological_Process_2021__retinal cone cell differentiation (GO:0042670),-0.4167420380370501,-0.6196787832254692,0.9047619047619048,1.0,1.0,2/5,16.36%,RP1;USH1C
prerank,GO_Biological_Process_2021__regulation of bile acid metabolic process (GO:1904251),-0.4017897073090719,-0.619275115091944,0.8870967741935484,1.0,1.0,4/5,21.83%,NR1H4;FGFR4;ABCB11;PANK2
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),-0.29914549435035825,-0.6186499576631822,0.9846153846153847,1.0,1.0,1/29,2.76%,CAV3
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.2291109055409802,0.6185943167676167,1.0,1.0,1.0,25/130,19.27%,KSR1;CDH13;RALB;DNMT1;RRAS2;RAPGEF1;RALA;RAP2A;MYO9B;FARP2;PHACTR4;EPS8L2;RAP1A;EPS8;NF1;TP53;BRAP;CRKL;RIT2;RAPGEF3;LIMK1;RASSF1;ELMO1;ARHGAP5;SOS1
prerank,GO_Biological_Process_2021__mucosal immune response (GO:0002385),-0.36810567711831405,-0.618437383306499,0.9710144927536232,1.0,1.0,2/8,14.17%,BPIFB1;NOS2
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),-0.33910187531505576,-0.617663277498436,0.9166666666666666,1.0,1.0,1/14,2.65%,BLK
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),-0.36577342008832286,-0.6173182293103833,0.8983050847457628,1.0,1.0,2/9,19.10%,ACSS3;SLC27A5
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.3028920143319866,0.6169176684563571,1.0,1.0,1.0,5/14,26.98%,GNL3L;HDAC4;RASD2;EGR1;SAE1
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),-0.30225492876285426,-0.6165630120682776,0.9605263157894737,1.0,1.0,3/21,11.29%,TNP1;NLRC4;USP17L2
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.24932414982737008,0.6163181005981072,0.96875,1.0,1.0,8/45,16.34%,SNX18;CNTROB;SPAST;RAB35;KIF4B;SNX9;ESPL1;ARL3
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.2686399350555376,0.6162351017830976,1.0,1.0,1.0,7/19,22.12%,MOV10;TNRC6C;TNRC6A;AGO3;AGO2;CNOT6;NRDE2
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),-0.366280058550021,-0.6158968753927108,0.9166666666666666,1.0,1.0,2/8,19.10%,ACSS3;SLC27A5
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),-0.3847015754965052,-0.6157443313328973,0.9672131147540983,1.0,1.0,2/8,10.89%,TAF7;SPI1
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),0.3700845220900665,0.6154303295554456,0.85,1.0,1.0,1/6,12.94%,FADD
prerank,GO_Biological_Process_2021__protein localization to membrane raft (GO:1903044),-0.39945115971563816,-0.6154036296014738,0.9038461538461539,1.0,1.0,3/5,32.97%,FLOT1;RFTN1;CAV1
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.271798704854328,-0.6152418758643226,0.9864864864864865,1.0,1.0,5/43,18.03%,TGFBI;UBE2L6;MFGE8;SIAH1;RPS27A
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),-0.2984190492511881,-0.6148006544067256,0.9523809523809523,1.0,1.0,6/34,18.74%,HCK;BAIAP2L1;TEK;BAIAP2L2;NTRK3;CSF1R
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),0.3850095306549218,0.6143503520669582,0.8888888888888888,1.0,1.0,2/5,10.59%,LDLR;RNF128
prerank,GO_Biological_Process_2021__sensory perception of bitter taste (GO:0050913),-0.3561163195787552,-0.6140938359161313,0.9180327868852459,1.0,1.0,4/11,24.09%,GNAT3;RTP5;GNAT2;RTP1
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.29591052496912457,0.6136802633628479,1.0,1.0,1.0,8/21,24.20%,HEXIM2;LATS1;NR2F2;MEN1;PTEN;TFAP4;PLK1;IPO7
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),0.3914361879157222,0.613602143658334,0.9142857142857143,1.0,1.0,1/5,10.61%,PPIB
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.26567026234674473,-0.6134183695963926,0.9859154929577465,1.0,1.0,9/72,20.12%,ARIH2;DAB2;CLU;RBX1;STUB1;NOP53;RNF144B;RFPL1;HERPUD1
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.25651461358722466,0.6132837027462756,0.96875,1.0,1.0,4/30,12.99%,MAGI2;BOD1L1;STYXL1;PPP1R15B
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),-0.3093370435587618,-0.61302349381115,0.9672131147540983,1.0,1.0,3/29,15.70%,DONSON;RAD1;TIPRL
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),-0.257930768764677,-0.6126994858996787,0.987012987012987,1.0,1.0,14/76,22.05%,NDUFS2;COX17;TMEM126A;NDUFA2;NDUFB4;NDUFC1;NDUFA1;NDUFB9;COX20;CHCHD4;NDUFB10;NDUFS5;NDUFB11;NDUFAF5
prerank,GO_Biological_Process_2021__succinate transport (GO:0015744),-0.3999856929352695,-0.6126514165717429,0.8787878787878788,1.0,1.0,1/6,23.32%,SLC25A11
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.25573565867013165,0.6124266117054934,0.9696969696969697,1.0,1.0,9/31,26.51%,LGALS9;GDF6;MFHAS1;GADD45A;RELL1;DLG1;BMP2;EMC10;RELL2
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.3504784902954549,0.6124003261466754,0.868421052631579,1.0,1.0,5/7,26.53%,GREM1;PMEPA1;EMILIN1;SMAD7;SNX25
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.2925995131025466,-0.6118705534462658,1.0,1.0,1.0,5/28,13.42%,WNT5A;IL7;TXK;C1QTNF4;CD300LF
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.3521911889240574,0.6118688748144616,0.8723404255319149,1.0,1.0,3/9,18.66%,ANTXR2;ANTXR1;ADAM10
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.30582059770099956,0.611698083746024,0.9714285714285714,1.0,1.0,5/26,9.01%,ROBO2;JAG1;SLIT2;TWIST1;SNAI2
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),-0.2774345916300359,-0.6116780339326836,1.0,1.0,1.0,6/44,16.92%,TGFB1;PLA2G10;RBM4B;EDNRB;AGT;METTL18
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),0.32627743579973156,0.6114392906740054,0.9142857142857143,1.0,1.0,3/10,17.21%,FZD5;WLS;SKI
prerank,GO_Biological_Process_2021__calcitonin family receptor signaling pathway (GO:0097646),0.40873049117617044,0.6111159253280724,0.868421052631579,1.0,1.0,2/5,29.59%,IAPP;RAMP1
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.3298838791695028,0.6108897322826471,0.9285714285714286,1.0,1.0,2/10,14.06%,CLYBL;PNPT1
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.3298838791695028,0.6108897322826471,0.9285714285714286,1.0,1.0,2/10,14.06%,CLYBL;PNPT1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.32650286501555204,0.6108548022830491,0.967741935483871,1.0,1.0,4/13,27.54%,NOP9;NOP14;TBL3;RRS1
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),0.367447585137165,0.6107369208962531,0.9545454545454546,1.0,1.0,3/7,16.67%,HES1;NF1;NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),-0.25666202815810274,-0.6104921355351474,0.9861111111111112,1.0,1.0,12/90,16.56%,BOLL;EIF6;DAZL;MPV17L2;THBS1;RPS4X;RPS9;EEF2;DDX3X;METTL14;RCC1L;EIF2S3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),-0.2766621035886989,-0.6102721790669058,1.0,1.0,1.0,2/48,5.18%,STAC;GPER1
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),0.3060381176176438,0.6102677296468974,0.9487179487179487,1.0,1.0,2/11,12.32%,F2R;ATPSCKMT
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.3432614108940726,0.6096802212093174,0.8918918918918919,1.0,1.0,4/9,22.74%,ABCA1;SREBF2;SMAD7;NFE2L2
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),-0.2558277684174971,-0.6094156591270914,1.0,1.0,1.0,1/84,0.62%,PSMB9
prerank,GO_Biological_Process_2021__G protein-coupled opioid receptor signaling pathway (GO:0038003),0.40599831170913214,0.6093464288029281,0.9111111111111111,1.0,1.0,2/5,18.92%,OPRD1;OPRK1
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),-0.22737606939643143,-0.6093037921081915,1.0,1.0,1.0,13/287,8.64%,PSMB9;ARIH2;TRIM62;PRAME;DTL;TRIM5;UBE2L6;FBXL7;FBXL13;RNF213;UBE2U;BRCA1;UBE3A
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),0.3395923264100233,0.6087187365474299,0.9130434782608695,1.0,1.0,1/8,4.59%,SIRT1
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.27677864611037073,-0.6087135492683484,1.0,1.0,1.0,11/61,19.41%,STAT1;IL7;PTPRC;PALM3;IFNGR2;HIPK1;CDC37;CD24;SPATA2;AXL;CASP8
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.2831848843717485,-0.6085578778616773,0.9848484848484849,1.0,1.0,2/36,8.70%,ACTN3;AZIN1
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),0.3382295325757085,0.608270258115633,0.9705882352941176,1.0,1.0,1/9,7.29%,DRD4
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),0.31590723599764325,0.6078216914388465,0.9210526315789473,1.0,1.0,4/11,24.51%,UPP2;UCK2;PUDP;CDA
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),0.31590723599764325,0.6078216914388465,0.9210526315789473,1.0,1.0,4/11,24.51%,UPP2;UCK2;PUDP;CDA
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),0.41181405880205013,0.6076027636231768,0.9333333333333333,1.0,1.0,1/7,16.83%,ATM
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),0.2941353598994708,0.6075402939288048,0.9722222222222222,1.0,1.0,3/20,9.67%,RAB7A;GCC2;ZFYVE16
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),-0.31464195627728003,-0.607312744228927,0.9545454545454546,1.0,1.0,3/20,14.24%,OBSCN;CSRP3;TTN
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),-0.37146558077610775,-0.606988801648502,0.9841269841269841,1.0,1.0,3/9,17.85%,COL1A1;COL4A6;OTOL1
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.3143592481502168,-0.6064478723513227,0.9850746268656716,1.0,1.0,2/22,10.05%,ESR1;HNF1A
prerank,GO_Biological_Process_2021__negative regulation of bone resorption (GO:0045779),-0.3954519284096911,-0.6063718531160279,0.9818181818181818,1.0,1.0,1/5,13.18%,CARTPT
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),-0.26281293494435537,-0.6060851626989674,0.9859154929577465,1.0,1.0,11/57,20.22%,WNT5A;NLRP12;OSMR;TLR2;IL18;ZP3;AGT;GRN;IFI35;CD81;VAMP7
prerank,GO_Biological_Process_2021__oxaloacetate transport (GO:0015729),-0.40919500519549895,-0.6058761430283914,0.9344262295081968,1.0,1.0,1/5,23.32%,SLC25A11
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),-0.4039399117853127,-0.6056940320584947,0.9473684210526315,1.0,1.0,1/6,9.90%,STOML2
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),0.3802169262803124,0.6041251521781862,0.9622641509433962,1.0,1.0,2/6,21.82%,DLG2;CARF
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),0.3802169262803124,0.6041251521781862,0.9622641509433962,1.0,1.0,2/6,21.82%,DLG2;CARF
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),-0.32031795778897654,-0.6039185199854493,0.9411764705882353,1.0,1.0,3/20,14.39%,CYP26B1;CYP4F12;HAO2
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),0.32021445871884935,0.6034665703953093,0.972972972972973,1.0,1.0,5/11,35.81%,LAPTM5;EHD3;CCDC91;CLN3;ANKFY1
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),0.30992162389447186,0.6029523416917937,0.9743589743589743,1.0,1.0,2/11,13.81%,DRD5;NF1
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),0.36677297557886124,0.6029190512333061,0.9210526315789473,1.0,1.0,2/8,14.95%,ABCD2;INSR
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),0.305985486810784,0.601418809022924,0.96875,1.0,1.0,3/15,16.83%,CYB5R4;RIMS2;RAB11B
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),0.3463285145142342,0.6013426404645482,0.9285714285714286,1.0,1.0,6/12,33.42%,PARP11;PARP6;PARP16;TIPARP;TNKS2;TNKS
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.2970003138545539,0.6011173260730389,0.9487179487179487,1.0,1.0,4/10,26.02%,EMC2;EMC4;EMC8;EMC10
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.29195593320380686,0.6009395723928485,0.975,1.0,1.0,3/19,12.69%,SCD5;SLC25A1;ACSM2A
prerank,GO_Biological_Process_2021__regulation of cell adhesion molecule production (GO:0060353),-0.3721640249182094,-0.600934837952338,0.96,1.0,1.0,4/6,32.99%,COLEC12;FLOT1;CAV1;APOA1
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),-0.3852842512972075,-0.6008127536348095,0.9583333333333334,1.0,1.0,2/7,13.80%,CEACAM1;LEF1
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),-0.39238700806567606,-0.6001597485227005,0.9333333333333333,1.0,1.0,1/7,12.51%,APOD
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),-0.39238700806567606,-0.6001597485227005,0.9333333333333333,1.0,1.0,1/7,12.51%,APOD
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),-0.3568877396871498,-0.6000570655262406,0.9193548387096774,1.0,1.0,4/10,24.09%,GNAT3;RTP5;GNAT2;RTP1
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),-0.3712373940956276,-0.5996959213768599,0.9454545454545454,1.0,1.0,1/7,13.52%,TMEM79
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.31036311849470055,-0.5995569552176188,0.9818181818181818,1.0,1.0,3/18,13.95%,IFNK;IFIT1;COLEC12
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),-0.28932068620728446,-0.5994095195550694,0.971830985915493,1.0,1.0,4/30,11.29%,ABRAXAS1;USP13;USP50;USP17L2
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),-0.3529350306710448,-0.5980861901186417,0.9696969696969697,1.0,1.0,2/12,20.24%,GPR151;PKD1L3
prerank,GO_Biological_Process_2021__epithelial cell differentiation involved in kidney development (GO:0035850),0.3588958638034178,0.5980205196973107,0.9318181818181818,1.0,1.0,3/6,31.77%,BMP4;MEF2C;SALL1
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),0.3515176591841537,0.597680965736035,0.8974358974358975,1.0,1.0,2/6,18.91%,CARD9;SLA2
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.2868907922928251,-0.5973453454362588,0.9846153846153847,1.0,1.0,5/21,22.14%,RPS21;ERI2;WDR12;EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),-0.3852011047580731,-0.5970913279298226,0.9180327868852459,1.0,1.0,2/5,23.82%,ORAI1;CRACR2A
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),-0.3615797675538605,-0.5966066977321705,0.9342105263157895,1.0,1.0,1/9,9.32%,ACOT4
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),-0.36259536068463244,-0.596588661601963,0.9473684210526315,1.0,1.0,2/7,26.51%,PRPS1;CTPS1
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.2871206017582331,0.5962791729052226,1.0,1.0,1.0,5/20,19.41%,SLC3A2;SLC6A20;SLC7A8;SLC16A2;SLC1A3
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),-0.30027061827399537,-0.5961966733920895,0.9859154929577465,1.0,1.0,1/28,2.44%,CYP26B1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),0.260303436636207,0.5957013307182638,0.972972972972973,1.0,1.0,5/22,15.48%,TICAM2;HMGB1;MFHAS1;NR1H3;LBP
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),0.3208653341285445,0.5953420416275719,0.9523809523809523,1.0,1.0,4/17,21.51%,MAN1A1;RAB10;EDEM1;SEC61A1
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),-0.29305504609006394,-0.595109897722988,1.0,1.0,1.0,3/31,10.89%,TAF7;BRCA1;SPI1
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.23719797002654697,-0.5944009813112688,1.0,1.0,1.0,16/134,16.16%,PSMB9;TEC;INPP5D;HLA-A;WAS;HLA-DPB1;STOML2;HLA-DRB1;PTPRC;BTN3A3;TXK;HLA-DPA1;PIK3CB;EIF2B2;CD4;PSMA3
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),0.32390275882391484,0.5941516417158182,0.9090909090909091,1.0,1.0,3/9,20.14%,CARM1;PRMT5;PRDM4
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.25443131130650337,-0.5936841993938407,1.0,1.0,1.0,8/77,18.22%,TGFB1;TERF2IP;WARS1;ATG14;CACTIN;ARPP19;BEX4;NTRK3
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),-0.38248594762331983,-0.5936721556992375,0.8333333333333334,1.0,1.0,1/5,25.10%,APAF1
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),0.3530762599454855,0.5933542543894692,0.8421052631578947,1.0,1.0,1/5,16.49%,SNF8
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),0.3530762599454855,0.5933542543894692,0.8421052631578947,1.0,1.0,1/5,16.49%,SNF8
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.22302211132067562,0.5927609903175152,1.0,1.0,1.0,6/82,9.74%,HLA-DQB1;RAB7A;HLA-DRA;SEC24C;DYNC1I2;CTSV
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),-0.30255750828741806,-0.5927206264162386,0.96875,1.0,1.0,1/28,1.49%,TGFB1
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),-0.36687602849381407,-0.5926119654574953,0.890625,1.0,1.0,2/7,20.93%,SERINC1;TLCD1
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),0.33172387844327655,0.5923144790122464,0.9302325581395349,1.0,1.0,3/11,16.99%,TTLL9;CEP41;TTLL1
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.3896846799705844,-0.5922454518714426,0.9516129032258065,1.0,1.0,1/5,12.50%,TLR2
prerank,GO_Biological_Process_2021__regulation of NAD(P)H oxidase activity (GO:0033860),0.3807440580202405,0.5920965983292601,0.9433962264150944,1.0,1.0,1/5,4.25%,DRD5
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),-0.3351608780264701,-0.5917938933136259,0.9666666666666667,1.0,1.0,3/12,15.40%,CEACAM1;HEY2;RRAS
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),-0.30746389543476604,-0.5917547127294109,0.9206349206349206,1.0,1.0,3/21,19.64%,DGAT2L6;PLA2G4A;MOGAT1
prerank,GO_Biological_Process_2021__positive regulation of deoxyribonuclease activity (GO:0032077),-0.3988309436276033,-0.5917096806955405,0.9375,1.0,1.0,3/5,27.41%,DDX11;RPS3;PCNA
prerank,GO_Biological_Process_2021__positive regulation of steroid metabolic process (GO:0045940),0.37266703333185386,0.5911355467656015,0.9318181818181818,1.0,1.0,1/6,2.66%,APOE
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.25104470553293745,0.5906190977660019,1.0,1.0,1.0,8/43,17.22%,BCL2;IL16;PKD2;EPB41;F2R;ANK2;WNK3;STIM2
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.2716634445208242,-0.5905809422969065,0.9876543209876543,1.0,1.0,10/46,21.32%,H1-0;NAP1L2;GRWD1;H1-3;CHAF1A;HMGA2;SMARCA5;H2BC18;POLE3;SOX9
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.26971308132610156,0.5901867770832093,0.9722222222222222,1.0,1.0,6/20,22.12%,SIRT1;HDAC1;SMCHD1;BAZ2A;BAHD1;NRDE2
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.276387727235141,-0.5898652051837252,0.9841269841269841,1.0,1.0,3/25,14.91%,HLA-DRB1;NR1H4;ABCA12
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),0.33952584821182474,0.5896352052345736,0.975609756097561,1.0,1.0,3/7,32.10%,ABCA7;DYRK1A;NCSTN
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),-0.32921013844590313,-0.5895298634378929,0.9285714285714286,1.0,1.0,2/10,17.79%,USP17L2;ACP4
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),-0.24798999526406285,-0.5894614636299756,1.0,1.0,1.0,3/81,8.10%,F7;CPM;PHEX
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),0.28684368589702236,0.5891425974890047,0.9722222222222222,1.0,1.0,5/21,14.60%,LGALS1;KPNA6;LGALS9;TYRO3;TMPRSS2
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),0.3052115136957189,0.5891018399658376,0.925,1.0,1.0,3/13,15.64%,CDK6;MYC;ACIN1
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),-0.37257333515314606,-0.5883166006413562,0.921875,1.0,1.0,2/6,14.16%,ENG;HEY2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),-0.24390028260588575,-0.5879709786155786,1.0,1.0,1.0,4/77,12.96%,KIF14;GPSM2;SVIL;CXCR5
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),-0.3612702595846482,-0.5878347268012352,0.9245283018867925,1.0,1.0,3/6,30.69%,RAE1;NUP133;NUP155
prerank,GO_Biological_Process_2021__regulation of natural killer cell proliferation (GO:0032817),-0.3871669160810143,-0.5877977994255209,0.8909090909090909,1.0,1.0,1/6,15.16%,IL18
prerank,GO_Biological_Process_2021__negative regulation of pinocytosis (GO:0048550),-0.3466427497745036,-0.5876977211276725,0.9183673469387755,1.0,1.0,1/5,15.53%,PROM2
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.28389212777433603,-0.5876130141290775,1.0,1.0,1.0,5/40,15.80%,WNT5A;FTH1;CDKN1A;NLRC3;AGT
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",-0.3523227701078003,-0.5870863330943603,0.9473684210526315,1.0,1.0,2/7,22.14%,EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),-0.3523227701078003,-0.5870863330943603,0.9473684210526315,1.0,1.0,2/7,22.14%,EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),0.3714935575462317,0.5870003407748368,0.9387755102040817,1.0,1.0,2/6,23.39%,METTL16;METTL4
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),0.32622108981364406,0.5863029030679034,0.9459459459459459,1.0,1.0,1/6,12.57%,TANK
prerank,GO_Biological_Process_2021__regulation of potassium ion export across plasma membrane (GO:1903764),-0.3790005228908663,-0.5861744976314767,0.9636363636363636,1.0,1.0,1/6,14.89%,KCNE3
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.2590411481990863,-0.5860786419430661,0.9863013698630136,1.0,1.0,15/64,21.32%,H1-0;NAP1L2;TNP1;GRWD1;H1-3;CHAF1A;SMARCE1;ANP32E;SMARCA5;HMGA1;SET;H2BC18;POLE3;BRDT;SOX9
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),0.3177028606318808,0.5857549311934717,0.9318181818181818,1.0,1.0,4/6,34.67%,CERT1;PLEKHA8;GLTP;CPTP
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),0.336897310849794,0.5856411373903272,0.8974358974358975,1.0,1.0,2/8,12.41%,RIN2;RAP1A
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",0.37943653885456274,0.5856058056635142,0.925,1.0,1.0,2/6,27.95%,UXT;LRPPRC
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.3115795301516223,-0.5854532183199568,0.9841269841269841,1.0,1.0,1/13,11.94%,DDX20
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.24143180318722024,0.5854160390512285,1.0,1.0,1.0,16/63,22.33%,HSPB1;ATF3;EIF2AK3;EIF3H;PPP1R15B;EIF3E;YTHDF1;DNAJC3;NCK1;EIF4EBP1;IMPACT;KHDRBS1;AGO2;LARP1;NCK2;TPR
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.2337888236115556,-0.5852941531376441,1.0,1.0,1.0,3/98,5.08%,PSMB9;VAV3;TEC
prerank,GO_Biological_Process_2021__positive regulation of memory T cell differentiation (GO:0043382),0.3516282565239141,0.585230865300695,0.9047619047619048,1.0,1.0,2/7,15.56%,HLA-DRA;IL23A
prerank,GO_Biological_Process_2021__regulation of memory T cell differentiation (GO:0043380),0.3516282565239141,0.585230865300695,0.9047619047619048,1.0,1.0,2/7,15.56%,HLA-DRA;IL23A
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),-0.23178839481080937,-0.5852218735887891,1.0,1.0,1.0,14/103,20.45%,PLA2G10;PLEKHA4;INPP5D;ARF3;PIK3R3;PLEKHA2;PIK3CB;PIK3C2G;PIK3CG;BMX;PLA2G4A;CSF1R;PLA2G4D;IMPA1
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell apoptotic process (GO:0010664),-0.3960653040419657,-0.5847076896781447,0.9636363636363636,1.0,1.0,3/6,30.48%,GATA4;NUPR1;BAG3
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.29600836698992183,-0.5844274676588169,0.9848484848484849,1.0,1.0,6/30,20.56%,PWP2;TSR2;RPS21;RPS16;RPS8;RPS14
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),-0.34854589510448275,-0.5841993544185808,0.927536231884058,1.0,1.0,2/9,21.19%,COPS5;HSPA5
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),-0.22049285316854772,-0.583983292620357,1.0,1.0,1.0,11/322,8.50%,PSMB9;ARIH2;KIF14;PRAME;DTL;PINK1;UBE2L6;FBXL7;TRIM25;RNF213;UBE2U
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),-0.23647339719076593,-0.5839484271296348,1.0,1.0,1.0,6/102,13.30%,RASGRF2;ERN2;ALOX15;THBS1;WFS1;ERLEC1
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),-0.3602653157475341,-0.5833665740869721,0.9230769230769231,1.0,1.0,2/6,18.18%,PAICS;PRPS1
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),-0.33579146326842946,-0.5833550675948974,0.9571428571428572,1.0,1.0,2/12,11.81%,CSRP3;ENG
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),-0.21296778230641983,-0.5832325430693811,1.0,1.0,1.0,46/393,18.75%,TRIP10;RASGRF2;WNT5A;ARHGAP9;TAGAP;NLRP12;TAF7;OBSCN;VAV3;ROS1;RPA3;ARHGAP15;CEACAM1;RHOQ;BRCA1;GBP1;ARHGAP12;ARAP3;VWF;ARHGAP28;ARHGDIG;TAF9B;RAD1;TEK;A2M;ATP6AP2;RBBP7;GATA4;SETD9;TAF10;RRAS;REN;TAF6;HIPK1;AKAP13;F2RL1;DDIT4;RAC2;ECT2;RAC1;CD24;CDK5R1;NTRK3;NOP53;CARD8;ARHGAP31
prerank,GO_Biological_Process_2021__histone-serine phosphorylation (GO:0035404),-0.37491468977415177,-0.5830664455678702,0.8909090909090909,1.0,1.0,2/5,22.57%,HMGA2;MST1
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.24977194788844043,0.5827400440263901,1.0,1.0,1.0,4/31,17.89%,ZBTB7B;ARRB1;RPS6KA4;NIPBL
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),-0.3587727013381319,-0.582124671941156,0.9583333333333334,1.0,1.0,1/6,18.18%,PRPS1
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.2751686296033785,-0.5813705562262754,0.9850746268656716,1.0,1.0,4/32,17.06%,TGFB1;APOD;SMAD3;ECT2
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),-0.3123706231370012,-0.5811956186231011,0.9464285714285714,1.0,1.0,3/15,17.81%,POPDC2;AKAP13;MESP1
prerank,GO_Biological_Process_2021__mesoderm morphogenesis (GO:0048332),-0.34451198960796103,-0.5808728245377776,0.9655172413793104,1.0,1.0,2/8,18.40%,MESP1;MESP2
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell cytokine production (GO:2000553),-0.38695473786863865,-0.5804937185097366,0.88,1.0,1.0,2/6,18.80%,NLRP3;CD81
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell cytokine production (GO:2000551),-0.38695473786863865,-0.5804937185097366,0.88,1.0,1.0,2/6,18.80%,NLRP3;CD81
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.26376502694083437,0.5792191706083791,1.0,1.0,1.0,10/25,27.79%,DCUN1D1;CDC14B;UBE2L3;FZR1;PTEN;AXIN1;PLK1;DCUN1D2;BTRC;GORASP1
prerank,GO_Biological_Process_2021__maintenance of protein location in extracellular region (GO:0071694),-0.37227992665908427,-0.5775004707534914,0.9411764705882353,1.0,1.0,2/5,19.47%,FBN2;DAND5
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),-0.3358432444273307,-0.5770900857685817,0.9824561403508771,1.0,1.0,2/9,19.87%,SCPEP1;ACE2
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),-0.3358432444273307,-0.5770900857685817,0.9824561403508771,1.0,1.0,2/9,19.87%,SCPEP1;ACE2
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),0.32146863718243135,0.5770724472407057,0.9487179487179487,1.0,1.0,4/7,31.37%,CLEC16A;RUBCN;TMEM39A;UBQLN4
prerank,GO_Biological_Process_2021__regulation of entry of bacterium into host cell (GO:2000535),0.3982724426087927,0.5768733185714569,0.9534883720930233,1.0,1.0,3/5,30.84%,EXOC7;EXOC2;ITGAV
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),-0.36665252142418236,-0.5762567091924667,0.9354838709677419,1.0,1.0,2/7,21.55%,HMGA2;TFIP11
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),-0.36055644932336517,-0.576174274701418,0.9137931034482759,1.0,1.0,5/5,63.96%,TMEM70;ATP5F1D;ATP23;OXA1L;ATPAF1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),-0.3120945430093158,-0.5760571762276394,0.9,1.0,1.0,1/14,7.49%,ALOX15
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),-0.3339847975363465,-0.5753573378130533,0.9523809523809523,1.0,1.0,1/10,8.28%,ZFPM1
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),0.3366266336904765,0.5752942139453422,0.868421052631579,1.0,1.0,1/6,12.22%,ADGRV1
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),0.35580188593512846,0.5746180101487166,0.9772727272727273,1.0,1.0,2/7,19.97%,RPIA;XYLB
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),-0.29305316785057817,-0.5744319087326056,0.9428571428571428,1.0,1.0,3/17,20.26%,PLA2G10;PLA2G4A;PLA2G4D
prerank,PanglaoDB_Augmented_2021__Reticulocytes,-0.24277085686768352,-0.5742038017093511,1.0,1.0,1.0,6/96,14.09%,MCM2;MCM3;DARS2;DHX38;CHAF1A;INCENP
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.2506942472424443,0.5737990596016808,1.0,1.0,1.0,10/28,29.03%,TOP2A;PKN2;TARBP2;LARP1;PPIH;ADAR;SRPK2;PABPC1;PPIA;TMEM39A
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),-0.25606944013581634,-0.5737289106348059,0.9855072463768116,1.0,1.0,4/57,9.69%,PDE6B;CDC25A;GPR88;GNGT1
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),0.2903286692706132,0.5735286817322959,0.9487179487179487,1.0,1.0,1/11,6.89%,PPP1R3E
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),-0.3442044313207928,-0.5734727159785415,0.9491525423728814,1.0,1.0,3/7,26.31%,TRMT10A;SUPV3L1;TRMT10B
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),0.35859538593707296,0.5723607274976833,0.9024390243902439,1.0,1.0,2/6,27.65%,HIF1A;MCL1
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),0.34342765212453863,0.5716132844706895,0.8823529411764706,1.0,1.0,5/5,65.67%,ANO6;CLCN3;KCNMA1;P2RX7;SHANK3
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.24559344161586016,-0.5711866170673722,1.0,1.0,1.0,1/64,0.62%,PSMB9
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.24050728529423027,-0.5700515444244387,1.0,1.0,1.0,18/58,28.18%,RPL38;EMG1;RPL35A;RPS16;WDR12;RPL5;RPS7;RPL11;RPS15;SURF6;EBNA1BP2;RPS28;RPS19;RPS24;RPL26L1;RPS6;DHX37;RBIS
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),0.3388349508274947,0.5699246836025016,0.9069767441860465,1.0,1.0,2/6,22.44%,TWSG1;TNFRSF14
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.35229531471840986,-0.5688488643275801,0.9365079365079365,1.0,1.0,9/9,64.79%,AP2A2;CLTA;AP2S1;VLDLR;AP2M1;AP2A1;AP2B1;CLTC;MYLIP
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.35229531471840986,-0.5688488643275801,0.9365079365079365,1.0,1.0,9/9,64.79%,AP2A2;CLTA;AP2S1;VLDLR;AP2M1;AP2A1;AP2B1;CLTC;MYLIP
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),0.3155500967403859,0.5686202028167067,1.0,1.0,1.0,8/11,27.08%,SGK1;SGK2;NR1H3;WNK3;TRPC6;RXRA;KMT2A;STK39
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.2653757408352409,-0.5683186380033889,1.0,1.0,1.0,2/36,9.68%,HMGB3;ENDOG
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.3211842833588413,0.5681145478027381,0.9545454545454546,1.0,1.0,1/9,11.65%,TSPAN6
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),0.25627812887975177,0.5680019214686053,0.9428571428571428,1.0,1.0,7/20,35.63%,ME3;UQCRC2;UQCRHL;SLC25A14;SDHB;SURF1;MTFR1L
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),-0.26793879162838924,-0.567966200587339,0.9866666666666667,1.0,1.0,2/38,5.47%,DEGS2;ALOX12B
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),-0.23144309160100032,-0.5676418625889725,1.0,1.0,1.0,1/81,0.62%,PSMB9
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),0.3096024527371027,0.5674622390765134,0.8857142857142857,1.0,1.0,1/9,13.55%,PELI1
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),-0.24495527743708456,-0.5666170515760041,1.0,1.0,1.0,4/81,6.54%,STAC;MMP9;SHISA6;KCNS2
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),0.32247474680344934,0.5664407707821167,0.9714285714285714,1.0,1.0,3/9,33.88%,FURIN;EPHA4;NELL1
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),-0.27076341343478394,-0.5663957345340459,0.9491525423728814,1.0,1.0,4/25,16.80%,CDKN1A;TOM1L1;FGFR4;PARP4
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.2663621115547189,-0.5662647906356548,0.9852941176470589,1.0,1.0,4/40,13.30%,AZIN1;CLU;PTX3;EDNRB
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),0.34462282682723167,0.5660907794561139,0.9032258064516129,1.0,1.0,1/7,18.10%,PPFIA2
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),0.318807922239533,0.5658453566448577,0.9736842105263158,1.0,1.0,1/10,10.30%,PDE4B
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.28832364434814667,-0.5654790022972913,1.0,1.0,1.0,7/19,27.22%,RPL5;RPL23;RPS7;RPL11;SKP1;GOLGA2;RAB1A
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),0.23139123301844794,0.5651624878906417,1.0,1.0,1.0,18/65,25.76%,SMYD5;NCOA3;MYC;RAB11FIP3;PLK3;MLLT3;CSPP1;SETD2;PIK3R4;GIT1;EFHC1;AURKC;MYO19;PLK1;CDK2AP2;PRDM15;BCL2L1;SHH
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.2163616897581407,0.5645531441106716,1.0,1.0,1.0,11/68,22.28%,INTS11;SP1;INTS14;INTS9;GTF2F2;SNAPC3;ICE1;RPRD2;POU2F1;ICE2;POLR2F
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),-0.3492259002851797,-0.5636382125100358,0.9444444444444444,1.0,1.0,1/7,18.65%,CDC6
prerank,GO_Biological_Process_2021__granulocyte activation (GO:0036230),-0.37528354214996484,-0.5627675606431166,0.98,1.0,1.0,2/6,25.89%,F2RL1;CCL5
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),0.30763781427543835,0.5625236946587856,0.9767441860465116,1.0,1.0,3/10,26.07%,TENM4;ABCA2;TPPP
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),-0.3450815750221329,-0.562463489072621,0.9272727272727272,1.0,1.0,2/6,27.22%,FLOT1;RFTN1
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),-0.280375479037528,-0.5619012094766351,0.9714285714285714,1.0,1.0,3/17,17.56%,FUT2;B4GALNT2;MPDU1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.3319197051367432,-0.5612559990778939,0.8688524590163934,1.0,1.0,1/10,9.60%,PLG
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.2830430685629981,-0.5612286693950364,1.0,1.0,1.0,1/22,4.03%,SP100
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),-0.34348854187209954,-0.561070707558093,0.9642857142857143,1.0,1.0,2/8,25.89%,F2RL1;CCL5
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),-0.37242046906333287,-0.5604379420803517,0.9818181818181818,1.0,1.0,1/5,20.86%,SSU72
prerank,GO_Biological_Process_2021__regulation of low-density lipoprotein particle clearance (GO:0010988),-0.35971081063370325,-0.5603470200328481,0.96,1.0,1.0,2/5,18.30%,NR1H4;LDLRAP1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),-0.3003211747871928,-0.5602242559542019,0.9846153846153847,1.0,1.0,3/14,18.66%,FGFR4;AGT;ANGPTL7
prerank,GO_Biological_Process_2021__response to heparin (GO:0071503),-0.36129589217777247,-0.56020393616419,0.8867924528301887,1.0,1.0,3/5,24.21%,GPIHBP1;SOX9;SFRP1
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),0.339612259142618,0.560158257844322,0.9574468085106383,1.0,1.0,2/8,19.66%,NUDT5;ENTPD2
prerank,GO_Biological_Process_2021__regulation of glial cell differentiation (GO:0045685),0.3660780307032242,0.5597810827957275,0.9512195121951219,1.0,1.0,4/6,29.44%,NF1;SLC45A3;CDK1;EPHA4
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),0.2906203863719108,0.5594111234565677,1.0,1.0,1.0,5/14,29.82%,CTC1;FAF1;DNA2;STN1;BRPF3
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),0.3393831678608513,0.5584121983280528,0.8918918918918919,1.0,1.0,2/7,28.40%,ME3;ME2
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.266802803931127,-0.5577378513076814,1.0,1.0,1.0,10/31,25.39%,GPER1;SNAPIN;CAMK2A;BAIAP3;CHRNA3;PREPL;VPS18;CPLX2;HCRT;SYT11
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.265101964485084,0.5573487153708466,1.0,1.0,1.0,5/22,22.04%,NLGN4X;ACHE;GRIK3;SLC24A2;PTEN
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.34191088562370864,-0.5572396772425474,0.9508196721311475,1.0,1.0,1/8,12.50%,TLR2
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),0.28376573758885804,0.5562492598754978,0.9705882352941176,1.0,1.0,1/20,5.26%,TIMM29
prerank,GO_Biological_Process_2021__positive regulation of blood pressure (GO:0045777),-0.3261225555843146,-0.5560996806783329,0.9473684210526315,1.0,1.0,1/6,13.18%,CARTPT
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.3267829091628739,0.5559595943056937,0.972972972972973,1.0,1.0,2/12,8.76%,ABL1;ABL2
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",0.3403235010210524,0.555478565403577,0.96875,1.0,1.0,2/8,18.57%,NOP9;NOP14
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),-0.22906335918437468,-0.5551030383023535,1.0,1.0,1.0,9/67,21.34%,ACTL6A;HAT1;SPI1;LEF1;TAF10;TAF6;TAF6L;POLE3;BRD8
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),-0.27640317889949284,-0.5544167012031253,0.9855072463768116,1.0,1.0,3/18,17.56%,FUT2;B4GALNT2;MPDU1
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),-0.3235948742115067,-0.553695189130744,1.0,1.0,1.0,2/11,13.43%,ABCB1;OPRM1
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),0.28629645383433977,0.5535930682703967,0.9761904761904762,1.0,1.0,8/22,21.01%,ZBTB20;MLXIPL;NFKB1;INSR;PFKFB4;PRKAA2;HIF1A;PFKFB3
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),-0.26730185936673256,-0.5535925606186105,0.9855072463768116,1.0,1.0,4/30,17.06%,CYP1B1;ANXA1;ZNF580;ECT2
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),-0.3524468414200497,-0.5532348926969192,0.921875,1.0,1.0,2/7,14.16%,ENG;HEY2
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.25919230847571645,-0.5530781340196065,1.0,1.0,1.0,4/41,15.80%,CAV3;DNAJA1;PIK3CB;AGT
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.29341405485167427,0.5528283737743968,0.8947368421052632,1.0,1.0,5/15,25.75%,ERN1;NCK1;RNF185;BAG6;TMEM259
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),-0.31472331698827594,-0.5525187242723991,0.9672131147540983,1.0,1.0,2/11,10.87%,THBS1;CTSZ
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),0.33830232707209784,0.5521819658747711,0.95,1.0,1.0,3/8,18.77%,GMPS;HPRT1;SHMT2
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.282151148238806,-0.5516553125092344,0.9859154929577465,1.0,1.0,2/15,16.60%,CAMLG;EMC1
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),-0.3679264724999415,-0.5511107408373404,0.94,1.0,1.0,2/5,27.74%,SLU7;SF3A1
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),-0.31713301285320467,-0.5509973857758815,0.9672131147540983,1.0,1.0,3/9,23.48%,F2RL1;CSF1R;PRTN3
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),-0.25083957775666993,-0.5506264816627586,0.9857142857142858,1.0,1.0,7/41,21.27%,MAB21L1;FREM2;HIPK1;WNT10A;SALL2;MYO7B;SIX4
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),0.3272022350797014,0.5504822600551553,0.9534883720930233,1.0,1.0,1/5,14.06%,PNPT1
prerank,GO_Biological_Process_2021__C-terminal protein deglutamylation (GO:0035609),0.33983567331812925,0.5494456510937477,0.9148936170212766,1.0,1.0,1/5,11.19%,AGBL4
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.21430066189959326,0.548375665711201,1.0,1.0,1.0,11/69,22.28%,INTS11;SP1;INTS14;INTS9;GTF2F2;SNAPC3;ICE1;RPRD2;POU2F1;ICE2;POLR2F
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),-0.2678867471316583,-0.5478317442273788,0.9193548387096774,1.0,1.0,6/23,25.20%,ATP10B;ABCB1;ATP8B3;ATP11C;ABCA4;ATP11A
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.2915309238151166,-0.5477842871179762,0.9523809523809523,1.0,1.0,4/24,18.02%,CAV3;JPH2;PLN;CALM1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),-0.3388932443793643,-0.5472500683272615,0.9642857142857143,1.0,1.0,5/8,37.07%,BLOC1S2;BNIP3;VDAC2;RHOT2;ATF2
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),0.2605363734429457,0.54624601394056,1.0,1.0,1.0,8/17,33.32%,ATM;SMG6;LDB2;EMP2;FEM1A;HMBOX1;NLRC5;SPTSSB
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),0.3474060412083276,0.5450434496630878,0.975609756097561,1.0,1.0,2/6,16.61%,MSRB3;MSRB1
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),0.344328759567602,0.5447589408637465,0.9428571428571428,1.0,1.0,3/6,19.85%,METTL15;BUD23;METTL16
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),-0.24439055484906155,-0.5443498430766011,1.0,1.0,1.0,3/46,13.80%,ACTL6A;HAT1;LEF1
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),-0.3091935009364159,-0.5440750674788243,0.9841269841269841,1.0,1.0,2/16,17.64%,SLC25A18;SLC25A22
prerank,GO_Biological_Process_2021__negative regulation of meiotic nuclear division (GO:0045835),-0.35631340796347305,-0.5440744630685173,0.9803921568627451,1.0,1.0,1/6,13.23%,RAD1
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),0.3481634981004412,0.5431030855469845,0.8958333333333334,1.0,1.0,1/5,12.54%,IDH2
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.23610507350176313,0.5412304831947915,0.9761904761904762,1.0,1.0,13/33,22.84%,SETMAR;TIMELESS;H2AX;CLSPN;ATM;RAD17;RAD9A;ATR;DNA2;HINFP;CDC5L;ATRIP;BRIP1
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),0.28832302615711175,0.5411018087811479,0.975609756097561,1.0,1.0,4/10,24.57%,SETMAR;FBH1;XRN2;MUS81
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),0.2515703099454337,0.5407879011826291,1.0,1.0,1.0,7/19,26.51%,GDF6;MFHAS1;GADD45A;RELL1;BMP2;EMC10;RELL2
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.2847536718009137,0.54047815066452,1.0,1.0,1.0,2/14,14.12%,HSPA1A;BID
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.28993236850941867,-0.5401198331074881,1.0,1.0,1.0,6/18,24.92%,HLA-A;NLRP3;IL18;CD81;IL1R1;TNFSF4
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),-0.3033003480632257,-0.5400847116595902,0.9827586206896551,1.0,1.0,1/9,11.15%,DCTN1
prerank,GO_Biological_Process_2021__negative regulation of macrophage migration (GO:1905522),0.32131807491982356,0.5400811555363724,0.94,1.0,1.0,1/6,20.62%,EMILIN1
prerank,GO_Biological_Process_2021__regulation of plasma membrane organization (GO:1903729),0.32696129459638495,0.5391426400293017,0.9555555555555556,1.0,1.0,5/5,67.31%,GSN;MYH9;SYTL4;NOX5;RAB3A
prerank,GO_Biological_Process_2021__regulation of sensory perception (GO:0051931),-0.3047842591443527,-0.5380007554544485,0.9836065573770492,1.0,1.0,1/9,11.90%,ACP3
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.30992097335658697,-0.5374477496525017,0.9682539682539683,1.0,1.0,1/11,9.78%,THBS1
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),0.24135757280086426,0.5370692251032855,1.0,1.0,1.0,4/16,20.34%,NR4A3;PRKAG2;APPL2;ACADVL
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),-0.3218720786463602,-0.5368723067027267,1.0,1.0,1.0,1/7,14.63%,CTCFL
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.27914604402116233,-0.5358052235848406,0.9523809523809523,1.0,1.0,5/13,28.29%,WFS1;HSPA5;UFL1;DDRGK1;RACK1
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),-0.3039951309753002,-0.5357173317549052,0.9824561403508771,1.0,1.0,2/11,22.96%,SNAPIN;BLOC1S2
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),-0.3039951309753002,-0.5357173317549052,0.9824561403508771,1.0,1.0,2/11,22.96%,SNAPIN;BLOC1S2
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),0.3412860001556075,0.5353707794164169,1.0,1.0,1.0,3/7,20.13%,SYAP1;CORO1B;MARS1
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),0.3006455083795807,0.5351444360396759,1.0,1.0,1.0,1/8,17.85%,PNKP
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.2589636057226351,-0.5346161967950782,1.0,1.0,1.0,6/35,20.56%,PWP2;TSR2;NOB1;RPS16;RPS8;RPS14
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.3008754585872235,0.5338346253833538,1.0,1.0,1.0,3/8,28.70%,SMC5;SMC6;NUMA1
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.2402666860849965,-0.5333381602443841,1.0,1.0,1.0,8/38,21.85%,OAS2;IFIT1;OAS1;HMGA2;MX1;PARP10;ISG15;SRPK1
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),0.2695369134340832,0.5330715221205297,0.975609756097561,1.0,1.0,3/17,15.27%,TIMELESS;SPIDR;HSF1
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),-0.30337356876313465,-0.5308798143656578,0.9850746268656716,1.0,1.0,4/12,31.29%,LMO2;BRD8;KLF9;CTSS
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.2693363627757265,0.530866649110102,0.9722222222222222,1.0,1.0,13/13,73.08%,DHRS7B;PLA2G6;NCEH1;TMEM86B;PEX7;AGPS;FAR1;GNPAT;PAFAH1B1;AGMO;PLAAT3;LIPE;PLA2G7
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),-0.30362030873958545,-0.5300244067869236,0.9850746268656716,1.0,1.0,4/11,31.29%,LMO2;BRD8;KLF9;CTSS
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.27465320596118403,-0.5297079307093727,1.0,1.0,1.0,2/19,14.41%,ACTN3;EFHB
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),0.32519497806647846,0.5296043562331053,0.9512195121951219,1.0,1.0,3/6,21.79%,HSPA1A;MECP2;GIT1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),0.2745540717735326,0.5293883478535815,1.0,1.0,1.0,5/10,36.49%,ICE1;ICE2;CEBPA;CHD8;ZC3H8
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.26733710765851115,-0.5280890924354664,1.0,1.0,1.0,2/14,17.21%,PGAM1;CD24
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),-0.29583642638047525,-0.5278842842191646,0.9818181818181818,1.0,1.0,4/14,23.50%,KCNS2;KCNE3;KCNE4;KCNS1
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.27790454731127,0.5268883006725208,1.0,1.0,1.0,6/10,25.69%,SMAD2;NOTCH1;ACVR1;MDM4;BMPR1A;BMP2
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),-0.32469812624876593,-0.5266464747837265,0.9649122807017544,1.0,1.0,1/7,14.99%,DDX3X
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),-0.3189206828764345,-0.5264956649634397,0.9642857142857143,1.0,1.0,2/8,17.74%,PLA2G10;PLA2G4A
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),0.22811594649642697,0.526058362852452,1.0,1.0,1.0,4/30,22.28%,CCNH;GTF2F2;ERCC3;POLR2F
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),0.22811594649642697,0.526058362852452,1.0,1.0,1.0,4/30,22.28%,CCNH;GTF2F2;ERCC3;POLR2F
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),-0.3350210571144655,-0.5260335262587574,0.9791666666666666,1.0,1.0,6/6,66.51%,CDC7;DBF4;DBF4B;ATRX;WIZ;INO80
prerank,GO_Biological_Process_2021__cellular response to prostaglandin E stimulus (GO:0071380),-0.3066968868360452,-0.5259579062173955,0.9827586206896551,1.0,1.0,2/6,24.92%,SFRP1;TNFSF4
prerank,GO_Biological_Process_2021__choline transport (GO:0015871),0.3315770160416364,0.5257158413397176,0.9423076923076923,1.0,1.0,2/5,33.49%,SLC44A2;SLC44A4
prerank,GO_Biological_Process_2021__regulation of meiotic nuclear division (GO:0040020),0.30636002271436696,0.5256239111111688,0.9375,1.0,1.0,7/7,69.37%,DMRT1;SIRT2;NPM2;FBXO5;OOEP;WEE2;FBXO43
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),0.28051488561573756,0.5250359442197112,0.9761904761904762,1.0,1.0,4/14,23.57%,NUDT18;NUDT5;ENTPD2;ADPRM
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.2745734915164233,-0.5242268375731528,1.0,1.0,1.0,5/14,26.40%,ZFP36L1;CRTAM;PRDM1;SPINK5;XRCC6
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),-0.24218581957990173,-0.5237437582753238,1.0,1.0,1.0,9/38,25.10%,BRCA1;MAX;FOXO4;RBBP7;L3MBTL2;DUX4;CDC7;CHEK1;APAF1
prerank,GO_Biological_Process_2021__vitamin K metabolic process (GO:0042373),-0.3424982699790615,-0.5237126650772304,0.9827586206896551,1.0,1.0,1/6,13.26%,CYP4F12
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),0.3017555481947665,0.5235637186099902,0.9772727272727273,1.0,1.0,6/6,69.83%,PHF1;OGT;MACROH2A1;PHF19;SUPT6H;MTF2
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),0.30191396213531047,0.5233272539408128,0.95,1.0,1.0,1/11,9.27%,GCC2
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),0.2960818617948945,0.522886890121819,0.9615384615384616,1.0,1.0,3/6,24.22%,SAT1;SMS;SRM
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),0.302958436618369,0.5226242933376554,0.9545454545454546,1.0,1.0,3/8,30.95%,MIEF2;DNM2;DNM3
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),0.302958436618369,0.5226242933376554,0.9545454545454546,1.0,1.0,3/8,30.95%,MIEF2;DNM2;DNM3
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),0.21976778523701182,0.522563716177744,1.0,1.0,1.0,3/51,9.13%,UBXN2A;CHMP6;SPAST
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),-0.2590759626187249,-0.5223480200410926,0.9857142857142858,1.0,1.0,1/16,10.71%,TERT
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.28726282590357954,-0.522013803074653,1.0,1.0,1.0,2/16,17.09%,COX17;COX20
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.30392152288479773,-0.5220121959396177,1.0,1.0,1.0,3/10,26.49%,TXN;PARK7;PDE8A
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),0.2966419636124653,0.5217003431721452,0.9512195121951219,1.0,1.0,3/8,24.44%,RPS6KA4;BAZ1B;PRKCD
prerank,GO_Biological_Process_2021__phospholipid homeostasis (GO:0055091),-0.2970502489372039,-0.521241123688066,1.0,1.0,1.0,3/11,20.93%,ANGPTL3;ABCB11;TLCD1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.23057356508569943,0.5206996579606172,1.0,1.0,1.0,13/47,24.85%,CFLAR;SHARPIN;NLRP2B;HSPA1A;FADD;CLIP3;ZNF675;CPNE1;LAPTM5;CCDC3;IKBKB;TRAF1;GAS6
prerank,GO_Biological_Process_2021__lymphoid progenitor cell differentiation (GO:0002320),-0.3340694669946097,-0.5205424079040338,0.9838709677419355,1.0,1.0,1/6,10.89%,SPI1
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),0.18322289236788028,0.5203753227157495,1.0,1.0,1.0,20/111,20.85%,RIPK2;ADAMTS12;PSME4;PSMA1;PLCB1;TANK;TAB3;PELI1;RPS6KA4;NFKB1;PELI2;IRAK4;GBP2;PTGIS;RC3H1;TAB1;TAB2;TRAF6;HIF1A;PSMD4
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.2962972003953403,-0.5203601561973518,0.9523809523809523,1.0,1.0,1/12,8.63%,BRCA1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.2855731626324491,-0.52017802596389,0.984375,1.0,1.0,6/14,25.54%,RPL5;RPL23;RPS7;RPL11;BAG5;PARK7
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),-0.3252400709773498,-0.518853995336094,0.9622641509433962,1.0,1.0,4/7,37.54%,HERPUD1;CAV1;UBQLN2;BCAP31
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),0.18998656065853722,0.5181334828458074,1.0,1.0,1.0,17/85,28.79%,MRPL4;MRPL41;MRRF;MTRF1;ETF1;DAP3;MRPL2;AURKAIP1;MRPS7;MRPL55;MRPL43;MRPL58;ERAL1;MRPL3;MRPL1;MRPS16;MRPS18A
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),0.2908795580195376,0.517606547410867,1.0,1.0,1.0,4/10,23.62%,TOM1L2;AURKAIP1;BMP4;DMRT1
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),-0.3397433187581422,-0.5173318584902588,0.9615384615384616,1.0,1.0,1/5,10.28%,PTPRC
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),0.31152627037175734,0.5173245061656078,0.9791666666666666,1.0,1.0,2/8,24.91%,CCNH;CDK13
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),-0.3243422297936778,-0.5168541102906768,0.9655172413793104,1.0,1.0,7/7,67.58%,PRKD2;SPHK2;CAMK2D;VEGFA;PRKD1;C6ORF89;KDM5A
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),-0.28985155335030344,-0.5166739634253423,0.9649122807017544,1.0,1.0,4/11,31.34%,TJP3;RAB1A;RAP2C;RAPGEF6
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),-0.2424889026581118,-0.51638791525139,1.0,1.0,1.0,9/37,25.10%,BRCA1;MAX;FOXO4;RBBP7;L3MBTL2;DUX4;CDC7;CHEK1;APAF1
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),-0.3115409540127889,-0.5162197463055753,0.9473684210526315,1.0,1.0,1/6,16.15%,SMAD3
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),0.303633457267282,0.5161313386489351,0.9512195121951219,1.0,1.0,2/8,15.48%,PLSCR1;LBP
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),0.31956228789747787,0.5153729911054898,0.9459459459459459,1.0,1.0,2/7,18.70%,ERC2;ERC1
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),-0.3151934213094688,-0.5153318387995205,0.96875,1.0,1.0,3/8,22.70%,NLRC3;NOP53;PIK3IP1
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.2430360276133387,0.5152350979181296,1.0,1.0,1.0,8/25,28.03%,KAT6A;EP300;KAT2B;KAT6B;BAG6;PHF20L1;CREBBP;CPA4
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),0.2838246487523324,0.5144205604607278,0.967741935483871,1.0,1.0,2/11,15.27%,FADD;HSF1
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.2629459586772755,-0.5142579565465611,0.9833333333333333,1.0,1.0,2/16,13.95%,IFIT1;COLEC12
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.3130439672273846,0.5129132770116874,0.9473684210526315,1.0,1.0,2/8,21.65%,RBPJ;BMP4
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),0.30341079721804687,0.5128029209823581,0.9464285714285714,1.0,1.0,1/5,21.97%,ABHD12
prerank,GO_Biological_Process_2021__neuroblast proliferation (GO:0007405),0.32435467103222343,0.5127408325378642,0.9772727272727273,1.0,1.0,4/6,40.42%,SHH;EML1;PLXNB2;RACGAP1
prerank,GO_Biological_Process_2021__postsynaptic endocytosis (GO:0140239),-0.33068663398925957,-0.5127018833333101,0.9454545454545454,1.0,1.0,1/5,21.14%,MX1
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor internalization (GO:0098884),-0.33068663398925957,-0.5127018833333101,0.9454545454545454,1.0,1.0,1/5,21.14%,MX1
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),0.31571475890786915,0.5124703931571568,0.9555555555555556,1.0,1.0,6/6,68.44%,ATPAF2;ATPAF1;OXA1L;ATP23;ATP5F1D;TMEM70
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),-0.33048477472878696,-0.5113205560249382,0.9833333333333333,1.0,1.0,1/7,16.19%,DUSP22
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),0.29607555120401846,0.5111201274317032,0.9795918367346939,1.0,1.0,3/7,30.95%,SNAP91;DNM2;DNM3
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.24882460242527293,0.5096636524180567,1.0,1.0,1.0,6/24,21.95%,GFI1B;HPSE;INSR;NIPBL;DUSP6;BAG6
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),-0.28708587532028784,-0.509130341452242,1.0,1.0,1.0,4/12,25.02%,ENG;GATA4;SOX9;HEY1
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.26620339600371146,-0.508778724401591,1.0,1.0,1.0,5/14,28.29%,TLR2;CD300LF;PRTN3;SYT11;RACK1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),-0.22930815372298813,-0.5085138263290128,1.0,1.0,1.0,11/48,31.95%,CHMP3;CC2D1B;NUP93;SEC13;NDC1;CHMP4B;RAN;VPS4A;NUP133;NUP155;CCNB1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),-0.22930815372298813,-0.5085138263290128,1.0,1.0,1.0,11/48,31.95%,CHMP3;CC2D1B;NUP93;SEC13;NDC1;CHMP4B;RAN;VPS4A;NUP133;NUP155;CCNB1
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),0.31056508419798656,0.5077761860506236,0.9761904761904762,1.0,1.0,1/8,5.28%,JAG1
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),-0.27367891435243064,-0.5072050728845888,1.0,1.0,1.0,3/14,28.14%,ITGA5;FUT1;FGF2
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),0.24159803086244414,0.5071197380490707,0.972972972972973,1.0,1.0,13/13,75.86%,EPHB2;EIF2AK4;SHISA7;ZDHHC2;ADCY8;SQSTM1;APP;CHRNA7;LGMN;RELN;AKAP5;SHANK3;ADCY1
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),-0.3151391833608766,-0.5068178603243565,0.9642857142857143,1.0,1.0,2/6,25.80%,IL18;TMBIM1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.26661181603046785,0.5066194570269661,1.0,1.0,1.0,3/12,14.61%,SSC5D;ARRB1;OTUD7B
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),-0.25170023523781304,-0.5062910773680518,1.0,1.0,1.0,6/31,21.01%,THBS1;RBBP7;IER5;STUB1;SLU7;HSBP1L1
prerank,GO_Biological_Process_2021__positive regulation of necrotic cell death (GO:0010940),-0.3287593451310684,-0.5053207046066152,0.9848484848484849,1.0,1.0,5/5,67.14%,SLC6A6;MT3;RIPK1;SLC6A13;HEBP2
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),0.26113293265817983,0.5052975181941222,0.9795918367346939,1.0,1.0,8/8,73.90%,KDM5B;KDM5D;KDM5A;RIOX2;KDM1B;KDM5C;RIOX1;KDM1A
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),-0.2798140842435767,-0.5052281743003978,1.0,1.0,1.0,4/20,23.60%,AGBL5;TTLL4;GGCX;TPGS1
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),-0.2965165335444803,-0.5047368433364097,0.9836065573770492,1.0,1.0,3/10,25.89%,CD4;CRTAM;CCL5
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),0.3003095000108534,0.5046981310792105,0.9607843137254902,1.0,1.0,2/5,17.89%,ATM;NIPBL
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.2599551876882124,0.5043287648122475,1.0,1.0,1.0,7/19,21.01%,ZBTB20;MLXIPL;INSR;PFKFB4;PRKAA2;HIF1A;PFKFB3
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.2599551876882124,0.5043287648122475,1.0,1.0,1.0,7/19,21.01%,ZBTB20;MLXIPL;INSR;PFKFB4;PRKAA2;HIF1A;PFKFB3
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),0.2917599982805032,0.5041435191464132,1.0,1.0,1.0,3/8,21.65%,TOM1L2;AURKAIP1;BMP4
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),0.344010595982495,0.5037373573637192,0.9791666666666666,1.0,1.0,1/5,13.40%,EIF3E
prerank,GO_Biological_Process_2021__positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),0.3194378726223149,0.5035121475685359,1.0,1.0,1.0,5/5,68.06%,HNRNPU;SIRT2;RCC2;BECN1;CCNB1
prerank,GO_Biological_Process_2021__medium-chain fatty acid biosynthetic process (GO:0051792),0.31544335796801143,0.5033271687719809,0.9487179487179487,1.0,1.0,2/6,15.24%,ABHD3;OXSM
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),-0.319528463500902,-0.5033195513497447,0.9444444444444444,1.0,1.0,2/7,25.89%,PLAUR;CCL5
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),-0.297937428938038,-0.5032973523910805,0.9655172413793104,1.0,1.0,2/7,20.45%,IMPA2;IMPA1
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.2673594394430133,-0.5032948047733161,0.9649122807017544,1.0,1.0,2/13,13.95%,IFIT1;COLEC12
prerank,GO_Biological_Process_2021__cardiac atrium development (GO:0003230),-0.3350339331492894,-0.5032364383016843,0.9852941176470589,1.0,1.0,2/6,19.47%,ENG;DAND5
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),-0.3175429463820927,-0.5014954583488634,0.9830508474576272,1.0,1.0,8/8,68.26%,EHD2;AKAP5;PLA2G4E;ACTN2;ZDHHC2;SORL1;EIPR1;EHD1
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),-0.3015194837240601,-0.5011171358171486,1.0,1.0,1.0,1/9,18.23%,MYL9
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),-0.29147856249980236,-0.5005371597482322,0.984375,1.0,1.0,1/11,11.15%,DCTN1
prerank,GO_Biological_Process_2021__pentose catabolic process (GO:0019323),-0.3310298996759721,-0.500068349216272,0.9803921568627451,1.0,1.0,2/5,21.68%,DHDH;RPEL1
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),-0.33783270123652526,-0.49840084206876206,0.9464285714285714,1.0,1.0,2/5,18.22%,AGT;NTRK3
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),0.2851925173145895,0.49836776709673325,0.9761904761904762,1.0,1.0,1/9,12.32%,ATPSCKMT
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),-0.30924517131677187,-0.49763145604813913,0.9473684210526315,1.0,1.0,1/5,20.22%,VAMP7
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),-0.2929359710251812,-0.4972861982395037,0.967741935483871,1.0,1.0,2/8,27.86%,GRM6;RAMP3
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),0.27841811136255334,0.49708083767108935,1.0,1.0,1.0,1/7,7.74%,SP1
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell chemotaxis (GO:2000510),-0.3322315748091288,-0.4961997558472737,0.9583333333333334,1.0,1.0,1/5,14.26%,IL12A
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),0.2971420829696726,0.4954936308341785,1.0,1.0,1.0,3/7,32.10%,ADAM10;GALNT11;NCSTN
prerank,GO_Biological_Process_2021__regulation of sequestering of zinc ion (GO:0061088),-0.3253051954197028,-0.49454316025288675,0.9807692307692307,1.0,1.0,5/5,67.48%,SLC30A2;SLC30A4;AP3D1;SLC30A3;SLC30A8
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.23574968709402058,-0.4943407913650093,1.0,1.0,1.0,4/30,16.07%,TMEM17;IFT27;GLI3;HIPK1
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),0.30666469074753727,0.493904901689706,0.9607843137254902,1.0,1.0,1/5,22.51%,NEMF
prerank,GO_Biological_Process_2021__regulation of transmission of nerve impulse (GO:0051969),-0.2964284639970377,-0.4938839917123413,0.9583333333333334,1.0,1.0,1/6,13.18%,CARTPT
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),-0.28700186217109636,-0.493249481259793,0.9833333333333333,1.0,1.0,1/10,14.16%,HEY2
prerank,GO_Biological_Process_2021__positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.30671646694518395,-0.4926002666111222,1.0,1.0,1.0,2/7,15.16%,CD80;IL18
prerank,GO_Biological_Process_2021__regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.30671646694518395,-0.4926002666111222,1.0,1.0,1.0,2/7,15.16%,CD80;IL18
prerank,GO_Biological_Process_2021__DNA deamination (GO:0045006),0.2956593118435564,0.4923579622642403,0.9487179487179487,1.0,1.0,2/7,28.20%,EXOSC5;CDADC1
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),-0.24961116663545896,-0.4921919655983925,1.0,1.0,1.0,4/17,28.20%,SCIN;SOX9;BMP1;PTHLH
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),0.23258924823059307,0.4921846052358338,1.0,1.0,1.0,5/19,29.79%,AKAP9;TPPP;CCDC57;NDE1;CLASP2
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.285034414048914,-0.4918337857786907,1.0,1.0,1.0,4/9,22.87%,EPAS1;RPL5;RPL11;COPS9
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.2197422369138149,-0.48989268267885827,1.0,1.0,1.0,13/53,26.27%,CEACAM1;PPT1;HSPA8;SIAH1;ELANE;CLN8;LAMP2;TPP1;DDB1;FBXO2;DENND3;CELA2A;PRPF19
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),-0.2853795339681515,-0.48880432035756866,1.0,1.0,1.0,1/8,13.42%,CD300LF
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),-0.2784967245097217,-0.4883885649919731,0.984375,1.0,1.0,1/10,20.84%,AGER
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.2969289736431173,0.48808514859626084,0.9787234042553191,1.0,1.0,6/6,70.32%,WNK1;MAPK7;MBP;MAP2K5;APOA1;MYADM
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.2969289736431173,0.48808514859626084,0.9787234042553191,1.0,1.0,6/6,70.32%,WNK1;MAPK7;MBP;MAP2K5;APOA1;MYADM
prerank,GO_Biological_Process_2021__regulation of dendritic cell chemotaxis (GO:2000508),-0.3224166720915891,-0.48796162467161924,0.9791666666666666,1.0,1.0,1/6,14.26%,IL12A
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta activation (GO:1901388),0.30666282445854176,0.48750885973679026,0.9574468085106383,1.0,1.0,1/5,7.55%,LTBP1
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),-0.2898232657114672,-0.4868365845476066,0.9833333333333333,1.0,1.0,1/9,13.35%,GNL3
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),-0.29751088396744274,-0.48615326599910047,1.0,1.0,1.0,7/7,70.26%,INHBA;SHANK3;LHX6;ERBB4;RAPGEF2;SALL1;ZSWIM6
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),0.30559353033915343,0.48600645039966334,0.9777777777777777,1.0,1.0,2/6,21.57%,ACE;DMD
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),0.22567344949835494,0.4851389633210451,1.0,1.0,1.0,3/18,15.09%,CYB5R4;RIMS2;CDK16
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),0.2539409613894283,0.48508332290062806,0.95,1.0,1.0,3/10,16.57%,OSR1;AMH;EPHB2
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),0.29604247541926537,0.4846780194924865,1.0,1.0,1.0,3/8,30.95%,SNAP91;DNM2;DNM3
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.2399802570482055,0.48269455689720947,1.0,1.0,1.0,9/26,31.96%,RNF168;ZMYND11;BRD4;TCERG1;CDK13;LEO1;CDC73;HNRNPU;EAPP
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.24391245902026729,-0.482377486380142,1.0,1.0,1.0,1/17,9.60%,PLG
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.20454294909700835,-0.4820623227355597,1.0,1.0,1.0,17/98,26.27%,RPA3;UVSSA;COPS5;RBX1;POLD4;COPS4;RPS27A;OGG1;RPA2;FANCC;XRCC1;POLR2B;DDB1;COPS7A;CDK7;BRCA2;PRPF19
prerank,GO_Biological_Process_2021__ammonium transmembrane transport (GO:0072488),-0.2905962044583615,-0.48020703263899633,0.9830508474576272,1.0,1.0,4/7,30.17%,RHBG;SLC12A7;RHCE;RHD
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.27798158414643487,-0.47982190345440456,1.0,1.0,1.0,5/12,29.23%,GNL3;CCT6A;CCT8;CCT7;CCT2
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),-0.2834319359792229,-0.47941612292042907,1.0,1.0,1.0,4/10,29.23%,CCT6A;CCT8;CCT7;CCT2
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),-0.226037406531026,-0.47792368648871125,1.0,1.0,1.0,4/40,17.06%,CYP1B1;ANXA1;ZNF580;ECT2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),-0.2879242956958175,-0.47680412345160256,0.9791666666666666,1.0,1.0,1/8,8.12%,KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),-0.296223378906444,-0.47508126966039943,0.9375,1.0,1.0,1/5,14.99%,DDX3X
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),-0.28904451749291715,-0.4711228786949213,0.9791666666666666,1.0,1.0,2/7,22.81%,WARS1;XRCC1
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.2334894693052912,-0.4710366330268434,1.0,1.0,1.0,1/32,9.16%,SNAP23
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),-0.26662282399332826,-0.47049618382194625,0.9833333333333333,1.0,1.0,1/7,13.80%,LEF1
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),0.17442326643317402,0.4704466658117762,1.0,1.0,1.0,16/79,28.79%,MRPL4;MRPL41;MRRF;MTRF1;DAP3;MRPL2;AURKAIP1;MRPS7;MRPL55;MRPL43;MRPL58;ERAL1;MRPL3;MRPL1;MRPS16;MRPS18A
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.2685648960454491,-0.47024825721301544,1.0,1.0,1.0,3/11,29.10%,CD81;TMEM30A;SEC16A
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.22515555018358002,0.4699749991083873,1.0,1.0,1.0,4/14,27.28%,HSPA1A;CREB3L1;BCL2L1;TXNDC12
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),0.23649704142011851,0.4695340923249949,1.0,1.0,1.0,14/14,76.37%,ENTPD2;ENTPD7;AK4;ENTPD6;ENTPD4;CMPK1;AK1;AK7;AK5;ENTPD3;AK8;ENTPD1;CMPK2;ENTPD5
prerank,GO_Biological_Process_2021__mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337),0.29748272925144315,0.4689787086917475,1.0,1.0,1.0,5/5,70.26%,BMP4;SALL1;SMO;PAX8;PAX2
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),-0.2466594580906749,-0.4684402111227516,1.0,1.0,1.0,6/19,26.14%,CLU;TMEM35A;HSPA4;PFDN6;HSP90AB1;PSMG1
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),0.27497279136894887,0.46798457652750214,0.9574468085106383,1.0,1.0,6/6,72.51%,DLG1;PTPN22;DUSP1;EZR;DUSP10;CYLD
prerank,GO_Biological_Process_2021__negative regulation of organ growth (GO:0046621),-0.30905636236471323,-0.46703593163971135,0.9811320754716981,1.0,1.0,1/5,14.15%,SLC6A4
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),-0.20008990736996934,-0.46538094237338967,1.0,1.0,1.0,13/52,27.72%,OAS2;IFIT1;OAS1;DDX3X;MX1;PARP10;ISG15;SRPK1;DDB1;PPID;CCL5;ISG20;APOBEC3G
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),0.24971601666035614,0.4652295019666236,1.0,1.0,1.0,11/11,75.04%,MTHFR;MYOCD;SETD5;UBE2N;NNMT;AKAP8L;HPF1;PARG;CDK9;PARK7;AKAP8
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.2479438461062743,-0.46307191039401396,0.9841269841269841,1.0,1.0,2/11,20.19%,NUCKS1;IFI27
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.17240262192533176,0.46289358480455695,1.0,1.0,1.0,17/80,25.95%,GBF1;STX18;TMED3;KIF4B;COG7;SEC22B;SCYL1;KIF3B;COG4;TMEM115;PLPP3;COG3;BNIP1;TAPBP;PITPNB;DNAJC28;COPB1
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),-0.2608685396476808,-0.46167606200492967,1.0,1.0,1.0,5/20,24.47%,SOX10;EIF2B2;MYRF;SOX9;ZNF488
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),-0.23232762847474941,-0.4614064523176787,1.0,1.0,1.0,2/19,15.69%,THBS1;EIF2B2
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.24708835509111088,-0.4610541713633223,1.0,1.0,1.0,5/17,35.87%,MSN;ATRAID;VPS35;AMER1;EZR
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),0.2946437020914166,0.4609203031475449,1.0,1.0,1.0,5/5,70.54%,ALKBH3;FTO;ALKBH2;ALKBH1;TDG
prerank,GO_Biological_Process_2021__contact inhibition (GO:0060242),-0.27856171808762736,-0.4607396632424289,1.0,1.0,1.0,1/6,16.08%,YAP1
prerank,GO_Biological_Process_2021__ammonium transport (GO:0015696),0.2825356149515518,0.4582470451267185,1.0,1.0,1.0,1/6,10.28%,RHCG
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.2464145406352063,0.4564041289214268,1.0,1.0,1.0,12/12,75.37%,RAPGEF3;EHD1;MAPK14;ADGRB1;IL4;CAMK1;RIPOR2;CD53;ADAM9;DCSTAMP;EHD2;FLOT1
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),0.2667121444319652,0.4561756341539296,0.9782608695652174,1.0,1.0,1/7,16.35%,LIG4
prerank,GO_Biological_Process_2021__aldehyde biosynthetic process (GO:0046184),0.2718127508973971,0.45561018786266005,1.0,1.0,1.0,1/5,22.46%,PNPO
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.23483708421855848,-0.45529553385714094,1.0,1.0,1.0,1/19,8.63%,BRCA1
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),-0.264053973114005,-0.4549142129509796,0.9807692307692307,1.0,1.0,2/8,18.95%,PTPRC;AXL
prerank,GO_Biological_Process_2021__cellular hyperosmotic response (GO:0071474),0.29147345509605377,0.4541780177941546,1.0,1.0,1.0,5/5,70.86%,AQP1;YBX3;ARHGEF2;AKR1B1;RCSD1
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),-0.2965989250212912,-0.4540142595911821,0.9833333333333333,1.0,1.0,2/6,23.60%,SPATA18;BNIP3
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.24137793706818778,-0.4528758093799091,0.984375,1.0,1.0,2/16,19.71%,THBS1;LRIT3
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),0.2813806492968593,0.4525757924693239,0.9795918367346939,1.0,1.0,2/7,21.25%,SNAI2;CASK
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),0.2721709042550493,0.44934155839031753,0.9772727272727273,1.0,1.0,2/8,21.39%,PIP4K2A;RUBCN
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),-0.2537529875094921,-0.44829678087687486,1.0,1.0,1.0,1/11,8.12%,KCNQ1
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.18884760084962476,0.44822186266196706,1.0,1.0,1.0,8/28,29.10%,MAP3K10;ZNF675;DUSP19;TRAF6;AIDA;EDN1;TAOK3;DVL2
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),-0.26671284056660477,-0.44746650662716475,1.0,1.0,1.0,3/9,27.00%,ANGPTL3;TKFC;TPI1
prerank,GO_Biological_Process_2021__positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),-0.30265094763999656,-0.4465132306036453,1.0,1.0,1.0,1/5,18.76%,GPS2
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),-0.23323172933942105,-0.4453712547750159,1.0,1.0,1.0,6/18,34.61%,RPS27A;MAN1B1;UBB;UBC;SEL1L;TRIM13
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),0.24176802768799727,0.44191058032753794,0.9811320754716981,1.0,1.0,3/11,26.78%,INPP1;PTEN;SYNJ2
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),0.24176802768799727,0.44191058032753794,0.9811320754716981,1.0,1.0,3/11,26.78%,INPP1;PTEN;SYNJ2
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.23343299886466817,0.4414201312539154,0.9705882352941176,1.0,1.0,6/11,25.69%,NOTCH1;ACVR1;MDM4;BMP4;BMPR1A;BMP2
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),-0.2605881934489433,-0.44140287869476275,0.9538461538461539,1.0,1.0,1/7,20.22%,VAMP7
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),-0.2313083727532318,-0.44106320777762575,1.0,1.0,1.0,3/15,19.91%,ITGB6;SMAD3;FN1
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),-0.27821746217876575,-0.4404566848563741,1.0,1.0,1.0,1/6,18.38%,CAMK2A
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.25214296012159104,-0.43936152114972443,1.0,1.0,1.0,5/12,29.37%,PARP4;PARP10;PARP15;PARP14;PARP9
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),0.23605468258632226,0.439124409289656,1.0,1.0,1.0,2/8,19.39%,ZC3H14;RNF40
prerank,GO_Biological_Process_2021__regulation of urine volume (GO:0035809),-0.2643676333867855,-0.4386651105870438,1.0,1.0,1.0,2/6,30.72%,NPR3;TRPV5
prerank,GO_Biological_Process_2021__glyoxylate metabolic process (GO:0046487),0.2834295602075349,0.437925272237741,1.0,1.0,1.0,2/6,22.00%,AGXT2;ALDH4A1
prerank,GO_Biological_Process_2021__glycerol ether metabolic process (GO:0006662),-0.2894861360840352,-0.4368466192187337,1.0,1.0,1.0,5/5,71.06%,LIPE;PLAAT3;AGMO;TMEM86B;NCEH1
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),0.27199669461255244,0.43629550750412044,0.9444444444444444,1.0,1.0,1/7,17.42%,LGALS3
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),0.23655317815987661,0.4328817286062548,1.0,1.0,1.0,2/9,19.39%,UBE2E1;RNF40
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),-0.26140450501608936,-0.42672152722308176,1.0,1.0,1.0,7/7,73.87%,FLOT1;ADAM19;PTPRU;SERPINF2;TJP1;DENND6A;AFDN
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),-0.2727487815265225,-0.4260526638161871,0.9661016949152542,1.0,1.0,6/6,72.74%,VPS18;VPS4A;NDP;VPS11;ATP13A2;ULK3
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),0.2420499716070414,0.4240873534446644,1.0,1.0,1.0,7/7,75.80%,ADCY6;TGFBR3;GNG2;GNB1;PTGER2;TNFSF4;SFRP1
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),0.24547359324294543,0.42396291260097774,0.9787234042553191,1.0,1.0,1/7,15.41%,PLA2G15
prerank,GO_Biological_Process_2021__cytidine to uridine editing (GO:0016554),0.2771968012113757,0.42372246838954714,1.0,1.0,1.0,6/6,72.29%,APOBEC1;APOBEC3A;APOBEC2;APOBEC3H;A1CF;APOBEC3G
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),-0.2401232260533387,-0.42296299814455135,1.0,1.0,1.0,2/11,24.17%,ZFP36L1;PAF1
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),-0.2839615776939226,-0.42021797016770496,1.0,1.0,1.0,1/5,17.78%,BEX4
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),0.2360039752023092,0.4156930660146071,1.0,1.0,1.0,8/8,76.41%,RNF122;HEBP2;MAPT;PIP5KL1;BAX;PRELID1;ARL6IP5;BNIP3
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),-0.22342137650288743,-0.415126964183209,1.0,1.0,1.0,13/13,77.68%,NUP93;NDC1;NUP133;RTN4;NUP35;NUP107;AHCTF1;NUP205;NUP54;NUP98;NUP153;SEH1L;TPR
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",0.19478521062758444,0.41418946259006884,1.0,1.0,1.0,7/24,34.38%,ZMYND11;THOC1;HMGN1;SCAF8;CCNT1;ALYREF;SETD5
prerank,GO_Biological_Process_2021__regulation of glomerular mesangial cell proliferation (GO:0072124),0.2546607362543768,0.41359901735400073,1.0,1.0,1.0,5/5,74.54%,BMP4;PDGFB;BMP7;PDGFA;IL6R
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",0.2567078342757301,0.41321945371505275,0.975609756097561,1.0,1.0,1/5,18.66%,ADAM10
prerank,GO_Biological_Process_2021__mesenchymal to epithelial transition (GO:0060231),-0.2552424643330187,-0.41177834383682554,1.0,1.0,1.0,3/6,31.28%,BASP1;PAX2;PAX8
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),0.21962463190517195,0.41045310031903937,1.0,1.0,1.0,2/9,19.39%,ZC3H14;RNF40
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.2314311972266659,-0.4087829946280228,1.0,1.0,1.0,4/12,28.29%,TXN;PARK7;PDE8A;RACK1
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),0.27145831361786676,0.40855266063873347,0.9795918367346939,1.0,1.0,5/5,72.86%,TPRKB;TRIT1;TP53RK;OSGEP;LAGE3
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.2125281696953309,0.40654208357095345,1.0,1.0,1.0,1/24,4.60%,TENT4A
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),-0.2721916175250665,-0.40316606192954396,0.9803921568627451,1.0,1.0,2/5,21.48%,GPS2;PARP10
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),-0.2347765244844468,-0.40103275153992224,0.9848484848484849,1.0,1.0,4/9,36.97%,HSPA5;MBTPS2;MBTPS1;HSP90B1
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by hormone (GO:0001990),0.23195919974899867,0.3999378247575904,1.0,1.0,1.0,3/8,30.60%,ACE;EDN1;EDN3
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),-0.20292880783534006,-0.3950433739204972,1.0,1.0,1.0,2/18,17.09%,COX17;COX20
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),-0.24410720848454742,-0.39453894574974335,1.0,1.0,1.0,2/9,20.24%,NOX1;PKD1L3
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),0.25588977797192847,0.393767052786384,1.0,1.0,1.0,1/6,13.40%,EIF3E
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),-0.25769813428938704,-0.3909578845808496,0.9821428571428571,1.0,1.0,1/5,17.91%,MCCC2
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),-0.21828370562095878,-0.39077314242966354,1.0,1.0,1.0,1/18,8.63%,BRCA1
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),-0.22928232066812612,-0.3892436014967883,1.0,1.0,1.0,3/9,30.60%,NUP93;NDC1;RTN4
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.24771773680383946,0.38785597046544246,1.0,1.0,1.0,3/6,29.41%,PDZD8;VMP1;PACS2
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),0.14713353636295134,0.38575593895964894,1.0,1.0,1.0,18/93,28.79%,MRPL4;EEFSEC;MRPL41;EEF2K;DAP3;MRPL2;AURKAIP1;EEF1D;MRPS7;NEMF;MRPL55;MRPL43;MRPL58;ERAL1;MRPL3;MRPL1;MRPS16;MRPS18A
prerank,GO_Biological_Process_2021__alditol metabolic process (GO:0019400),-0.2620294032691535,-0.3846032341003362,1.0,1.0,1.0,1/5,16.59%,ANGPTL3
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),0.2062160712518659,0.3769029797500996,1.0,1.0,1.0,1/12,9.52%,INPP1
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),0.22135995835896471,0.37216732663865787,1.0,1.0,1.0,6/6,77.87%,EXOSC5;EXOSC10;PARN;EXOSC4;EXOSC6;EXOSC2
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),0.22807930724459372,0.3708302609798176,1.0,0.9998577943737327,1.0,6/6,77.20%,NIPBL;RAD21L1;REC8;RAD21;FANCB;XRCC1
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),-0.15397660154847986,-0.36735301265891407,1.0,1.0,1.0,13/79,28.69%,MRPL19;MRPL40;MRPS34;MRPL20;MRPL34;MRPS22;MRPS25;MRPS26;MRPS2;GADD45GIP1;MRPL50;MRPL21;GFM2
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.21965866475086995,-0.366667489698208,0.9818181818181818,0.9999910014213739,1.0,2/8,22.92%,ALG10B;LRRC38
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),-0.19662974533749883,-0.36415797053803084,1.0,0.9996385498952899,1.0,13/13,80.35%,NUDT15;ENTPD5;ENTPD1;ENTPD3;ENPP3;ENTPD4;ENTPD6;DCTPP1;ENTPD7;ITPA;ENPP1;SMPDL3A;ENTPD2
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),0.18650887573964503,0.36231264202377017,1.0,0.9997373084142503,1.0,14/14,81.36%,ANAPC7;TPR;PLK1;HECW2;CDC16;CENPE;RIOK2;CDC23;CDC27;NEK6;ANAPC1;TACC3;PTTG1;CDC6
